Clustering O 0 0.0006002396694384515
of O 0 4.522890958469361e-05
missense O 0 0.0008686917717568576
mutations O 0 0.0002803713141474873
in O 0 2.5097140678553842e-05
the O 0 0.0002161582960980013
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.999445378780365
telangiectasia I-Disease 1 0.9999774694442749
gene O 0 3.735225982381962e-05
in O 0 6.6386328398948535e-06
a O 0 3.727305374923162e-05
sporadic B-Disease 0 0.008543998934328556
T I-Disease 1 0.9860140085220337
- I-Disease 0 0.3958022892475128
cell I-Disease 0 0.49189701676368713
leukaemia I-Disease 1 0.9979467988014221
. O 0 0.0001497200137237087

Ataxia B-Disease 1 0.9999996423721313
- I-Disease 1 0.999991774559021
telangiectasia I-Disease 1 0.9999996423721313
( O 0 0.04214836657047272
A B-Disease 1 0.9999822378158569
- I-Disease 1 0.9999988079071045
T I-Disease 1 0.9999997615814209
) O 0 3.872693469020305e-06
is O 0 1.1628642369032605e-06
a O 0 6.0113320614618715e-06
recessive B-Disease 0 0.0030974685214459896
multi I-Disease 1 0.6335005760192871
- I-Disease 1 0.9991247057914734
system I-Disease 1 0.5396549701690674
disorder I-Disease 1 0.9914326667785645
caused O 0 0.0004795631975866854
by O 0 3.182944738000515e-06
mutations O 0 1.1993372027063742e-05
in O 0 1.0875451152969617e-06
the O 0 1.4979159459471703e-06
ATM O 0 0.0003377945104148239
gene O 0 7.183158231782727e-06
at O 0 1.7136882888735272e-05
11q22 O 0 0.00015447985788341612
- O 0 0.00017509993631392717
q23 O 0 0.00016933919687289745
( O 0 4.295935923437355e-06
ref O 0 0.008724835701286793
. O 0 3.2377497518609744e-06
3 O 0 1.747080750647001e-05
) O 0 8.590963261667639e-06
. O 0 2.435568967484869e-05

The O 0 0.00019782379968091846
risk O 0 0.000561338325496763
of O 0 2.6969197278958745e-05
cancer B-Disease 0 0.46161866188049316
, O 0 8.463841368211433e-06
especially O 0 1.1773982805607375e-05
lymphoid B-Disease 0 0.0057605658657848835
neoplasias I-Disease 0 0.0669252946972847
, O 0 6.2452827478409745e-06
is O 0 3.248264874855522e-06
substantially O 0 2.8806251066271216e-05
elevated O 0 0.00012535387941170484
in O 0 2.4206197849707678e-05
A B-Disease 1 0.9999641180038452
- I-Disease 1 0.9999996423721313
T I-Disease 1 1.0
patients O 0 0.015319944359362125
and O 0 8.954712939157616e-06
has O 0 1.0451865819049999e-05
long O 0 3.961856054957025e-05
been O 0 2.0420708096935414e-05
associated O 0 1.7949112589121796e-05
with O 0 8.68827264639549e-05
chromosomal O 1 0.9999985694885254
instability O 1 0.9991670846939087
. O 0 0.00029611034551635385

By O 0 0.00024406379088759422
analysing O 0 0.003945650067180395
tumour B-Disease 1 0.9999783039093018
DNA O 0 0.0003427607298363
from O 0 3.249460496590473e-05
patients O 0 0.0001333337859250605
with O 0 1.0682399988581892e-05
sporadic B-Disease 0 0.009027319960296154
T I-Disease 1 0.9910585284233093
- I-Disease 0 0.056447528302669525
cell I-Disease 0 0.06488670408725739
prolymphocytic I-Disease 1 0.7795619368553162
leukaemia I-Disease 1 0.9995177984237671
( O 0 7.644775905646384e-05
T B-Disease 1 0.8438160419464111
- I-Disease 0 0.03346560150384903
PLL I-Disease 0 0.023407133296132088
) O 0 3.6263654692447744e-06
, O 0 1.2600254422068247e-06
a O 0 3.21711513606715e-06
rare O 0 8.912216799217276e-06
clonal B-Disease 0 0.00027601391775533557
malignancy I-Disease 0 0.03221859410405159
with O 0 3.2101797842187807e-06
similarities O 0 5.527416760742199e-06
to O 0 2.7701112230715808e-06
a O 0 5.46104165550787e-05
mature B-Disease 0 0.0001271069049835205
T I-Disease 0 0.2774064540863037
- I-Disease 0 0.002730252454057336
cell I-Disease 0 0.01656441204249859
leukaemia I-Disease 1 0.9461309313774109
seen O 0 4.7824185458011925e-05
in O 0 1.5299036022042856e-05
A B-Disease 1 0.9988420605659485
- I-Disease 1 0.9999548196792603
T I-Disease 1 0.999998927116394
, O 0 3.212142701158882e-06
we O 0 1.135475940827746e-06
demonstrate O 0 1.291102307732217e-06
a O 0 8.543579497199971e-07
high O 0 2.284138872710173e-06
frequency O 0 2.900475010392256e-06
of O 0 1.1198587799299276e-06
ATM O 0 0.027616411447525024
mutations O 0 0.00011899317178176716
in O 0 5.809415233670734e-05
T B-Disease 1 0.9880158305168152
- I-Disease 0 0.13393834233283997
PLL I-Disease 0 0.02610328607261181
. O 0 0.00012273249740246683

In O 0 0.00010745197505457327
marked O 0 5.681719267158769e-05
contrast O 0 1.3255271369416732e-05
to O 0 2.8017620934406295e-06
the O 0 4.828574219573056e-06
ATM O 0 0.0044035883620381355
mutation O 0 2.5940773412003182e-05
pattern O 0 1.280698870687047e-05
in O 0 1.6169222362805158e-05
A B-Disease 1 0.9996823072433472
- I-Disease 1 0.9999632835388184
T I-Disease 1 0.9999979734420776
, O 0 1.4690265288663795e-06
the O 0 3.941708826005197e-07
most O 0 4.460436571207538e-07
frequent O 0 3.05770845443476e-06
nucleotide O 0 1.0020742593042087e-05
changes O 0 1.7141881016868865e-06
in O 0 2.0224683794367593e-06
this O 0 4.727434316009749e-06
leukaemia B-Disease 1 0.9552692174911499
were O 0 0.00010712765651987866
missense O 0 0.0008193470421247184
mutations O 0 0.00035069527802988887
. O 0 9.177579340757802e-05

These O 0 4.9690788728185e-05
clustered O 0 0.00015060401347000152
in O 0 7.761413144180551e-06
the O 0 2.986737399623962e-06
region O 0 4.23019355366705e-06
corresponding O 0 1.96040468836145e-06
to O 0 6.245451800168667e-07
the O 0 1.180782533083402e-06
kinase O 0 2.2875658032717183e-05
domain O 0 3.149107442368404e-06
, O 0 6.760353130630392e-07
which O 0 3.000424726451456e-07
is O 0 1.7935143148406496e-07
highly O 0 7.451239412148425e-07
conserved O 0 1.170327209365496e-06
in O 0 8.162959943547321e-07
ATM O 0 0.0006352054770104587
- O 0 6.413267692551017e-05
related O 0 1.262924797629239e-06
proteins O 0 1.3615576790471096e-06
in O 0 1.2370765034575015e-06
mouse O 0 1.541549681860488e-05
, O 0 1.9495500964694656e-06
yeast O 0 1.4098839528742246e-05
and O 0 7.983110663190018e-06
Drosophila O 0 0.0001246297179022804
. O 0 4.885014277533628e-05

The O 0 0.0001083534152712673
resulting O 0 0.0001266185281565413
amino O 0 4.243270086590201e-05
- O 0 0.0001343688927590847
acid O 0 1.1732824532373343e-05
substitutions O 0 4.497955615079263e-06
are O 0 8.575660217502445e-07
predicted O 0 6.771304015273927e-06
to O 0 8.973229341791011e-07
interfere O 0 3.435388862271793e-06
with O 0 2.7289545414532768e-06
ATP O 0 0.004005060996860266
binding O 0 2.1025000023655593e-05
or O 0 1.0418012607260607e-05
substrate O 0 0.00010546073463046923
recognition O 0 0.00010609297169139609
. O 0 0.00010982523963321

Two O 0 4.998231088393368e-05
of O 0 1.828309723350685e-05
seventeen O 0 0.00010352938988944516
mutated O 0 0.0002825742703862488
T B-Disease 0 0.016076218336820602
- I-Disease 0 0.00022566408733837306
PLL I-Disease 0 0.00033171914401464164
samples O 0 2.021697764575947e-05
had O 0 3.331253174110316e-05
a O 0 1.189228078146698e-05
previously O 0 0.00010220001422567293
reported O 0 0.00023560035333503038
A B-Disease 1 0.977029025554657
- I-Disease 1 0.9985253214836121
T I-Disease 1 0.9999700784683228
allele O 0 0.0005094849038869143
. O 0 7.817280129529536e-05

In O 0 0.0001464102097088471
contrast O 0 8.629902004031464e-05
, O 0 1.1615581570367794e-05
no O 0 1.051912477123551e-05
mutations O 0 1.4565131095878314e-05
were O 0 6.884767117298907e-06
detected O 0 1.5101053577382118e-05
in O 0 1.1777088957387605e-06
the O 0 1.2295325859668083e-06
p53 O 0 1.300040639762301e-05
gene O 0 4.84470456285635e-06
, O 0 1.5269355344571522e-06
suggesting O 0 3.946597644244321e-06
that O 0 9.275408388020878e-07
this O 0 3.635635493992595e-06
tumour B-Disease 1 0.9999834299087524
suppressor O 0 0.00015191809507086873
is O 0 1.0006484671976068e-06
not O 0 1.265685909856984e-06
frequently O 0 3.301853894299711e-06
altered O 0 9.296821190218907e-06
in O 0 4.172497938270681e-06
this O 0 2.3390763089992106e-05
leukaemia B-Disease 1 0.992742657661438
. O 0 7.357660069828853e-05

Occasional O 0 0.0012777707306668162
missense O 0 0.001698128879070282
mutations O 0 0.0002356947079533711
in O 0 2.0471499738050625e-05
ATM O 0 0.005623317323625088
were O 0 3.06777328660246e-05
also O 0 6.949188446014887e-06
found O 0 1.1293815077806357e-05
in O 0 2.8670207029790618e-05
tumour B-Disease 1 0.9999982118606567
DNA O 0 0.00018285763508174568
from O 0 1.5283911125152372e-05
patients O 0 9.284832049161196e-05
with O 0 1.1746045856853016e-05
B B-Disease 0 0.010799079202115536
- I-Disease 0 0.0028440586756914854
cell I-Disease 0 0.0004731195222120732
non I-Disease 0 9.810519986785948e-05
- I-Disease 1 0.9830061793327332
Hodgkins I-Disease 1 0.9999995231628418
lymphomas I-Disease 1 0.9986371397972107
( O 0 1.0335686965845525e-05
B B-Disease 0 0.00031651658355258405
- I-Disease 0 0.00013862780178897083
NHL I-Disease 0 4.255512249073945e-05
) O 0 1.190555508401303e-06
and O 0 1.1497560308271204e-06
a O 0 5.304378191794967e-06
B B-Disease 0 0.0002199519076384604
- I-Disease 0 0.0001194090727949515
NHL I-Disease 0 4.542385431705043e-05
cell O 0 0.0001107889402192086
line O 0 9.70916953519918e-05
. O 0 4.4408101530279964e-05

The O 0 4.4397180317901075e-05
evidence O 0 1.3913830116507597e-05
of O 0 1.746659108903259e-06
a O 0 4.610707037500106e-06
significant O 0 2.4885077891667606e-06
proportion O 0 4.052239546581404e-06
of O 0 1.8795523146764026e-06
loss O 0 0.0013135942863300443
- O 0 0.0002159926516469568
of O 0 1.3672557770405547e-06
- O 0 0.01098843477666378
function O 0 7.61560022510821e-06
mutations O 0 6.987739197938936e-06
and O 0 1.3056364878138993e-06
a O 0 4.6975715122243855e-06
complete O 0 1.753179276420269e-05
absence O 0 3.6695489598059794e-06
of O 0 3.289453331944969e-07
the O 0 1.1428589914430631e-06
normal O 0 1.995018692468875e-06
copy O 0 1.370813492940215e-06
of O 0 2.677400061656954e-07
ATM O 0 0.0003853586968034506
in O 0 1.2126471347073675e-06
the O 0 8.646226206110441e-07
majority O 0 1.797985760276788e-06
of O 0 1.92177913049818e-06
mutated O 0 0.006968020461499691
tumours B-Disease 1 0.9993810653686523
establishes O 0 3.513531919452362e-05
somatic O 0 4.2589592339936644e-05
inactivation O 0 0.00024234395823441446
of O 0 6.648869543823821e-07
this O 0 7.482528872060357e-07
gene O 0 2.640354068716988e-06
in O 0 8.54538086514367e-07
the O 0 1.7229466493517975e-06
pathogenesis O 0 1.8974737031385303e-05
of O 0 1.8372810473010759e-06
sporadic B-Disease 0 0.020630646497011185
T I-Disease 1 0.9934903383255005
- I-Disease 0 0.017718512564897537
PLL I-Disease 0 0.0031004457268863916
and O 0 8.193852409021929e-06
suggests O 0 6.563205715792719e-06
that O 0 2.0408806449268013e-06
ATM O 0 0.00023081987455952913
acts O 0 7.627135346410796e-06
as O 0 5.703641363652423e-06
a O 0 0.00021938282588962466
tumour B-Disease 1 0.9999932050704956
suppressor O 0 0.003338526701554656
. O 0 0.00010649648902472109

As O 0 6.15158278378658e-05
constitutional O 0 8.679031452629715e-05
DNA O 0 0.00014211481902748346
was O 0 7.452516729244962e-05
not O 0 2.4546068289055256e-06
available O 0 1.5340523304985254e-06
, O 0 1.948143108165823e-06
a O 0 8.534795597370248e-06
putative O 0 0.0005549213383346796
hereditary O 1 0.6295956373214722
predisposition O 0 0.026468316093087196
to O 0 9.809696348384023e-05
T B-Disease 1 0.9910032749176025
- I-Disease 0 0.022951651364564896
PLL I-Disease 0 0.00378900533542037
will O 0 2.672863729458186e-06
require O 0 4.236418590153335e-06
further O 0 4.355795226729242e-06
investigation O 0 1.8850307242246345e-05
. O 0 1.3262693755677901e-05
. O 0 5.8991390687879175e-05

Myotonic B-Disease 1 0.9999939203262329
dystrophy I-Disease 1 0.9999982118606567
protein O 0 0.027084656059741974
kinase O 0 0.0024417764507234097
is O 0 6.672545623587212e-06
involved O 0 4.5132828745408915e-06
in O 0 1.4526652876156732e-06
the O 0 9.103166007662367e-07
modulation O 0 4.0390173126070295e-06
of O 0 8.110952762763191e-07
the O 0 3.539142653607996e-06
Ca2 O 0 0.00018092920072376728
+ O 0 0.00010843641211977229
homeostasis O 0 0.0002542977163102478
in O 0 2.655063508427702e-05
skeletal O 0 0.1921265423297882
muscle O 0 0.26181867718696594
cells O 0 0.0007382641779258847
. O 0 7.805920176906511e-05

Myotonic B-Disease 1 0.9999994039535522
dystrophy I-Disease 1 1.0
( O 1 0.9547948837280273
DM B-Disease 1 0.9999998807907104
) O 0 9.463211608817801e-05
, O 0 5.455013706523459e-06
the O 0 2.6596464977046708e-06
most O 0 4.5783053792547435e-06
prevalent O 0 0.0002497448876965791
muscular B-Disease 1 0.9967560172080994
disorder I-Disease 1 0.9989687204360962
in O 0 0.0007420555339194834
adults O 0 0.04726085811853409
, O 0 2.8244199711480178e-05
is O 0 6.707214652124094e-06
caused O 0 6.293299520621076e-05
by O 0 3.2287150588672375e-06
( O 0 4.639399776351638e-06
CTG O 0 0.00015716972120571882
) O 0 1.6933593087742338e-06
n O 0 1.3386166756390594e-05
- O 0 1.6402307664975524e-05
repeat O 0 4.420825007400708e-06
expansion O 0 1.2792505685865763e-06
in O 0 5.959594204796304e-07
a O 0 1.5644162658645655e-06
gene O 0 3.178924998792354e-06
encoding O 0 3.610502062656451e-06
a O 0 4.473105946090072e-06
protein O 0 1.6451653209514916e-05
kinase O 0 7.223959983093664e-05
( O 0 4.957747933076462e-06
DM B-Disease 1 0.9987596273422241
protein O 0 2.1642345018335618e-05
kinase O 0 5.504389991983771e-05
; O 0 4.9106743063020986e-06
DMPK O 0 0.0002987845509778708
) O 0 7.902627316980215e-07
and O 0 5.187858960198355e-07
involves O 0 1.6110063825180987e-06
changes O 0 1.3911939049648936e-06
in O 0 2.1947967070445884e-06
cytoarchitecture O 0 0.00025389701477251947
and O 0 1.5210697711154353e-05
ion O 0 0.00044722098391503096
homeostasis O 0 0.00650483975186944
. O 0 0.00010875578300328925

To O 0 8.843428804539144e-05
obtain O 0 5.367845733417198e-05
clues O 0 3.352948260726407e-05
to O 0 3.4463650990801398e-06
the O 0 2.481712954249815e-06
normal O 0 7.294535407709191e-06
biological O 0 7.098110472725239e-06
role O 0 1.680833747741417e-06
of O 0 1.1384087201804505e-06
DMPK O 0 0.000818838132545352
in O 0 3.7886186419200385e-06
cellular O 0 0.00011296819138806313
ion O 0 7.481246575480327e-05
homeostasis O 0 0.0006897294661030173
, O 0 3.5503933304426027e-06
we O 0 1.5948503460094798e-06
have O 0 1.0769474556582281e-06
compared O 0 1.2710880810118397e-06
the O 0 1.284145923818869e-06
resting O 0 0.0001842103520175442
[ O 0 1.3704559933103155e-05
Ca2 O 0 2.8405353077687323e-05
+ O 0 1.8805651052389294e-05
] O 0 1.060037175193429e-05
i O 0 5.968483492324594e-06
, O 0 5.819436523779586e-07
the O 0 3.906762060523761e-07
amplitude O 0 1.7875530602395884e-06
and O 0 7.120540317373525e-07
shape O 0 3.6803155580855673e-06
of O 0 6.817027724537184e-07
depolarization O 0 3.712406396516599e-05
- O 0 0.009097094647586346
induced O 0 0.00029414918390102684
Ca2 O 0 4.814798739971593e-05
+ O 0 1.993630030483473e-05
transients O 0 2.4961755116237327e-05
, O 0 6.977610951253155e-07
and O 0 2.893532666803367e-07
the O 0 2.885670369323634e-07
content O 0 5.194205527914164e-07
of O 0 2.864983912331809e-07
ATP O 0 2.6212805096292868e-05
- O 0 1.204681393573992e-05
driven O 0 5.183312168810517e-06
ion O 0 6.153996764624026e-06
pumps O 0 1.0368632501922548e-05
in O 0 2.274040753036388e-06
cultured O 0 2.9834960514563136e-05
skeletal O 0 0.0004314905672799796
muscle O 0 0.00035252448287792504
cells O 0 5.2487835091596935e-06
of O 0 7.789158189552836e-07
wild O 0 3.899536295648431e-06
- O 0 6.096244396758266e-05
type O 0 1.4347174328577239e-05
and O 0 7.990460289875045e-06
DMPK O 0 0.006240614224225283
[ O 0 2.8169795768917538e-05
- O 0 0.00010259918053634465
/ O 0 4.0706145227886736e-05
- O 0 0.0002832661266438663
] O 0 7.99241170170717e-05
knockout O 0 0.00529091851785779
mice O 0 0.0011574708623811603
. O 0 5.8856530813500285e-05

In O 0 0.00023732644331175834
vitro O 0 0.0008241722825914621
- O 0 0.0008487962768413126
differentiated O 0 0.00029907948919571936
DMPK O 0 0.009740445762872696
[ O 0 5.795681136078201e-05
- O 0 0.0003021190350409597
/ O 0 7.461675704689696e-05
- O 0 0.00012905288895126432
] O 0 2.1261290385155007e-05
myotubes O 0 3.5346776712685823e-05
exhibit O 0 6.65031711832853e-06
a O 0 6.088162990636192e-06
higher O 0 1.381110996589996e-05
resting O 0 0.00035422772634774446
[ O 0 1.7972151908907108e-05
Ca2 O 0 2.9317323424038477e-05
+ O 0 1.4623390597989783e-05
] O 0 6.3829056671238504e-06
i O 0 3.2193647712119855e-06
than O 0 6.32196474725788e-07
do O 0 1.4797464018556639e-06
wild O 0 2.5406063741684193e-06
- O 0 3.0504121241392568e-05
type O 0 1.715827420412097e-05
myotubes O 0 0.00012895841791760176
because O 0 9.246263630302565e-07
of O 0 4.0076744767247874e-07
an O 0 2.185362518503098e-06
altered O 0 1.4246674254536629e-05
open O 0 2.7450203106127447e-06
probability O 0 1.8737251821221435e-06
of O 0 8.832057574181817e-07
voltage O 0 5.64237343496643e-05
- O 0 0.0019498196197673678
dependent O 0 3.530756657710299e-05
l O 0 0.00012773809430655092
- O 0 5.460749889607541e-05
type O 0 2.243995368189644e-05
Ca2 O 0 5.801011138828471e-05
+ O 0 2.149394276784733e-05
and O 0 6.212652806425467e-06
Na O 0 0.00017865262634586543
+ O 0 3.837089752778411e-05
channels O 0 3.5525918065104634e-05
. O 0 5.807199340779334e-05

The O 0 0.00013788347132503986
mutant O 0 0.0003864170575980097
myotubes O 0 0.0003914506232831627
exhibit O 0 3.4118427720386535e-05
smaller O 0 1.1954877663811203e-05
and O 0 4.278461801732192e-06
slower O 0 3.1651812605559826e-05
Ca2 O 0 4.753391840495169e-05
+ O 0 8.493678251397796e-06
responses O 0 3.4761953884299146e-06
upon O 0 1.9223732579121133e-06
triggering O 0 1.1930846085306257e-05
by O 0 1.5653237142032594e-06
acetylcholine O 0 4.385009378893301e-05
or O 0 3.1856018267717445e-06
high O 0 2.185326775361318e-05
external O 0 6.385549932019785e-05
K O 0 0.0005680426256731153
+ O 0 9.814844088396057e-05
. O 0 2.829596633091569e-05

In O 0 8.143712329911068e-05
addition O 0 1.85637272807071e-05
, O 0 5.632335160044022e-06
we O 0 2.0172478798485827e-06
observed O 0 1.6236324427154614e-06
that O 0 5.688094120159803e-07
these O 0 8.07296146376757e-07
Ca2 O 0 3.567033490980975e-05
+ O 0 3.109295721515082e-05
transients O 0 0.00013038294855505228
partially O 0 5.900984979234636e-05
result O 0 1.8194330095866462e-06
from O 0 4.912824920211278e-07
an O 0 4.986113708582707e-07
influx O 0 1.6753909903854947e-06
of O 0 8.279876624328608e-07
extracellular O 0 1.2745967978844419e-05
Ca2 O 0 2.8661024771281518e-05
+ O 0 4.451734639587812e-06
through O 0 1.3743135696131503e-06
the O 0 2.7430837690189946e-06
l O 0 0.00012420795974321663
- O 0 4.867139796260744e-05
type O 0 2.2585212718695402e-05
Ca2 O 0 0.00011752271529985592
+ O 0 8.157765114447102e-05
channel O 0 0.0001119104927056469
. O 0 5.6157161452574655e-05

Neither O 0 0.00015989864186849445
the O 0 1.0655214282451198e-05
content O 0 5.986937139823567e-06
nor O 0 4.048731625516666e-06
the O 0 8.83257939676696e-07
activity O 0 1.3646581464854535e-06
of O 0 1.175567945210787e-06
Na O 0 0.00010913246660493314
+ O 0 1.6067755495896563e-05
/ O 0 9.313273039879277e-06
K O 0 1.743252869346179e-05
+ O 0 1.440294181520585e-05
ATPase O 0 4.592685218085535e-05
and O 0 6.76233366903034e-06
sarcoplasmic O 0 0.0002863807894755155
reticulum O 0 0.0003965778450947255
Ca2 O 0 0.00015096388233359903
+ O 0 5.9787951613543555e-05
- O 0 8.445786079391837e-05
ATPase O 0 7.36865695216693e-05
are O 0 3.0363769383257022e-06
affected O 0 9.917003808368463e-06
by O 0 7.795053534209728e-06
DMPK O 0 0.0033008470200002193
absence O 0 0.00012032977247145027
. O 0 6.95275521138683e-05

In O 0 0.00010135778575204313
conclusion O 0 3.619542985688895e-05
, O 0 4.7789835662115365e-06
our O 0 3.384570845810231e-06
data O 0 3.499048716548714e-06
suggest O 0 2.8291028684179764e-06
that O 0 1.1659045640044496e-06
DMPK O 0 0.0014014976331964135
is O 0 7.573843276986736e-07
involved O 0 1.2218225720062037e-06
in O 0 7.222953399832477e-07
modulating O 0 1.202447856485378e-05
the O 0 8.423285748904163e-07
initial O 0 1.5543810150120407e-06
events O 0 8.895777909856406e-07
of O 0 6.760778319403471e-07
excitation O 0 3.0089722713455558e-05
- O 0 0.0035010604187846184
contraction O 0 0.00013265229063108563
coupling O 0 5.8226876717526466e-05
in O 0 2.6504792913328856e-05
skeletal O 0 0.27899181842803955
muscle O 0 0.05375507101416588
. O 0 2.036229125224054e-05
. O 0 3.7071415135869756e-05

Constitutional O 0 0.0020283579360693693
RB1 O 1 0.6860816478729248
- O 0 0.002303894143551588
gene O 0 0.00013038443285040557
mutations O 0 8.539005648344755e-05
in O 0 1.3130764273228124e-05
patients O 0 0.0003391662612557411
with O 0 2.2207392248674296e-05
isolated O 0 0.001632810803130269
unilateral B-Disease 0 0.0011004044208675623
retinoblastoma I-Disease 0 0.46407097578048706
. O 0 0.0001384555216645822

In O 0 0.00017276320431847125
most O 0 3.543294224073179e-05
patients O 0 0.002018581610172987
with O 0 2.1704972823499702e-05
isolated O 0 0.0007353040273301303
unilateral B-Disease 0 0.0016907484969124198
retinoblastoma I-Disease 1 0.6033300161361694
, O 0 0.00011530529445735738
tumor B-Disease 0 0.02575014904141426
development O 0 1.9620110833784565e-06
is O 0 5.547154273699562e-07
initiated O 0 1.5662703845009673e-06
by O 0 6.034371722307696e-07
somatic O 0 1.9513727238518186e-05
inactivation O 0 7.036913302727044e-05
of O 0 7.703413871240627e-07
both O 0 1.0878221701204893e-06
alleles O 0 5.2457712627074216e-06
of O 0 1.4895924778102199e-06
the O 0 2.8567752451635897e-05
RB1 O 0 0.06694337725639343
gene O 0 8.447333675576374e-05
. O 0 4.1196639358531684e-05

However O 0 9.612762369215488e-05
, O 0 6.909525382070569e-06
some O 0 1.2030817515551462e-06
of O 0 1.0351432138122618e-06
these O 0 1.8014321767623187e-06
patients O 0 6.591308920178562e-05
can O 0 4.235319920553593e-06
transmit O 0 0.0034127221442759037
retinoblastoma B-Disease 0 0.22775742411613464
predisposition O 0 0.0009807344758883119
to O 0 6.415597908926429e-06
their O 0 5.607925049844198e-05
offspring O 0 0.0007125867996364832
. O 0 4.768037251778878e-05

To O 0 6.389899499481544e-05
determine O 0 2.819344626914244e-05
the O 0 5.0751527851389255e-06
frequency O 0 9.697900168248452e-06
and O 0 3.0748619792575482e-06
nature O 0 2.914846845669672e-06
of O 0 1.5032181863716687e-06
constitutional O 0 5.2797429816564545e-05
RB1 O 0 0.1491585671901703
- O 0 0.0005308628315106034
gene O 0 1.8945427655125968e-05
mutations O 0 2.1004480004194193e-05
in O 0 9.051527740666643e-06
patients O 0 9.677741763880476e-05
with O 0 7.48376669434947e-06
isolated O 0 0.00017628481145948172
unilateral B-Disease 0 6.230379221960902e-05
retinoblastoma I-Disease 0 0.011500155553221703
, O 0 5.185773716220865e-06
we O 0 1.4562536989615182e-06
analyzed O 0 3.3638186778262025e-06
DNA O 0 4.201142019155668e-06
from O 0 1.966533318409347e-06
peripheral O 0 0.00011150573118356988
blood O 0 4.5574590330943465e-05
and O 0 4.754426299768966e-06
from O 0 2.4357175789191388e-05
tumor B-Disease 1 0.6978252530097961
tissue O 0 0.022839507088065147
. O 0 5.898643939872272e-05

The O 0 5.9402926126495004e-05
analysis O 0 2.933410542027559e-05
of O 0 1.4321255548566114e-05
tumors B-Disease 1 0.9999570846557617
from O 0 2.14763840631349e-05
54 O 0 0.00012479560973588377
( O 0 2.9346142582653556e-06
71 O 0 9.352095730719157e-06
% O 0 9.07476987777045e-07
) O 0 3.548778408912767e-07
of O 0 4.420494690293708e-07
76 O 0 2.3860075089032762e-05
informative O 0 1.706678631308023e-05
patients O 0 0.00028754299273714423
showed O 0 0.00022849229571875185
loss O 0 6.528446829179302e-05
of O 0 3.081596332776826e-06
constitutional O 0 9.953544213203713e-05
heterozygosity O 0 0.47694432735443115
( O 0 0.00012553020496852696
LOH O 1 0.9999805688858032
) O 0 1.3714064152736682e-05
at O 0 4.374951095087454e-05
intragenic O 0 0.0017764692893251777
loci O 0 0.0002477422822266817
. O 0 7.462700159521773e-05

Three O 0 9.584140934748575e-05
of O 0 2.8196940547786653e-05
13 O 0 0.00042912500794045627
uninformative O 1 0.6825637817382812
patients O 0 0.10009128600358963
had O 0 0.0002845279814209789
constitutional O 0 6.576522719115019e-05
deletions O 0 0.0005506161251105368
. O 0 0.00015702008386142552

For O 0 0.000130437285406515
39 O 0 0.0002092073846142739
randomly O 0 8.308897668030113e-05
selected O 0 5.006560240872204e-05
tumors B-Disease 1 0.9996108412742615
, O 0 1.91434064618079e-05
SSCP O 0 0.007186034228652716
, O 0 8.389170034206472e-06
hetero O 0 0.0001701517030596733
- O 0 4.923025699099526e-05
duplex O 0 0.00013975649198982865
analysis O 0 2.6917805371340364e-06
, O 0 8.480465112370439e-07
sequencing O 0 4.100404566997895e-06
, O 0 7.309503757824132e-07
and O 0 9.228416502082837e-07
Southern O 0 3.565574388630921e-06
blot O 0 7.237474346766248e-05
analysis O 0 2.0126381059526466e-06
were O 0 4.0576455830887426e-06
used O 0 3.3008841455739457e-06
to O 0 3.738029363375972e-06
identify O 0 6.14978198427707e-05
mutations O 0 0.0001551111345179379
. O 0 7.036155147943646e-05

Mutations O 0 0.0017264491179957986
were O 0 0.0001516830234322697
detected O 0 0.00018613255815580487
in O 0 8.617516868980601e-06
21 O 0 3.96921495848801e-05
( O 0 1.7405531025360688e-06
91 O 0 8.081596206466202e-06
% O 0 9.888349268294405e-07
) O 0 6.283477773649793e-07
of O 0 2.169272192986682e-06
23 O 0 0.09805368632078171
tumors B-Disease 1 0.9999955892562866
with O 0 0.004198205191642046
LOH O 1 0.9999946355819702
. O 0 0.00018436042591929436

In O 0 0.00017029290029313415
6 O 0 0.00014737948367837816
( O 0 8.0745157902129e-06
38 O 0 1.583055745868478e-05
% O 0 2.8541619485622505e-06
) O 0 1.0572985047474504e-06
of O 0 1.7785948784876382e-06
16 O 0 0.08860164880752563
tumors B-Disease 1 0.9999995231628418
without O 0 0.012601449154317379
LOH O 1 0.9999747276306152
, O 0 6.755069080099929e-06
one O 0 3.5228076740168035e-06
mutation O 0 1.1724044270522427e-05
was O 0 4.741339944303036e-05
detected O 0 2.8086855309084058e-05
, O 0 1.286216047446942e-06
and O 0 1.5539452533630538e-06
in O 0 4.1127873373625334e-06
9 O 0 7.358116999967024e-05
( O 0 5.846749786542205e-07
56 O 0 3.2053646918939194e-06
% O 0 4.5603115950143547e-07
) O 0 2.7181366135664575e-07
of O 0 4.43273307837444e-07
the O 0 0.00027847770252265036
tumors B-Disease 1 0.9999997615814209
without O 0 0.03426387533545494
LOH O 1 0.9999959468841553
, O 0 6.938533715583617e-06
both O 0 3.4356769447185798e-06
mutations O 0 5.123756272951141e-05
were O 0 2.193963337049354e-05
found O 0 2.8638374715228565e-05
. O 0 4.351446477812715e-05

Thus O 0 0.00020005350233986974
, O 0 1.1883913430210669e-05
a O 0 4.382616680231877e-06
total O 0 3.018660663656192e-06
of O 0 1.2397574664646527e-06
45 O 0 9.63013280852465e-06
mutations O 0 7.964129508764017e-06
were O 0 4.068727776029846e-06
identified O 0 1.1949326108151581e-05
in O 0 2.3471988242818043e-05
tumors B-Disease 1 0.9999464750289917
of O 0 8.587178854213562e-06
36 O 0 0.015603181906044483
patients O 0 0.012770069763064384
. O 0 6.887969357194379e-05

Thirty O 0 0.00047126514255069196
- O 0 0.00022976835316512734
nine O 0 1.1152164006489329e-05
of O 0 1.8408660480417893e-06
the O 0 3.5162561289325822e-06
mutations O 0 1.328016060142545e-05
- O 0 1.8924660253105685e-05
including O 0 1.7889514083435643e-06
34 O 0 1.918152702273801e-05
small O 0 8.156181138474494e-06
mutations O 0 2.0772369680344127e-05
, O 0 1.3340900295588654e-06
2 O 0 1.6925084764807252e-06
large O 0 1.9068147594225593e-06
structural O 0 4.6730649046367034e-05
alterations O 0 6.655658944509923e-05
, O 0 4.40361509390641e-06
and O 0 3.3539815831318265e-06
hypermethylation O 0 0.00033713431912474334
in O 0 1.9865508875227533e-05
3 O 0 0.01036373432725668
tumors O 1 0.9999935626983643
- O 0 0.019349347800016403
were O 0 1.1368171726644505e-05
not O 0 1.8671358930077986e-06
detected O 0 7.990499398147222e-06
in O 0 6.535871079904609e-07
the O 0 1.3269550436234567e-06
corresponding O 0 1.0667263268260285e-05
peripheral O 0 0.0013078083284199238
blood O 0 0.001269752625375986
DNA O 0 0.0002977452240884304
. O 0 8.274999709101394e-05

In O 0 0.00015344194252975285
6 O 0 0.00013335795665625483
( O 0 4.236886979924748e-06
17 O 0 1.3089655112707987e-05
% O 0 1.4899732150297496e-06
) O 0 3.0978566201156355e-07
of O 0 2.055225536423677e-07
the O 0 2.0077036424481776e-06
36 O 0 0.00019662233535200357
patients O 0 5.209360097069293e-05
, O 0 1.0401881809229963e-06
a O 0 5.170949407329317e-06
mutation O 0 2.155431138817221e-05
was O 0 2.8369187930366024e-05
detected O 0 1.3547650269174483e-05
in O 0 9.642102440921008e-07
constitutional O 0 3.2752591323514935e-06
DNA O 0 2.5114763047895394e-05
, O 0 1.5281270862033125e-06
and O 0 7.885462309786817e-07
1 O 0 6.290571263889433e-07
of O 0 1.8200580598204397e-07
these O 0 3.8479103636746004e-07
mutations O 0 3.6052722407475812e-06
is O 0 3.354620048412471e-07
known O 0 7.852981980249751e-07
to O 0 8.139762712744414e-07
be O 0 1.7860329535324126e-06
associated O 0 4.985066880180966e-06
with O 0 8.694617463333998e-06
reduced O 0 0.00017586760804988444
expressivity O 0 0.050869930535554886
. O 0 0.0001337815629085526

The O 0 4.278205233276822e-05
presence O 0 1.192981108033564e-05
of O 0 1.938999503181549e-06
a O 0 5.087286808702629e-06
constitutional O 0 1.5914507457637228e-05
mutation O 0 5.868851440027356e-05
was O 0 0.0001667276374064386
not O 0 1.4140739494905574e-06
associated O 0 1.0457752068759874e-06
with O 0 5.158775024938222e-07
an O 0 1.497071934863925e-06
early O 0 1.3699464034289122e-05
age O 0 4.6799410483799875e-05
at O 0 0.00013076717732474208
treatment O 0 0.00022881539189256728
. O 0 5.3662741265725344e-05

In O 0 0.00030219738255254924
1 O 0 9.687224519439042e-05
patient O 0 0.0002025930880336091
, O 0 9.35115895117633e-06
somatic O 0 0.00010971051960950717
mosaicism O 0 0.014140901155769825
was O 0 0.00010599973029457033
demonstrated O 0 8.96780602488434e-06
by O 0 9.181862878904212e-07
molecular O 0 4.534310392045882e-06
analysis O 0 1.3187284366722452e-06
of O 0 5.785934718005592e-07
DNA O 0 7.930297215352766e-06
and O 0 2.380675368840457e-06
RNA O 0 1.1668996194202919e-05
from O 0 8.35800983622903e-06
peripheral O 0 0.0007068850100040436
blood O 0 0.0014198599383234978
. O 0 5.826719643664546e-05

In O 0 0.0004055548633914441
2 O 0 0.0005188523791730404
patients O 0 0.0008662987384013832
without O 0 1.9293971490697004e-05
a O 0 1.4361945432028733e-05
detectable O 0 0.00016815624258015305
mutation O 0 1.5386151062557474e-05
in O 0 4.635874574887566e-06
peripheral O 0 0.0019386238418519497
blood O 0 0.0035800340119749308
, O 0 1.559207339596469e-05
mosaicism O 0 0.011177213862538338
was O 0 0.0004958196659572423
suggested O 0 7.2359262048848905e-06
because O 0 9.56446797317767e-07
1 O 0 8.120379675347067e-07
of O 0 4.447599906143296e-07
the O 0 1.9368540961295366e-05
patients O 0 0.0025617515202611685
showed O 0 0.03065391629934311
multifocal O 1 0.9959153532981873
tumors B-Disease 1 0.9999991655349731
and O 0 1.346210774499923e-05
the O 0 2.762963958957698e-06
other O 0 9.474528042119346e-07
later O 0 1.624086689844262e-05
developed O 0 5.447247895062901e-05
bilateral B-Disease 0 0.00016811264504212886
retinoblastoma I-Disease 0 0.2895287573337555
. O 0 0.00019632038311101496

In O 0 9.106408833758906e-05
conclusion O 0 2.529151606722735e-05
, O 0 5.268040695227683e-06
our O 0 4.677779998019105e-06
results O 0 5.62793275094009e-06
emphasize O 0 3.892818313033786e-06
that O 0 5.998361984893563e-07
the O 0 5.973894303679117e-07
manifestation O 0 5.071480700280517e-06
and O 0 1.7319380276603624e-06
transmissibility O 0 2.1579486201517284e-05
of O 0 1.3935800780018326e-06
retinoblastoma B-Disease 0 0.0011314491275697947
depend O 0 2.7351322842150694e-06
on O 0 1.0736014246504055e-06
the O 0 6.70480176268029e-07
nature O 0 6.538464276673039e-07
of O 0 2.0707621217752603e-07
the O 0 6.95451888077514e-07
first O 0 3.5849548112310003e-06
mutation O 0 4.06176877731923e-06
, O 0 3.326210276100028e-07
its O 0 2.2788378828408895e-07
time O 0 2.748011525000038e-07
in O 0 2.3166013818354259e-07
development O 0 4.0191071093431674e-07
, O 0 2.4867256342986366e-07
and O 0 1.9017210206584423e-07
the O 0 1.768398334434096e-07
number O 0 1.885497198372832e-07
and O 0 2.3709954177775217e-07
types O 0 2.976272241994593e-07
of O 0 3.803080801390024e-07
cells O 0 5.9968565437884536e-06
that O 0 4.7310558670687897e-07
are O 0 6.814050834691443e-07
affected O 0 8.096260899037588e-06
. O 0 4.033377990708686e-06
. O 0 2.6618072297424078e-05

Hereditary B-Disease 1 0.999996542930603
deficiency I-Disease 1 0.9999102354049683
of I-Disease 0 2.149400461348705e-05
the I-Disease 0 1.6450274415547028e-05
fifth I-Disease 0 5.132637306815013e-05
component I-Disease 0 4.318293576943688e-06
of I-Disease 0 1.0829115808519418e-06
complement I-Disease 0 1.3805499293084722e-05
in O 0 1.2434621567081194e-05
man O 0 0.0004881250497419387
. O 0 3.557439777068794e-05

I O 0 0.022387146949768066
. O 0 0.0018739589722827077

Clinical O 0 0.02476196363568306
, O 0 0.00011443917901488021
immunochemical O 0 0.004290211945772171
, O 0 1.2080511623935308e-05
and O 0 1.0597106665954925e-05
family O 0 5.5737807997502387e-05
studies O 0 2.8082302378606983e-05
. O 0 4.422511119628325e-05

The O 0 8.913428609957919e-05
first O 0 4.818022716790438e-05
recognized O 0 4.102876118849963e-05
human O 0 1.2624512237380259e-05
kindred O 0 0.011721290647983551
with O 0 0.014485141262412071
hereditary B-Disease 1 0.9999995231628418
deficiency I-Disease 1 0.9961846470832825
of I-Disease 0 2.0014790607092436e-06
the I-Disease 0 8.846515811455902e-06
fifth I-Disease 0 0.00014546408783644438
component I-Disease 0 4.912772510579089e-06
of I-Disease 0 1.0745141025836347e-06
complement I-Disease 0 5.5683522077742964e-05
( O 0 9.67097730608657e-06
C5 O 0 0.002810464473441243
) O 0 3.6774454201804474e-06
is O 0 3.802514811468427e-06
described O 0 6.143100472399965e-05
. O 0 5.630580926663242e-05

The O 0 0.00017611966177355498
proband O 0 0.0015552635304629803
, O 0 1.840708137024194e-05
a O 0 9.690642400528304e-06
20 O 0 1.2120080100430641e-05
- O 0 9.795273945201188e-05
year O 0 6.8886288318026345e-06
- O 0 0.0001019145711325109
old O 0 6.5423890191596e-05
black O 0 6.206315447343513e-05
female O 0 0.00014754328003618866
with O 1 0.5617699027061462
systemic B-Disease 1 1.0
lupus I-Disease 1 1.0
erythematosus I-Disease 1 0.9999998807907104
since O 0 0.007885945029556751
age O 0 0.0003604714584071189
11 O 0 6.677985948044807e-05
, O 0 7.333085704885889e-06
lacked O 0 0.0009014595998451114
serum O 0 0.03477773815393448
hemolytic O 1 0.5771424770355225
complement O 0 1.2600418813235592e-05
activity O 0 8.955088560469449e-06
, O 0 2.853612386388704e-06
even O 0 8.484043974021915e-06
during O 0 0.00010197698429692537
remission O 0 0.010609599761664867
. O 0 8.951034396886826e-05

C5 O 0 0.016018057242035866
was O 0 0.0009253196185454726
undetectable O 0 0.0005479970132000744
in O 0 1.5416362657560967e-05
her O 0 0.00012056659761583433
serum O 0 0.00036467696190811694
by O 0 3.158768549837987e-06
both O 0 4.526706106844358e-06
immunodiffusion O 0 0.006947242189198732
and O 0 8.682392217451707e-05
hemolytic O 1 0.9953131675720215
assays O 0 0.0010722331935539842
. O 0 0.000153938279254362

Other O 0 3.95451788790524e-05
complement O 0 4.2873209167737514e-05
components O 0 1.4520153854391538e-05
were O 0 7.723961061856244e-06
normal O 0 7.310713954211678e-06
during O 0 1.889757186290808e-05
remission O 0 0.0008341645589098334
of O 0 7.403890322166262e-06
lupus O 1 0.9498644471168518
, O 0 8.7753114712541e-06
but O 0 5.921284810028737e-06
C1 O 0 0.021392185240983963
, O 0 3.039815965166781e-06
C4 O 0 0.00011874062329297885
, O 0 5.036792117607547e-06
C2 O 0 0.000781814509537071
, O 0 1.965877117982018e-06
and O 0 3.4300555853405967e-06
C3 O 0 0.001709792879410088
levels O 0 2.4879689590306953e-05
fell O 0 0.0003592638240661472
during O 0 6.737087824149057e-05
exacerbations O 0 0.3335566818714142
. O 0 0.00010259918053634465

A O 0 0.00029905870906077325
younger O 0 0.00015542500477749854
half O 0 2.2001086108502932e-05
- O 0 0.00021831571939401329
sister O 0 0.0003553147835191339
, O 0 3.2711793664930156e-06
who O 0 1.1274326425336767e-05
had O 0 0.000546927796676755
no O 0 0.000393756665289402
underlying O 0 0.08078502863645554
disease O 0 0.22270430624485016
, O 0 8.518338290741667e-06
was O 0 8.040465036174282e-05
also O 0 2.986199206134188e-06
found O 0 4.580821041599847e-06
to O 0 4.390975391288521e-06
lack O 0 7.150344754336402e-05
immunochemically O 0 0.020638179033994675
detectable O 0 0.0019155570771545172
C5 O 0 0.0022743595764040947
. O 0 0.00011459336383268237

By O 0 0.0003084068594034761
hemolytic O 1 0.9953833222389221
assay O 0 0.0020592669025063515
, O 0 3.511341492412612e-05
she O 0 5.939267066423781e-05
exhibited O 0 2.7415606382419355e-05
1 O 0 2.7361600132280728e-06
- O 0 2.3960632461239584e-05
2 O 0 1.4941508652555058e-06
% O 0 3.905435903561738e-07
of O 0 3.024611885393824e-07
the O 0 1.5190312296908814e-06
normal O 0 2.2141668523545377e-05
serum O 0 0.00018931318481918424
C5 O 0 5.070352563052438e-05
level O 0 3.0785706712777028e-06
and O 0 2.1752257453044876e-06
normal O 0 6.174595910124481e-06
concentrations O 0 6.0164707065268885e-06
of O 0 1.210539721796522e-06
other O 0 2.6756183615361806e-06
complement O 0 2.972448965010699e-05
components O 0 7.105767872417346e-05
. O 0 5.439124652184546e-05

C5 O 0 0.006292412057518959
levels O 0 6.422454316634685e-05
of O 0 3.674504341688589e-06
other O 0 1.5486193660763092e-06
family O 0 7.596429441036889e-06
members O 0 1.3452715847961372e-06
were O 0 2.327630681975279e-06
either O 0 1.6071840036602225e-06
normal O 0 3.510118176563992e-06
or O 0 1.0354888217989355e-06
approximately O 0 1.3275284800329246e-06
half O 0 3.7366962715168484e-06
- O 0 0.00036515964893624187
normal O 0 1.0919288797595073e-05
, O 0 1.9831986719509587e-06
consistent O 0 8.147660082613584e-06
with O 0 9.204419257002883e-06
autosomal O 0 0.028315911069512367
codominant O 0 0.01478409394621849
inheritance O 0 2.6437517590238713e-05
of O 0 2.7067389964940958e-06
the O 0 3.278851727372967e-05
gene O 0 0.001557413605041802
determining O 1 0.5799327492713928
C5 B-Disease 1 0.9999994039535522
deficiency I-Disease 1 0.999997615814209
. O 0 0.0002742901269812137

Normal O 0 0.04552073776721954
hemolytic O 1 0.999508261680603
titers O 0 0.03144565969705582
were O 0 0.0001549446751596406
restored O 0 8.3980179624632e-05
to O 0 7.207889211713336e-06
both O 0 2.3430431610904634e-05
homozygous O 1 0.7508233189582825
C5 B-Disease 1 0.9999926090240479
- I-Disease 1 0.9999765157699585
deficient I-Disease 1 0.9999998807907104
( O 0 8.424085535807535e-05
C5D B-Disease 1 0.9999871253967285
) O 0 6.669879894616315e-06
sera O 0 1.9080398487858474e-05
by O 0 8.211032422877906e-07
addition O 0 1.1203683243365958e-06
of O 0 1.3170305237508728e-06
highly O 0 1.374116436636541e-05
purified O 0 8.592924859840423e-05
human O 0 2.6075649657286704e-05
C5 O 0 0.0016951437573879957
. O 0 7.956549961818382e-05

In O 0 0.0001319653238169849
specific O 0 7.127457502065226e-05
C5 O 0 0.0016522289952263236
titrations O 0 0.0016932905418798327
, O 0 9.561572369420901e-06
however O 0 4.042809450766072e-06
, O 0 1.3299779766384745e-06
it O 0 6.711557603011897e-07
was O 0 8.229923878388945e-06
noted O 0 6.384991024788178e-07
that O 0 2.995684269535559e-07
when O 0 8.651290954730939e-07
limited O 0 5.926562494096288e-07
amounts O 0 5.55085875930672e-07
of O 0 3.917791104868229e-07
C5 O 0 5.0431888666935265e-05
were O 0 3.983625447290251e-06
assayed O 0 1.324973527516704e-05
in O 0 7.692511871937313e-07
the O 0 5.592394245468313e-07
presence O 0 8.148143706421251e-07
of O 0 5.207244839766645e-07
low O 0 1.2673995115619618e-05
dilutions O 0 2.748327278823126e-05
of O 0 1.754185973368294e-06
either O 0 4.9791677156463265e-05
C5D B-Disease 1 0.999984622001648
serum O 0 0.003776060650125146
, O 0 2.7791634238383267e-06
curving O 0 1.0112885320268106e-05
rather O 0 2.052901436400134e-06
than O 0 7.072738981150906e-07
linear O 0 2.9598595574498177e-06
dose O 0 1.52968023030553e-05
- O 0 2.9718592486460693e-05
response O 0 1.9037694301005104e-06
plots O 0 3.5110590488329763e-06
were O 0 7.261670361913275e-06
consistently O 0 2.2113621525932103e-05
obtained O 0 5.714847247872967e-06
, O 0 1.4824513527855743e-06
suggesting O 0 7.338633622566704e-06
some O 0 2.088282371914829e-06
inhibitory O 0 4.923992673866451e-05
effect O 0 3.3375494240317494e-05
. O 0 3.801204729825258e-05

Further O 0 8.239212911576033e-05
studies O 0 3.874262984027155e-05
suggested O 0 1.6854803106980398e-05
that O 0 2.271543962706346e-06
low O 0 2.1786036086268723e-05
dilutions O 0 6.4354513597209e-05
of O 0 9.884616702038329e-06
C5D B-Disease 1 0.9999982118606567
serum O 0 0.19877073168754578
contain O 0 2.61575205513509e-05
a O 0 2.2321537471725605e-05
factor O 0 1.039752532960847e-05
( O 0 9.74205704551423e-07
or O 0 1.4234532272894285e-06
factors O 0 1.4652767958978075e-06
) O 0 5.041430313212913e-07
interfering O 0 1.4279522702054237e-06
at O 0 2.064241016341839e-06
some O 0 3.176138534399797e-07
step O 0 2.482413719917531e-06
in O 0 1.3874985143047525e-06
the O 0 1.0268594451190438e-05
hemolytic O 1 0.5401278734207153
assay O 0 7.060715142870322e-05
of O 0 3.5310920338815777e-06
C5 O 0 0.0028733392246067524
, O 0 2.2150038603285793e-06
rather O 0 9.76908381744579e-07
than O 0 5.628751864605874e-07
a O 0 4.2992023736587726e-06
true O 0 2.3727880034130067e-05
C5 O 0 0.000555653590708971
inhibitor O 0 5.504468936123885e-05
or O 0 2.8958427719771862e-05
inactivator O 0 0.0016690484480932355
. O 0 9.280741505790502e-05

Of O 0 8.043026900850236e-05
clinical O 0 0.0036449511535465717
interest O 0 1.2142929335823283e-05
are O 0 3.1227091312757693e-06
( O 0 1.0081889740831684e-06
a O 0 2.6111761144420598e-06
) O 0 6.552746754096006e-07
the O 0 8.897246175365581e-07
documentation O 0 1.1185310540895443e-05
of O 0 1.641761264181696e-05
membranous O 1 0.9996545314788818
glomerulonephritis B-Disease 1 1.0
, O 0 0.3222365975379944
vasculitis B-Disease 1 0.9999998807907104
, O 0 0.011954782530665398
and O 1 0.6122551560401917
arthritis B-Disease 1 1.0
in O 0 0.00011580609134398401
an O 0 1.2826385500375181e-05
individual O 0 1.521594913356239e-05
lacking O 0 0.0011503492714837193
C5 O 0 0.0024012920912355185
( O 0 1.1339284355926793e-06
and O 0 1.2095449619664578e-06
its O 0 1.6214336255870876e-06
biologic O 0 7.471145363524556e-05
functions O 0 2.5262957024096977e-06
) O 0 1.1485647064546356e-06
, O 0 1.2066553836120875e-06
and O 0 2.9537404770962894e-06
( O 0 1.4463976185652427e-06
b O 0 8.556457942177076e-06
) O 0 4.1937943251468823e-07
a O 0 1.1304592817396042e-06
remarkable O 0 7.880705197749194e-06
propensity O 0 0.00015829427866265178
to O 0 0.0001826964144129306
bacterial B-Disease 1 0.9998975992202759
infections I-Disease 1 0.9999313354492188
in O 0 1.5105173588381149e-05
the O 0 1.5951385648804717e-05
proband O 0 0.03246205672621727
, O 0 1.7150382518593688e-06
even O 0 8.521242875758617e-07
during O 0 1.0880577292482485e-06
periods O 0 7.95613573245646e-07
of O 0 2.942798573712935e-07
low O 0 3.0980605515651405e-05
- O 0 0.0003155698359478265
dose O 0 1.586777034390252e-05
or O 0 1.6243882328126347e-06
alternate O 0 7.535905297118006e-06
- O 0 0.0001936144835781306
day O 0 3.5004053643206134e-05
corticosteroid O 0 0.0019864067435264587
therapy O 0 0.0006544346106238663
. O 0 5.746503302361816e-05

Other O 0 2.660558675415814e-05
observations O 0 5.372761734179221e-05
indicate O 0 3.543926140991971e-05
that O 0 3.4198321827716427e-06
the O 0 1.0477234354766551e-05
C5D B-Disease 1 0.9999521970748901
state O 0 4.1344878809468355e-06
is O 0 6.45835200430156e-07
compatible O 0 2.078590341625386e-06
with O 0 1.5284185792552307e-06
normal O 0 7.1748049776942935e-06
coagulation O 0 1.55760226334678e-05
function O 0 1.69611337241804e-06
and O 0 6.571370363417373e-07
the O 0 6.246142447707825e-07
capacity O 0 2.4533380837965524e-06
to O 0 1.1704455573635641e-06
mount O 0 4.958130375598557e-05
a O 0 8.980787970358506e-05
neutrophilic O 1 0.8083903193473816
leukocytosis O 0 0.11132372915744781
during O 0 0.0005911057814955711
pyogenic B-Disease 1 0.9778467416763306
infection I-Disease 0 0.27620917558670044
. O 0 1.8757955331238918e-05
. O 0 5.591883018496446e-05

Susceptibility O 0 0.42608630657196045
to O 0 0.02669980190694332
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
in O 0 0.28229808807373047
twins O 1 0.9803056716918945
: O 0 4.981792244507233e-06
the O 0 1.6571659671171801e-06
role O 0 2.808096269291127e-06
of O 0 1.1981834404650726e-06
genes O 0 6.302692327153636e-06
, O 0 3.492457835818641e-06
HLA O 0 0.0001865853409981355
, O 0 1.969130153156584e-06
and O 0 2.3151492314354982e-06
the O 0 7.6769483712269e-06
environment O 0 3.995388397015631e-05
. O 0 4.0421706216875464e-05

OBJECTIVE O 0 0.00041505141416564584
To O 0 1.874110967037268e-05
determine O 0 1.5695310139562935e-05
the O 0 3.5667135307448916e-06
relative O 0 2.3753780624247156e-05
effects O 0 1.549674016132485e-05
of O 0 1.9112424070044653e-06
genetic O 0 6.133148417575285e-05
and O 0 6.988531822571531e-06
environmental O 0 2.112442598445341e-05
factors O 0 4.192009782855166e-06
in O 0 1.3863590538676362e-05
susceptibility O 0 0.05418672785162926
to O 0 0.04787861183285713
ankylosing B-Disease 1 1.0
spondylitis I-Disease 1 1.0
( O 0 0.008807137608528137
AS B-Disease 1 0.6704002022743225
) O 0 3.536043004714884e-05
. O 0 6.575249426532537e-05

METHODS O 0 0.0013840765459463
Twins O 0 0.3869171440601349
with O 0 2.783553827612195e-05
AS B-Disease 0 0.03527320176362991
were O 0 1.8103730326402e-05
identified O 0 4.635247023543343e-06
from O 0 1.0393969205324538e-06
the O 0 1.96261566998146e-06
Royal O 0 0.0003373016952537
National O 0 0.0001032379805110395
Hospital O 1 0.9508322477340698
for O 0 0.0012961728498339653
Rheumatic B-Disease 1 0.9999998807907104
Diseases I-Disease 1 0.9974157810211182
database O 0 0.0005114158848300576
. O 0 0.00018420579726807773

Clinical O 0 0.0041763149201869965
and O 0 7.17016591806896e-05
radiographic O 0 0.001809408189728856
examinations O 0 0.0009585698717273772
were O 0 0.00011881027603521943
performed O 0 8.92431489774026e-05
to O 0 5.616104772343533e-06
establish O 0 9.511558164376765e-05
diagnoses O 0 0.35262250900268555
, O 0 5.254067218629643e-05
and O 0 0.010094703175127506
disease O 1 0.9807718396186829
severity O 0 0.47769346833229065
was O 0 0.018690645694732666
assessed O 0 1.0104267857968807e-05
using O 0 9.846079365161131e-07
a O 0 2.7158873763255542e-06
combination O 0 6.089068392611807e-06
of O 0 1.3417878790278337e-06
validated O 0 7.650974293937907e-05
scoring O 0 2.954937008325942e-05
systems O 0 0.00020950181351508945
. O 0 6.109949754318222e-05

HLA O 0 0.00975708570331335
typing O 0 0.0013472730061039329
for O 0 8.054039790295064e-05
HLA O 0 0.0015891068615019321
- O 0 0.0003458276914898306
B27 O 0 0.00015477222041226923
, O 0 8.261268703790847e-06
HLA O 0 0.00010246083547826856
- O 0 7.540788647020236e-05
B60 O 0 6.993415445322171e-05
, O 0 2.6137572604056913e-06
and O 0 5.405882802733686e-06
HLA O 0 0.0006101347971707582
- O 0 0.0015632309950888157
DR1 O 0 0.04198488965630531
was O 0 4.8094207159010693e-05
performed O 0 1.528002212580759e-05
by O 0 2.0842735466430895e-06
polymerase O 0 1.7319120161118917e-05
chain O 0 3.4386408515274525e-05
reaction O 0 2.411891955489409e-06
with O 0 6.616717200813582e-07
sequence O 0 1.443470637241262e-06
- O 0 4.301548415241996e-06
specific O 0 6.588143151020631e-07
primers O 0 1.2049144970660564e-05
, O 0 1.5074516568347462e-06
and O 0 3.4086021969415015e-06
zygosity O 0 0.001920847687870264
was O 0 1.813320704968646e-05
assessed O 0 1.0568364814389497e-05
using O 0 9.820461855269969e-06
microsatellite O 0 0.0009893059032037854
markers O 0 0.0008484627469442785
. O 0 0.00011505289876367897

Genetic O 0 0.002669355133548379
and O 0 8.401959348702803e-05
environmental O 0 7.087975973263383e-05
variance O 0 2.0513538402155973e-05
components O 0 2.469444189046044e-05
were O 0 2.041272455244325e-05
assessed O 0 8.513059583492577e-06
with O 0 1.2926694807902095e-06
the O 0 2.198739366576774e-06
program O 0 4.4970934141019825e-06
Mx O 0 4.759233706863597e-05
, O 0 6.374034455802757e-07
using O 0 4.787403895534226e-07
data O 0 7.14026725745498e-07
from O 0 2.9576091264971183e-07
this O 0 1.9227860548198805e-07
and O 0 5.84334998166014e-07
previous O 0 1.2173250070190988e-06
studies O 0 1.0278549780196045e-06
of O 0 1.3537335235014325e-06
twins O 0 0.09596560895442963
with O 0 2.3461714590666816e-05
AS B-Disease 0 0.29204559326171875
. O 0 5.874337875866331e-05

RESULTS O 0 0.0006019323482178152
Six O 0 2.802317976602353e-05
of O 0 6.768301773263374e-06
8 O 0 0.00011466080468380824
monozygotic O 0 0.0007488153642043471
( O 0 1.1965770681854337e-05
MZ O 1 0.9615160226821899
) O 0 5.205941306485329e-06
twin O 0 0.005234626587480307
pairs O 0 0.00012795973452739418
were O 0 0.0014877538196742535
disease O 0 0.01401218120008707
concordant O 0 0.00010049258708022535
, O 0 3.6469070892053423e-06
compared O 0 2.452917215123307e-06
with O 0 9.232016395799292e-07
4 O 0 2.4760347514529712e-06
of O 0 6.771993525944708e-07
15 O 0 1.0403297892480623e-05
B27 O 0 0.00021700082288589329
- O 0 0.00018533473485149443
positive O 0 4.321251253713854e-06
dizygotic O 0 0.00012409027840476483
( O 0 4.3243599066045135e-06
DZ O 1 0.5283804535865784
) O 0 2.4061000658548437e-06
twin O 0 0.00018627458484843373
pairs O 0 1.6703843357390724e-05
( O 0 1.5094771015355946e-06
27 O 0 1.2386617527226917e-05
% O 0 1.0434092700961628e-06
) O 0 4.088192326889839e-07
and O 0 3.716704952694272e-07
4 O 0 1.5202457461782615e-06
of O 0 8.065628094300337e-07
32 O 0 0.00011444200936239213
DZ O 1 0.9559738039970398
twin O 0 0.008930828422307968
pairs O 0 4.737516792374663e-05
overall O 0 4.020216147182509e-05
( O 0 1.1194999842700781e-06
12 O 0 3.964860297855921e-06
. O 0 7.414719220832922e-07
5 O 0 4.603826255333843e-06
% O 0 4.9865075197885744e-06
) O 0 7.303995971597033e-06
. O 0 1.9439396055531688e-05

Nonsignificant O 0 0.06916069239377975
increases O 0 0.00027667576796375215
in O 0 1.8589009414426982e-05
similarity O 0 2.479811337252613e-05
with O 0 4.033839559269836e-06
regard O 0 6.624453362746863e-06
to O 0 6.165798822621582e-06
age O 0 0.0011922878911718726
at O 0 0.11268502473831177
disease O 0 0.2726198434829712
onset O 0 0.012971070595085621
and O 0 2.9129435006325366e-06
all O 0 4.972978331352351e-07
of O 0 1.186637973660254e-06
the O 0 0.001474604126997292
disease O 1 0.5748565793037415
severity O 0 0.013756823725998402
scores O 0 0.0001377079461235553
assessed O 0 7.972650928422809e-05
were O 0 1.3863564163330011e-05
noted O 0 1.0134444892173633e-05
in O 0 8.159119170159101e-05
disease O 0 0.2280174344778061
- O 0 0.04251747578382492
concordant O 0 0.026037203148007393
MZ O 1 0.9999315738677979
twins O 0 0.4310663044452667
compared O 0 3.8222220609895885e-05
with O 0 3.074485721299425e-05
concordant O 0 0.04351864755153656
DZ O 1 0.9999537467956543
twins O 1 0.6016083359718323
. O 0 0.0001895685854833573

HLA O 0 0.13611920177936554
- O 0 0.0028406803030520678
B27 O 0 0.000716802547685802
and O 0 2.0582043362082914e-05
B60 O 0 0.00023274784325622022
were O 0 1.0704111446102615e-05
associated O 0 4.916231773677282e-06
with O 0 4.438207724888343e-06
the O 0 4.540202280622907e-05
disease O 0 0.06686745584011078
in O 0 1.3390609638008755e-05
probands O 0 0.09399652481079102
, O 0 3.5727359772863565e-06
and O 0 1.4953853906263248e-06
the O 0 1.0396782954558148e-06
rate O 0 2.444925257805153e-06
of O 0 2.0105508156120777e-06
disease O 0 0.0006695223855786026
concordance O 0 0.00012138633610447869
was O 0 0.00034346041502431035
significantly O 0 1.6106521798064932e-05
increased O 0 4.16031934946659e-06
among O 0 2.8659233066719025e-06
DZ O 1 0.833679735660553
twin O 0 0.00500757759436965
pairs O 0 1.1574578820727766e-05
in O 0 2.333885504413047e-06
which O 0 1.8289665604243055e-06
the O 0 3.211744569853181e-06
co O 0 0.00023298563610296696
- O 0 0.000475727254524827
twin O 0 0.021781735122203827
was O 0 3.77556134480983e-05
positive O 0 7.933451229291677e-07
for O 0 5.652906338582397e-07
both O 0 2.5188812742271693e-06
B27 O 0 0.00028196550556458533
and O 0 3.4852269891416654e-05
DR1 O 0 0.27503880858421326
. O 0 9.011224028654397e-05

Additive O 0 0.001378971035592258
genetic O 0 0.0004424919025041163
effects O 0 0.0001654628722462803
were O 0 2.1133713744347915e-05
estimated O 0 1.00846682471456e-05
to O 0 1.7325938870271784e-06
contribute O 0 3.316446282042307e-06
97 O 0 4.31152830060455e-06
% O 0 5.895102503927774e-07
of O 0 5.719518867408624e-07
the O 0 2.4546043277950957e-06
population O 0 1.0046310308098327e-05
variance O 0 4.2138730350416154e-05
. O 0 3.531332185957581e-05

CONCLUSION O 0 0.0010721938451752067
Susceptibility O 0 0.0012129319366067648
to O 0 4.732485831482336e-05
AS B-Disease 0 0.06205292046070099
is O 0 7.125273441488389e-06
largely O 0 7.625309990544338e-06
genetically O 0 1.2295805390749592e-05
determined O 0 4.601487034960883e-06
, O 0 7.356470064223686e-07
and O 0 5.571744168264559e-07
the O 0 1.933590738190105e-06
environmental O 0 8.27993790153414e-06
trigger O 0 8.422895916737616e-05
for O 0 2.3730069642624585e-06
the O 0 0.00042299102642573416
disease O 0 0.416192889213562
is O 0 6.494703029602533e-06
probably O 0 3.6637793527916074e-05
ubiquitous O 0 0.00018672680016607046
. O 0 5.9528363635763526e-05

HLA O 0 0.17299160361289978
- O 0 0.0029864259995520115
B27 O 0 0.0004942674422636628
accounts O 0 1.2130150935263373e-05
for O 0 1.3960262776890886e-06
a O 0 2.4686098640813725e-06
minority O 0 1.9322947082400788e-06
of O 0 4.740757617582858e-07
the O 0 2.476965164532885e-06
overall O 0 0.00013223200221545994
genetic O 0 0.00012106405483791605
susceptibility O 0 0.00017255278362426907
to O 0 1.2491625057009514e-05
AS B-Disease 0 0.14249983429908752
. O 0 9.385019075125456e-05

Cell O 0 0.00872108805924654
cycle O 0 0.000987136154435575
- O 0 0.0005581114673987031
dependent O 0 5.096281893202104e-05
colocalization O 0 7.219730468932539e-05
of O 0 2.792473651425098e-06
BARD1 O 0 0.0011705505894497037
and O 0 1.1316963536955882e-05
BRCA1 O 0 0.00025287026073783636
proteins O 0 5.385099484556122e-06
in O 0 4.3196937440370675e-06
discrete O 0 3.275820199633017e-05
nuclear O 0 0.0003406124596949667
domains O 0 0.00013768010830972344
. O 0 8.486620936309919e-05

Germ O 0 0.045094363391399384
- O 0 0.0016340736765414476
line O 0 6.355066579999402e-05
mutations O 0 2.6634526875568554e-05
of O 0 2.648759846124449e-06
the O 0 6.104226031311555e-06
BRCA1 O 0 0.0005255424766801298
gene O 0 2.987009247590322e-05
predispose O 0 3.965348150813952e-05
women O 0 9.079037226911169e-06
to O 0 3.3751425689843018e-06
early O 0 2.3380303900921717e-05
- O 1 0.9194455146789551
onset O 1 0.9983055591583252
breast B-Disease 1 0.9999772310256958
and I-Disease 1 0.9992105960845947
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999971389770508
by O 0 7.30268629922648e-06
compromising O 0 0.00047261203872039914
the O 0 7.413315870508086e-06
genes O 0 2.6487916329642758e-05
presumptive O 0 0.006025494541972876
function O 0 1.0186859071836807e-05
as O 0 6.890553777338937e-06
a O 0 0.00018513640679884702
tumor B-Disease 0 0.2819956839084625
suppressor O 0 0.0019367277855053544
. O 0 0.00010389293311163783

Although O 0 0.00010845989163499326
the O 0 1.8621160052134655e-05
biochemical O 0 6.625527748838067e-05
properties O 0 1.0451277375977952e-05
of O 0 2.173202119593043e-06
BRCA1 O 0 0.0005664530908688903
polypeptides O 0 3.328522507217713e-05
are O 0 1.53560392845975e-06
not O 0 1.7790342781154322e-06
understood O 0 2.2766816982766613e-06
, O 0 4.0709838344810123e-07
their O 0 8.46823752453929e-07
expression O 0 1.35042341753433e-06
pattern O 0 2.9989278118591756e-06
and O 0 1.0963592558255186e-06
subcellular O 0 4.4453056034399197e-05
localization O 0 1.0699294762162026e-05
suggest O 0 2.8358047075016657e-06
a O 0 1.77265792444814e-06
role O 0 2.869355512302718e-06
in O 0 3.690722451210604e-06
cell O 0 0.0024558098521083593
- O 0 0.01938549056649208
cycle O 0 0.00010447700333315879
regulation O 0 0.00010884832590818405
. O 0 5.0405345973558724e-05

When O 0 0.0005000776727683842
resting O 0 0.004804202355444431
cells O 0 8.389612776227295e-05
are O 0 3.840017598122358e-06
induced O 0 5.5229407735168934e-05
to O 0 2.258311951663927e-06
proliferate O 0 3.456585545791313e-05
, O 0 9.074640274775447e-07
the O 0 6.676955308648758e-07
steady O 0 8.076449375948869e-06
- O 0 1.2638111002161168e-05
state O 0 4.843595888814889e-07
levels O 0 5.591855369857512e-07
of O 0 3.5434044320936664e-07
BRCA1 O 0 1.6416517610196024e-05
increase O 0 1.5576218856949708e-06
in O 0 1.5858186088735238e-06
late O 0 1.2628317563212477e-05
G1 O 0 0.00019050830451305956
and O 0 1.4025264363226597e-06
reach O 0 2.0094812498427927e-06
a O 0 2.299903144376003e-06
maximum O 0 9.87344446912175e-06
during O 0 2.903510903706774e-05
S O 0 0.01082548126578331
phase O 0 0.00013938784832134843
. O 0 5.571055589825846e-05

Moreover O 0 0.0005197074497118592
, O 0 3.843528247671202e-05
in O 0 1.3289206435729284e-05
S O 0 0.001009098021313548
phase O 0 3.2431700674351305e-05
cells O 0 1.573795270815026e-05
, O 0 2.8000313250231557e-06
BRCA1 O 0 6.303215923253447e-05
polypeptides O 0 1.1648615327430889e-05
are O 0 1.4590423234039918e-06
hyperphosphorylated O 0 7.67784149502404e-05
and O 0 4.362996151030529e-06
accumulate O 0 2.088117071252782e-05
into O 0 2.989493168570334e-06
discrete O 0 1.7236599887837656e-05
subnuclear O 0 0.0005013407208025455
foci O 0 0.00018748878210317343
termed O 0 0.0002016633952734992
" O 0 3.544409264577553e-05
BRCA1 O 0 0.0006357789970934391
nuclear O 0 0.0005457206862047315
dots O 0 0.0007239338592626154
. O 0 8.709167741471902e-05

" O 0 0.0016548186540603638
BRCA1 O 0 0.06233946606516838
associates O 0 0.00844636932015419
in O 0 3.6095501855015755e-05
vivo O 0 0.0003991061821579933
with O 0 7.527803063567262e-06
a O 0 7.835536234779283e-05
structurally O 0 0.020319467410445213
related O 0 2.9002565497648902e-05
protein O 0 0.0001051458457368426
termed O 0 0.0006709173903800547
BARD1 O 0 0.11618690937757492
. O 0 0.000148475868627429

Here O 0 0.00011312192509649321
we O 0 1.5996110960259102e-05
show O 0 4.854602138948394e-06
that O 0 6.53718586818286e-07
the O 0 1.103226054510742e-06
steady O 0 9.543743544782046e-06
- O 0 1.8280412405147217e-05
state O 0 8.565329494558682e-07
levels O 0 9.464231993661087e-07
of O 0 4.4026560885868093e-07
BARD1 O 0 0.0009628406842239201
, O 0 9.404607794749609e-07
unlike O 0 7.463229962922924e-07
those O 0 3.5979522294837807e-07
of O 0 7.465037583642697e-07
BRCA1 O 0 0.001543501508422196
, O 0 3.3100793643825455e-06
remain O 0 2.552830210333923e-06
relatively O 0 2.4043636130954837e-06
constant O 0 4.925880602968391e-06
during O 0 1.958690700121224e-05
cell O 0 0.002567675895988941
cycle O 0 0.0003629279090091586
progression O 0 0.0006108004599809647
. O 0 6.834598752902821e-05

However O 0 0.0002577984123490751
, O 0 5.141112342244014e-05
immunostaining O 0 0.0007727219490334392
revealed O 0 8.265276119345799e-05
that O 0 4.286278453946579e-06
BARD1 O 0 0.009888722561299801
resides O 0 3.606625250540674e-05
within O 0 5.64902165933745e-06
BRCA1 O 0 0.0003112140402663499
nuclear O 0 9.826811583479866e-05
dots O 0 7.045937672955915e-05
during O 0 1.7909464077092707e-05
S O 0 0.00025353103410452604
phase O 0 2.6712712042353814e-06
of O 0 6.717948508594418e-07
the O 0 2.9331172299862374e-06
cell O 0 0.00019898588652722538
cycle O 0 1.8383205315330997e-05
, O 0 1.2043342394463252e-06
but O 0 7.195109787971887e-07
not O 0 6.554759579557867e-07
during O 0 2.2210110728337895e-06
the O 0 5.332222826837096e-06
G1 O 0 0.002318390877917409
phase O 0 7.665521843591705e-05
. O 0 5.651916580973193e-05

Nevertheless O 0 0.0009274387848563492
, O 0 8.233526023104787e-05
BARD1 O 0 0.0011631964007392526
polypeptides O 0 4.459759293240495e-05
are O 0 2.9271066068758955e-06
found O 0 2.8981025934626814e-06
exclusively O 0 1.644261942601588e-06
in O 0 1.050430114446499e-06
the O 0 7.915917876744061e-07
nuclear O 0 5.9972171584377065e-06
fractions O 0 1.6756099512349465e-06
of O 0 3.728853812390298e-07
both O 0 1.775855935193249e-06
G1 O 0 0.00048281269846484065
- O 0 0.00010414338612463325
and O 0 7.666135388717521e-06
S O 0 0.0019865119829773903
- O 0 0.00019309049821458757
phase O 0 7.904595258878544e-05
cells O 0 7.497859769500792e-05
. O 0 2.964163286378607e-05

Therefore O 0 0.0002713920548558235
, O 0 4.4207019527675584e-05
progression O 0 0.00011196846753591672
to O 0 9.959643648471683e-06
S O 0 0.004240354988723993
phase O 0 1.284385234612273e-05
is O 0 1.2065495411661686e-06
accompanied O 0 2.3066179437591927e-06
by O 0 3.8987411699054064e-07
the O 0 5.816107204736909e-07
aggregation O 0 3.6439380437514046e-06
of O 0 1.2713256865026779e-06
nuclear O 0 0.00012900601723231375
BARD1 O 0 0.00032522183028049767
polypeptides O 0 2.308633156644646e-05
into O 0 7.687776815146208e-06
BRCA1 O 0 0.0004816488071810454
nuclear O 0 0.00030862921266816556
dots O 0 0.000583469751290977
. O 0 6.673338066320866e-05

This O 0 8.962248830357566e-05
cell O 0 0.0004075971955899149
cycle O 0 0.00011205454939045012
- O 0 0.0001177158483187668
dependent O 0 2.336385296075605e-05
colocalization O 0 4.2635430872906e-05
of O 0 3.646837740234332e-06
BARD1 O 0 0.007839708589017391
and O 0 1.3147504432708956e-05
BRCA1 O 0 0.002599073341116309
indicates O 0 8.742526006244589e-06
a O 0 2.7166436211700784e-06
role O 0 2.5816755169216776e-06
for O 0 1.5799101902302937e-06
BARD1 O 0 0.0038806982338428497
in O 0 1.388849523209501e-05
BRCA1 O 0 0.012417764402925968
- O 0 0.12043226510286331
mediated O 0 0.011842820793390274
tumor B-Disease 0 0.17068834602832794
suppression O 0 0.000387736625270918
. O 0 0.0001383935014018789

Ethnic O 0 0.0002400292141828686
differences O 0 0.00012419716222211719
in O 0 3.15366851282306e-05
the O 0 2.8077749448129907e-05
HFE O 0 0.0023777890019118786
codon O 0 0.00012880589929409325
282 O 0 0.0001980563101824373
( O 0 3.584799560485408e-05
Cys O 0 0.007807872258126736
/ O 0 0.0002725877857301384
Tyr O 0 0.0015502511523663998
) O 0 5.0373921112623066e-05
polymorphism O 0 0.000407337152864784
. O 0 0.00014798047777730972

Recent O 0 0.00014346888929139823
studies O 0 5.879252785234712e-05
have O 0 2.706504164962098e-05
shown O 0 7.112424646038562e-05
that O 0 0.002306615002453327
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
( O 0 0.47840455174446106
HH B-Disease 1 0.9999881982803345
) O 0 6.62127649775357e-06
is O 0 1.1569505886654952e-06
likely O 0 4.03795047532185e-06
to O 0 1.2907847803944605e-06
be O 0 3.833921255136374e-06
caused O 0 1.6300900824717246e-05
by O 0 1.4645321471107309e-06
homozygosity O 0 0.00011986836034338921
for O 0 7.935350367915817e-07
a O 0 7.947650374262594e-06
Cys282Tyr O 0 0.0007015921291895211
mutation O 0 7.497303613490658e-06
in O 0 1.7927925455296645e-06
the O 0 6.2415974753093906e-06
HFE O 0 0.0061599500477313995
gene O 0 2.5427891159779392e-05
located O 0 3.5388904507271945e-05
4 O 0 6.660565850324929e-05
. O 0 7.964004180394113e-05

5 O 0 0.0006785851437598467
Mb O 0 0.0025911813136190176
telomeric O 0 0.0018569733947515488
to O 0 8.852186147123575e-05
HLA O 0 0.025979958474636078
- O 0 0.0013176730135455728
A O 0 0.0002294049772899598
. O 0 7.187349547166377e-05

Population O 0 0.00018191037815995514
studies O 0 2.3086111468728632e-05
of O 0 3.376455879333662e-06
this O 0 1.7962478295885376e-06
polymorphism O 0 1.81055766006466e-05
are O 0 1.0295137826688006e-06
facilitated O 0 3.2160812679649098e-06
by O 0 6.261231533244427e-07
the O 0 1.3669257441506488e-06
fact O 0 1.4868688822389231e-06
that O 0 6.640574383709463e-07
the O 0 3.514737500154297e-06
Cys282Tyr O 0 0.0006790428305976093
mutation O 0 1.9956160031142645e-05
creates O 0 1.138959214586066e-05
a O 0 1.2027918273815885e-05
Rsal O 0 0.0004679157573264092
restriction O 0 3.902649768861011e-05
site O 0 5.412085374700837e-05
. O 0 3.56684613507241e-05

We O 0 0.00011835525947390124
have O 0 2.014092569879722e-05
studied O 0 1.9599390725488774e-05
the O 0 6.579311957466416e-06
codon O 0 7.367004582192749e-05
282 O 0 9.76786031969823e-05
( O 0 1.1930720575037412e-05
Cys O 0 0.00570691330358386
/ O 0 8.451474423054606e-05
Tyr O 0 0.0005281621124595404
) O 0 4.7401558731507976e-06
polymorphism O 0 1.3270488125272095e-05
in O 0 2.4516402845620178e-06
different O 0 1.5774696748849237e-06
ethnic O 0 7.638323040737305e-06
groups O 0 1.3510699318430852e-05
. O 0 4.470110434340313e-05

In O 0 0.00015195518790278584
agreement O 0 2.32732345466502e-05
with O 0 5.1468764468154404e-06
previous O 0 5.949717888142914e-06
observations O 0 7.5402181209938135e-06
the O 0 2.796882199618267e-06
Tyr O 0 0.00019125868857372552
allele O 0 1.9132165107293986e-05
appeared O 0 1.2558071830426343e-05
to O 0 1.1535759085745667e-06
be O 0 1.668953132138995e-06
rare O 0 2.887079290303518e-06
or O 0 4.0032418837654404e-06
absent O 0 1.608739694347605e-05
in O 0 4.316922513680765e-06
Asiatic O 0 2.8184711482026614e-05
( O 0 8.002234608284198e-07
Indian O 0 1.1571888762773597e-06
, O 0 9.205097057929379e-07
Chinese O 0 1.267708171326376e-06
) O 0 2.635375494719483e-06
populations O 0 1.2858437003160361e-05
. O 0 2.3791162675479427e-05

The O 0 7.121329690562561e-05
highest O 0 8.588215132476762e-05
allele O 0 4.995233757654205e-05
frequency O 0 1.6311818399117328e-05
( O 0 2.721560349527863e-06
7 O 0 6.584521543118171e-06
. O 0 7.93841593349498e-07
5 O 0 1.966762056326843e-06
% O 0 1.0400235623819754e-06
) O 0 8.307457051159872e-07
was O 0 9.015249816002324e-06
found O 0 3.352788553456776e-06
in O 0 9.868652341538109e-06
Swedes O 0 0.0006642753724008799
. O 0 5.3415787988342345e-05

Saamis O 0 0.11240750551223755
( O 0 4.6032080717850477e-05
2 O 0 1.7529469914734364e-05
% O 0 6.024197773513151e-06
) O 0 1.3927696045357152e-06
and O 0 2.786737923088367e-06
Mordvinians O 0 0.0002644170599523932
( O 0 9.409999393028556e-07
1 O 0 1.0926672757705091e-06
. O 0 7.225819445011439e-07
8 O 0 3.4755787510221126e-06
% O 0 7.933912797852827e-07
) O 0 5.93070694776543e-07
had O 0 2.7482237783260643e-06
significantly O 0 1.9235028503317153e-06
lower O 0 1.2935906852362677e-06
frequencies O 0 2.793443172777188e-06
of O 0 8.655103442833934e-07
the O 0 7.288555025297683e-06
Tyr O 0 0.0008542947471141815
allele O 0 0.0002528528857510537
. O 0 6.956042489036918e-05

Comparisons O 0 0.00024419999681413174
with O 0 2.412185858702287e-05
allele O 0 6.215900066308677e-05
frequencies O 0 1.635591615922749e-05
based O 0 4.249634457664797e-06
on O 0 3.907689006155124e-06
prevalence O 0 5.9915055317105725e-05
estimates O 0 5.787077043351019e-06
of O 0 2.586678419902455e-06
HH B-Disease 1 0.9911742210388184
showed O 0 5.892078115721233e-05
some O 0 9.724792562337825e-07
disagreements O 0 1.0102166925207712e-05
with O 0 2.0131449218752095e-06
the O 0 2.76396781373478e-06
RFLP O 0 0.000385135441320017
data O 0 4.741991688206326e-06
, O 0 1.594222226231068e-06
particularly O 0 3.7446372971317032e-06
in O 0 1.1342128345859237e-05
Finns O 0 0.001098070410080254
. O 0 7.928192644612864e-05

The O 0 0.0001155117352027446
newly O 0 0.00045850471360608935
described O 0 0.00018159582396037877
HFE O 0 0.015179580077528954
marker O 0 3.604937228374183e-05
provides O 0 3.7322763546399074e-06
a O 0 2.340893615837558e-06
new O 0 9.563245839672163e-07
approach O 0 1.2476521078497171e-06
to O 0 3.5803788023258676e-07
the O 0 3.741599527984363e-07
screening O 0 3.3166231787618017e-06
of O 0 1.7798334965846152e-06
HH B-Disease 1 0.8089819550514221
as O 0 1.1609648709054454e-06
well O 0 1.561511226100265e-06
as O 0 6.094048785598716e-07
studies O 0 7.384614946204238e-07
of O 0 3.9552949715471186e-07
the O 0 2.098884351653396e-06
relationship O 0 3.673989112940035e-06
between O 0 1.581953142704151e-06
the O 0 9.785255315364338e-06
HFE O 0 0.05154772102832794
Tyr O 0 0.00047489136341027915
allele O 0 4.621170228347182e-05
and O 0 1.0272139661537949e-05
different O 0 5.015984061174095e-05
disorders O 1 0.9963363409042358
including O 0 0.006154736503958702
cancer B-Disease 1 0.9978221654891968

Autosomal B-Disease 1 0.9988462924957275
dominant I-Disease 1 0.9895408749580383
neurohypophyseal I-Disease 1 0.9999735355377197
diabetes I-Disease 1 0.9999994039535522
insipidus I-Disease 1 0.999755322933197
associated O 0 0.0005425263661891222
with O 0 1.6912945284275338e-05
a O 0 2.9713663025177084e-05
missense O 0 0.00014010047016199678
mutation O 0 3.264422048232518e-05
encoding O 0 1.9274420992587693e-05
Gly23 O 0 0.0007366622448898852
- O 0 0.0013121789088472724
- O 0 0.0014731050468981266
> O 0 0.00014486280269920826
Val O 0 0.0014123800210654736
in O 0 2.2407062715501525e-05
neurophysin O 0 0.08688898384571075
II O 0 0.06794331967830658
. O 0 7.78768298914656e-05

Autosomal B-Disease 1 0.9993211030960083
dominant I-Disease 1 0.9596819877624512
neurohypophyseal I-Disease 1 0.9999542236328125
diabetes I-Disease 1 0.9999995231628418
insipidus I-Disease 1 0.9999783039093018
( O 0 0.0018508300418034196
ADNDI B-Disease 1 0.9811425805091858
) O 0 2.1802330593345687e-05
is O 0 1.49940860865172e-05
an O 0 0.08953651040792465
inherited B-Disease 1 1.0
disease I-Disease 1 0.9999991655349731
caused O 0 0.01401225384324789
by O 0 1.2226733815623447e-05
progressive O 0 0.058658987283706665
degeneration O 0 0.005799705162644386
of O 0 1.7900403008752619e-06
the O 0 1.0278774425387383e-05
magnocellular O 0 0.0008787474944256246
neurons O 0 9.878925993689336e-06
of O 0 6.197251423145644e-07
the O 0 2.1835644474776927e-06
hypothalamus O 0 4.966311826137826e-05
leading O 0 4.05938317271648e-06
to O 0 1.4549405022989959e-06
decreased O 0 1.5577343219774775e-05
ability O 0 2.6799875740834977e-06
to O 0 1.1745077017621952e-06
produce O 0 2.6931543288810644e-06
the O 0 3.4493675684643677e-06
hormone O 0 4.11177497880999e-05
arginine O 0 4.560958404908888e-05
vasopressin O 0 4.2274412408005446e-05
( O 0 9.003513696370646e-06
AVP O 0 0.00023522730043623596
) O 0 1.9519759007380344e-05
. O 0 4.9189657147508115e-05

Affected O 0 0.002351396484300494
individuals O 0 4.793531843461096e-05
are O 0 6.386577751982259e-06
not O 0 4.7360986172861885e-06
symptomatic O 0 0.00020749455143231899
at O 0 0.00016429634706582874
birth O 0 0.012032397091388702
, O 0 5.186936050449731e-06
but O 0 4.14855639974121e-06
usually O 0 1.577827424625866e-05
develop O 0 0.0011231579119339585
diabetes B-Disease 1 0.8881548047065735
insipidus I-Disease 0 0.01558444369584322
at O 0 3.9408525481121615e-05
1 O 0 1.0288601515640039e-05
- O 0 0.00024705068790353835
6 O 0 3.505463246256113e-05
yr O 0 0.0009697768837213516
of O 0 3.9793158066459e-06
age O 0 9.644411329645663e-05
. O 0 4.938750134897418e-05

The O 0 9.58474338403903e-05
genetic O 0 0.00014534901129081845
locus O 0 9.607510583009571e-05
of O 0 7.525692581111798e-06
the O 0 0.0002790323633234948
disease O 0 0.25684115290641785
is O 0 2.2675117179460358e-06
the O 0 6.193426543177338e-06
AVP O 0 0.028654035180807114
- O 0 0.06894604861736298
neurophysin O 0 0.16210658848285675
II O 0 0.07624121010303497
( O 0 3.67053939953621e-06
NPII O 0 0.0014519540127366781
) O 0 1.6266297961919918e-06
gene O 0 2.376610382270883e-06
, O 0 9.323654239778989e-07
and O 0 2.0765041881531943e-06
mutations O 0 8.49717889650492e-06
that O 0 2.342429979762528e-06
cause O 0 2.0122455680393614e-05
ADNDI B-Disease 0 0.11540568619966507
have O 0 6.080921139073325e-06
been O 0 4.533743776846677e-06
found O 0 1.9723795503523434e-06
in O 0 5.987856752653897e-07
both O 0 3.1078823781172105e-07
the O 0 8.010572400962701e-07
signal O 0 8.251614417531528e-06
peptide O 0 2.2114493276603753e-06
of O 0 4.2501267216721317e-07
the O 0 2.8086265047022607e-06
prepro O 0 0.00046224301331676543
- O 0 0.00038880115607753396
AVP O 0 0.0003816442913375795
- O 0 0.00020476662029977888
NPII O 0 0.00041307343053631485
precursor O 0 1.6240217519225553e-05
and O 0 4.371350769361015e-06
within O 0 1.1575274584174622e-05
NPII O 0 0.008527558296918869
itself O 0 9.132828563451767e-05
. O 0 6.910891534062102e-05

An O 0 0.00013702810974791646
affected O 0 0.00042979844147339463
girl O 0 0.003750550327822566
who O 0 2.0697267245850526e-05
presented O 0 5.873043846804649e-06
at O 0 1.569926280353684e-05
9 O 0 1.724998583085835e-05
months O 0 3.320240466564428e-06
of O 0 6.08108507549332e-07
age O 0 1.6577316273469478e-05
and O 0 3.581701321309083e-06
her O 0 5.647773286909796e-05
similarly O 0 2.386772212048527e-05
affected O 0 6.961273811612045e-06
younger O 0 1.237445576407481e-05
brother O 0 2.9337825253605843e-05
and O 0 2.2458850708062528e-06
father O 0 3.7867503124289215e-05
were O 0 3.165481075484422e-06
all O 0 3.0189923450052447e-07
found O 0 1.5131582813410205e-06
to O 0 9.281425263907295e-07
have O 0 2.4693044906598516e-06
a O 0 2.5949111659429036e-06
novel O 0 5.789389888377627e-06
missense O 0 3.8906502595636994e-05
mutation O 0 1.899965172924567e-05
( O 0 3.2331272450392134e-06
G1758 O 0 0.00012106624490115792
- O 0 0.0017713127890601754
- O 0 0.007289939559996128
> O 0 0.00024622862110845745
T O 0 0.0004127563734073192
) O 0 9.482283758188714e-07
encoding O 0 1.581239757797448e-06
the O 0 1.257228745998873e-06
amino O 0 6.143049176898785e-06
acid O 0 7.651957275811583e-06
substitution O 0 3.9168671719380654e-06
Gly23 O 0 5.436910214484669e-05
- O 0 7.377473230008036e-05
- O 0 0.0001695867395028472
> O 0 7.468010880984366e-05
Val O 0 0.0007933725719340146
within O 0 2.6951251129503362e-05
NPII O 0 0.019831089302897453
. O 0 8.954167424235493e-05

The O 0 0.00014447516878135502
mutation O 0 0.000510471232701093
was O 0 0.00014562408614438027
confirmed O 0 3.1140945793595165e-05
by O 0 6.483409379143268e-06
restriction O 0 2.952184877358377e-05
endonuclease O 0 0.00038911504088900983
analysis O 0 7.90261328802444e-05
. O 0 9.951797983376309e-05

A O 0 0.0004575108177959919
T1 O 0 0.0017412829911336303
- O 0 0.00011230305244680494
weighted O 0 2.357816993026063e-05
magnetic O 0 1.3391069842327852e-05
resonance O 0 1.9430202883086167e-05
imaging O 0 0.00010954451136058196
of O 0 3.6054750580660766e-06
the O 0 2.283073808939662e-05
fathers O 0 0.025690093636512756
pituitary O 0 0.015314549207687378
gland O 0 0.0003169160336256027
demonstrates O 0 1.4844495126453694e-05
an O 0 1.0481671779416502e-05
attenuated O 0 0.004150699358433485
posterior O 0 0.07780016958713531
pituitary O 0 0.11355875432491302
bright O 0 0.0012274711625650525
spot O 0 0.0004628582682926208
. O 0 9.689949365565553e-05

This O 0 7.401523180305958e-05
mutation O 0 0.00024852590286172926
may O 0 4.987261490896344e-05
be O 0 1.025110009322816e-06
valuable O 0 1.3718831723963376e-06
for O 0 5.008407697459916e-07
developing O 0 3.1733638934383634e-06
models O 0 4.1618159229983576e-06
of O 0 2.3670875179959694e-06
dominantly B-Disease 1 0.9507118463516235
inherited I-Disease 1 0.9998601675033569
neurodegeneration I-Disease 1 0.9999998807907104
, O 0 1.715186044748407e-05
as O 0 6.090591568863601e-07
the O 0 6.226836717360129e-07
early O 0 2.9884413379477337e-06
age O 0 4.651023573387647e-06
of O 0 9.509460596746067e-07
onset O 0 0.3760871887207031
of O 0 6.130184920039028e-05
symptoms O 1 0.8887934684753418
suggests O 0 1.5600551705574617e-05
that O 0 1.4920135527063394e-06
this O 0 2.4282576305267867e-06
mutation O 0 7.741628360236064e-05
may O 0 1.6422607586719096e-05
be O 0 1.080002220987808e-06
particularly O 0 1.556520032863773e-06
deleterious O 0 1.4624046343669761e-05
to O 0 1.687792178017844e-06
the O 0 6.209761522768531e-06
magnocellular O 0 0.001480614417232573
neuron O 0 0.0003302500117570162
. O 0 7.449246822943678e-06
. O 0 2.5573070161044598e-05

Frequent O 0 0.0017527376767247915
inactivation O 0 0.024772116914391518
of O 0 0.00011352433648426086
PTEN O 0 0.025871720165014267
/ O 0 0.0006820480339229107
MMAC1 O 0 0.05653294920921326
in O 0 0.0004173817578703165
primary O 1 0.9996718168258667
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
. O 0 0.0007555769989266992

Sporadic B-Disease 1 0.9997701048851013
prostate I-Disease 1 1.0
carcinoma I-Disease 1 1.0
is O 0 0.00011414653999963775
the O 0 7.713780178164598e-06
most O 0 3.265817895226064e-06
common O 0 1.2249072824488394e-05
male B-Disease 0 0.002670187735930085
cancer I-Disease 0 0.010916173458099365
in O 0 2.2661690763925435e-06
the O 0 2.2961598915571813e-06
Western O 0 4.406391781230923e-06
world O 0 1.818271448428277e-05
, O 0 2.1518201265280368e-06
yet O 0 4.932880983687937e-07
many O 0 9.967970981961116e-08
of O 0 1.532616380472973e-07
the O 0 1.3238885685495916e-06
major O 0 5.377120032790117e-06
genetic O 0 8.70597614266444e-06
events O 0 1.8950671574202715e-06
involved O 0 4.169307885604212e-06
in O 0 1.4184149677021196e-06
the O 0 2.9625198294525035e-06
progression O 0 3.0251560019678436e-05
of O 0 9.958048394764774e-07
this O 0 7.741712579445448e-06
often O 0 0.001187728950753808
fatal O 1 0.9977497458457947
cancer B-Disease 1 0.9604824781417847
remain O 0 2.9014074243605137e-05
to O 0 7.055054538795957e-06
be O 0 3.140131593681872e-05
elucidated O 0 0.0008039353997446597
. O 0 6.16975303273648e-05

Numerous O 0 0.00030325978877954185
cytogenetic O 0 0.006057806313037872
and O 0 0.00012898190470878035
allelotype O 0 0.016009801998734474
studies O 0 1.5697361959610134e-05
have O 0 1.4987252143328078e-05
reported O 0 3.217045377823524e-05
frequent O 0 1.3691405001736712e-05
loss O 0 0.0001032613217830658
of O 0 2.5968570298573468e-06
heterozygosity O 0 0.0015412640059366822
on O 0 3.0516135666402988e-05
chromosomal O 1 0.5448971390724182
arm O 1 0.9703463315963745
10q O 0 0.1464875042438507
in O 0 0.0014486733125522733
sporadic B-Disease 1 0.9999198913574219
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
. O 0 0.0005825309781357646

Deletion O 0 0.0025906648952513933
mapping O 0 0.0005020320531912148
studies O 0 0.0001200834522023797
have O 0 6.254655454540625e-05
unambiguously O 0 0.0008548988844268024
identified O 0 1.704131682345178e-05
a O 0 4.328143404563889e-06
region O 0 6.032281362422509e-06
of O 0 2.1124510567460675e-06
chromosome O 0 0.0034231331665068865
10q23 O 0 0.00015512856771238148
to O 0 1.5329716234191437e-06
be O 0 8.254237968685629e-07
the O 0 1.25079952795204e-06
minimal O 0 1.1157355402247049e-05
area O 0 5.827250333823031e-06
of O 0 4.2565902731439564e-06
loss O 0 0.001407247269526124
. O 0 5.290372428135015e-05

A O 0 0.0002740345080383122
new O 0 0.00010376332647865638
tumor B-Disease 0 0.008671336807310581
suppressor O 0 0.00034881685860455036
gene O 0 4.589637683238834e-05
, O 0 1.1921076293219812e-05
PTEN O 0 0.0003537717857398093
/ O 0 4.126245767110959e-05
MMAC1 O 0 0.0025767514016479254
, O 0 4.250485289958306e-06
was O 0 4.96035318064969e-05
isolated O 0 1.9070103007834405e-05
recently O 0 1.1397795788070653e-05
at O 0 4.472078217077069e-06
this O 0 3.471235459073796e-07
region O 0 2.0538061562547227e-06
of O 0 9.338586437479535e-07
chromosome O 0 0.0023913553450256586
10q23 O 0 0.0002801086811814457
and O 0 4.743756107927766e-06
found O 0 5.631276962958509e-06
to O 0 8.339724786310398e-07
be O 0 1.7118633195423172e-06
inactivated O 0 2.1828023818670772e-05
by O 0 9.139552616943547e-07
mutation O 0 6.647755526500987e-06
in O 0 4.939297014061594e-06
three O 0 0.03960176929831505
prostate B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
cell O 0 0.31275784969329834
lines O 0 0.001714496174827218
. O 0 0.00010740853758761659

We O 0 0.0002941735729109496
screened O 0 0.0008312786230817437
80 O 0 0.007600374985486269
prostate B-Disease 1 0.9999688863754272
tumors I-Disease 1 0.9999964237213135
by O 0 1.0801570169860497e-05
microsatellite O 0 0.00025625014677643776
analysis O 0 8.715612239029724e-06
and O 0 6.90665319780237e-06
found O 0 2.2845397324999794e-05
chromosome O 0 0.0003423578746151179
10q23 O 0 7.324395119212568e-05
to O 0 1.3854967164661502e-06
be O 0 1.6896185570658417e-06
deleted O 0 1.0042114809039049e-05
in O 0 4.38913320977008e-06
23 O 0 0.00011884643026860431
cases O 0 2.2547810658579692e-05
. O 0 5.2043647883692756e-05

We O 0 9.30231690290384e-05
then O 0 1.591915133758448e-05
proceeded O 0 1.4028210898686666e-05
with O 0 1.130333203036571e-06
sequence O 0 1.7710847259877482e-06
analysis O 0 7.978147777976119e-07
of O 0 5.535390528166317e-07
the O 0 3.2555526559008285e-06
entire O 0 5.354527456802316e-05
PTEN O 0 0.0020168812479823828
/ O 0 5.7063763961195946e-05
MMAC1 O 0 0.0012028280179947615
coding O 0 5.544687155634165e-05
region O 0 9.759347449289635e-06
and O 0 6.960304745007306e-06
tested O 0 3.595694215619005e-05
for O 0 2.189219230785966e-06
homozygous O 0 6.509121158160269e-05
deletion O 0 1.864767364168074e-05
with O 0 1.3432935475066188e-06
new O 0 5.157691248314222e-06
intragenic O 0 0.0016184165142476559
markers O 0 2.8554022719617933e-05
in O 0 2.2333344986691372e-06
these O 0 8.317073252328555e-07
23 O 0 2.1398695025709458e-05
cases O 0 1.161474301625276e-06
with O 0 4.356929366622353e-06
10q23 O 0 0.005034431349486113
loss O 0 0.00016991239681374282
of O 0 2.343892447242979e-05
heterozygosity O 0 0.11348528414964676
. O 0 0.00016975631297100335

The O 0 2.6800647901836783e-05
identification O 0 1.9374969269847497e-05
of O 0 2.3024006168270716e-06
the O 0 2.9649420412170002e-06
second O 0 1.689121563686058e-05
mutational O 0 0.00033766188425943255
event O 0 2.6999847250408493e-05
in O 0 6.028140433045337e-06
10 O 0 1.0397446203569416e-05
( O 0 1.8106139805240673e-06
43 O 0 1.6150204828591086e-05
% O 0 9.964213859348092e-06
) O 0 2.7742544261855073e-05
tumors B-Disease 1 0.9997826218605042
establishes O 0 0.0003646679106168449
PTEN O 0 0.007563520222902298
/ O 0 8.089855691650882e-05
MMAC1 O 0 0.000653526745736599
as O 0 1.0688673910408397e-06
a O 0 1.6328546053046011e-06
main O 0 6.4679943534429185e-06
inactivation O 0 9.519833838567138e-05
target O 0 6.5418844314990565e-06
of O 0 2.0454442619666224e-06
10q O 0 0.00047614809591323137
loss O 0 0.00020630854123737663
in O 0 9.251001029042527e-05
sporadic B-Disease 1 0.999891996383667
prostate I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 0.0001000699121505022
. O 0 0.00013178437075112015

Risk O 0 0.006553302984684706
reversals O 0 0.0010130859445780516
in O 0 5.0353559345239773e-05
predictive O 0 0.0005252485862001777
testing O 0 0.0005960645503364503
for O 0 0.007405158597975969
Huntington B-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999969005584717
. O 0 0.0005653357948176563

The O 0 4.41934862465132e-05
first O 0 2.842768662958406e-05
predictive O 0 8.984359010355547e-05
testing O 0 8.757110481383279e-05
for O 0 0.0003003344754688442
Huntington B-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999828338623047
( O 0 7.311794433917385e-06
HD B-Disease 0 0.025635957717895508
) O 0 3.925606961274752e-06
was O 0 1.2815295121981762e-05
based O 0 1.1360001508364803e-06
on O 0 8.539913665117638e-07
analysis O 0 9.309030133408669e-07
of O 0 8.138133011925675e-07
linked O 0 4.110233930987306e-05
polymorphic O 0 4.180204632575624e-05
DNA O 0 2.906655390688684e-05
markers O 0 2.1762840333394706e-05
to O 0 1.515078679403814e-06
estimate O 0 2.6551863356871763e-06
the O 0 5.966548997093923e-07
likelihood O 0 3.3026790333678946e-06
of O 0 8.571866487727675e-07
inheriting O 0 0.00011338628974044695
the O 0 5.016164777771337e-06
mutation O 0 3.0493240046780556e-05
for O 0 9.94160564005142e-06
HD B-Disease 0 0.002330734394490719
. O 0 7.896406896179542e-05

Limits O 0 0.00016139091167133301
to O 0 1.2902141861559357e-05
accuracy O 0 2.995338581968099e-05
included O 0 6.318080068012932e-06
recombination O 0 9.995163964049425e-06
between O 0 2.29067018153728e-06
the O 0 4.185769739706302e-06
DNA O 0 5.5292213801294565e-05
markers O 0 1.80182141775731e-05
and O 0 1.7718703020364046e-06
the O 0 4.0892437027650885e-06
mutation O 0 2.193934233218897e-05
, O 0 3.036029511349625e-06
pedigree O 0 7.639703107997775e-05
structure O 0 8.983231055026408e-06
, O 0 1.2305895324971061e-06
and O 0 8.327533009833132e-07
whether O 0 1.087161535906489e-06
DNA O 0 3.3180153877765406e-06
samples O 0 1.9032992213396938e-06
were O 0 1.6218186829064507e-06
available O 0 6.130684937488695e-07
from O 0 1.989987140404992e-06
family O 0 1.946249176398851e-05
members O 0 1.4331380953080952e-05
. O 0 3.97918229282368e-05

With O 0 3.939717498724349e-05
direct O 0 1.5503184840781614e-05
tests O 0 1.4611568985856138e-05
for O 0 1.1613436754487338e-06
the O 0 2.100818846884067e-06
HD B-Disease 0 0.00047073938185349107
mutation O 0 8.124337000481319e-06
, O 0 8.048231734392175e-07
we O 0 1.0165322237298824e-06
have O 0 5.580236575042363e-07
assessed O 0 1.176136379399395e-06
the O 0 3.634924041762133e-07
accuracy O 0 3.3538533443788765e-06
of O 0 8.343829449586337e-07
results O 0 1.162579792435281e-05
obtained O 0 2.0027009668410756e-06
by O 0 4.013112970824295e-07
linkage O 0 7.967320925672539e-06
approaches O 0 2.545944880694151e-06
when O 0 1.3368436384553206e-06
requested O 0 1.0484324093340547e-06
to O 0 6.297239565355994e-07
do O 0 6.897503226355184e-07
so O 0 3.863478923449293e-07
by O 0 2.192488040009266e-07
the O 0 8.384230909541657e-07
test O 0 2.78401294053765e-05
individuals O 0 7.577132691949373e-06
. O 0 2.7419268008088693e-05

For O 0 4.143465412198566e-05
six O 0 1.925281685544178e-05
such O 0 2.1293767531460617e-06
individuals O 0 2.853699470506399e-06
, O 0 2.6000834623118863e-06
there O 0 1.8543751139077358e-06
was O 0 1.7121101336670108e-05
significant O 0 1.9342676296218997e-06
disparity O 0 1.0974170436384156e-05
between O 0 2.0840489014517516e-06
the O 0 7.380985152849462e-06
tests O 0 0.00015865542809478939
. O 0 7.294749957509339e-05

Three O 0 0.00011885685671586543
went O 0 0.00013884634245187044
from O 0 6.103841315052705e-06
a O 0 1.38114382934873e-05
decreased O 0 0.00017726530495565385
risk O 0 3.179945997544564e-05
to O 0 1.0639682841429021e-06
an O 0 1.660980728956929e-06
increased O 0 9.799309736990836e-06
risk O 0 2.2285634258878417e-05
, O 0 6.704482302666293e-07
while O 0 6.02088562118297e-07
in O 0 5.939859306636208e-07
another O 0 1.11007864234125e-06
three O 0 1.6369785953429528e-06
the O 0 4.986521616956452e-06
risk O 0 0.00018152485426981002
was O 0 9.10970993572846e-05
decreased O 0 0.00022199578233994544
. O 0 2.9003229428781196e-05

Knowledge O 0 0.00010563768591964617
of O 0 8.875890671333764e-06
the O 0 9.519581908534747e-06
potential O 0 1.0239072253170889e-05
reasons O 0 3.3470350899733603e-06
for O 0 6.396790581675305e-07
these O 0 5.47033835118782e-07
changes O 0 1.2393826409606845e-06
in O 0 2.981040552185732e-06
results O 0 2.098101504088845e-05
and O 0 1.51842004925129e-06
impact O 0 2.3144912120187655e-06
of O 0 3.55425157749778e-07
these O 0 1.1189663382538129e-06
risk O 0 2.0756328012794256e-05
reversals O 0 1.3714613487536553e-05
on O 0 4.203827302262653e-06
both O 0 5.753037839895114e-06
patients O 0 0.00021813513012602925
and O 0 2.0229563233442605e-06
the O 0 2.4364480850636028e-06
counseling O 0 0.00013286672765389085
team O 0 1.5960697055561468e-05
can O 0 7.300029665202601e-07
assist O 0 1.714487211756932e-06
in O 0 8.902763397600211e-07
the O 0 4.904749744127912e-07
development O 0 4.3477467670527403e-07
of O 0 3.03704069892774e-07
strategies O 0 3.1078161555342376e-06
for O 0 5.292607170304109e-07
the O 0 2.9587504286610056e-06
prevention O 0 2.844726259354502e-05
and O 0 4.071491275681183e-06
, O 0 2.9826528589183e-06
where O 0 3.554499471647432e-06
necessary O 0 1.528237930870091e-06
, O 0 1.5532310726484866e-06
management O 0 3.5273394587420626e-06
of O 0 2.565193142345379e-07
a O 0 2.2087890101829544e-05
risk O 0 0.00010014094004873186
reversal O 0 1.0652624041540548e-05
in O 0 1.077439605978725e-06
any O 0 1.2772951549777645e-06
predictive O 0 4.582998371915892e-05
testing O 0 4.2161282181041315e-05
program O 0 1.8568951418274082e-05
. O 0 1.2621020687220152e-05
. O 0 3.4311917261220515e-05

A O 0 0.0004327461065258831
novel O 0 0.00010086230031447485
common O 0 3.456315243965946e-05
missense O 0 0.00021000459673814476
mutation O 0 6.457003473769873e-05
G301C O 0 0.00011888384324265644
in O 0 3.4404772577545373e-06
the O 0 6.2936228459875565e-06
N O 0 0.0005195549456402659
- O 0 0.00024101234157569706
acetylgalactosamine O 0 0.001718613551929593
- O 0 0.00042998322169296443
6 O 0 5.743686779169366e-05
- O 0 0.0021253633312880993
sulfate O 0 0.0001893973385449499
sulfatase O 0 0.0002471581392455846
gene O 0 2.309754017915111e-05
in O 0 2.4049251805990934e-05
mucopolysaccharidosis B-Disease 0 0.03215760365128517
IVA I-Disease 0 0.007649214006960392
. O 0 9.507087816018611e-05

Mucopolysaccharidosis B-Disease 1 0.992760419845581
IVA I-Disease 1 0.9975681900978088
( O 0 0.006163910496979952
MPS B-Disease 1 0.9999971389770508
IVA I-Disease 1 0.9999966621398926
) O 0 9.522629989078268e-05
is O 0 1.208491357829189e-05
an O 0 7.67453238950111e-05
autosomal B-Disease 1 0.9816955327987671
recessive I-Disease 1 0.999546468257904
lysosomal I-Disease 1 0.9999902248382568
storage I-Disease 1 0.9999978542327881
disorder I-Disease 1 0.9999953508377075
caused O 0 0.07199064642190933
by O 0 1.211656581290299e-05
a O 0 0.0031658855732530355
genetic B-Disease 1 0.9990910291671753
defect I-Disease 1 0.9991377592086792
in O 0 2.1160532924113795e-05
N O 0 0.03557118400931358
- O 0 0.0036736014299094677
acetylgalactosamine O 0 0.005464996676892042
- O 0 0.007289464585483074
6 O 0 0.00027524473262019455
- O 0 0.29477551579475403
sulfate O 0 0.0031559544149786234
sulfatase O 0 0.002958798548206687
( O 0 2.121221950801555e-05
GALNS O 0 0.006311456672847271
) O 0 2.0623816453735344e-05
. O 0 3.240736623411067e-05

In O 0 9.956279245670885e-05
previous O 0 3.2381140044890344e-05
studies O 0 8.236049325205386e-06
, O 0 4.717418505606474e-06
we O 0 1.2035580994051998e-06
have O 0 7.729096296316129e-07
found O 0 7.540596698163426e-07
two O 0 5.690926627721637e-07
common O 0 1.5598277514072834e-06
mutations O 0 7.06198125044466e-06
in O 0 1.7255676993954694e-06
Caucasians O 0 9.32032799028093e-06
and O 0 3.4314266486035194e-06
Japanese O 0 1.954880281118676e-05
, O 0 9.986302757170051e-06
respectively O 0 0.0001073174353223294
. O 0 3.814982846961357e-05

To O 0 8.493381028529257e-05
characterize O 0 8.151605288730934e-05
the O 0 1.038878417602973e-05
mutational O 0 0.00013042472710367292
spectrum O 0 1.279086518479744e-05
in O 0 1.9040253391722217e-06
various O 0 6.594686965399887e-07
ethnic O 0 2.258298991364427e-06
groups O 0 1.2789053016604157e-06
, O 0 1.9253288883192e-06
mutations O 0 4.665163487516111e-06
in O 0 8.791082564130193e-07
the O 0 2.6738402993942145e-06
GALNS O 0 0.004047677852213383
gene O 0 5.974650775897317e-06
in O 0 4.161498054600088e-06
Colombian O 0 7.705530151724815e-05
MPS B-Disease 1 0.9999876022338867
IVA I-Disease 1 0.99998939037323
patients O 0 0.2137710154056549
were O 0 9.784370195120573e-05
investigated O 0 4.0320417610928416e-05
, O 0 2.7030991986976005e-06
and O 0 3.0968692499300232e-06
genetic O 0 1.462534328311449e-05
backgrounds O 0 4.785477813129546e-06
were O 0 5.212350060901372e-06
extensively O 0 3.7596048514387803e-06
analyzed O 0 5.951091225142591e-06
to O 0 9.945777037501102e-07
identify O 0 5.3944286264595576e-06
racial O 0 2.294303840244538e-06
origin O 0 1.1331868563502212e-06
, O 0 7.829860351193929e-07
based O 0 8.728469538255013e-07
on O 0 1.0569395954007632e-06
mitochondrial O 0 5.217279976932332e-05
DNA O 0 5.340488496585749e-05
( O 0 2.907850330302608e-06
mtDNA O 0 1.943500137713272e-05
) O 0 7.327081675612135e-06
lineages O 0 5.896372385905124e-05
. O 0 4.418375465320423e-05

Three O 0 0.00021370610920712352
novel O 0 0.00016961812798399478
missense O 0 0.000551532139070332
mutations O 0 0.00042503225267864764
never O 0 0.00015522890316788107
identified O 0 1.8603801436256617e-05
previously O 0 1.055903521773871e-05
in O 0 1.1699600008796551e-06
other O 0 4.5319140440369665e-07
populations O 0 1.243598944711266e-06
and O 0 8.243915772254695e-07
found O 0 2.125773107763962e-06
in O 0 1.027328721647791e-06
16 O 0 3.969771569245495e-06
out O 0 9.85144197329646e-07
of O 0 6.252608955037431e-07
19 O 0 4.6312557969940826e-05
Colombian O 0 2.2158694264362566e-05
MPS B-Disease 1 0.987941324710846
IVA I-Disease 1 0.9084249138832092
unrelated O 0 2.9364306101342663e-05
alleles O 0 1.7061383914551698e-05
account O 0 1.018309012579266e-05
for O 0 8.036412509682123e-06
84 O 0 0.0001367443474009633
. O 0 7.029480912024155e-05

2 O 0 0.00017779902555048466
% O 0 1.9754159438889474e-05
of O 0 2.6805373636307195e-06
the O 0 2.7090220555692213e-06
alleles O 0 1.14804115582956e-05
in O 0 3.2586654015176464e-06
this O 0 3.0438334306381876e-06
study O 0 2.5924553483491763e-05
. O 0 3.882970122504048e-05

The O 0 0.00026530493050813675
G301C O 0 0.0011660073651000857
and O 0 5.597452400252223e-05
S162F O 0 0.0005517300451174378
mutations O 0 9.951133688446134e-05
account O 0 1.3451302038447466e-05
for O 0 9.989617865358014e-06
68 O 0 0.0002179369912482798
. O 0 5.845079795108177e-05

4 O 0 0.0006807780591771007
% O 0 0.00011047308362321928
and O 0 4.456919486983679e-05
10 O 0 8.895258361008018e-05
. O 0 0.00010940034553641453

5 O 0 0.00024238716287072748
% O 0 1.8346147044212557e-05
of O 0 3.904247023456264e-06
mutations O 0 2.264868817292154e-05
, O 0 3.2292014111590106e-06
respectively O 0 9.674834473116789e-06
, O 0 1.0549638318479992e-06
whereas O 0 1.1580015097933938e-06
the O 0 1.0526583764658426e-06
remaining O 0 5.863530077476753e-06
F69V O 0 0.004230205435305834
is O 0 9.163248364529863e-07
limited O 0 1.992750185308978e-06
to O 0 1.3387815442911233e-06
a O 0 9.698778740130365e-06
single O 0 0.00011012998584192246
allele O 0 0.00023231285740621388
. O 0 8.162651647580788e-05

The O 0 0.00011667644139379263
skewed O 0 0.0003596130118239671
prevalence O 0 0.00025848139193840325
of O 0 9.198943189403508e-06
G301C O 0 0.00029415590688586235
in O 0 4.456024726096075e-06
only O 0 2.0269653759896755e-06
Colombian O 0 1.5286668713088147e-05
patients O 0 6.418437988031656e-05
and O 0 4.736531991511583e-06
haplotype O 0 6.117815792094916e-05
analysis O 0 2.97006158689328e-06
by O 0 2.1998573629389284e-06
restriction O 0 7.1046119956008624e-06
fragment O 0 2.761774157988839e-05
length O 0 1.7947402739082463e-05
polymorphisms O 0 4.715115574072115e-05
in O 0 2.8146544082119362e-06
the O 0 5.974559826427139e-06
GALNS O 0 0.011054813861846924
gene O 0 1.0853158528334461e-05
suggest O 0 3.578089263100992e-06
that O 0 1.0480705441295868e-06
G301C O 0 3.115606523351744e-05
originated O 0 3.92303581975284e-06
from O 0 1.4605208207285614e-06
a O 0 6.8146628109388985e-06
common O 0 1.4387923329195473e-05
ancestor O 0 9.484522888669744e-05
. O 0 7.120155351003632e-05

Investigation O 0 0.00012103069457225502
of O 0 1.417160365235759e-05
the O 0 1.2005044482066296e-05
genetic O 0 4.373165938886814e-05
background O 0 8.525652447133325e-06
by O 0 9.766009725353797e-07
means O 0 9.107290566134907e-07
of O 0 5.91692810303357e-07
mtDNA O 0 7.001126959949033e-06
lineages O 0 5.770043117081514e-06
indicate O 0 5.045248144597281e-06
that O 0 8.687536592333345e-07
all O 0 6.297617574091419e-07
our O 0 7.762790119159035e-06
patients O 0 5.1421615353319794e-05
are O 0 7.003958444329328e-07
probably O 0 2.5223573629773455e-06
of O 0 1.00137981462467e-06
native O 0 7.365747023868607e-06
American O 0 2.9826427635271102e-05
descent O 0 0.00064767588628456

Low O 0 0.0004897474427707493
frequency O 0 0.00010478720651008189
of O 0 2.1440857381094247e-05
BRCA1 O 0 0.0028943384531885386
germline O 0 0.0007437971653416753
mutations O 0 4.660421109292656e-05
in O 0 1.1373625966371037e-05
45 O 0 9.222417429555207e-05
German O 1 0.971877932548523
breast B-Disease 1 0.9999991655349731
/ I-Disease 1 0.9999982118606567
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
families O 0 0.00904789101332426
. O 0 0.0001920952054206282

In O 0 5.7376164477318525e-05
this O 0 8.337995495821815e-06
study O 0 6.112637947808253e-06
we O 0 2.4989717530843336e-06
investigated O 0 8.571862053941004e-06
45 O 0 1.560138480272144e-05
German O 1 0.8083950877189636
breast B-Disease 1 0.9999984502792358
/ I-Disease 1 0.999998927116394
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
families O 0 0.0001320419687544927
for O 0 1.3427155863610096e-05
germline O 0 0.001778876525349915
mutations O 0 2.751390275079757e-05
in O 0 3.059648179259966e-06
the O 0 1.5076419913384598e-05
BRCA1 O 0 0.004459384363144636
gene O 0 0.00013742694864049554
. O 0 6.74891343805939e-05

We O 0 0.00013603594561573118
identified O 0 6.676533666905016e-05
four O 0 1.5773550330777653e-05
germline O 0 0.0002872988407034427
mutations O 0 2.5820405426202342e-05
in O 0 4.7003632062114775e-06
three O 0 0.0008614372927695513
breast B-Disease 1 0.9999191761016846
cancer I-Disease 1 0.9347676038742065
families O 0 2.7760119337472133e-05
and O 0 5.2727154979947954e-06
in O 0 1.3816088539897464e-05
one O 0 0.006607610732316971
breast B-Disease 1 0.9999991655349731
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
family O 0 0.0014385187532752752
. O 0 9.160643799077661e-07
among O 0 5.148409627508954e-07
these O 0 4.649652680654981e-07
were O 0 3.2400414511357667e-06
one O 0 2.5038621060957666e-06
frameshift O 0 0.00019996044284198433
mutation O 0 1.4246715181798209e-05
, O 0 1.7930045714820153e-06
one O 0 2.4467585717502516e-06
nonsense O 0 5.137029438628815e-05
mutation O 0 7.853455826989375e-06
, O 0 1.0981370905938093e-06
one O 0 1.0326890560463653e-06
novel O 0 2.945436563095427e-06
splice O 0 9.246978152077645e-05
site O 0 3.238941644667648e-05
mutation O 0 1.4025013115315232e-05
, O 0 2.3736542971164454e-06
and O 0 3.1515771752310684e-06
one O 0 9.866233995126095e-06
missense O 0 0.00039085603202693164
mutation O 0 0.0003903213073499501
. O 0 9.235804463969544e-05

The O 0 0.00015982426702976227
missense O 0 0.0007319918368011713
mutation O 0 0.0002735826128628105
was O 0 0.00016122001397889107
also O 0 6.832037342974218e-06
found O 0 1.1276671102677938e-05
in O 0 1.0473638212715741e-05
2 O 0 5.888663145015016e-05
. O 0 4.3873766117030755e-05

8 O 0 0.0003180865605827421
% O 0 1.575077658344526e-05
of O 0 1.8099597127729794e-06
the O 0 2.395115643594181e-06
general O 0 2.2847511900181416e-06
population O 0 1.4880959042784525e-06
, O 0 1.1289090480204322e-06
suggesting O 0 4.272529167792527e-06
that O 0 7.731278515166196e-07
it O 0 1.6011229035939323e-06
is O 0 3.4194247291452484e-06
not O 0 3.810695488937199e-05
disease O 0 0.008623738773167133
associated O 0 0.00010086355177918449
. O 0 7.218257087515667e-05

The O 0 0.0001280180731555447
average O 0 0.0002609200309962034
age O 0 0.00011329216795274988
of O 0 3.973971979576163e-05
disease O 1 0.9819011092185974
onset O 1 0.7826560735702515
in O 0 3.9035279769450426e-05
those O 0 2.057038727798499e-05
families O 0 0.00014078627282287925
harbouring O 0 0.26736095547676086
causative O 0 0.0002921503328252584
mutations O 0 5.287663952913135e-05
was O 0 3.4276366932317615e-05
between O 0 1.1612180969677866e-05
32 O 0 0.00017145427409559488
. O 0 7.181424007285386e-05

3 O 0 0.0006860880530439317
and O 0 0.0001586417929502204
37 O 0 0.0005337337497621775
. O 0 0.00021808063320349902

4 O 0 0.00037363619776442647
years O 0 3.898148497682996e-05
, O 0 7.173498488555197e-06
whereas O 0 4.747566890728194e-06
the O 0 1.8844073110813042e-06
family O 0 2.151057378796395e-05
harbouring O 0 0.00017962181300390512
the O 0 2.3595055154146394e-06
missense O 0 3.817079050350003e-05
mutation O 0 1.9362503735464998e-05
had O 0 1.1725319382094312e-05
an O 0 1.1369061212462839e-06
average O 0 1.4394675417861436e-05
age O 0 3.14662770506402e-06
of O 0 1.1844964546980918e-06
onset O 0 0.0012363378191366792
of O 0 1.0052520337922033e-05
51 O 0 0.0006920784362591803
. O 0 6.422938167816028e-05

2 O 0 0.0013751816004514694
years O 0 0.0005458928062580526
. O 0 0.0003060008166357875

These O 0 3.3293606975348666e-05
findings O 0 3.275951530667953e-05
show O 0 1.4610510334023274e-05
that O 0 3.861198820231948e-06
BRCA1 O 0 0.0004228168982081115
is O 0 3.2440918857901124e-06
implicated O 0 2.019986459345091e-05
in O 0 1.2303372614042019e-06
a O 0 2.2531576178153045e-06
small O 0 2.938705620181281e-06
fraction O 0 8.103947038762271e-06
of O 0 3.617027687141672e-05
breast B-Disease 1 0.999998927116394
/ I-Disease 1 0.9999986886978149
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
families O 0 0.0001305792829953134
suggesting O 0 1.906190300360322e-05
the O 0 1.706638954601658e-06
involvement O 0 5.1901774895668495e-06
of O 0 1.3217564855949604e-06
another O 0 2.3923827029648237e-05
susceptibility O 0 0.002244003815576434
gene O 0 8.861004607751966e-05
( O 0 2.247151678602677e-05
s O 0 0.0013665042351931334
) O 0 7.322495366679505e-05

Paternal O 0 0.34976664185523987
transmission O 1 0.8408194184303284
of O 0 0.17563556134700775
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
. O 0 0.1831541508436203

We O 0 0.00020281225442886353
report O 0 4.371468457975425e-05
a O 0 1.4801056750002317e-05
rare O 0 2.2490146875497885e-05
case O 0 1.2400752893881872e-05
of O 0 4.2823809053516015e-05
paternally O 1 0.9998869895935059
transmitted O 1 0.9999747276306152
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 1 0.862191379070282
DM B-Disease 1 0.9999998807907104
) O 0 0.00022950605489313602
. O 0 0.00015500024892389774

The O 0 0.00012947678624186665
proband O 0 0.0030973402317613363
is O 0 1.151760807260871e-05
a O 0 9.5655223049107e-06
23 O 0 3.657307388493791e-05
year O 0 1.060743034031475e-05
old O 0 0.0032229728531092405
, O 0 0.0003639347560238093
mentally B-Disease 1 0.999998927116394
retarded I-Disease 1 0.9997982382774353
male O 0 0.002069581765681505
who O 0 0.2401721328496933
suffers O 1 0.9999830722808838
severe O 1 0.9999799728393555
muscular B-Disease 1 0.9999746084213257
weakness I-Disease 1 0.999082088470459
. O 0 0.0006866512121632695

He O 0 0.0008124180603772402
presented O 0 0.00011205625924048945
with O 0 0.00030014666845090687
respiratory O 1 0.9993605017662048
and O 0 0.00021159666357561946
feeding O 0 0.00704174255952239
difficulties O 0 0.007152050267904997
at O 0 0.0004548339347820729
birth O 0 0.011139842681586742
. O 0 7.957217167131603e-05

His O 0 0.0006995424628257751
two O 0 0.000513517705257982
sibs O 1 0.9726366400718689
suffer O 0 0.34731411933898926
from O 0 0.0002733093861024827
childhood O 1 0.9800204038619995
onset O 1 0.999977707862854
DM B-Disease 1 0.9999992847442627
. O 0 0.0015182716306298971

Their O 0 0.0001613941421965137
late O 0 9.954987035598606e-05
father O 0 0.00013820556341670454
had O 0 1.7265409042011015e-05
the O 0 1.7974542743104394e-06
adult O 0 6.383545041899197e-06
type O 0 8.509601684636436e-06
of O 0 1.0528980055823922e-05
DM B-Disease 1 0.999998927116394
, O 0 1.2847919606429059e-05
with O 0 1.1584495950955898e-05
onset O 0 0.06769807636737823
around O 0 3.599069896154106e-05
30 O 0 7.115118205547333e-05
years O 0 6.44606479909271e-05
. O 0 4.585021815728396e-05

Only O 0 2.9807659302605316e-05
six O 0 1.3048613254795782e-05
other O 0 2.03471631721186e-06
cases O 0 2.0965196654287865e-06
of O 0 2.3409272671415238e-06
paternal O 0 0.10912667959928513
transmission O 1 0.5064954161643982
of O 0 0.07757568359375
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
have O 0 0.009378851391375065
been O 0 0.0005606648046523333
reported O 0 0.0004548068391159177
recently O 0 0.0004209187754895538
. O 0 0.00010016052692662925

We O 0 7.097397610777989e-05
review O 0 1.563831392559223e-05
the O 0 5.59971840630169e-06
sex O 0 1.0705418389989063e-05
related O 0 5.987822078168392e-06
effects O 0 1.9859333406202495e-05
on O 0 2.7795989808510058e-05
transmission O 0 0.12361061573028564
of O 0 0.01887059584259987
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.0013264946173876524

Decreased O 0 0.003916616551578045
fertility O 0 0.0006206239922903478
of O 0 1.3198332453612238e-05
males O 0 4.022958455607295e-05
with O 0 1.2965986570634414e-05
adult O 0 0.0009079479495994747
onset O 1 0.9992000460624695
DM B-Disease 1 0.9999997615814209
and O 0 5.324383528204635e-05
contraction O 0 0.0002513022336643189
of O 0 1.0063426998385694e-06
the O 0 4.308947154640919e-06
repeat O 0 3.610985368140973e-05
upon O 0 5.212414635025198e-06
male O 0 1.2867784789705183e-05
transmission O 0 2.7224659788771532e-05
contribute O 0 2.199280515924329e-06
to O 0 6.816188715674798e-07
the O 0 1.0013759492721874e-06
almost O 0 2.8618537726288196e-06
absent O 0 9.178560503642075e-06
occurrence O 0 3.659016556412098e-06
of O 0 2.1244477466098033e-06
paternal O 0 0.04115348309278488
transmission O 0 0.21677759289741516
of O 0 0.030351998284459114
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.002276256214827299

Also O 0 8.093583164736629e-05
the O 0 1.0763267709990032e-05
fathers O 0 3.2772546546766534e-05
of O 0 2.353381660213927e-06
the O 0 9.0293960965937e-06
reported O 0 0.00014979767729528248
congenitally O 0 0.010748137719929218
affected O 0 2.8754269806086086e-05
children O 0 3.3431810152251273e-05
showed O 0 3.8985908759059384e-05
, O 0 1.5135017292777775e-06
on O 0 2.929019274233724e-06
average O 0 3.031021151400637e-05
, O 0 2.9734653708146652e-06
shorter O 0 6.132044654805213e-05
CTG O 0 0.0021765967831015587
repeat O 0 2.8282503990340047e-05
lengths O 0 6.96834540576674e-05
and O 0 6.406671673175879e-06
hence O 0 3.339134491397999e-05
less O 0 4.079101199749857e-05
severe O 1 0.9981154203414917
clinical O 1 0.9545831084251404
symptoms O 1 0.578609824180603
than O 0 2.4103376290440792e-06
the O 0 6.720435976603767e-06
mothers O 0 0.0007586292340420187
of O 0 3.5049699818046065e-06
children O 0 0.0097660506144166
with O 1 0.5479079484939575
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
. O 0 0.0009578622994013131

We O 0 0.00017009915609378368
conclude O 0 9.571354166837409e-05
that O 0 7.924990313767921e-06
paternal O 0 0.00038849213160574436
transmission O 0 0.11207069456577301
of O 0 0.018107393756508827
congenital B-Disease 1 1.0
DM I-Disease 1 1.0
is O 0 8.078169048530981e-05
rare O 0 2.4961136659840122e-05
and O 0 8.264577445515897e-06
preferentially O 0 2.261404733872041e-05
occurs O 0 1.2193571592433727e-06
with O 0 2.2958906811254565e-06
onset O 0 0.008603297173976898
of O 0 6.676753400824964e-06
DM B-Disease 1 0.9999834299087524
past O 0 1.063007402990479e-05
30 O 0 7.44011640563258e-06
years O 0 2.6988566332875052e-06
in O 0 1.3489947150446824e-06
the O 0 4.345651177573018e-06
father O 0 0.0005026701255701482
. O 0 7.572343292849837e-06
. O 0 3.0505108952638693e-05

The O 0 0.0004322429886087775
RB1 O 0 0.07360275834798813
gene O 0 0.00021947592904325575
mutation O 0 8.661206084070727e-05
in O 0 1.0247776117466856e-05
a O 0 1.8388394892099313e-05
child O 0 0.0006231940351426601
with O 0 0.00017286272486671805
ectopic B-Disease 1 0.9995947480201721
intracranial I-Disease 1 0.9999727010726929
retinoblastoma I-Disease 1 0.9992610812187195
. O 0 0.0005926501471549273

The O 0 0.00029554544016718864
RB1 O 0 0.06102295219898224
gene O 0 0.0002784309908747673
mutation O 0 0.00013293669326230884
was O 0 0.0001180414910777472
investigated O 0 2.4564224077039398e-05
in O 0 3.04362174574635e-06
a O 0 1.4700632164021954e-05
child O 0 0.0005439065280370414
with O 0 4.952157905790955e-05
ectopic B-Disease 1 0.9983181953430176
intracranial I-Disease 1 0.9995554089546204
retinoblastoma I-Disease 1 0.7147475481033325
using O 0 3.1284562282962725e-05
DNA O 0 7.829739479348063e-05
obtained O 0 7.829412425053306e-06
from O 0 1.213211703543493e-06
both O 0 1.0038620530394837e-06
the O 0 4.018607342004543e-06
pineal B-Disease 0 0.0004203899879939854
and I-Disease 0 6.051326636224985e-05
retinal I-Disease 1 0.6653374433517456
tumours I-Disease 1 0.9999663829803467
of O 0 9.327619409305044e-06
the O 0 0.0001229931804118678
patient O 0 0.06100625917315483
. O 0 9.408701589563861e-05

A O 0 0.00038775178836658597
nonsense O 0 0.0002737195754889399
mutation O 0 5.925966615905054e-05
in O 0 9.379292350786272e-06
exon O 0 9.433542436454445e-05
17 O 0 3.596434908104129e-05
( O 0 2.787189714581473e-06
codon O 0 1.1865997294080444e-05
556 O 0 9.328544365416747e-06
) O 0 7.967518058649148e-07
of O 0 3.5535873621483915e-07
the O 0 3.419000677240547e-06
RB1 O 0 0.0009295757627114654
gene O 0 6.66056121190195e-06
was O 0 1.0612347068672534e-05
found O 0 1.6384624359488953e-06
to O 0 6.617190706492693e-07
be O 0 7.765061695863551e-07
present O 0 1.0080390211442136e-06
homozygously O 0 3.8081419916125014e-05
in O 0 8.553060979465954e-07
both O 0 6.278584123720066e-07
the O 0 3.3001349493133603e-06
retinal B-Disease 0 0.00016203976701945066
and I-Disease 0 1.1652815373963676e-05
the I-Disease 0 9.503399633103982e-05
pineal I-Disease 1 0.9538384079933167
tumours I-Disease 1 0.999974250793457
. O 0 0.0002285079681314528

The O 0 8.846566925058141e-05
same O 0 4.7162669943645597e-05
mutation O 0 5.942478674114682e-05
was O 0 3.412236401345581e-05
present O 0 4.96971506436239e-06
heterozygously O 0 8.459537639282644e-05
in O 0 1.5752824538139976e-06
the O 0 1.150637899627327e-06
DNA O 0 5.025674909120426e-06
from O 0 6.266452032832603e-07
the O 0 6.745477207914519e-07
constitutional O 0 1.8583548353490187e-06
cells O 0 1.478475496696774e-06
of O 0 2.0389164490097755e-07
the O 0 3.324346835142933e-06
patient O 0 0.0006097243749536574
, O 0 5.338461050996557e-06
proving O 0 8.406094275414944e-05
it O 0 8.500027774971386e-07
to O 0 8.783942462287087e-07
be O 0 9.407989409737638e-07
of O 0 1.8905058141172049e-06
germline O 0 0.0002498249232303351
origin O 0 2.764947021205444e-05
. O 0 5.096641325508244e-05

The O 0 7.216414087451994e-05
initial O 0 0.00010138909419765696
mutation O 0 9.275221964344382e-05
was O 0 5.438066727947444e-05
shown O 0 4.03214335165103e-06
to O 0 1.5334176168835256e-06
have O 0 3.151023975078715e-06
occurred O 0 6.891520115459571e-06
in O 0 2.474830580467824e-06
the O 0 1.296808841289021e-05
paternally O 0 0.0009504039771854877
derived O 0 7.195729267550632e-05
RB1 O 0 0.001565761398524046
allele O 0 0.0001817430747905746
. O 0 6.141207995824516e-05

The O 0 9.822670836001635e-05
mutation O 0 0.0001506035914644599
is O 0 3.5425398436927935e-06
in O 0 1.3925543953519082e-06
an O 0 6.537055696753669e-07
area O 0 1.3803808087686775e-06
of O 0 1.835115170933932e-07
the O 0 6.426557206395955e-07
gene O 0 1.8141398641091655e-06
that O 0 3.258716674281459e-07
encodes O 0 1.7589972003406729e-06
the O 0 1.1307849945296766e-06
protein O 0 7.09410460331128e-06
- O 0 3.6201778129907325e-05
binding O 0 3.9320552787103225e-06
region O 0 4.168027771811467e-06
known O 0 2.89798640551453e-06
as O 0 9.638371238906984e-07
the O 0 1.6149797374964692e-06
pocket O 0 0.004163107369095087
region O 0 5.56322402189835e-06
and O 0 3.550643896232941e-06
has O 0 2.761428049780079e-06
been O 0 2.799604089886998e-06
detected O 0 6.6001698542095255e-06
in O 0 5.318863713910105e-07
other O 0 4.857992621509766e-07
cases O 0 1.4611491678806487e-06
of O 0 5.052528194937622e-06
retinoblastoma B-Disease 0 0.11220704764127731
. O 0 2.5321176508441567e-05
. O 0 7.153659680625424e-05

Low O 0 0.0008064216817729175
levels O 0 6.420378485927358e-05
of O 0 5.90935405853088e-06
beta O 0 3.0347868232638575e-05
hexosaminidase O 0 0.0002137234405381605
A O 0 2.682176636881195e-05
in O 0 1.5469231584575027e-05
healthy O 0 0.00011017621727660298
individuals O 0 3.7336615150707075e-06
with O 0 4.669812187785283e-05
apparent O 1 0.9967154264450073
deficiency O 1 0.9351767897605896
of O 0 3.2389418720413232e-06
this O 0 1.127912400988862e-05
enzyme O 0 0.0002595007244963199
. O 0 6.191779539221898e-05

Appreciable O 0 0.0039624315686523914
beta O 0 0.0007879294571466744
hexosaminidase O 0 0.00636994419619441
A O 0 0.00010772980022011325
( O 0 6.3455677263846155e-06
hex O 0 3.2022580853663385e-05
A O 0 7.382442618109053e-06
) O 0 8.032328651097487e-07
activity O 0 1.1060208180424524e-06
has O 0 7.424703767355822e-07
been O 0 1.9855510799970943e-06
detected O 0 5.451950073620537e-06
in O 0 2.1190128336456837e-06
cultured O 0 0.00010277035471517593
skin O 0 0.008323277346789837
fibroblasts O 0 5.727977259084582e-05
and O 0 0.0001592477347003296
melanoma B-Disease 1 0.9970448613166809
tissue O 0 0.049883998930454254
from O 0 2.2976599211688153e-05
healthy O 0 0.00028755259700119495
individuals O 0 5.158241947356146e-06
previously O 0 7.399715832434595e-05
reported O 0 0.00014943574205972254
as O 0 2.033675082202535e-05
having O 0 0.3025738298892975
deficiency B-Disease 0 0.07497763633728027
of I-Disease 0 5.834641001456475e-07
hex I-Disease 0 5.183834218769334e-05
A I-Disease 0 2.9873897346988088e-06
activity O 0 1.2532198070402956e-06
indistinguishable O 0 2.059576900137472e-06
from O 0 4.665976973683428e-07
that O 0 5.163372520655685e-07
of O 0 1.4428362646867754e-06
patients O 0 0.0019920801278203726
with O 0 0.08483657985925674
Tay B-Disease 1 1.0
- I-Disease 1 1.0
Sachs I-Disease 1 1.0
disease I-Disease 1 0.9832543730735779
( O 0 3.56912896677386e-05
TSD B-Disease 0 0.11578021943569183
) O 0 3.9101705624489114e-05
. O 0 6.530158862005919e-05

Identification O 0 0.0003445314650889486
and O 0 5.186543785384856e-05
quantitation O 0 0.0005919864634051919
of O 0 1.0883401955652516e-05
hex O 0 0.00028014046256430447
A O 0 2.4116705390042625e-05
, O 0 4.0466202335665e-06
amounting O 0 1.2816567505069543e-05
to O 0 4.483304564928403e-06
3 O 0 2.4727978598093614e-05
. O 0 3.3786876883823425e-05

5 O 0 0.0008051885524764657
% O 0 0.00025092469877563417
- O 0 0.0016730743227526546
6 O 0 0.0003072927356697619
. O 0 0.00012010805221507326

9 O 0 0.0006290117744356394
% O 0 2.2537189579452388e-05
of O 0 2.5197944069077494e-06
total O 0 5.154372047400102e-06
beta O 0 9.266795132134575e-06
hexosaminidase O 0 0.0001069803474820219
activity O 0 3.259765662733116e-06
, O 0 1.044890836965351e-06
has O 0 1.2199072898511076e-06
been O 0 1.3121798474458046e-06
obtained O 0 2.0903225959045812e-06
by O 0 1.5410672631333e-06
cellulose O 0 8.792581502348185e-05
acetate O 0 6.601360655622557e-05
gel O 0 0.0008191269589588046
electrophoresis O 0 0.00015050395450089127
, O 0 5.166709797777003e-06
DEAE O 0 0.0002517787797842175
- O 0 6.77931311656721e-05
cellulose O 0 2.55945651588263e-05
ion O 0 1.697867082839366e-05
- O 0 3.7467416404979303e-05
exchange O 0 6.35934384263237e-06
chromatography O 0 5.086105738882907e-05
, O 0 4.40832945969305e-06
radial O 0 4.8278237954946235e-05
immunodiffusion O 0 0.00024244101950898767
, O 0 5.778788363386411e-06
and O 0 1.3646915249410085e-05
radioimmunoassay O 0 0.0012888923520222306
. O 0 6.849571946077049e-05

Previous O 0 0.0002670855028554797
family O 0 0.00014207782805897295
studies O 0 1.3810345080855768e-05
suggested O 0 1.3361067431105766e-05
that O 0 1.4384343103301944e-06
these O 0 1.0610359595375485e-06
individuals O 0 1.932189661602024e-06
may O 0 1.501881706644781e-05
be O 0 2.3063894332153723e-06
compound O 0 3.148872929159552e-05
heterozygotes O 0 2.129277891071979e-05
for O 0 5.522878154806676e-07
the O 0 1.2638693078770302e-06
common O 0 3.458049150140141e-06
mutant O 0 0.00011790975258918479
TSD B-Disease 0 0.0014693477423861623
gene O 0 7.575456038466655e-06
and O 0 1.7745676359481877e-06
a O 0 6.83016105540446e-06
rare O 0 1.2646515642700251e-05
( O 0 2.930463779193815e-06
allelic O 0 7.793655822752044e-05
) O 0 7.449069471476832e-06
mutant O 0 9.768643212737516e-05
gene O 0 6.035017941030674e-05
. O 0 4.0124941733665764e-05

Thus O 0 0.0002765926474239677
, O 0 1.604005774424877e-05
the O 0 4.068708221893758e-06
postulated O 0 2.4790333554847166e-05
rate O 0 5.674885869666468e-06
mutant O 0 2.0457058781175874e-05
gene O 0 8.212126886064652e-06
appears O 0 2.4904995825636433e-06
to O 0 5.663287652168947e-07
code O 0 8.109745976980776e-07
for O 0 2.0619948770672636e-07
the O 0 2.5503015876893187e-07
expression O 0 5.040247970100609e-07
of O 0 3.717324830176949e-07
low O 0 1.4658548934676219e-05
amounts O 0 2.9483592243195744e-06
of O 0 3.036669340872322e-06
hex O 0 0.00039062340511009097
A O 0 0.00013609549205284566
. O 0 7.883705984568223e-05

Heterozygotes O 0 0.004602576140314341
for O 0 2.7824526114272885e-05
the O 0 1.249083834409248e-05
rare O 0 2.0705796487163752e-05
mutant O 0 0.00027258414775133133
may O 0 5.1113991503370926e-05
be O 0 2.9254542823764496e-06
indistinguishable O 0 9.936477908922825e-06
from O 0 2.6590657853375887e-06
heterozygotes O 0 4.350516974227503e-05
for O 0 1.7034780057656462e-06
the O 0 5.329532996256603e-06
common O 0 3.669762736535631e-05
TSD B-Disease 0 0.050759922713041306
mutant O 0 0.0010951446602120996
. O 0 0.0001242875587195158

However O 0 0.00010810984531417489
, O 0 1.0467088031873573e-05
direct O 0 5.275315743347164e-06
visualization O 0 2.6244520995533094e-05
and O 0 4.196825557301054e-06
quantitation O 0 0.0001072956292773597
of O 0 2.0042543837917037e-06
hex O 0 0.00010425138316350058
A O 0 5.3694438975071535e-06
by O 0 7.617051096531213e-07
the O 0 1.125565745496715e-06
methods O 0 6.832213330199011e-06
described O 0 6.15476310485974e-05
may O 0 2.357396442675963e-05
prevent O 0 1.888989754661452e-05
false O 0 4.0267081203637645e-05
- O 0 0.005990170873701572
positive O 0 1.1810014257207513e-05
prenatal O 1 0.7680401802062988
diagnosis O 0 0.26911431550979614
of O 0 6.517107067338657e-06
TSD B-Disease 0 0.3991566002368927
in O 0 7.484993693651631e-05
fetuses O 0 0.36467695236206055
having O 0 6.001301881042309e-05
the O 0 8.415725460508838e-06
incomplete O 0 0.00415418017655611
hex B-Disease 0 0.02182595618069172
A I-Disease 0 0.06537734717130661
deficiency I-Disease 0 0.3065021336078644
of O 0 4.836783205064421e-07
the O 0 2.2105973584984895e-06
type O 0 3.4341639548074454e-05
described O 0 1.1740794434444979e-05
in O 0 1.2333117638263502e-06
the O 0 3.2752561764937127e-06
four O 0 4.652521602110937e-05
healthy O 0 0.00043060959433205426
individuals O 0 8.353450539289042e-05

The O 0 0.0005808153655380011
tumor B-Disease 0 0.03503057360649109
suppressor O 0 0.0012217815965414047
gene O 0 0.00020525687432382256
Smad4 O 0 0.0011854374315589666
/ O 0 0.00014940867549739778
Dpc4 O 0 0.00034909247187897563
is O 0 1.7039230897353264e-06
required O 0 1.7927601447809138e-06
for O 0 7.834879625079338e-07
gastrulation O 0 2.7446920285001397e-05
and O 0 1.5210085848593735e-06
later O 0 3.387086053407984e-06
for O 0 1.0612282039801357e-06
anterior O 0 0.0003524777421262115
development O 0 2.2363396965374704e-06
of O 0 1.1818730172308278e-06
the O 0 9.781541848497e-06
mouse O 0 0.0005243571940809488
embryo O 0 0.00031502972706221044
. O 0 4.7372184781124815e-05

Mutations O 0 0.002387451473623514
in O 0 0.00010831983672687784
the O 0 5.878496085642837e-05
SMAD4 O 0 0.2295813262462616
/ O 0 0.0010999806690961123
DPC4 O 0 0.3992960453033447
tumor B-Disease 0 0.035209279507398605
suppressor O 0 0.0002186980127589777
gene O 0 2.180877527280245e-05
, O 0 2.565388740549679e-06
a O 0 3.597263230403769e-06
key O 0 6.765771559003042e-06
signal O 0 1.3282909094414208e-05
transducer O 0 3.079894304391928e-05
in O 0 1.2110292573197512e-06
most O 0 1.6441724710603012e-06
TGFbeta O 0 0.0017850871663540602
- O 0 0.0004113454488106072
related O 0 3.7276913644745946e-06
pathways O 0 1.2079048246960156e-05
, O 0 6.882009984110482e-07
are O 0 1.9396823347506142e-07
involved O 0 6.808984380768379e-07
in O 0 5.352901553123957e-07
50 O 0 2.345087750654784e-06
% O 0 2.2482165604742477e-06
of O 0 1.2577079360198695e-05
pancreatic B-Disease 1 0.9999262094497681
cancers I-Disease 1 0.9924924969673157
. O 0 0.0002198732690885663

Homozygous O 0 0.019703011959791183
Smad4 O 0 0.0573897510766983
mutant O 0 0.008909161202609539
mice O 0 0.18274080753326416
die O 0 0.09882217645645142
before O 0 4.2411098547745496e-05
day O 0 4.414577051647939e-05
7 O 0 7.673866639379412e-05
. O 0 5.675865395460278e-05

5 O 0 0.0005590554210357368
of O 0 0.00014259139425121248
embryogenesis O 0 0.001989135053008795
. O 0 0.00029263063333928585

Mutant O 0 0.0016649581957608461
embryos O 0 0.0004208525351714343
have O 0 2.1190706320339814e-05
reduced O 0 2.000279891944956e-05
size O 0 2.0759851395268925e-05
, O 0 5.821129434480099e-06
fail O 0 2.5993100280174986e-05
to O 0 2.0289439817133825e-06
gastrulate O 0 0.0005072802887298167
or O 0 2.56474800153228e-06
express O 0 4.168902250967221e-06
a O 0 3.538764985933085e-06
mesodermal O 0 7.734912651358172e-05
marker O 0 3.69379558833316e-05
, O 0 3.2347929845855106e-06
and O 0 3.3349497243762016e-06
show O 0 2.9031176381977275e-05
abnormal O 0 0.0003526000655256212
visceral O 0 0.0007226290763355792
endoderm O 0 0.0027421254198998213
development O 0 0.00013024812506046146
. O 0 0.00013651388871949166

Growth B-Disease 1 0.9887912273406982
retardation I-Disease 1 0.999808132648468
of O 0 2.0907511498080567e-05
the O 0 2.7442523787613027e-05
Smad4 O 0 0.42594119906425476
- O 0 0.370484322309494
deficient O 0 0.018410351127386093
embryos O 0 1.2690444236795884e-05
results O 0 2.62193361777463e-06
from O 0 1.9758360849664314e-06
reduced O 0 1.4349418961501215e-05
cell O 0 5.2235875045880675e-05
proliferation O 0 1.0186334293393884e-05
rather O 0 1.955374273165944e-06
than O 0 1.7851680240710266e-06
increased O 0 2.0831525034736842e-05
apoptosis O 0 0.0002892565680667758
. O 0 4.8101723223226145e-05

Aggregation O 0 0.0005785831599496305
of O 0 6.177702016429976e-05
mutant O 0 0.0004138485237490386
Smad4 O 0 0.0014605827163904905
ES O 0 0.0008301684283651412
cells O 0 2.459505049046129e-05
with O 0 5.792554475192446e-06
wild O 0 1.99291534954682e-05
- O 0 0.00015746825374662876
type O 0 3.903636024915613e-05
tetraploid O 0 0.0001729035866446793
morulae O 0 0.0003389186749700457
rescues O 0 0.00020789221161976457
the O 0 3.134841244900599e-05
gastrulation B-Disease 0 0.008214851841330528
defect I-Disease 0 0.030617091804742813
. O 0 0.00014758901670575142

These O 0 8.885915303835645e-05
results O 0 0.00010781890159705654
indicate O 0 3.6876925150863826e-05
that O 0 5.43804435437778e-06
Smad4 O 0 0.00027785103884525597
is O 0 1.8429369674777263e-06
initially O 0 4.4286907723289914e-06
required O 0 1.0588343002382317e-06
for O 0 3.658789466953749e-07
the O 0 4.906283948002965e-07
differentiation O 0 1.490452063990233e-06
of O 0 4.5773657575409743e-07
the O 0 1.7009519979183096e-06
visceral O 0 2.4376417059102096e-05
endoderm O 0 0.00010839744936674833
and O 0 1.986706593015697e-06
that O 0 7.627431273249385e-07
the O 0 2.23159941015183e-06
gastrulation B-Disease 0 0.00017829220450948924
defect I-Disease 0 0.0001651301427045837
in O 0 2.7640444386634044e-06
the O 0 6.183004643389722e-06
epiblast O 0 0.0015110514359548688
is O 0 1.5066066225699615e-06
secondary O 0 7.581628324260237e-06
and O 0 3.2772650229162537e-06
non O 0 2.300567393831443e-05
- O 0 0.0028379776049405336
cell O 0 0.0002680580073501915
autonomous O 0 0.00016821399913169444
. O 0 9.786283044377342e-05

Rescued O 0 0.08372700959444046
embryos O 0 0.004166402388364077
show O 0 0.0016310036880895495
severe O 1 0.9872346520423889
anterior O 1 0.9776776432991028
truncations O 1 0.595602810382843
, O 0 0.0001243412698386237
indicating O 0 7.798606384312734e-05
a O 0 7.634143003087956e-06
second O 0 8.835554581310134e-06
important O 0 7.949355449454742e-07
role O 0 1.7390051425536512e-06
for O 0 1.516473730589496e-06
Smad4 O 0 0.0002409881999483332
in O 0 1.0171132998948451e-05
anterior O 0 0.03093317709863186
patterning O 0 0.0010178699158132076
during O 0 0.00018247564730700105
embryogenesis O 0 0.0009199660271406174
. O 0 0.00012582189810927957

Prevalence O 0 0.003039129078388214
of O 0 7.280474528670311e-05
p16 O 0 0.0005185579648241401
and O 0 3.985236253356561e-05
CDK4 O 0 0.03217402845621109
germline O 0 0.0006724022096022964
mutations O 0 7.558665674878284e-05
in O 0 2.1152063709450886e-05
48 O 0 0.024629322811961174
melanoma B-Disease 1 0.9991357922554016
- O 1 0.5868734121322632
prone O 0 0.2708389461040497
families O 0 7.024597289273515e-05
in O 0 2.1972151444060728e-05
France O 0 0.00034011725801974535
. O 0 9.585648513166234e-05

The O 0 0.0002124286984326318
French O 0 0.0013592506293207407
Familial B-Disease 1 0.9923990368843079
Melanoma I-Disease 1 0.9999494552612305
Study O 0 0.00034920431789942086
Group O 0 0.0005535922246053815
. O 0 0.00010228600149275735

Germline O 0 0.012203843332827091
mutations O 0 0.00062501837965101
in O 0 3.572391142370179e-05
the O 0 1.4392726370715536e-05
p16 O 0 9.836928074946627e-05
and O 0 1.081977734429529e-05
CDK4 O 0 0.007525659631937742
genes O 0 1.0211883818556089e-05
have O 0 4.044718025397742e-06
been O 0 6.987625511101214e-06
reported O 0 6.602417215617606e-06
in O 0 1.0100849294758518e-06
a O 0 1.7751092400430935e-06
subset O 0 3.632446805568179e-06
of O 0 4.6678560465807095e-06
melanoma B-Disease 1 0.9381702542304993
pedigrees O 0 0.002427379135042429
, O 0 6.086310804676032e-06
but O 0 1.7730890249367803e-06
their O 0 7.1289982770395e-06
prevalence O 0 0.00034042279003188014
is O 0 1.5412246057167067e-06
not O 0 1.2629728871615953e-06
well O 0 2.9837483452865854e-06
known O 0 2.0973331629647873e-05
. O 0 2.224647869297769e-05

We O 0 6.957436562515795e-05
searched O 0 7.659369293833151e-05
for O 0 4.160371190664591e-06
such O 0 2.8638958156079752e-06
germline O 0 0.00014841473603155464
mutations O 0 1.5589323083986528e-05
in O 0 4.478407845454058e-06
48 O 0 6.121264596004039e-05
French O 0 0.00022612909378949553
melanoma B-Disease 1 0.9963340759277344
- O 0 0.3626650869846344
prone O 0 0.06659242510795593
families O 0 1.1072535016865004e-05
selected O 0 1.6504990298926714e-06
according O 0 8.591443361183337e-07
to O 0 5.415905661720899e-07
two O 0 1.3547344224207336e-06
major O 0 6.3410179791389965e-06
criteria O 0 1.071906717697857e-05
families O 0 3.0397463888220955e-06
with O 0 1.3938405345470528e-06
at O 0 2.7941257940256037e-05
least O 0 2.1375235519371927e-06
three O 0 1.4747353134225705e-06
affected O 0 8.812548003334086e-06
members O 0 1.5898040146566927e-06
( O 0 1.2349053122306941e-06
n O 0 0.00010121792001882568
= O 0 4.4046941184205934e-05
20 O 0 1.4135104038359714e-06
) O 0 2.860978440821782e-07
or O 0 3.726130728409771e-07
families O 0 7.976678944032756e-07
with O 0 3.646531183676416e-07
two O 0 1.2514462923718384e-06
affected O 0 4.564650680549676e-06
members O 0 7.130910262276302e-07
, O 0 2.9529616085710586e-07
one O 0 2.8437759169719357e-07
of O 0 2.2788334774759278e-07
them O 0 7.878960559537518e-07
affected O 0 2.1090390873723663e-06
before O 0 1.1080985586886527e-06
the O 0 6.544415782627766e-07
age O 0 1.780254592631536e-06
of O 0 3.799988235186902e-07
50 O 0 4.272920250514289e-06
( O 0 1.6527766319995862e-06
n O 0 5.503492502612062e-05
= O 0 8.122307190205902e-05
28 O 0 1.0048072908830363e-05
) O 0 4.4636624352278886e-07
, O 0 3.740871363788756e-07
and O 0 5.931266855441208e-07
one O 0 1.0848642659766483e-06
additional O 0 8.469145541312173e-06
minor O 0 0.00019729428458958864
criterion O 0 0.00033184504718519747
. O 0 9.385959128849208e-05

Sixteen O 0 0.0006070391391403973
different O 0 6.832533108536154e-05
p16 O 0 0.0005003924015909433
germline O 0 0.0005646789795719087
mutations O 0 8.890983735909685e-05
were O 0 1.9848541342071258e-05
found O 0 1.0217543604085222e-05
in O 0 4.504862772591878e-06
21 O 0 3.906946585630067e-05
families O 0 4.6288241719594225e-06
, O 0 1.1594402167247608e-06
while O 0 1.134902163357765e-06
one O 0 2.8983236006752122e-06
germline O 0 7.338957220781595e-05
mutation O 0 7.3854421316355e-06
, O 0 1.4274635304900585e-06
Arg24His O 0 6.616120663238689e-05
, O 0 1.6830473441586946e-06
was O 0 1.5844740119064227e-05
detected O 0 9.692139428807423e-06
in O 0 1.015143084259762e-06
the O 0 4.562953563436167e-06
CDK4 O 0 0.008678898215293884
gene O 0 7.075731991790235e-05
. O 0 4.3874853872694075e-05

The O 0 5.7218687288695946e-05
frequency O 0 5.361317744245753e-05
of O 0 1.050535047397716e-05
p16 O 0 0.0001260745630133897
gene O 0 2.3017766579869203e-05
mutation O 0 6.612436209252337e-06
in O 0 1.3299994634508039e-06
our O 0 1.9736573904083343e-06
sample O 0 2.6123168481717585e-06
( O 0 6.754636956429749e-07
44 O 0 2.953210923806182e-06
% O 0 9.333066373073962e-07
) O 0 3.695089674238261e-07
is O 0 2.09295876629767e-07
among O 0 2.024037684122959e-07
the O 0 4.827114707950386e-07
highest O 0 9.423313713341486e-06
rates O 0 5.2377085921762045e-06
yet O 0 2.6796683414431754e-06
reported O 0 4.995470135327196e-06
and O 0 1.1560814527911134e-06
the O 0 3.1710435450804653e-06
CDK4 O 0 0.1810561865568161
mutation O 0 9.257564670406282e-06
is O 0 3.105695611793635e-07
the O 0 4.107783979634405e-07
second O 0 8.497899216308724e-06
mutation O 0 1.5309135051211342e-05
detected O 0 1.5444376913364977e-05
in O 0 1.5553656567135477e-06
this O 0 1.5837947557884036e-06
gene O 0 1.882991273305379e-05
worldwide O 0 3.394748637219891e-05
. O 0 2.670540925464593e-05

In O 0 0.00013851653784513474
summary O 0 0.00012074367259629071
, O 0 8.851452548697125e-06
our O 0 5.100325324747246e-06
results O 0 5.604665147984633e-06
show O 0 3.840233603114029e-06
frequent O 0 3.7456802601809613e-06
involvement O 0 3.841376383206807e-06
of O 0 7.787323852426198e-07
the O 0 3.2010848372010514e-06
p16 O 0 5.304552905727178e-05
gene O 0 1.2094401427020784e-05
in O 0 1.1843817446788307e-05
familial B-Disease 1 0.7895804643630981
melanoma I-Disease 1 0.9970542192459106
and O 0 3.4888344089267775e-05
confirm O 0 2.425426100671757e-05
the O 0 1.1467719787106034e-06
role O 0 1.209571450999647e-06
of O 0 6.684282425339916e-07
the O 0 4.604485184245277e-06
CDK4 O 0 0.008718754164874554
gene O 0 5.530184807867045e-06
as O 0 2.022605258389376e-06
a O 0 6.980543548706919e-05
melanoma B-Disease 1 0.9896117448806763
- O 0 0.02093593031167984
predisposing O 0 0.0007470299606211483
gene O 0 5.3311261581256986e-05
. O 0 1.2222770237713121e-05
. O 0 4.708214328275062e-05

Progression O 0 0.0012789065949618816
of O 0 5.959481859463267e-05
somatic O 0 0.0012898010900244117
CTG O 0 0.005503591615706682
repeat O 0 0.00014311964332591742
length O 0 3.25904693454504e-05
heterogeneity O 0 5.270999827189371e-05
in O 0 6.396232492988929e-06
the O 0 9.451259757042862e-06
blood O 0 0.0008922189008444548
cells O 0 0.0001056646797223948
of O 0 0.00012335646897554398
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9976971745491028
. O 0 0.000664943887386471

The O 0 8.173727110261098e-05
genetic O 0 0.000245220260694623
basis O 0 2.3920267267385498e-05
of O 0 0.00013680773554369807
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.21816188097000122
DM B-Disease 1 1.0
) O 0 6.355214736686321e-06
is O 0 6.708057185278449e-07
the O 0 6.271498023124877e-07
expansion O 0 1.0890915973504889e-06
of O 0 6.209064622453297e-07
an O 0 1.2713069736491889e-05
unstable O 0 0.3529817759990692
CTG O 0 0.0036168070510029793
repeat O 0 2.113959999405779e-05
in O 0 1.5336619298977894e-06
the O 0 2.1569956061284756e-06
34 O 0 1.4796330106037203e-05
UTR O 0 4.5219247112981975e-05
of O 0 1.5577020349155646e-06
the O 0 2.289486292283982e-05
DM B-Disease 1 0.9999468326568604
protein O 0 3.881270458805375e-05
kinase O 0 6.844903691671789e-05
gene O 0 1.7837141058407724e-05
on O 0 1.2825026715290733e-05
chromosome O 0 0.0008453971822746098
19 O 0 0.00013415751163847744
. O 0 4.747701677842997e-05

One O 0 4.854008511756547e-05
of O 0 6.980179477977799e-06
the O 0 5.209487881074892e-06
principal O 0 7.2593852564750705e-06
features O 0 1.5573247083011665e-06
of O 0 1.1595794831009698e-06
the O 0 7.941616786411032e-05
DM B-Disease 1 0.9999998807907104
mutation O 0 0.00012539680756162852
is O 0 1.0888486485782778e-06
an O 0 8.738706469557656e-07
extraordinarily O 0 5.246487125987187e-05
high O 0 9.731204954732675e-06
level O 0 1.5077276884767343e-06
of O 0 1.2418448704920593e-06
somatic O 0 7.570986781502143e-05
mosaicism O 0 0.0037177326157689095
, O 0 4.795931090484373e-06
due O 0 4.761368927574949e-06
to O 0 1.1995576869594515e-06
an O 0 2.3295895061892224e-06
extremely O 0 1.6162561223609373e-05
high O 0 1.0913001460721716e-05
degree O 0 5.662840521836188e-06
of O 0 6.692134206787159e-07
somatic O 0 3.2512583857169375e-05
instability O 0 1.699824133538641e-05
both O 0 9.706482160254382e-07
within O 0 1.1528665027071838e-06
and O 0 1.289164515583252e-06
between O 0 1.895548052743834e-06
different O 0 6.633955308643635e-06
tissues O 0 0.0003063123149331659
. O 0 4.99426678288728e-05

This O 0 9.896192204905674e-05
instability O 0 0.00021828015451319516
appears O 0 1.8633772924658842e-05
to O 0 1.6758591527832323e-06
be O 0 8.586446256231284e-07
biased O 0 1.8312250631424831e-06
towards O 0 5.502212161445641e-07
further O 0 3.944529112231976e-07
expansion O 0 7.594405815325445e-07
and O 0 3.825721535122284e-07
continuous O 0 1.8567127426649677e-06
throughout O 0 6.276536055338511e-07
the O 0 5.857689302501967e-07
life O 0 8.176330084097572e-07
of O 0 1.682901569211026e-07
an O 0 7.797103194207011e-07
individual O 0 3.639239025687857e-07
, O 0 5.109762355459679e-07
features O 0 1.1826273293991107e-06
that O 0 1.3077749372314429e-06
could O 0 8.415179763687775e-06
be O 0 1.3025595535509638e-06
associated O 0 9.072753641703457e-07
with O 0 5.837584922119277e-07
the O 0 1.9846538634737954e-06
progressive O 0 2.062479870801326e-05
nature O 0 1.6413806633863715e-06
of O 0 1.7604202184884343e-06
the O 0 0.0005964402225799859
disease O 1 0.5229530334472656
. O 0 7.941124204080552e-05

Although O 0 0.0001027933758450672
increasing O 0 3.52701754309237e-05
measured O 0 5.5099098972277716e-05
allele O 0 4.045722744194791e-05
size O 0 1.7370894056512043e-05
between O 0 1.0226415724901017e-05
patients O 0 0.0005190939991734922
clearly O 0 7.958632522786502e-06
correlates O 0 4.409069788380293e-06
with O 0 8.966094924289791e-07
an O 0 2.088668679789407e-06
increased O 0 1.909752973006107e-05
severity O 0 0.000949396169744432
of O 0 1.1369093954272103e-05
symptoms O 0 0.4335092604160309
and O 0 3.7550512388406787e-06
an O 0 2.647335350047797e-06
earlier O 0 1.5958550648065284e-05
age O 0 1.3621858670376241e-05
of O 0 1.3792083564112545e-06
onset O 0 0.2115260809659958
, O 0 4.411374447954586e-06
this O 0 6.733297368555213e-07
correlation O 0 5.755671736551449e-06
is O 0 8.546504659534548e-07
not O 0 4.802174089491018e-07
precise O 0 3.832817128568422e-06
and O 0 2.1202904463279992e-06
measured O 0 2.3051594325806946e-05
allele O 0 8.398032150580548e-06
length O 0 1.1024982995877508e-05
cannot O 0 8.753496331337374e-06
be O 0 4.7615142761969764e-07
used O 0 6.251660806810833e-07
as O 0 3.8904883581381e-07
an O 0 4.533448532129114e-07
accurate O 0 1.518485714768758e-05
predictor O 0 9.231340663973242e-05
of O 0 9.448306741433043e-07
age O 0 2.529646189941559e-05
of O 0 8.227617399825249e-06
onset O 1 0.7714250087738037
. O 0 0.0001629036123631522

In O 0 0.00010872664279304445
order O 0 3.0142364266794175e-05
to O 0 4.608310973708285e-06
further O 0 3.5758005196839804e-06
characterize O 0 1.3949968888482545e-05
the O 0 3.2107063816511072e-06
dynamics O 0 6.26782129984349e-05
of O 0 1.9132765373797156e-05
DM B-Disease 1 0.9999991655349731
CTG O 0 0.019801875576376915
repeat O 0 0.0001144990892498754
somatic O 0 0.0001265453756786883
instability O 0 0.00013344240142032504
, O 0 4.675051059166435e-06
we O 0 2.6353804969403427e-06
have O 0 1.5346245163527783e-06
studied O 0 7.5419443419377785e-06
repeat O 0 2.7162108381162398e-05
length O 0 5.764911747974111e-06
changes O 0 1.3570879673352465e-06
over O 0 9.374797400596435e-07
time O 0 3.220565531592001e-06
in O 0 1.8145421563531272e-05
111 O 0 0.3321850895881653
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 0.9999998807907104
patients O 1 0.7600628137588501
with O 0 2.86280810541939e-05
varying O 0 0.000346473854733631
clinical O 0 0.22166287899017334
severity O 0 0.1402728110551834
and O 0 5.8937526773661375e-05
CTG O 0 0.01998167484998703
repeat O 0 3.914610715582967e-05
size O 0 5.958354449830949e-06
over O 0 1.1925360468012514e-06
time O 0 1.5604364307364449e-06
intervals O 0 2.5850235942925792e-06
of O 0 6.336873639156693e-07
1 O 0 6.947929250600282e-06
- O 0 0.00013470140402205288
7 O 0 3.6552290112013e-05
years O 0 1.6156782294274308e-05
. O 0 1.882793912955094e-05

We O 0 0.00011273629934294149
have O 0 9.210829375660978e-06
found O 0 4.055803856317652e-06
a O 0 2.4676896828168537e-06
direct O 0 2.468927732479642e-06
progression O 0 1.6583246178925037e-05
of O 0 5.217156626713404e-07
the O 0 1.2399963225107058e-06
size O 0 7.283114882739028e-06
heterogeneity O 0 7.982325769262388e-06
over O 0 2.0238710476405686e-06
time O 0 2.480742750776699e-06
related O 0 1.5876404404480127e-06
to O 0 1.7302721744272276e-06
initial O 0 3.510795795591548e-05
CTG O 0 0.0003465855261310935
repeat O 0 1.262732894247165e-05
size O 0 4.351166353444569e-06
and O 0 1.0736537205957575e-06
the O 0 1.201987743115751e-06
time O 0 1.8161322259402368e-06
interval O 0 4.966891538060736e-06
and O 0 1.3787440593659994e-06
always O 0 2.8545975965243997e-06
biased O 0 4.905918103759177e-06
towards O 0 4.20668311562622e-06
further O 0 7.242229457915528e-06
expansion O 0 4.306038681534119e-05
. O 0 5.540025813388638e-05

Attempts O 0 0.0003141239285469055
to O 0 3.246803316869773e-05
mathematically O 0 4.783959957421757e-05
model O 0 1.0908994227065705e-05
the O 0 4.061478193762014e-06
dynamics O 0 6.397868128260598e-05
have O 0 1.0640987966326065e-05
proved O 0 3.3236818126169965e-05
only O 0 1.622700665393495e-06
partially O 0 0.0001602882257429883
successful O 0 4.691576123150298e-06
suggesting O 0 3.983036549470853e-06
that O 0 3.9918634797686536e-07
individual O 0 4.698040925177338e-07
specific O 0 9.300874808104709e-07
genetic O 0 2.269214382977225e-05
and O 0 1.3463238246913534e-05
/ O 0 9.821049752645195e-05
or O 0 5.328323368303245e-06
environmental O 0 6.601762834179681e-06
factors O 0 1.5761119129820145e-06
also O 0 8.744716524233809e-07
play O 0 1.037343054122175e-06
a O 0 2.3958580186445033e-06
role O 0 3.275737071817275e-06
in O 0 4.033254754176596e-06
somatic O 0 0.000252568133873865
mosaicism O 0 0.006162850186228752
. O 0 1.313220400334103e-05
. O 0 4.1692608647281304e-05

Aspartylglucosaminuria B-Disease 1 0.9706450700759888
among O 0 0.0002822777896653861
Palestinian O 0 0.0015964441699907184
Arabs O 0 0.000620208855252713
. O 0 0.00020579183183144778

Aspartylglucosaminuria B-Disease 1 0.9999955892562866
( O 0 0.29838812351226807
AGU B-Disease 1 0.9999948740005493
) O 0 4.372452531242743e-05
is O 0 3.084798436248093e-06
a O 0 1.6176516510313377e-05
rare O 0 9.564000356476754e-05
disorder B-Disease 0 0.24271221458911896
of I-Disease 0 4.544210696622031e-06
glycoprotein I-Disease 0 0.03804941847920418
metabolism I-Disease 0 0.011601347476243973
caused O 0 0.0002403188991593197
by O 0 3.2445993838337017e-06
the O 0 0.00029309693491086364
deficiency B-Disease 0 0.25523993372917175
of I-Disease 0 9.84300072559563e-07
the I-Disease 0 1.1921201803488657e-05
lysosomal I-Disease 0 0.3772512674331665
enzyme I-Disease 0 0.00042311527067795396
aspartylglucosaminidase I-Disease 0 0.007139857858419418
( O 0 6.354330253088847e-06
AGA O 0 0.009284025058150291
) O 0 1.1734379768313374e-05
. O 0 2.9818322218488902e-05

AGU B-Disease 1 0.9999978542327881
is O 0 0.005072533152997494
inherited O 1 0.9481729865074158
as O 0 4.439489566721022e-05
an O 0 0.00012474933464545757
autosomal O 1 0.8713399171829224
recessive O 1 0.7790854573249817
trait O 0 0.001325134071521461
and O 0 1.3577450772572774e-05
occurs O 0 2.3561819944006857e-06
with O 0 1.1085213600381394e-06
a O 0 4.55461895398912e-06
high O 0 1.6473321011289954e-05
frequency O 0 6.784950073779328e-06
in O 0 2.7308160497341305e-06
Finland O 0 0.00011817765334853902
because O 0 2.002891960728448e-06
of O 0 7.762951099721249e-07
a O 0 1.7526443116366863e-05
founder O 0 0.000335013959556818
effect O 0 3.2178031688090414e-05
. O 0 2.839522494468838e-05

While O 0 0.00013614221825264394
very O 0 3.53007999365218e-05
few O 0 2.630119342938997e-05
patients O 0 0.0006582107744179666
with O 0 0.00011347769031999633
AGU B-Disease 1 0.9999984502792358
have O 0 0.0002733841829467565
been O 0 5.4155807447386906e-05
reported O 0 2.2622631149715744e-05
from O 0 2.440736807329813e-06
non O 0 9.444528586755041e-06
- O 0 7.018282485660166e-05
Finnish O 0 8.605438051745296e-05
origin O 0 6.873659913253505e-06
, O 0 1.5570542018394917e-05
we O 0 0.0002806473057717085
diagnosed O 1 0.8992526531219482
the O 0 4.24902027589269e-05
disorder O 1 0.8796030282974243
in O 0 1.595684625499416e-05
8 O 0 0.0013469414552673697
patients O 0 2.8686015866696835e-05
originating O 0 2.4919893348851474e-06
from O 0 1.5302766769309528e-06
3 O 0 8.634957339381799e-06
unrelated O 0 7.898100193415303e-06
families O 0 3.4915753985842457e-06
, O 0 6.370721621351549e-07
all O 0 3.397016143935616e-07
Palestinian O 0 9.926749953592662e-06
Arabs O 0 1.910221953949076e-06
from O 0 6.491987960544066e-07
the O 0 7.743734613541164e-07
region O 0 2.6935035748465452e-06
of O 0 3.245242851335206e-06
Jerusalem O 0 0.0008323625661432743
. O 0 7.80926420702599e-05

The O 0 0.0006626538233831525
clinical O 0 0.45224905014038086
diagnosis O 1 0.9979464411735535
of O 0 0.001186862587928772
AGU B-Disease 1 0.9999998807907104
is O 0 5.1595790864666924e-05
often O 0 1.8393253412796184e-05
difficult O 0 5.5373635404976085e-05
, O 0 2.985920218634419e-06
in O 0 8.937701068134629e-07
particular O 0 5.564357934417785e-07
early O 0 1.1870566822835826e-06
in O 0 9.915763712342596e-07
the O 0 1.0852223795154714e-06
course O 0 6.370239134412259e-06
of O 0 5.419998387878877e-07
the O 0 0.00012138795136706904
disease O 0 0.011687136255204678
, O 0 2.2494409677165095e-06
and O 0 1.0928528126896708e-06
most O 0 2.7261037871539884e-07
of O 0 3.6760249599865347e-07
the O 0 3.054068292840384e-05
patients O 0 0.01656346395611763
are O 0 5.888943633181043e-05
diagnosed O 1 0.9898214340209961
after O 0 3.134847429464571e-05
the O 0 2.980261797347339e-06
age O 0 1.5958474250510335e-05
of O 0 1.4551874301105272e-06
5 O 0 2.2559337594429962e-05
years O 0 2.9772658308502287e-05
. O 0 3.238855060772039e-05

However O 0 0.00022294011432677507
, O 0 2.2051710402593017e-05
since O 0 1.6930518540902995e-05
these O 0 3.3737746889528353e-06
patients O 0 3.9401005778927356e-05
excrete O 0 2.073144423775375e-05
early O 0 1.36480002765893e-06
large O 0 1.7458830825489713e-06
amounts O 0 1.3356724366531125e-06
of O 0 7.192008411038842e-07
aspartylglucosamine O 0 0.0001550593733554706
in O 0 6.109176410973305e-06
urine O 0 7.136809290386736e-05
, O 0 2.8158492568763904e-06
biochemical O 0 2.1601641492452472e-05
screening O 0 1.6052284991019405e-05
is O 0 1.4113485349298571e-06
easy O 0 4.993688435206423e-06
by O 0 2.7645821774058277e-06
urine O 0 9.306309220846742e-05
chromatography O 0 0.0003962470218539238
. O 0 8.344534762727562e-06
. O 0 2.7706539185601287e-05

Detection O 0 0.000585863774176687
of O 0 3.867098712362349e-05
heterozygous O 0 0.0002216489374404773
carriers O 0 3.154471778543666e-05
of O 0 5.100509952171706e-06
the O 0 0.0007419981411658227
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999927282333374
telangiectasia I-Disease 1 0.9999995231628418
( O 0 1.3111181942804251e-05
ATM O 0 0.0044296481646597385
) O 0 2.2490742139780195e-06
gene O 0 3.475098310445901e-06
by O 0 1.5943408016028116e-06
G2 O 0 0.0003511451941449195
phase O 0 1.9399392840568908e-05
chromosomal O 0 0.0005880707176402211
radiosensitivity O 0 0.0003743528504855931
of O 0 8.14691429695813e-06
peripheral O 0 0.20943936705589294
blood O 0 0.19090764224529266
lymphocytes O 0 0.006303791422396898
. O 0 0.00011029846064047888

In O 0 0.084797702729702
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999902248382568
telangiectasia I-Disease 1 0.9999998807907104
( O 0 0.007115551270544529
A B-Disease 1 0.9999852180480957
- I-Disease 1 0.9999988079071045
T I-Disease 1 0.9999998807907104
) O 0 3.0494316888507456e-05
patients O 0 5.40466389793437e-05
, O 0 2.299727611898561e-06
mutations O 0 4.482047643250553e-06
in O 0 8.3119664395781e-07
a O 0 3.420151870159316e-06
single O 0 2.2157510102260858e-05
gene O 0 8.244605851359665e-06
, O 0 2.325500645383727e-06
ATM O 0 0.011011281050741673
, O 0 5.53761583432788e-06
result O 0 1.606105979590211e-05
in O 0 7.403521158266813e-05
an O 1 0.8937607407569885
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
syndrome I-Disease 1 1.0
that O 0 2.2609841835219413e-05
embraces O 0 4.522239396465011e-05
a O 0 3.4012505238933954e-06
variety O 0 1.0989166412400664e-06
of O 0 1.204560589940229e-06
clinical O 0 0.0001200379992951639
features O 0 6.7674041019927245e-06
and O 0 1.2683741260843817e-05
manifests O 0 8.553014049539343e-05
extreme O 0 9.822558786254376e-05
radiosensitivity O 0 0.010191799141466618
and O 0 3.7407039599202108e-06
a O 0 6.677046258118935e-06
strong O 0 1.123753099818714e-05
pre O 0 0.002464588964357972
- O 0 0.007867179811000824
disposition O 0 0.0001456082536606118
to O 0 3.5938675864599645e-05
malignancy B-Disease 0 0.2787751257419586
. O 0 8.290590631077066e-05

Heterozygotes O 0 0.002488700905814767
for O 0 3.076195571338758e-05
the O 0 1.2243442142789718e-05
ATM O 0 0.0014318478060886264
gene O 0 2.1918158381595276e-05
have O 0 3.984419436164899e-06
no O 0 5.156746738066431e-06
clinical O 0 1.264287311641965e-05
expression O 0 3.120146175206173e-06
of O 0 3.114085075139883e-06
A B-Disease 1 0.9998658895492554
- I-Disease 1 0.9999933242797852
T I-Disease 1 0.9999998807907104
but O 0 8.430763409705833e-05
may O 0 0.0014390992000699043
be O 0 8.137237455230206e-05
cancer B-Disease 0 0.04886799678206444
prone O 0 0.002677293261513114
with O 0 3.3126561902463436e-06
a O 0 1.891807551146485e-05
moderate O 0 0.00016769110516179353
increase O 0 7.867413842177484e-06
in O 0 6.31658622296527e-06
in O 0 2.8356744223856367e-05
vitro O 0 0.00510026840493083
radiosensitivity O 0 0.02809879742562771
. O 0 6.988796667428687e-05

We O 0 0.00019929996051359922
performed O 0 0.00011543399887159467
a O 0 2.4525696062482893e-05
blind O 0 0.00016928011609707028
chromosomal O 0 0.00031885196221992373
analysis O 0 9.841612154559698e-06
on O 0 1.3435083928925451e-05
G2 O 0 0.006198206916451454
- O 0 0.00018337075016461313
phase O 0 3.606824975577183e-05
lymphocytes O 0 5.074715954833664e-05
from O 0 2.662879978743149e-06
7 O 0 2.5801724405027926e-05
unrelated O 0 5.927712845732458e-05
A B-Disease 1 0.999249279499054
- I-Disease 1 0.9999994039535522
T I-Disease 1 1.0
patients O 0 0.05491827800869942
, O 0 6.952343937882688e-06
13 O 0 2.8035263312631287e-05
obligate O 0 2.4855904484866187e-05
A B-Disease 1 0.9995450377464294
- I-Disease 1 0.9999923706054688
T I-Disease 1 0.9999998807907104
heterozygotes O 0 0.00034557984326966107
( O 0 9.15800626444252e-07
parents O 0 2.8623533125937684e-06
of O 0 4.4631258333538426e-07
the O 0 2.820651570800692e-05
patients O 0 0.003842036472633481
) O 0 1.066893560164317e-06
, O 0 9.665635616329382e-07
and O 0 1.3210949418862583e-06
14 O 0 5.128938028065022e-06
normal O 0 2.8713948267977685e-06
controls O 0 4.922978405375034e-06
following O 0 2.2671504211757565e-06
X O 0 0.0001713091623969376
- O 0 4.395329233375378e-05
irradiation O 0 6.218621365405852e-06
with O 0 1.4552235825249227e-06
1 O 0 5.686261829396244e-06
Gy O 0 0.00029634503880515695
in O 0 9.140807719631994e-07
order O 0 9.853397386905272e-07
to O 0 5.871593202755321e-07
evaluate O 0 3.6016363083035685e-06
this O 0 5.506527145371365e-07
cytogenetic O 0 3.5236218536738306e-05
method O 0 2.001345364988083e-06
as O 0 6.147769227027311e-07
a O 0 1.0621597539284267e-06
tool O 0 5.25834366271738e-06
for O 0 7.445521532645216e-07
detection O 0 1.3404026503849309e-05
of O 0 5.962288014416117e-06
ATM O 0 0.22100718319416046
carriers O 0 0.00041727954521775246
. O 0 8.661948959343135e-05

Both O 0 0.00025461215409450233
A B-Disease 1 0.9520630836486816
- I-Disease 1 0.9981684684753418
T I-Disease 1 0.9999678134918213
homozygotes O 0 0.0006761997938156128
and O 0 8.98718190001091e-06
heterozygotes O 0 9.948780643753707e-05
showed O 0 4.050988354720175e-05
significantly O 0 1.0216725968348328e-05
increased O 0 3.4182346553279785e-06
levels O 0 2.8203103283885866e-06
of O 0 2.0956563275831286e-06
radiation O 0 0.15607686340808868
- O 0 0.43641197681427
induced O 0 0.0361076183617115
chromatid O 0 0.06461729854345322
damage O 0 0.0006206706748344004
relative O 0 1.883293043647427e-05
to O 0 1.8145673266189988e-06
that O 0 9.032953016685497e-07
of O 0 1.8008412325798417e-06
normal O 0 3.744070272659883e-05
controls O 0 0.0002828720898833126
. O 0 7.828051457181573e-05

These O 0 8.307280950248241e-05
results O 0 4.670676571549848e-05
show O 0 9.99011353997048e-06
that O 0 1.5816696077308734e-06
the O 0 3.2903365081438096e-06
G2 O 0 0.0006667476845905185
- O 0 0.00010453700087964535
phase O 0 2.179567854909692e-05
chromosomal O 0 0.0009323232807219028
radiosensitivity O 0 0.001618682174012065
assay O 0 0.0001454377343179658
can O 0 3.402236870897468e-06
be O 0 6.981664455452119e-07
used O 0 6.721748491145263e-07
for O 0 2.426951084544271e-07
the O 0 6.017441478434193e-07
detection O 0 1.1384293429728132e-05
of O 0 3.835025836451678e-06
A B-Disease 1 0.9986440539360046
- I-Disease 1 0.9999840259552002
T I-Disease 1 0.9999980926513672
heterozygotes O 0 0.002556961728259921
. O 0 7.145539711927995e-05

In O 0 0.00016149773728102446
combination O 0 0.00011724310752470046
with O 0 1.929045538417995e-05
molecular O 0 0.0002288612158736214
genetic O 0 9.460178989684209e-05
analyses O 0 3.1750761991133913e-05
, O 0 3.578772066248348e-06
this O 0 6.052676440049254e-07
test O 0 7.224621367640793e-05
may O 0 9.340562428405974e-06
be O 0 2.4067534809546487e-07
of O 0 1.579679747010232e-07
value O 0 2.816634037117183e-07
in O 0 4.0477561924490146e-07
studies O 0 6.898818583067623e-07
of O 0 5.398553639679449e-07
familial B-Disease 0 0.00023269948724191636
and I-Disease 0 1.200357928610174e-05
sporadic I-Disease 0 0.010084248147904873
cancers I-Disease 0 0.3491082787513733
aimed O 0 8.644539047963917e-05
at O 0 2.2535899915965274e-05
determination O 0 3.2907191780395806e-06
of O 0 4.1966791286540683e-07
the O 0 1.6357332697225502e-06
potential O 0 2.663227860466577e-06
involvement O 0 3.4080301247740863e-06
of O 0 1.2030370726279216e-06
ATM O 0 0.056558869779109955
mutations O 0 8.083625289145857e-05
in O 0 6.138134631328285e-05
tumor B-Disease 1 0.955373227596283
risk O 0 0.0002556137624196708
or O 0 6.046490398148308e-06
development O 0 9.926154234563e-06
. O 0 9.677602065494284e-06
. O 0 3.166098758811131e-05

Ataxia B-Disease 1 0.9999994039535522
- I-Disease 1 0.9999549388885498
telangiectasia I-Disease 1 0.9999886751174927
: O 0 5.8816814998863265e-05
identification O 0 2.1081415980006568e-05
and O 0 4.927459485770669e-06
detection O 0 1.6308815247612074e-05
of O 0 3.2397447284893133e-06
founder O 0 0.000894460070412606
- O 0 0.0006842825096100569
effect O 0 5.479828359966632e-06
mutations O 0 4.1153061829390936e-06
in O 0 7.955673027026933e-07
the O 0 1.043982592818793e-06
ATM O 0 0.0005142730660736561
gene O 0 6.827321612945525e-06
in O 0 1.957454514922574e-06
ethnic O 0 9.04528860701248e-06
populations O 0 3.734784331754781e-05
. O 0 2.8202399334986694e-05

To O 0 3.5887162084691226e-05
facilitate O 0 2.9242994060041383e-05
the O 0 3.4179934118583333e-06
evaluation O 0 7.838011697458569e-06
of O 0 2.627971525726025e-06
ATM O 0 0.02617984265089035
heterozygotes O 0 0.00011203233589185402
for O 0 2.0074526219104882e-06
susceptibility O 0 6.428115739254281e-05
to O 0 3.939028829336166e-06
other O 0 6.180540367495269e-06
diseases O 0 0.05648424103856087
, O 0 1.808793172131118e-06
such O 0 1.1314840548948268e-06
as O 0 0.0007427990203723311
breast B-Disease 1 0.9999018907546997
cancer I-Disease 1 0.9686314463615417
, O 0 1.0726419532147702e-05
we O 0 4.031301159557188e-06
have O 0 1.5676796465413645e-06
attempted O 0 1.470964889449533e-05
to O 0 1.2869522834080271e-06
define O 0 3.06616516354552e-06
the O 0 9.157656677416526e-07
most O 0 6.280116622292553e-07
common O 0 1.4933317515897215e-06
mutations O 0 5.978025001240894e-06
and O 0 8.186316904357227e-07
their O 0 2.0670856883953093e-06
frequencies O 0 3.181638749083504e-05
in O 0 0.0007592399488203228
ataxia B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999861717224121
telangiectasia I-Disease 1 0.9999997615814209
( O 0 8.482518023811281e-05
A B-Disease 1 0.9998196959495544
- I-Disease 1 0.9999822378158569
T I-Disease 1 0.9999977350234985
) O 0 8.048330528254155e-06
homozygotes O 0 6.32444498478435e-05
from O 0 3.997046405856963e-06
10 O 0 8.859002264216542e-06
ethnic O 0 1.7781128917704336e-05
populations O 0 7.138768705772236e-05
. O 0 6.672600284218788e-05

Both O 0 0.00012961663014721125
genomic O 0 0.00041951786261051893
mutations O 0 0.00012725764827337116
and O 0 7.086268396960804e-06
their O 0 8.0314248407376e-06
effects O 0 1.168808557849843e-05
on O 0 3.6369458484841743e-06
cDNA O 0 2.5701132472022437e-05
were O 0 2.213058360212017e-05
characterized O 0 0.00012701032392214984
. O 0 6.231704901438206e-05

Protein O 0 0.0005347471451386809
- O 0 0.0002469659666530788
truncation O 0 0.00010305020987289026
testing O 0 2.0308707462390885e-05
of O 0 2.3633565433556214e-06
the O 0 2.558618916737032e-06
entire O 0 7.247777375596343e-06
ATM O 0 5.206464265938848e-05
cDNA O 0 1.3008095265831798e-05
detected O 0 1.850905391620472e-05
92 O 0 1.2518266885308549e-05
( O 0 1.993664454857935e-06
66 O 0 7.389613074337831e-06
% O 0 2.1219977952569025e-06
) O 0 1.754209279170027e-06
truncating O 0 1.6185389540623873e-05
mutations O 0 1.0516777365410235e-05
in O 0 2.6996390261047054e-06
140 O 0 1.4380350876308512e-05
mutant O 0 0.00010310093784937635
alleles O 0 5.812008021166548e-05
screened O 0 0.00030249773408286273
. O 0 0.00012391715426929295

The O 0 0.00012164008512627333
haplotyping O 0 0.0010916126193478703
of O 0 1.8111950339516625e-05
patients O 0 0.0030220039188861847
with O 0 1.3239744475868065e-05
identical O 0 0.004610423464328051
mutations O 0 0.00020016648340970278
indicates O 0 9.4516381068388e-06
that O 0 6.503663030343887e-07
almost O 0 6.309520586000872e-07
all O 0 1.259411135379196e-07
of O 0 1.864305403387334e-07
these O 0 3.938259567348723e-07
represent O 0 8.034075449359079e-07
common O 0 1.1260294741077814e-06
ancestry O 0 1.1405026270949747e-05
and O 0 3.467110445853905e-06
that O 0 2.062456360363285e-06
very O 0 3.5343330182513455e-06
few O 0 7.612485205754638e-06
spontaneously O 0 0.00013265077723190188
recurring O 0 0.00011078070383518934
ATM O 0 0.08034466207027435
mutations O 0 0.0003527902299538255
exist O 0 8.340396016137674e-05
. O 0 5.9760081057902426e-05

Assays O 0 0.0010282339062541723
requiring O 0 0.00016567946295253932
minimal O 0 8.692458504810929e-05
amounts O 0 1.5317678844439797e-05
of O 0 3.190542656739126e-06
genomic O 0 4.467659891815856e-05
DNA O 0 3.4956319723278284e-05
were O 0 6.693176146654878e-06
designed O 0 1.1375774192856625e-05
to O 0 7.96285348769743e-07
allow O 0 9.83031668511103e-07
rapid O 0 8.194477231882047e-06
screening O 0 1.3234126527095214e-05
for O 0 1.890139856186579e-06
common O 0 5.663791398546891e-06
ethnic O 0 1.8310489394934848e-05
mutations O 0 0.0002589152136351913
. O 0 7.710712816333398e-05

These O 0 6.459392898250371e-05
rapid O 0 0.00014307734090834856
assays O 0 9.766734001459554e-05
detected O 0 9.907390631269664e-05
mutations O 0 2.0624562239390798e-05
in O 0 5.0716644182102755e-06
76 O 0 5.1196049753343686e-05
% O 0 1.6199189758481225e-06
of O 0 1.2638018915822613e-06
Costa O 0 1.7449910956202075e-05
Rican O 0 9.554100688546896e-05
patients O 0 0.00043292768532410264
( O 0 8.663733410685381e-07
3 O 0 2.4399569156230427e-06
) O 0 3.953827842906321e-07
, O 0 3.6738802577929164e-07
50 O 0 8.683817895871471e-07
% O 0 3.248919995257893e-07
of O 0 7.346556571974361e-07
Norwegian O 1 0.839482843875885
patients O 0 0.013691949658095837
( O 0 9.76231262939109e-07
1 O 0 1.634368913983053e-06
) O 0 4.0674410684005124e-07
, O 0 3.514689979056129e-07
25 O 0 1.480302557865798e-06
% O 0 4.7114474455156596e-07
of O 0 7.205230758700054e-07
Polish O 1 0.5394344925880432
patients O 0 0.019776390865445137
( O 0 1.4571149904440972e-06
4 O 0 8.861875357979443e-06
) O 0 7.285354399755306e-07
, O 0 5.455188443193038e-07
and O 0 1.1947056464123307e-06
14 O 0 3.5203458992327796e-06
% O 0 4.899036980532401e-07
of O 0 4.06113059625568e-07
Italian O 0 0.0021872022189199924
patients O 0 0.008427564986050129
( O 0 8.144732532855414e-07
1 O 0 1.1578988505789312e-06
) O 0 2.837363695107342e-07
, O 0 2.1805875860536617e-07
as O 0 2.014123055005257e-07
well O 0 4.3471786170812265e-07
as O 0 7.427791501868342e-07
in O 0 4.166167855146341e-06
patients O 0 9.257008059648797e-06
of O 0 1.0669415360098355e-06
Amish O 0 0.0005861317622475326
/ O 0 4.135463677812368e-05
Mennonite O 0 0.00015489014913327992
and O 0 7.981770977494307e-06
Irish O 0 3.528188244672492e-05
English O 0 2.2790867660660297e-05
backgrounds O 0 0.0001300082658417523
. O 0 7.193807687144727e-05

Additional O 0 0.0001833894639275968
mutations O 0 0.0002198588044848293
were O 0 2.3234402760863304e-05
observed O 0 9.917845090967603e-06
in O 0 2.105191015289165e-06
Japanese O 0 5.554249582928605e-06
, O 0 1.3988690170663176e-06
Utah O 0 7.175332029873971e-06
Mormon O 0 3.4405297810735647e-06
, O 0 6.91077730152756e-07
and O 0 9.309562187809206e-07
African O 0 4.014910700789187e-06
American O 0 1.4864611330267508e-05
patients O 0 0.0002164788165828213
. O 0 3.790403206949122e-05

These O 0 3.384866431588307e-05
assays O 0 4.5447774027707055e-05
should O 0 5.9885014707106166e-06
facilitate O 0 6.183299319673097e-06
screening O 0 1.5960469681886025e-05
for O 0 7.240537343022879e-06
A B-Disease 1 0.998589813709259
- I-Disease 1 0.9998564720153809
T I-Disease 1 0.9999932050704956
heterozygotes O 0 0.00013489279081113636
in O 0 4.0775762499833945e-06
the O 0 4.0860318222257774e-06
populations O 0 1.4610161088057794e-05
studied O 0 2.5967383407987654e-05
. O 0 1.1659240044537e-05
. O 0 3.730729440576397e-05

The O 0 0.0005305643426254392
von B-Disease 1 0.9485688805580139
Hippel I-Disease 1 0.9691261649131775
- I-Disease 1 0.919342041015625
Lindau I-Disease 1 0.997519314289093
tumor I-Disease 0 0.4595477283000946
suppressor O 0 0.0003816286043729633
gene O 0 3.096075670327991e-05
is O 0 2.6013085516751744e-06
required O 0 3.0821695418126183e-06
for O 0 1.7979034510062775e-06
cell O 0 0.00014671582903247327
cycle O 0 3.96269497286994e-05
exit O 0 6.18861013208516e-05
upon O 0 2.9051392630208284e-05
serum O 0 0.0010041991481557488
withdrawal O 0 0.0002615651173982769
. O 0 0.00010312945232726634

The O 0 0.00013503474474418908
inactivation O 0 0.0011599808931350708
of O 0 1.7620712242205627e-05
the O 0 7.197068043751642e-05
von B-Disease 1 0.9987816214561462
Hippel I-Disease 1 0.999351441860199
- I-Disease 1 0.9838693737983704
Lindau I-Disease 1 0.9980140924453735
( I-Disease 0 0.00013377606228459626
VHL I-Disease 0 0.29889166355133057
) I-Disease 0 1.8899354472523555e-05
tumor I-Disease 0 0.0005421356181614101
suppressor O 0 0.00013493422011379153
gene O 0 2.824269176926464e-05
predisposes O 0 0.0001359300222247839
affected O 0 1.6903561117942445e-05
individuals O 0 1.5231918268909794e-06
to O 0 1.6607257293799194e-06
the O 0 2.8887461667181924e-05
human O 0 0.03709948807954788
VHL B-Disease 1 0.9999998807907104
cancer I-Disease 1 0.9999997615814209
syndrome I-Disease 1 0.9999998807907104
and O 0 0.0002901841071434319
is O 0 1.5556575817754492e-05
associated O 0 2.1675019524991512e-05
with O 0 7.083016680553555e-05
sporadic B-Disease 1 0.9982833862304688
renal I-Disease 1 1.0
cell I-Disease 1 0.9999979734420776
carcinomas I-Disease 1 1.0
( O 0 0.009138754568994045
RCC B-Disease 1 0.9987488985061646
) O 0 1.7441590898670256e-05
and O 0 6.632153235841542e-05
brain B-Disease 1 0.8582858443260193
hemangioblastomas I-Disease 0 0.10274490714073181
. O 0 0.00011173404345754534

VHL O 0 0.2352779358625412
- O 0 0.001575429574586451
negative O 0 0.00013065514212939888
786 O 0 0.0007623021374456584
- O 0 0.007972556166350842
0 O 0 0.00025700326659716666
RCC B-Disease 0 0.07353368401527405
cells O 0 2.3296594008570537e-05
are O 0 2.2412054931919556e-06
tumorigenic O 0 0.00010002546332543716
in O 0 5.991180387354689e-06
nude O 0 0.0010955710895359516
mice O 0 9.599058830644935e-05
which O 0 1.0617768566589803e-06
is O 0 7.934873451631574e-07
suppressed O 0 2.9578814064734615e-06
by O 0 5.555026518777595e-07
the O 0 1.9574526959331706e-06
reintroduction O 0 5.6178803788498044e-05
of O 0 2.673575909284409e-05
VHL B-Disease 0 0.07107380032539368
. O 0 0.00010987037239829078

Remarkably O 0 0.013657670468091965
, O 0 2.7114310796605423e-05
this O 0 3.307778797534411e-06
occurs O 0 2.977114263558178e-06
without O 0 2.068174126179656e-06
affecting O 0 2.734287136263447e-06
the O 0 1.1052574109271518e-06
growth O 0 2.7275807497062488e-06
rate O 0 1.273639895771339e-06
and O 0 1.326450160377135e-06
cell O 0 2.6725307179731317e-05
cycle O 0 3.973695584136294e-06
profile O 0 2.009856871154625e-06
of O 0 5.585193321167026e-07
these O 0 1.4280176401371136e-06
cells O 0 8.513344255334232e-06
in O 0 4.6289164856716525e-06
culture O 0 1.9598493963712826e-05
. O 0 2.5622455723350868e-05

The O 0 0.00015735687338747084
786 O 0 0.0009513257537037134
- O 0 0.0006259158253669739
0 O 0 6.0932514315936714e-05
cell O 0 5.712665733881295e-05
line O 0 2.0820085410377942e-05
, O 0 1.7002173535729526e-06
like O 0 1.6286771824525204e-06
many O 0 1.4097274743107846e-06
cancer B-Disease 0 0.004634154494851828
cells O 0 1.420227545168018e-05
, O 0 1.178273919322237e-06
fails O 0 4.154641828790773e-06
to O 0 7.891759423728217e-07
exit O 0 7.133065082598478e-06
the O 0 2.7328376290824963e-06
cell O 0 7.729545177426189e-05
cycle O 0 3.0367673389264382e-05
upon O 0 1.5375677321571857e-05
serum O 0 0.0007241677376441658
withdrawal O 0 0.0002367049892200157
. O 0 7.537518831668422e-05

Here O 0 9.95193186099641e-05
, O 0 9.58323562372243e-06
it O 0 1.8759851627692115e-06
is O 0 7.343334118559142e-07
shown O 0 7.953981366881635e-07
that O 0 3.4128399306609936e-07
reintroduction O 0 2.6824550332094077e-06
of O 0 3.5733660297410097e-07
the O 0 1.3543598242904409e-06
wild O 0 7.5606612881529145e-06
- O 0 0.00026165563031099737
type O 0 6.953530828468502e-05
VHL B-Disease 0 0.0015866296598687768
gene O 0 1.2659221283684019e-05
restores O 0 1.9576695194700733e-05
the O 0 2.468019147272571e-06
ability O 0 4.698167231254047e-06
of O 0 3.5302941796544474e-06
VHL O 0 0.11890275776386261
- O 0 0.011925795115530491
negative O 0 0.00018017756519839168
RCC B-Disease 1 0.9737846255302429
cancer I-Disease 0 0.03478601202368736
cells O 0 7.529152753704693e-06
to O 0 9.242763212569116e-07
exit O 0 6.8201502472220454e-06
the O 0 1.70712735325651e-06
cell O 0 4.619496030500159e-05
cycle O 0 7.1404633672500495e-06
and O 0 1.715489815978799e-06
enter O 0 1.340353992418386e-05
G0 O 0 0.0003009091014973819
/ O 0 2.5715378797031008e-05
quiescence O 0 7.821963663445786e-05
in O 0 1.260594763152767e-05
low O 0 0.0008732117130421102
serum O 0 0.007215219549834728
. O 0 7.030392589513212e-05

Both O 0 0.0001625591394258663
VHL O 0 0.014384971931576729
- O 0 0.0006323698326013982
positive O 0 1.6600621165707707e-05
and O 0 9.962151125364471e-06
VHL O 0 0.001992148347198963
- O 0 0.00018247739353682846
negative O 0 2.5307657779194415e-05
RCC B-Disease 0 0.02300138771533966
cells O 0 9.073550245375372e-06
exit O 0 6.7789151216857135e-06
the O 0 2.464549879732658e-06
cell O 0 7.509085844503716e-05
cycle O 0 1.4647900570707861e-05
by O 0 2.8838019261456793e-06
contact O 0 2.667272747203242e-05
inhibition O 0 0.0001129034862970002
. O 0 0.00010844944335985929

The O 0 0.00020268274238333106
cyclin O 0 0.0008648125221952796
- O 0 0.0002184056502301246
dependent O 0 2.5467301384196617e-05
kinase O 0 3.8586807932006195e-05
inhibitor O 0 1.3121000847604591e-05
, O 0 3.3070662084355718e-06
p27 O 0 2.8256781661184505e-05
, O 0 1.377341845909541e-06
accumulates O 0 7.939468559925444e-06
upon O 0 2.5904851099767257e-06
serum O 0 4.629074828699231e-05
withdrawal O 0 8.736575182410888e-06
, O 0 4.641102009372844e-07
only O 0 1.8479934738024895e-07
in O 0 2.3209047128602833e-07
the O 0 3.882060184423608e-07
presence O 0 6.516216899399296e-07
of O 0 8.277776260001701e-07
VHL B-Disease 0 0.006825033575296402
, O 0 8.89407317572477e-07
as O 0 4.5556953409686685e-07
a O 0 1.1902375263161957e-06
result O 0 1.3496406836566166e-06
of O 0 2.4372400275751716e-07
the O 0 7.801759807080089e-07
stabilization O 0 4.990185061615193e-06
of O 0 1.1281103979854379e-06
the O 0 8.935280675359536e-06
protein O 0 7.127436401788145e-05
. O 0 5.0533275498310104e-05

We O 0 8.97462377906777e-05
propose O 0 5.6188233429566026e-05
that O 0 3.0286089440778596e-06
the O 0 2.1562573238043115e-06
loss O 0 1.2250053259776905e-05
of O 0 9.132130003308703e-07
wild O 0 1.1791164070018567e-05
- O 0 0.0015343789709731936
type O 0 0.0001490191207267344
VHL B-Disease 0 0.07484117150306702
gene O 0 2.0834702809224837e-05
results O 0 9.716404747450724e-06
in O 0 2.1644530079356628e-06
a O 0 3.3785174764489057e-06
specific O 0 2.539353999964078e-06
cellular O 0 0.004975546151399612
defect O 0 0.004554020706564188
in O 0 1.3096409929858055e-05
serum O 0 0.010597729124128819
- O 0 0.006589360069483519
dependent O 0 2.3393753508571535e-05
growth O 0 3.921883489965694e-06
control O 0 1.0807546459545847e-05
, O 0 1.5519399312324822e-06
which O 0 2.5174069833155954e-06
may O 0 1.743748362059705e-05
initiate O 0 6.729498272761703e-05
tumor B-Disease 0 0.012684469111263752
formation O 0 0.0001358315348625183
. O 0 4.49454782938119e-05

This O 0 5.304198930389248e-05
is O 0 1.3633347407449037e-05
corrected O 0 2.8176191335660405e-05
by O 0 1.1307612339805928e-06
the O 0 1.2649232985495473e-06
reintroduction O 0 8.793918823357671e-06
of O 0 1.4847108786852914e-06
wild O 0 1.8553762856754474e-05
- O 0 0.016351845115423203
type O 0 0.001138178282417357
VHL B-Disease 0 0.0811736062169075
, O 0 1.1576764336496126e-05
implicating O 0 0.001470618532039225
VHL B-Disease 0 0.0026661744341254234
as O 0 1.5925111256365199e-06
the O 0 1.700557731965091e-06
first O 0 1.6149111615959555e-05
tumor B-Disease 0 0.0015906835906207561
suppressor O 0 3.605686652008444e-05
involved O 0 1.929674454004271e-06
in O 0 6.964753538341029e-07
the O 0 9.556416671330226e-07
regulation O 0 3.5655880310514476e-06
of O 0 7.795169949531555e-07
cell O 0 0.00025065927184186876
cycle O 0 3.442988236201927e-05
exit O 0 3.432920129853301e-05
, O 0 2.3908137336547952e-06
which O 0 1.0516108659430756e-06
is O 0 5.160182467989216e-07
consistent O 0 1.2709982684100396e-06
with O 0 4.915022486784437e-07
its O 0 2.5611846012907336e-06
gatekeeper O 0 0.0004023727960884571
function O 0 3.4253257581440266e-06
in O 0 4.54908877145499e-06
the O 0 8.67312410264276e-05
kidney O 1 0.9889660477638245
. O 0 2.8835469493060373e-05
. O 0 4.774539411300793e-05

Piebaldism B-Disease 1 0.9999710321426392
with O 0 0.0797203779220581
deafness B-Disease 1 1.0
: O 0 0.00010159214434679598
molecular O 0 0.00013116507034283131
evidence O 0 4.877405899605947e-06
for O 0 3.745226649698452e-06
an O 0 0.0001116880084737204
expanded O 1 0.6004713177680969
syndrome O 1 0.9999967813491821
. O 0 0.00026543193962424994

In O 0 8.053771307459101e-05
a O 0 2.97875412798021e-05
South O 0 1.570913264004048e-05
African O 0 8.129701200232375e-06
girl O 0 5.1462280680425465e-05
of O 0 2.106327656292706e-06
Xhosa O 0 0.032453350722789764
stock O 0 6.39539139228873e-05
with O 0 3.0706469260621816e-05
severe O 1 0.9896512031555176
piebaldism B-Disease 1 0.9513874650001526
and O 0 0.00492293294519186
profound O 1 0.9961052536964417
congenital O 1 1.0
sensorineural B-Disease 1 1.0
deafness I-Disease 1 1.0
we O 0 0.039135828614234924
identified O 0 5.030104875913821e-05
a O 0 7.519465270888759e-06
novel O 0 5.5621312640141696e-06
missense O 0 1.0907207069976721e-05
substitution O 0 2.0387369659147225e-06
at O 0 5.457433417177526e-06
a O 0 3.1049899007484782e-06
highly O 0 3.864197424263693e-06
conserved O 0 4.361860646895366e-06
residue O 0 7.883659236540552e-06
in O 0 6.295065873018757e-07
the O 0 9.441190513825859e-07
intracellular O 0 1.8927603377960622e-05
kinase O 0 1.045699082169449e-05
domain O 0 1.9347307897987776e-06
of O 0 7.601079232699703e-07
the O 0 3.055414481423213e-06
KIT O 0 0.0008036604267545044
proto O 0 0.0004987502470612526
- O 0 0.0009314308990724385
oncogene O 0 0.0008965313318185508
, O 0 2.499312540749088e-05
R796G O 0 0.00033307389821857214
. O 0 5.850857269251719e-05

Though O 0 0.0003572335990611464
auditory B-Disease 0 0.0025192222092300653
anomalies I-Disease 0 0.16153687238693237
have O 0 5.847777720191516e-05
been O 0 1.617219822946936e-05
observed O 0 8.022935617191251e-06
in O 0 9.52265145315323e-06
mice O 0 0.0018754579359665513
with O 0 1.03258244052995e-05
dominant O 0 0.0008990133064799011
white O 0 0.0006683735991828144
spotting O 0 0.2845108211040497
( O 0 5.4095515224616975e-05
W O 1 0.9861328601837158
) O 0 1.986820052479743e-06
due O 0 3.948265202780021e-06
to O 0 6.59996203467017e-06
KIT O 1 0.8935846090316772
mutations O 0 0.00261088483966887
, O 0 0.00042514895903877914
deafness B-Disease 1 0.9999998807907104
is O 0 1.1702932170010172e-05
not O 0 2.899280161727802e-06
typical O 0 8.395533768634778e-06
in O 0 1.0706184184527956e-05
human O 0 2.8662227123277262e-05
piebaldism B-Disease 0 0.01677148975431919
. O 0 8.601057197665796e-05

Thus O 0 0.00021930146613158286
, O 0 1.4101891792961396e-05
the O 0 4.98600775244995e-06
occurrence O 0 1.99310525204055e-05
of O 0 2.4355271307285875e-05
sensorineural B-Disease 1 0.9999682903289795
deafness I-Disease 1 1.0
in O 0 0.0010037824977189302
this O 0 1.9586084818001837e-05
patient O 0 0.0007244418375194073
extends O 0 8.791981599642895e-06
considerably O 0 9.2716300059692e-06
the O 0 9.595732990419492e-07
phenotypic O 0 6.10597271588631e-06
range O 0 2.465026909703738e-06
of O 0 1.5882567367953015e-06
piebaldism B-Disease 0 0.003053762251511216
due O 0 1.0254560947942082e-05
to O 0 3.87242425858858e-06
KIT O 0 0.009272073395550251
gene O 0 9.486078852205537e-06
mutation O 0 5.831731414218666e-06
in O 0 1.8321682091482216e-06
humans O 0 3.6667922813649056e-06
and O 0 4.316403646953404e-06
tightens O 0 0.024279415607452393
the O 0 4.062028438056586e-06
clinical O 0 4.981404708814807e-05
similarity O 0 4.700986210082192e-06
between O 0 3.4767092529364163e-06
piebaldism B-Disease 0 0.0029134356882423162
and O 0 1.0248627404507715e-06
the O 0 5.669064080393582e-07
various O 0 5.864530976396054e-07
forms O 0 4.344093213148881e-06
of O 0 0.0013548472197726369
Waardenburg B-Disease 1 1.0
syndrome I-Disease 1 0.9999997615814209
. O 0 4.8093566874740645e-05
. O 0 7.761644519632682e-05

Cycloheximide O 0 0.0044455695897340775
facilitates O 0 0.00018176142475567758
the O 0 1.0547511919867247e-05
identification O 0 1.0936307262454648e-05
of O 0 3.1478164146392373e-06
aberrant O 0 8.719887409824878e-05
transcripts O 0 2.4216611564042978e-05
resulting O 0 1.2887827324448153e-05
from O 0 2.042352662101621e-06
a O 0 5.366050118027488e-06
novel O 0 5.523406798602082e-06
splice O 0 0.0003973905695602298
- O 0 0.00028875836869701743
site O 0 1.791211252566427e-05
mutation O 0 1.5078634532983415e-05
in O 0 3.975385880039539e-06
COL17A1 O 0 0.0068958657793700695
in O 0 4.053220891364617e-06
a O 0 4.819718742510304e-05
patient O 0 0.0011295430595055223
with O 0 9.211625001626089e-05
generalized O 0 0.4898289144039154
atrophic B-Disease 1 0.9999582767486572
benign I-Disease 1 0.9971940517425537
epidermolysis I-Disease 1 0.9996883869171143
bullosa I-Disease 1 0.9986168146133423
. O 0 0.0009371417690999806

Patients O 1 0.9918031096458435
with O 0 0.0017342978389933705
generalized O 1 0.6640632152557373
atrophic B-Disease 1 0.999937891960144
benign I-Disease 1 0.9991739392280579
epidermolysis I-Disease 1 0.9994707703590393
bullosa I-Disease 1 0.995036780834198
often O 0 0.0002064797590719536
show O 0 4.972563328919932e-05
decreased O 0 3.763199129025452e-05
expression O 0 4.019143943878589e-06
of O 0 3.5112464047415415e-06
type O 0 0.0015259309438988566
XVII O 1 0.9341602921485901
collagen O 0 0.0002054648066405207
, O 0 2.7318005777487997e-06
a O 0 6.0700222093146294e-06
transmembrane O 0 0.0001780462043825537
hemidesmosomal O 0 0.0002564417663961649
protein O 0 1.3910710549680516e-05
encoded O 0 1.6487403627252206e-05
by O 0 2.0181494619464502e-05
COL17A1 O 0 0.0028598117642104626
. O 0 6.657726771663874e-05

This O 0 9.690264414530247e-05
report O 0 4.436403833096847e-05
documents O 0 7.984564945218153e-06
a O 0 5.849053650308633e-06
novel O 0 7.599559467053041e-06
splice O 0 0.0003048991784453392
- O 0 0.00026461982633918524
site O 0 2.8662663680734113e-05
mutation O 0 1.7622007362660952e-05
in O 0 8.222244105127174e-06
COL17A1 O 0 0.007185298949480057
in O 0 7.697311957599595e-06
a O 0 0.00010375482816016302
patient O 0 0.009950388222932816
with O 0 4.120033190702088e-05
generalized O 0 0.1696881353855133
atrophic B-Disease 1 0.9998371601104736
benign I-Disease 1 0.9719754457473755
epidermolysis I-Disease 1 0.9916029572486877
bullosa I-Disease 1 0.9673516154289246
, O 0 2.509379010007251e-05
and O 0 3.503085508782533e-06
applies O 0 1.4730470638824045e-06
a O 0 1.052499783327221e-06
new O 0 9.821161484069307e-07
methodology O 0 3.874972207995597e-06
to O 0 8.160204743035138e-07
define O 0 3.019348696398083e-06
and O 0 1.4996799109212589e-06
characterize O 0 1.1361062206560746e-05
the O 0 3.2098371320898877e-06
resulting O 0 1.9682536731124856e-05
mRNA O 0 3.690207813633606e-05
splice O 0 0.0004405029467307031
variants O 0 0.00013162412506062537
. O 0 9.599416080163792e-05

Mutational O 0 0.004856624640524387
analysis O 0 0.00018556584836915135
of O 0 3.112971899099648e-05
COL17A1 O 0 0.05445452034473419
identified O 0 5.825281186844222e-05
a O 0 3.609956183936447e-05
maternally O 0 0.007934742607176304
inherited O 0 0.19453047215938568
G O 0 0.009094997309148312
- O 0 0.00012403135770000517
to O 0 6.662003215751611e-06
- O 0 0.01678856648504734
T O 0 0.011297667399048805
transversion O 0 3.4263721317984164e-05
at O 0 2.745502115431009e-06
the O 0 6.694355079162051e-07
- O 0 1.6212778064073063e-05
1 O 0 1.1286301742075011e-06
position O 0 2.2061831259634346e-06
of O 0 1.7451937992518651e-06
exon O 0 9.872929513221607e-05
32 O 0 5.988438715576194e-05
. O 0 4.324334076954983e-05

This O 0 0.00010056274913949892
acceptor O 0 0.00019501887436490506
splice O 0 0.0005013336194679141
- O 0 0.00021773575281258672
site O 0 2.8534454031614587e-05
mutation O 0 1.5171351151366252e-05
led O 0 3.386682465134072e-06
to O 0 8.611852422291122e-07
the O 0 1.250541913577763e-06
formation O 0 3.933772859454621e-06
of O 0 1.038352593241143e-06
aberrant O 0 2.285559276060667e-05
transcripts O 0 1.389595399814425e-05
present O 0 4.435660684976028e-06
at O 0 3.6670928238891065e-05
extremely O 0 5.3954867325956e-05
low O 0 0.00021283944079186767
levels O 0 5.910118852625601e-05
. O 0 5.536006938200444e-05

Based O 0 6.0792925069108605e-05
on O 0 8.72306372912135e-06
our O 0 6.041446795279626e-06
recent O 0 3.101456286458415e-06
finding O 0 3.947764525946695e-06
that O 0 2.320029125257861e-06
cycloheximide O 0 0.00019813394465018064
stabilized O 0 0.00018746661953628063
mutant O 0 4.743551471619867e-05
COL17A1 O 0 0.00022564837126992643
transcripts O 0 1.5927063941489905e-05
in O 0 5.8089513004233595e-06
keratinocytes O 0 9.240931831300259e-05
homozygous O 0 9.610572305973619e-05
for O 0 1.265171704289969e-06
a O 0 1.778816840669606e-05
frameshift O 0 0.0035432507283985615
mutation O 0 2.293645047757309e-05
, O 0 1.3830359648636659e-06
the O 0 8.289065362987458e-07
effects O 0 2.7073508590547135e-06
of O 0 4.291499351438688e-07
the O 0 1.4253522522267303e-06
splice O 0 0.0008371426374651492
- O 0 0.00012381923443172127
site O 0 6.629705694649601e-06
mutation O 0 3.916979494533734e-06
on O 0 1.080010406440124e-06
splicing O 0 7.671430466871243e-06
of O 0 1.281059780922078e-06
COL17A1 O 0 0.0003452107193879783
transcripts O 0 1.240159326698631e-05
were O 0 7.14443422111799e-06
determined O 0 6.323728484858293e-06
using O 0 2.780499471555231e-06
reverse O 0 1.3596511962532531e-05
transcriptase O 0 1.721866283332929e-05
polymerase O 0 1.4198498320183717e-05
chain O 0 1.7625487089389935e-05
reaction O 0 2.465158786435495e-06
of O 0 6.608519242945476e-07
total O 0 2.3569909899379127e-06
RNA O 0 4.85848340758821e-06
from O 0 3.2297589314111974e-06
keratinocytes O 0 6.213559390744194e-05
incubated O 0 4.3470001401146874e-05
for O 0 4.219210040901089e-06
2 O 0 3.3969670766964555e-05
. O 0 2.5931796699296683e-05

5 O 0 0.0004683664592448622
h O 0 0.000391640787711367
in O 0 3.94785911339568e-06
the O 0 1.5382890978798969e-06
presence O 0 2.224230911451741e-06
or O 0 1.2523834129751776e-06
absence O 0 2.288150426466018e-06
of O 0 7.751092425678507e-07
10 O 0 1.0368068615207449e-05
microg O 0 0.00027589526143856347
cycloheximide O 0 0.00019688949396368116
per O 0 1.2622754184121732e-05
ml O 0 0.0004172429325990379
. O 0 4.9440273869549856e-05

Using O 0 7.034000736894086e-05
this O 0 7.747347808617633e-06
approach O 0 9.632070941734128e-06
, O 0 2.465659463268821e-06
an O 0 4.026974693260854e-06
abnormally O 0 0.006291821599006653
spliced O 0 0.0005620422889478505
transcript O 0 7.072582229739055e-05
was O 0 6.643863889621571e-05
identified O 0 4.004196398454951e-06
that O 0 2.7541929625840567e-07
contains O 0 2.727156811488385e-07
an O 0 3.896169005201955e-07
extra O 0 2.3235720618686173e-06
264 O 0 6.654492153757019e-06
bases O 0 6.182509878271958e-06
upstream O 0 4.1756106838874985e-06
from O 0 1.2482352076403913e-06
exon O 0 1.0346781891712453e-05
32 O 0 6.469370418926701e-06
, O 0 1.4861558383927331e-06
resulting O 0 4.4227308535482734e-06
in O 0 1.923024001371232e-06
a O 0 2.279245381942019e-05
premature O 0 0.0022637618239969015
termination O 0 5.630580926663242e-05
codon O 0 2.907218186010141e-05
27 O 0 3.2012598239816725e-05
bp O 0 6.9783280196134e-05
downstream O 0 1.0037020729214419e-05
from O 0 1.6730996321712155e-06
the O 0 4.4645703383139335e-06
cryptic O 0 0.00014214015391189605
splice O 0 0.0008571216021664441
site O 0 0.0002279893815284595
. O 0 9.669485734775662e-05

Three O 0 6.807480531278998e-05
other O 0 8.981055543699767e-06
splice O 0 0.00021393383212853223
variants O 0 1.6554882677155547e-05
, O 0 1.938195282491506e-06
including O 0 9.95159325611894e-07
one O 0 1.5323957995860837e-06
derived O 0 9.253364510186657e-07
from O 0 4.053280520111002e-07
the O 0 4.2574367853376316e-07
skipping O 0 4.189239916740917e-06
of O 0 6.772600613658142e-07
exon O 0 1.957563108589966e-05
32 O 0 1.4926903531886637e-05
, O 0 1.7831279137681122e-06
were O 0 4.190522759017767e-06
also O 0 6.7537939685280435e-06
identified O 0 3.6159759474685416e-05
. O 0 2.9451972295646556e-05

These O 0 7.862705388106406e-05
results O 0 5.4674819693900645e-05
indicate O 0 1.61299485625932e-05
the O 0 2.819958126565325e-06
usefulness O 0 1.2293905456317589e-05
of O 0 2.9356331197050167e-06
cycloheximide O 0 0.04138760641217232
treatment O 0 6.565719377249479e-05
in O 0 3.3594137676118407e-06
evaluating O 0 9.49342665990116e-06
the O 0 1.7682006046015886e-06
abnormal O 0 2.9026528864051215e-05
processing O 0 2.435309852444334e-06
of O 0 5.359353281164658e-07
mRNA O 0 2.6293480459571583e-06
due O 0 1.671152631388395e-06
to O 0 1.0664856517905719e-06
splice O 0 0.00019405804050620645
- O 0 0.00027366477297618985
site O 0 3.0992778192739934e-05
mutations O 0 1.5479561625397764e-05
, O 0 2.202189307354274e-06
because O 0 2.331282757950248e-06
( O 0 9.285365081268537e-07
i O 0 7.77626883063931e-06
) O 0 6.527324671878887e-07
aberrant O 0 4.864960374106886e-06
splicing O 0 6.7363548623688985e-06
often O 0 2.005020860451623e-06
generates O 0 3.885996648023138e-06
a O 0 9.014940587803721e-06
premature O 0 0.0004746630147565156
termination O 0 6.182167999213561e-05
codon O 0 2.309302544745151e-05
, O 0 2.861215307348175e-06
( O 0 1.273727320949547e-06
ii O 0 4.071219882462174e-05
) O 0 1.0486104429219267e-06
transcripts O 0 3.4884567412518663e-06
with O 0 8.02416070655454e-06
premature O 0 0.01887272484600544
termination O 0 0.00010544725955696777
codons O 0 1.1435794476710726e-05
can O 0 1.4865498769722763e-06
occur O 0 1.558959297653928e-06
at O 0 9.273770047002472e-06
low O 0 6.764808495063335e-05
or O 0 8.78736227605259e-06
undetectable O 0 0.00011105081648565829
levels O 0 3.3056219308491563e-06
due O 0 2.471797415637411e-06
to O 0 1.6294742408717866e-06
nonsense O 0 2.6773415811476298e-05
- O 0 3.1670802854932845e-05
mediated O 0 1.1094002729805652e-05
mRNA O 0 5.336109097697772e-06
decay O 0 8.876600986695848e-06
, O 0 1.3539414567276253e-06
and O 0 1.6417752704001032e-06
( O 0 1.5535081274720142e-06
iii O 0 4.6478828153340146e-05
) O 0 2.583579714610096e-07
the O 0 2.5915403512044577e-07
levels O 0 4.764984566918429e-07
of O 0 1.0934839878018465e-07
these O 0 2.120313666864604e-07
transcripts O 0 4.256083229847718e-06
can O 0 1.2133506288591889e-06
be O 0 1.301283305110701e-06
increased O 0 3.856348484987393e-06
by O 0 6.084157575969584e-06
cycloheximide O 0 0.0008402601233683527
. O 0 4.280050052329898e-05

A O 0 0.0004608079616446048
deletion O 0 0.0016215089708566666
mutation O 0 0.00022766161418985575
in O 0 3.6356777854962274e-05
COL17A1 O 0 0.08735202997922897
in O 0 1.2402574611769523e-05
five O 0 1.652062746870797e-05
Austrian O 0 0.010589955374598503
families O 0 0.00010632874182192609
with O 0 6.331771874101833e-05
generalized O 0 0.10549087077379227
atrophic B-Disease 1 0.9998947381973267
benign I-Disease 1 0.968716025352478
epidermolysis I-Disease 1 0.9956476092338562
bullosa I-Disease 1 0.8684937953948975
represents O 0 4.8611276724841446e-05
propagation O 0 1.8430389900458977e-05
of O 0 3.2592186016699998e-06
an O 0 1.6277832401101477e-05
ancestral O 0 0.00048016812070272863
allele O 0 0.0003637520130723715
. O 0 7.82154529588297e-05

Patients O 1 0.9909694790840149
with O 0 0.0010581002570688725
generalized O 1 0.7624005675315857
atrophic B-Disease 1 0.9999728202819824
benign I-Disease 1 0.9995837807655334
epidermolysis I-Disease 1 0.999931812286377
bullosa I-Disease 1 0.9995083808898926
, O 0 8.084088040050119e-05
a O 0 2.3703092665527947e-05
usually O 0 1.240742585650878e-05
nonlethal O 0 2.409059197816532e-05
form O 0 5.26982967130607e-06
of O 0 9.895935363601893e-06
junctional B-Disease 1 0.6846463680267334
epidermolysis I-Disease 1 0.9843674302101135
bullosa I-Disease 1 0.9435645937919617
, O 0 3.213053059880622e-05
have O 0 6.88744648869033e-06
generalized O 0 6.0511421906994656e-05
blistering B-Disease 0 0.15152345597743988
, O 0 0.0004895110614597797
nail B-Disease 1 0.999984622001648
dystrophy I-Disease 1 0.9996973276138306
, O 0 0.0007916013128124177
patchy B-Disease 1 0.9998291730880737
alopecia I-Disease 1 0.9999996423721313
, O 0 0.00011066773004131392
and O 0 0.0033813943155109882
dental B-Disease 1 0.9999738931655884
abnormalities I-Disease 1 0.9999887943267822
. O 0 0.0004976722411811352

Skin B-Disease 1 0.9991912245750427
fragility I-Disease 1 0.8900954127311707
in O 0 0.00012375361984595656
most O 0 1.4251852007873822e-05
cases O 0 1.3012711860937998e-05
is O 0 2.398539663772681e-06
due O 0 6.0517454585351516e-06
to O 0 2.2202616491995286e-06
mutations O 0 5.837584922119277e-06
in O 0 7.576493885608215e-07
the O 0 1.4159484180709114e-06
gene O 0 8.388346941501368e-06
encoding O 0 1.7401915101800114e-05
type O 0 0.0004037678590975702
XVII O 1 0.9437520503997803
collagen O 0 0.0042847334407269955
( O 0 1.6246227460214868e-05
COL17A1 O 0 0.01194174587726593
) O 0 1.509618687123293e-05
. O 0 3.956438013119623e-05

Recently O 0 0.0010056189494207501
, O 0 2.5126309992629103e-05
we O 0 8.824632459436543e-06
reported O 0 1.0671576092136092e-05
five O 0 4.5212136683403514e-06
Austrian O 0 0.00049184774979949
families O 0 5.263726052362472e-05
with O 0 7.892898429417983e-05
generalized O 0 0.06946341693401337
atrophic B-Disease 1 0.9998667240142822
benign I-Disease 1 0.9627888798713684
epidermolysis I-Disease 1 0.9988559484481812
bullosa I-Disease 1 0.9930023550987244
who O 0 0.00022480871120933443
share O 0 1.3727804798691068e-05
the O 0 5.832810074934969e-06
same O 0 4.054354576510377e-05
COL17A1 O 0 0.37175482511520386
mutation O 0 0.0003439886204432696
. O 0 7.070895662764087e-05

Affected O 0 0.001236213487572968
individuals O 0 2.6273270123056136e-05
in O 0 6.4793730416568e-06
three O 0 6.504234988824464e-06
families O 0 1.7565031157573685e-05
are O 0 1.6145223753483151e-06
homozygous O 0 2.4923840101109818e-05
for O 0 1.0566675427980954e-06
4003delTC O 0 0.00015935923147480935
, O 0 1.4581381719835917e-06
whereas O 0 1.238039658346679e-06
those O 0 3.456996751083352e-07
in O 0 4.7011064907565014e-07
two O 0 1.281719733015052e-06
others O 0 9.007936569105368e-06
are O 0 3.3094545415224275e-06
compound O 0 0.00015570239338558167
heterozygotes O 0 0.0004511289007496089
. O 0 3.758712773560546e-05

To O 0 6.652155570918694e-05
determine O 0 3.977517189923674e-05
if O 0 2.7127007342642173e-06
the O 0 1.4889889143887558e-06
occurrence O 0 4.246701337251579e-06
of O 0 1.2418910273481742e-06
4003delTC O 0 0.00021400664991233498
in O 0 2.4872479116311297e-06
these O 0 7.862529400881613e-07
unrelated O 0 1.1032997463189531e-05
families O 0 5.147082447365392e-06
signifies O 0 2.397844582446851e-06
propagation O 0 1.4784177437832113e-06
of O 0 4.272364151347574e-07
an O 0 1.3414922932497575e-06
ancestral O 0 3.847936386591755e-05
allele O 0 1.5040231119201053e-05
or O 0 1.178397610601678e-06
a O 0 3.312763510621153e-06
mutational O 0 0.00021855167869944125
hot O 0 9.695385961094871e-05
spot O 0 6.370156916091219e-05
, O 0 3.7846066334168427e-06
haplotypes O 0 1.376617728965357e-05
were O 0 7.255634045577608e-06
determined O 0 5.789141596324043e-06
for O 0 2.098033746733563e-06
polymorphisms O 0 2.720882730500307e-05
both O 0 1.519399347671424e-06
within O 0 3.5971670513390563e-06
and O 0 1.4503421880363021e-05
flanking O 0 0.003035458968952298
COL17A1 O 0 0.42395907640457153
. O 0 0.00011129389895359054

Five O 0 0.0005786098772659898
intragenic O 0 0.01113046519458294
polymorphisms O 0 0.0005557576660066843
were O 0 1.596719812368974e-05
chosen O 0 6.548169949383009e-06
based O 0 3.733451421794598e-06
on O 0 4.703205831901869e-06
their O 0 3.150058910250664e-05
informativeness O 0 0.004066405352205038
. O 0 4.5426535507431254e-05

One O 0 3.7549900298472494e-05
of O 0 3.779978669626871e-06
these O 0 1.708989202597877e-06
, O 0 2.238449951619259e-06
not O 0 2.307253680555732e-06
previously O 0 1.6758234778535552e-05
reported O 0 1.6148911527125165e-05
, O 0 1.620815169189882e-06
was O 0 1.2890593097836245e-05
2988 O 0 2.705926090129651e-05
A O 0 6.4749874582048506e-06
or O 0 3.0525920919899363e-06
C O 0 2.5153232854790986e-05
that O 0 3.351009922880621e-07
introduces O 0 8.074940183178114e-07
a O 0 5.240973450781894e-07
new O 0 7.625583862136409e-07
restriction O 0 1.9276694729342125e-06
site O 0 5.92448213865282e-06
for O 0 4.166207872913219e-06
Eco0109 O 0 0.0010040001943707466
I O 0 0.00034220024826936424
. O 0 3.9925547753227875e-05

All O 0 4.257229375070892e-05
the O 0 1.9650145986815915e-05
4003delTC O 0 0.00018584492499940097
alleles O 0 2.6573179638944566e-05
showed O 0 2.095244053634815e-05
the O 0 2.3027519091556314e-06
same O 0 2.4607545583421597e-06
haplotype O 0 2.211819992226083e-05
for O 0 1.0620382226989022e-06
these O 0 1.216459168063011e-06
five O 0 8.159479875757825e-06
polymorphic O 0 0.0003139395557809621
markers O 0 0.0007255630916915834
. O 0 7.613324851263314e-05

Fourteen O 0 0.000987031264230609
microsatellite O 0 0.0018369946628808975
polymorphisms O 0 0.000728890358004719
were O 0 2.307488648511935e-05
selected O 0 4.124752194911707e-06
based O 0 1.4478617913482594e-06
on O 0 1.2680321788138826e-06
their O 0 2.35609445553564e-06
high O 0 1.8871514839702286e-05
heterozygosity O 0 3.6354213079903275e-05
and O 0 1.0576999329714454e-06
their O 0 2.2311503471428296e-06
location O 0 4.872854333370924e-06
within O 0 3.810104999502073e-06
10q23 O 0 0.0001904984819702804
- O 0 0.0002796664775814861
q25 O 0 0.00041087064892053604
near O 0 0.0003648692509159446
COL17A1 O 0 0.020258713513612747
. O 0 7.081253716023639e-05

Three O 0 0.00026460696244612336
families O 0 0.00016918362234719098
shared O 0 7.592249312438071e-05
microsatellite O 0 0.0005226662615314126
polymorphisms O 0 0.00019057007739320397
covering O 0 0.0001477316691307351
at O 0 0.00011638297291938215
most O 0 4.9050668167183176e-06
19 O 0 0.00020578438125085086
cM O 0 0.0006895438418723643
, O 0 1.7519106449981336e-06
whereas O 0 1.4163887271934072e-06
the O 0 1.2143264029873535e-06
others O 0 3.4131237498513656e-06
shared O 0 3.2880745948205004e-06
smaller O 0 2.5110982733167475e-06
regions O 0 2.782449200822157e-06
consistent O 0 4.864273705607047e-06
with O 0 1.1365028740328853e-06
cross O 0 7.928935701784212e-06
- O 0 5.572436930378899e-05
over O 0 9.672089618106838e-07
events O 0 4.772606985170569e-07
during O 0 8.268631859209563e-07
passage O 0 7.397301828859781e-07
of O 0 2.2470193528079108e-07
this O 0 5.115632575325435e-07
mutation O 0 2.614151071611559e-06
through O 0 1.6080380191851873e-06
several O 0 6.218514499778394e-06
generations O 0 3.37742458214052e-05
. O 0 3.29375070577953e-05

These O 0 5.425107156042941e-05
results O 0 7.960192306200042e-05
indicate O 0 2.374825271544978e-05
that O 0 2.8120839488110505e-06
4003delTC O 0 8.705938671482727e-05
occurs O 0 1.9277981664345134e-06
on O 0 1.2727887224173173e-06
a O 0 3.4771305763570126e-06
single O 0 1.985529888770543e-05
ancestral O 0 9.843880980042741e-05
allele O 0 8.860995876602829e-05
. O 0 1.1320698831696063e-05
. O 0 3.843850936391391e-05

The O 0 0.00018752527830656618
haptoglobin O 0 0.0017976697999984026
- O 0 0.000583261251449585
gene O 0 7.351986278081313e-05
deletion O 0 0.00021554212435148656
responsible O 0 8.074226207099855e-05
for O 0 2.724247497098986e-05
anhaptoglobinemia B-Disease 0 0.021586701273918152
. O 0 0.0001486518158344552

We O 0 0.00018229395209345967
have O 0 1.2275629160285462e-05
found O 0 5.0502399062679615e-06
an O 0 1.9296669506729813e-06
allelic O 0 3.153175566694699e-05
deletion O 0 2.4057762857410125e-05
of O 0 2.5066481157409726e-06
the O 0 1.6824806152726524e-05
haptoglobin O 0 0.002554234117269516
( O 0 3.280375949543668e-06
Hp O 0 1.4024465599504765e-05
) O 0 8.435697509412421e-07
gene O 0 2.1823132101417286e-06
from O 0 5.615808618131268e-07
an O 0 8.513665079590282e-07
individual O 0 1.4411572237804648e-06
with O 0 7.933262168080546e-06
anhaptoglobinemia B-Disease 0 0.00917353481054306
. O 0 5.1598792197182775e-05

The O 0 0.00014834270405117422
Hp O 0 0.0004225167213007808
gene O 0 5.8691086451290175e-05
cluster O 0 4.2216521251248196e-05
consists O 0 4.985299256077269e-06
of O 0 1.5198268101812573e-06
coding O 0 2.229583878943231e-05
regions O 0 2.5585088678781176e-06
of O 0 4.768862709170207e-07
the O 0 1.271364453714341e-06
alpha O 0 5.9447606872709e-06
chain O 0 1.3664325706486125e-05
and O 0 1.0661684655133286e-06
beta O 0 3.1734487038193038e-06
chain O 0 6.545634732901817e-06
of O 0 4.975150886821211e-07
the O 0 2.436176373521448e-06
haptoglobin O 0 0.0001482339866925031
gene O 0 8.751285349717364e-06
( O 0 1.3814633348374628e-06
Hp O 0 6.428496362786973e-06
) O 0 3.4099670642717683e-07
and O 0 2.3579461583267403e-07
of O 0 2.53294899721368e-07
the O 0 7.391632266262604e-07
alpha O 0 4.550850462692324e-06
chain O 0 2.1159727111808024e-05
and O 0 1.0402546877230634e-06
beta O 0 2.648279860295588e-06
chain O 0 4.543660452327458e-06
of O 0 5.010290351492586e-07
the O 0 2.4016435418161564e-06
haptoglobin O 0 0.00015051945229060948
- O 0 0.00012353656347841024
related O 0 4.572130819724407e-06
gene O 0 6.4772107180033345e-06
( O 0 1.5413304481626255e-06
Hpr O 0 6.954346463317052e-05
) O 0 6.949426847313589e-07
, O 0 4.4221729922355735e-07
in O 0 7.02583463407791e-07
tandem O 0 1.703218549664598e-05
from O 0 1.205891521749436e-06
the O 0 2.785877086353139e-06
5 O 0 1.9830435121548362e-05
side O 0 5.459349631564692e-05
. O 0 5.1687191444216296e-05

Southern O 0 0.00043237910722382367
blot O 0 0.0010182695696130395
and O 0 2.497947025403846e-05
PCR O 0 0.00019172813335899264
analyses O 0 2.6869003704632632e-05
have O 0 6.292866601143032e-06
indicated O 0 1.0220526746707037e-05
that O 0 4.02550540457014e-07
the O 0 6.460957706622139e-07
individual O 0 7.083836521815101e-07
with O 0 2.626976765895961e-06
anhaptoglobinemia B-Disease 0 0.013268030248582363
was O 0 0.0001063850213540718
homozygous O 0 1.3461414710036479e-05
for O 0 4.4964147605242033e-07
the O 0 8.990531910058053e-07
gene O 0 3.5517173273547087e-06
deletion O 0 8.932895070756786e-06
and O 0 1.0164557124880957e-06
that O 0 4.832328954762488e-07
the O 0 1.1447275483078556e-06
gene O 0 3.354234195285244e-06
deletion O 0 1.0989219845214393e-05
was O 0 1.5586736481054686e-05
included O 0 1.1540337254700717e-06
at O 0 6.202535132615594e-06
least O 0 6.739034006386646e-07
from O 0 3.572554874153866e-07
the O 0 6.617707981604326e-07
promoter O 0 7.87843600846827e-06
region O 0 9.495224162492377e-07
of O 0 4.564880384805292e-07
Hp O 0 8.696839358890429e-06
to O 0 1.1070761729570222e-06
Hpr O 0 4.112869282835163e-05
alpha O 0 3.5684113299794262e-06
but O 0 7.74479019582941e-07
not O 0 1.086834004127013e-06
to O 0 3.2693735647626454e-06
Hpr O 0 0.0002983857411891222
beta O 0 2.7887854230357334e-05
( O 0 7.70626593293855e-06
Hpdel O 0 0.00036529041244648397
) O 0 1.4970968550187536e-05
. O 0 4.147936851950362e-05

In O 0 0.0001346143544651568
addition O 0 4.006988092442043e-05
, O 0 1.1526825801411178e-05
we O 0 2.837195097527001e-06
found O 0 2.4767857667029602e-06
seven O 0 2.90483740172931e-06
individuals O 0 6.940538241906324e-07
with O 0 1.4705431112815859e-06
hypohaptoglobinemia B-Disease 0 0.0007093026069924235
in O 0 2.1737118913733866e-06
three O 0 4.897915005130926e-06
families O 0 8.506185622536577e-06
, O 0 6.122733111624257e-07
and O 0 4.7361615429508674e-07
the O 0 6.606300644307339e-07
genotypes O 0 4.417107902554562e-06
of O 0 2.0380592502533545e-07
six O 0 6.737748208252015e-07
of O 0 2.816894379975565e-07
the O 0 1.3957707096778904e-06
seven O 0 6.2638032432005275e-06
individuals O 0 8.538163456250913e-07
were O 0 2.728699655563105e-06
found O 0 2.1437274426716613e-06
to O 0 1.5040826610857039e-06
be O 0 6.587190910067875e-06
Hp2 O 0 0.0006012986996211112
/ O 0 8.629663352621719e-05
Hpdel O 0 0.0009060450247488916
. O 0 6.360135012073442e-05

The O 0 0.00015756783250253648
phenotypes O 0 0.0005293096764944494
and O 0 2.3780594347044826e-05
genotypes O 0 0.00012093805707991123
in O 0 3.1661029424867593e-06
one O 0 1.057604094967246e-06
of O 0 4.063416554345167e-07
these O 0 3.649116138149111e-07
three O 0 1.7038028090610169e-06
families O 0 5.550109108298784e-06
showed O 0 6.573523023689631e-06
the O 0 9.6275675787183e-07
father O 0 2.060242695733905e-05
to O 0 1.424705487806932e-06
be O 0 3.3140688628918724e-06
hypohaptoglobinemic B-Disease 0 0.00014489665045402944
( O 0 9.17809018119442e-07
Hp2 O 0 4.140656892559491e-05
) O 0 7.592769293296442e-07
and O 0 1.3393830613495084e-06
Hp2 O 0 0.00032213475788012147
/ O 0 1.564490594319068e-05
Hpdel O 0 8.033989433897659e-05
, O 0 1.370774270981201e-06
the O 0 1.436997422388231e-06
mother O 0 4.147066283621825e-05
to O 0 1.087084797291027e-06
be O 0 2.0225377284077695e-06
Hp2 O 0 6.101589315221645e-05
- O 0 2.1918973288848065e-05
1 O 0 1.675341422924248e-06
and O 0 1.825888830353506e-06
Hp1 O 0 0.00013227549789007753
/ O 0 7.639227078470867e-06
Hp2 O 0 3.5701843444257975e-05
, O 0 3.780631629979325e-07
one O 0 1.4393356195796514e-07
of O 0 1.5045576162719954e-07
the O 0 4.6781767082393344e-07
two O 0 1.3024205145484302e-06
children O 0 1.1503808309498709e-05
to O 0 2.7781563858297886e-06
be O 0 7.441549769282574e-06
hypohaptoglobinemic B-Disease 0 0.0005922472337260842
( O 0 1.5182795323198661e-06
Hp2 O 0 5.0400489271851256e-05
) O 0 7.059066433612315e-07
and O 0 1.752249886521895e-06
Hp2 O 0 0.0002666870423126966
/ O 0 1.8108394215232693e-05
Hpdel O 0 0.00010858500172616914
, O 0 1.187952534564829e-06
and O 0 5.701438112737378e-07
the O 0 4.2041537540171703e-07
other O 0 2.902622782130493e-07
child O 0 4.394226380100008e-06
to O 0 7.218663427011052e-07
be O 0 1.616623990230437e-06
Hp1 O 0 6.129805115051568e-05
and O 0 4.48924356533098e-06
Hp1 O 0 0.0007149348966777325
/ O 0 2.3154576410888694e-05
Hpdel O 0 0.00019947295368183404
, O 0 1.8185482986154966e-06
showing O 0 8.671629075251985e-06
an O 0 1.415220822309493e-06
anomalous O 0 2.9405890018097125e-05
inheritance O 0 1.2857970432378352e-05
of O 0 1.5666080344090005e-06
Hp O 0 9.143634088104591e-05
phenotypes O 0 5.5915414122864604e-05
in O 0 1.8624605218064971e-06
the O 0 5.52877190784784e-06
child O 0 0.0002583963505458087
with O 0 3.967224256484769e-05
Hp1 O 0 0.10482846200466156
. O 0 0.000100101409771014

The O 0 0.00017619490972720087
Hp2 O 0 0.008634539321064949
/ O 0 0.0005235238349996507
Hpdel O 0 0.0025990174617618322
individuals O 0 8.647052709420677e-06
had O 0 2.8757342079188675e-05
an O 0 1.9359358702786267e-06
extremely O 0 1.5022455954749603e-05
low O 0 1.7877569916890934e-05
level O 0 2.783972831821302e-06
of O 0 1.581972810527077e-06
Hp O 0 4.197734233457595e-05
( O 0 1.5331689837694285e-06
mean O 0 5.014294856664492e-06
+ O 0 6.499150913441554e-06
/ O 0 6.028192274243338e-06
- O 0 3.138365354971029e-05
SD O 0 0.0006966218934394419
= O 0 8.74715406098403e-05
0 O 0 6.115728410804877e-06
. O 0 1.5373829000964179e-06
049 O 0 5.815728582092561e-05
+ O 0 9.986683835450094e-06
/ O 0 5.197319751459872e-06
- O 0 1.5838002582313493e-05
0 O 0 6.1680279941356275e-06
. O 0 1.7651880170888035e-06
043 O 0 4.566842835629359e-05
mg O 0 2.8668842787737958e-05
/ O 0 1.7194082829519175e-05
ml O 0 6.820469570811838e-05
; O 0 2.4065154775598785e-06
n O 0 3.468161594355479e-05
= O 0 4.9306127039017156e-05
6 O 0 4.505266588239465e-06
) O 0 7.129040113795782e-07
, O 0 5.106927005726902e-07
compared O 0 8.863260063662892e-07
with O 0 2.801479297431797e-07
the O 0 6.508776095870417e-07
level O 0 2.105171006405726e-06
( O 0 4.3101368873976753e-07
1 O 0 6.680394903924025e-07
. O 0 3.830036803265102e-07
64 O 0 4.578222160489531e-06
+ O 0 6.404362466128077e-06
/ O 0 4.591085144056706e-06
- O 0 7.477624421881046e-06
1 O 0 1.241924223904789e-06
. O 0 7.285146352842276e-07
07 O 0 3.515080607030541e-05
mg O 0 2.0710536773549393e-05
/ O 0 6.5719805206754245e-06
ml O 0 1.740427251206711e-05
) O 0 8.78920502600522e-07
obtained O 0 1.0080448191729374e-06
from O 0 9.96783455775585e-07
52 O 0 2.098381628456991e-05
healthy O 0 8.97995869308943e-06
volunteers O 0 9.276326636609156e-06
having O 0 1.7251977624255233e-05
phenotype O 0 0.00017010433657560498
Hp2 O 0 0.0001291103835683316
, O 0 1.6461777931908728e-06
whereas O 0 2.234787643828895e-06
the O 0 2.207018496847013e-06
serum O 0 0.00017590115021448582
Hp O 0 7.502338576159673e-06
level O 0 9.47812395679648e-07
of O 0 4.27569403882444e-07
an O 0 1.1430072390794521e-06
individual O 0 1.1607954775172402e-06
with O 0 7.458558229700429e-06
Hp1 O 0 0.022150501608848572
/ O 0 0.00011472150799818337
Hpdel O 0 0.0009000786812976003
was O 0 0.00016016967128962278
0 O 0 0.00013874020078219473
. O 0 4.3750427721533924e-05

50 O 0 0.00045859935926273465
mg O 0 0.0008097173413261771
/ O 0 0.00010942894004983827
ml O 0 0.00020764458167832345
, O 0 4.6311110963870306e-06
which O 0 1.7883851342048729e-06
was O 0 2.8534709599625785e-06
approximately O 0 5.179924755793763e-07
half O 0 5.251670245343121e-07
the O 0 2.6335538905186695e-07
level O 0 5.808374794469273e-07
of O 0 4.799161388291395e-07
Hp O 0 1.2047376912960317e-05
in O 0 1.9587207589211175e-06
control O 0 5.3521689551416785e-05
sera O 0 4.3565454689087346e-05
from O 0 1.199445591737458e-06
the O 0 4.954959422320826e-06
Hp1 O 0 0.0434001125395298
phenotype O 0 0.00021125655621290207
( O 0 1.2389207313390216e-06
1 O 0 9.738862445374252e-07
. O 0 3.627195042099629e-07
26 O 0 4.201710908091627e-06
+ O 0 4.0318204810319e-06
/ O 0 3.9107985685404856e-06
- O 0 1.3400664101936854e-05
0 O 0 3.948822723032208e-06
. O 0 1.090869204745104e-06
33 O 0 7.739622560620774e-06
mg O 0 1.958468601515051e-05
/ O 0 9.544536624161992e-06
ml O 0 4.1075225453823805e-05
; O 0 3.820631718554068e-06
n O 0 5.3546958952210844e-05
= O 0 7.196566730272025e-05
9 O 0 8.408674148085993e-06
) O 0 7.145880545067484e-07
, O 0 6.558523182320641e-07
showing O 0 3.870703494612826e-06
a O 0 5.213876193010947e-06
gene O 0 1.8462000298313797e-05
- O 0 0.00026988823083229363
dosage O 0 0.00018485239706933498
effect O 0 3.352938438183628e-05
. O 0 4.1381106711924076e-05

The O 0 5.8019515563501045e-05
other O 0 8.412323040829506e-06
allele O 0 5.043872079113498e-05
( O 0 4.2883680180239026e-06
Hp2 O 0 0.0001121551395044662
) O 0 8.59913200201845e-07
of O 0 3.664509335976618e-07
individuals O 0 1.152026811723772e-06
with O 0 3.919285063602729e-06
Hp2 O 0 0.010528411716222763
/ O 0 5.1320690545253456e-05
Hpdel O 0 0.0016265559243038297
was O 0 5.187399801798165e-05
found O 0 1.280907099499018e-06
to O 0 7.082221600285266e-07
have O 0 1.3618603134091245e-06
, O 0 4.314385364523332e-07
in O 0 4.032802394249302e-07
all O 0 3.339407044222753e-07
exons O 0 1.0897339961957186e-05
, O 0 1.853436174314993e-06
no O 0 3.6595399706129683e-06
mutation O 0 6.266121545195347e-06
, O 0 9.200051067637105e-07
by O 0 1.500957637290412e-06
DNA O 0 2.8501683118520305e-05
sequencing O 0 8.978955156635493e-05
. O 0 4.5554599637398496e-05

On O 0 3.676670530694537e-05
the O 0 4.959025318385102e-06
basis O 0 1.0752060006780084e-06
of O 0 5.875996293980279e-07
the O 0 8.220371228162549e-07
present O 0 9.317619173998537e-07
study O 0 7.125173056010681e-07
, O 0 3.526481293647521e-07
the O 0 2.9554237812590145e-07
mechanism O 0 9.625216534914216e-07
of O 0 3.419798986215028e-07
anhaptoglobinemia B-Disease 0 0.0009964212076738477
and O 0 6.665147225248802e-07
the O 0 5.438959647108277e-07
mechanism O 0 2.0988902633689577e-06
of O 0 6.110372510192974e-07
anomalous O 0 3.456499689491466e-05
inheritance O 0 1.2457338925742079e-05
of O 0 2.27122541218705e-06
Hp O 0 0.0001736282283673063
phenotypes O 0 0.0001572595356265083
were O 0 2.4726303308852948e-05
well O 0 1.8176631783717312e-05
explained O 0 8.891822653822601e-05
. O 0 5.740543201682158e-05

However O 0 0.00012599369802046567
, O 0 1.5808982425369322e-05
the O 0 5.005914317735005e-06
mechanism O 0 1.5428027836605906e-05
of O 0 1.3665341612068005e-05
hypohaptoglobinemia B-Disease 0 0.0265247393399477
remains O 0 0.00026778975734487176
unknown O 0 0.0008072447380982339

ATM O 0 0.06287557631731033
mutations O 0 0.0014182700542733073
and O 0 9.984305506804958e-05
phenotypes O 0 0.009222615510225296
in O 0 0.006194046698510647
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999896287918091
telangiectasia I-Disease 1 0.9999996423721313
families O 0 0.000648541608825326
in O 0 7.5610937528836075e-06
the O 0 3.6616136185330106e-06
British O 0 2.068572212010622e-05
Isles O 0 2.0543333448586054e-05
: O 0 5.708848789254262e-07
expression O 0 5.212411906541092e-07
of O 0 3.001675281666394e-07
mutant O 0 1.0069369636767078e-05
ATM O 0 8.421442180406302e-05
and O 0 1.5896100649115397e-06
the O 0 3.235801841583452e-06
risk O 0 7.347360951825976e-05
of O 0 3.5239547287346795e-05
leukemia B-Disease 1 0.9999995231628418
, O 1 0.6966513991355896
lymphoma B-Disease 1 1.0
, O 0 0.0007062238291837275
and O 0 0.1357652097940445
breast B-Disease 1 0.9999978542327881
cancer I-Disease 1 0.9972905516624451
. O 0 0.0001303374592680484

We O 0 6.809681508457288e-05
report O 0 1.2077712199243251e-05
the O 0 1.4327471262731706e-06
spectrum O 0 7.536782050010515e-06
of O 0 2.4911173568398226e-06
59 O 0 7.82238130341284e-05
ATM O 0 0.007376383524388075
mutations O 0 5.1978426199639216e-05
observed O 0 1.7819222193793394e-05
in O 0 0.00015923011233098805
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999978542327881
telangiectasia I-Disease 1 0.9999998807907104
( O 0 0.0003217363846488297
A B-Disease 1 0.9999592304229736
- I-Disease 1 0.9999995231628418
T I-Disease 1 1.0
) O 0 1.6345218682545237e-05
patients O 0 2.1826566808158532e-05
in O 0 1.8608449181556352e-06
the O 0 4.192113919998519e-06
British O 0 7.090652798069641e-05
Isles O 0 0.0003949824604205787
. O 0 6.275093619478866e-05

Of O 0 7.800183811923489e-05
51 O 0 0.00028109663981013
ATM O 0 0.004117377568036318
mutations O 0 7.827021909179166e-05
identified O 0 1.2970166608283762e-05
in O 0 3.8771381696278695e-06
families O 0 6.834201030869735e-06
native O 0 1.3377248251345009e-06
to O 0 7.975530706971767e-07
the O 0 1.2339316981524462e-06
British O 0 1.1560292477952316e-05
Isles O 0 3.480344093986787e-05
, O 0 1.7446647007091087e-06
11 O 0 6.82508243698976e-06
were O 0 5.481767402670812e-06
founder O 0 3.06287947751116e-05
mutations O 0 4.402590548124863e-06
, O 0 5.340114057617029e-07
and O 0 4.3408192595961737e-07
2 O 0 5.803607336929417e-07
of O 0 2.062232624666649e-07
these O 0 4.98642293678131e-07
11 O 0 9.912994755723048e-06
conferred O 0 1.0527835911489092e-05
a O 0 1.0294912499375641e-05
milder O 0 0.001007842249237001
clinical O 0 0.0034409768413752317
phenotype O 0 0.0013849058886989951
with O 0 3.2618368095427286e-06
respect O 0 3.330245817778632e-06
to O 0 3.725797114384477e-06
both O 0 1.702218287391588e-05
cerebellar B-Disease 0 0.21172358095645905
degeneration I-Disease 0 0.3827110230922699
and O 0 2.8000153179164045e-05
cellular O 0 0.00639961427077651
features O 0 0.00014414793986361474
. O 0 0.00010016100713983178

We O 0 0.0002459282986819744
report O 0 3.645547985797748e-05
, O 0 5.451097877084976e-06
in O 0 1.956786491064122e-06
two O 0 7.231228210002882e-06
A B-Disease 1 0.9989472031593323
- I-Disease 1 0.9998788833618164
T I-Disease 1 0.9999940395355225
families O 0 6.868136551929638e-06
, O 0 6.003020303069206e-07
an O 0 8.840021337164217e-07
ATM O 0 0.0013010842958465219
mutation O 0 1.5091594832483679e-05
( O 0 1.476818283663306e-06
7271T O 0 7.411877595586702e-05
- O 0 0.002143576741218567
- O 0 0.039239294826984406
> O 0 0.0013014946598559618
G O 0 0.06573884189128876
) O 0 1.9556109691620804e-06
that O 0 1.1813671108029666e-06
may O 0 9.201066859532148e-06
be O 0 6.966719183765235e-07
associated O 0 1.003039074021217e-06
with O 0 6.097943696659058e-07
an O 0 2.092037902912125e-06
increased O 0 1.7737907910486683e-05
risk O 0 4.9521346227265894e-05
of O 0 1.1624058060988318e-05
breast B-Disease 1 0.9996249675750732
cancer I-Disease 1 0.5442262291908264
in O 0 6.685686457785778e-06
both O 0 7.6936721598031e-06
homozygotes O 0 0.008138300850987434
and O 0 3.5983906855108216e-05
heterozygotes O 0 0.000797891931142658
( O 0 4.487111709750025e-06
relative O 0 8.86108900886029e-05
risk O 0 0.00014646828640252352
12 O 0 1.191937190014869e-05
. O 0 1.4770182588108582e-06
7 O 0 2.352828232687898e-05
; O 0 5.987850272504147e-06
P O 0 0.06919743865728378
= O 0 0.00010454756557010114
. O 0 1.5660539247619454e-06
0025 O 0 0.00013234881043899804
) O 0 9.412395911567728e-07
, O 0 5.034593186792335e-07
although O 0 4.979223717782588e-07
there O 0 7.784383342368528e-07
is O 0 6.384857442753855e-07
a O 0 8.60578893480124e-06
less O 0 3.6602454201783985e-05
severe O 1 0.9870150089263916
A B-Disease 1 0.9999921321868896
- I-Disease 1 0.9999992847442627
T I-Disease 1 0.9999998807907104
phenotype O 0 0.0022933052387088537
in O 0 1.589616090313939e-06
terms O 0 1.3251024029159453e-06
of O 0 4.4652375663645216e-07
the O 0 2.563696398283355e-06
degree O 0 0.0001079615976777859
of O 0 3.211733201169409e-05
cerebellar B-Disease 1 0.9789971709251404
degeneration I-Disease 1 0.9893725514411926
. O 0 0.00038254293031059206

This O 0 7.521627412643284e-05
mutation O 0 0.00014701805775985122
( O 0 1.5051451555336826e-05
7271T O 0 0.00030160933965817094
- O 0 0.0017984092701226473
- O 0 0.015394255518913269
> O 0 0.0004535360203590244
G O 0 0.014553964138031006
) O 0 8.787981187197147e-07
also O 0 5.323628329279018e-07
allows O 0 4.537834570328414e-07
expression O 0 6.503074132524489e-07
of O 0 2.923254953657306e-07
full O 0 3.410354793231818e-06
- O 0 1.612149026186671e-05
length O 0 5.3721792028227355e-06
ATM O 0 0.00014885948621667922
protein O 0 3.7029847135272576e-06
at O 0 2.2594965685129864e-06
a O 0 1.6093144949991256e-06
level O 0 1.5494910030611209e-06
comparable O 0 4.131185050937347e-06
with O 0 1.0371056760050124e-06
that O 0 1.929481186380144e-06
in O 0 8.11453446658561e-06
unaffected O 0 0.0005439368542283773
individuals O 0 1.3550623407354578e-05
. O 0 3.9870534237707034e-05

In O 0 0.0001076256885426119
addition O 0 3.0222841814975254e-05
, O 0 7.129378900572192e-06
we O 0 2.8916256269440055e-06
have O 0 1.5897509229034767e-06
studied O 0 9.312722795584705e-06
18 O 0 9.491924720350653e-05
A B-Disease 1 0.998313307762146
- I-Disease 1 0.9999725818634033
T I-Disease 1 0.9999998807907104
patients O 0 0.0006265798001550138
, O 0 1.0118550335391774e-06
in O 0 1.195612981064187e-06
15 O 0 6.8644890234281775e-06
families O 0 5.407460321293911e-06
, O 0 2.4408761873928597e-06
who O 0 5.3391082474263385e-05
developed O 0 0.44413456320762634
leukemia B-Disease 1 0.9999991655349731
, O 0 0.4493482708930969
lymphoma B-Disease 1 1.0
, O 0 0.00048343808157369494
preleukemic O 1 0.7814046740531921
T O 1 0.8678127527236938
- O 0 0.0062988377176225185
cell O 0 0.0035627528559416533
proliferation O 0 0.00033862603595480323
, O 0 3.9433405618183315e-05
or O 0 0.12922076880931854
Hodgkin B-Disease 1 1.0
lymphoma I-Disease 1 1.0
, O 0 3.354470754857175e-05
mostly O 0 8.926950613385998e-06
in O 0 1.9763036107178777e-05
childhood O 0 0.008586687035858631
. O 0 0.00011198341962881386

A O 0 0.00011643458128673956
wide O 0 4.1198640246875584e-05
variety O 0 5.362207957659848e-06
of O 0 2.8644478788919514e-06
ATM O 0 0.08928649872541428
mutation O 0 4.3664065742632374e-05
types O 0 4.673388048104243e-06
, O 0 2.1107978227519197e-06
including O 0 2.5463698420935543e-06
missense O 0 5.1142764277756214e-05
mutations O 0 1.525788593426114e-05
and O 0 1.6752520650697988e-06
in O 0 5.119730303704273e-06
- O 0 0.0018176238518208265
frame O 0 0.00024183890491258353
deletions O 0 4.834637729800306e-05
, O 0 5.236250217421912e-06
were O 0 7.130759513529483e-06
seen O 0 5.788346697954694e-06
in O 0 2.4961352664831793e-06
these O 0 7.284810635610484e-06
patients O 0 0.0006226255791261792
. O 0 3.764872235478833e-05

We O 0 8.071331831160933e-05
also O 0 1.3862969353795052e-05
show O 0 6.144285634945845e-06
that O 0 9.314820204053831e-07
25 O 0 2.987663265230367e-06
% O 0 8.994485369839822e-07
of O 0 5.20504556789092e-07
all O 0 4.65029143015272e-06
A B-Disease 1 0.9996451139450073
- I-Disease 1 0.9999879598617554
T I-Disease 1 0.9999998807907104
patients O 0 0.0005114799132570624
carried O 0 2.24983632506337e-05
in O 0 6.520097485918086e-06
- O 0 0.0005913929198868573
frame O 0 9.457546548219398e-05
deletions O 0 2.371869413764216e-05
or O 0 7.301920504687587e-06
missense O 0 5.035653884988278e-05
mutations O 0 1.3731470971833915e-05
, O 0 7.809866815478017e-07
many O 0 2.202478270874053e-07
of O 0 5.160615614840935e-07
which O 0 4.266421456122771e-06
were O 0 6.955653134355089e-06
also O 0 2.836859493982047e-06
associated O 0 1.7494229496151092e-06
with O 0 8.606146479905874e-07
expression O 0 2.5626409296819475e-06
of O 0 2.2121962501842063e-06
mutant O 0 0.00010082757944473997
ATM O 0 0.001243838225491345
protein O 0 0.00011151390935992822
. O 0 5.686548684025183e-05

The O 0 0.00025903768255375326
DMPK O 0 0.004840018693357706
gene O 0 0.0001694422389846295
of O 0 6.640866922680289e-05
severely O 1 0.9995177984237671
affected O 1 0.9707278609275818
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
patients O 1 0.9998773336410522
is O 0 0.00010328042844776064
hypermethylated O 0 0.05324198305606842
proximal O 0 0.0013294352684170008
to O 0 8.420944141107611e-06
the O 0 7.45739907870302e-06
largely O 0 3.344373544678092e-05
expanded O 0 0.0001078543791663833
CTG O 0 0.00271188048645854
repeat O 0 0.0003549244429450482
. O 0 9.526226494926959e-05

Using O 0 0.00010869347170228139
methylation O 0 0.00016092314035631716
- O 0 0.00019246170995756984
sensitive O 0 2.522286922612693e-05
restriction O 0 1.1071648259530775e-05
enzymes O 0 9.14589054445969e-06
, O 0 2.2010326574672945e-06
we O 0 1.2098679462724249e-06
characterized O 0 2.021135969698662e-06
the O 0 4.1680257822918065e-07
methylation O 0 2.363999101362424e-06
pattern O 0 3.3907317629200406e-06
on O 0 8.14628606349288e-07
the O 0 9.531987075206416e-07
5 O 0 1.953003675225773e-06
side O 0 1.3171825230529066e-06
of O 0 3.0157463015711983e-07
the O 0 4.498642283579102e-06
CTG O 0 0.0011321682250127196
repeat O 0 8.538557267456781e-06
in O 0 9.042399256031786e-07
the O 0 2.192115061916411e-06
DMPK O 0 0.004273508209735155
gene O 0 2.2557933334610425e-06
of O 0 4.4375252628015005e-07
normal O 0 7.4586578193702735e-06
individuals O 0 8.234864594669489e-07
and O 0 8.599845386925153e-07
of O 0 5.380177299230127e-06
patients O 0 0.015568978153169155
affected O 0 8.874414925230667e-05
with O 0 0.0029743111226707697
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 0.9999998807907104
, O 0 5.082484130980447e-05
showing O 0 4.2827810830203816e-05
expansions O 0 1.3237307030067313e-05
of O 0 1.5733980944787618e-06
the O 0 1.049101229000371e-05
repetitive O 0 0.0017943682614713907
sequence O 0 5.9570269513642415e-05
. O 0 4.4541571696754545e-05

The O 0 8.81487867445685e-05
gene O 0 7.698735862504691e-05
segment O 0 5.5161868658615276e-05
analyzed O 0 2.0076149667147547e-05
corresponds O 0 6.831255632278044e-06
to O 0 1.5407587170557235e-06
the O 0 3.6259575608710293e-06
genomic O 0 3.9698585169389844e-05
SacI O 0 0.0003382482682354748
- O 0 9.646278340369463e-05
HindIII O 0 7.538258068962023e-05
fragment O 0 2.5996670956374146e-05
carrying O 0 2.3368042093352415e-05
exons O 0 5.8678102504927665e-05
11 O 0 2.8975666282349266e-05
- O 0 0.0001722132001304999
15 O 0 5.126072937855497e-05
. O 0 4.846981755690649e-05

There O 0 8.113682270050049e-05
is O 0 1.1417530004109722e-05
constitutive O 0 3.297565854154527e-05
methylation O 0 1.9423441699473187e-05
in O 0 4.823185463465052e-06
intron O 0 0.00017986808961723
12 O 0 7.903940058895387e-06
at O 0 3.099132527495385e-06
restriction O 0 1.2465674217310152e-06
sites O 0 9.103590628001257e-07
of O 0 8.870498504620628e-07
SacII O 0 0.0001294908724958077
and O 0 4.459451702132355e-06
HhaI O 0 0.00012709794100373983
, O 0 1.210592813549738e-06
localized O 0 6.007773208693834e-06
1 O 0 1.7020292943925597e-06
, O 0 1.1730738833648502e-06
159 O 0 5.697068900190061e-06
- O 0 2.0991903511458077e-05
1 O 0 1.452478272767621e-06
, O 0 7.12883661435626e-07
232 O 0 3.729590162038221e-06
bp O 0 1.2367670933599584e-05
upstream O 0 2.0615655103028985e-06
of O 0 6.436911235141451e-07
the O 0 4.1960092858062126e-06
CTG O 0 0.0002604304172564298
repeat O 0 2.045916517090518e-05
, O 0 1.650034846534254e-06
whereas O 0 1.7610785789656802e-06
most O 0 4.5172131990511843e-07
, O 0 1.4627399878008873e-06
if O 0 4.624132543540327e-07
not O 0 2.3833825935071218e-07
all O 0 1.0014258577939472e-07
, O 0 1.0960921059677275e-07
of O 0 6.293198850926274e-08
the O 0 2.201421835934525e-07
other O 0 1.0517556603417688e-07
sites O 0 5.807815455227683e-07
of O 0 5.206500190979568e-07
SacII O 0 0.0008459737291559577
, O 0 1.8487370425646077e-06
HhaI O 0 9.850360947893932e-05
, O 0 1.3971783801025595e-06
and O 0 1.4188573231876944e-06
HpaII O 0 0.00017942649719770998
in O 0 1.2885130900031072e-06
this O 0 5.757751182500215e-07
region O 0 2.1695618670491967e-06
are O 0 8.604110917076468e-07
unmethylated O 0 2.9809365514665842e-05
, O 0 9.126662234848482e-07
in O 0 1.0853921139641898e-06
normal O 0 7.150876626837999e-06
individuals O 0 4.898475935988245e-07
and O 0 4.6510095330631884e-07
most O 0 3.728053741269832e-07
of O 0 1.5853302102186717e-06
the O 0 5.57290950382594e-05
patients O 0 0.00332642812281847
. O 0 8.827353303786367e-05

In O 0 6.292441685218364e-05
a O 0 1.3999945622344967e-05
number O 0 2.9320181056391448e-06
of O 0 2.1951943836029386e-06
young O 0 2.120843782904558e-05
and O 0 2.4659233531565405e-05
severely O 1 0.970518171787262
affected O 0 0.0009485246264375746
patients O 0 0.006590633187443018
, O 0 6.55247413305915e-06
however O 0 1.5761751228637877e-06
, O 0 7.131400252546882e-07
complete O 0 1.7400669776179711e-06
methylation O 0 1.1196366358490195e-06
of O 0 2.544633446177613e-07
these O 0 2.576191207026568e-07
restriction O 0 1.4807289971940918e-06
sites O 0 1.6360953623006935e-06
was O 0 1.2698528735199943e-05
found O 0 1.456942754884949e-06
in O 0 7.955885621413472e-07
the O 0 3.4960567063535564e-06
mutated O 0 0.0001047829064191319
allele O 0 0.0001742724416544661
. O 0 4.697039184975438e-05

In O 0 6.40603102510795e-05
most O 0 4.337159225542564e-06
of O 0 1.828635163292347e-06
these O 0 3.313654588055215e-06
patients O 0 0.00011545391316758469
, O 0 1.3947035313321976e-06
the O 0 1.7463191852584714e-06
onset O 0 0.0024840838741511106
of O 0 4.208039172226563e-06
the O 0 0.08945070952177048
disease O 1 0.9999768733978271
was O 1 0.9867218732833862
congenital O 1 0.999998927116394
. O 0 0.0005085454322397709

Preliminary O 0 0.0006034062243998051
in O 0 0.00015139492461457849
vivo O 0 0.001746476860716939
footprinting O 0 0.001086092204786837
data O 0 1.3966688129585236e-05
gave O 0 6.2415497268375475e-06
evidence O 0 1.6425645981144044e-06
for O 0 8.576208756494452e-07
protein O 0 4.144206741329981e-06
- O 0 3.0135206543491222e-05
DNA O 0 7.2379484663542826e-06
contact O 0 3.493030817480758e-06
in O 0 1.7232604250239092e-06
normal O 0 1.1311957678117324e-05
genes O 0 4.862395599047886e-06
at O 0 1.077292108675465e-05
an O 0 3.460876769167953e-06
Sp1 O 0 5.566276013269089e-05
consensus O 0 2.236791942777927e-06
binding O 0 2.813119408529019e-06
site O 0 2.653419414855307e-06
upstream O 0 2.857653726096032e-06
of O 0 4.582121846397058e-07
the O 0 2.882413127736072e-06
CTG O 0 0.00036857507075183094
repeat O 0 6.044789188308641e-06
and O 0 5.314457212080015e-07
for O 0 2.366529230357628e-07
a O 0 1.5195703326753573e-06
significant O 0 1.0102313581228373e-06
reduction O 0 8.980831580629456e-07
of O 0 1.661912421013767e-07
this O 0 3.194425914898602e-07
interaction O 0 1.0632076055117068e-06
in O 0 3.3644732866378035e-06
cells O 0 7.440293757099425e-06
with O 0 1.8930820715468144e-06
a O 0 1.9321627405588515e-05
hypermethylated O 0 0.02285979501903057
DMPK O 0 0.019511397927999496
gene O 0 3.1184390536509454e-05
. O 0 8.500088370055892e-06
. O 0 3.445773836574517e-05

The O 0 0.0008621212327852845
hemochromatosis B-Disease 1 0.9999738931655884
gene O 0 0.00020148578914813697
product O 0 2.1828502212883905e-05
complexes O 0 2.206220779044088e-05
with O 0 2.080415015370818e-06
the O 0 3.216182449250482e-06
transferrin O 0 0.00012109083763789386
receptor O 0 1.2635725397558417e-05
and O 0 3.118890845144051e-06
lowers O 0 2.2872165573062375e-05
its O 0 1.3822184428136097e-06
affinity O 0 8.406373126490507e-06
for O 0 3.888766059390036e-06
ligand O 0 4.6997451136121526e-05
binding O 0 8.796145266387612e-05
. O 0 4.147683648625389e-05

We O 0 0.00016745319589972496
recently O 0 9.21107130125165e-05
reported O 0 1.623460957489442e-05
the O 0 2.190626901210635e-06
positional O 0 2.6588513719616458e-05
cloning O 0 7.503962933697039e-06
of O 0 1.1896509022335522e-06
a O 0 8.220213203458115e-06
candidate O 0 2.768841659417376e-05
gene O 0 7.042141805868596e-05
for O 0 0.00016071737627498806
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
called O 1 0.5114712715148926
HFE O 1 0.9974930286407471
. O 0 0.0003323582641314715

The O 0 0.00011289443500572816
gene O 0 9.214331657858565e-05
product O 0 1.2451413567760028e-05
, O 0 2.040573235717602e-06
a O 0 1.3417430864137714e-06
member O 0 9.842990493780235e-07
of O 0 4.93818049562833e-07
the O 0 1.3044927982264198e-06
major O 0 5.737860192311928e-06
histocompatibility O 0 0.00017681962344795465
complex O 0 1.3435275832307525e-05
class O 0 1.536523996037431e-05
I O 0 0.00011419162183301523
- O 0 2.688041058718227e-05
like O 0 2.327040192540153e-06
family O 0 8.542099749320187e-06
, O 0 1.6968836007436039e-06
was O 0 1.563700061524287e-05
found O 0 1.1101061545559787e-06
to O 0 4.6175932766345795e-07
have O 0 1.054190420290979e-06
a O 0 3.367657654962386e-06
mutation O 0 8.467975021630991e-06
, O 0 2.824983312166296e-06
Cys O 0 0.0003615469322539866
- O 0 9.609811240807176e-05
282 O 0 4.895166421192698e-05
- O 0 0.0008593864040449262
- O 0 0.0016495607560500503
> O 0 8.638917643111199e-05
Tyr O 0 0.00019021860498469323
( O 0 3.3924977742572082e-06
C282Y O 0 4.4838110625278205e-05
) O 0 7.988159040905884e-07
, O 0 4.309241035116429e-07
in O 0 9.57090037445596e-07
85 O 0 5.3312769523472525e-06
% O 0 1.7464242318965262e-06
of O 0 2.617843620100757e-06
patient O 0 0.0007191343465819955
chromosomes O 0 0.0001983254187507555
. O 0 5.606470222119242e-05

This O 0 6.060428495402448e-05
mutation O 0 7.699162233620882e-05
eliminates O 0 4.222795905661769e-05
the O 0 3.554200930011575e-06
ability O 0 6.275199211813742e-06
of O 0 2.2418917069444433e-06
HFE O 0 0.004536088556051254
to O 0 3.7584507026622305e-06
associate O 0 1.8903212549048476e-05
with O 0 5.882292043679627e-06
beta2 O 0 0.039616554975509644
- O 0 0.1121179386973381
microglobulin O 0 0.013340340927243233
( O 0 4.637147867470048e-06
beta2m O 0 0.00013368870713748038
) O 0 1.7500954072602326e-06
and O 0 2.138587660738267e-06
prevents O 0 1.133896967075998e-05
cell O 0 4.9784648581407964e-05
- O 0 0.00014318953617475927
surface O 0 6.184007361298427e-05
expression O 0 4.127583815716207e-05
. O 0 5.433421392808668e-05

A O 0 0.0003821098944172263
second O 0 0.0001525444386061281
mutation O 0 4.77092107757926e-05
that O 0 4.114862804271979e-06
has O 0 3.9078231566236354e-06
no O 0 2.796215312628192e-06
effect O 0 2.3123113805922912e-06
on O 0 4.247875949658919e-06
beta2m O 0 0.0006290914607234299
association O 0 6.522099738504039e-06
, O 0 2.514911102480255e-06
H63D O 0 0.0025652090553194284
, O 0 1.9505262116581434e-06
was O 0 1.1314093171677087e-05
found O 0 1.37161759994342e-06
in O 0 4.5405835180645227e-07
eight O 0 1.0945582289423328e-06
out O 0 8.085975196081563e-07
of O 0 3.5407663290243363e-07
nine O 0 7.317525160033256e-05
patients O 0 6.719641532981768e-05
heterozygous O 0 1.8240376448375173e-05
for O 0 1.3735693755734246e-06
the O 0 1.0980431397911161e-05
C282Y O 0 0.0008587524644099176
mutant O 0 0.00035929467412643135
. O 0 5.369008067646064e-05

In O 0 0.00011292124690953642
this O 0 1.4767218090128154e-05
report O 0 1.0973113603540696e-05
, O 0 2.1272333015076583e-06
we O 0 1.1386867981855175e-06
demonstrate O 0 3.3938215437956387e-06
in O 0 2.1223579551588045e-06
cultured O 0 1.4398918210645206e-05
293 O 0 2.7902433430426754e-05
cells O 0 1.649256046221126e-05
overexpressing O 0 5.9817433793796226e-05
wild O 0 5.135751507623354e-06
- O 0 2.674009374459274e-05
type O 0 5.462015451485058e-06
or O 0 1.4183932535161148e-06
mutant O 0 2.332431176910177e-05
HFE O 0 0.00037051551043987274
proteins O 0 1.6916919776122086e-06
that O 0 4.034248775042215e-07
both O 0 4.0788688693282893e-07
the O 0 9.989284990297165e-07
wild O 0 4.843475380766904e-06
- O 0 9.454011888010427e-05
type O 0 1.4732138879480772e-05
and O 0 1.192709260067204e-05
H63D O 0 0.08204401284456253
HFE O 0 0.00419501680880785
proteins O 0 5.314028385328129e-06
form O 0 3.6279254800319904e-06
stable O 0 3.3353790058754385e-05
complexes O 0 1.3757581655227114e-05
with O 0 2.4359651433769614e-06
the O 0 1.2846608115069102e-05
transferrin O 0 0.02023974433541298
receptor O 0 0.0001963819668162614
( O 0 1.1938153875235002e-05
TfR O 0 0.0005082003772258759
) O 0 1.4311466657090932e-05
. O 0 2.7622823836281896e-05

The O 0 0.00016540811338927597
C282Y O 0 0.0013158550718799233
mutation O 0 0.00016755811520852149
nearly O 0 3.804290827247314e-05
completely O 0 3.9884216676000506e-05
prevents O 0 6.671827122772811e-06
the O 0 1.2338646229181904e-06
association O 0 2.1881339762330754e-06
of O 0 8.489981837556115e-07
the O 0 4.034112862427719e-06
mutant O 0 0.00017717236187309027
HFE O 0 0.003826139261946082
protein O 0 1.582112417963799e-05
with O 0 5.023906396672828e-06
the O 0 3.3722266380209476e-05
TfR O 0 0.00706333015114069
. O 0 0.00011904526763828471

Studies O 0 0.00018092489335685968
on O 0 3.519501842674799e-05
cell O 0 0.00019394040282350034
- O 0 0.00016591216262895614
associated O 0 1.2696797057287768e-05
transferrin O 0 4.0227703721029684e-05
at O 0 7.614402420585975e-06
37 O 0 8.59542160469573e-06
degrees O 0 2.0125642549828626e-05
C O 0 8.105971937766299e-05
suggest O 0 2.285564050907851e-06
that O 0 4.971726639269036e-07
the O 0 1.212294478136755e-06
overexpressed O 0 2.826732088578865e-05
wild O 0 4.884122972725891e-06
- O 0 4.6681914682267234e-05
type O 0 2.0079614841961302e-05
HFE O 0 0.00037809720379300416
protein O 0 7.353267847065581e-06
decreases O 0 3.842244950647e-06
the O 0 8.36968297335261e-07
affinity O 0 4.368504505691817e-06
of O 0 1.337899561804079e-06
the O 0 8.693265954207163e-06
TfR O 0 0.0005728061078116298
for O 0 1.4669890333607327e-05
transferrin O 0 0.0022894658613950014
. O 0 9.679052891442552e-05

The O 0 0.0003092633851338178
overexpressed O 0 0.002043242333456874
H63D O 0 0.007400501985102892
protein O 0 5.468868766911328e-05
does O 0 4.084235570189776e-06
not O 0 1.1203320582353626e-06
have O 0 6.571295330104476e-07
this O 0 2.837855959114677e-07
effect O 0 1.0140805670744157e-06
, O 0 4.386110958876088e-07
providing O 0 5.664217042067321e-07
the O 0 2.4946069743236876e-07
first O 0 5.836499781253224e-07
direct O 0 8.307544590024918e-07
evidence O 0 5.85394730023836e-07
for O 0 4.4354686679071165e-07
a O 0 6.408174613170559e-06
functional O 0 3.098024899372831e-05
consequence O 0 6.337421382340835e-06
of O 0 1.0579370837149327e-06
the O 0 1.1990421626251191e-05
H63D O 0 0.3903915584087372
mutation O 0 0.0001423737412551418
. O 0 7.358410948654637e-05

Addition O 0 0.00010373524128226563
of O 0 3.0709747079527006e-05
soluble O 0 0.00019707373576238751
wild O 0 3.894729888997972e-05
- O 0 0.0003668249992188066
type O 0 0.00015104351041372865
HFE O 0 0.06944682449102402
/ O 0 0.00012915543629787862
beta2m O 0 0.0006269612349569798
heterodimers O 0 0.00031590458820573986
to O 0 9.408048754266929e-06
cultured O 0 0.00012134305143263191
cells O 0 3.269459557486698e-05
also O 0 3.372619858055259e-06
decreased O 0 7.306741281354334e-06
the O 0 6.639251068918384e-07
apparent O 0 4.952857125317678e-06
affinity O 0 2.516967697374639e-06
of O 0 4.870968268733122e-07
the O 0 2.07425000553485e-06
TfR O 0 8.967873873189092e-05
for O 0 8.871835461832234e-07
its O 0 1.7146687696367735e-06
ligand O 0 7.438151442329399e-06
under O 0 8.269425961771049e-06
steady O 0 4.470071871764958e-05
- O 0 0.00027033351943828166
state O 0 1.5915804851829307e-06
conditions O 0 1.1108220860478468e-05
, O 0 4.965017410540895e-07
both O 0 4.311921202315716e-07
in O 0 1.7231011497642612e-06
293 O 0 2.6344549041823484e-05
cells O 0 4.605969479598571e-06
and O 0 1.9629133021226153e-06
in O 0 1.4106007256486919e-05
HeLa O 0 0.01226507592946291
cells O 0 6.346304144244641e-05
. O 0 2.71544668066781e-05

Furthermore O 0 0.0004183362179901451
, O 0 2.384974686719943e-05
at O 0 2.0004823454655707e-05
4 O 0 1.1073358109570108e-05
degrees O 0 3.18717175105121e-05
C O 0 0.00016431653057225049
, O 0 1.4199512179402518e-06
the O 0 2.1059058781247586e-06
added O 0 2.0336963643785566e-05
soluble O 0 1.6352454622392543e-05
complex O 0 5.643346412398387e-06
of O 0 3.46609226653527e-06
HFE O 0 0.22732992470264435
/ O 0 0.00010791498061735183
beta2m O 0 0.00042269000550732017
inhibited O 0 2.504970325389877e-05
binding O 0 5.4205956985242665e-06
of O 0 2.190330405937857e-06
transferrin O 0 8.491802145726979e-05
to O 0 7.0758010224381e-06
HeLa O 0 0.0006252039456740022
cell O 0 0.00013087221304886043
TfR O 0 0.00014159714919514954
in O 0 4.264655672159279e-06
a O 0 1.7425230907974765e-05
concentration O 0 0.0023706553038209677
- O 0 0.002863194327801466
dependent O 0 6.0561760619748384e-05
manner O 0 5.946259989286773e-05
. O 0 6.186898826854303e-05

Scatchard O 0 0.0017075528157874942
plots O 0 0.00010739584831753746
of O 0 1.0577993634797167e-05
these O 0 2.719933263506391e-06
data O 0 4.440523753146408e-06
indicate O 0 4.589500804286217e-06
that O 0 8.422988457823521e-07
the O 0 2.290239763169666e-06
added O 0 1.2694389624812175e-05
heterodimer O 0 0.0001716967235552147
substantially O 0 2.084002881019842e-05
reduced O 0 2.7255368877376895e-06
the O 0 7.616041557412245e-07
affinity O 0 6.3346656133944634e-06
of O 0 3.6893677588523133e-06
TfR O 0 0.0005284433718770742
for O 0 1.935329237312544e-05
transferrin O 0 0.006286215968430042
. O 0 0.00016744776803534478

These O 0 7.6599171734415e-05
results O 0 9.126394434133545e-05
establish O 0 3.0509792850352824e-05
a O 0 1.1824788998637814e-05
molecular O 0 4.213684951537289e-05
link O 0 2.2766816982766613e-05
between O 0 9.994782885769382e-06
HFE O 0 0.07126201689243317
and O 0 3.838897100649774e-06
a O 0 5.347036221792223e-06
key O 0 9.379381481267046e-06
protein O 0 4.186073056189343e-06
involved O 0 1.675481939855672e-06
in O 0 1.784830942597182e-06
iron O 0 0.006062042899429798
transport O 0 1.5751527826068923e-05
, O 0 1.0942252401946462e-06
the O 0 1.3323963230504887e-06
TfR O 0 7.855376316001639e-05
, O 0 8.241950695264677e-07
and O 0 4.793054699803179e-07
raise O 0 1.5849234387133038e-06
the O 0 5.08395658016525e-07
possibility O 0 1.6374876850022702e-06
that O 0 7.808325221958512e-07
alterations O 0 1.0320282854081597e-05
in O 0 1.962263695531874e-06
this O 0 9.986065379052889e-07
regulatory O 0 1.955171137524303e-05
mechanism O 0 1.650215926929377e-05
may O 0 1.1844686923723202e-05
play O 0 1.1801092796304147e-06
a O 0 1.6319671658493462e-06
role O 0 1.5292555417545373e-06
in O 0 1.1427478057157714e-06
the O 0 4.395173618831905e-06
pathogenesis O 0 0.0004470398125704378
of O 0 0.00017711798136588186
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.00047305101179517806
. O 0 0.0001977542124222964

Genomic O 0 0.0009130220860242844
organization O 0 7.334340625675395e-05
of O 0 7.309054581128294e-06
the O 0 1.6954947568592615e-05
UBE3A O 0 0.002870555268600583
/ O 0 0.0001362588518531993
E6 O 0 0.00019446181249804795
- O 0 0.0005575355608016253
AP O 0 0.00027410872280597687
gene O 0 1.7405982362106442e-05
and O 0 6.8351137088029645e-06
related O 0 2.9735321732005104e-05
pseudogenes O 0 0.0002101061400026083
. O 0 7.19722593203187e-05

The O 0 0.00018441511201672256
UBE3A O 0 0.0018014669185504317
gene O 0 9.9987315479666e-05
encodes O 0 5.087226236355491e-05
the O 0 1.076205626304727e-05
E6 O 0 8.987882029032335e-05
- O 0 0.00013302278239279985
AP O 0 5.697464803233743e-05
ubiquitin O 0 2.5958097467082553e-05
- O 0 2.1616171579807997e-05
protein O 0 4.506345248955768e-06
ligase O 0 5.6838930504454765e-06
and O 0 1.1409009630369837e-06
has O 0 2.150380169041455e-06
recently O 0 8.782461009104736e-06
been O 0 2.4257878976641223e-06
shown O 0 1.2821096788684372e-06
to O 0 1.316137741014245e-06
be O 0 7.284781986527378e-06
mutated O 0 0.0009729447192512453
in O 1 0.8982391953468323
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9922069907188416
who O 0 0.0015199489425867796
lack O 0 0.00028483144706115127
15q11 O 0 0.02590763568878174
- O 0 0.006035220809280872
q13 O 0 0.0005459783715195954
deletions O 0 9.058030263986439e-05
or O 0 2.6467740099178627e-05
chromosome O 0 0.001672869548201561
15 O 0 0.00014062997070141137
paternal O 0 0.00890442542731762
uniparental B-Disease 1 0.9054836630821228
disomy I-Disease 0 0.22554349899291992
. O 0 0.0002617734426166862

Previous O 0 0.00041829096153378487
UBE3A O 0 0.0012366781011223793
cDNA O 0 0.0001804079074645415
analysis O 0 2.2287038518697955e-05
has O 0 6.067059075576253e-06
shown O 0 2.1972343802190153e-06
a O 0 2.3199852421385003e-06
coding O 0 1.635669650568161e-05
region O 0 3.6543019632517826e-06
of O 0 1.7759084585122764e-06
approximately O 0 1.583342600497417e-05
2 O 0 3.390054916962981e-05
. O 0 4.821677430300042e-05

6 O 0 0.0008856681524775922
kb O 0 0.003984085749834776
and O 0 1.660921952861827e-05
a O 0 1.8398885003989562e-05
3 O 0 2.7810758183477446e-05
- O 0 0.00019162066746503115
untranslated O 0 0.0003516178694553673
region O 0 1.633212923479732e-05
( O 0 2.8784411369997542e-06
UTR O 0 5.479210085468367e-05
) O 0 9.111582244258898e-07
of O 0 6.86353985202004e-07
< O 0 2.4687140466994606e-05
50 O 0 5.54497182747582e-06
bp O 0 7.438813190674409e-05
, O 0 7.98547773683822e-07
whereas O 0 8.59490114635264e-07
Northern O 0 8.163108304870548e-07
analysis O 0 1.2771660067301127e-06
has O 0 8.730592639949464e-07
indicated O 0 2.0610443698387826e-06
mRNA O 0 2.7751589186664205e-06
sizes O 0 3.484486569504952e-06
of O 0 1.4513733503918047e-06
5 O 0 1.5008693480922375e-05
- O 0 0.00022056973830331117
8 O 0 6.94756381562911e-05
kb O 0 0.006256609223783016
. O 0 7.758365973131731e-05

We O 0 0.00010356819984735921
have O 0 1.2766844520228915e-05
analyzed O 0 1.2134814824094065e-05
additional O 0 2.9318000542843947e-06
cDNA O 0 1.3344334547582548e-05
clones O 0 1.2200306628074031e-05
and O 0 1.3438918813335476e-06
provide O 0 1.5057906921356334e-06
evidence O 0 8.768834618422261e-07
for O 0 4.4777149810215633e-07
an O 0 1.0395395975137944e-06
additional O 0 5.145924205862684e-06
0 O 0 9.732047328725457e-05
. O 0 2.92909153358778e-05

5 O 0 0.00022540881764143705
kb O 0 0.00042642405605874956
of O 0 8.976842764241155e-06
5 O 0 1.5686615370213985e-05
- O 0 4.7552228352287784e-05
UTR O 0 7.080929935909808e-05
and O 0 2.9320181056391448e-06
> O 0 1.586185499036219e-05
2 O 0 3.5854811812896514e-06
kb O 0 0.00011033748160116374
of O 0 3.67960637959186e-06
3 O 0 4.032272408949211e-05
- O 0 0.000644648855086416
UTR O 0 0.0010713622905313969
. O 0 7.035497401375324e-05

We O 0 0.0001059400019585155
have O 0 9.584122381056659e-06
established O 0 6.572676738869632e-06
the O 0 2.5579870452929754e-06
genomic O 0 1.4834788998996373e-05
organization O 0 3.5858506635122467e-06
of O 0 1.6949977634794777e-06
UBE3A O 0 0.00012209820852149278
and O 0 1.1696588444465306e-06
the O 0 1.1767702972065308e-06
sequence O 0 2.0710954231617507e-06
of O 0 2.0087531993340235e-06
intron O 0 0.0008874809718690813
- O 0 0.0015547719085589051
exon O 0 0.00039718794869259
borders O 0 0.00016911457350943238
. O 0 0.00011665096099022776

We O 0 0.000200605922145769
have O 0 1.2819342373404652e-05
also O 0 4.103044375369791e-06
mapped O 0 1.163855631602928e-05
two O 0 1.9992792203993304e-06
highly O 0 3.2769464723969577e-06
homologous O 0 7.821002327546012e-06
processed O 0 8.201857781386934e-06
pseudogenes O 0 1.736037665978074e-05
, O 0 3.2502882731932914e-06
UBE3AP1 O 0 0.00040013188845478
and O 0 3.517862296575913e-06
UBE3AP2 O 0 0.0008405661210417747
, O 0 1.021897674036154e-06
to O 0 6.569490551555646e-07
chromosomes O 0 3.965643372794148e-06
2 O 0 9.218511536346341e-07
and O 0 6.26158964678325e-07
21 O 0 5.814393716718769e-06
, O 0 5.367782023313339e-07
respectively O 0 2.3179327399702743e-06
, O 0 4.825835731026018e-07
and O 0 5.051185780757805e-07
determined O 0 3.21019228977093e-06
their O 0 4.079517566424329e-06
genomic O 0 6.843885785201564e-05
organization O 0 6.274471525102854e-05
. O 0 5.474896533996798e-05

These O 0 5.546416650759056e-05
results O 0 4.538877328741364e-05
will O 0 1.5069198298078845e-06
form O 0 5.473897317642695e-07
the O 0 3.574930360628059e-07
basis O 0 2.683793525193323e-07
for O 0 2.4996174374791735e-07
studies O 0 6.308064826043847e-07
of O 0 4.937883772981877e-07
mutation O 0 8.287987839139532e-06
and O 0 2.44596526499663e-06
imprinting O 0 9.033352398546413e-05
of O 0 1.6671345292706974e-05
UBE3A O 0 0.01301595475524664
. O 0 0.00011095988884335384

Mutation O 0 0.0010803285986185074
spectrum O 0 0.00022206544235814363
and O 0 4.422139681992121e-05
genotype O 0 0.003940355498343706
- O 0 0.0066047715954482555
phenotype O 0 0.0009108923259191215
analyses O 0 6.147219392005354e-05
in O 0 8.787091064732522e-05
Cowden B-Disease 1 0.9982927441596985
disease I-Disease 1 0.6813046336174011
and O 0 0.0002002052206080407
Bannayan B-Disease 1 0.9995023012161255
- I-Disease 1 0.9999860525131226
Zonana I-Disease 1 0.9999978542327881
syndrome I-Disease 1 0.9999997615814209
, O 0 4.692812217399478e-05
two O 0 0.00017728896636981517
hamartoma B-Disease 1 0.9998488426208496
syndromes I-Disease 1 0.9950318336486816
with O 0 0.0005723083741031587
germline O 1 0.9218384027481079
PTEN O 0 0.44855284690856934
mutation O 0 0.0012594901490956545
. O 0 0.00023997017706278712

The O 0 0.0009620402124710381
tumour B-Disease 1 0.9999533891677856
suppressor O 0 0.006968288216739893
gene O 0 0.00033901623100973666
PTEN O 0 0.0011935157235711813
, O 0 8.799841452855617e-06
which O 0 3.7084059840708505e-06
maps O 0 1.611670813872479e-05
to O 0 1.8394515791442245e-05
10q23 O 0 0.0010580618400126696
. O 0 4.409325629239902e-05

3 O 0 0.00015910762886051089
and O 0 1.1615581570367794e-05
encodes O 0 2.129479071300011e-05
a O 0 8.164749488059897e-06
403 O 0 2.9776319934171624e-05
amino O 0 1.1799397725553717e-05
acid O 0 8.912812518246938e-06
dual O 0 9.435804713575635e-06
specificity O 0 3.4186265111202374e-05
phosphatase O 0 0.06118815764784813
( O 0 3.538579221640248e-06
protein O 0 1.265176251763478e-05
tyrosine O 0 6.842084985692054e-05
phosphatase O 0 0.0011674666311591864
; O 0 3.3060221085179364e-06
PTPase O 0 8.544355659978464e-05
) O 0 8.62557897107763e-07
, O 0 6.273095323194866e-07
was O 0 9.062592653208412e-06
shown O 0 1.2810940006602323e-06
recently O 0 2.3169006908574374e-06
to O 0 4.0445226545671176e-07
play O 0 8.510775160175399e-07
a O 0 1.9712306311703287e-06
broad O 0 8.675194294482935e-06
role O 0 6.055036465113517e-06
in O 0 9.09397658688249e-06
human O 0 5.133283048053272e-05
malignancy B-Disease 0 0.10689125210046768
. O 0 9.293263428844512e-05

Somatic O 0 0.004700654186308384
PTEN O 0 0.007501973304897547
deletions O 0 0.0007240559789352119
and O 0 7.090882718330249e-05
mutations O 0 0.00010506606486160308
were O 0 1.5952799003571272e-05
observed O 0 7.480740805476671e-06
in O 0 4.383908617455745e-06
sporadic B-Disease 0 0.007003867998719215
breast I-Disease 1 0.9776622653007507
, I-Disease 0 0.0006954736891202629
brain I-Disease 1 0.9506034851074219
, I-Disease 0 0.0026174692902714014
prostate I-Disease 1 0.9997368454933167
and I-Disease 0 0.36026203632354736
kidney I-Disease 1 0.9999991655349731
cancer I-Disease 1 0.9967693090438843
cell O 0 0.02236943691968918
lines O 0 6.546876102220267e-05
and O 0 4.6333821046573576e-06
in O 0 2.0300683445384493e-06
several O 0 4.399837052915245e-06
primary O 0 0.033376216888427734
tumours B-Disease 1 0.9999308586120605
such O 0 5.075162334833294e-06
as O 0 0.0019333497621119022
endometrial B-Disease 1 0.9999768733978271
carcinomas I-Disease 1 1.0
, O 1 0.9970625042915344
malignant B-Disease 1 1.0
melanoma I-Disease 1 1.0
and O 1 0.9966683983802795
thyroid B-Disease 1 0.9999998807907104
tumours I-Disease 1 0.9999998807907104
. O 0 0.0008899905369617045

In O 0 0.00013981753727421165
addition O 0 5.065640652901493e-05
, O 0 1.9343347958056256e-05
PTEN O 0 0.0005722219357267022
was O 0 2.8085729354643263e-05
identified O 0 3.0267754027590854e-06
as O 0 6.292184480116703e-07
the O 0 1.7619167920202017e-06
susceptibility O 0 3.665585973067209e-05
gene O 0 4.650034497899469e-06
for O 0 2.0627178400900448e-06
two O 0 0.0012910855002701283
hamartoma B-Disease 1 0.9999983310699463
syndromes I-Disease 1 0.9999985694885254
Cowden B-Disease 1 0.9999927282333374
disease I-Disease 1 0.9956223368644714
( O 0 8.45177419250831e-06
CD B-Disease 0 0.0003410796925891191
; O 0 2.076108103210572e-05
MIM O 0 0.015166418626904488
158350 O 0 0.00019435911963228136
) O 0 2.54257929555024e-06
and O 0 6.980685157031985e-06
Bannayan B-Disease 0 0.0037851426750421524
- I-Disease 0 0.018268289044499397
Zonana I-Disease 0 0.020237956196069717
( I-Disease 0 7.3335195338586345e-06
BZS I-Disease 0 0.00012536799476947635
) I-Disease 0 3.296923068774049e-06
or I-Disease 0 6.012897301843623e-06
Ruvalcaba I-Disease 0 0.0007829618989489973
- I-Disease 0 0.007492921780794859
Riley I-Disease 0 0.0023315793368965387
- I-Disease 1 0.9256364107131958
Smith I-Disease 1 0.963484525680542
syndrome I-Disease 1 0.9999676942825317
( O 0 4.8381523811258376e-05
MIM O 0 0.12284273654222488
153480 O 0 0.0016873938729986548
) O 0 4.522450763033703e-05
. O 0 6.600296910619363e-05

Constitutive O 0 0.0011069270549342036
DNA O 0 0.0002656390133779496
from O 0 3.546066000126302e-05
37 O 0 7.619157258886844e-05
CD B-Disease 0 5.3453240980161354e-05
families O 0 7.584658305859193e-06
and O 0 3.0495543796860147e-06
seven O 0 1.2511559361882973e-05
BZS B-Disease 0 0.0003934153646696359
families O 0 1.5701389202149585e-05
was O 0 2.6448438802617602e-05
screened O 0 6.215395842446014e-05
for O 0 2.8129155907663517e-05
germline O 0 0.04996206611394882
PTEN O 0 0.01205812394618988
mutations O 0 0.0004865280061494559
. O 0 0.00012590303958859295

PTEN O 0 0.0548015832901001
mutations O 0 0.0012922185705974698
were O 0 7.65491568017751e-05
identified O 0 2.8478234526119195e-05
in O 0 4.323320808907738e-06
30 O 0 4.9142913667310495e-06
of O 0 1.386681105941534e-06
37 O 0 3.4359789424343035e-05
( O 0 1.877273803074786e-06
81 O 0 9.265204425901175e-06
% O 0 1.694805291663215e-06
) O 0 6.85411407630454e-07
CD B-Disease 0 7.221560281323036e-06
families O 0 3.2125349207490217e-06
, O 0 5.757817120866093e-07
including O 0 6.800119649597036e-07
missense O 0 2.2667683879262768e-05
and O 0 5.9397007134975865e-06
nonsense O 0 4.352666292106733e-05
point O 0 5.545622116187587e-06
mutations O 0 1.2474707546061836e-05
, O 0 1.4194906725606415e-06
deletions O 0 6.971631592023186e-06
, O 0 1.831341933211661e-06
insertions O 0 1.6534639144083485e-05
, O 0 1.735616933729034e-06
a O 0 4.4191178858454805e-06
deletion O 0 0.00010158875375054777
/ O 0 2.1327512513380498e-05
insertion O 0 4.250138226780109e-05
and O 0 1.4320382433652412e-05
splice O 0 0.0035770635586231947
site O 0 0.00039862250559963286
mutations O 0 0.0003883910831063986
. O 0 8.40527645777911e-05

These O 0 0.00010874447616515681
mutations O 0 0.00012229604180902243
were O 0 1.6446523659396917e-05
scattered O 0 1.3843390661349986e-05
over O 0 2.8860331440228038e-06
the O 0 2.3631109797861427e-06
entire O 0 4.657144017983228e-06
length O 0 4.233704203215893e-06
of O 0 1.548202931189735e-06
PTEN O 0 0.0032471579033881426
, O 0 7.968376394273946e-07
with O 0 4.4958315470466914e-07
the O 0 5.540402980841463e-07
exception O 0 4.807213827007217e-07
of O 0 2.345711322959687e-07
the O 0 6.357885240504402e-07
first O 0 5.5552504818479065e-06
, O 0 2.562919689808041e-06
fourth O 0 2.5538294721627608e-05
and O 0 4.774427907250356e-06
last O 0 2.9444501706166193e-05
exons O 0 0.00020511676848400384
. O 0 5.3507603297475725e-05

A O 0 0.00029231078224256635
hot O 0 0.00020177474652882665
spot O 0 0.00012972544936928898
for O 0 8.878447260940447e-06
PTEN O 0 0.0003943252086173743
mutation O 0 1.8428350813337602e-05
in O 0 2.727291985138436e-06
CD B-Disease 0 4.121982419746928e-05
was O 0 8.431318565271795e-05
identified O 0 4.107421773369424e-06
in O 0 1.1257513961027144e-06
exon O 0 1.3114607099851128e-05
5 O 0 2.0593961380654946e-06
that O 0 3.8952217096266395e-07
contains O 0 5.729350505134789e-07
the O 0 9.171544661512598e-07
PTPase O 0 5.79815823584795e-05
core O 0 6.337614649964962e-06
motif O 0 2.380143996560946e-06
, O 0 6.120648663454631e-07
with O 0 5.015338047087425e-07
13 O 0 1.9705953491211403e-06
of O 0 3.313745082778041e-07
30 O 0 4.5499477892008144e-06
( O 0 6.866747526146355e-07
43 O 0 4.790309048985364e-06
% O 0 1.48378933317872e-06
) O 0 7.666022838748177e-07
CD B-Disease 0 9.194294761982746e-06
mutations O 0 7.368529622908682e-06
identified O 0 4.076868663105415e-06
in O 0 1.982043613679707e-06
this O 0 3.8034033877920592e-06
exon O 0 0.00019562526722438633
. O 0 5.857612632098608e-05

Seven O 0 0.00011883872502949089
of O 0 1.4779067896597553e-05
30 O 0 3.270217348472215e-05
( O 0 3.3414185054425616e-06
23 O 0 1.2848385267716367e-05
% O 0 1.1158844017700176e-06
) O 0 3.156474974730372e-07
were O 0 5.357176178222289e-07
within O 0 2.6430899424667587e-07
the O 0 4.2839999991883815e-07
core O 0 1.4105778063822072e-05
motif O 0 5.258172677713446e-06
, O 0 8.895218002180627e-07
the O 0 7.732406288596394e-07
majority O 0 3.4294341730856104e-06
( O 0 5.095134838484228e-07
five O 0 4.5146677507545974e-07
of O 0 2.448130658194714e-07
seven O 0 3.20606773129839e-06
) O 0 2.5230500000361644e-07
of O 0 1.938940812351575e-07
which O 0 7.605872269778047e-07
were O 0 6.919997304066783e-06
missense O 0 3.638827183749527e-05
mutations O 0 1.737095954013057e-05
, O 0 1.8817369209500612e-06
possibly O 0 4.461472144612344e-06
pointing O 0 5.736590537708253e-06
to O 0 8.957718478086463e-07
the O 0 7.978581493262027e-07
functional O 0 4.9981144911726005e-06
significance O 0 1.578819706082868e-06
of O 0 1.063685317603813e-06
this O 0 4.814711701328633e-06
region O 0 6.89897351549007e-05
. O 0 6.871568621136248e-05

Germline O 0 0.0698547288775444
PTEN O 0 0.039758484810590744
mutations O 0 0.0009997602319344878
were O 0 6.56577612971887e-05
identified O 0 2.3643829990760423e-05
in O 0 2.7271280487184413e-06
four O 0 1.59753085426928e-06
of O 0 8.519755851921218e-07
seven O 0 8.826737030176446e-06
( O 0 2.2844330942461966e-06
57 O 0 1.3692684660782106e-05
% O 0 3.136764462396968e-06
) O 0 4.093980805919273e-06
BZS B-Disease 0 0.00021560089953709394
families O 0 1.814649294828996e-05
studied O 0 7.210401236079633e-05
. O 0 5.700883411918767e-05

Interestingly O 0 0.00163016386795789
, O 0 4.35524525528308e-05
none O 0 8.670777788211126e-06
of O 0 1.148266846939805e-06
these O 0 1.816173835322843e-06
mutations O 0 2.429940468573477e-05
was O 0 2.3693823095527478e-05
observed O 0 3.6901419662171975e-06
in O 0 1.739174308568181e-06
the O 0 5.281995981931686e-06
PTPase O 0 0.0004314675461500883
core O 0 8.764329686528072e-05
motif O 0 8.584931492805481e-05
. O 0 3.884651596308686e-05

It O 0 0.00010732980445027351
is O 0 7.82503866503248e-06
also O 0 2.388899247307563e-06
worthy O 0 3.2268897030007793e-06
of O 0 9.799643976293737e-07
note O 0 4.800671831617365e-06
that O 0 4.5169414875090297e-07
a O 0 1.4454709571509738e-06
single O 0 1.5008951777417678e-05
nonsense O 0 1.583288212714251e-05
point O 0 3.240742898924509e-06
mutation O 0 7.002702204772504e-06
, O 0 1.5029744417915936e-06
R233X O 0 3.137311796308495e-05
, O 0 1.4294906804934726e-06
was O 0 8.283910574391484e-06
observed O 0 1.170477844425477e-06
in O 0 3.5684516319633985e-07
the O 0 9.912624818753102e-07
germline O 0 3.2750580430729315e-05
DNA O 0 4.173078650637763e-06
from O 0 9.818633088798379e-07
two O 0 1.9355500171513995e-06
unrelated O 0 1.5129263374547008e-05
CD B-Disease 0 5.518439138540998e-05
families O 0 1.244037503056461e-05
and O 0 5.886871804250404e-06
one O 0 2.8727517928928137e-05
BZS B-Disease 0 0.020796652883291245
family O 0 0.00019381930178496987
. O 0 5.350464562070556e-05

Genotype O 0 0.07839015871286392
- O 0 0.05810428783297539
phenotype O 0 0.0016016968293115497
studies O 0 2.235967622254975e-05
were O 0 2.3424267055816017e-05
not O 0 2.37361814470205e-06
performed O 0 7.455358172592241e-06
on O 0 1.460708858758153e-06
this O 0 5.726870995204081e-07
small O 0 1.6897457726372522e-06
group O 0 3.449962832746678e-06
of O 0 2.7355833935871487e-06
BZS B-Disease 0 0.0016680315602570772
families O 0 6.355194636853412e-05
. O 0 6.856892287032679e-05

However O 0 0.0001752482494339347
, O 0 4.194924622424878e-05
genotype O 0 0.0009050531662069261
- O 0 0.0004379455931484699
phenotype O 0 0.00014564201410394162
analysis O 0 8.32727619126672e-06
inthe O 0 0.00010677744285203516
group O 0 6.644193035754142e-06
of O 0 1.8053017356578493e-06
CD B-Disease 0 0.00011587370681809261
families O 0 1.6214031347772107e-05
revealed O 0 1.218771194544388e-05
two O 0 6.395863465513685e-07
possible O 0 9.894292816170491e-07
associations O 0 1.349466970168578e-06
worthy O 0 1.7826042721935664e-06
of O 0 5.597350991592975e-07
follow O 0 3.663646339191473e-06
- O 0 0.00010924866364803165
up O 0 6.425211267924169e-06
in O 0 2.597800630610436e-06
independent O 0 8.940224688558374e-06
analyses O 0 6.71538946335204e-05
. O 0 4.426257874001749e-05

The O 0 7.864078361308202e-05
first O 0 4.923438609694131e-05
was O 0 6.860829307697713e-05
an O 0 3.550904466464999e-06
association O 0 5.725632036046591e-06
noted O 0 1.5678051568102092e-06
in O 0 6.561106715707865e-07
the O 0 9.473624231759459e-07
group O 0 1.5134424984353245e-06
of O 0 7.988951438164804e-07
CD B-Disease 0 0.00015608605463057756
families O 0 3.545538493199274e-05
with O 0 0.005413709208369255
breast B-Disease 1 0.9999759197235107
disease I-Disease 1 0.912749707698822
. O 0 0.0001624252472538501

A O 0 0.0002730840933509171
correlation O 0 0.0001243607111973688
was O 0 7.64167052693665e-05
observed O 0 4.055332283314783e-06
between O 0 9.28923554965877e-07
the O 0 1.8398040992906317e-06
presence O 0 5.388361842051381e-06
/ O 0 9.071075510291848e-06
absence O 0 2.1381799797381973e-06
of O 0 6.053496122149227e-07
a O 0 1.88543890544679e-05
PTEN O 0 0.004826624412089586
mutation O 0 6.400796792149777e-06
and O 0 8.842710030876333e-07
the O 0 1.103683871406247e-06
type O 0 1.0285314601787832e-05
of O 0 4.654382792068645e-06
breast O 1 0.7992309331893921
involvement O 0 0.0001748960348777473
( O 0 1.3939967175247148e-05
unaffected O 0 0.0003575584851205349
versus O 0 0.0006134174764156342
benign O 0 0.15361493825912476
versus O 0 0.10206172615289688
malignant O 1 0.9990085959434509
) O 0 4.9503119953442365e-05
. O 0 6.321840919554234e-05

Specifically O 0 0.0001101617090171203
and O 0 1.1050055036321282e-05
more O 0 1.4441646953855525e-06
directly O 0 2.9351765533647267e-06
, O 0 1.2572575087688165e-06
an O 0 1.8100114402841427e-06
association O 0 1.2265144505363423e-05
was O 0 6.292903708526865e-05
also O 0 1.1013979701601784e-06
observed O 0 7.869160754125915e-07
between O 0 2.3635497825580387e-07
the O 0 3.6438302686292445e-07
presence O 0 7.4773572578124e-07
of O 0 4.3041973185609095e-07
a O 0 3.738461236935109e-05
PTEN O 0 0.30346938967704773
mutation O 0 0.00022383042960427701
and O 0 0.0289418026804924
malignant B-Disease 1 0.9999995231628418
breast I-Disease 1 0.9999990463256836
disease I-Disease 1 0.9994764924049377
. O 0 0.0004036802565678954

Secondly O 0 0.005907836370170116
, O 0 4.218762842356227e-05
there O 0 9.013127055368386e-06
appeared O 0 1.6998499631881714e-05
to O 0 1.8866209074985818e-06
be O 0 1.36082564949902e-06
an O 0 1.5425670198965236e-06
interdependent O 0 0.00016328740457538515
association O 0 4.968217581335921e-06
between O 0 1.4021948118170258e-06
mutations O 0 8.952885764301755e-06
upstream O 0 3.83568385586841e-06
and O 0 5.735041668231133e-07
within O 0 6.47943238618609e-07
the O 0 1.2344059996394208e-06
PTPase O 0 5.50524600839708e-05
core O 0 6.22497645963449e-06
motif O 0 3.6525075302051846e-06
, O 0 6.467492426054378e-07
the O 0 8.998106295621255e-07
core O 0 7.715141691733152e-06
motif O 0 3.0234575660870178e-06
containing O 0 1.5593400348734576e-06
the O 0 9.486118415225064e-07
majority O 0 1.6466785837110365e-06
of O 0 7.79810022777383e-07
missense O 0 4.601904583978467e-05
mutations O 0 1.2588563549797982e-05
, O 0 9.039708857017104e-07
and O 0 6.263309728637978e-07
the O 0 6.041108235876891e-07
involvement O 0 2.8496824597823434e-06
of O 0 3.9337101043201983e-07
all O 0 7.304346922865079e-07
major O 0 1.5858226106502116e-05
organ O 0 0.051312439143657684
systems O 0 0.0007888847030699253
( O 0 2.543988330216962e-06
central O 0 6.950248916837154e-06
nervous O 0 0.009715287014842033
system O 0 5.212725227465853e-05
, O 0 0.0001330279919784516
thyroid O 1 0.9145211577415466
, O 0 8.310038538184017e-05
breast O 1 0.864967942237854
, O 0 0.0005180913722142577
skin O 1 0.9517131447792053
and O 0 0.0414717011153698
gastrointestinal O 1 0.9998970031738281
tract O 1 0.9952961802482605
) O 0 5.994883395032957e-05
. O 0 6.697149365209043e-05

However O 0 0.00010836137516889721
, O 0 8.425426130997948e-06
these O 0 9.904121043291525e-07
observations O 0 3.180729663654347e-06
would O 0 1.7091847439587582e-06
need O 0 1.0790622582135256e-06
to O 0 8.962726951722289e-07
be O 0 1.4058744000067236e-06
confirmed O 0 1.446152054995764e-06
by O 0 2.7065843255513755e-07
studying O 0 8.611942803327111e-07
a O 0 1.0013865221480955e-06
larger O 0 1.1934871508856304e-06
number O 0 6.658565325778909e-07
of O 0 1.4805355021962896e-06
CD B-Disease 0 0.00023724632046651095
families O 0 5.6953624152811244e-05
. O 0 4.213174543110654e-05

Molecular O 0 0.1305888295173645
defects O 1 0.9944185018539429
leading O 0 0.0001506212429376319
to O 0 1.2177638382127043e-05
human O 0 1.5997880836948752e-05
complement B-Disease 0 0.00020300534379202873
component I-Disease 1 0.6332656741142273
C6 I-Disease 1 1.0
deficiency I-Disease 1 0.9999963045120239
in O 0 1.0957009180856403e-05
an O 0 5.448535830510082e-06
African O 0 1.561292083351873e-05
- O 0 0.0016693692887201905
American O 0 1.993253499676939e-05
family O 0 7.353402907028794e-05
. O 0 5.2620001952163875e-05

Complement B-Disease 0 0.016135308891534805
component I-Disease 1 0.9847819209098816
C6 I-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999998807907104
( O 0 0.00014473937335424125
C6D B-Disease 1 0.5578204989433289
) O 0 2.8070042390027083e-05
was O 0 0.0351218655705452
diagnosed O 1 0.902476966381073
in O 0 4.219798029225785e-06
a O 0 1.1650147826003376e-05
16 O 0 2.506786404410377e-05
- O 0 7.040993659757078e-05
year O 0 2.940580998256337e-06
- O 0 2.874928031815216e-05
old O 0 1.3895371012040414e-05
African O 0 1.8220376887256862e-06
- O 0 3.255397314205766e-05
American O 0 3.444410140218679e-06
male O 0 2.2840145902591757e-05
with O 0 0.0004775949928443879
meningococcal B-Disease 1 0.9999973773956299
meningitis I-Disease 1 0.9999938011169434
. O 0 0.00041560860699974

The O 0 0.00017446429410483688
patients O 0 0.043873563408851624
father O 0 0.0006804430740885437
and O 0 7.406171334878309e-06
two O 0 8.508928658557124e-06
brothers O 0 0.015390424989163876
also O 0 7.78532830736367e-06
had O 0 0.00015605377848260105
C6D B-Disease 0 0.003001938806846738
, O 0 1.16042474473943e-06
but O 0 9.79018068392179e-07
gave O 0 2.723097395573859e-06
no O 0 7.674786388633947e-07
history O 0 1.122966750699561e-06
of O 0 4.186687874607742e-06
meningitis B-Disease 1 0.9998288154602051
or O 0 2.5086830646614544e-05
other O 0 1.7038733858498745e-05
neisserial B-Disease 1 0.9891201257705688
infection I-Disease 0 0.18777748942375183
. O 0 0.0001077094639185816

By O 0 0.00010695240780478343
using O 0 3.990308687207289e-05
exon O 0 0.00014097178063821048
- O 0 6.152597779873759e-05
specific O 0 4.956944394507445e-06
polymerase O 0 3.984685099567287e-05
chain O 0 9.291509195463732e-05
reaction O 0 1.1552764590305742e-05
( O 0 3.5073944673058577e-06
PCR O 0 2.490240876795724e-05
) O 0 1.4088391253608279e-06
/ O 0 3.69626332030748e-06
single O 0 5.4407105380960274e-06
- O 0 2.4187575036194175e-05
strand O 0 1.3386588761932217e-05
conformation O 0 9.531891919323243e-06
polymorphism O 0 6.763294095435413e-06
as O 0 6.962800398468971e-07
a O 0 1.6384624359488953e-06
screening O 0 6.571002813871019e-06
step O 0 3.7324298318708315e-06
and O 0 1.2393011274980381e-06
nucleotide O 0 5.332924047252163e-06
sequencing O 0 3.1480412872042507e-06
of O 0 6.818328301960719e-07
target O 0 5.807793058920652e-06
exons O 0 9.8632617664407e-06
, O 0 1.5025473203422735e-06
we O 0 1.2163662859165925e-06
determined O 0 8.784277270024177e-07
that O 0 1.8798253620389005e-07
the O 0 8.145129299919063e-07
proband O 0 0.00040797796100378036
was O 0 7.682763680350035e-06
a O 0 2.7448659238871187e-06
compound O 0 2.333690645173192e-05
heterozygote O 0 2.9632697987835854e-05
for O 0 1.5678575664423988e-06
two O 0 9.838657206273638e-06
C6 O 0 0.007092679385095835
gene O 0 0.0001186319932457991
mutations O 0 0.00019769725622609258
. O 0 6.55449039186351e-05

The O 0 4.4299522414803505e-05
first O 0 2.4560944439144805e-05
, O 0 9.113163287111092e-06
1195delC O 0 5.15900828759186e-05
located O 0 1.048268131853547e-05
in O 0 4.286773219064344e-06
exon O 0 6.156730523798615e-05
7 O 0 3.512483453960158e-05
, O 0 2.173583425246761e-06
is O 0 4.523295444869291e-07
a O 0 9.188862577502732e-07
novel O 0 1.476588749937946e-06
mutation O 0 2.7655737540044356e-06
, O 0 5.277990453578241e-07
while O 0 4.1317264276585774e-07
the O 0 4.556694364055147e-07
second O 0 4.010475549875991e-06
, O 0 1.8893865671998356e-06
1936delG O 0 1.6581048839725554e-05
in O 0 1.3954992255094112e-06
exon O 0 1.553231049911119e-05
12 O 0 8.338632142113056e-06
, O 0 1.2355155831755837e-06
has O 0 1.2925695500598522e-06
been O 0 2.164556235584314e-06
described O 0 3.771682486330974e-06
before O 0 2.5708848170324927e-06
to O 0 1.6736455563659547e-06
cause O 0 1.3890758964407723e-05
C6D B-Disease 0 0.002923264866694808
in O 0 2.04169054995873e-06
an O 0 2.9986019853822654e-06
unrelated O 0 1.1030482710339129e-05
African O 0 4.725036433228524e-06
- O 0 0.00013446320372167975
American O 0 8.816430636215955e-06
individual O 0 1.572097244206816e-05
. O 0 3.130724508082494e-05

Both O 0 0.00017469600425101817
mutations O 0 0.0006010726792737842
result O 0 6.897183629916981e-05
in O 0 3.7398378481157124e-05
premature O 0 0.07974570989608765
termination O 0 0.0004242825089022517
codons O 0 8.64910616655834e-05
and O 0 2.8386317353579216e-05
C6 O 0 0.00867508351802826
null O 0 0.0006836004322394729
alleles O 0 0.0004310510994400829
. O 0 0.00020537353702820837

Allele O 0 0.001269197673536837
- O 0 0.00033751223236322403
specific O 0 2.4258653866127133e-05
PCR O 0 0.0001439229672541842
indicated O 0 2.2435246137320064e-05
that O 0 1.3777386129731894e-06
the O 0 2.8514170935522998e-06
probands O 0 0.00023035117192193866
two O 0 8.837434506858699e-06
brothers O 0 0.06273972988128662
also O 0 5.404388048191322e-06
inherited O 0 0.00019103196973446757
the O 0 3.996955001639435e-06
1195delC O 0 8.405749395024031e-05
mutation O 0 5.292080004437594e-06
from O 0 1.08973472379148e-06
their O 0 4.205046479910379e-06
heterozygous O 0 5.325191159499809e-05
mother O 0 4.122556492802687e-05
and O 0 1.7826195062298211e-06
the O 0 2.9562711461039726e-06
1936delG O 0 0.000192323190276511
mutation O 0 9.081540156330448e-06
from O 0 2.4184262201742968e-06
their O 0 1.637171044421848e-05
homozygous O 0 0.0007906914106570184
father O 0 0.00015175160660874099
. O 0 1.2162063285359181e-05
. O 0 3.882843884639442e-05

PAX6 O 1 0.5975585579872131
mutations O 0 0.02008078061044216
reviewed O 0 0.0027292310260236263
. O 0 0.0008010895107872784

Mutations O 0 0.0018556189024820924
in O 0 8.613163663540035e-05
PAX6 O 0 0.0017063486156985164
are O 0 6.18877447777777e-06
responsible O 0 1.3572686839324888e-05
for O 0 2.8422323339327704e-06
human O 0 8.93660126166651e-06
aniridia B-Disease 1 0.9996559619903564
and O 0 1.994847298192326e-05
have O 0 1.764837907103356e-05
also O 0 1.2716077435470652e-05
been O 0 1.4606805052608252e-05
found O 0 1.1158568668179214e-05
in O 0 3.4981298085767776e-05
patients O 0 0.016752861440181732
with O 0 0.00044734845869243145
Peters B-Disease 1 0.9999881982803345
anomaly I-Disease 1 0.9999396800994873
, O 0 0.0010046202223747969
with O 1 0.8948497772216797
congenital B-Disease 1 1.0
cataracts I-Disease 1 0.9999995231628418
, O 0 0.0009748635347932577
with O 0 0.0017334389267489314
autosomal B-Disease 1 0.9503999352455139
dominant I-Disease 0 0.1101892963051796
keratitis I-Disease 1 0.6580095291137695
, O 0 2.5256542357965373e-05
and O 0 1.4896882930770516e-05
with O 0 0.0001945126277860254
isolated B-Disease 1 0.8679271340370178
foveal I-Disease 1 0.9999985694885254
hypoplasia I-Disease 1 0.9999961853027344
. O 0 0.00042833946645259857

No O 0 0.00013228206080384552
locus O 0 0.00012589186371769756
other O 0 4.534496383712394e-06
than O 0 5.308496838551946e-06
chromosome O 0 0.0007627655286341906
11p13 O 0 0.0007963819080032408
has O 0 1.741601045068819e-05
been O 0 1.2788072126568295e-05
implicated O 0 2.8268805181141943e-05
in O 0 8.900970897229854e-06
aniridia B-Disease 1 0.9999200105667114
, O 0 8.11461177363526e-06
and O 0 9.376877642353065e-06
PAX6 O 0 0.026263006031513214
is O 0 2.6159816570725525e-06
clearly O 0 2.896262230933644e-06
the O 0 5.206713353800296e-07
major O 0 2.4613177629362326e-06
, O 0 2.762489430097048e-06
if O 0 9.032522143570532e-07
not O 0 4.361937726571341e-07
only O 0 3.8709288219251903e-07
, O 0 1.497881726209016e-06
gene O 0 1.4194639334164094e-05
responsible O 0 2.470824620104395e-05
. O 0 2.766595389402937e-05

Twenty O 0 0.0006195457535795867
- O 0 0.0005137033294886351
eight O 0 2.931763265223708e-05
percent O 0 1.0973290955007542e-05
of O 0 1.7433857237847405e-06
identified O 0 2.6348241590312682e-05
PAX6 O 0 0.00031278125243261456
mutations O 0 1.9059392798226327e-05
are O 0 3.63259596269927e-06
C O 0 0.004896034486591816
- O 0 0.057718995958566666
T O 0 0.009714351035654545
changes O 0 2.2296549104794394e-06
at O 0 1.0407217814645264e-05
CpG O 0 6.251018203329295e-05
dinucleotides O 0 0.00023545707517769188
, O 0 1.4720627632414107e-06
20 O 0 1.941840082508861e-06
% O 0 6.015742997078632e-07
are O 0 4.4589310732590093e-07
splicing O 0 1.0010237019741908e-05
errors O 0 1.1671789252432063e-05
, O 0 1.0783081734189182e-06
and O 0 6.013454481035296e-07
more O 0 3.217297717128531e-07
than O 0 3.901873242284637e-07
30 O 0 2.3109578251023777e-06
% O 0 1.2543976026790915e-06
are O 0 7.124486387510842e-07
deletion O 0 2.3336730009759776e-05
or O 0 5.771843007096322e-06
insertion O 0 6.572623533429578e-05
events O 0 5.2119543397566304e-05
. O 0 8.59972060425207e-05

There O 0 0.00010725154425017536
is O 0 8.90603223524522e-06
a O 0 1.0405520697531756e-05
noticeably O 0 9.801927080843598e-05
elevated O 0 6.589021359104663e-05
level O 0 1.5551460137430695e-06
of O 0 7.123256864360883e-07
mutation O 0 6.297753316175658e-06
in O 0 1.2812357681468711e-06
the O 0 1.1269888773313141e-06
paired O 0 1.3078025403956417e-05
domain O 0 2.0533166207314935e-06
compared O 0 1.3240843372841482e-06
with O 0 2.565863326253748e-07
the O 0 5.388255885918625e-07
rest O 0 1.2607706594280899e-06
of O 0 6.942669870113605e-07
the O 0 5.301197688822867e-06
gene O 0 5.368976781028323e-05
. O 0 3.1405623303726315e-05

Increased O 0 0.00041193701326847076
mutation O 0 0.00020348188991192728
in O 0 1.2020992471661884e-05
the O 0 6.164740170788718e-06
homeodomain O 0 0.0001073753519449383
is O 0 2.096787738992134e-06
accounted O 0 5.064163815404754e-06
for O 0 3.9322773659478116e-07
by O 0 7.404423740808852e-07
the O 0 3.003430038006627e-06
hypermutable O 0 0.00031801252043806016
CpG O 0 8.669932140037417e-05
dinucleotide O 0 9.470216900808737e-05
in O 0 6.140114692243515e-06
codon O 0 6.099977690610103e-05
240 O 0 6.596169259864837e-05
. O 0 5.446603609016165e-05

Very O 0 0.00013056361058261245
nearly O 0 4.176284346613102e-05
all O 0 4.804491709364811e-06
mutations O 0 2.154093272110913e-05
appear O 0 5.487128419190412e-06
to O 0 4.406866992212599e-06
cause O 0 9.176809544442222e-05
loss O 0 4.8485813749721274e-05
of O 0 6.025256880093366e-07
function O 0 1.2869178362961975e-06
of O 0 3.316103232009482e-07
the O 0 1.8428087287247763e-06
mutant O 0 1.569487722008489e-05
allele O 0 6.0129259509267285e-06
, O 0 7.147870633161801e-07
and O 0 3.077509518334409e-07
more O 0 1.1516562636870731e-07
than O 0 1.651006158454038e-07
80 O 0 5.935719968874764e-07
% O 0 3.82009972099695e-07
of O 0 4.3396644855420163e-07
exonic O 0 0.00019763282034546137
substitutions O 0 1.4318825378722977e-05
result O 0 9.35017851588782e-06
in O 0 1.0317299711459782e-05
nonsense O 0 0.00028895746800117195
codons O 0 0.00015767483273521066
. O 0 4.85209675389342e-05

In O 0 8.305340452352539e-05
a O 0 2.7177655283594504e-05
gene O 0 1.6484007574035786e-05
with O 0 1.2923625263283611e-06
such O 0 7.890923825470963e-07
extraordinarily O 0 0.00011098899994976819
high O 0 1.1352290130162146e-05
sequence O 0 1.4656876601293334e-06
conservation O 0 7.328789024541038e-07
throughout O 0 3.343865273564006e-07
evolution O 0 6.921303565832204e-07
, O 0 6.793430316065496e-07
there O 0 8.858122555466252e-07
are O 0 1.4704028217238374e-06
presumed O 0 0.00012291216989979148
undiscovered O 0 0.00015921281010378152
missense O 0 5.694080391549505e-05
mutations O 0 2.069276524707675e-05
, O 0 1.2088312359992415e-06
these O 0 4.938835331813607e-07
are O 0 6.14671989751514e-07
hypothesized O 0 7.237913905555615e-06
to O 0 9.580453479429707e-07
exist O 0 1.2370576314424397e-06
in O 0 1.552974822516262e-06
as O 0 3.7324082313716644e-06
- O 0 0.003113728016614914
yet O 0 1.7063368431990966e-05
unidentified O 0 8.986947796074674e-05
phenotypes O 0 0.00010364012996433303
. O 0 7.966614248289261e-06
. O 0 4.9469657824374735e-05

Genetic O 0 0.0021371229086071253
heterogeneity O 0 0.0005865436978638172
and O 0 5.11857979290653e-05
penetrance O 0 0.0008013288606889546
analysis O 0 8.174347385647707e-06
of O 0 2.0818399661948206e-06
the O 0 6.434323040593881e-06
BRCA1 O 0 0.000542073103133589
and O 0 2.078521174553316e-05
BRCA2 O 0 0.002944017294794321
genes O 0 4.8687368689570576e-05
in O 0 0.0015374419745057821
breast B-Disease 1 0.9999916553497314
cancer I-Disease 1 0.9994105100631714
families O 0 0.0006409639026969671
. O 0 0.00011185812036274001

The O 0 0.12436140328645706
Breast B-Disease 1 0.9999997615814209
Cancer I-Disease 1 0.9999966621398926
Linkage O 0 0.30449992418289185
Consortium O 0 0.004786591045558453
. O 0 0.0006009497446939349

The O 0 7.598326919833198e-05
contribution O 0 4.601926411851309e-05
of O 0 7.864623512432445e-06
BRCA1 O 0 0.0011854502372443676
and O 0 6.589586701011285e-05
BRCA2 O 0 0.10248277336359024
to O 0 0.04753866419196129
inherited B-Disease 1 1.0
breast I-Disease 1 1.0
cancer I-Disease 1 1.0
was O 0 0.3939521312713623
assessed O 0 5.563431477639824e-05
by O 0 1.9368555967957946e-06
linkage O 0 5.793106174678542e-05
and O 0 5.4205233936954755e-06
mutation O 0 6.6337343014311045e-06
analysis O 0 1.3755093277723063e-06
in O 0 1.900565848700353e-06
237 O 0 1.910175706143491e-05
families O 0 4.202120180707425e-06
, O 0 4.7095292643462017e-07
each O 0 2.3852061303841765e-07
with O 0 6.791655664528662e-07
at O 0 9.292689355788752e-06
least O 0 8.766501764512213e-07
four O 0 1.277761725759774e-06
cases O 0 7.662924303986074e-07
of O 0 6.448834028560668e-06
breast B-Disease 1 0.99991774559021
cancer I-Disease 1 0.8564976453781128
, O 0 4.63939068140462e-06
collected O 0 3.029259005415952e-06
by O 0 4.009339590993477e-06
the O 0 0.004793284926563501
Breast B-Disease 1 1.0
Cancer I-Disease 1 0.9999939203262329
Linkage O 0 0.01827133260667324
Consortium O 0 0.000934466952458024
. O 0 0.0001312941894866526

Families O 0 0.0005747675895690918
were O 0 2.573372876213398e-05
included O 0 3.7369457004388096e-06
without O 0 3.3162123145302758e-06
regard O 0 1.1611066383920843e-06
to O 0 4.724072368844645e-07
the O 0 8.434901133114181e-07
occurrence O 0 5.755161510023754e-06
of O 0 1.0695642231439706e-05
ovarian B-Disease 1 0.999813973903656
or I-Disease 0 3.9598537114216015e-05
other I-Disease 0 3.378590918146074e-05
cancers I-Disease 1 0.7541067600250244
. O 0 7.604335405630991e-05

Overall O 0 0.16634415090084076
, O 0 0.008559919893741608
disease O 1 0.8855524659156799
was O 0 0.0010662274435162544
linked O 0 0.00012678708299063146
to O 0 5.292579771776218e-06
BRCA1 O 0 0.00024522189050912857
in O 0 2.6717780201579444e-06
an O 0 2.352286628592992e-06
estimated O 0 6.559550911333645e-06
52 O 0 1.2845518540416379e-05
% O 0 9.381110999129305e-07
of O 0 6.175257567520021e-07
families O 0 8.775235983193852e-06
, O 0 1.010285359370755e-06
to O 0 1.489051328462665e-06
BRCA2 O 0 4.180272662779316e-05
in O 0 9.913494523061672e-07
32 O 0 8.046772563830018e-06
% O 0 5.494304673447914e-07
of O 0 2.681897512957221e-07
families O 0 4.232981609675335e-06
, O 0 7.024025876489759e-07
and O 0 5.168131451682711e-07
to O 0 8.710549650459143e-07
neither O 0 2.578609610282001e-06
gene O 0 1.5119436511668027e-06
in O 0 7.439999762937077e-07
16 O 0 5.782310381619027e-06
% O 0 8.69080167831271e-07
( O 0 6.12488804563327e-07
95 O 0 2.071031985906302e-06
% O 0 2.0829263576160884e-06
confidence O 0 2.2840908059151843e-05
interval O 0 6.398282857844606e-05
[ O 0 3.4743490687105805e-05
CI O 0 0.00031130420393310487
] O 0 1.093259470508201e-05
6 O 0 5.7584284149925224e-06
% O 0 2.0867096282017883e-06
- O 0 4.857087697018869e-05
28 O 0 1.56072637764737e-05
% O 0 1.2531170341389952e-06
) O 0 7.092570513123064e-07
, O 0 6.190257977323199e-07
suggesting O 0 4.895393431070261e-06
other O 0 2.015609652517014e-06
predisposition O 0 0.0003220070502720773
genes O 0 3.810506677837111e-05
. O 0 3.4270586183993146e-05

The O 0 0.00011237610306125134
majority O 0 8.133087249007076e-05
( O 0 1.2752327165799215e-05
81 O 0 3.381236456334591e-05
% O 0 3.6405651826498797e-06
) O 0 7.926705052341276e-07
of O 0 7.831533253011003e-07
the O 0 0.0005382661474868655
breast B-Disease 1 0.9999985694885254
- I-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999979734420776
families O 0 0.0009665931575000286
were O 0 5.231918112258427e-05
due O 0 1.8141856344300322e-05
to O 0 6.474604106188053e-06
BRCA1 O 0 0.004084349609911442
, O 0 1.925889137055492e-06
with O 0 9.07476987777045e-07
most O 0 8.736106451578962e-07
others O 0 6.031136308592977e-06
( O 0 9.650418633100344e-07
14 O 0 5.894073183299042e-06
% O 0 2.5887266019708477e-06
) O 0 1.7719937659421703e-06
due O 0 1.0492613910173532e-05
to O 0 2.342560765100643e-05
BRCA2 O 0 0.0018219409976154566
. O 0 5.398821667768061e-05

Conversely O 0 0.0007674972293898463
, O 0 1.3699359442398418e-05
the O 0 3.301088554508169e-06
majority O 0 3.1702875276096165e-06
of O 0 8.739356189835235e-07
families O 0 6.4732771534181666e-06
with O 0 2.8624378956010332e-06
male B-Disease 0 5.003328260499984e-05
and I-Disease 0 2.5651796022430062e-05
female I-Disease 0 0.19252066314220428
breast I-Disease 1 0.9999648332595825
cancer I-Disease 1 0.9737371206283569
were O 0 6.0972262872383e-05
due O 0 4.552054815576412e-05
to O 0 3.1977724574971944e-05
BRCA2 O 0 0.007115574553608894
( O 0 6.510335879283957e-06
76 O 0 8.20771892904304e-05
% O 0 1.5577938029309735e-05
) O 0 1.5322175386245362e-05
. O 0 5.979803972877562e-05

The O 0 9.29461166379042e-05
largest O 0 0.00011396012996556237
proportion O 0 5.171673183212988e-05
( O 0 4.849585820920765e-06
67 O 0 2.472361666150391e-05
% O 0 1.746810653457942e-06
) O 0 3.712807767897175e-07
of O 0 2.76184465519691e-07
families O 0 2.795895170493168e-06
due O 0 2.2700191948388238e-06
to O 0 4.91741843688942e-07
other O 0 3.475302889910381e-07
genes O 0 1.9009446532436414e-06
was O 0 1.8283375538885593e-05
found O 0 3.0988428534328705e-06
in O 0 1.2625514500541613e-06
families O 0 2.1109526642248966e-06
with O 0 7.042377205834782e-07
four O 0 2.807713599395356e-06
or O 0 1.0266498975397553e-06
five O 0 7.613463139932719e-07
cases O 0 7.078318731146283e-07
of O 0 2.252723334095208e-06
female O 0 0.4634411931037903
breast B-Disease 1 0.9999839067459106
cancer I-Disease 1 0.9754695296287537
only O 0 2.8122931325924583e-05
. O 0 7.682674186071381e-05

These O 0 7.507998088840395e-05
estimates O 0 7.17201255611144e-05
were O 0 2.3904349291115068e-05
not O 0 5.138362212164793e-06
substantially O 0 1.736928606987931e-05
affected O 0 3.240455498598749e-06
either O 0 9.658374438004103e-07
by O 0 4.860787043980963e-07
changing O 0 2.573264282546006e-06
the O 0 1.2070662478436134e-06
assumed O 0 2.9988139431225136e-05
penetrance O 0 2.6843084924621508e-05
model O 0 2.5928036393452203e-06
for O 0 1.3492649486579467e-06
BRCA1 O 0 0.0003372465434949845
or O 0 1.8026660200121114e-06
by O 0 5.861298859599628e-07
including O 0 1.7494946860097116e-06
or O 0 6.563969236594858e-06
excluding O 0 2.3506709112552926e-05
BRCA1 O 0 0.001879231072962284
mutation O 0 7.344222831306979e-05
data O 0 3.9790385926607996e-05
. O 0 6.839077832410112e-05

Among O 0 7.82009883550927e-05
those O 0 2.410279557807371e-05
families O 0 7.108133286237717e-05
with O 0 0.00020164338639006019
disease O 0 0.39906150102615356
due O 0 2.8445090720197186e-05
to O 0 1.0995226148224901e-05
BRCA1 O 0 0.008184162899851799
that O 0 4.250955498719122e-06
were O 0 1.8907829144154675e-05
tested O 0 1.2865673852502368e-05
by O 0 1.9083014990428637e-07
one O 0 2.480399530213617e-07
of O 0 1.9264146544628602e-07
the O 0 5.999339691697969e-07
standard O 0 3.363302312209271e-06
screening O 0 7.513537184422603e-06
methods O 0 5.340355073712999e-06
, O 0 3.6661945159721654e-06
mutations O 0 5.021616743761115e-06
were O 0 5.1059655561402906e-06
detected O 0 9.213193152390886e-06
in O 0 6.856853360659443e-07
the O 0 1.0621374713082332e-06
coding O 0 1.0849267710000277e-05
sequence O 0 1.9150520529365167e-06
or O 0 9.365502933178504e-07
splice O 0 2.499353104212787e-05
sites O 0 1.9286164842924336e-06
in O 0 8.807386961962038e-07
an O 0 1.4730865132150939e-06
estimated O 0 5.4120882850838825e-06
63 O 0 9.913334906741511e-06
% O 0 9.81485072770738e-07
( O 0 8.647281219964498e-07
95 O 0 4.457962859305553e-06
% O 0 3.7719987631135155e-06
CI O 0 0.0002885407011490315
51 O 0 2.3923827029648237e-05
% O 0 5.314752797858091e-06
- O 0 0.00010086393740493804
77 O 0 3.224564352422021e-05
% O 0 9.617916475690436e-06
) O 0 9.04599619389046e-06
. O 0 3.1478190066991374e-05

The O 0 0.00010864487558137625
estimated O 0 6.0985639720456675e-05
sensitivity O 0 3.156518141622655e-05
was O 0 2.934812437160872e-05
identical O 0 5.966935077594826e-06
for O 0 4.3246714653832896e-07
direct O 0 1.3450586493490846e-06
sequencing O 0 9.290899470215663e-06
and O 0 2.6290219921065727e-06
other O 0 2.177712303819135e-06
techniques O 0 4.788094884133898e-05
. O 0 4.9238566134590656e-05

The O 0 0.00025272995117120445
penetrance O 0 0.0019187205471098423
of O 0 5.7902121625375e-05
BRCA2 O 0 0.01692342199385166
was O 0 0.00022270981571637094
estimated O 0 7.587762411276344e-06
by O 0 1.486995074628794e-06
maximizing O 0 9.491380296822172e-06
the O 0 3.5142079468641896e-06
LOD O 0 0.003696416039019823
score O 0 2.121476791216992e-05
in O 0 1.5151080333453137e-05
BRCA2 O 0 0.0015075698029249907
- O 0 0.006701903883367777
mutation O 0 1.7877653590403497e-05
families O 0 5.45318789590965e-06
, O 0 1.0883586583076976e-06
over O 0 9.715456599224126e-07
all O 0 1.4258472447181703e-06
possible O 0 1.2118392987758853e-05
penetrance O 0 0.000531974365003407
functions O 0 3.2005518733058125e-05
. O 0 7.563806138932705e-05

The O 0 8.107403118629009e-05
estimated O 0 0.00011087508028140292
cumulative O 0 0.0001729411887936294
risk O 0 0.00016974691243376583
of O 0 1.82672192750033e-05
breast B-Disease 1 0.9998914003372192
cancer I-Disease 1 0.9877058863639832
reached O 0 0.0002510632330086082
28 O 0 0.00011376481415936723
% O 0 3.090664449700853e-06
( O 0 1.116744670071057e-06
95 O 0 3.858754553220933e-06
% O 0 4.07777906730189e-06
CI O 0 0.0008348145638592541
9 O 0 1.0341394954593852e-05
% O 0 1.9936949229304446e-06
- O 0 2.787115954561159e-05
44 O 0 6.896385457366705e-06
% O 0 9.577602213539649e-07
) O 0 2.428849654734222e-07
by O 0 3.501284595586185e-07
age O 0 2.651997419889085e-06
50 O 0 1.2644251228266512e-06
years O 0 1.4541345763063873e-06
and O 0 1.4812233075645054e-06
84 O 0 8.630321644886862e-06
% O 0 9.169708619083394e-07
( O 0 5.455750056171382e-07
95 O 0 1.5252413732014247e-06
% O 0 2.113285518134944e-06
CI O 0 0.0001056399050867185
43 O 0 5.897654773434624e-06
% O 0 1.7940479892786243e-06
- O 0 1.787787550711073e-05
95 O 0 4.085938144271495e-06
% O 0 1.5475682175747352e-06
) O 0 6.213169854163425e-07
by O 0 5.510272558240104e-07
age O 0 6.500911240436835e-06
70 O 0 7.746098162897397e-06
years O 0 1.2326308024057653e-05
. O 0 2.9399216145975515e-05

The O 0 0.0010226911399513483
corresponding O 1 0.9844092726707458
ovarian B-Disease 1 1.0
cancer I-Disease 1 1.0
risks O 1 0.5277037620544434
were O 0 0.00015597134188283235
0 O 0 0.00026824872475117445
. O 0 6.598528125323355e-05

4 O 0 0.0004533246683422476
% O 0 4.6089448005659506e-05
( O 0 6.272411155805457e-06
95 O 0 1.1856723176606465e-05
% O 0 6.917186510690954e-06
CI O 0 0.00039131479570642114
0 O 0 1.2106286703783553e-05
% O 0 2.1195323824940715e-06
- O 0 2.498897629266139e-05
1 O 0 1.5473970051971264e-06
% O 0 5.357304075914726e-07
) O 0 2.563625400853198e-07
by O 0 2.1344098399822542e-07
age O 0 1.6200378922803793e-06
50 O 0 9.174475508189062e-07
years O 0 1.1827548860310344e-06
and O 0 9.987398925659363e-07
27 O 0 1.5570125469821505e-05
% O 0 8.883553164196201e-07
( O 0 4.5131477577342594e-07
95 O 0 3.0721596431249054e-06
% O 0 5.023590347263962e-06
CI O 0 0.0005974495434202254
0 O 0 1.0953289347526152e-05
% O 0 2.6929537852993235e-06
- O 0 2.5785735488170758e-05
47 O 0 1.1404492397559807e-05
% O 0 1.5324819742090767e-06
) O 0 7.383727052001632e-07
by O 0 1.0642240795277758e-06
age O 0 1.2201469871797599e-05
70 O 0 9.938135917764157e-06
years O 0 1.678278567851521e-05
. O 0 2.8512718927231617e-05

The O 0 0.0002449153398629278
lifetime O 0 0.0124947065487504
risk O 0 0.000987912411801517
of O 0 8.208517829189077e-05
breast B-Disease 1 0.9999969005584717
cancer I-Disease 1 0.9969694018363953
appears O 0 3.2154352084035054e-05
similar O 0 2.8256674795557046e-06
to O 0 1.705896920611849e-06
the O 0 5.883234734938014e-06
risk O 0 5.9889585827477276e-05
in O 0 7.547081622760743e-06
BRCA1 O 0 0.004830498713999987
carriers O 0 4.771904059452936e-05
, O 0 2.7367968868929893e-06
but O 0 1.0708702120609814e-06
there O 0 5.8788094747797e-07
was O 0 2.681570322238258e-06
some O 0 1.8341913232688967e-07
suggestion O 0 1.2896650787297403e-06
of O 0 4.879667017121392e-07
a O 0 1.4662492503703106e-05
lower O 0 0.0008754581212997437
risk O 0 0.000158555296366103
in O 0 5.956036602583481e-06
BRCA2 O 0 0.0003917048452422023
carriers O 0 2.710042826947756e-05
< O 0 1.9692637579282746e-05
50 O 0 2.073963287330116e-06
years O 0 1.5207648402792984e-06
of O 0 1.7275403934036149e-06
age O 0 0.00012656880426220596
. O 0 3.068369915126823e-05

Eye B-Disease 1 0.9452509880065918
movement I-Disease 0 0.010704700835049152
abnormalities I-Disease 1 0.9961177110671997
correlate O 0 0.000948109372984618
with O 0 8.765825623413548e-05
genotype O 1 0.5073022842407227
in O 0 0.00033625480136834085
autosomal O 1 0.9477946162223816
dominant O 0 0.09897913783788681
cerebellar B-Disease 1 0.9786257743835449
ataxia I-Disease 1 0.9999803304672241
type I-Disease 1 0.8339447975158691
I I-Disease 1 0.6271247267723083
. O 0 0.00015561006148345768

We O 0 0.00018813597853295505
compared O 0 6.41934311715886e-05
horizontal O 0 0.0002288206305820495
eye O 0 0.002773175947368145
movements O 0 3.4718283131951466e-05
( O 0 6.115273663453991e-06
visually O 0 2.4875869712559506e-05
guided O 0 3.6348734283819795e-05
saccades O 0 0.0016446044901385903
, O 0 9.53493781707948e-06
antisaccades O 0 0.000383359583793208
, O 0 2.5534973246976733e-06
and O 0 2.130715301973396e-06
smooth O 0 2.9797882234561257e-05
pursuit O 0 5.226248686085455e-05
) O 0 1.2568272040880402e-06
in O 0 1.5984010133252013e-06
control O 0 2.956292883027345e-05
subjects O 0 1.1906033250852488e-05
( O 0 4.315329078963259e-06
n O 0 0.0012207720428705215
= O 0 0.001120382105000317
14 O 0 9.489207513979636e-06
) O 0 9.60971647145925e-07
and O 0 5.094783773529343e-06
patients O 0 2.4366119760088623e-05
with O 0 1.3304688764037564e-06
three O 0 3.3518615509819938e-06
forms O 0 2.241714128103922e-06
of O 0 9.648114428273402e-06
autosomal O 0 0.3655588626861572
dominant O 0 0.019872859120368958
cerebellar B-Disease 0 0.11636776477098465
ataxias I-Disease 1 0.7821552753448486
type I-Disease 0 0.029323553666472435
I I-Disease 0 0.24433928728103638
spinocerebellar B-Disease 0 0.48550406098365784
ataxias I-Disease 0 0.04538615047931671
1 I-Disease 0 1.2703543688985519e-05
and I-Disease 0 3.780104862016742e-06
2 I-Disease 0 6.301670509856194e-06
( O 0 2.291345253979671e-06
SCA1 B-Disease 0 0.0012326190480962396
, O 0 3.5888340335077373e-06
n O 0 7.902266224846244e-05
= O 0 9.333567140856758e-05
11 O 0 9.085524652618915e-06
; O 0 2.39698238146957e-06
SCA2 B-Disease 0 0.0006615747697651386
, O 0 3.2227530937234405e-06
n O 0 7.693783118156716e-05
= O 0 4.718687341664918e-05
10 O 0 2.3114846499083797e-06
) O 0 1.2990363984499709e-06
and O 0 3.6244914554117713e-06
SCA3 B-Disease 1 0.9989559650421143
/ O 0 0.00012650580902118236
Machado B-Disease 0 0.0002723775978665799
- I-Disease 0 0.34105685353279114
Joseph I-Disease 0 0.32395386695861816
disease I-Disease 1 0.7533611059188843
( O 0 2.755699460976757e-05
MJD B-Disease 1 0.9999212026596069
) O 0 9.46688396652462e-06
( O 0 6.724744253006065e-06
n O 0 0.00015186553355306387
= O 0 0.00020144930749665946
16 O 0 2.5425151761737652e-05
) O 0 9.33018236537464e-06
. O 0 2.5850387828540988e-05

In O 0 0.0002202807809226215
SCA1 B-Disease 0 0.0030608694069087505
, O 0 2.1896428734180517e-05
saccade O 0 0.00017967542225960642
amplitude O 0 3.762079359148629e-05
was O 0 4.159034870099276e-05
significantly O 0 1.1164252100570593e-05
increased O 0 3.8497346395161e-06
, O 0 2.4431772089883452e-06
resulting O 0 1.4505994840874337e-05
in O 0 1.8563603589427657e-05
hypermetria B-Disease 0 0.010208284482359886
. O 0 6.655455217696726e-05

The O 0 0.0001745974295772612
smooth O 0 0.00022636272478848696
pursuit O 0 0.00024737269268371165
gain O 0 0.00017250311793759465
was O 0 0.000279761734418571
decreased O 0 0.0003534157876856625
. O 0 5.11597900185734e-05

In O 0 0.0002957743126899004
SCA2 B-Disease 0 0.002862252527847886
, O 0 2.994410169776529e-05
saccade O 0 0.0003135396109428257
velocity O 0 0.00010444512736285105
was O 0 0.00010059315536636859
markedly O 0 0.00035364466020837426
decreased O 0 0.0002482634736225009
. O 0 7.852177805034444e-05

The O 0 7.847395318094641e-05
percentage O 0 8.628298382973298e-05
of O 0 5.825327662023483e-06
errors O 0 5.8129058743361384e-05
in O 0 1.1831443771370687e-05
antisaccades O 0 0.00791782047599554
was O 0 0.000125199556350708
greatly O 0 6.654371190961683e-06
increased O 0 2.250515990454005e-06
and O 0 3.578826408556779e-06
was O 0 3.457106140558608e-05
significantly O 0 8.064896064752247e-06
correlated O 0 9.938211405824404e-06
with O 0 3.983644546678988e-06
age O 0 0.0002762144722510129
at O 0 0.034313496202230453
disease O 1 0.9494888782501221
onset O 1 0.7857303619384766
. O 0 0.00012805787264369428

In O 0 8.28825868666172e-05
addition O 0 2.315998608537484e-05
, O 0 3.7912857351329876e-06
a O 0 2.7110429527965607e-06
correlation O 0 3.789146148847067e-06
between O 0 1.6136142448885948e-06
smooth O 0 1.1369428648322355e-05
pursuit O 0 2.39455584960524e-05
gain O 0 1.8178243408328854e-05
and O 0 1.0590827059786534e-06
the O 0 4.847801164942211e-07
number O 0 5.230807005318638e-07
of O 0 1.6258915138678276e-06
trinucleotide O 0 0.013323807157576084
repeats O 0 4.896067184745334e-05
was O 0 0.00010743313032435253
found O 0 4.896436075796373e-05
. O 0 3.54539297404699e-05

In O 0 0.0008815804612822831
SCA3 B-Disease 1 0.9996844530105591
, O 0 6.278116052271798e-05
gaze B-Disease 0 0.0009429963538423181
- I-Disease 0 0.0013396081048995256
evoked I-Disease 0 0.0002990760840475559
nystagmus I-Disease 0 0.01904718391597271
was O 0 0.0001172819102066569
often O 0 3.4965667055075755e-06
present O 0 1.4737089486516197e-06
as O 0 1.4035567801329307e-06
was O 0 1.2797930139640812e-05
saccade O 0 6.10148417763412e-05
hypometria O 0 8.204871119232848e-05
and O 0 2.730711685217102e-06
smooth O 0 1.578525552758947e-05
pursuit O 0 6.971709080971777e-05
gain O 0 0.00011368010746082291
was O 0 0.0001966313284356147
markedly O 0 0.00039082940202206373
decreased O 0 0.0002660590107552707
. O 0 6.41331062070094e-05

Three O 0 0.00010426839435240254
major O 0 4.832942067878321e-05
criteria O 0 2.6214054742013104e-05
, O 0 4.251510745234555e-06
saccade O 0 4.792736581293866e-05
amplitude O 0 9.66660627454985e-06
, O 0 3.3090282158809714e-06
saccade O 0 3.4349406632827595e-05
velocity O 0 9.286895874538459e-06
, O 0 7.820412406545074e-07
and O 0 4.6928420260883286e-07
presence O 0 7.540050432908174e-07
of O 0 8.711405712347187e-07
gaze B-Disease 0 8.846432319842279e-05
- I-Disease 0 0.00010119707440026104
evoked I-Disease 0 4.3235668272245675e-05
nystagmus I-Disease 0 0.00012432692165020853
, O 0 1.0641196013239096e-06
permitted O 0 9.688116051620455e-07
the O 0 1.1629928167167236e-06
correct O 0 1.3524274436349515e-05
assignment O 0 3.971013484260766e-06
of O 0 3.616859771682357e-07
90 O 0 1.5705047644587466e-06
% O 0 5.182128006708808e-07
of O 0 2.0924737498262402e-07
the O 0 1.5224147773551522e-06
SCA1 B-Disease 0 0.020373528823256493
, O 0 8.718378694538842e-07
90 O 0 5.68265591027739e-07
% O 0 2.2349018991008052e-07
of O 0 1.512914451495817e-07
the O 0 2.0684719856944866e-06
SCA2 B-Disease 0 0.011440127156674862
, O 0 1.3290092510942486e-06
and O 0 1.1197179219379905e-06
93 O 0 7.002615348028485e-06
% O 0 5.356961878533184e-07
of O 0 3.379157647032116e-07
the O 0 7.572003596578725e-06
patients O 0 0.00022352863743435591
with O 0 1.0706204193411395e-05
SCA3 B-Disease 1 0.9999581575393677
to O 0 4.738687039207434e-06
their O 0 2.3237726054503582e-05
genetically O 0 5.426700590760447e-05
confirmed O 0 6.758741074008867e-05
patient O 0 0.00011912430636584759
group O 0 8.206560778489802e-06
and O 0 2.907192993006902e-06
, O 0 3.3854842058644863e-06
therefore O 0 2.5501583422737895e-06
, O 0 1.7170840465041692e-06
may O 0 8.562515176890884e-06
help O 0 3.91834691981785e-06
orient O 0 4.0531056583859026e-05
diagnoses O 0 0.00010339325672248378
of O 0 1.7761947219696594e-06
SCA1 B-Disease 0 0.08387964963912964
, O 0 7.214015568024479e-06
SCA2 B-Disease 0 0.005410963203758001
, O 0 2.73842351816711e-06
and O 0 8.794429959380068e-06
SCA3 B-Disease 1 0.999761164188385
at O 0 2.476419831509702e-05
early O 0 1.0649037903931458e-05
clinical O 0 3.869182546623051e-05
stages O 0 1.224602328875335e-05
of O 0 3.07890263684385e-06
the O 0 0.0003601362113840878
diseases O 1 0.635247528553009
. O 0 2.2947913748794235e-05
. O 0 6.29076748737134e-05

Genetic O 0 0.0009696632623672485
basis O 0 4.637664096662775e-05
and O 0 2.0591232896549627e-05
molecular O 0 0.0004208768077660352
mechanism O 0 0.0007608290761709213
for O 0 0.007290506269782782
idiopathic B-Disease 1 1.0
ventricular I-Disease 1 0.9999995231628418
fibrillation I-Disease 1 0.9999998807907104
. O 0 0.003753992263227701

Ventricular B-Disease 1 0.9997425675392151
fibrillation I-Disease 1 0.9993450045585632
causes O 0 0.0005767056718468666
more O 0 7.431677204294829e-06
than O 0 2.293161742272787e-06
300 O 0 2.8716194719891064e-06
, O 0 1.0824170431078528e-06
000 O 0 4.985808118362911e-06
sudden O 0 3.442230081418529e-05
deaths O 0 1.1572746188903693e-05
each O 0 7.908507768661366e-07
year O 0 2.736097485467326e-06
in O 0 1.7607477502679103e-06
the O 0 8.434157280134968e-06
USA O 0 0.0002974041271954775
alone O 0 7.04256453900598e-05
. O 0 2.803189454425592e-05

In O 0 9.742577094584703e-05
approximately O 0 4.821608672500588e-05
5 O 0 2.3162194338510744e-05
- O 0 5.841401798534207e-05
12 O 0 9.297990800405387e-06
% O 0 1.2228692867211066e-06
of O 0 5.179455229153973e-07
these O 0 5.681041557181743e-07
cases O 0 1.186567715194542e-06
, O 0 2.514095967853791e-06
there O 0 1.358810322926729e-06
are O 0 8.146752747961727e-07
no O 0 9.272576789953746e-06
demonstrable O 0 0.43781808018684387
cardiac O 1 0.9960793852806091
or O 0 8.240831812145188e-05
non O 0 0.002876515965908766
- O 1 0.9980477094650269
cardiac O 1 0.9979446530342102
causes O 0 1.9312692529638298e-05
to O 0 1.696001845630235e-06
account O 0 1.5384330254164524e-06
for O 0 3.8751358033550787e-07
the O 0 1.301133011111233e-06
episode O 0 1.9388942746445537e-05
, O 0 1.8722622598943417e-06
which O 0 1.9826636616926407e-06
is O 0 1.7118845789809711e-06
therefore O 0 4.39685891251429e-06
classified O 0 6.530053360620514e-05
as O 0 0.001247373758815229
idiopathic B-Disease 1 0.9999998807907104
ventricular I-Disease 1 0.9999994039535522
fibrillation I-Disease 1 1.0
( O 0 0.03628930822014809
IVF B-Disease 1 0.9999974966049194
) O 0 8.785114187048748e-05
. O 0 7.455446029780433e-05

A O 0 0.0003647871781140566
distinct O 0 8.696553413756192e-05
group O 0 4.001901106676087e-05
of O 0 2.388092798355501e-05
IVF B-Disease 1 0.9999995231628418
patients O 1 0.6397823691368103
has O 0 2.557299922045786e-05
been O 0 1.2092464203306008e-05
found O 0 2.9830655421392294e-06
to O 0 1.078877971849579e-06
present O 0 1.035556010720029e-06
with O 0 1.3024490499446983e-06
a O 0 1.4774713235965464e-05
characteristic O 0 0.00011643380275927484
electrocardiographic O 0 0.12580080330371857
pattern O 0 0.00024867517640814185
. O 0 6.550385296577588e-05

Because O 0 4.882303619524464e-05
of O 0 3.33403067998006e-06
the O 0 1.452531023460324e-06
small O 0 1.7464609527451103e-06
size O 0 2.1441815079015214e-06
of O 0 2.5208058218595397e-07
most O 0 4.2921217868752137e-07
pedigrees O 0 1.9220182366552763e-05
and O 0 1.2381057103993953e-06
the O 0 1.7760320361048798e-06
high O 0 7.916491449577734e-05
incidence O 0 0.00012862645962741226
of O 0 2.443463927193079e-06
sudden B-Disease 0 0.21207286417484283
death I-Disease 0 0.02926432155072689
, O 0 4.875778358837124e-06
however O 0 2.3517841327702627e-06
, O 0 1.0526322284931666e-06
molecular O 0 9.425551979802549e-06
genetic O 0 4.613618784787832e-06
studies O 0 8.136457267937658e-07
of O 0 2.115192728524562e-06
IVF B-Disease 1 0.9999663829803467
have O 0 1.3492556718119886e-05
not O 0 2.898633283621166e-06
yet O 0 5.0632124839467e-06
been O 0 7.988905963429715e-06
done O 0 2.1063853637315333e-05
. O 0 2.7068861527368426e-05

Because O 0 0.01656767539680004
IVF B-Disease 1 0.999994158744812
causes O 0 0.20555874705314636
cardiac O 1 0.9998371601104736
rhythm O 1 0.7202178239822388
disturbance O 0 0.0019490126287564635
, O 0 1.6434858480351977e-05
we O 0 5.085215889266692e-06
investigated O 0 1.1927229024877306e-05
whether O 0 3.0864612199366093e-06
malfunction O 0 0.000409213884267956
of O 0 1.013601035992906e-06
ion O 0 2.2732105207978748e-05
channels O 0 3.631145227700472e-05
could O 0 6.534501153510064e-05
cause O 0 4.4087155401939526e-05
the O 0 1.696983235888183e-05
disorder O 0 0.07777809351682663
by O 0 1.3292425364852534e-06
studying O 0 5.90666604693979e-06
mutations O 0 1.1259038728894666e-05
in O 0 1.2577107781908126e-06
the O 0 1.1657150025712326e-05
cardiac O 0 0.34394320845603943
sodium O 0 9.359038813272491e-05
channel O 0 0.00011927080777240917
gene O 0 0.0001357207220280543
SCN5A O 0 0.002329858485609293
. O 0 7.174140046117827e-05

We O 0 0.0001600660034455359
have O 0 2.1159003154025413e-05
now O 0 8.380702638532966e-06
identified O 0 5.502770818566205e-06
a O 0 3.991215180576546e-06
missense O 0 4.477853872231208e-05
mutation O 0 1.6697789760655724e-05
, O 0 2.2769290808355436e-06
a O 0 4.7405087570950855e-06
splice O 0 0.011722808703780174
- O 0 0.009146569296717644
donor O 0 9.224546374753118e-05
mutation O 0 2.195198248955421e-05
, O 0 1.8155157022192725e-06
and O 0 1.1516303857206367e-06
a O 0 8.124647138174623e-06
frameshift O 0 0.00017611427756492049
mutation O 0 7.619007192261051e-06
in O 0 8.158656328305369e-07
the O 0 1.3419529523162055e-06
coding O 0 1.641125709284097e-05
region O 0 4.831614660361083e-06
of O 0 2.156158643629169e-06
SCN5A O 0 0.03217286616563797
in O 0 7.732524863968138e-06
three O 0 7.535929762525484e-05
IVF B-Disease 1 0.9999868869781494
families O 0 0.0003797967219725251
. O 0 6.886668415972963e-05

We O 0 8.77764614415355e-05
show O 0 2.3422548110829666e-05
that O 0 2.9371058190008625e-06
sodium O 0 5.804398824693635e-06
channels O 0 2.6545708351477515e-06
with O 0 1.5345718793469132e-06
the O 0 3.592936309360084e-06
missense O 0 8.177547715604305e-05
mutation O 0 3.0406215955736116e-05
recover O 0 4.821993934456259e-05
from O 0 1.94096242012165e-06
inactivation O 0 9.05358319869265e-05
more O 0 1.0796088645292912e-06
rapidly O 0 5.180811513127992e-06
than O 0 5.032961212236842e-07
normal O 0 1.963894419532153e-06
and O 0 6.856081427031313e-07
that O 0 5.010108452552231e-07
the O 0 1.6749548876759945e-06
frameshift O 0 0.00011784007074311376
mutation O 0 8.3269587776158e-06
causes O 0 3.1569647944706958e-06
the O 0 1.7168695194413885e-06
sodium O 0 8.045561116887257e-06
channel O 0 1.1264397471677512e-05
to O 0 1.5681864624639275e-06
be O 0 2.52807444667269e-06
non O 0 9.755708560987841e-06
- O 0 0.00030805449932813644
functional O 0 0.00011950167390750721
. O 0 4.0828759665600955e-05

Our O 0 0.00026574768708087504
results O 0 0.00010821360774571076
indicate O 0 2.2100575733929873e-05
that O 0 2.651327349667554e-06
mutations O 0 1.818618329707533e-05
in O 0 7.040811397018842e-06
cardiac O 0 0.08589654415845871
ion O 0 5.337718175724149e-05
- O 0 0.00014812037989031523
channel O 0 1.3013455827604048e-05
genes O 0 3.6012036161992e-06
contribute O 0 1.3183524742998998e-06
to O 0 5.156492761670961e-07
the O 0 1.8279778259966406e-06
risk O 0 9.383506039739586e-06
of O 0 2.000459971895907e-06
developing O 0 0.00036496907705441117
IVF B-Disease 1 0.9999282360076904
. O 0 2.127451625710819e-05
. O 0 5.02842667629011e-05

Molecular O 0 0.0009880700381472707
heterogeneity O 0 0.0008752970607019961
in O 0 0.00011370037827873603
mucopolysaccharidosis B-Disease 0 0.09720568358898163
IVA I-Disease 0 0.0026339152827858925
in O 0 1.2928229807585012e-05
Australia O 0 8.60208001540741e-06
and O 0 2.6134132440347457e-06
Northern O 0 5.392535967985168e-06
Ireland O 0 7.696049578953534e-06
: O 0 1.7749450762494234e-06
nine O 0 2.9610762339871144e-06
novel O 0 2.632697714943788e-06
mutations O 0 5.986291853332659e-06
including O 0 2.242220944026485e-06
T312S O 0 0.0005980046698823571
, O 0 1.4097437315285788e-06
a O 0 1.963250269909622e-06
common O 0 2.867456942112767e-06
allele O 0 2.4205597583204508e-05
that O 0 2.3923555545479758e-06
confers O 0 3.839191049337387e-05
a O 0 6.78865471854806e-05
mild O 0 0.12372953444719315
phenotype O 0 0.2558334171772003
. O 0 0.00011336769966874272

Mucopolysaccharidosis B-Disease 1 0.9986599683761597
IVA I-Disease 1 0.9996153116226196
( O 0 0.13152757287025452
MPS B-Disease 1 0.9999991655349731
IVA I-Disease 1 0.9999961853027344
) O 0 0.00011923703277716413
is O 0 1.6159094229806215e-05
an O 0 0.0001195078220916912
autosomal B-Disease 1 0.9904206991195679
recessive I-Disease 1 0.9997045397758484
lysosomal I-Disease 1 0.9999970197677612
storage I-Disease 1 0.9999996423721313
disorder I-Disease 1 0.9999988079071045
caused O 0 0.12787124514579773
by O 0 1.198582504002843e-05
a O 0 0.005931626074016094
genetic B-Disease 1 0.9998906850814819
defect I-Disease 1 0.9992146492004395
in O 0 3.4661443351069465e-05
N O 0 0.0176578089594841
- O 0 0.002014921046793461
acetylgalactosamine O 0 0.0031588312704116106
- O 0 0.0019490644335746765
6 O 0 0.00011319744953652844
- O 0 0.13889579474925995
sulfate O 0 0.0017666008789092302
sulfatase O 0 0.0011066198348999023
( O 0 1.4486542568192817e-05
GALNS O 0 0.0052584498189389706
) O 0 2.5957750040106475e-05
. O 0 3.6399171222001314e-05

Previous O 0 0.00014786918472964317
studies O 0 2.759999370027799e-05
of O 0 9.90974331216421e-06
patients O 0 0.0008189326617866755
from O 0 3.2533184821659233e-06
a O 0 1.035386958392337e-05
British O 0 2.8351767468848266e-05
- O 0 0.0008825722616165876
Irish O 0 9.295978088630363e-06
population O 0 1.4799722976022167e-06
showed O 0 6.9557459028146695e-06
that O 0 4.428596298566845e-07
the O 0 1.8177263427787693e-06
I113F O 0 0.0014789749402552843
mutation O 0 7.011643901932985e-06
is O 0 3.490831943508965e-07
the O 0 3.99114014726365e-07
most O 0 5.483119025484484e-07
common O 0 2.0995350951125147e-06
single O 0 5.283762948238291e-05
mutation O 0 5.986428732285276e-05
among O 0 2.5937632017303258e-05
MPS B-Disease 1 0.9999978542327881
IVA I-Disease 1 0.9999959468841553
patients O 0 0.3305709660053253
and O 0 4.1171231714542955e-05
produces O 0 0.00010029404074884951
a O 0 0.0074347639456391335
severe O 1 0.9999192953109741
clinical O 1 0.8272085785865784
phenotype O 1 0.8618971705436707
. O 0 0.00022152194287627935

We O 0 0.00022040032490622252
studied O 0 0.00010829835082404315
mutations O 0 6.650753493886441e-05
in O 0 5.160318778507644e-06
the O 0 6.164857950352598e-06
GALNS O 0 0.003722354071214795
gene O 0 6.615022357436828e-06
from O 0 2.504855501683778e-06
23 O 0 2.5765184545889497e-05
additional O 0 1.7484675481682643e-05
MPS B-Disease 1 0.9999926090240479
IVA I-Disease 1 0.9999934434890747
patients O 0 0.036284562200307846
( O 0 1.6900584114409867e-06
15 O 0 2.5372623895236757e-06
from O 0 7.103278676368063e-07
Australia O 0 1.1274607913946966e-06
, O 0 4.092838423730427e-07
8 O 0 1.0303016324542114e-06
from O 0 3.0759571245653206e-07
Northern O 0 1.3501298781193327e-06
Ireland O 0 6.912635853950633e-06
) O 0 7.330480684686336e-07
, O 0 3.2632848956382077e-07
with O 0 3.7805159536219435e-07
various O 0 3.0606640848418465e-06
clinical O 0 0.26011961698532104
phenotypes O 1 0.6022024750709534
( O 0 2.4560078600188717e-05
severe O 1 0.7203709483146667
, O 0 2.1632873540511355e-05
16 O 0 2.318791848665569e-05
cases O 0 1.904526698126574e-06
; O 0 1.763626528372697e-06
intermediate O 0 1.1853851901832968e-05
, O 0 2.078314992104424e-06
4 O 0 1.1524748515512329e-05
cases O 0 1.7107355461121188e-06
; O 0 4.9632121772447135e-06
mild O 0 0.0007086070254445076
, O 0 1.0379494597145822e-05
3 O 0 2.612854768813122e-05
cases O 0 6.982443210290512e-06
) O 0 7.525140517827822e-06
. O 0 2.132962799805682e-05

We O 0 0.0001517380151199177
found O 0 2.3000782675808296e-05
two O 0 3.6987423754908377e-06
common O 0 5.446919658425031e-06
mutations O 0 1.2947425602760632e-05
that O 0 1.0105840146934497e-06
together O 0 3.826093688985566e-06
accounted O 0 3.1033853247208754e-06
for O 0 3.6246257195671205e-07
32 O 0 2.1247963104542578e-06
% O 0 3.3017516898325994e-07
of O 0 2.1541987393902673e-07
the O 0 9.162452556665812e-07
44 O 0 1.1958503819187172e-05
unrelated O 0 7.805519999237731e-06
alleles O 0 9.998205314332154e-06
in O 0 4.887146133114584e-06
these O 0 8.90526735020103e-06
patients O 0 0.0006074858829379082
. O 0 4.994390474166721e-05

One O 0 6.576127634616569e-05
is O 0 8.76249214343261e-06
the O 0 5.178406354389153e-06
T312S O 0 0.00021740177180618048
mutation O 0 1.5784245988470502e-05
, O 0 1.9181484276487026e-06
a O 0 2.5150504825433018e-06
novel O 0 4.229544174449984e-06
mutation O 0 8.404986147070304e-06
found O 0 2.491637815182912e-06
exclusively O 0 4.563410584523808e-06
in O 0 1.3478447726811282e-05
milder O 0 0.01388567965477705
patients O 0 0.020274825394153595
. O 0 8.8664804934524e-05

The O 0 3.5610715713119134e-05
other O 0 6.422576916520484e-06
is O 0 2.597946831883746e-06
the O 0 2.6727261683845427e-06
previously O 0 2.8621199817280285e-05
described O 0 1.9560065993573517e-05
I113F O 0 9.65423823799938e-05
that O 0 2.8196757284604246e-06
produces O 0 1.6359052096959203e-05
a O 0 0.00015364089631475508
severe O 1 0.9950507283210754
phenotype O 1 0.8682763576507568
. O 0 0.0003886866325046867

The O 0 0.0001546965359011665
I113F O 0 0.0006170530105009675
and O 0 2.5945499146473594e-05
T312S O 0 0.0004372560069896281
mutations O 0 3.674163963296451e-05
accounted O 0 1.1170236575708259e-05
for O 0 1.8187304249295266e-06
8 O 0 2.008488263527397e-05
( O 0 1.0943452934952802e-06
18 O 0 8.275666914414614e-06
% O 0 1.7948659660760313e-06
) O 0 4.201051808649936e-07
and O 0 7.814761602276121e-07
6 O 0 7.946937330416404e-06
( O 0 7.544891786892549e-07
14 O 0 2.399063532720902e-06
% O 0 5.073644615549711e-07
) O 0 2.3898829226709495e-07
of O 0 4.0124319866663427e-07
44 O 0 7.517472567997174e-06
unrelated O 0 8.454531780444086e-06
alleles O 0 2.342118568776641e-05
, O 0 1.0785894119180739e-05
respectively O 0 7.5643474701792e-05
. O 0 3.915159322787076e-05

The O 0 0.00012609381519723684
relatively O 0 9.506045171292499e-05
high O 0 8.063524001045153e-05
residual O 0 0.00021629146067425609
GALNS O 0 0.0011098535032942891
activity O 0 8.15058228909038e-06
seen O 0 6.6408238126314245e-06
when O 0 2.157798007829115e-06
the O 0 1.1931252856811625e-06
T312S O 0 2.312981268914882e-05
mutant O 0 9.92872901406372e-06
cDNA O 0 1.0703080988605507e-05
is O 0 1.4683192830489133e-06
overexpressed O 0 1.2835770576202776e-05
in O 0 1.5762907423777506e-06
mutant O 0 3.2932450267253444e-05
cells O 0 6.881071385578252e-06
provides O 0 1.2474831692088628e-06
an O 0 9.345054650111706e-07
explanation O 0 1.6916017102630576e-06
for O 0 7.641103820787976e-07
the O 0 1.1287451343378052e-05
mild O 0 0.11958221346139908
phenotype O 0 0.44916921854019165
in O 0 0.00016038805188145489
patients O 0 0.00528543908149004
with O 0 8.479612006340176e-06
this O 0 1.4672311408503447e-05
mutation O 0 0.00022212007024791092
. O 0 5.846919157193042e-05

The O 0 5.653291009366512e-05
distribution O 0 2.8878783268737607e-05
and O 0 3.557324362191139e-06
relative O 0 6.044823749107309e-06
frequencies O 0 3.7544282349699643e-06
of O 0 6.863101020826434e-07
the O 0 1.9266881281509995e-06
I113F O 0 4.73821273772046e-05
and O 0 2.5130507310677785e-06
T312S O 0 6.478109571617097e-05
mutations O 0 6.467877483373741e-06
in O 0 1.1091093483628356e-06
Australia O 0 1.8983159861818422e-06
corresponded O 0 2.286928975081537e-06
to O 0 5.836839136463823e-07
those O 0 5.855443987456965e-07
observed O 0 1.021058892547444e-06
in O 0 5.082279699308856e-07
Northern O 0 1.938038167281775e-06
Ireland O 0 7.405656106129754e-06
and O 0 1.385431914968649e-06
are O 0 2.785808419503155e-07
unique O 0 2.923547697264439e-07
to O 0 3.2416161843684677e-07
these O 0 1.898372374853352e-07
two O 0 5.518539865079219e-07
populations O 0 1.5382598803626024e-06
, O 0 8.200287311410648e-07
suggesting O 0 2.4896353352232836e-06
that O 0 3.2425003837488475e-07
both O 0 4.7109489287322504e-07
mutations O 0 5.5058731049939524e-06
were O 0 4.89622925670119e-06
probably O 0 2.655961225173087e-06
introduced O 0 7.82591087045148e-07
to O 0 4.873760985901754e-07
Australia O 0 8.424329394074448e-07
by O 0 4.348953268618061e-07
Irish O 0 2.433591816952685e-06
migrants O 0 2.286750031998963e-06
during O 0 3.2702344014978735e-06
the O 0 4.234099833411165e-06
19th O 0 3.075321365031414e-05
century O 0 4.229961632518098e-05
. O 0 5.247427907306701e-05

Haplotype O 0 0.002064022934064269
analysis O 0 6.49716384941712e-05
using O 0 1.9633362171589397e-05
6 O 0 4.720748620457016e-05
RFLPs O 0 0.00014677713625133038
provides O 0 4.075582182849757e-06
additional O 0 2.057809751931927e-06
data O 0 2.794892907331814e-06
that O 0 7.089993232511915e-07
the O 0 1.3717470892515848e-06
I113F O 0 5.680180402123369e-05
mutation O 0 6.76100489727105e-06
originated O 0 2.7478333777253283e-06
from O 0 1.787546239029325e-06
a O 0 5.959161171631422e-06
common O 0 1.1659151823550928e-05
ancestor O 0 0.0001085782641894184
. O 0 5.7726028899196535e-05

The O 0 6.422411388484761e-05
other O 0 9.033177775563672e-06
9 O 0 3.704985647345893e-05
novel O 0 8.074269317148719e-06
mutations O 0 9.95743084786227e-06
identified O 0 5.1582715059339534e-06
in O 0 1.2187688298581634e-06
these O 0 1.2381281067064265e-06
23 O 0 0.0008469981839880347
patients O 0 4.560758316074498e-05
were O 0 3.5133666642650496e-06
each O 0 6.86898772528366e-07
limited O 0 1.8803197008310235e-06
to O 0 1.2228600780872512e-06
a O 0 7.797083526384085e-06
single O 0 0.00010007153468905017
family O 0 0.000262004672549665
. O 0 4.090421134606004e-05

These O 0 4.380620885058306e-05
data O 0 2.283012872794643e-05
provide O 0 7.776275197102223e-06
further O 0 4.215297394694062e-06
evidence O 0 3.157738547088229e-06
for O 0 1.2807507800971507e-06
extensive O 0 1.817992415453773e-05
allelic O 0 0.00012933438119944185
heterogeneity O 0 0.00014276852016337216
in O 0 0.000136123679112643
MPS B-Disease 1 0.9999779462814331
IVA I-Disease 1 0.9960565567016602
in O 0 4.86574754177127e-05
British O 0 0.0005703388014808297
- O 0 0.04483969509601593
Irish O 0 5.329742998583242e-05
patients O 0 2.815078551066108e-05
and O 0 8.956386636782554e-07
provide O 0 1.1492769544929615e-06
evidence O 0 9.305240382673219e-07
for O 0 4.789632725987758e-07
their O 0 4.7640396587667055e-06
transmission O 0 3.590061896829866e-05
to O 0 1.3185850775698782e-06
Australia O 0 1.1668300885503413e-06
by O 0 5.976047532385564e-07
British O 0 8.986949978861958e-06
- O 0 0.00011981568241026253
Irish O 0 1.4425993867916986e-05
migrants O 0 1.6124165995279327e-05
. O 0 1.0155062227568123e-05
. O 0 3.1787210900802165e-05

Identification O 0 0.0001592908811289817
of O 0 3.6343015381135046e-05
constitutional O 0 0.00018012707005254924
WT1 O 0 0.14137491583824158
mutations O 0 0.00017363153165206313
, O 0 8.846591299516149e-06
in O 0 1.8583230485091917e-05
patients O 0 0.0006459280266426504
with O 0 3.656048284028657e-05
isolated O 0 0.23288896679878235
diffuse B-Disease 1 0.9977624416351318
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
, O 0 4.143295518588275e-05
and O 0 4.275525043340167e-06
analysis O 0 3.4217864595120773e-06
of O 0 2.638720161485253e-06
genotype O 0 0.10301510244607925
/ O 0 0.00025481227203272283
phenotype O 0 0.00021699647186324
correlations O 0 1.2831695130444132e-05
by O 0 8.295478437503334e-07
use O 0 8.406224196733092e-07
of O 0 1.2550174233183498e-06
a O 0 3.32328854710795e-05
computerized O 0 0.026812460273504257
mutation O 0 0.00023298496671486646
database O 0 8.863353286869824e-05
. O 0 6.670984294032678e-05

Constitutional O 0 0.0005033657653257251
mutations O 0 0.00018731330055743456
of O 0 1.4257725524657872e-05
the O 0 2.3058741135173477e-05
WT1 O 0 0.0011293708812445402
gene O 0 2.4275548639707267e-05
, O 0 2.395008323219372e-06
encoding O 0 7.74129784986144e-06
a O 0 2.010484786296729e-05
zinc O 0 0.0396229550242424
- O 0 0.0028499781619757414
finger O 0 0.0005726470844820142
transcription O 0 2.0045614292030223e-05
factor O 0 6.3185680119204335e-06
involved O 0 4.002398327429546e-06
in O 0 1.8430635464028455e-05
renal O 1 0.9942992925643921
and O 0 6.278199725784361e-05
gonadal O 0 0.24493765830993652
development O 0 4.862214609602233e-06
, O 0 2.0466579826461384e-06
are O 0 5.291486786518362e-07
found O 0 1.920165232149884e-06
in O 0 1.6465388625874766e-06
most O 0 2.799032699840609e-06
patients O 0 8.165765757439658e-05
with O 0 8.128629269776866e-05
Denys B-Disease 1 0.9999066591262817
- I-Disease 1 0.9999983310699463
Drash I-Disease 1 0.9999992847442627
syndrome I-Disease 1 0.9999998807907104
( O 0 0.000151060099597089
DDS B-Disease 1 0.9999990463256836
) O 0 2.5823457690421492e-05
, O 0 1.657867687754333e-05
or O 0 0.00012291650637052953
diffuse B-Disease 1 0.9951063394546509
mesangial I-Disease 1 1.0
sclerosis I-Disease 1 1.0
( O 0 0.00039622699841856956
DMS B-Disease 1 0.9924672245979309
) O 0 5.060074727225583e-06
associated O 0 6.909485364303691e-06
with O 0 1.851721026469022e-05
pseudohermaphroditism B-Disease 1 0.9999722242355347
and O 0 0.00020350671547930688
/ O 0 0.008713253773748875
or O 0 0.0002983729063998908
Wilms B-Disease 1 0.9999595880508423
tumor I-Disease 1 0.9915661811828613
( O 0 8.541758143110201e-05
WT B-Disease 1 0.9999923706054688
) O 0 3.841721991193481e-05
. O 0 5.778506965725683e-05

Most O 0 0.0003753179626073688
mutations O 0 0.001345428521744907
in O 0 0.0010619375389069319
DDS B-Disease 1 0.9999998807907104
patients O 1 0.9920694828033447
lie O 0 0.010922991670668125
in O 0 9.519872946839314e-06
exon O 0 5.8028035709867254e-05
8 O 0 1.0453041795699392e-05
or O 0 1.2578259429574246e-06
exon O 0 1.0045304406958167e-05
9 O 0 6.7052133090328425e-06
, O 0 8.644527156320692e-07
encoding O 0 6.386504082911415e-06
zinc O 0 0.003505173372104764
finger O 0 0.0012805166188627481
2 O 0 1.539249024062883e-05
or O 0 1.1482567970233504e-05
zinc O 0 0.010744226165115833
finger O 0 0.010441873222589493
3 O 0 2.287096685904544e-05
, O 0 2.6116567823919468e-06
respectively O 0 6.805856173741631e-06
, O 0 5.564639309341146e-07
with O 0 4.4121554765297333e-07
a O 0 3.2772650229162537e-06
hot O 0 6.681921513518319e-05
spot O 0 7.297017145901918e-05
( O 0 2.550652197896852e-06
R394W O 0 4.142185571254231e-05
) O 0 1.725747097225394e-06
in O 0 5.943422820564592e-06
exon O 0 0.00022666138829663396
9 O 0 0.0001648219913477078
. O 0 5.774871533503756e-05

We O 0 6.570386176463217e-05
analyzed O 0 3.518930680002086e-05
a O 0 5.706372576241847e-06
series O 0 4.371046543383272e-06
of O 0 2.059788812402985e-06
24 O 0 0.00357607938349247
patients O 0 0.0005622574244625866
, O 0 2.294246769452002e-06
10 O 0 2.982465048262384e-06
with O 0 1.1954000001423992e-05
isolated B-Disease 0 0.10496649146080017
DMS I-Disease 1 0.9534156918525696
( O 0 6.386206223396584e-06
IDMS B-Disease 0 0.2092115879058838
) O 0 2.5999372610385763e-06
, O 0 1.105124624700693e-06
10 O 0 2.0022998796775937e-06
with O 0 7.3920095928770024e-06
DDS B-Disease 1 0.9999967813491821
, O 0 4.645540229830658e-06
and O 0 2.6333982532378286e-06
4 O 0 7.590425866510486e-06
with O 0 6.5954759520536754e-06
urogenital B-Disease 1 0.9390370845794678
abnormalities I-Disease 1 0.9996287822723389
and O 0 0.001226343447342515
/ O 0 0.0670548602938652
or O 0 0.0008440686506219208
WT B-Disease 1 0.9999947547912598
. O 0 0.00027085153851658106

We O 0 0.0003165790403727442
report O 0 0.00010807428043335676
WT1 O 0 0.0011845574481412768
heterozygous O 0 0.00015596509911119938
mutations O 0 5.313108704285696e-05
in O 0 1.0346465387556236e-05
16 O 0 0.0009298910736106336
patients O 0 0.002172891516238451
, O 0 2.2131141577119706e-06
4 O 0 2.922069370470126e-06
of O 0 9.612118674340309e-07
whom O 0 2.5353601813549176e-05
presented O 0 2.2981990696280263e-05
with O 0 9.217215119861066e-05
IDMS B-Disease 1 0.9901519417762756
. O 0 0.00014352265861816704

One O 0 8.599499415140599e-05
male O 0 8.020692621357739e-05
and O 0 6.914231562404893e-06
two O 0 1.4985223970143124e-05
female O 0 0.004960884805768728
IDMS B-Disease 1 0.9982582926750183
patients O 0 0.012630989775061607
with O 0 8.546996832592413e-05
WT1 O 1 0.9389890432357788
mutations O 0 0.0010533540043979883
underwent O 1 0.5103276968002319
normal O 0 0.0015215476742014289
puberty O 0 0.162876695394516
. O 0 0.00017593370284885168

Two O 0 0.00031288061290979385
mutations O 0 0.0009702963288873434
associated O 0 7.658616959815845e-05
with O 0 2.518703149689827e-05
IDMS B-Disease 1 0.8082457184791565
are O 0 2.3718282591289608e-06
different O 0 9.558075362292584e-07
from O 0 2.5484127945674118e-06
those O 0 4.087286470166873e-06
described O 0 0.00016957477782852948
in O 0 0.0021879381965845823
DDS B-Disease 1 1.0
patients O 1 0.8708696961402893
. O 0 0.00020578438125085086

No O 0 0.000943169929087162
WT1 O 0 0.010746054351329803
mutations O 0 0.0003131921694148332
were O 0 3.624330202001147e-05
detected O 0 4.4854870793642476e-05
in O 0 3.0859841899655294e-06
the O 0 2.280173475810443e-06
six O 0 1.5582114428980276e-05
other O 0 8.873088518157601e-06
IDMS B-Disease 1 0.9987382292747498
patients O 0 0.005293537396937609
, O 0 5.7466168073005974e-06
suggesting O 0 2.4156293875421397e-05
genetic O 0 3.0045392122701742e-05
heterogeneity O 0 2.3303860871237703e-05
of O 0 7.023154012131272e-06
this O 0 0.00016991369193419814
disease O 1 0.8117977380752563
. O 0 0.0001178202946903184

We O 0 0.0002496829838491976
analyzed O 0 0.00028816211852245033
genotype O 0 0.001854368718340993
/ O 0 0.0002750393468886614
phenotype O 0 0.00035647719050757587
correlations O 0 4.505370088736527e-05
, O 0 2.8134495551057626e-06
on O 0 1.2897818351120804e-06
the O 0 6.447281180044229e-07
basis O 0 3.492913549507648e-07
of O 0 2.963911356346216e-07
the O 0 1.7819650111050578e-06
constitution O 0 1.188718670164235e-06
of O 0 4.880542405771848e-07
a O 0 1.3599559679278173e-05
WT1 O 0 0.001597667345777154
mutation O 0 6.892900728416862e-06
database O 0 2.1849123186257202e-06
of O 0 1.1453772685854346e-06
84 O 0 3.013911373273004e-05
germ O 0 0.0003358578833285719
- O 0 0.000204384297830984
line O 0 6.302650581346825e-05
mutations O 0 1.03576812762185e-05
, O 0 6.494898912023928e-07
to O 0 5.045080797572155e-07
compare O 0 1.354589699076314e-06
the O 0 3.6693703009405e-07
distribution O 0 1.2656255421461537e-06
and O 0 7.192413136181131e-07
type O 0 4.29976034865831e-06
of O 0 1.0812625532707898e-06
mutations O 0 1.6196538126678206e-05
, O 0 1.1092446356997243e-06
according O 0 9.135283107752912e-07
to O 0 9.57065481088648e-07
the O 0 4.131090463488363e-06
different O 0 2.3835287720430642e-05
symptoms O 0 0.06657570600509644
. O 0 9.925773338181898e-05

This O 0 0.00011074108624598011
demonstrated O 0 0.00018280322547070682
( O 0 5.645553301292239e-06
1 O 0 4.064934728376102e-06
) O 0 5.446215709525859e-07
the O 0 5.415430450739223e-07
association O 0 1.9814046936517116e-06
between O 0 9.919386911860784e-07
mutations O 0 5.446712293633027e-06
in O 0 1.6075626945166732e-06
exons O 0 3.3789128792705014e-05
8 O 0 1.0466189451108221e-05
and O 0 2.9770005767204566e-06
9 O 0 1.9551467630662955e-05
and O 0 8.660405910632107e-06
DMS B-Disease 1 0.5812093019485474
; O 0 2.439433728795848e-06
( O 0 5.60749754185963e-07
2 O 0 1.5494910030611209e-06
) O 0 5.419290118879871e-07
among O 0 9.030110277308268e-07
patients O 0 3.4988668630830944e-05
with O 0 7.887457286415156e-06
DMS B-Disease 1 0.8392500281333923
, O 0 1.1972514357694308e-06
a O 0 1.433120246474573e-06
higher O 0 1.1556272738744156e-06
frequency O 0 1.428956352356181e-06
of O 0 6.474539873124741e-07
exon O 0 2.939400110335555e-05
8 O 0 1.1889376764884219e-05
mutations O 0 9.273955583921634e-06
among O 0 1.4142236750558368e-06
46 O 0 2.1478392227436416e-05
, O 0 3.088921221205965e-05
XY O 0 0.49776479601860046
patients O 0 4.184408680885099e-05
with O 0 2.74229910246504e-06
female O 0 3.6180175811750814e-05
phenotype O 0 8.728581451578066e-05
than O 0 7.923251246211294e-07
among O 0 1.1718080941136577e-06
46 O 0 5.513757059816271e-05
, O 0 4.4543696276377887e-05
XY O 1 0.8383405208587646
patients O 0 7.373238622676581e-05
with O 0 3.7703084672102705e-06
sexual O 0 5.339300969353644e-06
ambiguity O 0 1.094971776183229e-05
or O 0 1.3384341400524136e-05
male O 0 0.00017717471928335726
phenotype O 0 0.004811341408640146
; O 0 3.779704684347962e-06
and O 0 6.724725153617328e-06
( O 0 2.0385152765811654e-06
3 O 0 4.809630809177179e-06
) O 0 6.482571848209773e-07
statistically O 0 2.7541664167074487e-06
significant O 0 5.789859187643742e-07
evidence O 0 9.614557257009437e-07
that O 0 8.802601314528147e-07
mutations O 0 3.543405000527855e-06
in O 0 9.116640740103321e-07
exons O 0 1.5346817235695198e-05
8 O 0 4.529271336650709e-06
and O 0 2.1805865344504127e-06
9 O 0 1.1677535439957865e-05
preferentially O 0 8.55270536703756e-06
affect O 0 3.5288430808577687e-06
amino O 0 3.1732458865008084e-06
acids O 0 1.9400945348024834e-06
with O 0 5.306926595949335e-07
different O 0 9.972684438253054e-07
functions O 0 4.368237568996847e-06
. O 0 6.991544978518505e-06
. O 0 2.47050411417149e-05

The O 0 0.00028954679146409035
185delAG O 0 0.00369484955444932
BRCA1 O 0 0.002239521825686097
mutation O 0 9.399751434102654e-05
originated O 0 2.511950515327044e-05
before O 0 4.399543286126573e-06
the O 0 1.4614544170399313e-06
dispersion O 0 7.154054401325993e-06
of O 0 7.097408456502308e-07
Jews O 0 2.8378283332131105e-06
in O 0 8.297511726595985e-07
the O 0 9.998129826271906e-07
diaspora O 0 4.435529262991622e-06
and O 0 1.4498281188934925e-06
is O 0 7.177687848525238e-07
not O 0 1.1123114518341026e-06
limited O 0 2.949771214844077e-06
to O 0 6.0151569414301775e-06
Ashkenazim O 0 0.0002442679542582482
. O 0 3.661310256575234e-05

The O 0 0.00015069467190187424
185delAG O 0 0.0017539379186928272
mutation O 0 0.0001426653761882335
in O 0 1.659476401982829e-05
BRCA1 O 0 0.0024053724482655525
is O 0 5.496367066371022e-06
detected O 0 2.5922303393599577e-05
in O 0 2.322916316188639e-06
Ashkenazi O 0 2.8348036721581593e-05
Jews O 0 3.019219320776756e-06
both O 0 9.977630952562322e-07
in O 0 1.2334233360888902e-05
familial B-Disease 1 0.8416814208030701
breast I-Disease 1 0.9999675750732422
and I-Disease 1 0.9995418787002563
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
and O 0 2.0308572857175022e-05
in O 0 3.939606813219143e-06
the O 0 2.8773379199265037e-06
general O 0 5.844136012456147e-06
population O 0 8.034473466977943e-06
. O 0 1.9210652681067586e-05

All O 0 0.00013661010598298162
tested O 0 0.0003811302303802222
Ashkenazi O 0 0.00030272052390500903
mutation O 0 6.4382009441033e-05
carriers O 0 2.3597944164066575e-05
share O 0 3.5000734897039365e-06
the O 0 1.2887539924122393e-06
same O 0 1.8900713030234328e-06
allelic O 0 2.471753214194905e-05
pattern O 0 1.3237383427622262e-05
at O 0 2.2668915335088968e-05
the O 0 2.3712813344900496e-05
BRCA1 O 0 0.006947370711714029
locus O 0 0.001360965659841895
. O 0 0.00010355605627410114

Our O 0 9.484441397944465e-05
previous O 0 3.390029087313451e-05
study O 0 9.540186511003412e-06
showed O 0 1.8959903172799386e-05
that O 0 9.855915550360805e-07
this O 0 7.675606639168109e-07
Ashkenazi O 0 4.4117990910308436e-05
mutation O 0 1.1312280548736453e-05
also O 0 2.9833583994332002e-06
occurs O 0 1.6585192952334182e-06
in O 0 1.3463265986501938e-06
Iraqi O 0 1.6467320165247656e-05
Jews O 0 2.231771759397816e-06
with O 0 1.391037358189351e-06
a O 0 8.054780664679129e-06
similar O 0 1.9493156287353486e-05
allelic O 0 0.0007347468635998666
pattern O 0 0.0003389188495930284
. O 0 8.118822006508708e-05

We O 0 6.453716923715547e-05
extended O 0 2.3395579773932695e-05
our O 0 5.265680101729231e-06
analysis O 0 1.994406147787231e-06
to O 0 1.122039748224779e-06
other O 0 5.924251240685408e-07
non O 0 3.64900142812985e-06
- O 0 2.2889165848027915e-05
Ashkenazi O 0 1.0910024684562813e-05
subsets O 0 2.986409981531324e-06
354 O 0 5.291161869536154e-06
of O 0 7.445656251547916e-07
Moroccan O 0 7.955780347401742e-06
origin O 0 1.957290351128904e-06
, O 0 8.634352752778796e-07
200 O 0 2.824530838552164e-06
Yemenites O 0 2.587833660072647e-05
and O 0 1.7154374063466094e-06
150 O 0 4.5286751628736965e-06
Iranian O 0 1.9855393475154415e-05
Jews O 0 2.57663141383091e-05
. O 0 3.4943022910738364e-05

Heteroduplex O 0 0.004256073851138353
analysis O 0 8.503990829922259e-05
complemented O 0 5.725121809518896e-05
by O 0 4.045956757181557e-06
direct O 0 5.188474915485131e-06
DNA O 0 1.1989860468020197e-05
sequencing O 0 1.220697504322743e-05
of O 0 3.023071485586115e-06
abnormally O 0 0.0006727941217832267
migrating O 0 2.928678077296354e-05
bands O 0 2.613475407997612e-05
were O 0 2.21756909013493e-05
employed O 0 0.00015604931104462594
. O 0 6.963470514165238e-05

Four O 0 8.062793494900689e-05
of O 0 9.917977877194062e-06
Moroccan O 0 6.392795330611989e-05
origin O 0 7.662604730285238e-06
( O 0 1.53952191794815e-06
1 O 0 1.3453330893753446e-06
. O 0 4.6430415068243747e-07
1 O 0 9.953974995369208e-07
% O 0 7.405391215797863e-07
) O 0 3.715280172400526e-07
and O 0 7.418241807499726e-07
none O 0 1.4792173033129075e-06
of O 0 4.5435075435307226e-07
the O 0 2.8477618343458744e-06
Yemenites O 0 0.00019221815455239266
or O 0 3.17343642564083e-06
Iranians O 0 6.569355264218757e-06
was O 0 9.204261004924774e-06
a O 0 2.3699603843851946e-06
carrier O 0 1.0893641047005076e-05
of O 0 9.458890986024926e-07
the O 0 6.795090030209394e-06
185delAG O 0 0.002300344640389085
mutation O 0 0.0001805252832127735
. O 0 5.4853950132383034e-05

BRCA1 O 0 0.010458145290613174
allelic O 0 0.0012493309332057834
patterns O 0 0.0003121437912341207
were O 0 5.9468045947141945e-05
determined O 0 8.724302460905164e-06
for O 0 6.291051022344618e-07
four O 0 1.155373865913134e-06
of O 0 4.7483095499956107e-07
these O 0 5.311923700901389e-07
individuals O 0 2.545747577187285e-07
and O 0 3.6522703794616973e-07
for O 0 3.5758748140324315e-07
12 O 0 3.900759566022316e-06
additional O 0 1.0746186944743386e-06
non O 0 4.705960691353539e-06
- O 0 7.762459426885471e-05
Ashkenazi O 0 6.158866744954139e-05
185delAG O 0 8.184889156837016e-05
mutation O 0 1.4037833352631424e-05
carriers O 0 4.29419924330432e-05
who O 0 6.661023508058861e-05
had O 1 0.7385020852088928
breast B-Disease 1 0.9999982118606567
/ I-Disease 1 0.9999979734420776
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999992847442627
. O 0 0.0007855937001295388

Six O 0 0.00028233134071342647
non O 0 0.00011038041702704504
- O 0 0.00037875742418691516
Ashkenazi O 0 0.0001514188916189596
individuals O 0 3.902743173966883e-06
shared O 0 3.438889507378917e-06
the O 0 2.170265361201018e-06
common O 0 4.921955223835539e-06
Ashkenazi O 0 0.00018339979578740895
haplotype O 0 0.00016167262219823897
, O 0 5.379222784540616e-06
four O 0 8.632569006294943e-06
had O 0 0.00028392154490575194
a O 0 6.137662239780184e-06
closely O 0 9.153840437647887e-06
related O 0 3.4608240184752503e-06
pattern O 0 1.2570055332616903e-05
, O 0 1.3795214499623398e-06
and O 0 2.783024910968379e-06
the O 0 3.1595998279954074e-06
rest O 0 1.310660536546493e-05
( O 0 2.2196177269506734e-06
n O 0 0.00029104272834956646
= O 0 0.00021263558301143348
6 O 0 5.453354788187426e-06
) O 0 7.359473670476291e-07
displayed O 0 2.783662012006971e-06
a O 0 4.531906597549096e-06
distinct O 0 2.3447533749276772e-05
BRCA1 O 0 0.0013410537503659725
allelic O 0 0.0011827838607132435
pattern O 0 0.0005231821560300887
. O 0 0.00019352641538716853

We O 0 0.000209647070732899
conclude O 0 0.00010165357525693253
that O 0 6.28541693004081e-06
the O 0 1.085023905034177e-05
185delAG O 0 0.000723591074347496
BRCA1 O 0 0.0008152878726832569
mutation O 0 4.021964923595078e-05
occurs O 0 3.727229341166094e-06
in O 0 1.5650549585188855e-06
some O 0 9.111043368648097e-07
non O 0 6.412698894564528e-06
- O 0 0.0001698246196610853
Ashkenazi O 0 3.7158628401812166e-05
populations O 0 2.9450377496686997e-06
at O 0 6.122790182416793e-06
rates O 0 2.8907766136399005e-06
comparable O 0 3.6045571505383123e-06
with O 0 1.3963898481961223e-06
that O 0 1.2863780511906953e-06
of O 0 7.478543466277188e-06
Ashkenazim O 0 0.001005343976430595
. O 0 5.36740553798154e-05

The O 0 9.968191443476826e-05
majority O 0 3.432998710195534e-05
of O 0 7.757135790598113e-06
Jewish O 0 4.081910810782574e-05
185delAG O 0 0.00034396801493130624
mutation O 0 2.9010672733420506e-05
carriers O 0 1.8872126020141877e-05
have O 0 2.5249998998333467e-06
a O 0 2.922108251368627e-06
common O 0 4.0651557355886325e-06
allelic O 0 9.236958430847153e-05
pattern O 0 5.440851964522153e-05
, O 0 3.837107215076685e-06
supporting O 0 2.4125199615809834e-06
the O 0 1.5240112816172768e-06
founder O 0 3.9710590499453247e-05
effect O 0 2.0476497866184218e-06
notion O 0 1.731617658151663e-06
, O 0 1.0433933539388818e-06
but O 0 5.918321903664037e-07
dating O 0 1.9090052774117794e-06
the O 0 9.581393669577665e-07
mutations O 0 3.5713017041416606e-06
origin O 0 8.283288366328634e-07
to O 0 6.591857300008996e-07
an O 0 9.474175612922409e-07
earlier O 0 3.652866325865034e-06
date O 0 2.6951888685289305e-06
than O 0 1.222190803673584e-06
currently O 0 4.4708626774081495e-06
estimated O 0 2.007132388825994e-05
. O 0 2.213056359323673e-05

However O 0 0.00011348949192324653
, O 0 8.106467248580884e-06
the O 0 2.429835149087012e-06
different O 0 1.4633859564128215e-06
allelic O 0 2.5494444344076328e-05
pattern O 0 1.4584951713914052e-05
at O 0 1.557377981953323e-05
the O 0 6.013585789332865e-06
BRCA1 O 0 0.0004101642989553511
locus O 0 6.025581751600839e-05
even O 0 3.989909600932151e-06
in O 0 1.288888029193913e-06
some O 0 8.316628168358875e-07
Jewish O 0 7.841361366445199e-06
mutation O 0 1.5745188647997566e-05
carriers O 0 1.31873857753817e-05
, O 0 2.0524239516817033e-06
might O 0 2.631379857120919e-06
suggest O 0 1.3697758731723297e-06
that O 0 3.57159763098025e-07
the O 0 1.708788659016136e-06
mutation O 0 2.497627974662464e-05
arose O 0 1.2789681932190433e-05
independently O 0 1.8722690583672374e-05
. O 0 9.287976354244165e-06
. O 0 3.72800204786472e-05

Crystal O 0 0.001101266941986978
structure O 0 7.672293577343225e-05
of O 0 1.08018793980591e-05
the O 0 9.48652159422636e-05
hemochromatosis B-Disease 1 0.999998927116394
protein O 0 0.00032836131867952645
HFE O 0 0.024032410234212875
and O 0 4.3029594962717965e-06
characterization O 0 9.0204703155905e-06
of O 0 8.928278703024262e-07
its O 0 2.0092513750569196e-06
interaction O 0 4.553959115582984e-06
with O 0 7.650870429642964e-06
transferrin O 0 0.0012341705150902271
receptor O 0 0.00017920232494361699
. O 0 3.849268614430912e-05

HFE O 1 0.6500900983810425
is O 0 7.086002005962655e-05
an O 0 2.2452626581070945e-05
MHC O 0 0.0006148614920675755
- O 0 0.0003838011180050671
related O 0 8.936337508202996e-06
protein O 0 5.912358574278187e-06
that O 0 8.211948170355754e-07
is O 0 8.387133902942878e-07
mutated O 0 7.70604583522072e-06
in O 0 1.825820959311386e-06
the O 0 2.093186958518345e-05
iron B-Disease 1 0.9998459815979004
- I-Disease 1 0.9999985694885254
overload I-Disease 1 0.9999996423721313
disease I-Disease 1 0.9999973773956299
hereditary B-Disease 1 1.0
hemochromatosis I-Disease 1 1.0
. O 0 0.008211503736674786

HFE O 0 0.03593244403600693
binds O 0 0.0005102598224766552
to O 0 4.809828897123225e-05
transferrin O 0 0.0004831808037124574
receptor O 0 6.650423893006518e-05
( O 0 5.097665507491911e-06
TfR O 0 7.29744861018844e-05
) O 0 1.5295981938834302e-06
and O 0 9.81654579845781e-07
reduces O 0 2.206477802246809e-06
its O 0 6.344051257656247e-07
affinity O 0 3.08177277474897e-06
for O 0 1.3525965414373786e-06
iron O 0 0.0037426939234137535
- O 0 0.00019119324861094356
loaded O 0 0.000116341034299694
transferrin O 0 0.0001279343559872359
, O 0 7.693686711718328e-06
implicating O 0 0.0004347063659224659
HFE O 0 0.009416107088327408
in O 0 3.791881681536324e-05
iron O 1 0.6789368391036987
metabolism O 0 0.0019044390646740794
. O 0 9.3768336228095e-05

The O 0 0.0002878027153201401
2 O 0 0.0005433132755570114
. O 0 0.0002597611164674163

6 O 0 0.0010812979890033603
A O 0 0.0001854147994890809
crystal O 0 0.00032378817559219897
structure O 0 2.0790861526620574e-05
of O 0 4.9289069465885404e-06
HFE O 0 0.0231068916618824
reveals O 0 2.6913929104921408e-05
the O 0 1.6083386071841232e-06
locations O 0 6.961407052585855e-06
of O 0 1.1649237421806902e-05
hemochromatosis B-Disease 1 0.9999998807907104
mutations O 0 0.000260273547610268
and O 0 7.319797077798285e-06
a O 0 2.4376975488848984e-05
patch O 0 0.32579389214515686
of O 0 3.3783885555749293e-06
histidines O 0 0.02692446857690811
that O 0 2.409739863651339e-06
could O 0 1.0051609933725558e-05
be O 0 9.891462013911223e-07
involved O 0 1.957725316970027e-06
in O 0 3.466551788733341e-06
pH O 0 0.008573516272008419
- O 0 0.0007788048824295402
dependent O 0 2.144785139535088e-05
interactions O 0 2.3611901269759983e-05
. O 0 3.3835109206847847e-05

We O 0 0.00010502829536562786
also O 0 1.678448279562872e-05
demonstrate O 0 2.2225614884519018e-05
that O 0 6.244371888897149e-06
soluble O 0 8.37041880004108e-05
TfR O 0 0.000187405152246356
and O 0 1.4603615454689134e-05
HFE O 0 0.010279517620801926
bind O 0 5.669103120453656e-05
tightly O 0 0.00010334386024624109
at O 0 1.313667689828435e-05
the O 0 1.2413487411322421e-06
basic O 0 3.3073688427975867e-06
pH O 0 1.5034366697364021e-05
of O 0 3.2698395102670474e-07
the O 0 1.7802850607040455e-06
cell O 0 4.7066027036635205e-05
surface O 0 2.4510496587026864e-05
, O 0 2.3276484171219636e-06
but O 0 7.350396913352597e-07
not O 0 5.223409402788093e-07
at O 0 3.5617949833977036e-06
the O 0 3.4297090678592212e-06
acidic O 0 5.2996074373368174e-05
pH O 0 4.583190457196906e-05
of O 0 3.5281771033623954e-06
intracellular O 0 0.0004910885472781956
vesicles O 0 0.00284363841637969
. O 0 0.00012566230725497007

TfR O 1 0.7446958422660828
HFE O 1 0.5054192543029785
stoichiometry O 0 0.0021768708247691393
( O 0 7.287490007001907e-05
2 O 0 2.252661761303898e-05
1 O 0 6.450149612646783e-06
) O 0 1.1976923133261153e-06
differs O 0 1.7188436913784244e-06
from O 0 2.051238197964267e-06
TfR O 0 0.00014301895862445235
transferrin O 0 0.0001228250184794888
stoichiometry O 0 4.2039995605591685e-05
( O 0 1.6913821809794172e-06
2 O 0 3.167540626236587e-06
2 O 0 3.981308964284835e-06
) O 0 7.265066983563884e-07
, O 0 4.0030408854363486e-07
implying O 0 1.5806999726919457e-06
a O 0 4.0487293517799117e-07
different O 0 2.1124178317677433e-07
mode O 0 9.652831067796797e-07
of O 0 3.801666537128767e-07
binding O 0 4.897242433798965e-06
for O 0 2.6799750685313484e-06
HFE O 0 0.004366596695035696
and O 0 5.07717641085037e-06
transferrin O 0 9.959640010492876e-05
to O 0 4.020374490210088e-06
TfR O 0 0.00032816038583405316
, O 0 2.5500271476630587e-06
consistent O 0 2.4290450255648466e-06
with O 0 7.890322422099416e-07
our O 0 2.8940203264937736e-06
demonstration O 0 9.11829192773439e-06
that O 0 2.8314457267697435e-06
HFE O 0 0.0008264057105407119
, O 0 3.878787538269535e-06
transferrin O 0 0.00011324474326102063
, O 0 2.0820702957280446e-06
and O 0 4.561174137052149e-06
TfR O 0 0.00012127919762860984
form O 0 3.925011696992442e-06
a O 0 1.491940474807052e-05
ternary O 0 0.0001620280381757766
complex O 0 0.0003280074743088335
. O 0 9.307383152190596e-05

Identification O 0 0.00011320910562062636
of O 0 1.4244922567741014e-05
three O 0 1.3898564247938339e-05
novel O 0 1.3631774891109671e-05
mutations O 0 1.181344941869611e-05
and O 0 1.3784982684228453e-06
a O 0 2.1525549982470693e-06
high O 0 1.0160787496715784e-05
frequency O 0 3.67138318324578e-06
of O 0 6.060173518562806e-07
the O 0 2.772423840724514e-06
Arg778Leu O 0 0.0017263356130570173
mutation O 0 1.1564912711037323e-05
in O 0 8.039455678954255e-06
Korean O 0 0.0006346729351207614
patients O 0 0.0003062681935261935
with O 0 8.86238194652833e-05
Wilson B-Disease 1 0.6950612664222717
disease I-Disease 0 0.14438730478286743
. O 0 6.774815847165883e-05

Four O 0 0.0004086151602678001
mutations O 0 0.0008619488216936588
- O 0 0.0011371234431862831
- O 0 0.0003524851053953171
R778L O 0 0.00015317676297854632
, O 0 5.511037215910619e-06
A874V O 0 2.943843719549477e-05
, O 0 1.7796671727410285e-06
L1083F O 0 1.5037419871077873e-05
, O 0 9.959948101823102e-07
and O 0 1.0268859114148654e-06
2304delC O 0 3.416625622776337e-05
- O 0 3.253776958445087e-05
- O 0 1.9540340872481465e-05
in O 0 9.98379846350872e-07
the O 0 1.2704082337222644e-06
copper O 0 3.7997910112608224e-05
- O 0 2.989154563692864e-05
transporting O 0 2.3542828785139136e-05
enzyme O 0 9.077289178094361e-06
, O 0 3.3558596896909876e-06
P O 0 0.00015106787031982094
- O 0 2.039068021986168e-05
type O 0 1.4728977475897409e-05
ATPase O 0 0.00010524874960538
( O 0 2.2885651560500264e-06
ATP7B O 0 0.00012273647007532418
) O 0 5.700693463950302e-07
, O 0 3.346618768773624e-07
were O 0 9.921562877934775e-07
identified O 0 2.041379048023373e-06
in O 0 2.3484917619498447e-06
Korean O 0 0.00038279572618193924
Patients O 0 0.00016325020988006145
with O 0 6.34148163953796e-05
Wilson B-Disease 1 0.7758045196533203
disease I-Disease 0 0.13738994300365448
. O 0 7.547710265498608e-05

Arg778Leu O 0 0.037456247955560684
, O 0 6.4947729697451e-05
the O 0 7.0718278948334046e-06
most O 0 3.167317117913626e-06
frequently O 0 9.290120033256244e-06
reported O 0 1.2697935744654387e-05
mutation O 0 2.589916903161793e-06
of O 0 3.4399417359054496e-07
this O 0 8.557629485039797e-07
enzyme O 0 7.3048177000600845e-06
, O 0 1.594156856299378e-06
was O 0 1.2919022083224263e-05
found O 0 1.435211515854462e-06
in O 0 5.905039301978832e-07
six O 0 1.708805029920768e-06
of O 0 6.866230251034722e-07
eight O 0 4.629074828699231e-05
unrelated O 0 9.543919441057369e-05
patients O 0 6.243976531550288e-05
studied O 0 7.441755769832525e-06
, O 0 6.466900117629848e-07
an O 0 8.338882366842881e-07
allele O 0 7.704648851358797e-06
frequency O 0 6.7921687332272995e-06
of O 0 4.309485575504368e-06
37 O 0 0.00014295447908807546
. O 0 5.7918856327887625e-05

5 O 0 0.0003527224762365222
% O 0 2.9064198315609246e-05
, O 0 3.499212425595033e-06
which O 0 1.3754544170296867e-06
is O 0 7.036617262201617e-07
considerably O 0 2.806382781272987e-06
higher O 0 9.48483375395881e-07
than O 0 2.627648143516126e-07
those O 0 3.5682882071341737e-07
in O 0 6.014285531819041e-07
other O 0 1.0064109119412024e-06
Asian O 0 2.3051265088724904e-05
populations O 0 2.4548300643800758e-05
. O 0 3.557012678356841e-05

The O 0 7.26199577911757e-05
novel O 0 7.503138476749882e-05
single O 0 2.9303851988515817e-05
nucleotide O 0 4.8563557356828824e-05
deletion O 0 4.576525680022314e-05
, O 0 6.425199444493046e-06
2304delC O 0 0.00010039623157354072
, O 0 4.1669109123176895e-06
was O 0 1.5631931091775186e-05
found O 0 3.5598866361397086e-06
in O 0 2.7963460524915718e-06
one O 0 2.135394788638223e-05
patient O 0 0.000595117686316371
. O 0 5.438201333163306e-05

Since O 0 0.0003323969431221485
a O 0 9.761602996150032e-05
mutation O 0 0.0001376692089252174
at O 0 4.824201823794283e-05
cDNA O 0 0.00012463339953683317
nucleotide O 0 0.00019637933291960508
2302 O 0 0.0012641424546018243
( O 0 5.48308480574633e-06
2302insC O 0 6.820802082074806e-05
) O 0 2.205325017712312e-06
had O 0 2.5984647436416708e-05
been O 0 6.5854260355990846e-06
previously O 0 1.0821479918377008e-05
described O 0 7.581122645206051e-06
, O 0 5.638046332023805e-07
this O 0 2.1497699265182746e-07
region O 0 7.891752034083765e-07
of O 0 5.664022069140628e-07
the O 0 7.710970749030821e-06
ATP7B O 0 0.4279063940048218
gene O 0 2.644808409968391e-05
may O 0 1.6308209524140693e-05
be O 0 2.333872316739871e-06
susceptible O 0 1.8421726053929888e-05
to O 0 2.8000420115859015e-06
gene O 0 4.771275780512951e-05
rearrangements O 0 0.0013811428798362613
causing O 0 0.11738603562116623
Wilson B-Disease 0 0.43657219409942627
disease I-Disease 0 0.09265021234750748
. O 0 8.134491508826613e-05

Disruption O 0 0.0013139210641384125
of O 0 4.546537093119696e-05
splicing O 0 0.00020198590937070549
regulated O 0 3.786194065469317e-05
by O 0 3.1386616683448665e-06
a O 0 7.364307293755701e-06
CUG O 0 0.0023880768567323685
- O 0 9.493029210716486e-05
binding O 0 1.6063264411059208e-05
protein O 0 3.1029867386678234e-05
in O 0 0.00013180849782656878
myotonic B-Disease 1 0.9999990463256836
dystrophy I-Disease 1 0.9999990463256836
. O 0 0.0006706974818371236

Myotonic B-Disease 1 0.9999996423721313
dystrophy I-Disease 1 1.0
( O 1 0.9967252612113953
DM B-Disease 1 1.0
) O 0 0.00014061077672522515
is O 0 7.009023192949826e-06
caused O 0 2.1421623387141153e-05
by O 0 1.2770977946274797e-06
a O 0 6.028071311448002e-06
CTG O 0 0.00010195374488830566
expansion O 0 1.8371548549112049e-06
in O 0 9.479001619183691e-07
the O 0 1.714081690806779e-06
3 O 0 1.0679985280148685e-05
untranslated O 0 7.830232061678544e-05
region O 0 2.5098295282077743e-06
of O 0 1.8780310711008497e-06
the O 0 0.00010540192306507379
DM B-Disease 1 0.9999957084655762
gene O 0 0.00026275136042386293
. O 0 8.394607721129432e-05

One O 0 6.927334470674396e-05
model O 0 6.608062540180981e-05
of O 0 2.9684659239137545e-05
DM B-Disease 1 0.999998927116394
pathogenesis O 0 0.0028350220527499914
suggests O 0 1.4347790965985041e-05
that O 0 2.1452019609569106e-06
RNAs O 0 1.2882052942586597e-05
from O 0 1.3175971389500774e-06
the O 0 1.0664633691703784e-06
expanded O 0 4.44773741037352e-06
allele O 0 7.0537362262257375e-06
create O 0 2.1508108147827443e-06
a O 0 2.765549879768514e-06
gain O 0 1.5882971638347954e-05
- O 0 3.0256898753577843e-05
of O 0 6.678687896055635e-07
- O 0 0.001376069849357009
function O 0 2.48737364927365e-06
mutation O 0 2.299828565810458e-06
by O 0 4.4010775468450447e-07
the O 0 6.287182259256952e-07
inappropriate O 0 2.5148872282443335e-06
binding O 0 9.96126004793041e-07
of O 0 4.711060910267406e-07
proteins O 0 2.6169498141825898e-06
to O 0 1.8636882259670529e-06
the O 0 1.1639475815172773e-05
CUG O 0 0.03701178729534149
repeats O 0 0.00024289055727422237
. O 0 4.892707147519104e-05

Data O 0 0.00016514919116161764
presented O 0 3.594459849409759e-05
here O 0 8.359668754565064e-06
indicate O 0 1.126688948716037e-05
that O 0 1.7759914499038132e-06
the O 0 3.3618689485592768e-06
conserved O 0 1.4375058526638895e-05
heterogeneous O 0 7.100084621924907e-05
nuclear O 0 0.00018782822007779032
ribonucleoprotein O 0 0.0002832828904502094
, O 0 6.879864031361649e-06
CUG O 0 0.0005502058193087578
- O 0 6.480326555902138e-05
binding O 0 1.0976127668982372e-05
protein O 0 8.323727342940401e-06
( O 0 3.1676947855885373e-06
CUG O 0 0.0035525511484593153
- O 0 0.009298408403992653
BP O 0 0.011797772720456123
) O 0 1.8486788349036942e-06
, O 0 1.3641571285916143e-06
may O 0 3.369945034137345e-06
mediate O 0 5.639924893330317e-06
the O 0 1.518677777312405e-06
trans O 0 2.7740217774407938e-05
- O 0 0.00018861552234739065
dominant O 0 1.1167244338139426e-05
effect O 0 2.151955641238601e-06
of O 0 1.330164423052338e-06
the O 0 7.630525942659006e-06
RNA O 0 7.50170074752532e-05
. O 0 4.425886436365545e-05

CUG O 1 0.8150221109390259
- O 0 0.33814486861228943
BP O 0 0.013864096254110336
was O 0 5.5403743317583576e-05
found O 0 7.68169411458075e-06
to O 0 2.1317723621905316e-06
bind O 0 6.444369773817016e-06
to O 0 1.1177845635756967e-06
the O 0 3.037150008822209e-06
human O 0 1.822443118726369e-05
cardiac O 1 0.9933521747589111
troponin O 1 0.9977217316627502
T O 1 0.7435861229896545
( O 0 2.344365384487901e-06
cTNT O 0 3.175351957906969e-05
) O 0 1.2144457741669612e-06
pre O 0 1.5684761820011772e-05
- O 0 4.9078189476858824e-05
messenger O 0 1.2054064427502453e-05
RNA O 0 3.266266276114038e-06
and O 0 1.1734117606465588e-06
regulate O 0 8.518095455656294e-06
its O 0 2.8448193916119635e-06
alternative O 0 2.696346382435877e-05
splicing O 0 0.00020835774193983525
. O 0 8.026691648410633e-05

Splicing O 0 0.0009664776152931154
of O 0 7.536526391049847e-05
cTNT O 0 0.0015857417602092028
was O 0 0.00029843009542673826
disrupted O 0 0.000644336745608598
in O 0 8.77058191690594e-05
DM B-Disease 1 0.9999990463256836
striated O 0 0.1468818336725235
muscle O 0 0.005846865940839052
and O 0 1.2562037227326073e-05
in O 0 8.159417120623402e-06
normal O 0 5.9944890381302685e-05
cells O 0 2.674011921044439e-05
expressing O 0 8.081017767835874e-06
transcripts O 0 9.239791324944235e-06
that O 0 2.55714553532016e-06
contain O 0 3.120051042060368e-05
CUG O 0 0.023481860756874084
repeats O 0 0.00016763595340307802
. O 0 5.948279067524709e-05

Altered O 0 0.0004831321712117642
expression O 0 3.366931196069345e-05
of O 0 8.611626071797218e-06
genes O 0 2.8162063244963065e-05
regulated O 0 2.8739792469423264e-05
posttranscriptionally O 0 0.00019270004122518003
by O 0 7.66673474572599e-06
CUG O 0 0.05401146784424782
- O 0 0.057012610137462616
BP O 0 0.009972364641726017
therefore O 0 6.021630269970046e-06
may O 0 6.721846148138866e-06
contribute O 0 6.492994089057902e-06
to O 0 2.148755083908327e-05
DM B-Disease 1 0.9999954700469971
pathogenesis O 0 0.0014730378752574325
. O 0 4.011461351183243e-05
. O 0 7.851338887121528e-05

Identification O 0 0.00021590616961475462
of O 0 2.238337583548855e-05
a O 0 2.896958903875202e-05
novel O 0 2.221122667833697e-05
nonsense O 0 6.0996346292085946e-05
mutation O 0 1.1322847058181651e-05
and O 0 1.8541699091656483e-06
a O 0 3.570756689441623e-06
missense O 0 1.598676317371428e-05
substitution O 0 3.0648202482552733e-06
in O 0 1.5273081999112037e-06
the O 0 3.376733047844027e-06
vasopressin O 0 2.4398510504397564e-05
- O 0 0.00013001235492993146
neurophysin O 0 0.0002656810684129596
II O 0 0.00013160781236365438
gene O 0 4.4128973968327045e-06
in O 0 1.0786599204948288e-06
two O 0 1.5850746422074735e-06
Spanish O 0 8.897933184925932e-06
kindreds O 0 6.855721585452557e-05
with O 0 4.0321145206689835e-05
familial B-Disease 1 0.9841348528862
neurohypophyseal I-Disease 1 0.9999512434005737
diabetes I-Disease 1 0.9999935626983643
insipidus I-Disease 1 0.9989657402038574
. O 0 0.0006232463638298213

Familial B-Disease 1 0.9998586177825928
neurohypophyseal I-Disease 1 0.9999885559082031
diabetes I-Disease 1 0.9999998807907104
insipidus I-Disease 1 0.999995231628418
( O 1 0.545383095741272
FNDI B-Disease 1 0.9999998807907104
) O 0 0.00012165377847850323
is O 0 1.1712758350768127e-05
an O 0 0.0001581102260388434
autosomal B-Disease 1 0.9971904158592224
dominant I-Disease 1 0.9981756210327148
disease I-Disease 1 0.9991069436073303
caused O 0 0.48899054527282715
by O 0 0.004427787847816944
deficiency O 1 0.9947693943977356
in O 0 8.171408808266278e-06
the O 0 2.2330736101139337e-05
antidiuretic O 0 0.0009173008147627115
hormone O 0 5.3571275202557445e-05
arginine O 0 3.968139935750514e-05
vasopressin O 0 1.872240682132542e-05
( O 0 1.6970858496279106e-06
AVP O 0 1.8103766706190072e-05
) O 0 7.539806574641261e-07
encoded O 0 1.545501845612307e-06
by O 0 6.39951224457036e-07
the O 0 1.8838161395251518e-06
AVP O 0 0.0001481568324379623
- O 0 0.00023653058451600373
neurophysin O 0 0.0004661401326302439
II O 0 0.00041606053127907217
( O 0 5.909337232878897e-06
AVP O 0 0.0002899940882343799
- O 0 0.0005900405230931938
NPII O 0 0.0016295694513246417
) O 0 4.74955004392541e-06
gene O 0 1.2185155355837196e-05
on O 0 1.6906962628127076e-05
chromosome O 0 0.0011021894169971347
20p13 O 0 0.0010818023001775146
. O 0 9.185599628835917e-05

In O 0 7.15253408998251e-05
this O 0 8.974188858701382e-06
study O 0 7.115481366781751e-06
, O 0 2.6222160158795305e-06
we O 0 1.542370000606752e-06
analyzed O 0 3.247846734666382e-06
two O 0 7.287285939128196e-07
families O 0 3.830277364613721e-06
with O 0 4.4995604184805416e-06
FNDI B-Disease 1 0.973068118095398
using O 0 1.7038402120306273e-06
direct O 0 1.2915211300423834e-06
automated O 0 2.3837470507714897e-05
fluorescent O 0 1.6537367628188804e-05
, O 0 1.2172611150162993e-06
solid O 0 1.048524154612096e-05
phase O 0 4.5584347390104085e-06
, O 0 9.686730209068628e-07
single O 0 5.6227718232548796e-06
- O 0 3.0835290090180933e-05
stranded O 0 9.235001016349997e-06
DNA O 0 6.258882876863936e-06
sequencing O 0 7.163120699260617e-06
of O 0 2.3103409603209e-06
PCR O 0 6.0977959947194904e-05
- O 0 0.00012197019532322884
amplified O 0 0.0002109946944983676
AVP O 0 0.000644340761937201
- O 0 0.0004515438340604305
NPII O 0 0.001623044372536242
DNA O 0 0.00016891765699256212
. O 0 5.956583481747657e-05

In O 0 4.265788084012456e-05
one O 0 4.8975648496707436e-06
of O 0 1.0850794751604553e-06
the O 0 4.259323304722784e-06
families O 0 2.2601543605560437e-05
, O 0 5.336618414730765e-06
affected O 0 1.2595372027135454e-05
individuals O 0 1.3010052271056338e-06
presented O 0 1.355060135210806e-06
a O 0 3.3219162105524447e-06
novel O 0 2.8932477107446175e-06
nonsense O 0 1.1164571333210915e-05
mutation O 0 2.875431391657912e-06
in O 0 9.750348226589267e-07
exon O 0 1.0305767318641301e-05
3 O 0 1.1916265520994784e-06
of O 0 2.562696579389012e-07
the O 0 1.2864393283962272e-06
gene O 0 2.9153500236134278e-06
, O 0 6.673142252111575e-07
consisting O 0 1.009897005133098e-06
in O 0 1.4511311974274577e-06
a O 0 2.1304642359609716e-05
G O 0 0.07150961458683014
to O 0 6.496895366581157e-06
T O 0 0.0078782569617033
transition O 0 7.798689694027416e-06
at O 0 1.024312587105669e-05
nucleotide O 0 1.9270009943284094e-05
2101 O 0 5.544021041714586e-05
, O 0 1.1397645494071185e-06
which O 0 7.2087362923412e-07
produces O 0 1.019948513203417e-06
a O 0 1.1057034043915337e-06
stop O 0 2.8960137115063844e-06
signal O 0 4.3320542317815125e-06
in O 0 2.309695446456317e-06
codon O 0 2.2019745301804505e-05
82 O 0 2.8357662813505158e-05
( O 0 4.351473307906417e-06
Glu O 0 0.0012832009233534336
) O 0 3.3719315979396924e-06
of O 0 5.518394573300611e-06
NPII O 0 0.012107324786484241
. O 0 6.072108226362616e-05

The O 0 0.0003162218490615487
premature O 0 0.07044894248247147
termination O 0 0.0002555738319642842
eliminates O 0 2.477291491231881e-05
part O 0 3.1673655485064955e-06
of O 0 1.3030702348260093e-06
the O 0 6.214323093445273e-06
C O 0 0.000568707357160747
- O 0 4.593885023496114e-05
terminal O 0 1.6095253158709966e-05
domain O 0 1.2321878557486343e-06
of O 0 6.716776397297508e-07
NPII O 0 0.0017237449064850807
, O 0 7.026250159469782e-07
including O 0 6.289251359703485e-07
a O 0 2.103529368469026e-06
cysteine O 0 2.8849378850281937e-06
residue O 0 5.766687536379322e-06
in O 0 9.536451557323744e-07
position O 0 4.757501756103011e-06
85 O 0 4.779594291903777e-06
, O 0 5.408597303357965e-07
which O 0 5.43756982551713e-07
could O 0 1.5455327684321674e-06
be O 0 4.767257451021578e-07
involved O 0 8.306165568683355e-07
in O 0 7.131563393159013e-07
the O 0 1.6075887288025115e-06
correct O 0 2.3996835807338357e-05
folding O 0 0.0001228012260980904
of O 0 2.4785199457255658e-06
the O 0 2.2785388864576817e-05
prohormone O 0 0.020942984148859978
. O 0 7.675916276639327e-05

In O 0 8.079863619059324e-05
the O 0 2.0153973309788853e-05
second O 0 4.51413870905526e-05
family O 0 2.6701971364673227e-05
, O 0 1.3350572771742009e-06
a O 0 1.9923759282391984e-06
G279A O 0 1.1450231795606669e-05
substitution O 0 1.0165884987145546e-06
at O 0 4.166537564742612e-06
position O 0 6.1310988712648395e-06
- O 0 1.2914476428704802e-05
1 O 0 5.273270744510228e-07
of O 0 1.7171777244584518e-07
the O 0 8.321713949044351e-07
signal O 0 1.5459305359399877e-05
peptide O 0 7.0858427534403745e-06
was O 0 7.263699899340281e-06
observed O 0 1.7076532685678103e-06
in O 0 7.125641445782094e-07
all O 0 1.3983981261844747e-06
affected O 0 1.6818627045722678e-05
individuals O 0 6.560183010151377e-06
. O 0 2.1907666450715624e-05

This O 0 8.337399049196392e-05
missense O 0 0.0005184581968933344
mutation O 0 0.00012995486031286418
, O 0 1.246411102329148e-05
which O 0 7.225479293992976e-06
replaces O 0 0.00023133499780669808
Ala O 0 0.005574649199843407
with O 0 9.5277655418613e-06
Thr O 0 0.009656389243900776
, O 0 2.047467887678067e-06
is O 0 6.40369421489595e-07
frequent O 0 3.3754065498214914e-06
among O 0 1.137336585088633e-05
FNDI B-Disease 1 0.9999995231628418
patients O 0 0.005269843153655529
and O 0 4.279069798940327e-06
is O 0 9.886510952128447e-07
thought O 0 1.7771977809388773e-06
to O 0 6.484290793196124e-07
reduce O 0 2.079658997899969e-06
the O 0 7.930871674943774e-07
efficiency O 0 3.0793637506576488e-06
of O 0 8.110256430882146e-07
cleavage O 0 0.0001250736677320674
by O 0 4.569031716528116e-06
signal O 0 0.00011639894364634529
peptidases O 0 0.000315212324494496
. O 0 1.0073229532281402e-05
. O 0 4.174237619736232e-05

Genetic O 0 0.0017760915216058493
heterogeneity O 0 0.0009002725128084421
of O 0 0.0001472936273785308
Saethre B-Disease 1 0.9945136308670044
- I-Disease 1 0.9997715353965759
Chotzen I-Disease 1 0.9999891519546509
syndrome I-Disease 1 0.9999996423721313
, O 0 2.701058292586822e-05
due O 0 2.0335392036940902e-05
to O 0 6.291174486250384e-06
TWIST O 0 0.00024286647385451943
and O 0 0.00010268698679283261
FGFR O 1 0.90231853723526
mutations O 0 0.0004613804048858583
. O 0 0.00010579917579889297

Thirty O 0 0.0014193252427503467
- O 0 0.0013228723546490073
two O 0 2.280016997247003e-05
unrelated O 0 0.00019192276522517204
patients O 0 0.0001182743872050196
with O 0 2.311923481101985e-06
features O 0 4.9965847210842185e-06
of O 0 1.14582499008975e-05
Saethre B-Disease 1 0.9995009899139404
- I-Disease 1 0.9999796152114868
Chotzen I-Disease 1 0.9999958276748657
syndrome I-Disease 1 0.9999995231628418
, O 0 1.6535017493879423e-05
a O 0 0.00010529564315220341
common O 0 0.0005877059884369373
autosomal B-Disease 1 0.879723310470581
dominant I-Disease 0 0.0518207885324955
condition I-Disease 0 0.054242346435785294
of O 0 3.7047313526272774e-05
craniosynostosis B-Disease 1 0.9999179840087891
and O 0 0.06003335490822792
limb B-Disease 1 0.9999264478683472
anomalies I-Disease 1 0.9597753286361694
, O 0 3.139143154839985e-05
were O 0 1.4320600712380838e-05
screened O 0 3.29209869960323e-05
for O 0 2.1569380805885885e-06
mutations O 0 2.4770812160568312e-05
in O 0 3.832528364000609e-06
TWIST O 0 0.00014362108777277172
, O 0 1.3245743502920959e-05
FGFR2 O 0 0.01325620524585247
, O 0 4.6409704737016e-06
and O 0 1.5112996152311098e-05
FGFR3 O 0 0.08632306009531021
. O 0 6.783362186979502e-05

Nine O 0 0.00029731629183515906
novel O 0 6.922816828591749e-05
and O 0 1.5747291399748065e-05
three O 0 1.1166423973918427e-05
recurrent O 0 0.000389460357837379
TWIST O 0 0.0016401276225224137
mutations O 0 0.0001525227853562683
were O 0 2.2884230929776095e-05
found O 0 1.3093675079289824e-05
in O 0 8.284463547170162e-06
12 O 0 0.00010208955791313201
families O 0 6.242737435968593e-05
. O 0 4.045031892019324e-05

Seven O 0 0.0004306385526433587
families O 0 0.00013785598275717348
were O 0 2.6777246603160165e-05
found O 0 8.391474693780765e-06
to O 0 1.5750750890219933e-06
have O 0 2.437149987599696e-06
the O 0 3.667799546747119e-06
FGFR3 O 0 0.02145976945757866
P250R O 0 0.00021976658899802715
mutation O 0 6.81118035572581e-06
, O 0 5.58362728497741e-07
and O 0 4.3269980665172625e-07
one O 0 5.982537345516903e-07
individual O 0 6.670081802440109e-07
was O 0 1.4857582755212206e-05
found O 0 9.976851060855552e-07
to O 0 4.376367144232063e-07
have O 0 1.974474344024202e-06
an O 0 3.0247208542277804e-06
FGFR2 O 0 0.004072125535458326
VV269 O 0 0.00019726193568203598
- O 0 0.0001701934088487178
270 O 0 7.036088209133595e-05
deletion O 0 0.0002972865186166018
. O 0 8.730171975912526e-05

To O 0 6.962521001696587e-05
date O 0 2.1366518922150135e-05
, O 0 2.7399908049119404e-06
our O 0 2.10244638765289e-06
detection O 0 7.399245987471659e-06
rate O 0 2.6910079213848803e-06
for O 0 9.835924856815836e-07
TWIST O 0 4.572429315885529e-05
or O 0 1.071134192898171e-05
FGFR O 0 0.10158852487802505
mutations O 0 1.6316096662194468e-05
is O 0 1.3471075135385036e-06
68 O 0 9.137032975559123e-06
% O 0 1.1853926480398513e-06
in O 0 1.967020580195822e-06
our O 0 2.3777307433192618e-05
Saethre B-Disease 1 0.8132802248001099
- I-Disease 1 0.9997751116752625
Chotzen I-Disease 1 0.9999891519546509
syndrome I-Disease 1 0.9999996423721313
patients O 0 0.0204627625644207
, O 0 1.8941639154945733e-06
including O 0 1.3158517049305374e-06
our O 0 7.684595402679406e-06
five O 0 3.1407813366968185e-05
patients O 0 0.0004336529818829149
elsewhere O 0 2.2930544218979776e-05
reported O 0 3.6607896618079394e-05
with O 0 1.4219542208593339e-05
TWIST O 0 0.0037576372269541025
mutations O 0 0.00050782022299245
. O 0 8.709026587894186e-05

More O 0 3.903330798493698e-05
than O 0 9.18036403163569e-06
35 O 0 9.950996172847226e-06
different O 0 1.6352108787032194e-06
TWIST O 0 4.517502384260297e-05
mutations O 0 1.4182568520482164e-05
are O 0 1.0449825822433922e-06
now O 0 1.7917567447511829e-06
known O 0 1.127699533753912e-06
in O 0 1.881801495073887e-06
the O 0 4.864037691731937e-06
literature O 0 1.6608395526418462e-05
. O 0 4.363896732684225e-05

The O 0 3.947973164031282e-05
most O 0 7.648550308658741e-06
common O 0 3.5517987271305174e-06
phenotypic O 0 9.623834557714872e-06
features O 0 7.0768946898169816e-06
, O 0 3.3712437925714767e-06
present O 0 1.2194373084639665e-06
in O 0 7.341570267271891e-07
more O 0 2.415850417492038e-07
than O 0 2.8400600626810046e-07
a O 0 1.348316914118186e-06
third O 0 4.262561560608447e-06
of O 0 8.183178579201922e-07
our O 0 2.3162834622780792e-05
patients O 0 3.172409560647793e-05
with O 0 4.81376082461793e-06
TWIST O 0 0.00045861356193199754
mutations O 0 3.624731471063569e-05
, O 0 1.4172628652886488e-06
are O 0 8.736122936170432e-07
coronal B-Disease 0 0.00018052766972687095
synostosis I-Disease 0 0.017876796424388885
, O 0 9.161857633444015e-06
brachycephaly B-Disease 0 0.0006536522996611893
, O 0 8.065303518378641e-06
low B-Disease 0 0.00018535189155954868
frontal I-Disease 1 0.753642201423645
hairline I-Disease 1 0.9999932050704956
, O 0 0.0008606627234257758
facial B-Disease 1 0.9944461584091187
asymmetry I-Disease 0 0.29285749793052673
, O 0 0.0006521577015519142
ptosis B-Disease 1 0.9889206290245056
, O 0 4.8522451834287494e-05
hypertelorism B-Disease 0 0.018107833340764046
, O 0 6.9348820943559986e-06
broad B-Disease 0 2.5688954337965697e-05
great I-Disease 0 3.800099148065783e-05
toes I-Disease 0 0.16019588708877563
, O 0 7.836240001779515e-06
and O 0 1.7038764781318605e-05
clinodactyly B-Disease 0 0.008441785350441933
. O 0 6.27969711786136e-05

Significant O 0 0.0002452946500852704
intra O 0 0.00043116207234561443
- O 0 0.0007461437489837408
and O 0 1.9390274246688932e-05
interfamilial O 0 0.0003669300931505859
phenotypic O 0 4.136875941185281e-05
variability O 0 5.229184534982778e-05
is O 0 2.7002547540178057e-06
present O 0 2.78379479823343e-06
for O 0 2.1206342353252694e-06
either O 0 1.3531329386751167e-05
TWIST O 0 0.0008422862738370895
mutations O 0 0.00018617711612023413
or O 0 3.6997327697463334e-05
FGFR O 0 0.2472594827413559
mutations O 0 0.0005180387524887919
. O 0 9.095248969970271e-05

The O 0 5.4536409152206033e-05
overlap O 0 5.605486876447685e-05
in O 0 8.639527550258208e-06
clinical O 0 3.718791049323045e-05
features O 0 3.233781171729788e-06
and O 0 2.2662445644527907e-06
the O 0 1.6927441492953221e-06
presence O 0 1.9788931240327656e-06
, O 0 6.248287718335632e-07
in O 0 4.043481567350682e-07
the O 0 4.7035325678734807e-07
same O 0 9.864453431873699e-07
genes O 0 1.2687071375694359e-06
, O 0 2.676922576938523e-07
of O 0 2.0922543342294375e-07
mutations O 0 1.5897752518867492e-06
for O 0 2.0692223756668682e-07
more O 0 2.3465165099878504e-07
than O 0 3.274186042290239e-07
one O 0 2.475446763128275e-06
craniosynostotic B-Disease 0 0.026157069951295853
condition I-Disease 0 0.00014064415881875902
- O 0 2.679226417967584e-05
such O 0 5.400855229709123e-07
as O 0 2.0632353425753536e-06
Saethre B-Disease 0 0.00047617306699976325
- I-Disease 0 0.00018240504141431302
Chotzen I-Disease 0 0.00017844969988800585
, I-Disease 0 3.3435894692956936e-06
Crouzon I-Disease 0 0.0001258386910194531
, I-Disease 0 3.407549229450524e-06
and I-Disease 0 1.887496910057962e-05
Pfeiffer I-Disease 0 0.335323691368103
syndromes I-Disease 0 0.23223870992660522
- O 0 3.800512058660388e-05
support O 0 1.6134141560542048e-06
the O 0 1.1597520597206312e-06
hypothesis O 0 3.5902992294722935e-06
that O 0 6.202300255608861e-07
TWIST O 0 1.1329630979162175e-05
and O 0 3.5591667710832553e-06
FGFRs O 0 0.00018257764168083668
are O 0 3.4564428119665536e-07
components O 0 9.616326224204386e-07
of O 0 2.646671646289178e-07
the O 0 9.670208100942546e-07
same O 0 2.1640030354319606e-06
molecular O 0 2.2918433387530968e-05
pathway O 0 4.970995178155135e-06
involved O 0 1.5669801314288634e-06
in O 0 7.109520652193169e-07
the O 0 7.966401085468533e-07
modulation O 0 6.739902346453164e-06
of O 0 3.2104217098094523e-06
craniofacial O 1 0.9791897535324097
and O 0 0.000325981731293723
limb O 1 0.917344868183136
development O 0 1.0615505743771791e-05
in O 0 1.5233692465699278e-05
humans O 0 1.8589169485494494e-05
. O 0 6.917898645042442e-06
. O 0 2.6746138246380724e-05

Mutation O 0 0.0010201329132542014
analysis O 0 0.00015484927280340344
of O 0 7.42601987440139e-05
UBE3A O 1 0.9863161444664001
in O 1 0.9907451868057251
Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
patients O 1 0.9999829530715942
. O 0 0.0016442654887214303

Angelman B-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 1 0.6847277879714966
AS B-Disease 1 0.997739315032959
) O 0 3.885881960741244e-05
is O 0 6.217559985088883e-06
caused O 0 3.228869172744453e-05
by O 0 3.5698478768608766e-06
chromosome O 0 0.0005411520833149552
15q11 O 0 0.0003695010091178119
- O 0 0.00022266524320002645
q13 O 0 5.64749825571198e-05
deletions O 0 1.4489126442640554e-05
of O 0 2.5730089419084834e-06
maternal O 0 0.00019059768237639219
origin O 0 6.079952981963288e-06
, O 0 2.113023356287158e-06
by O 0 2.611445097500109e-06
paternal O 0 0.0024350581225007772
uniparental B-Disease 1 0.9192256927490234
disomy I-Disease 1 0.8185428977012634
( O 0 2.115521056111902e-05
UPD B-Disease 1 0.999405026435852
) O 0 2.68866074293328e-06
15 O 0 2.728644858507323e-06
, O 0 7.294225383702724e-07
by O 0 1.6380936358473264e-06
imprinting O 0 0.0750548243522644
defects O 1 0.8433998227119446
, O 0 2.0712927835120354e-06
and O 0 1.1851461749756709e-06
by O 0 1.3321651977094007e-06
mutations O 0 8.465277460345533e-06
in O 0 3.054639364563627e-06
the O 0 1.8778893718263134e-05
UBE3A O 0 0.006185015197843313
gene O 0 0.00014328760153148323
. O 0 6.847430631751195e-05

UBE3A O 0 0.008180915378034115
encodes O 0 0.0005496303201653063
a O 0 6.862373265903443e-05
ubiquitin O 0 9.303035767516121e-05
- O 0 9.52682676143013e-05
protein O 0 1.1422856005083304e-05
ligase O 0 8.840940608934034e-06
and O 0 1.912741254272987e-06
shows O 0 1.316420457442291e-05
brain O 0 0.000955241615884006
- O 0 0.00012402661377564073
specific O 0 1.3109717656334396e-05
imprinting O 0 0.0008016996434889734
. O 0 7.060614007059485e-05

Here O 0 0.00017642555758357048
we O 0 4.8791294830152765e-05
describe O 0 6.829600897617638e-05
UBE3A O 0 0.0007721676374785602
coding O 0 0.0001529228175058961
- O 0 0.0005439642700366676
region O 0 2.5897001250996254e-05
mutations O 0 3.785194348893128e-05
detected O 0 2.2605509002460167e-05
by O 0 2.354667913095909e-06
SSCP O 0 0.0004369381058495492
analysis O 0 2.224623358415556e-06
in O 0 3.436394763411954e-06
13 O 0 7.285614992724732e-05
AS B-Disease 0 0.02338479831814766
individuals O 0 3.4788322409440298e-06
or O 0 6.229679911484709e-06
families O 0 4.214612636133097e-05
. O 0 3.416576873860322e-05

Two O 0 0.00022965556127019227
identical O 0 0.00023822419461794198
de O 0 0.00015162129420787096
novo O 0 9.860755380941555e-05
5 O 0 1.680532113823574e-05
- O 0 3.410788849578239e-05
bp O 0 4.917704063700512e-05
duplications O 0 2.097089236485772e-05
in O 0 4.398343662614934e-06
exon O 0 5.083351788925938e-05
16 O 0 2.0912399122607894e-05
were O 0 1.7474139895057306e-05
found O 0 3.5195855161873624e-05
. O 0 4.8355141188949347e-05

Among O 0 4.4847431126981974e-05
the O 0 1.0014036888605915e-05
other O 0 1.993945943468134e-06
11 O 0 7.823226042091846e-06
unique O 0 3.1324416340794414e-06
mutations O 0 2.407938336546067e-05
, O 0 1.4874020735078375e-06
8 O 0 3.3122169043053873e-06
were O 0 1.6389359416280058e-06
small O 0 1.6835257383718272e-06
deletions O 0 1.0866186130442657e-05
or O 0 3.844256752927322e-06
insertions O 0 4.585267015499994e-05
predicted O 0 7.064944657031447e-05
to O 0 7.804002052580472e-06
cause O 0 5.7902780099539086e-05
frameshifts O 0 0.012835820205509663
, O 0 3.3960002383537358e-06
1 O 0 3.501275159578654e-06
was O 0 6.889791620778851e-06
a O 0 1.3215624221629696e-06
mutation O 0 2.0247050542820944e-06
to O 0 4.441149030753877e-07
a O 0 1.6136173144332133e-06
stop O 0 4.844916929869214e-06
codon O 0 4.65839684693492e-06
, O 0 7.83554469308001e-07
1 O 0 1.0242559937978513e-06
was O 0 4.102626007806975e-06
a O 0 2.68988424068084e-06
missense O 0 2.0961215341230854e-05
mutation O 0 6.82893005432561e-06
, O 0 1.1239887953706784e-06
and O 0 1.0968361721097608e-06
1 O 0 2.9748239285254385e-06
was O 0 5.1522336434572935e-05
predicted O 0 7.797774742357433e-06
to O 0 6.925199045326735e-07
cause O 0 2.592274540802464e-06
insertion O 0 3.7273500765877543e-06
of O 0 5.92242088259809e-07
an O 0 5.47668787476141e-06
isoleucine O 0 0.009759919717907906
in O 0 2.1040550564066507e-06
the O 0 1.709333105281985e-06
hect O 0 5.461489126901142e-05
domain O 0 1.1533514907569042e-06
of O 0 2.883142542486894e-07
the O 0 2.1096445834700717e-06
UBE3A O 0 0.00020299333846196532
protein O 0 3.214606522305985e-06
, O 0 5.034747232457448e-07
which O 0 2.9906973963989003e-07
functions O 0 6.300261361502635e-07
in O 0 1.463532385059807e-06
E2 O 0 8.167946361936629e-05
binding O 0 6.325212325464236e-06
and O 0 3.3168005302286474e-06
ubiquitin O 0 5.728162796003744e-05
transfer O 0 3.8890775613253936e-05
. O 0 5.912452979828231e-05

Eight O 0 0.00015084359620232135
of O 0 1.3408091035671532e-05
the O 0 1.4882370123814326e-05
cases O 0 1.0587196811684407e-05
were O 0 7.039355114102364e-05
familial O 0 0.004754784516990185
, O 0 7.756307240924798e-06
and O 0 3.4701672575465636e-06
five O 0 9.310768291470595e-06
were O 0 3.255074261687696e-05
sporadic O 0 0.00018915440887212753
. O 0 4.756075577461161e-05

In O 0 9.658889030106366e-05
two O 0 3.4629396395757794e-05
familial O 0 0.0371151939034462
cases O 0 2.1265772375045344e-05
and O 0 8.64841331349453e-06
one O 0 8.790145329840016e-06
sporadic O 0 0.00023472902830690145
case O 0 1.8642731447471306e-05
, O 0 9.492991921433713e-06
mosaicism O 0 0.00027573827537707984
for O 0 4.027639079140499e-06
UBE3A O 0 0.0015437845140695572
mutations O 0 3.596222450141795e-05
was O 0 8.347112452611327e-05
detected O 0 1.762278043315746e-05
in O 0 1.4173359659253038e-06
the O 0 1.8384026816420374e-06
mother O 0 2.261825284222141e-05
of O 0 4.358785758995509e-07
three O 0 4.474240995477885e-06
AS B-Disease 0 0.354535847902298
sons O 0 0.10454865545034409
, O 0 9.791815500648227e-07
in O 0 5.883582616661442e-07
the O 0 1.2543066532089142e-06
maternal O 0 7.940609793877229e-05
grandfather O 0 0.0001100626977859065
of O 0 2.320342673556297e-07
two O 0 1.0227527127426583e-06
AS B-Disease 0 0.006186279002577066
first O 0 5.279926426737802e-06
cousins O 0 0.00014016219938639551
, O 0 7.158451467148552e-07
and O 0 4.889412252850889e-07
in O 0 6.603044084840803e-07
the O 0 1.6395142665714957e-06
mother O 0 2.8735134037560783e-05
of O 0 6.883486776132486e-07
an O 0 1.5526416973443702e-05
AS B-Disease 0 0.342206209897995
daughter O 0 0.4443366825580597
. O 0 7.558175275335088e-05

The O 0 3.81510253646411e-05
frequencies O 0 3.259189907112159e-05
with O 0 4.249945959600154e-06
which O 0 3.0255864658101927e-06
we O 0 3.1275046694645425e-06
detected O 0 1.5383098798338324e-05
mutations O 0 5.970925485598855e-06
were O 0 3.3383098525519017e-06
5 O 0 2.29291708819801e-06
( O 0 4.135889639655943e-07
14 O 0 2.271790663144202e-06
% O 0 4.5172646423452534e-07
) O 0 2.0035938064211223e-07
of O 0 2.18140300489722e-07
35 O 0 2.2544620605913224e-06
in O 0 9.860183354248875e-07
sporadic O 0 2.810038313327823e-05
cases O 0 1.5313263475036365e-06
and O 0 3.3456594792369287e-06
8 O 0 1.516361407993827e-05
( O 0 3.735751761269057e-07
80 O 0 9.920087222781149e-07
% O 0 5.420820343715604e-07
) O 0 2.14185632785302e-07
of O 0 1.9400913231493178e-07
10 O 0 2.0870759271929273e-06
in O 0 6.281917649175739e-06
familial O 0 0.022865451872348785
cases O 0 1.663378679950256e-05
. O 0 1.4557590475305915e-05
. O 0 5.655475615640171e-05

The O 0 0.0008035359787754714
hemochromatosis B-Disease 1 0.9999855756759644
845 O 0 0.06281516700983047
G O 0 0.19201664626598358
- O 0 0.0008533679647371173
- O 0 0.00015023956075310707
> O 0 1.7703954654280096e-05
A O 0 3.4457802939868998e-06
and O 0 1.475675162510015e-06
187 O 0 8.032197911234107e-06
C O 0 0.00011756643652915955
- O 0 0.00019193885964341462
- O 0 0.0011906218715012074
> O 0 0.0001632522325962782
G O 0 0.0038067649584263563
mutations O 0 1.3627445696329232e-05
: O 0 2.5510146315355087e-06
prevalence O 0 1.931385304487776e-05
in O 0 3.79727089239168e-06
non O 0 2.9725282729486935e-05
- O 0 0.0316745787858963
Caucasian O 0 0.0006800955743528903
populations O 0 0.00010195918730460107
. O 0 7.653521606698632e-05

Hemochromatosis B-Disease 1 0.9992590546607971
, O 0 0.002008314011618495
the O 0 0.02039100043475628
inherited B-Disease 1 0.9999998807907104
disorder I-Disease 1 0.9999995231628418
of I-Disease 0 9.444621537113562e-05
iron I-Disease 1 0.9971063733100891
metabolism I-Disease 0 0.044082362204790115
, O 0 1.6664431313984096e-05
leads O 0 2.70784930762602e-05
, O 0 7.371038918790873e-06
if O 0 6.0427259995776694e-06
untreated O 0 0.001441647531464696
, O 0 1.743748157423397e-06
to O 0 2.869768877644674e-06
progressive O 0 0.00041673617670312524
iron B-Disease 1 0.994437575340271
overload I-Disease 1 0.9351433515548706
and O 0 0.00037035407149232924
premature B-Disease 0 0.34833696484565735
death I-Disease 0 0.0012601142516359687
. O 0 0.00010336219565942883

The O 0 0.0012016692198812962
hemochromatosis B-Disease 1 0.9999847412109375
gene O 0 0.0006696254131384194
, O 0 4.502380397752859e-05
HFE O 0 0.03725142404437065
, O 0 1.037327092490159e-05
recently O 0 2.8755312087014318e-05
has O 0 2.3759077976137633e-06
been O 0 3.798933676080196e-06
identified O 0 3.5655439205584116e-06
, O 0 6.164978003653232e-07
and O 0 4.2915280573652126e-07
characterization O 0 1.9002214912688942e-06
of O 0 3.122987379811093e-07
this O 0 6.763899591533118e-07
gene O 0 2.3395189145958284e-06
has O 0 1.1463301916592172e-06
shown O 0 8.080302222879254e-07
that O 0 2.2374183572537731e-07
it O 0 2.0505444808804896e-07
contains O 0 1.939367990644314e-07
two O 0 6.494403237411461e-07
mutations O 0 5.000999408366624e-06
that O 0 4.5387434965959983e-07
result O 0 1.4357207192006172e-06
in O 0 1.2035684449074324e-06
amino O 0 5.129887085786322e-06
acid O 0 3.7906279430899303e-06
substitutions O 0 3.11447092826711e-06
- O 0 9.223469533026218e-06
cDNA O 0 9.069146472029388e-06
nucleotides O 0 1.020892432279652e-05
845 O 0 2.75939964922145e-05
G O 0 0.00018506721244193614
- O 0 0.00012478478311095387
- O 0 0.00027975987177342176
> O 0 1.3932816727901809e-05
A O 0 4.501805051404517e-06
( O 0 1.1467379863461247e-06
C282Y O 0 1.1267039553786162e-05
) O 0 5.427291398518719e-07
and O 0 7.309991474357957e-07
187 O 0 5.200711257202784e-06
C O 0 5.8161669585388154e-05
- O 0 0.00040281188557855785
- O 0 0.009222711436450481
> O 0 0.0004219705588184297
G O 0 0.04574432969093323
( O 0 1.0951555850624572e-05
H63D O 0 0.0018780248938128352
) O 0 1.670918209129013e-05
. O 0 2.9718792575295083e-05

Although O 0 0.018868524581193924
hemochromatosis B-Disease 1 0.9999985694885254
is O 0 4.5096858229953796e-05
common O 0 1.0652907803887501e-05
in O 0 1.3562852473114617e-05
Caucasians O 0 0.00012284536205697805
, O 0 6.701166512357304e-06
affecting O 0 2.5020623070304282e-05
> O 0 0.00032599165569990873
= O 0 0.00021460987045429647
1 O 0 2.8732631562888855e-06
/ O 0 3.86919737138669e-06
300 O 0 1.1581340686461772e-06
individuals O 0 3.7940603192510025e-07
of O 0 2.713992159897316e-07
northern O 0 1.2768688293363084e-06
European O 0 1.5102086763363332e-06
origin O 0 1.2646120239878655e-06
, O 0 1.0136348009837093e-06
it O 0 7.878020937823749e-07
has O 0 1.6748061852922547e-06
not O 0 8.904146966415283e-07
been O 0 1.1393722161301412e-06
recognized O 0 6.98641372309794e-07
in O 0 8.284165460281656e-07
other O 0 1.591935642863973e-06
populations O 0 2.4705654141143896e-05
. O 0 2.3935055651236326e-05

The O 0 6.66807172819972e-05
present O 0 1.757250356604345e-05
study O 0 6.669135927950265e-06
used O 0 4.0738837014941964e-06
PCR O 0 2.9107359296176583e-05
and O 0 2.2332662865665043e-06
restriction O 0 4.80535800306825e-06
- O 0 2.3380323909805156e-05
enzyme O 0 5.1101792450936045e-06
digestion O 0 3.712627631102805e-06
to O 0 5.185153781894769e-07
analyze O 0 1.4683416793559445e-06
the O 0 3.4806598137038236e-07
frequency O 0 1.115695113185211e-06
of O 0 4.823727977054659e-07
the O 0 1.909926822918351e-06
845 O 0 5.862099351361394e-05
G O 0 0.003614208195358515
- O 0 0.00011504105350468308
- O 0 3.6597150028683245e-05
> O 0 7.73009924159851e-06
A O 0 2.5767144506971817e-06
and O 0 1.4838715287623927e-06
187 O 0 8.260512004198972e-06
C O 0 4.833292405237444e-05
- O 0 4.2637177102733403e-05
- O 0 0.0001270054781343788
> O 0 5.873239933862351e-05
G O 0 0.000177660898771137
mutations O 0 7.783754881529603e-06
in O 0 3.468373961368343e-06
HLA O 0 0.00017831975128501654
- O 0 3.0747611162951216e-05
typed O 0 1.2780658835254144e-05
samples O 0 3.0487694857583847e-06
from O 0 1.36998892230622e-06
non O 0 3.2417351576441433e-06
- O 0 3.9791899325791746e-05
Caucasian O 0 1.883095501398202e-05
populations O 0 2.416517418168951e-06
, O 0 5.498278028426284e-07
comprising O 0 1.284153313463321e-06
Australian O 0 1.932768327606027e-06
Aboriginal O 0 2.317283133379533e-06
, O 0 7.824165209058265e-07
Chinese O 0 5.774710984951525e-07
, O 0 8.531155231139564e-07
and O 0 2.4595440208941e-06
Pacific O 0 5.2413113735383376e-05
Islanders O 0 0.00021755605121143162
. O 0 5.987188342260197e-05

Results O 0 0.0009094358538277447
showed O 0 0.0001443897926947102
that O 0 5.6564285841886885e-06
the O 0 6.815143933636136e-06
845 O 0 0.0004038856422994286
G O 0 0.07166922837495804
- O 0 0.002224021591246128
- O 0 0.0008404884138144553
> O 0 3.2788957469165325e-05
A O 0 1.4414923498407006e-05
mutation O 0 1.7064036001102068e-05
was O 0 1.979691478481982e-05
present O 0 1.0138495554201654e-06
in O 0 9.198734574056289e-07
these O 0 3.146103892959218e-07
populations O 0 1.0011525546360645e-06
( O 0 2.7011643055629975e-07
allele O 0 1.7411591670679627e-06
frequency O 0 2.86206682176271e-06
0 O 0 4.217206878820434e-06
. O 0 4.0690434843781986e-07
32 O 0 2.7629585019894876e-06
% O 0 7.088601137184014e-07
) O 0 3.915183981462178e-07
, O 0 4.3890437950722117e-07
and O 0 8.102139759103011e-07
, O 0 1.0319556622562231e-06
furthermore O 0 1.8514876956032822e-06
, O 0 5.683273798240407e-07
it O 0 8.228222441175603e-07
was O 0 1.977061401703395e-05
always O 0 1.5730200857433374e-06
seen O 0 1.2980049177713227e-06
in O 0 9.204070465784753e-07
conjunction O 0 4.808874564332655e-06
with O 0 9.369815415993799e-06
HLA O 0 0.013871349394321442
haplotypes O 0 2.540324021538254e-05
common O 0 3.2868331345525803e-06
in O 0 4.609695679391734e-06
Caucasians O 0 2.9023261959082447e-05
, O 0 3.0690700896229828e-06
suggesting O 0 4.862103651248617e-06
that O 0 1.1661836651910562e-06
845 O 0 5.895955837331712e-05
G O 0 0.01031037699431181
- O 0 0.003323204815387726
- O 0 0.0027209515683352947
> O 0 3.332330015837215e-05
A O 0 2.3575090381200425e-05
may O 0 2.509139994799625e-05
have O 0 1.5792836620676098e-06
been O 0 1.36325718358421e-06
introduced O 0 1.1622100828390103e-06
into O 0 9.075124580704141e-07
these O 0 7.540338629041798e-07
populations O 0 5.000884812034201e-06
by O 0 5.058699571236502e-06
Caucasian O 0 0.00016380952729377896
admixture O 0 0.0006136218435131013
. O 0 0.0001601035619387403

187 O 0 0.0010999190853908658
C O 0 0.0013049764093011618
- O 0 0.0007667807512916625
- O 0 0.0007055965252220631
> O 0 0.00019604837871156633
G O 0 0.002981474855914712
was O 0 1.1832052223326173e-05
present O 0 1.177308035948954e-06
at O 0 1.8198842326455633e-06
an O 0 9.507230060989968e-07
allele O 0 6.187121925904648e-06
frequency O 0 5.5323798733297735e-06
of O 0 1.9750657429540297e-06
2 O 0 4.094940231880173e-05
. O 0 3.234518590033986e-05

68 O 0 0.0016259134281426668
% O 0 5.301842247718014e-05
in O 0 3.967841166740982e-06
the O 0 1.4479253422905458e-06
two O 0 1.8061351738651865e-06
populations O 0 4.810204700333998e-06
analyzed O 0 9.802432032302022e-06
( O 0 1.3839515986546758e-06
Australian O 0 2.6886939394898945e-06
Aboriginal O 0 4.300728051020997e-06
and O 0 2.864958560166997e-06
Chinese O 0 7.000432105996879e-06
) O 0 1.2175745723652653e-05
. O 0 2.7737625714507885e-05

In O 0 6.487957580247894e-05
the O 0 1.2667686860368121e-05
Australian O 0 1.4359781744133215e-05
Aboriginal O 0 1.0148865840164945e-05
samples O 0 6.407337423297577e-06
, O 0 1.4643478607467841e-06
187 O 0 6.653381205978803e-06
C O 0 4.500603608903475e-05
- O 0 6.602595385629684e-05
- O 0 0.0010270557831972837
> O 0 0.0001329420047113672
G O 0 0.006005300674587488
was O 0 2.4797474907245487e-05
found O 0 1.9175702163920505e-06
to O 0 8.233427593040687e-07
be O 0 1.5643446431568009e-06
associated O 0 2.4912790195230627e-06
with O 0 6.151755314931506e-06
HLA O 0 0.009444883093237877
haplotypes O 0 1.676602005318273e-05
common O 0 2.031842541327933e-06
in O 0 6.057774044165853e-06
Caucasians O 0 3.0368250008905306e-05
, O 0 2.00886415768764e-06
suggesting O 0 4.494443601288367e-06
that O 0 5.550170385504316e-07
it O 0 6.51585594368953e-07
was O 0 4.52238236903213e-06
introduced O 0 1.7405300241080113e-06
by O 0 1.5695226238676696e-06
recent O 0 7.331826964218635e-06
admixture O 0 0.00013495737221091986
. O 0 6.248551653698087e-05

In O 0 7.344671030296013e-05
the O 0 1.4666324204881676e-05
Chinese O 0 7.00711188983405e-06
samples O 0 1.1868419278471265e-05
analyzed O 0 1.7508000382804312e-05
, O 0 2.7699634301825427e-06
187 O 0 9.348064850200899e-06
C O 0 4.345014531281777e-05
- O 0 9.256241173716262e-05
- O 0 0.0004714942770078778
> O 0 0.00010039517655968666
G O 0 0.0029882905073463917
was O 0 2.838190266629681e-05
present O 0 1.1209241392862168e-06
in O 0 1.810237563404371e-06
association O 0 2.1186290268815355e-06
with O 0 5.915128440392436e-07
a O 0 1.7362808648613282e-06
wide O 0 2.4620856038382044e-06
variety O 0 8.626327598904027e-07
of O 0 1.6420508472947404e-06
HLA O 0 0.03990038111805916
haplotypes O 0 3.698201180668548e-05
, O 0 3.04733316625061e-06
showing O 0 1.4259764611779246e-05
this O 0 8.843832119964645e-07
mutation O 0 4.151433586230269e-06
to O 0 8.558576496398018e-07
be O 0 1.031020133268612e-06
widespread O 0 2.426181254122639e-06
and O 0 3.800618742388906e-06
likely O 0 4.470215571927838e-06
to O 0 7.487233233405277e-07
predate O 0 1.2700515071628615e-05
the O 0 7.939324859762564e-07
more O 0 5.416453063844529e-07
genetically O 0 4.527932105702348e-06
restricted O 0 4.319994786783354e-06
845 O 0 6.605233647860587e-05
G O 0 0.010442109778523445
- O 0 0.0030475088860839605
- O 0 0.0051055774092674255
> O 0 0.00015095784328877926
A O 0 7.057577749947086e-05
mutation O 0 0.00018737977370619774
. O 0 9.310871973866597e-05

Genotype O 0 0.04992198199033737
- O 0 0.055153269320726395
phenotype O 0 0.009375082328915596
correlations O 0 0.0017606756882742047
in O 0 0.0018404751317575574
attenuated B-Disease 1 0.9997648596763611
adenomatous I-Disease 1 0.9999977350234985
polyposis I-Disease 1 0.9999939203262329
coli I-Disease 1 0.9999086856842041
. O 0 0.00153939554002136

Germ O 0 0.026432182639837265
- O 0 0.0015139990719035268
line O 0 0.0001006517923087813
mutations O 0 3.334335997351445e-05
of O 0 3.6973740407120204e-06
the O 0 2.3890748707344756e-05
tumor B-Disease 0 0.1811767816543579
suppressor O 0 0.0007852992275729775
APC O 0 0.0001655725500313565
are O 0 4.8350857468904e-06
implicated O 0 0.00011220489250263199
in O 0 0.00040604922105558217
attenuated B-Disease 1 0.9998038411140442
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999996423721313
coli I-Disease 1 0.9999974966049194
( O 0 0.0031691561453044415
AAPC B-Disease 1 0.9999969005584717
) O 0 1.5568477465421893e-05
, O 0 2.7471835437609116e-06
a O 0 9.05510205484461e-06
variant O 0 0.00022155512124300003
of O 0 0.0002618915168568492
familial B-Disease 1 0.9999998807907104
adenomatous I-Disease 1 0.9999994039535522
polyposis I-Disease 1 0.9999998807907104
( O 0 0.0019865941721946
FAP B-Disease 0 0.1785280704498291
) O 0 0.0001036933099385351
. O 0 0.00012231306754983962

AAPC B-Disease 1 0.9999597072601318
is O 0 7.618263771291822e-05
recognized O 0 1.5101514691195916e-05
by O 0 1.9239430457673734e-06
the O 0 1.5599439393554348e-06
occurrence O 0 5.802179657621309e-06
of O 0 1.716586325528624e-06
< O 0 0.00012187601532787085
100 O 0 1.3326148291525897e-05
colonic B-Disease 0 0.001168526359833777
adenomas I-Disease 0 0.0013495814055204391
and O 0 5.923284334130585e-06
a O 0 2.2115098545327783e-05
later O 0 0.0006652864976786077
onset O 1 0.9467839598655701
of O 0 0.3920905292034149
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 8.709425310371444e-05
age O 0 0.0009750494500622153
> O 0 0.00016799151489976794
40 O 0 1.1232066754018888e-05
years O 0 1.7135593225248158e-05
) O 0 8.169889952114318e-06
. O 0 2.3262828108272515e-05

The O 0 6.139633478596807e-05
aim O 0 3.846347681246698e-05
of O 0 2.174184601244633e-06
this O 0 1.2109450153729995e-06
study O 0 2.66552751782001e-06
was O 0 8.268819328804966e-06
to O 0 2.128799906131462e-06
assess O 0 5.735755621572025e-05
genotype O 0 0.0007055554888211191
- O 0 0.008181693963706493
phenotype O 0 0.0007523878593929112
correlations O 0 0.00017425698752049357
in O 0 0.00018122755864169449
AAPC B-Disease 1 0.9999715089797974
families O 0 0.0006397197721526027
. O 0 0.0001465028035454452

By O 0 8.466058352496475e-05
protein O 0 0.00010047706018667668
- O 0 0.00014758268662262708
truncation O 0 9.477679850533605e-05
test O 0 5.3173564083408564e-05
( O 0 4.749826530314749e-06
PTT O 0 2.6351182896178216e-05
) O 0 1.1775258599300287e-06
assay O 0 6.913282049936242e-06
, O 0 7.934101518003445e-07
the O 0 3.737768849987333e-07
entire O 0 2.647307610459393e-06
coding O 0 5.281537596601993e-06
region O 0 1.1877757515321719e-06
of O 0 3.559923698048806e-07
the O 0 1.7758492276698234e-06
APC B-Disease 0 4.674901356338523e-05
gene O 0 4.830449142900761e-06
was O 0 1.3594165466201957e-05
screened O 0 1.1167147931701038e-05
in O 0 3.1808719995751744e-06
affected O 0 1.486261226091301e-05
individuals O 0 1.7771029661162174e-06
from O 0 5.314555437507806e-06
11 O 0 0.0009761480032466352
AAPC B-Disease 1 0.9998263716697693
kindreds O 0 0.0002218001027358696
, O 0 3.0262040127126966e-06
and O 0 1.2061848337907577e-06
their O 0 2.6633804282027995e-06
phenotypic O 0 1.7441108866478316e-05
differences O 0 1.8400465705781244e-05
were O 0 6.993869465077296e-05
examined O 0 0.0002953285293187946
. O 0 6.540729373227805e-05

Five O 0 0.000204005409614183
novel O 0 0.0001270711509278044
germ O 0 0.0012324366252869368
- O 0 0.0003501691098790616
line O 0 8.020065433811396e-05
APC B-Disease 0 0.0001214405128848739
mutations O 0 1.2831829735659994e-05
were O 0 5.747959676227765e-06
identified O 0 5.620938281936105e-06
in O 0 3.1950855827744817e-06
seven O 0 2.4707516786293127e-05
kindreds O 0 0.0005406906711868942
. O 0 7.997397915460169e-05

Mutations O 0 0.0015667419647797942
were O 0 8.170859655365348e-05
located O 0 3.1207207939587533e-05
in O 0 3.916176410712069e-06
three O 0 1.1126583103759913e-06
different O 0 3.8236316868278664e-07
regions O 0 1.0067209359476692e-06
of O 0 6.074320708648884e-07
the O 0 4.934579010296147e-06
APC B-Disease 0 9.336895891465247e-05
gene O 0 3.2723180538596353e-06
( O 0 5.871559665138193e-07
1 O 0 1.162866510640015e-06
) O 0 3.956819227823871e-07
at O 0 1.6181850241991924e-06
the O 0 6.712076583426096e-07
5 O 0 1.973561211343622e-06
end O 0 2.3505353965447284e-06
spanning O 0 3.0819726362096844e-06
exons O 0 7.092671239661286e-06
4 O 0 3.3233484373340616e-06
and O 0 1.4187747865435085e-06
5 O 0 3.048914777536993e-06
, O 0 9.751333891472314e-07
( O 0 4.344314561421925e-07
2 O 0 7.763913458802563e-07
) O 0 2.8189046474835777e-07
within O 0 3.068910245929146e-07
exon O 0 8.178051757568028e-06
9 O 0 1.0658884093572851e-05
, O 0 8.523234669155499e-07
and O 0 9.968671292881481e-07
( O 0 4.93389677558298e-07
3 O 0 1.0128088661076617e-06
) O 0 2.2470022997822525e-07
at O 0 7.206179475360841e-07
the O 0 5.114710575071513e-07
3 O 0 2.9514540074160323e-06
distal O 0 1.4384520000021439e-05
end O 0 2.7370761017664336e-06
of O 0 1.0270856591887423e-06
the O 0 1.487355893914355e-05
gene O 0 5.779024650109932e-05
. O 0 4.020373307866976e-05

Variability O 0 0.0007610106258653104
in O 0 3.807470420724712e-05
the O 0 1.0189354725298472e-05
number O 0 8.201263881346676e-06
of O 0 0.0004508520069066435
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
was O 1 0.763966977596283
most O 0 7.537213605246507e-06
apparent O 0 0.000829102355055511
in O 0 1.2893137864011806e-05
individuals O 0 2.0440011212485842e-06
with O 0 4.290527613193262e-06
mutations O 0 2.5820945666055195e-05
in O 0 2.2229141904972494e-06
region O 0 9.24634969123872e-06
1 O 0 5.032470653532073e-06
, O 0 8.580265671298548e-07
and O 0 1.4774183227928006e-06
upper O 0 0.012066390365362167
- O 1 0.9543663263320923
gastrointestinal O 0 0.0887981653213501
manifestations O 0 9.647115075495094e-05
were O 0 3.930219463654794e-05
more O 0 5.024960501032183e-06
severe O 1 0.5570480823516846
in O 0 4.1744646296137944e-05
them O 0 4.113143586437218e-05
. O 0 9.75172224570997e-05

In O 0 0.00012308174336794764
individuals O 0 2.1630832634400576e-05
with O 0 8.357500519196037e-06
mutations O 0 3.999982072855346e-05
in O 0 3.343656317156274e-06
either O 0 4.981739948561881e-06
region O 0 1.1453661500127055e-05
2 O 0 6.535623469972052e-06
or O 0 1.7414082549294108e-06
region O 0 2.341536855965387e-06
3 O 0 3.063289341298514e-06
, O 0 4.2048034742947493e-07
the O 0 4.312707062581467e-07
average O 0 2.6357347451266833e-06
number O 0 4.2996680349460803e-07
of O 0 5.891432124371931e-07
adenomas B-Disease 0 0.0001469502312829718
tended O 0 1.3102380762575194e-05
to O 0 1.4565689525625203e-06
be O 0 1.9321473700983915e-06
lower O 0 5.126752057549311e-06
than O 0 4.545786964627041e-07
those O 0 5.735801664741302e-07
in O 0 9.676942909209174e-07
individuals O 0 5.140447001394932e-07
with O 0 1.4129254850558937e-06
mutations O 0 1.0183905033045448e-05
in O 0 1.340740254818229e-06
region O 0 6.000306257192278e-06
1 O 0 4.413158421812113e-06
, O 0 1.6320777831424493e-06
although O 0 1.7421209577150876e-06
age O 0 1.6275193047476932e-05
at O 0 0.00044884218368679285
diagnosis O 1 0.9041270017623901
was O 0 0.00021661055507138371
similar O 0 3.092304905294441e-05
. O 0 5.500565021065995e-05

In O 0 0.0002200653834734112
all O 0 6.575067527592182e-05
AAPC B-Disease 1 0.999112069606781
kindreds O 0 0.000825443072244525
, O 0 6.931251846253872e-06
a O 0 5.171743396203965e-06
predominance O 0 6.410430796677247e-05
of O 0 9.855362804955803e-06
right O 0 0.16229327023029327
- O 1 0.9996517896652222
sided O 1 0.9999912977218628
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999996423721313
and O 0 0.2496890425682068
rectal B-Disease 1 0.9999812841415405
polyp I-Disease 1 0.999339759349823
sparing O 0 0.0208794753998518
was O 0 0.004107982385903597
observed O 0 0.00017589963681530207
. O 0 7.66556549933739e-05

No O 0 0.0035319384187459946
desmoid B-Disease 1 0.9809707999229431
tumors I-Disease 1 0.9999984502792358
were O 0 0.00018188956892117858
found O 0 2.6593230359139852e-05
in O 0 6.377521458489355e-06
these O 0 5.687704287993256e-06
kindreds O 0 0.0007051407592371106
. O 0 7.164923590607941e-05

Our O 0 0.00011883827392011881
data O 0 3.9107897464418784e-05
suggest O 0 1.4010815903020557e-05
that O 0 2.502009920135606e-06
, O 0 2.8274469059397234e-06
in O 0 1.3621443031297531e-05
AAPC B-Disease 1 0.9999783039093018
families O 0 2.5208464649040252e-05
, O 0 1.44876241847669e-06
the O 0 6.381101229635533e-07
location O 0 2.2370691112882923e-06
of O 0 5.90974877923145e-07
the O 0 1.10264663817361e-05
APC B-Disease 0 0.022137239575386047
mutation O 0 0.00010948810813715681
may O 0 8.14497034298256e-05
partially O 0 0.0002621448365971446
predict O 0 1.9448816601652652e-05
specific O 0 3.6896001347486163e-06
phenotypic O 0 4.3617830669973046e-05
expression O 0 5.766594404121861e-05
. O 0 5.579120261245407e-05

This O 0 3.847554762614891e-05
should O 0 1.0929154996119905e-05
help O 0 4.708887445303844e-06
in O 0 1.0425200116515043e-06
the O 0 8.680182759235322e-07
design O 0 4.056786565342918e-06
of O 0 2.3203037926577963e-06
tailored O 0 0.02447330206632614
clinical O 0 0.019959483295679092
- O 0 0.3472217917442322
management O 0 0.00010080941137857735
protocols O 0 1.8171431293012574e-05
in O 0 1.4325941037895973e-06
this O 0 6.41132658074639e-07
subset O 0 4.674836873164168e-06
of O 0 5.1742645155172795e-06
FAP B-Disease 0 0.08622901886701584
patients O 0 0.004006664734333754
. O 0 1.1163623639731668e-05
. O 0 3.887838829541579e-05

Wilms B-Disease 1 0.9972793459892273
' I-Disease 0 0.2450505942106247
tumor I-Disease 0 0.05493248626589775
1 O 0 3.41857157764025e-05
and O 0 1.171114945464069e-05
Dax O 0 0.0005826911074109375
- O 0 4.215790249872953e-05
1 O 0 4.415330749907298e-06
modulate O 0 1.5448074918822385e-05
the O 0 2.9872817322029732e-06
orphan O 0 6.615318852709606e-05
nuclear O 0 3.367143290233798e-05
receptor O 0 1.8704560716287233e-05
SF O 0 0.0002221329923486337
- O 0 2.9367667593760416e-05
1 O 0 2.3083300675352803e-06
in O 0 1.2650474445763393e-06
sex O 0 4.370183887658641e-06
- O 0 1.9412571418797597e-05
specific O 0 6.373830274242209e-06
gene O 0 3.167838804074563e-05
expression O 0 3.621182986535132e-05
. O 0 5.6678713008295745e-05

Products O 0 0.0001623255666345358
of O 0 3.3400712709408253e-05
steroidogenic O 0 0.005262923892587423
factor O 0 2.6672905732993968e-05
1 O 0 9.734360901347827e-06
( O 0 5.305748800310539e-06
SF O 0 0.0021349529270082712
- O 0 9.39301389735192e-05
1 O 0 4.835661911783973e-06
) O 0 1.4323317145681358e-06
and O 0 7.0954233706288505e-06
Wilms B-Disease 1 0.9356628060340881
tumor I-Disease 0 0.026627851650118828
1 O 0 9.762306945049204e-06
( O 0 2.416321649434394e-06
WT1 O 0 0.00015480823640245944
) O 0 1.225721689479542e-06
genes O 0 1.966735908354167e-06
are O 0 2.8925751394126564e-07
essential O 0 9.734460491017671e-07
for O 0 5.784527274954598e-07
mammalian O 0 1.2739455087285023e-05
gonadogenesis O 0 0.00014863256365060806
prior O 0 5.181651431485079e-06
to O 0 2.0185932498861803e-06
sexual O 0 8.943600732891355e-06
differentiation O 0 6.7400440457277e-05
. O 0 6.865305476821959e-05

In O 0 0.00019692874047905207
males O 0 0.00019181263633072376
, O 0 2.899949686252512e-05
SF O 0 0.011893685907125473
- O 0 0.00012790289474651217
1 O 0 4.337254267738899e-06
participates O 0 2.4765777197899297e-06
in O 0 9.000328873298713e-07
sexual O 0 1.4849855460852268e-06
development O 0 1.0164411605728674e-06
by O 0 6.924769877514336e-07
regulating O 0 5.656364010064863e-06
expression O 0 1.5270840094672167e-06
of O 0 6.33501258562319e-07
the O 0 4.675773197959643e-06
polypeptide O 0 0.0002524190931580961
hormone O 0 8.072909986367449e-05
Mullerian O 0 0.0007041233475320041
inhibiting O 0 0.00013604281411971897
substance O 0 0.00018101719615515321
( O 0 2.624842818477191e-05
MIS O 0 0.11053095012903214
) O 0 1.644442272663582e-05
. O 0 3.8753791159251705e-05

Here O 0 0.0001536908675916493
, O 0 2.2396403437596746e-05
we O 0 5.093564141134266e-06
show O 0 6.5540366449567955e-06
that O 0 4.059921593579929e-06
WT1 O 0 0.00032825395464897156
- O 0 0.00015079182048793882
KTS O 0 0.0004740959848277271
isoforms O 0 1.2757971489918418e-05
associate O 0 1.2253068234713282e-05
and O 0 5.457787210616516e-06
synergize O 0 9.567602683091536e-05
with O 0 1.2149103895353619e-05
SF O 0 0.3222973346710205
- O 0 0.00022109760902822018
1 O 0 4.0268209886562545e-06
to O 0 2.881709860957926e-06
promote O 0 2.120861790899653e-05
MIS O 0 0.03562774509191513
expression O 0 4.0326609450858086e-05
. O 0 5.827047425555065e-05

In O 0 0.0001694123784545809
contrast O 0 0.00011849450675072148
, O 0 2.8731134079862386e-05
WT1 O 0 0.0013753609964624047
missense O 0 0.00021394547366071492
mutations O 0 7.443504000548273e-05
, O 0 6.376183591783047e-06
associated O 0 9.161482012132183e-06
with O 0 1.0000675501942169e-05
male B-Disease 0 0.0024676460307091475
pseudohermaphroditism I-Disease 1 0.9997215867042542
in O 0 0.0002988833875861019
Denys B-Disease 1 0.9991939663887024
- I-Disease 1 0.9999687671661377
Drash I-Disease 1 0.9999829530715942
syndrome I-Disease 1 0.9999985694885254
, O 0 2.2992513549979776e-05
fail O 0 0.00010291853686794639
to O 0 6.935040801181458e-06
synergize O 0 0.00016105640679597855
with O 0 1.88788580999244e-05
SF O 1 0.5049288272857666
- O 0 0.004063349682837725
1 O 0 5.084786971565336e-05
. O 0 3.557405943865888e-05

Additionally O 0 0.0004330655501689762
, O 0 2.385493462497834e-05
the O 0 1.0209342690359335e-05
X O 0 0.0026908107101917267
- O 0 0.000738043338060379
linked O 0 3.463620305410586e-05
, O 0 1.7027746253006626e-06
candidate O 0 3.993385689682327e-06
dosage O 0 1.2210479326313362e-05
- O 0 2.2303345758700743e-05
sensitive O 0 6.981397746130824e-06
sex O 0 6.548738383571617e-06
- O 0 5.5593642173334956e-05
reversal O 0 1.18922916954034e-05
gene O 0 5.427547421277268e-06
, O 0 2.3575553314003628e-06
Dax O 0 0.0006596256280317903
- O 0 4.94810265081469e-05
1 O 0 2.0673064682341646e-06
, O 0 7.203568088698376e-07
antagonizes O 0 5.742349003412528e-06
synergy O 0 3.277977839388768e-06
between O 0 1.7648277435000637e-06
SF O 0 0.005055988673120737
- O 0 9.984544158214703e-05
1 O 0 3.3768778848752845e-06
and O 0 2.9104276109137572e-06
WT1 O 0 0.0002160814474336803
, O 0 8.888077900337521e-07
most O 0 3.4045339702970523e-07
likely O 0 9.90157104752143e-07
through O 0 4.962925004292629e-07
a O 0 1.0020828540291404e-06
direct O 0 1.1261197414569324e-06
interaction O 0 2.0839179342146963e-06
with O 0 8.9228988144896e-06
SF O 1 0.8789211511611938
- O 0 0.013365928083658218
1 O 0 3.92076326534152e-05
. O 0 5.569700806518085e-05

We O 0 0.00019972473091911525
propose O 0 0.00015133889974094927
that O 0 1.6077518012025394e-05
WT1 O 0 0.0002654633135534823
and O 0 9.555766155244783e-06
Dax O 0 0.0075249262154102325
- O 0 0.0005376044427976012
1 O 0 6.542284154420486e-06
functionally O 0 1.2421916835592128e-05
oppose O 0 2.4480841602780856e-06
each O 0 3.192939459495392e-07
other O 0 2.802401013468625e-07
in O 0 2.0396316813275917e-06
testis O 0 7.348068902501836e-05
development O 0 1.98145767171809e-06
by O 0 2.412632738924003e-06
modulating O 0 0.0001349358935840428
SF O 0 0.025489145889878273
- O 0 0.00018433632794767618
1 O 0 9.770252290763892e-06
- O 0 0.00010837843001354486
mediated O 0 9.011894144350663e-05
transactivation O 0 0.00042636855505406857
. O 0 1.74341239471687e-05
. O 0 4.884185182163492e-05

A O 0 0.0003210047143511474
mouse O 0 0.0003757899976335466
model O 0 0.00012347579468041658
for O 0 0.00010973750613629818
Prader B-Disease 1 0.9999998807907104
- I-Disease 1 0.999998927116394
Willi I-Disease 1 1.0
syndrome I-Disease 1 0.9999998807907104
imprinting O 1 0.6041715741157532
- O 0 0.1406937837600708
centre O 0 0.0027666129171848297
mutations O 0 0.001387599273584783
. O 0 0.00014750361151527613

Imprinting O 0 0.001901100156828761
in O 0 5.7125947932945564e-05
the O 0 1.7430067600798793e-05
15q11 O 0 0.0005054563516750932
- O 0 0.0004927503177896142
q13 O 0 0.00011596964031923562
region O 0 7.83729410613887e-06
involves O 0 3.4916220101877116e-06
an O 0 2.7327387215336785e-06
imprinting O 0 0.0001883150835055858
centre O 0 0.00014632046804763377
( O 0 2.783800027827965e-06
IC O 0 0.00011590684880502522
) O 0 1.1249969702475937e-06
, O 0 6.224818207556382e-07
mapping O 0 2.7214150577492546e-06
in O 0 6.771231824131974e-07
part O 0 9.259923103854817e-07
to O 0 6.717435780956293e-07
the O 0 1.3977567050460493e-06
promoter O 0 1.0354333426221274e-05
and O 0 1.3572133639172534e-06
first O 0 2.878548230000888e-06
exon O 0 4.4179119868204e-05
of O 0 1.443609653506428e-05
SNRPN O 0 0.19180703163146973
. O 0 0.00010180549725191668

Deletion O 0 0.0016267867758870125
of O 0 5.026695362175815e-05
this O 0 1.98208108486142e-05
IC O 0 0.0004369735543150455
abolishes O 0 0.00031281437259167433
local O 0 1.0415468750579748e-05
paternally O 0 9.090505045605823e-05
derived O 0 4.340809027780779e-06
gene O 0 3.846985691779992e-06
expression O 0 2.2148772131913574e-06
and O 0 2.260906057927059e-06
results O 0 4.718201671494171e-05
in O 0 0.012420193292200565
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.011237405240535736
PWS B-Disease 1 0.9999992847442627
) O 0 7.742216985207051e-05
. O 0 6.302464316831902e-05

We O 0 0.00014772686699870974
have O 0 1.130411692429334e-05
created O 0 9.343260899186134e-06
two O 0 2.6445270577823976e-06
deletion O 0 0.00013575085904449224
mutations O 0 2.7241800125921145e-05
in O 0 4.954519681632519e-06
mice O 0 0.001129684504121542
to O 0 6.755217782483669e-06
understand O 0 6.709876470267773e-05
PWS B-Disease 1 0.9999477863311768
and O 0 3.0317848995764507e-06
the O 0 1.5195528249023482e-06
mechanism O 0 4.595982773025753e-06
of O 0 1.4198468534232234e-06
this O 0 6.105815373302903e-06
IC O 0 0.004494926426559687
. O 0 8.094571239780635e-05

Mice O 1 0.6600284576416016
harbouring O 0 0.12904532253742218
an O 0 0.00010108443530043587
intragenic O 0 0.013791536912322044
deletion O 0 0.0005592085653916001
in O 0 3.7584224628517404e-05
Snrpn O 0 0.0060629271902143955
are O 0 6.83257212585886e-06
phenotypically O 0 0.00029991555493324995
normal O 0 2.0113113350817002e-05
, O 0 2.693179794732714e-06
suggesting O 0 4.837908363697352e-06
that O 0 7.690700272178219e-07
mutations O 0 4.174408331891755e-06
of O 0 8.923332757149183e-07
SNRPN O 0 0.01742398366332054
are O 0 1.1420570444897749e-06
not O 0 1.6351187923646648e-06
sufficient O 0 6.659659447905142e-06
to O 0 2.0106726879021153e-05
induce O 0 0.043900445103645325
PWS B-Disease 1 0.9999933242797852
. O 0 0.00014696452126372606

Mice O 0 0.05210534855723381
with O 0 1.979061016754713e-05
a O 0 1.3780217159364838e-05
larger O 0 9.415625754627399e-06
deletion O 0 3.82503385480959e-05
involving O 0 7.5472471507964656e-06
both O 0 3.3405997328372905e-06
Snrpn O 0 0.0007848222157917917
and O 0 4.217034074827097e-06
the O 0 1.3814811609336175e-05
putative O 0 0.3118705451488495
PWS O 1 0.9999995231628418
- O 0 0.3349660038948059
IC O 0 0.0025208676233887672
lack O 0 1.0968489732476883e-05
expression O 0 1.6791258303783252e-06
of O 0 6.45487261863309e-07
the O 0 3.909895440301625e-06
imprinted O 0 0.0007441153866238892
genes O 0 1.2324709132371936e-05
Zfp127 O 0 0.0001319659495493397
( O 0 2.7143491934111807e-06
mouse O 0 1.1946101949433796e-05
homologue O 0 1.700352549960371e-05
of O 0 2.495547278158483e-06
ZNF127 O 0 0.058128856122493744
) O 0 2.401002120677731e-06
, O 0 2.2300314412859734e-06
Ndn O 0 0.0001331802923232317
and O 0 2.2302824618236627e-06
Ipw O 0 0.00025446800282225013
, O 0 3.2483610539202346e-06
and O 0 2.1722635210608132e-06
manifest O 0 1.4947630916140042e-05
several O 0 3.316326228741673e-06
phenotypes O 0 0.00013934480375610292
common O 0 1.7130216292571276e-05
to O 0 0.00040976741001941264
PWS B-Disease 1 0.9999998807907104
infants O 1 0.9914119243621826
. O 0 0.0001584126439411193

These O 0 4.480857023736462e-05
data O 0 2.7172885893378407e-05
demonstrate O 0 1.2940710803377442e-05
that O 0 8.228034289459174e-07
both O 0 3.9029188769745815e-07
the O 0 6.518770874208712e-07
position O 0 2.077690623991657e-06
of O 0 3.073977836720587e-07
the O 0 1.1549838063729112e-06
IC O 0 9.29963935050182e-05
and O 0 8.908784820960136e-07
its O 0 5.091695811643149e-07
role O 0 1.0097477343151695e-06
in O 0 4.01362967750174e-07
the O 0 3.72536334225515e-07
coordinate O 0 2.393037902947981e-06
expression O 0 8.487212994623405e-07
of O 0 3.3897831031026726e-07
genes O 0 1.416056420566747e-06
is O 0 2.9538094281633676e-07
conserved O 0 1.0242705457130796e-06
between O 0 6.065168918212294e-07
mouse O 0 9.324239726993255e-06
and O 0 1.139545020123478e-06
human O 0 7.987557069100149e-07
, O 0 1.0502698160053114e-06
and O 0 1.6375000768675818e-06
indicate O 0 5.952839273959398e-06
that O 0 2.946831330064015e-07
the O 0 7.096575700415997e-07
mouse O 0 2.0162951841484755e-05
is O 0 4.580011818688945e-07
a O 0 1.493791842221981e-06
suitable O 0 7.0322157625923865e-06
model O 0 6.908378509251634e-06
system O 0 7.328842912102118e-06
in O 0 1.6015671917557484e-06
which O 0 1.0304637498848024e-06
to O 0 6.899858817632776e-07
investigate O 0 1.4941623476261157e-06
the O 0 5.467417736326752e-07
molecular O 0 5.825961125083268e-06
mechanisms O 0 2.1752630345872603e-06
of O 0 7.816080938027881e-07
imprinting O 0 0.00010551707237027586
in O 0 2.2716674266121117e-06
this O 0 6.27213808002125e-07
region O 0 1.4529908867189079e-06
of O 0 4.2806186684174463e-07
the O 0 2.4823712010402232e-06
genome O 0 1.3678511095349677e-05
. O 0 6.701466645608889e-06
. O 0 3.9615762943867594e-05

Mutations O 0 0.00048694974975660443
of O 0 2.1246514734230004e-05
the O 0 1.6891506675165147e-05
ATM O 0 0.00254626851528883
gene O 0 4.2668372771004215e-05
detected O 0 4.9657057388685644e-05
in O 0 1.581362812430598e-05
Japanese O 0 0.011936759576201439
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999994039535522
telangiectasia I-Disease 1 1.0
patients O 1 0.9544363617897034
: O 0 4.541446742223343e-06
possible O 0 3.219668769816053e-06
preponderance O 0 2.2692382117384113e-05
of O 0 7.103041639311414e-07
the O 0 2.3413401777361287e-06
two O 0 5.2784307627007365e-06
founder O 0 0.0004701747966464609
mutations O 0 3.991572521044873e-05
4612del165 O 0 0.00015398042160086334
and O 0 1.9740715288207866e-05
7883del5 O 0 0.0008892115438356996
. O 0 6.6304077336099e-05

The O 0 0.00017563164874445647
ATM O 0 0.010965429246425629
( O 0 3.2474104955326766e-05
A O 1 0.8431974649429321
- O 1 0.9986030459403992
T O 1 0.9999864101409912
, O 0 4.1078642425418366e-06
mutated O 0 1.3912395843362901e-05
) O 0 1.4193458355293842e-06
gene O 0 3.397545015104697e-06
on O 0 2.8825149911426706e-06
human O 0 1.2039142347930465e-05
chromosome O 0 0.0009095610585063696
11q22 O 0 0.0013537046033889055
. O 0 7.8129734902177e-05

3 O 0 0.0003446165646892041
has O 0 3.3277097827522084e-05
recently O 0 5.86647838645149e-05
been O 0 7.153870683396235e-06
identified O 0 3.2522509627597174e-06
as O 0 5.901323447687901e-07
the O 0 8.9022449856202e-07
gene O 0 4.3882459976885e-06
responsible O 0 4.038231054437347e-06
for O 0 7.720580015302403e-07
the O 0 8.996760698209982e-06
human O 0 0.000133741763420403
recessive B-Disease 1 0.9999560117721558
disease I-Disease 1 0.9999915361404419
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999992847442627
telangiectasia I-Disease 1 1.0
( O 0 0.0007706272881478071
A B-Disease 1 0.9999499320983887
- I-Disease 1 0.9999973773956299
T I-Disease 1 0.9999992847442627
) O 0 2.368121931795031e-05
. O 0 4.327993519837037e-05

In O 0 9.050588414538652e-05
order O 0 1.7011017916956916e-05
to O 0 3.375393589521991e-06
define O 0 5.553746632358525e-06
the O 0 9.383670089846419e-07
types O 0 2.740040372373187e-06
of O 0 1.087948930944549e-05
disease O 0 0.4360751509666443
- O 0 0.06044616922736168
causing O 0 0.00035193783696740866
ATM O 0 0.049963850528001785
mutations O 0 2.9765105864498764e-05
in O 0 3.7799102301505627e-06
Japanese O 0 5.814879841636866e-05
A B-Disease 1 0.9996510744094849
- I-Disease 1 0.9999983310699463
T I-Disease 1 1.0
patients O 0 0.0009509341907687485
as O 0 7.507088639613357e-07
well O 0 8.658008709971909e-07
as O 0 6.380785180226667e-07
to O 0 7.434941835526843e-07
look O 0 2.465194029355189e-06
for O 0 7.128666084099677e-07
possible O 0 2.107693944708444e-06
mutational O 0 0.00015382235869765282
hotspots O 0 4.5840733946533874e-05
, O 0 3.5341308830538765e-06
reverse O 0 2.9739288947894238e-05
- O 0 7.867979002185166e-05
transcribed O 0 1.2453823728719726e-05
RNA O 0 5.5651557886449154e-06
derived O 0 1.8099493672707467e-06
from O 0 1.3003218555240892e-06
ten O 0 6.24226413492579e-06
patients O 0 2.0752191630890593e-05
belonging O 0 8.105400411295705e-06
to O 0 1.7147079915957875e-06
eight O 0 9.747534022608306e-06
unrelated O 0 2.1229823687463067e-05
Japanese O 0 4.701040597865358e-05
A B-Disease 1 0.9969316720962524
- I-Disease 1 0.9999350309371948
T I-Disease 1 0.9999994039535522
families O 0 2.297762875969056e-05
was O 0 2.4576831492595375e-05
analyzed O 0 5.373003659769893e-06
for O 0 7.297467732314544e-07
mutations O 0 3.3618528050283203e-06
by O 0 6.037629418642609e-07
the O 0 1.6892319081307505e-06
restriction O 0 7.316991741390666e-06
endonuclease O 0 0.00011009018635377288
fingerprinting O 0 7.243749860208482e-05
method O 0 4.811025792150758e-05
. O 0 9.270153532270342e-05

As O 0 0.00010713051597122103
has O 0 3.535382347763516e-05
been O 0 1.9361230442882515e-05
reported O 0 1.2522184078989085e-05
by O 0 1.5033141380627058e-06
others O 0 6.945882432773942e-06
, O 0 2.080548028970952e-06
mutations O 0 3.5068223951384425e-06
that O 0 3.5574390722104e-07
lead O 0 1.6110525393742137e-06
to O 0 9.177512083624606e-07
exon O 0 2.0597495677066036e-05
skipping O 0 2.869997115340084e-05
or O 0 9.890415640256833e-06
premature O 0 0.0001310289226239547
protein O 0 6.2350172811420634e-06
truncation O 0 1.79142825800227e-05
were O 0 5.286551640892867e-06
also O 0 1.9965584669989767e-06
predominant O 0 7.070675110298907e-06
in O 0 2.565677505117492e-06
our O 0 1.2333644917816855e-05
mutants O 0 0.0001744985784171149
. O 0 3.180685962433927e-05

Six O 0 0.00013575410412158817
different O 0 1.971862729988061e-05
mutations O 0 3.689947334351018e-05
were O 0 5.4245929277385585e-06
identified O 0 4.38958977611037e-06
on O 0 1.0932385521300603e-06
12 O 0 2.3669520032854052e-06
of O 0 5.708260459869052e-07
the O 0 3.2811235541885253e-06
16 O 0 5.500974293681793e-05
alleles O 0 8.33576123113744e-05
examined O 0 0.00023556755331810564
. O 0 5.4730433475924656e-05

Four O 0 0.00012123178748879582
were O 0 2.6938683731714264e-05
deletions O 0 4.994885603082366e-05
involving O 0 1.5279932995326817e-05
a O 0 2.7377669539419003e-05
loss O 0 0.00014498150267172605
of O 0 9.222099492944835e-07
a O 0 3.883244062308222e-06
single O 0 9.564098945702426e-06
exon O 0 3.443057357799262e-05
exon O 0 3.5870602005161345e-05
7 O 0 9.392862921231426e-06
, O 0 1.5471845244974247e-06
exon O 0 1.1633705980784725e-05
16 O 0 4.781609277415555e-06
, O 0 1.6898505919016316e-06
exon O 0 2.2939993868931197e-05
33 O 0 1.6006639270926826e-05
or O 0 5.344981673260918e-06
exon O 0 6.677756027784199e-05
35 O 0 5.405421325122006e-05
. O 0 3.668075805762783e-05

The O 0 9.286603017244488e-05
others O 0 5.892774788662791e-05
were O 0 1.340364269708516e-05
minute O 0 9.342236808151938e-06
deletions O 0 3.0024251827853732e-05
, O 0 3.4081472222169396e-06
4649delA O 0 2.976683754241094e-05
in O 0 3.3119770250777947e-06
exon O 0 4.301556327845901e-05
33 O 0 2.1306288545019925e-05
and O 0 3.7842419260414317e-06
7883del5 O 0 8.715640433365479e-05
in O 0 6.9251732384145726e-06
exon O 0 0.0001787673099897802
55 O 0 9.89035252132453e-05
. O 0 6.176670285640284e-05

The O 0 0.00015943021571729332
mutations O 0 0.00035580675466917455
4612del165 O 0 0.00031036484870128334
and O 0 1.4865603588987142e-05
7883del5 O 0 0.00022864484344609082
were O 0 1.1010199159500189e-05
found O 0 3.6852291032118956e-06
in O 0 7.832399546714441e-07
more O 0 3.100966239344416e-07
than O 0 3.4342841104262334e-07
two O 0 1.1428697916926467e-06
unrelated O 0 1.237020842381753e-05
families O 0 8.065850124694407e-06
; O 0 1.9268168216513004e-06
44 O 0 1.0091528565681074e-05
% O 0 1.3248168215795886e-06
( O 0 3.697211639064335e-07
7 O 0 1.0763088766907458e-06
of O 0 2.1142922435046785e-07
16 O 0 3.307359293103218e-06
) O 0 1.8439516225043917e-07
of O 0 1.2219281586567377e-07
the O 0 6.44814235783997e-07
mutant O 0 1.1752499631256796e-05
alleles O 0 3.838520115095889e-06
had O 0 4.7178864406305365e-06
one O 0 4.430894193774293e-07
of O 0 3.3704165502967953e-07
the O 0 2.3582276753586484e-06
two O 0 1.4220166121958755e-05
mutations O 0 0.00016007715021260083
. O 0 3.560589175322093e-05

The O 0 0.00012939890439156443
4612del165 O 0 0.0012883265735581517
mutations O 0 5.472427437780425e-05
in O 0 4.122762220504228e-06
three O 0 2.452762828397681e-06
different O 0 1.3022242910665227e-06
families O 0 4.750650987261906e-06
were O 0 1.99139185497188e-06
all O 0 3.4898300782515435e-07
ascribed O 0 2.2808867470303085e-06
to O 0 5.127335498400498e-07
the O 0 1.2418259984769975e-06
same O 0 1.328097096120473e-05
T O 0 0.04478505253791809
- O 0 8.740450721234083e-05
- O 0 3.702781759784557e-05
> O 0 4.568770691548707e-06
A O 0 9.685713848739397e-07
substitution O 0 1.038538812281331e-06
at O 0 1.1940985586988972e-06
the O 0 9.82044184638653e-07
splice O 0 9.061495075002313e-05
donor O 0 2.393044633208774e-05
site O 0 1.405193870596122e-05
in O 0 1.2163548490207177e-05
intron O 0 0.001584584009833634
33 O 0 0.00018880015704780817
. O 0 8.479001553496346e-05

Microsatellite O 0 0.0045862989500164986
genotyping O 0 0.0012851989595219493
around O 0 5.677186345565133e-05
the O 0 1.370096651953645e-05
ATM O 0 0.0026264723856002092
locus O 0 0.000327391957398504
also O 0 2.7743975806515664e-05
indicated O 0 2.732362918322906e-05
that O 0 1.3905506648370647e-06
a O 0 4.231678303767694e-06
common O 0 6.217346253833966e-06
haplotype O 0 0.000613287091255188
was O 0 7.69278485677205e-05
shared O 0 2.490281303835218e-06
by O 0 6.37547486803669e-07
the O 0 1.7228085198439658e-06
mutant O 0 2.8642007237067446e-05
alleles O 0 1.2766722647938877e-05
in O 0 4.082292434759438e-06
both O 0 9.707607205200475e-06
mutations O 0 0.00020348536781966686
. O 0 7.087718404363841e-05

This O 0 5.799838254461065e-05
suggests O 0 3.455095429671928e-05
that O 0 1.9585750123951584e-06
these O 0 1.1947762459385558e-06
two O 0 2.5337053557450417e-06
founder O 0 0.0005010591703467071
mutations O 0 7.934167661005631e-05
may O 0 7.344732239289442e-06
be O 0 9.270800660488021e-07
predominant O 0 4.406799234857317e-06
among O 0 2.506110149624874e-06
Japanese O 0 2.2871052351547405e-05
ATM O 0 0.0010851873084902763
mutant O 0 0.0004468152765184641
alleles O 0 0.0002910932234954089
. O 0 0.00010118703357875347

W474C O 0 0.006464246194809675
amino O 0 0.00043073357664979994
acid O 0 9.056043199962005e-05
substitution O 0 1.7606485926080495e-05
affects O 0 1.0660439329512883e-05
early O 0 2.376265683778911e-06
processing O 0 2.53185771725839e-06
of O 0 3.9877616586636577e-07
the O 0 6.361724445014261e-07
alpha O 0 2.8879437650175532e-06
- O 0 2.2802275907451985e-06
subunit O 0 1.4786644442210672e-06
of O 0 6.83449968619243e-07
beta O 0 6.550843409058871e-06
- O 0 4.4291158701526e-05
hexosaminidase O 0 9.292722825193778e-05
A O 0 6.249602847674396e-06
and O 0 4.0967379391076975e-06
is O 0 2.2250985693972325e-06
associated O 0 6.392298928403761e-06
with O 0 3.992356869275682e-05
subacute O 1 0.9989861845970154
G B-Disease 1 0.91215580701828
( I-Disease 0 1.853058347478509e-05
M2 I-Disease 0 0.022171854972839355
) I-Disease 0 2.291170494572725e-05
gangliosidosis I-Disease 0 0.0010684594744816422
. O 0 5.580062133958563e-05

Mutations O 0 0.0016153143951669335
in O 0 4.608984454534948e-05
the O 0 2.001619759539608e-05
HEXA O 0 0.0017709477106109262
gene O 0 1.3910485904489178e-05
, O 0 1.0564780268396134e-06
encoding O 0 1.663144303165609e-06
the O 0 9.925167887558928e-07
alpha O 0 2.9049924705759622e-06
- O 0 2.8838733214797685e-06
subunit O 0 2.7613596103037708e-06
of O 0 9.332087529401178e-07
beta O 0 8.072775926848408e-06
- O 0 9.680252696853131e-05
hexosaminidase O 0 0.000121652839879971
A O 0 1.116996008931892e-05
( O 0 1.4623744846176123e-06
Hex O 0 1.4610426660510711e-05
A O 0 4.835703293792903e-06
) O 0 4.661387151827512e-07
, O 0 3.81154819706353e-07
that O 0 3.4467655041225953e-07
abolish O 0 7.889074367994908e-06
Hex O 0 1.3487281648849603e-05
A O 0 7.155924322432838e-06
enzyme O 0 2.1313624529284425e-05
activity O 0 1.9645498468889855e-05
cause O 0 0.0272742360830307
Tay B-Disease 1 1.0
- I-Disease 1 0.9999992847442627
Sachs I-Disease 1 1.0
disease I-Disease 1 0.9576889276504517
( O 0 1.4653908692707773e-05
TSD B-Disease 0 0.08115941286087036
) O 0 3.7713225538027473e-06
, O 0 2.4080216007860145e-06
the O 0 1.2543170669232495e-05
fatal O 0 0.05395946651697159
infantile B-Disease 0 0.00635848892852664
form I-Disease 0 1.1938620446017012e-05
of I-Disease 0 1.585086101840716e-05
G I-Disease 1 0.8221712112426758
( I-Disease 0 5.069010057923151e-06
M2 I-Disease 0 0.0018245531246066093
) I-Disease 0 3.7971913116052747e-06
gangliosidosis I-Disease 0 0.0001019589981297031
, I-Disease 0 3.2650361845298903e-06
Type I-Disease 0 1.9005814465344884e-05
1 I-Disease 0 2.0472300093388185e-05
. O 0 3.742603075806983e-05

Less O 0 0.007272809743881226
severe O 1 0.9993690848350525
, O 0 0.004289307631552219
subacute O 1 0.9998297691345215
( O 0 0.0002981482830364257
juvenile O 1 0.8812779188156128
- O 1 0.9950807094573975
onset O 1 0.9978961944580078
) O 0 7.23141711205244e-05
and O 0 0.002279489068314433
chronic O 1 0.9999572038650513
( O 0 2.9730952519457787e-05
adult O 0 0.0006917408318258822
- O 1 0.9799061417579651
onset O 1 0.9701241254806519
) O 0 6.953669981157873e-06
variants O 0 6.941544597793836e-06
are O 0 1.8898909956988064e-06
characterized O 0 7.195849320851266e-06
by O 0 5.77879291085992e-07
a O 0 4.123328380956082e-06
broad O 0 1.0775253031169996e-05
spectrum O 0 6.948022473807214e-06
of O 0 1.606842374712869e-06
clinical O 0 0.0003834016097243875
manifestations O 0 4.6051798562984914e-05
and O 0 6.572181519004516e-06
are O 0 1.063832314684987e-06
associated O 0 2.498540425222018e-06
with O 0 1.952457978404709e-06
residual O 0 0.0001394138962496072
levels O 0 3.999044565716758e-06
of O 0 9.155307907349197e-07
Hex O 0 0.00010667637980077416
A O 0 2.177695932914503e-05
enzyme O 0 5.144098395248875e-05
activity O 0 3.1895127904135734e-05
. O 0 4.1467934352112934e-05

We O 0 0.0001519382349215448
identified O 0 5.6495991884730756e-05
a O 0 4.062838706886396e-05
1422 O 0 0.01969207637012005
G O 0 0.011015561409294605
- O 0 0.0003838232660200447
- O 0 0.000419159303419292
> O 0 5.27278971276246e-05
C O 0 3.820877100224607e-05
( O 0 1.7657301896178978e-06
amino O 0 3.727883495230344e-06
acid O 0 3.7603761029458838e-06
W474C O 0 5.2433560995268635e-06
) O 0 2.583744560524792e-07
substitution O 0 2.628385118441656e-07
in O 0 2.289583989067978e-07
the O 0 3.242314789986267e-07
first O 0 6.708108912789612e-07
position O 0 1.5484495179407531e-06
of O 0 3.735712539310043e-07
exon O 0 1.5711199012002908e-05
13 O 0 4.309033101890236e-06
of O 0 8.688779757903831e-07
HEXA O 0 0.00033082725713029504
of O 0 9.308657240580942e-07
a O 0 6.098133781051729e-06
non O 0 9.092605978366919e-06
- O 0 6.035513069946319e-05
Jewish O 0 1.3502867659553885e-05
proband O 0 0.00162232737056911
who O 0 2.4720689907553606e-05
manifested O 0 2.480790499248542e-05
a O 0 1.3768119970336556e-05
subacute O 0 0.18738652765750885
variant O 0 8.31707802717574e-05
of O 0 1.3110518921166658e-05
G B-Disease 1 0.9152589440345764
( I-Disease 0 1.3288053196447436e-05
M2 I-Disease 0 0.006521180272102356
) I-Disease 0 1.853893991210498e-05
gangliosidosis I-Disease 0 0.00048074242658913136
. O 0 4.450994310900569e-05

On O 0 7.538381032645702e-05
the O 0 2.0427680283319205e-05
second O 0 7.856020965846255e-05
maternally O 0 0.0019554418977349997
inherited O 0 0.003365481738001108
allele O 0 3.713195837917738e-05
, O 0 2.438782303215703e-06
we O 0 1.2042136177115026e-06
identified O 0 2.146597580576781e-06
the O 0 1.8959077578983852e-06
common O 0 7.122367242118344e-05
infantile O 1 0.9880064129829407
disease O 1 0.6044132709503174
- O 0 0.07118826359510422
causing O 0 0.0007307968335226178
4 O 0 3.998216561740264e-05
- O 0 0.0005677849403582513
bp O 0 0.00011777895269915462
insertion O 0 1.5641684512957e-05
, O 0 4.44285387857235e-06
+ O 0 2.5078552425839007e-05
TATC O 0 0.00033158957376144826
1278 O 0 0.00027588236844167113
, O 0 2.2261388039623853e-06
in O 0 4.569812062982237e-06
exon O 0 0.00010205723810940981
11 O 0 7.14048437657766e-05
. O 0 3.597450631787069e-05

Pulse O 0 0.004373665899038315
- O 0 0.0016419024905189872
chase O 0 0.00020229081565048546
analysis O 0 1.4812339941272512e-05
using O 0 9.62262311077211e-06
proband O 0 0.0003780968254432082
fibroblasts O 0 3.431044387980364e-05
revealed O 0 2.5922352506313473e-05
that O 0 7.743246897007339e-07
the O 0 1.4275369721872266e-06
W474C O 0 2.8245871362742037e-05
- O 0 7.749637916276697e-06
containing O 0 2.6734246603155043e-06
alpha O 0 4.963851097272709e-06
- O 0 4.258112767274724e-06
subunit O 0 2.621776047817548e-06
precursor O 0 3.580192014851491e-06
was O 0 4.38804090663325e-06
normally O 0 1.278854142583441e-06
synthesized O 0 3.682323722387082e-06
, O 0 4.904459274257533e-07
but O 0 4.155947408435168e-07
not O 0 3.6882454423903255e-07
phosphorylated O 0 1.9437854916759534e-06
or O 0 5.888348368898733e-07
secreted O 0 2.238913111796137e-06
, O 0 3.276029190146801e-07
and O 0 4.399080069106276e-07
the O 0 1.016646706375468e-06
mature O 0 3.2301934425049694e-06
lysosomal O 0 2.1284517060848884e-05
alpha O 0 5.7339984778082e-06
- O 0 8.139241799653973e-06
subunit O 0 8.579442692280281e-06
was O 0 1.4596265828004107e-05
not O 0 5.773902103101136e-06
detected O 0 8.911099575925618e-05
. O 0 3.881192969856784e-05

When O 0 0.00010702105646487325
the O 0 2.3258524379343726e-05
W474C O 0 9.482867608312517e-05
- O 0 2.5581974114174955e-05
containing O 0 8.255250577349216e-06
alpha O 0 1.5046227417769842e-05
- O 0 1.4809909771429375e-05
subunit O 0 1.0509889762033708e-05
was O 0 2.1202613424975425e-05
transiently O 0 6.0406258853618056e-05
co O 0 2.5411794922547415e-05
- O 0 1.5349467503256164e-05
expressed O 0 1.0582608638287638e-06
with O 0 5.13983934524731e-07
the O 0 8.919394076656317e-07
beta O 0 3.2070431643660413e-06
- O 0 4.577711479214486e-06
subunit O 0 2.5506399197183782e-06
to O 0 8.295905900013167e-07
produce O 0 1.953068931470625e-06
Hex O 0 1.8386765077593736e-05
A O 0 9.814798431762028e-06
( O 0 2.2229562546272064e-06
alphabeta O 0 6.646321708103642e-05
) O 0 1.5146799796639243e-06
in O 0 2.2444974092650227e-06
COS O 0 0.023248283192515373
- O 0 0.00026222883025184274
7 O 0 2.0559524273267016e-05
cells O 0 2.534664872655412e-06
, O 0 3.2658721238476573e-07
the O 0 4.662160506541113e-07
mature O 0 1.0068342817248777e-06
alpha O 0 1.5647805184926256e-06
- O 0 2.18630248127738e-06
subunit O 0 1.7797657392293331e-06
was O 0 3.188221853633877e-06
present O 0 7.287244443432428e-07
, O 0 3.8872948948665e-07
but O 0 2.0115642485052376e-07
its O 0 1.9351833202563284e-07
level O 0 5.649790750794637e-07
was O 0 3.0077869723754702e-06
much O 0 5.321257958712522e-07
lower O 0 1.2433782785592484e-06
than O 0 2.3644945201795053e-07
that O 0 1.6278343650810712e-07
from O 0 2.413089816855063e-07
normal O 0 9.902835245156894e-07
alpha O 0 1.5848887642277987e-06
- O 0 2.752144837359083e-06
subunit O 0 2.949219833681127e-06
transfections O 0 2.107016189256683e-05
, O 0 5.487513021762425e-07
although O 0 4.4868369286632515e-07
higher O 0 7.752165060992411e-07
than O 0 2.9099427933942934e-07
in O 0 5.114608825351752e-07
those O 0 1.0260744147672085e-06
cells O 0 4.36674645243329e-06
transfected O 0 1.5723400792921893e-05
with O 0 4.427878366186633e-07
an O 0 8.800653858997975e-07
alpha O 0 5.088781563244993e-06
- O 0 1.1898020602529868e-05
subunit O 0 1.5118574992811773e-05
associated O 0 1.5447927580680698e-05
with O 0 4.367835208540782e-05
infantile O 1 0.8295670747756958
TSD B-Disease 1 0.5769158005714417
. O 0 0.0002958894183393568

Furthermore O 0 0.0002930276095867157
, O 0 1.2547968253784347e-05
the O 0 3.3269063806073973e-06
precursor O 0 5.68344830753631e-06
level O 0 1.6989059758998337e-06
of O 0 5.92072183280834e-07
the O 0 1.2453375575205428e-06
W474C O 0 2.034315184573643e-05
alpha O 0 4.0096301745506935e-06
- O 0 5.501684881892288e-06
subunit O 0 3.625189947342733e-06
was O 0 4.673544481192948e-06
found O 0 1.121603190767928e-06
to O 0 8.513591751579952e-07
accumulate O 0 1.0141183338419069e-05
in O 0 4.6564952072003507e-07
comparison O 0 7.847128244975465e-07
to O 0 4.865833034273237e-07
the O 0 5.121422077536408e-07
normal O 0 2.1298865249264054e-06
alpha O 0 5.001266345061595e-06
- O 0 1.0942796507151797e-05
subunit O 0 2.0431070879567415e-05
precursor O 0 3.477988138911314e-05
levels O 0 3.0714112654095516e-05
. O 0 2.6985198928741738e-05

We O 0 0.00012397862155921757
conclude O 0 5.7468594604870304e-05
that O 0 4.868176802119706e-06
the O 0 6.386151198967127e-06
1422 O 0 0.008007715456187725
G O 0 0.011293322779238224
- O 0 0.0007355577545240521
- O 0 0.0010267808102071285
> O 0 0.00011157432163599879
C O 0 0.00011619578435784206
mutation O 0 7.632811502844561e-06
is O 0 5.895416848034074e-07
the O 0 1.138154857471818e-06
cause O 0 6.432372174458578e-06
of O 0 2.0460449832171435e-06
Hex B-Disease 0 0.07242941856384277
A I-Disease 1 0.904075562953949
enzyme I-Disease 1 0.9999967813491821
deficiency I-Disease 1 0.9999806880950928
in O 0 1.2824953046219889e-05
the O 0 4.175301000941545e-05
proband O 0 0.08013764023780823
. O 0 9.741498797666281e-05

The O 0 0.0001505529071437195
resulting O 0 0.0002152079832740128
W474C O 0 0.0001997965737245977
substitution O 0 2.0496094293775968e-05
clearly O 0 1.2261799383850303e-05
interferes O 0 1.0024480616266374e-05
with O 0 1.3613109786092537e-06
alpha O 0 3.1877111723588314e-06
- O 0 3.7652853279723786e-06
subunit O 0 3.030073685295065e-06
processing O 0 1.99732971850608e-06
, O 0 6.816104587414884e-07
but O 0 5.431708132164204e-07
because O 0 3.967618624756142e-07
the O 0 2.992919974076358e-07
base O 0 2.7732276066672057e-06
substitution O 0 1.7823236930780695e-06
falls O 0 2.3621720174560323e-05
at O 0 2.0573445453919703e-06
the O 0 4.309175380967645e-07
first O 0 7.760486369079445e-07
position O 0 2.1793807718495373e-06
of O 0 5.087259751235251e-07
exon O 0 2.2029051251593046e-05
13 O 0 7.750451004540082e-06
, O 0 1.6487826997035882e-06
aberrant O 0 1.3044668776274193e-05
splicing O 0 2.3726928702672012e-05
may O 0 7.4053027674381156e-06
also O 0 1.4626185702582006e-06
contribute O 0 2.8523661512736e-06
to O 0 2.575036660346086e-06
Hex B-Disease 0 0.0019087954424321651
A I-Disease 0 0.02721017226576805
deficiency I-Disease 0 0.4298236668109894
in O 0 5.245841293799458e-06
this O 0 4.070163868163945e-06
proband O 0 0.004260109271854162
. O 0 1.0989680959028192e-05
. O 0 3.28371133946348e-05

Two O 0 0.00023720924218650907
frequent O 0 0.000898883561603725
missense O 0 0.005366435740143061
mutations O 0 0.00793495960533619
in O 0 0.1272335797548294
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0014073837082833052

Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 1 0.9133281707763672
an O 1 0.9990897178649902
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
characterized O 1 0.8087334036827087
by O 0 7.846152584534138e-05
early O 0 0.19447635114192963
childhood O 1 0.9999849796295166
deafness B-Disease 1 1.0
and O 1 0.9866568446159363
goiter B-Disease 1 1.0
. O 0 0.00166708929464221

A O 0 0.00017047813162207603
century O 0 4.288923810236156e-05
after O 0 1.5526979041169398e-05
its O 0 2.248415739813936e-06
recognition O 0 5.211823008721694e-06
as O 0 5.273564966046251e-06
a O 0 0.0019444237696006894
syndrome O 1 0.9998342990875244
by O 0 1.1816875485237688e-05
Vaughan O 0 0.017583537846803665
Pendred O 0 0.002254301914945245
, O 0 5.330920885171508e-06
the O 0 2.4567925720475614e-05
disease O 0 0.0691547691822052
gene O 0 1.7151418433059007e-05
( O 0 3.327871127112303e-06
PDS O 0 0.002064490457996726
) O 0 2.5707083750603488e-06
was O 0 1.0568737707217224e-05
mapped O 0 2.4003084035939537e-05
to O 0 8.128956324071623e-06
chromosome O 0 0.0010457165772095323
7q22 O 0 0.0017686790088191628
- O 0 0.006522202864289284
q31 O 0 0.0011514171492308378
. O 0 7.489777635782957e-05

1 O 0 0.0001516876509413123
and O 0 1.9985391190857626e-05
, O 0 6.825329364801291e-06
recently O 0 1.2332563528616447e-05
, O 0 1.155852146439429e-06
found O 0 1.2064321026628022e-06
to O 0 8.508251312377979e-07
encode O 0 7.5422249210532755e-06
a O 0 1.2436780707503203e-05
putative O 0 0.0007009225082583725
sulfate O 0 0.0010642827255651355
transporter O 0 0.002742439741268754
. O 0 9.78557436610572e-05

We O 0 0.00012698030332103372
performed O 0 6.848938937764615e-05
mutation O 0 1.6336773114744574e-05
analysis O 0 2.681069190657581e-06
of O 0 8.713707302376861e-07
the O 0 3.863216988975182e-06
PDS B-Disease 0 0.007887584157288074
gene O 0 1.073461589840008e-05
in O 0 7.34095056031947e-06
patients O 0 5.7186229241779074e-05
from O 0 2.156181153623038e-06
14 O 0 1.8638535038917325e-05
Pendred B-Disease 0 0.00010615529026836157
families O 0 2.335090130145545e-06
originating O 0 1.7236023950317758e-06
from O 0 7.603173912684724e-07
seven O 0 1.2156740467617055e-06
countries O 0 5.232473085925449e-07
and O 0 2.927170498878695e-06
identified O 0 1.1001247003150638e-05
all O 0 4.291346158424858e-06
mutations O 0 7.921150245238096e-05
. O 0 5.976218744763173e-05

The O 0 8.496605005348101e-05
mutations O 0 8.803764649201185e-05
include O 0 5.901340045966208e-06
three O 0 3.3675291888357606e-06
single O 0 1.4589264537789859e-05
base O 0 1.249043270945549e-05
deletions O 0 1.3335798030311707e-05
, O 0 1.930766075020074e-06
one O 0 3.249126166338101e-06
splice O 0 0.00022447286755777895
site O 0 2.397828211542219e-05
mutation O 0 1.7184967873618007e-05
and O 0 3.410657427593833e-06
10 O 0 2.1704723621951416e-05
missense O 0 0.0002979260461870581
mutations O 0 0.00023088416492100805
. O 0 8.001731475815177e-05

One O 0 0.00023227144265547395
missense O 0 0.0009324538987129927
mutation O 0 0.0002785759570542723
( O 0 1.997363506234251e-05
L236P O 0 0.0005034140194766223
) O 0 5.860164492332842e-06
was O 0 5.572782174567692e-05
found O 0 4.863406502408907e-06
in O 0 2.5506278689135797e-06
a O 0 1.7792019207263365e-05
homozygous O 0 0.00028669112361967564
state O 0 2.037112153630005e-06
in O 0 1.3588285128207644e-06
two O 0 2.2339820588967996e-06
consanguineous O 0 0.004639731720089912
families O 0 6.865883278805995e-06
and O 0 1.3151917528375634e-06
in O 0 1.283512915506435e-06
a O 0 4.62721709482139e-06
heterozygous O 0 2.830119956342969e-05
state O 0 8.912999192034476e-07
in O 0 7.377293513854966e-07
five O 0 1.2960455251231906e-06
additional O 0 3.6323017411632463e-06
non O 0 1.7628191926633008e-05
- O 0 0.0011615006951615214
consanguineous O 0 0.003259589895606041
families O 0 9.811624477151781e-05
. O 0 6.115558062447235e-05

Another O 0 0.0006208496633917093
missense O 0 0.0015398492105305195
mutation O 0 0.0004063667729496956
( O 0 2.0323839635238983e-05
T416P O 0 0.00044902731315232813
) O 0 6.0683960327878594e-06
was O 0 3.573890353436582e-05
found O 0 3.1166400731308386e-06
in O 0 1.3428452803054824e-06
a O 0 9.110434803005774e-06
homozygous O 0 0.000161146410391666
state O 0 1.2233102779646288e-06
in O 0 1.2561429230117938e-06
one O 0 2.6253089799865847e-06
family O 0 8.96488199941814e-06
and O 0 1.1223371529922588e-06
in O 0 1.2251958878550795e-06
a O 0 5.551934918912593e-06
heterozygous O 0 4.620813706424087e-05
state O 0 1.330487862105656e-06
in O 0 1.950366367964307e-06
four O 0 1.1364139027136844e-05
families O 0 4.7227167669916525e-05
. O 0 3.5037450288655236e-05

Pendred B-Disease 1 0.9028116464614868
patients O 1 0.6103141903877258
in O 0 4.885181624558754e-05
three O 0 2.1492118321475573e-05
non O 0 2.9619961424032226e-05
- O 0 0.001094558509066701
consanguineous O 0 0.0009821723215281963
families O 0 1.782365688995924e-05
were O 0 8.872987564245705e-06
shown O 0 2.1341786577977473e-06
to O 0 1.0049444654214312e-06
be O 0 2.42298574448796e-06
compound O 0 5.4574909881921485e-05
heterozygotes O 0 3.8338341255439445e-05
for O 0 3.130524419248104e-06
L236P O 0 0.00017950845358427614
and O 0 1.9519702618708834e-05
T416P O 0 0.0015942498575896025
. O 0 7.07982835592702e-05

In O 0 8.427364082308486e-05
total O 0 3.675783227663487e-05
, O 0 4.199812337901676e-06
one O 0 1.1758077107515419e-06
or O 0 6.708741580041533e-07
both O 0 2.2896821860740602e-07
of O 0 3.1020931601233315e-07
these O 0 6.095617663959274e-07
mutations O 0 6.546627446368802e-06
were O 0 3.982231191912433e-06
found O 0 1.4781173831579508e-06
in O 0 5.361132480175002e-07
nine O 0 1.0366409242124064e-06
of O 0 3.1839996950111527e-07
the O 0 2.4478413251927122e-06
14 O 0 3.075720451306552e-05
families O 0 1.676889951340854e-05
analyzed O 0 6.253737228689715e-05
. O 0 3.1971318094292656e-05

The O 0 4.535412153927609e-05
identification O 0 2.1232315702945925e-05
of O 0 3.07668665300298e-06
two O 0 5.1048605200776365e-06
frequent O 0 0.00014172575902193785
PDS B-Disease 1 0.7190396189689636
mutations O 0 6.817829125793651e-05
will O 0 1.5303760392271215e-06
facilitate O 0 6.568453045474598e-06
the O 0 9.077704817173071e-06
molecular O 0 0.010564745403826237
diagnosis O 1 0.9789025783538818
of O 0 0.012950695119798183
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0010333419777452946

Insertional O 0 0.013368349522352219
mutation O 0 0.0007037290488369763
by O 0 3.5035776818403974e-05
transposable O 0 0.00030132452957332134
element O 0 3.679363362607546e-05
, O 0 1.0417615158075932e-05
L1 O 0 0.0005327134858816862
, O 0 5.8199857448926196e-06
in O 0 4.259363777237013e-06
the O 0 2.3519309252151288e-05
DMD B-Disease 1 0.9999889135360718
gene O 0 3.887987259076908e-05
results O 0 4.256770625943318e-05
in O 0 2.681747173483018e-05
X B-Disease 1 0.9887794256210327
- I-Disease 1 0.9856913685798645
linked I-Disease 1 0.6395144462585449
dilated I-Disease 1 0.9993013143539429
cardiomyopathy I-Disease 1 0.9999985694885254
. O 0 0.0007242885185405612

X B-Disease 1 0.9924299120903015
- I-Disease 1 0.9955293536186218
linked I-Disease 1 0.9588789939880371
dilated I-Disease 1 0.9999526739120483
cardiomyopathy I-Disease 1 1.0
( O 0 0.0015467243501916528
XLDCM B-Disease 1 0.9859510064125061
) O 0 8.649221854284406e-06
is O 0 1.5772516235301737e-06
a O 0 1.0945416761387605e-05
clinical O 0 0.00037773943040519953
phenotype O 0 0.0009756710496731102
of O 0 4.816272394236876e-06
dystrophinopathy B-Disease 0 0.1324988752603531
which O 0 7.973021638463251e-06
is O 0 2.4032863166212337e-06
characterized O 0 1.002830595098203e-05
by O 0 2.4067862796073314e-06
preferential O 0 0.007644925732165575
myocardial B-Disease 1 0.999940037727356
involvement I-Disease 0 0.00015473637904506177
without O 0 8.391234587179497e-06
any O 0 1.9857518509525107e-06
overt O 0 5.2385283197509125e-05
clinical O 0 0.003878689371049404
signs O 0 0.0010806260397657752
of O 0 0.00034068807144649327
skeletal B-Disease 1 0.9999998807907104
myopathy I-Disease 1 1.0
. O 0 0.0051001617684960365

To O 0 8.673636330058798e-05
date O 0 4.559579610941e-05
, O 0 4.9303407649858855e-06
several O 0 2.5646158974268474e-06
mutations O 0 1.432711724191904e-05
in O 0 4.27038639827515e-06
the O 0 5.6051234423648566e-05
Duchenne B-Disease 1 0.9999096393585205
muscular I-Disease 1 0.999763548374176
dystrophy I-Disease 1 0.999902606010437
gene O 0 0.02606600895524025
, O 0 0.0015090404776856303
DMD O 1 0.9999997615814209
, O 0 5.8800604165298864e-05
have O 0 1.499415793659864e-05
been O 0 1.8919823560281657e-05
identified O 0 1.8583654309622943e-05
in O 0 1.1943254321522545e-05
patients O 0 0.0001526984415249899
with O 0 7.026617367955623e-06
XLDCM B-Disease 1 0.6128728985786438
, O 0 2.7933581350225722e-06
but O 0 5.973933525638131e-07
a O 0 1.5632768963769195e-06
pathogenic O 0 3.7490183331101434e-06
correlation O 0 2.15233740163967e-06
of O 0 6.755236086064542e-07
these O 0 2.0821021280426066e-06
cardiospecific O 0 0.02836061827838421
mutations O 0 5.5146407248685136e-05
in O 0 3.747152732103132e-05
DMD O 1 0.9999955892562866
with O 0 1.1932496818189975e-05
the O 0 3.485765046207234e-05
XLDCM B-Disease 1 0.9172611236572266
phenotype O 0 0.0024663854856044054
has O 0 5.573606358666439e-06
remained O 0 2.4601218683528714e-05
to O 0 2.0963236693205545e-06
be O 0 7.884554179327097e-06
elucidated O 0 0.0003945504140574485
. O 0 4.409909888636321e-05

We O 0 0.00017620500875636935
report O 0 2.5004686904139817e-05
here O 0 3.5137452414346626e-06
the O 0 8.860623097461939e-07
identification O 0 1.4575695104213082e-06
of O 0 4.2085383711309987e-07
a O 0 2.5379449652973562e-06
unique O 0 3.1784188649908174e-06
de O 0 1.4399742212845013e-05
novo O 0 1.3142190255166497e-05
L1 O 0 6.253588071558625e-05
insertion O 0 1.1935045222344343e-05
in O 0 1.812806317502691e-06
the O 0 2.864920588763198e-06
muscle O 0 0.0002569557400420308
exon O 0 7.817586447345093e-05
1 O 0 1.1114843800896779e-05
in O 0 1.852886998676695e-05
DMD O 1 0.9999837875366211
in O 0 2.0057337678736076e-05
three O 0 7.550244481535628e-05
XLDCM B-Disease 1 0.9936656355857849
patients O 0 0.0003828657791018486
from O 0 3.306132612124202e-06
two O 0 1.073456496669678e-05
unrelated O 0 9.481593588134274e-05
Japanese O 0 5.7140819990308955e-05
families O 0 6.686606502626091e-05
. O 0 5.2840048738289624e-05

The O 0 8.197754505090415e-05
insertion O 0 0.00028284190921112895
was O 0 9.7582524176687e-05
a O 0 8.483372766932007e-06
5 O 0 7.54403799874126e-06
- O 0 2.527408469177317e-05
truncated O 0 6.847640634077834e-06
form O 0 9.204526350004016e-07
of O 0 5.682900336978491e-07
human O 0 1.551315563119715e-06
L1 O 0 0.00015832930512260646
inversely O 0 2.8492224373621866e-05
integrated O 0 1.7508617020212114e-05
in O 0 2.1416185518319253e-06
the O 0 2.567988531154697e-06
5 O 0 1.5491745216422714e-05
- O 0 0.00021798086527269334
untranslated O 0 9.917221177602187e-05
region O 0 5.146567218616838e-06
in O 0 1.9662031718326034e-06
the O 0 4.219000857119681e-06
muscle O 0 0.0001358245499432087
exon O 0 3.8805264921393245e-05
1 O 0 4.2093233787454665e-06
, O 0 1.0796294418469188e-06
which O 0 6.849259079899639e-07
affected O 0 1.6617681239949889e-06
the O 0 5.052438041275309e-07
transcription O 0 2.9806908514729002e-06
or O 0 1.066851950781711e-06
the O 0 8.14582051589241e-07
stability O 0 1.6333281109837117e-06
of O 0 3.892440076924686e-07
the O 0 3.435198550505447e-06
muscle O 0 5.800319559057243e-05
form O 0 1.1523311513883527e-06
of O 0 9.906169680107269e-07
dystrophin O 0 0.00027501911972649395
transcripts O 0 2.0259649318177253e-05
but O 0 1.949533270817483e-06
not O 0 5.762782961937774e-07
that O 0 1.492810639547315e-07
of O 0 2.9999924322510196e-07
the O 0 7.060459665808594e-06
brain O 0 0.06610821187496185
or O 0 1.1006672139046714e-05
Purkinje O 0 0.005088017787784338
cell O 0 0.0009047156781889498
form O 0 7.304776318051154e-06
, O 0 5.889511157874949e-06
probably O 0 9.406497156305704e-06
due O 0 1.4326104746942292e-06
to O 0 3.9589329503542103e-07
its O 0 5.682710479959496e-07
unique O 0 1.1825800356746186e-06
site O 0 3.993038717453601e-06
of O 0 1.777391048563004e-06
integration O 0 5.153496385901235e-05
. O 0 7.085785910021514e-05

We O 0 0.00012667554256040603
speculate O 0 4.089551293873228e-05
that O 0 1.9624117157945875e-06
this O 0 5.841767460879055e-07
insertion O 0 4.003627054771641e-06
of O 0 7.793215672791121e-07
an O 0 3.986152478319127e-06
L1 O 0 0.016653167083859444
sequence O 0 1.4914225175743923e-05
in O 0 8.238206646637991e-05
DMD O 1 0.9999997615814209
is O 0 6.1130754147598054e-06
responsible O 0 4.427301519172033e-06
for O 0 2.576640838469757e-07
some O 0 1.313254927026719e-07
of O 0 1.9583757193686324e-07
the O 0 6.180206355566042e-07
population O 0 5.447119519885746e-07
of O 0 5.471648023558373e-07
Japanese O 0 3.6572793760569766e-05
patients O 0 7.000115874689072e-05
with O 0 1.0561200724623632e-05
XLDCM B-Disease 1 0.6202876567840576
. O 0 1.3729245438298676e-05
. O 0 2.8571701477630995e-05

Severe O 1 0.9965978264808655
early O 0 0.04060414433479309
- O 1 0.9997559189796448
onset O 1 0.9999932050704956
obesity B-Disease 1 0.9999997615814209
, O 1 0.8443966507911682
adrenal B-Disease 1 0.9999998807907104
insufficiency I-Disease 1 0.9999997615814209
and O 0 0.021649498492479324
red O 1 0.5515192151069641
hair O 1 0.9966045618057251
pigmentation O 1 0.625302791595459
caused O 0 0.0008163000456988811
by O 0 2.220112583017908e-05
POMC O 0 0.3141094744205475
mutations O 0 9.470595250604674e-05
in O 0 1.6948595657595433e-05
humans O 0 6.643559754593298e-05
. O 0 4.145595448790118e-05

Sequential O 0 0.0007522419327870011
cleavage O 0 0.0005981551366858184
of O 0 1.742310450936202e-05
the O 0 1.277259252674412e-05
precursor O 0 2.815873085637577e-05
protein O 0 1.1745944902941119e-05
pre O 0 6.50593065074645e-05
- O 0 0.0001828499516705051
pro O 0 8.405140397371724e-05
- O 0 0.006508735939860344
opiomelanocortin O 0 0.0020201592706143856
( O 0 4.285661361791426e-06
POMC O 0 0.00019531141151674092
) O 0 1.4424358596443199e-06
generates O 0 4.604844889399828e-06
the O 0 3.1110541840462247e-06
melanocortin O 0 0.0002913225325755775
peptides O 0 3.9644783100811765e-05
adrenocorticotrophin O 0 0.0005151876248419285
( O 0 6.150787157821469e-06
ACTH O 0 9.622584911994636e-05
) O 0 1.9194933429389494e-06
, O 0 2.6740162866190076e-06
melanocyte O 0 0.00013505766401067376
- O 0 0.0002126481558661908
stimulating O 0 4.830398393096402e-05
hormones O 0 4.3923126213485375e-05
( O 0 2.737446720857406e-06
MSH O 0 5.433857222669758e-05
) O 0 8.694300390743592e-07
alpha O 0 1.7376092955601052e-06
, O 0 3.09158821210076e-07
beta O 0 6.288903477980057e-07
and O 0 2.956937805720372e-07
gamma O 0 1.9712965695362072e-06
as O 0 2.798069260734337e-07
well O 0 5.249517016636673e-07
as O 0 4.0104922049977176e-07
the O 0 1.173994860437233e-06
opioid O 0 2.7452837457531132e-05
- O 0 5.118033732287586e-05
receptor O 0 2.4328042854904197e-05
ligand O 0 2.693349597393535e-05
beta O 0 6.780244439141825e-05
- O 0 0.0004646200977731496
endorphin O 0 0.0021762559190392494
. O 0 8.784913370618597e-05

While O 0 0.00012145846267230809
a O 0 3.0839553801342845e-05
few O 0 9.536182915326208e-06
cases O 0 4.084512056579115e-06
of O 0 1.5208681361400522e-05
isolated O 1 0.9827750325202942
ACTH B-Disease 1 0.9999887943267822
deficiency I-Disease 1 0.9991235136985779
have O 0 5.6913395383162424e-05
been O 0 0.00021214976732153445
reported O 0 0.0007370340754278004
( O 0 9.427008080820087e-06
OMIM O 0 0.07394663244485855
201400 O 0 0.0006318935193121433
) O 0 2.763037628028542e-06
, O 0 2.4271278107335092e-06
an O 0 1.2613199942279607e-05
inherited O 1 0.9399785399436951
POMC O 1 0.9840461611747742
defect O 0 0.12370885908603668
has O 0 1.5726685887784697e-05
not O 0 4.581768735079095e-06
been O 0 9.729144039738458e-06
described O 0 2.3169151972979307e-05
so O 0 5.616768703475827e-06
far O 0 1.2589884136104956e-05
. O 0 2.7528179998626e-05

Recent O 0 0.00016870985564310104
studies O 0 4.1701237933011726e-05
in O 0 1.3214201317168772e-05
animal O 0 1.4982994798629079e-05
models O 0 1.2370655895210803e-05
elucidated O 0 3.3954445825656876e-05
a O 0 1.9429996882536216e-06
central O 0 1.648679017307586e-06
role O 0 9.66618813436071e-07
of O 0 4.355739804395853e-07
alpha O 0 1.0553236279520206e-05
- O 0 0.00020643645257223397
MSH O 0 0.00012116348079871386
in O 0 8.917437526179128e-07
the O 0 7.378328064078232e-07
regulation O 0 1.7089059838326648e-06
of O 0 4.336640131441527e-07
food O 0 2.5846072730928427e-06
intake O 0 5.3504181778407656e-06
by O 0 5.824905997542373e-07
activation O 0 2.79318760476599e-06
of O 0 6.447435225709341e-07
the O 0 5.079147740616463e-06
brain O 0 0.0005797650665044785
melanocortin O 0 0.0002168946957681328
- O 0 0.00011269868991803378
4 O 0 1.5370678738690913e-05
- O 0 9.063992911251262e-05
receptor O 0 1.3381635653786361e-05
( O 0 4.364706455817213e-06
MC4 O 0 0.0003441654553171247
- O 0 0.0002863201661966741
R O 0 0.0005299714975990355
; O 0 3.00083320325939e-06
refs O 0 2.6437139240442775e-05
3 O 0 5.265308573143557e-06
- O 0 3.258257856941782e-05
5 O 0 1.9664844330691267e-06
) O 0 4.6333099135154043e-07
and O 0 3.0285431762422377e-07
the O 0 5.61277772703761e-07
linkage O 0 1.0211893822997808e-05
of O 0 9.073981459550851e-07
human O 0 7.1832882895250805e-06
obesity B-Disease 1 0.939568042755127
to O 0 1.0285726602887735e-05
chromosome O 0 0.0025018537417054176
2 O 0 8.036588951654267e-06
in O 0 2.144504378520651e-06
close O 0 5.856052666786127e-06
proximity O 0 4.277951575204497e-06
to O 0 1.6773989273133338e-06
the O 0 3.698929276652052e-06
POMC O 0 0.001102285459637642
locus O 0 2.1597996237687767e-05
, O 0 1.3543314025810105e-06
led O 0 1.559569000164629e-06
to O 0 4.106279902771348e-07
the O 0 5.515735210792627e-07
proposal O 0 7.434218787238933e-07
of O 0 2.4223515993071487e-07
an O 0 1.1377879900464904e-06
association O 0 3.5805815059575252e-06
of O 0 2.156201617253828e-06
POMC O 0 0.03750164434313774
with O 0 2.3172422515926883e-05
human O 0 0.00011995218665106222
obesity B-Disease 1 0.9995445609092712
. O 0 0.00018993426056113094

The O 0 7.713183003943413e-05
dual O 0 6.876707629999146e-05
role O 0 1.3617574040836189e-05
of O 0 4.327578153606737e-06
alpha O 0 4.232221544953063e-05
- O 0 0.0008746356470510364
MSH O 0 0.0003785027365665883
in O 0 3.903792730852729e-06
regulating O 0 1.8216072930954397e-05
food O 0 5.6920403039839584e-06
intake O 0 1.0388883310952224e-05
and O 0 3.1251013297151076e-06
influencing O 0 3.762542473850772e-05
hair O 0 0.2649891972541809
pigmentation O 0 0.0021152121480554342
predicts O 0 0.00011560374696273357
that O 0 1.3810799828206655e-06
the O 0 4.657748377212556e-06
phenotype O 0 0.009549850597977638
associated O 0 1.244106260855915e-05
with O 0 4.977010121365311e-06
a O 0 0.0003014325920958072
defect O 0 0.22112399339675903
in O 0 3.8967769796727225e-05
POMC O 0 0.23493802547454834
function O 0 7.037059276626678e-06
would O 0 7.611810360685922e-06
include O 0 2.1197212845436297e-05
obesity B-Disease 1 0.9988631010055542
, O 0 2.7345917260390706e-05
alteration O 0 0.00015304374392144382
in O 0 9.557034354656935e-05
pigmentation O 1 0.8962308764457703
and O 0 0.43098679184913635
ACTH B-Disease 1 0.9999849796295166
deficiency I-Disease 1 0.9992918968200684
. O 0 0.0001694955863058567

The O 0 4.761630407301709e-05
observation O 0 9.265347034670413e-05
of O 0 8.22527908894699e-06
these O 0 1.1662977158266585e-05
symptoms O 0 0.017490601167082787
in O 0 7.799106242600828e-06
two O 0 1.158559007308213e-05
probands O 0 0.0059256344102323055
prompted O 0 9.005565516417846e-06
us O 0 1.3335201174413669e-06
to O 0 5.254581196822983e-07
search O 0 1.7318239997621276e-06
for O 0 1.0073758858197834e-06
mutations O 0 1.0450929039507173e-05
within O 0 3.5810012377623934e-06
their O 0 1.7891759853227995e-05
POMC O 0 0.01646951027214527
genes O 0 0.00010380312596680596
. O 0 5.723838694393635e-05

Patient O 0 0.26529785990715027
1 O 0 0.0001424495130777359
was O 0 0.00010874623694689944
found O 0 4.650837126973784e-06
to O 0 1.154693109128857e-06
be O 0 1.073634280146507e-06
a O 0 1.9657456959976116e-06
compound O 0 1.925516698975116e-05
heterozygote O 0 1.2638207408599555e-05
for O 0 5.113506063025852e-07
two O 0 1.1647688324956107e-06
mutations O 0 6.8651374931505416e-06
in O 0 1.6402666460635373e-06
exon O 0 2.6556306693237275e-05
3 O 0 1.1426810488046613e-05
( O 0 2.0863953977823257e-06
G7013T O 0 3.293593545095064e-05
, O 0 1.8594824950923794e-06
C7133delta O 0 7.514723984058946e-05
) O 0 6.283956963670789e-07
which O 0 3.49195090620924e-07
interfere O 0 1.3963672245154157e-06
with O 0 4.634582637663698e-07
appropriate O 0 1.2993313021070207e-06
synthesis O 0 2.6364361929154256e-06
of O 0 1.3524753512683674e-06
ACTH O 0 0.00016726250760257244
and O 0 4.867285497311968e-06
alpha O 0 7.377810834441334e-05
- O 0 0.001011987216770649
MSH O 0 0.0025078346952795982
. O 0 7.395597640424967e-05

Patient O 1 0.5884142518043518
2 O 0 0.00044617734965868294
was O 0 0.00031846799538470805
homozygous O 0 9.517474245512858e-05
for O 0 1.7883509144667187e-06
a O 0 5.27082511325716e-06
mutation O 0 8.461096513201483e-06
in O 0 3.1379254323837813e-06
exon O 0 7.328425272135064e-05
2 O 0 9.881008736556396e-06
( O 0 3.6439589621295454e-06
C3804A O 0 0.00010729041241575032
) O 0 3.994081907876534e-06
which O 0 4.469644409255125e-06
abolishes O 0 0.0008202595636248589
POMC O 0 0.0025131627917289734
translation O 0 7.974119216669351e-05
. O 0 8.287421223940328e-05

These O 0 3.619021663325839e-05
findings O 0 2.2636702851741575e-05
represent O 0 3.938878307963023e-06
the O 0 1.0718367775552906e-06
first O 0 1.560649138809822e-06
examples O 0 1.355851168227673e-06
of O 0 1.7817526440921938e-06
a O 0 0.01920711249113083
genetic B-Disease 1 0.9998738765716553
defect I-Disease 1 0.9987082481384277
within O 0 3.8045786823204253e-06
the O 0 8.278730092570186e-06
POMC O 0 0.15275701880455017
gene O 0 1.1489807548059616e-05
and O 0 3.1508857318840455e-06
define O 0 1.0497307812329382e-05
a O 0 1.636786873859819e-05
new O 0 0.0002939086698461324
monogenic B-Disease 1 0.9965685606002808
endocrine I-Disease 1 0.9998574256896973
disorder I-Disease 1 0.9057165384292603
resulting O 0 6.936297722859308e-05
in O 0 1.6472095012431964e-05
early O 0 0.0040055387653410435
- O 1 0.9999300241470337
onset O 1 0.9999960660934448
obesity B-Disease 1 0.9999995231628418
, O 0 0.4537276327610016
adrenal B-Disease 1 0.9999997615814209
insufficiency I-Disease 1 0.9999996423721313
and O 0 0.004241524264216423
red O 0 0.2656410336494446
hair O 1 0.994945228099823
pigmentation O 0 0.37722352147102356
. O 0 5.781328945886344e-05
. O 0 8.880408859113231e-05

A O 0 0.0004293209931347519
European O 0 0.0001285470207221806
multicenter O 0 0.0027282589580863714
study O 0 5.559661076404154e-05
of O 0 0.0004172248882241547
phenylalanine B-Disease 1 1.0
hydroxylase I-Disease 1 0.9999996423721313
deficiency I-Disease 1 1.0
: O 0 6.083432708692271e-06
classification O 0 7.59030990593601e-06
of O 0 8.762473271417548e-07
105 O 0 1.6866588339325972e-05
mutations O 0 7.913722583907656e-06
and O 0 7.95630285210791e-07
a O 0 2.6103843993041664e-06
general O 0 1.2919645087094977e-06
system O 0 2.800645461320528e-06
for O 0 1.3184292129153619e-06
genotype O 0 0.00020414999744389206
- O 0 0.0002052541240118444
based O 0 4.40368194176699e-06
prediction O 0 2.8130976716056466e-05
of O 0 6.159028544061584e-06
metabolic O 1 0.7957488298416138
phenotype O 0 0.12531818449497223
. O 0 0.00018605662626214325

Phenylketonuria B-Disease 1 0.9994593262672424
( O 0 0.009661419317126274
PKU B-Disease 1 0.9903703331947327
) O 0 9.258359932573512e-05
and O 0 0.00015861155407037586
mild B-Disease 1 0.9950581789016724
hyperphenylalaninemia I-Disease 1 1.0
( O 0 0.04158812761306763
MHP B-Disease 1 0.9999997615814209
) O 0 1.96420332940761e-05
are O 0 1.2499549484346062e-05
allelic B-Disease 0 0.27700987458229065
disorders I-Disease 1 0.9996538162231445
caused O 0 0.0012461504666134715
by O 0 3.4848321774916258e-06
mutations O 0 1.5941408491926268e-05
in O 0 1.125538801716175e-06
the O 0 2.200866674684221e-06
gene O 0 1.5178891771938652e-05
encoding O 0 3.7520050682360306e-05
phenylalanine O 0 0.038176100701093674
hydroxylase O 0 0.02401723712682724
( O 0 7.422352064168081e-05
PAH O 1 0.9493917226791382
) O 0 2.7512591259437613e-05
. O 0 4.500612340052612e-05

Previous O 0 0.00016886323282960802
studies O 0 4.609832103597e-05
have O 0 1.5482100934605114e-05
suggested O 0 3.944652235077228e-06
that O 0 8.336361361216404e-07
the O 0 1.524258323115646e-06
highly O 0 5.19002878718311e-06
variable O 0 6.935358396731317e-05
metabolic O 0 0.28164562582969666
phenotypes O 0 0.013054395094513893
of O 0 0.011163583025336266
PAH B-Disease 1 1.0
deficiency I-Disease 1 0.9998676776885986
correlate O 0 0.00582129554823041
with O 0 0.015662487596273422
PAH O 1 0.999985933303833
genotypes O 0 0.01220625825226307
. O 0 0.0002042964188149199

We O 0 0.0001640643458813429
identified O 0 7.512531738029793e-05
both O 0 1.2114302080590278e-05
causative O 0 0.00010818667215062305
mutations O 0 4.8234705900540575e-05
in O 0 2.220129499619361e-05
686 O 0 0.013055783696472645
patients O 0 0.0003988170938100666
from O 0 3.745151616385556e-06
seven O 0 1.175718534796033e-05
European O 0 1.422544210072374e-05
centers O 0 6.837446562713012e-05
. O 0 5.45390066690743e-05

On O 0 4.783238910022192e-05
the O 0 6.127042070147581e-06
basis O 0 2.017986844293773e-06
of O 0 6.09918856753211e-07
the O 0 1.5241348592098802e-06
phenotypic O 0 1.0030466910393443e-05
characteristics O 0 5.734102160204202e-06
of O 0 2.9572918265330372e-06
297 O 0 0.0006465711048804224
functionally O 0 0.004772836808115244
hemizygous O 0 0.10225719958543777
patients O 0 0.0003216873446945101
, O 0 1.4261994465414318e-06
105 O 0 1.7651577763899695e-06
of O 0 3.709764087034273e-07
the O 0 1.7315944660367677e-06
mutations O 0 6.964195563341491e-06
were O 0 2.763962584140245e-06
assigned O 0 3.0103008157311706e-06
to O 0 5.190714205127733e-07
one O 0 4.983066901331767e-07
of O 0 3.4133279314119136e-07
four O 0 2.4456387563986937e-06
arbitrary O 0 1.94076474144822e-05
phenotype O 0 0.0007049760897643864
categories O 0 6.994402792770416e-05
. O 0 5.076239904155955e-05

We O 0 0.00011025734420400113
proposed O 0 3.6590619856724516e-05
and O 0 9.348012099508196e-06
tested O 0 2.5896359147736803e-05
a O 0 3.420898792683147e-06
simple O 0 4.770791292685317e-06
model O 0 6.493873115687165e-06
for O 0 1.3341091289476026e-06
correlation O 0 9.807827154872939e-06
between O 0 3.3466740205767564e-06
genotype O 0 0.00032025828841142356
and O 0 4.866533799940953e-06
phenotypic O 0 8.644884655950591e-05
outcome O 0 0.00010824849596247077
. O 0 5.309679909260012e-05

The O 0 0.0001315292902290821
observed O 0 0.00011542123684193939
phenotype O 0 0.0004891916760243475
matched O 0 6.510759703814983e-05
the O 0 6.089178896218073e-06
predicted O 0 9.109206439461559e-05
phenotype O 0 0.00011045622522942722
in O 0 5.1747133511526044e-06
79 O 0 3.129679316771217e-05
% O 0 7.954527632136887e-07
of O 0 3.692366590257734e-07
the O 0 2.425091679469915e-06
cases O 0 1.4479364836006425e-06
, O 0 1.423287585566868e-06
and O 0 1.2301353535804083e-06
in O 0 8.642657007840171e-07
only O 0 5.416846420303045e-07
5 O 0 8.531228559149895e-07
of O 0 5.144056558492593e-07
184 O 0 7.808049122104421e-05
patients O 0 0.00011234705743845552
was O 0 1.3777576896245591e-05
the O 0 9.80768390945741e-07
observed O 0 3.294883299531648e-06
phenotype O 0 9.446105650567915e-06
more O 0 2.78668238706814e-07
than O 0 3.5234924666838197e-07
one O 0 6.021942340339592e-07
category O 0 2.5439835553697776e-06
away O 0 2.437224338791566e-06
from O 0 1.3295505141286412e-06
that O 0 1.284240283894178e-06
expected O 0 1.1124557204311714e-05
. O 0 2.116570067300927e-05

Among O 0 9.150525147560984e-05
the O 0 1.4734118849446531e-05
seven O 0 1.680575223872438e-05
contributing O 0 1.4239789379644208e-05
centers O 0 7.441521574946819e-06
, O 0 1.4514632766804425e-06
the O 0 1.1187892141606426e-06
proportion O 0 6.56298016110668e-06
of O 0 2.0094735191378277e-06
patients O 0 0.0001269364875042811
for O 0 1.4305393278846168e-06
whom O 0 6.257278073462658e-06
the O 0 1.693414333203691e-06
observed O 0 1.742867061693687e-05
phenotype O 0 0.0002779922797344625
did O 0 1.037983201968018e-05
not O 0 1.2528803381428588e-06
match O 0 5.351198979042238e-06
the O 0 2.810068053804571e-06
predicted O 0 0.00017107445455621928
phenotype O 0 0.0002241960755782202
was O 0 2.7529757062438875e-05
4 O 0 4.3686668504960835e-06
% O 0 1.8443030285197892e-06
- O 0 0.0001058669004123658
23 O 0 3.9604317862540483e-05
% O 0 3.0480948680633446e-06
( O 0 2.6733303002401954e-06
P O 0 0.00114151940215379
< O 0 1.4135309356788639e-05
. O 0 7.186345669651928e-07
0001 O 0 2.6833946321858093e-05
) O 0 3.78737610162716e-07
, O 0 5.378075798034843e-07
suggesting O 0 2.2817746412329143e-06
that O 0 3.860591561988258e-07
differences O 0 1.1192694273631787e-06
in O 0 6.19485206243553e-07
methods O 0 1.8380713981969166e-06
used O 0 2.159813675461919e-06
for O 0 1.6784374565759208e-06
mutation O 0 2.113742448273115e-05
detection O 0 7.775505218887702e-05
or O 0 2.93424709525425e-05
phenotype O 0 0.05682262405753136
classification O 0 0.0020205306354910135
may O 0 3.39037760568317e-05
account O 0 1.6428340359198046e-06
for O 0 6.05162028932682e-07
a O 0 2.132307145075174e-06
considerable O 0 5.130464160174597e-06
proportion O 0 9.836892786552198e-06
of O 0 4.556248313747346e-06
genotype O 0 0.09879200905561447
- O 0 0.46977511048316956
phenotype O 0 0.019376564770936966
inconsistencies O 0 0.00040485913632437587
. O 0 0.00013145328557584435

Our O 0 0.0001862483040895313
data O 0 5.1524890295695513e-05
indicate O 0 2.2919550247024745e-05
that O 0 3.2225073027802864e-06
the O 0 2.755988680291921e-05
PAH O 1 0.9885578155517578
- O 0 0.0010095296893268824
mutation O 0 2.33906066569034e-05
genotype O 0 4.957454075338319e-05
is O 0 1.0852430705199367e-06
the O 0 7.124079388631799e-07
main O 0 3.1748654691909906e-06
determinant O 0 1.0062361980089918e-05
of O 0 2.6374270873930072e-06
metabolic O 0 0.2920883297920227
phenotype O 0 0.007335461676120758
in O 0 1.9218843590351753e-05
most O 0 8.325641101691872e-05
patients O 1 0.9066064357757568
with O 1 0.9635924696922302
PAH B-Disease 1 1.0
deficiency I-Disease 1 0.9994319081306458
. O 0 0.00013044611841905862

In O 0 6.570048572029918e-05
the O 0 1.071360929927323e-05
present O 0 5.256783879303839e-06
study O 0 2.2874000933370553e-06
, O 0 1.199118514705333e-06
the O 0 6.488905341939244e-07
classification O 0 6.148376996861771e-06
of O 0 1.389492808812065e-06
105 O 0 0.006671183742582798
PAH O 1 0.9992696642875671
mutations O 0 4.864532093051821e-05
may O 0 5.8841551435762085e-06
allow O 0 7.636107284270111e-07
the O 0 9.66194875218207e-07
prediction O 0 1.0639750144036952e-05
of O 0 4.3752152123488486e-07
the O 0 2.0204806787660345e-06
biochemical O 0 0.0006111310794949532
phenotype O 0 0.0001605779689271003
in O 0 4.689607976615662e-06
> O 0 5.3037791076349095e-05
10 O 0 4.287402589397971e-06
, O 0 1.3451228824123973e-06
000 O 0 4.2286687857995275e-06
genotypes O 0 1.7593260054127313e-05
, O 0 1.519880470368662e-06
which O 0 2.3709528704785043e-06
may O 0 9.687574674899224e-06
be O 0 4.6722155389034015e-07
useful O 0 4.993832476429816e-07
for O 0 4.059407672230009e-07
the O 0 1.888552446871472e-06
management O 0 1.7509921235614456e-05
of O 0 3.711742238010629e-06
hyperphenylalaninemia B-Disease 1 0.9999345541000366
in O 0 0.00018296627968084067
newborns O 1 0.9406595230102539
. O 0 0.0001187761954497546

Somatic O 0 0.0017799226334318519
instability O 0 0.0004131181340198964
of O 0 2.3247392164194025e-05
the O 0 2.2751906726625748e-05
CTG O 0 0.0065699294209480286
repeat O 0 8.951743075158447e-05
in O 0 7.500614628952462e-06
mice O 0 0.00018923520110547543
transgenic O 0 1.9339398932061158e-05
for O 0 2.845134076778777e-06
the O 0 0.00040819038986228406
myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 0.9999992847442627
region O 0 0.0003984621725976467
is O 0 1.3832872355123982e-05
age O 0 6.132851558504626e-05
dependent O 0 1.2044010873069055e-05
but O 0 2.1136684154043905e-06
not O 0 1.1527764627317083e-06
correlated O 0 3.845239461952588e-06
to O 0 6.128744303168787e-07
the O 0 9.067338169188588e-07
relative O 0 2.433674490021076e-05
intertissue O 0 0.00017410068539902568
transcription O 0 1.619406793906819e-05
levels O 0 1.2332257938396651e-05
and O 0 1.2492327186919283e-05
proliferative O 0 0.11352311819791794
capacities O 0 0.0008464882266707718
. O 0 0.00010522026423132047

A O 0 0.0009538033627904952
( O 0 0.00010126136476173997
CTG O 0 0.0012025908799842
) O 0 6.6971347223443445e-06
nexpansion O 0 3.720596942002885e-05
in O 0 1.8577949276732397e-06
the O 0 1.8640276948644896e-06
3 O 0 2.0115070583415218e-05
- O 0 0.0004526121192611754
untranslated O 0 0.00036423015990294516
region O 0 9.663122909842059e-06
( O 0 2.927162313426379e-06
UTR O 0 9.146442607743666e-05
) O 0 8.767488566263637e-07
of O 0 4.386244540910411e-07
the O 0 1.1011218703060877e-05
DM O 1 0.9999892711639404
protein O 0 7.776773418299854e-05
kinase O 0 0.00018133060075342655
gene O 0 2.2333462766255252e-05
( O 0 3.631040726759238e-06
DMPK O 0 0.0026435728650540113
) O 0 1.3706984418604407e-06
is O 0 1.2199828915981925e-06
responsible O 0 9.188614967570174e-06
for O 0 1.5862566215218976e-05
causing O 1 0.9587075710296631
myotonic B-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.09916260838508606
DM B-Disease 1 0.9999996423721313
) O 0 8.677276491653174e-05
. O 0 0.0001161319887614809

Major O 0 0.0006206907564774156
instability O 0 0.0009933903347700834
, O 0 1.5720837836852297e-05
with O 0 4.283859198039863e-06
very O 0 2.8687343274214072e-06
large O 0 2.0793220301129622e-06
expansions O 0 4.484369583224179e-06
between O 0 1.3789742752123857e-06
generations O 0 2.714639094847371e-06
and O 0 1.2843969443565584e-06
high O 0 1.3754367500951048e-05
levels O 0 2.353502850382938e-06
of O 0 8.783205203144462e-07
somatic O 0 4.993256879970431e-05
mosaicism O 0 0.0022544630337506533
, O 0 3.5803764149022754e-06
is O 0 1.6241032199104666e-06
observed O 0 6.602215762541164e-06
in O 0 2.9759259632555768e-05
patients O 0 0.001313357730396092
. O 0 4.473300214158371e-05

There O 0 8.812214946374297e-05
is O 0 8.325600902026054e-06
a O 0 6.8338358687469736e-06
good O 0 6.7456312535796314e-06
correlation O 0 6.134701379778562e-06
between O 0 3.137533440167317e-06
repeat O 0 5.992385922581889e-05
size O 0 1.580048046889715e-05
( O 0 8.815051160127041e-07
at O 0 4.545038336800644e-06
least O 0 1.3385160855250433e-06
in O 0 2.2285305476543726e-06
leucocytes O 0 0.0012787203304469585
) O 0 9.213291036758164e-07
, O 0 9.608158961782465e-07
clinical O 0 1.2642583897104487e-05
severity O 0 0.00014281971380114555
and O 0 7.095484306773869e-06
age O 0 4.793065818375908e-05
of O 0 1.2744472769554704e-05
onset O 1 0.8471822738647461
. O 0 0.00013007051893509924

The O 0 0.0005744635709561408
trinucleotide O 0 0.35516154766082764
repeat O 0 0.001856818562373519
instability O 0 0.0004783768090419471
mechanisms O 0 0.0001182477644761093
involved O 0 4.393041308503598e-05
in O 0 0.0001918192283483222
DM B-Disease 1 0.9999991655349731
and O 0 2.7416677767178044e-05
other O 0 8.43825182528235e-06
human O 0 0.0006746992585249245
genetic B-Disease 1 0.999996542930603
diseases I-Disease 1 0.9999982118606567
are O 0 5.1441278628772125e-05
unknown O 0 0.0005220563616603613
. O 0 0.00012034216342726722

We O 0 0.00013224761642049998
studied O 0 0.00013337956625036895
somatic O 0 0.00028322747675701976
instability O 0 9.980556205846369e-05
by O 0 7.026745151961222e-06
measuring O 0 0.0007923246594145894
the O 0 2.7901689463760704e-05
CTG O 0 0.008191388100385666
repeat O 0 5.496517042047344e-05
length O 0 9.213184057443868e-06
at O 0 4.748861556436168e-06
several O 0 7.823098258086247e-07
ages O 0 3.819123321591178e-06
in O 0 6.797085347898246e-07
various O 0 7.950424674163514e-07
tissues O 0 1.3026283340877853e-05
of O 0 1.215988277181168e-06
transgenic O 0 8.898684609448537e-05
mice O 0 8.591252844780684e-05
carrying O 0 1.231675469171023e-05
a O 0 1.0435592230351176e-05
( O 0 5.190380306885345e-06
CTG O 0 0.00019436913134995848
) O 0 1.883431764326815e-06
55expansion O 0 2.019187195401173e-05
surrounded O 0 5.05807247463963e-06
by O 0 9.152793154498795e-07
45 O 0 3.767210273508681e-06
kb O 0 0.00013736801338382065
of O 0 9.542628731651348e-07
the O 0 3.6651351820182754e-06
human O 0 1.042912572302157e-05
DM B-Disease 1 0.9998792409896851
region O 0 6.442526682803873e-06
, O 0 1.1581727221710025e-06
using O 0 1.573510758134944e-06
small O 0 7.396564797090832e-06
- O 0 0.0004023064684588462
pool O 0 0.00015919626457616687
PCR O 0 0.00026704222545959055
. O 0 3.581423879950307e-05

These O 0 6.8021981860511e-05
mice O 0 0.00087105727288872
have O 0 1.4192230082699098e-05
been O 0 8.970706403488293e-06
shown O 0 3.46773890669283e-06
to O 0 1.5774937764945207e-06
reproduce O 0 1.0241211384709459e-05
the O 0 1.1285225127721787e-06
intergenerational O 0 1.4290558283391874e-05
and O 0 1.3393498647928936e-06
somatic O 0 1.0670028132153675e-05
instability O 0 4.817512490262743e-06
of O 0 5.362691695154354e-07
the O 0 3.178209908583085e-06
55 O 0 0.00012416565732564777
CTG O 0 0.0011392045998945832
repeat O 0 2.3658400095882826e-05
suggesting O 0 4.7851358431216795e-06
that O 0 6.224853450476076e-07
surrounding O 0 1.7252814359380864e-06
sequences O 0 1.4845169289401383e-06
and O 0 6.813277764194936e-07
the O 0 1.0041788982562139e-06
chromatin O 0 1.30865837491001e-05
environment O 0 8.41010933072539e-06
are O 0 9.244094485438836e-07
involved O 0 3.4252473142259987e-06
in O 0 9.274222065869253e-06
instability O 0 0.00038669697823934257
mechanisms O 0 0.00033797393552958965
. O 0 9.156722808256745e-05

As O 0 5.126420364831574e-05
observed O 0 2.267494892294053e-05
in O 0 1.5647148075004225e-06
some O 0 4.945782734466775e-07
of O 0 3.6421832305677526e-07
the O 0 3.0801008961134357e-06
tissues O 0 0.0002022404660237953
of O 0 6.310685421340168e-05
DM B-Disease 1 1.0
patients O 0 0.31829634308815
, O 0 5.688453256880166e-06
there O 0 2.3418829186994117e-06
is O 0 7.375957125077548e-07
a O 0 2.2253873339650454e-06
tendency O 0 2.9711607112403726e-06
for O 0 9.479335858486593e-07
repeat O 0 1.374812563881278e-05
length O 0 5.662743660650449e-06
and O 0 3.2248990464722738e-06
somatic O 0 3.892620952683501e-05
mosaicism O 0 0.00012886831245850772
to O 0 1.6624466070425115e-06
increase O 0 1.469232529416331e-06
with O 0 7.282047818080173e-07
the O 0 1.5033457430035924e-06
age O 0 5.6551070883870125e-06
of O 0 1.3277993957672152e-06
the O 0 1.2192141184641514e-05
mouse O 0 0.000366395601304248
. O 0 6.442469748435542e-05

Furthermore O 0 0.0004550071607809514
, O 0 3.412897058296949e-05
we O 0 7.27742190065328e-06
observed O 0 5.938040885666851e-06
no O 0 1.792778903109138e-06
correlation O 0 3.130464847345138e-06
between O 0 8.333682330885495e-07
the O 0 2.1740477222920163e-06
somatic O 0 3.7631096347467974e-05
mutation O 0 2.104106533806771e-05
rate O 0 8.764890480961185e-06
and O 0 8.77126967679942e-06
tissue O 0 0.009053745307028294
proliferation O 0 0.00038525403942912817
capacity O 0 8.819158392725512e-05
. O 0 4.097487544640899e-05

The O 0 0.00010761152225313708
somatic O 0 0.0005215351120568812
mutation O 0 0.0001391217519994825
rates O 0 1.7158208720502444e-05
in O 0 3.1414076602231944e-06
different O 0 1.6077742657216731e-06
tissues O 0 8.093745418591425e-05
were O 0 1.8007753169513308e-05
also O 0 3.1416293495567515e-06
not O 0 9.881891855911817e-07
correlated O 0 2.706759687498561e-06
to O 0 4.474880199722975e-07
the O 0 7.423068382195197e-07
relative O 0 8.129561138048302e-06
inter O 0 2.4030427084653638e-05
- O 0 0.005962328985333443
tissue O 0 0.00014946084411349148
difference O 0 2.8536314857774414e-06
in O 0 1.1221895874768961e-06
transcriptional O 0 1.3608692825073376e-05
levels O 0 1.3660175000040908e-06
of O 0 2.0070744710665167e-07
the O 0 8.349720133082883e-07
three O 0 2.3948757643665886e-06
genes O 0 4.652838015317684e-06
( O 0 1.4787688087380957e-06
DMAHP O 0 0.00021099367586430162
, O 0 2.8145361739007058e-06
DMPK O 0 0.0005646956851705909
and O 0 2.5085801098612137e-06
59 O 0 1.715205689833965e-05
) O 0 7.025620334388805e-07
surrounding O 0 2.281534989378997e-06
the O 0 1.8950166804643231e-06
repeat O 0 7.923311204649508e-05
. O 0 7.566604836029001e-06
. O 0 2.970884452224709e-05

A O 0 0.00044691518996842206
novel O 0 0.00020071727340109646
missense O 0 0.00032690915395505726
mutation O 0 0.00013308264897204936
in O 0 3.054740955121815e-05
patients O 0 0.0023275301791727543
from O 0 3.7420243188535096e-06
a O 0 4.3467760406201705e-05
retinoblastoma B-Disease 0 0.29586902260780334
pedigree O 0 0.010027159936726093
showing O 0 6.90244123688899e-05
only O 0 3.244466142859892e-06
mild O 0 3.385476520634256e-05
expression O 0 2.814085291902302e-06
of O 0 2.163060344173573e-06
the O 0 0.0001508395653218031
tumor B-Disease 1 0.8759729862213135
phenotype O 0 0.013264646753668785
. O 0 0.00011868628644151613

We O 0 0.00011916098446818069
have O 0 1.7080497855204158e-05
used O 0 7.92717492004158e-06
single O 0 1.1974435437878128e-05
strand O 0 3.2979183743009344e-05
conformation O 0 3.5124965506838635e-05
polymorphism O 0 1.4418430509977043e-05
analysis O 0 2.8168292374175508e-06
to O 0 1.178176262328634e-06
study O 0 1.4632576039730338e-06
the O 0 1.1240692856517853e-06
27 O 0 1.113766757043777e-05
exons O 0 4.777470621775137e-06
of O 0 6.681968898192281e-07
the O 0 3.5319676499057095e-06
RB1 O 0 0.0016965485410764813
gene O 0 3.7190275179455057e-06
in O 0 1.1792385521403048e-06
individuals O 0 5.314305440151657e-07
from O 0 7.165199349401519e-07
a O 0 9.28692224988481e-06
family O 0 4.0671846363693476e-05
showing O 0 7.088015991030261e-05
mild O 0 6.883510650368407e-05
expression O 0 1.9638587218651082e-06
of O 0 1.132443685492035e-06
the O 0 1.9261191482655704e-05
retinoblastoma B-Disease 0 0.472202867269516
phenotype O 0 0.10756974667310715
. O 0 9.785238216863945e-05

In O 0 0.00017741072224453092
this O 0 2.178638897021301e-05
family O 0 0.00010496871254872531
affected O 0 4.6961340558482334e-05
individuals O 0 6.2320568758877926e-06
developed O 0 8.992639777716249e-05
unilateral B-Disease 0 0.07820689678192139
tumors I-Disease 1 0.9999996423721313
and O 0 8.792313019512221e-05
, O 0 6.221545845619403e-06
as O 0 8.225139822570782e-07
a O 0 2.874118081308552e-06
result O 0 2.836615976775647e-06
of O 0 8.435118274974229e-07
linkage O 0 9.430214413441718e-05
analysis O 0 6.795692570449319e-06
, O 0 4.603685738402419e-06
unaffected O 0 6.155562005005777e-05
mutation O 0 1.033841817843495e-05
carriers O 0 1.2484311810112558e-05
were O 0 6.941200354049215e-06
also O 0 2.3480304207623703e-06
identified O 0 3.6818739772570552e-06
within O 0 1.633103806852887e-06
the O 0 7.234959866764257e-06
pedigree O 0 0.0011157537810504436
. O 0 5.6190274335676804e-05

A O 0 0.0002575647667981684
single O 0 7.633440691279247e-05
band O 0 5.6218243116745725e-05
shift O 0 1.5927746062516235e-05
using O 0 6.099506663304055e-06
SSCP O 0 0.002513265237212181
was O 0 2.5489727704552934e-05
identified O 0 4.289317075745203e-06
in O 0 1.7058839603123488e-06
exon O 0 3.5954300983576104e-05
21 O 0 1.4402146007341798e-05
which O 0 1.0040707820735406e-06
resulted O 0 6.327330083877314e-06
in O 0 2.3267384676728398e-06
a O 0 6.73735075906734e-06
missense O 0 2.9015016480116174e-05
mutation O 0 7.194971203716705e-06
converting O 0 7.74480668042088e-06
a O 0 1.1893924238393083e-05
cys O 0 0.020932869985699654
- O 0 0.000989095657132566
- O 0 0.0003910064115189016
> O 0 6.412075890693814e-05
arg O 0 2.8276059310883284e-05
at O 0 7.862958227633499e-06
nucleotide O 0 1.32222694446682e-05
position O 0 6.1516143432527315e-06
28 O 0 7.51953757571755e-06
in O 0 3.0357891773746815e-06
the O 0 8.277103916043416e-06
exon O 0 0.00034338439581915736
. O 0 0.00011527560855029151

The O 0 0.00018557610746938735
mutation O 0 0.0005439793458208442
destroyed O 0 0.0004024633963126689
an O 0 3.081371687585488e-05
NdeI O 0 0.0005254143034107983
restriction O 0 5.380832590162754e-05
enzyme O 0 0.00014534153160639107
site O 0 9.714356565382332e-05
. O 0 7.045950769679621e-05

Analysis O 0 7.878587348386645e-05
of O 0 1.3040228623140138e-05
all O 0 4.373210686026141e-06
family O 0 2.1443946025101468e-05
members O 0 3.782816975217429e-06
demonstrated O 0 7.337101123994216e-06
that O 0 7.71291183809808e-07
the O 0 1.5926752894301899e-06
missense O 0 3.662214658106677e-05
mutation O 0 2.784623757179361e-05
co O 0 0.00010869232937693596
- O 0 0.0005285285296849906
segregated O 0 8.028543379623443e-05
with O 0 2.2532267394126393e-05
patients O 0 0.005975932814180851
with O 0 0.005277151707559824
tumors B-Disease 1 0.9999998807907104
or O 0 0.00018600480689201504
who O 0 8.848709694575518e-05
, O 0 1.4596045048165252e-06
as O 0 3.9319510847235506e-07
a O 0 1.8927607925434131e-06
result O 0 1.3215535545896273e-06
of O 0 4.7558458504681766e-07
linkage O 0 3.868960993713699e-05
analysis O 0 3.0198382319213124e-06
had O 0 6.363538705045357e-05
been O 0 5.683518338628346e-06
predicted O 0 5.256919394014403e-06
to O 0 6.85102293118689e-07
carry O 0 6.363924512697849e-06
the O 0 1.3392091204877943e-05
predisposing O 0 0.0015134498244151473
mutation O 0 0.00019151509332004935
. O 0 5.561590660363436e-05

These O 0 3.334828943479806e-05
observations O 0 2.944166772067547e-05
point O 0 1.20152035378851e-05
to O 0 3.43168858307763e-06
another O 0 2.9984075808897614e-06
region O 0 2.5039098545676097e-06
of O 0 1.0187177394982427e-06
the O 0 1.5973839254002087e-05
RB1 O 0 0.0062532247975468636
gene O 0 7.419567737088073e-06
where O 0 3.116473635600414e-06
mutations O 0 4.158494448347483e-06
only O 0 5.533464104701125e-07
modify O 0 2.1342398213164415e-06
the O 0 4.0210852603195235e-07
function O 0 6.007773549754347e-07
of O 0 2.3525171854998916e-07
the O 0 7.635757697244117e-07
gene O 0 2.27462646762433e-06
and O 0 7.134814836717851e-07
raise O 0 1.7309010900135036e-06
important O 0 5.104765250507626e-07
questions O 0 1.1369278354322887e-06
for O 0 9.427865279576508e-07
genetic O 0 7.467727118637413e-05
counseling O 0 9.820937702897936e-05
in O 0 7.685373020649422e-06
families O 0 1.937761226145085e-05
with O 0 2.8625688628380885e-06
these O 0 1.5402297321998049e-06
distinctive O 0 4.3297812226228416e-05
phenotypes O 0 0.00019284195150248706
. O 0 1.0957939593936317e-05
. O 0 3.831082722172141e-05

Maternal B-Disease 0 0.3425903618335724
disomy I-Disease 1 0.860293447971344
and O 0 0.1843799203634262
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
consistent O 0 0.0008491428452543914
with O 0 3.1539031624561176e-05
gamete O 0 0.0006451699882745743
complementation O 0 0.04480300098657608
in O 0 6.653882792306831e-06
a O 0 5.446369414130459e-06
case O 0 2.6508394057600526e-06
of O 0 1.5270403537215316e-06
familial O 0 0.019739676266908646
translocation O 0 0.038261137902736664
( O 0 5.979347861284623e-06
3 O 0 9.028345630213153e-06
; O 0 1.9818205601040972e-06
15 O 0 4.644477485271636e-06
) O 0 9.373947591484466e-07
( O 0 9.298808549829118e-07
p25 O 0 1.747002352203708e-05
; O 0 1.5403503539346275e-06
q11 O 0 4.892464494332671e-05
. O 0 1.621401224838337e-06
2 O 0 8.95140055945376e-06
) O 0 6.93611900715041e-06
. O 0 2.3515496650361456e-05

Maternal B-Disease 1 0.8725711703300476
uniparental I-Disease 1 0.9980611205101013
disomy I-Disease 1 0.9954472184181213
( I-Disease 0 0.003807397559285164
UPD I-Disease 1 0.9999829530715942
) I-Disease 0 2.7305704861646518e-05
for I-Disease 0 8.146052095980849e-06
chromosome I-Disease 0 0.0034687810111790895
15 I-Disease 0 3.6923658626619726e-05
is O 0 2.8408883281372255e-06
responsible O 0 4.317897946748417e-06
for O 0 5.265532081466517e-07
an O 0 1.179084506475192e-06
estimated O 0 3.2653570087859407e-06
30 O 0 1.7514311139166239e-06
% O 0 5.114091550240119e-07
of O 0 5.068760060567001e-07
cases O 0 3.3107960462075425e-06
of O 0 0.0002067126042675227
Prader B-Disease 1 1.0
- I-Disease 1 1.0
Willi I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.01375261414796114
PWS B-Disease 1 0.9999994039535522
) O 0 8.38566993479617e-05
. O 0 7.537525380030274e-05

We O 0 0.00017333889263682067
report O 0 2.47607513301773e-05
on O 0 3.351701707288157e-06
an O 0 1.722059437270218e-06
unusual O 0 3.2970365282380953e-06
case O 0 1.985215931199491e-06
of O 0 1.2844484444940463e-06
maternal B-Disease 0 0.003573959693312645
disomy I-Disease 0 0.08747720718383789
15 I-Disease 0 4.357940997579135e-05
in O 0 0.00019039063772652298
PWS B-Disease 1 0.9999997615814209
that O 0 3.6367448501550825e-06
is O 0 8.063851169026748e-07
most O 0 5.019899163016817e-07
consistent O 0 2.4685086827958003e-06
with O 0 1.2541308933577966e-06
adjacent O 0 1.7910608221427538e-05
- O 0 0.00036148802610114217
1 O 0 2.1364799067669082e-06
segregation O 0 2.9932332381577e-06
of O 0 4.0407675783171726e-07
a O 0 1.28855426737573e-05
paternal O 0 0.1127660945057869
t O 0 0.07419208437204361
( O 0 1.053182586474577e-06
3 O 0 3.7182544474489987e-06
; O 0 9.523781727693859e-07
15 O 0 3.667149030661676e-06
) O 0 5.250598746897595e-07
( O 0 3.723257293586357e-07
p25 O 0 6.896681043144781e-06
; O 0 1.0493587296878104e-06
q11 O 0 1.8949982404592447e-05
. O 0 4.854445023738663e-07
2 O 0 1.0374103567301063e-06
) O 0 2.717540610319702e-07
with O 0 4.207462893646152e-07
simultaneous O 0 1.0245948942610994e-05
maternal O 0 0.00016179984959308058
meiotic O 0 0.0002676963631529361
nondisjunction O 0 0.003028180683031678
for O 0 9.293522452935576e-06
chromosome O 0 0.0028222689870744944
15 O 0 0.00011691555118886754
. O 0 6.160617340356112e-05

The O 0 0.00033686895039863884
patient O 0 0.17528456449508667
( O 0 4.402389458846301e-05
J O 0 0.09870883077383041
. O 0 5.037200480728643e-06
B O 0 5.8809520851355046e-05
. O 0 4.5652592461919994e-07
) O 0 2.7967729465672164e-07
, O 0 2.566690966432361e-07
a O 0 1.9101380530628376e-06
17 O 0 2.0083560229977593e-05
- O 0 3.8841328205307946e-05
year O 0 3.845631908916403e-06
- O 0 7.210332114482298e-05
old O 0 6.677730561932549e-05
white O 0 1.2834692824981175e-05
male O 0 9.454045539314393e-06
with O 0 2.0914752894896083e-05
PWS B-Disease 1 0.999998927116394
, O 0 1.1677925613184925e-05
was O 0 4.000313856522553e-05
found O 0 1.7389454569638474e-06
to O 0 6.168653499116772e-07
have O 0 1.6803898006401141e-06
47 O 0 6.962455699976999e-06
chromosomes O 0 3.7118979889783077e-06
with O 0 8.429215654359723e-07
a O 0 7.2581397034809925e-06
supernumerary O 0 0.012763399630784988
, O 0 1.3808712537866086e-05
paternal O 0 0.004594909958541393
der O 0 0.27943143248558044
( O 0 1.9050916080232128e-06
15 O 0 2.4853770810295828e-06
) O 0 4.0348064089812397e-07
consisting O 0 4.7139732828327396e-07
of O 0 2.8606154955923557e-07
the O 0 2.2878668914927403e-06
short O 0 3.125003422610462e-05
arm O 0 0.04344850033521652
and O 0 2.8698536880256142e-06
the O 0 3.639117721832008e-06
proximal O 0 0.0008121576975099742
long O 0 0.00032560373074375093
arm O 0 0.028475895524024963
of O 0 2.8056442715751473e-06
chromosome O 0 0.0014105170266702771
15 O 0 2.797036722768098e-05
, O 0 5.1671190703928005e-06
and O 0 1.1944348443648778e-05
distal O 0 0.034945812076330185
chromosome O 0 0.27490583062171936
arm O 1 0.9397479891777039
3p O 1 0.8353224396705627
. O 0 0.0002910091425292194

The O 0 0.0002632061659824103
t O 0 0.008922264911234379
( O 0 5.417505235527642e-06
3 O 0 3.9993724385567475e-06
; O 0 1.0343400163037586e-06
15 O 0 2.3339680410572328e-06
) O 0 6.586830068044947e-07
was O 0 3.0504095320793567e-06
present O 0 3.987115064774116e-07
in O 0 4.2292793978049303e-07
the O 0 5.721390152757522e-07
balanced O 0 2.486498487996869e-06
state O 0 6.542805977005628e-07
in O 0 9.293258358411549e-07
the O 0 8.840468581183814e-06
patients O 0 0.00047977990470826626
father O 0 6.0873033362440765e-05
and O 0 3.5591262985690264e-06
a O 0 3.807034590863623e-05
sister O 0 0.01316163968294859
. O 0 6.497820868389681e-05

Fluorescent O 0 0.00045415747445076704
in O 0 3.592609937186353e-05
situ O 0 9.260073420591652e-05
hybridization O 0 1.9499590052873828e-05
analysis O 0 7.817095138307195e-06
demonstrated O 0 1.409258766216226e-05
that O 0 1.7534869130031439e-06
the O 0 1.269296080863569e-05
PWS B-Disease 1 0.9999865293502808
critical O 0 2.6938043447444215e-05
region O 0 1.7325264707324095e-05
resided O 0 5.988090197206475e-05
on O 0 2.5911720058502397e-06
the O 0 4.008471933047986e-06
derivative O 0 5.536909884540364e-05
chromosome O 0 0.00010726963955676183
3 O 0 4.6198842937883455e-06
and O 0 1.929819745782879e-06
that O 0 8.612501574134512e-07
there O 0 1.8201307057097438e-06
was O 0 2.774746644718107e-05
no O 0 1.6063014527389896e-06
deletion O 0 7.12458677298855e-06
of O 0 1.2339928616711404e-06
the O 0 5.203704859013669e-05
PWS B-Disease 1 0.9999979734420776
region O 0 6.476142061728751e-06
on O 0 2.0421111912583e-06
the O 0 1.4993938748375513e-06
normal O 0 4.365143468021415e-06
pair O 0 5.924414381297538e-06
of O 0 8.702794502823963e-07
15s O 0 7.178985833888873e-05
present O 0 7.2372235990769695e-06
in O 0 3.3999840525211766e-05
J O 1 0.7994688153266907
. O 0 8.48625713842921e-05

B O 0 0.02731912024319172
. O 0 0.0015375377843156457

Methylation O 0 0.0004510957805905491
analysis O 0 6.25606335233897e-05
at O 0 2.5229410312022083e-05
exon O 0 5.276541560306214e-05
alpha O 0 1.2585538570419885e-05
of O 0 1.5672775361963431e-06
the O 0 3.1018259960546857e-06
small O 0 1.0386922440375201e-05
nuclear O 0 0.0003970452235080302
ribonucleoprotein O 0 0.0004442890640348196
- O 0 0.00043902816832996905
associated O 0 1.603366581548471e-05
polypeptide O 0 6.86480852891691e-05
N O 0 0.00033224804792553186
( O 0 3.0728979254490696e-06
SNRPN O 0 0.0004001599445473403
) O 0 1.7455183751735603e-06
gene O 0 3.41275926984963e-06
showed O 0 4.003215053671738e-06
a O 0 1.432020440006454e-06
pattern O 0 5.601950761047192e-06
characteristic O 0 1.3370283795666182e-06
of O 0 3.063012457005243e-07
only O 0 7.560211656709726e-07
the O 0 2.865248461603187e-06
maternal O 0 0.002785429824143648
chromosome O 0 0.011795131489634514
15 O 0 7.553109026048332e-05
in O 0 5.666757715516724e-05
J O 1 0.8626348376274109
. O 0 9.978452726500109e-05

B O 0 0.02907850220799446
. O 0 0.0016329598147422075

Maternal B-Disease 0 0.35797932744026184
disomy I-Disease 0 0.47829416394233704
was O 0 0.0014033820480108261
confirmed O 0 3.8004614907549694e-05
by O 0 4.966806045558769e-06
polymerase O 0 3.6046691093361005e-05
chain O 0 4.126776912016794e-05
reaction O 0 5.014543603465427e-06
analysis O 0 1.3236398217486567e-06
of O 0 8.779235258771223e-07
microsatellite O 0 6.137572199804708e-05
repeats O 0 1.0613724043651018e-05
at O 0 4.673241164709907e-06
the O 0 3.884485067828791e-06
gamma O 0 5.435302955447696e-05
- O 0 0.00025355519028380513
aminobutyric O 0 0.0004580735694617033
acid O 0 3.428797208471224e-05
receptor O 0 2.551531360950321e-05
beta3 O 0 6.097447476349771e-05
subunit O 0 2.159962423320394e-05
( O 0 7.685548553126864e-06
GABRB3 O 0 0.0011187423951923847
) O 0 1.4214430848369375e-05
locus O 0 0.00030326584237627685
. O 0 0.0001041862997226417

A O 0 0.0015714106848463416
niece O 0 0.44448885321617126
( O 0 7.16077774995938e-05
B O 0 0.00041656213579699397
. O 0 3.387531933185528e-06
B O 0 3.157394166919403e-05
. O 0 5.14606313117838e-07
) O 0 3.0381994520212174e-07
with O 0 2.752622663138027e-07
45 O 0 1.70664384313568e-06
chromosomes O 0 2.971639560200856e-06
and O 0 6.127458505034156e-07
the O 0 1.0177709555136971e-06
derivative O 0 7.012038167886203e-06
3 O 0 2.5174597340082983e-06
but O 0 1.0209108722847304e-06
without O 0 1.327576455878443e-06
the O 0 1.8900353779827128e-06
der O 0 0.003477443940937519
( O 0 6.746737994944851e-07
15 O 0 2.7458529530122178e-06
) O 0 5.489203545039345e-07
demonstrated O 0 2.9337550131458556e-06
a O 0 4.755886948260013e-06
phenotype O 0 0.00018937131972052157
consistent O 0 3.7853969843126833e-06
with O 0 1.3100742535243626e-06
that O 0 1.832509042287711e-06
reported O 0 1.0030418707174249e-05
for O 0 1.084340851775778e-06
haploinsufficiency O 0 0.00011742257629521191
of O 0 2.6487848572287476e-06
distal O 0 0.0009428055491298437
3 O 0 0.00019598710059653968
p O 0 0.01837490312755108
. O 0 5.446198338177055e-05

Uniparental B-Disease 1 0.9999085664749146
disomy I-Disease 1 0.9997645020484924
associated O 0 0.0006236628978513181
with O 0 3.2539726817049086e-05
unbalanced O 0 0.002962335478514433
segregation O 0 9.17052966542542e-05
of O 0 2.871154038075474e-06
non O 0 3.6861740227323025e-05
- O 0 0.0012592358980327845
Robertsonian O 0 0.0006703031249344349
translocations O 0 0.00011808415729319677
has O 0 1.1684018318192102e-05
been O 0 1.7221420421265066e-05
reported O 0 5.616675116471015e-05
previously O 0 1.9019085812033154e-05
but O 0 1.9059893929807004e-06
has O 0 1.2685123920164187e-06
not O 0 5.426618372439407e-07
, O 0 2.5422855287615675e-07
to O 0 2.2281172107341263e-07
our O 0 6.203850375641196e-07
knowledge O 0 6.314932647910609e-07
, O 0 6.222859383342438e-07
been O 0 1.2272130334167741e-06
observed O 0 9.566977041686187e-07
in O 0 4.7146480142146174e-07
a O 0 4.8443303057865705e-06
case O 0 5.165089078218443e-06
of O 0 2.1848976757610217e-05
PWS B-Disease 1 0.999996542930603
. O 0 0.00014372343139257282

Furthermore O 0 0.0004686556349042803
, O 0 3.59262376150582e-05
our O 0 1.4759826626686845e-05
findings O 0 8.139102646964602e-06
are O 0 1.1404669066905626e-06
best O 0 2.8539768663904397e-06
interpreted O 0 2.9431369057419943e-06
as O 0 1.1883807928825263e-06
true O 0 6.862715054012369e-06
gamete O 0 5.553604205488227e-05
complementation O 0 0.00041511288145557046
resulting O 0 3.660521178971976e-05
in O 0 3.636697510955855e-05
maternal B-Disease 1 0.5357286334037781
UPD I-Disease 1 0.9999926090240479
15 I-Disease 0 0.0017095031216740608
and O 0 0.0022552483715116978
PWS B-Disease 1 0.9999717473983765

Schwartz B-Disease 1 0.9384618997573853
- I-Disease 1 0.9944145679473877
Jampel I-Disease 1 0.9996507167816162
syndrome I-Disease 1 0.9999973773956299
type I-Disease 0 0.0005216608988121152
2 I-Disease 0 6.87091305735521e-05
and O 0 0.00010988116991939023
Stuve B-Disease 1 0.9960010647773743
- I-Disease 1 0.9999840259552002
Wiedemann I-Disease 1 0.9999994039535522
syndrome I-Disease 1 0.9999996423721313
: O 0 5.956876975687919e-06
a O 0 9.819956176215783e-06
case O 0 4.954571977577871e-06
for O 0 1.6770774209362571e-06
" O 0 1.1908566193596926e-05
lumping O 0 0.0002157433918910101
" O 0 2.6012690796051174e-05
. O 0 2.740619493124541e-05

Recent O 0 0.00022937325411476195
studies O 0 5.214643897488713e-05
demonstrated O 0 4.547187563730404e-05
the O 0 5.504088221641723e-06
existence O 0 7.5555221883405466e-06
of O 0 1.6417970982729457e-06
a O 0 2.0355882952571847e-05
genetically O 0 2.3242891984409653e-05
distinct O 0 2.679300223462633e-06
, O 0 2.068250978481956e-06
usually O 0 1.645174734221655e-06
lethal O 0 6.834552550571971e-06
form O 0 6.94290861247282e-07
of O 0 8.951604968387983e-07
the O 0 4.5409386075334623e-05
Schwartz B-Disease 1 0.8177903294563293
- I-Disease 1 0.9998180270195007
Jampel I-Disease 1 0.9999879598617554
syndrome I-Disease 1 0.9999992847442627
( O 0 2.8253036362002604e-05
SJS B-Disease 0 0.4006136655807495
) O 0 1.2757442391375662e-06
of O 0 1.4232197145247483e-06
myotonia B-Disease 0 0.3856496512889862
and O 0 0.00010988190479110926
skeletal B-Disease 1 0.9816070795059204
dysplasia I-Disease 1 0.9994598031044006
, O 0 1.0869989637285471e-05
which O 0 2.3063473690854153e-06
we O 0 6.102025963627966e-06
called O 0 4.629418981494382e-05
SJS B-Disease 1 0.6367975473403931
type I-Disease 0 5.4436022765003145e-05
2 I-Disease 0 4.2037507228087634e-05
. O 0 3.7715093640144914e-05

This O 0 0.0008516880334354937
disorder O 1 0.9926193356513977
is O 0 1.4615512554883026e-05
reminiscent O 0 3.736893631867133e-05
of O 0 3.6213023122400045e-06
another O 0 4.689931665780023e-05
rare O 0 7.261961582116783e-05
condition O 0 0.008752194233238697
, O 0 7.750370059511624e-06
the O 0 3.661540540633723e-05
Stuve B-Disease 1 0.9982990622520447
- I-Disease 1 0.999990701675415
Wiedemann I-Disease 1 0.9999997615814209
syndrome I-Disease 1 0.9999998807907104
( O 0 4.101866579730995e-05
SWS B-Disease 1 0.7550223469734192
) O 0 4.324887868278893e-06
, O 0 1.204340037475049e-06
which O 0 8.694183861734928e-07
comprises O 0 3.498771775412024e-06
campomelia B-Disease 0 0.0002219674497609958
at O 0 3.438644125708379e-05
birth O 0 0.0012789638713002205
with O 0 5.786403562524356e-05
skeletal B-Disease 1 0.9963608384132385
dysplasia I-Disease 1 0.9999161958694458
, O 0 0.0002329623093828559
contractures B-Disease 1 0.8656912446022034
, O 0 1.1916620678675827e-05
and O 0 6.1472564993891865e-06
early B-Disease 0 5.548961053136736e-05
death I-Disease 0 0.0006646214169450104
. O 0 5.313229848979972e-05

To O 0 6.802814459661022e-05
test O 0 6.419281999114901e-05
for O 0 5.59082809559186e-06
possible O 0 1.3570421288022771e-05
nosologic O 0 0.0005074476357549429
identity O 0 1.2955097190570086e-05
between O 0 4.740219537779922e-06
these O 0 1.6458056052215397e-05
disorders O 1 0.9289841651916504
, O 0 1.0532706255617086e-05
we O 0 1.7635339872867917e-06
reviewed O 0 5.965536615804012e-07
the O 0 2.5031789618878975e-07
literature O 0 2.574736868155014e-07
and O 0 5.259078079689061e-07
obtained O 0 1.3761076615992351e-06
a O 0 9.297851306655502e-07
follow O 0 6.722210059706413e-07
- O 0 1.3796918210573494e-05
up O 0 5.097560347167018e-07
of O 0 1.5933103725274123e-07
the O 0 4.5265537096383923e-07
only O 0 4.576178298520972e-07
two O 0 2.1655989712598966e-06
surviving O 0 0.006573616061359644
patients O 0 5.611321103060618e-05
, O 0 7.920297093733097e-07
one O 0 7.092218083926127e-07
with O 0 7.044512585707707e-06
SJS B-Disease 0 0.4378339946269989
type I-Disease 0 7.460607321263524e-06
2 I-Disease 0 2.1662103790731635e-06
at O 0 1.0240859410259873e-05
age O 0 5.129872079123743e-06
10 O 0 1.2920976359964698e-06
years O 0 1.3867062307326705e-06
and O 0 8.76849185260653e-07
another O 0 1.7703450794215314e-06
with O 0 5.677581611962523e-06
SWS B-Disease 1 0.5568124651908875
at O 0 0.0001007189930533059
age O 0 4.404631181387231e-05
7 O 0 2.6976887966156937e-05
years O 0 2.371710979787167e-05
. O 0 2.4852162823663093e-05

Patients O 1 0.991279661655426
reported O 0 0.001120250322856009
as O 0 3.24006614391692e-05
having O 0 0.00015694134344812483
either O 0 0.0002478887909092009
neonatal O 1 0.999998927116394
SJS B-Disease 1 0.9999092817306519
or O 0 8.492174674756825e-05
SWS B-Disease 0 0.3707812428474426
presented O 0 8.302187779918313e-06
a O 0 4.97733299198444e-06
combination O 0 9.360750482301228e-06
of O 0 1.5493343425987405e-06
a O 0 0.00024571269750595093
severe O 1 0.9896332025527954
, O 0 0.011210708878934383
prenatal O 1 0.9999994039535522
- O 1 1.0
onset O 1 1.0
neuromuscular B-Disease 1 1.0
disorder I-Disease 1 0.9999996423721313
( O 0 0.0005482863634824753
with O 0 0.26298317313194275
congenital B-Disease 1 1.0
joint I-Disease 1 0.999711811542511
contractures I-Disease 1 0.9999994039535522
, O 0 0.43663039803504944
respiratory O 1 0.999444305896759
and O 0 0.0006109491805545986
feeding O 0 0.016704687848687172
difficulties O 0 0.010567636229097843
, O 0 6.997595392022049e-06
tendency O 0 9.419711204827763e-06
to O 0 8.718846402189229e-06
hyperthermia B-Disease 0 0.3424857258796692
, O 0 4.213657575746765e-06
and O 0 2.331878704353585e-06
frequent O 0 2.8063805075362325e-05
death O 0 0.009064074605703354
in O 0 2.7644380679703318e-05
infancy O 0 0.1281139850616455
) O 0 1.4374428474184242e-06
with O 0 8.397522606173879e-07
a O 0 4.0556069507147186e-06
distinct O 0 1.680729110375978e-05
campomelic B-Disease 0 0.15860247611999512
- I-Disease 1 0.7546389698982239
metaphyseal I-Disease 1 0.8849122524261475
skeletal I-Disease 1 0.9249167442321777
dysplasia I-Disease 1 0.9994627833366394
. O 0 0.0002334158925805241

The O 0 5.64522051718086e-05
similarity O 0 4.959989382768981e-05
of O 0 6.376183591783047e-06
the O 0 8.293949576909654e-06
clinical O 0 0.0002046873705694452
and O 0 1.3684722034668084e-05
radiographic O 0 0.1364871710538864
findings O 0 7.400485628750175e-05
is O 0 1.946226575455512e-06
so O 0 1.3198206261222367e-06
extensive O 0 5.512598363566212e-06
that O 0 6.646525434916839e-06
these O 0 8.988055924419314e-06
disorders O 1 0.8088575005531311
appear O 0 1.8714319594437256e-05
to O 0 2.3262571176019264e-06
be O 0 2.672170694495435e-06
a O 0 6.967763056309195e-06
single O 0 9.531441901344806e-05
entity O 0 0.00010600994573906064
. O 0 4.7111065214267e-05

The O 0 6.795422814320773e-05
follow O 0 2.5550647478667088e-05
- O 0 3.962196205975488e-05
up O 0 2.993727321154438e-06
observation O 0 4.3476907194417436e-06
of O 0 5.044104227636126e-07
an O 0 1.8732142734734225e-06
identical O 0 2.485074037394952e-05
and O 0 3.2161397029994987e-06
unique O 0 1.9242863800172927e-06
pattern O 0 8.337050530826673e-06
of O 0 3.880608346662484e-06
progressive O 0 0.42942073941230774
bone B-Disease 1 0.9992374181747437
dysplasia I-Disease 1 0.9997677206993103
in O 0 4.217712921672501e-05
the O 0 1.977678039111197e-05
two O 0 0.0005303802900016308
patients O 0 0.022449348121881485
( O 0 9.710992117106798e-07
one O 0 1.259311829926446e-06
with O 0 2.0715908249258064e-05
SJS B-Disease 1 0.9522177577018738
type I-Disease 0 2.812735692714341e-05
2 I-Disease 0 5.177818366064457e-06
, O 0 1.1481934052426368e-06
one O 0 1.3294820746523328e-06
with O 0 6.555536401720019e-06
SWS B-Disease 1 0.5361148118972778
) O 0 2.5688261757750297e-06
surviving O 0 1.3238974133855663e-05
beyond O 0 6.893229056004202e-06
infancy O 0 0.0003342878189869225
adds O 0 3.4478346151445294e-06
to O 0 5.295359528645349e-07
the O 0 9.439444283998455e-07
evidence O 0 1.8472110241418704e-06
in O 0 1.363470346404938e-06
favor O 0 4.535490916168783e-06
of O 0 3.1548429433314595e-06
identity O 0 8.051468466874212e-05
. O 0 6.139738252386451e-05

The O 0 9.514851990388706e-05
hypothesis O 0 7.159719098126516e-05
that O 0 1.0942660992441233e-05
SWS B-Disease 0 0.0452328659594059
and O 0 5.5585685913683847e-05
SJS B-Disease 1 0.8500180244445801
type I-Disease 0 4.643001011572778e-05
2 I-Disease 0 4.524345058598556e-06
are O 0 4.892215770269104e-07
the O 0 1.6191560234801727e-06
same O 0 5.446728027891368e-05
disorder O 1 0.5403895974159241
should O 0 2.9692516818613512e-06
be O 0 6.597807669095346e-07
testable O 0 4.1853068069031e-06
by O 0 7.553372256552393e-07
molecular O 0 1.5034150237624999e-05
methods O 0 1.1652515240712091e-05
. O 0 1.245982275577262e-05
. O 0 4.526916745817289e-05

A O 0 0.0005942001007497311
mouse O 0 0.0007872040732763708
model O 0 0.00013523781672120094
of O 0 0.00017479329835623503
severe O 1 0.9999997615814209
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 1.0
: O 0 0.0514451265335083
defects O 1 0.999776303768158
in O 0 0.0017659763107076287
hemostasis O 1 0.999704897403717
and O 0 0.028351401910185814
thrombosis B-Disease 1 0.999932050704956
. O 0 0.00043878049473278224

von B-Disease 1 0.9999136924743652
Willebrand I-Disease 1 0.9997805953025818
factor I-Disease 0 0.03648167476058006
( I-Disease 0 0.001482094288803637
vWf I-Disease 1 0.9260736107826233
) I-Disease 0 0.36001503467559814
deficiency I-Disease 1 0.999990701675415
causes O 1 0.916083037853241
severe O 1 0.9999998807907104
von B-Disease 1 1.0
Willebrand I-Disease 1 1.0
disease I-Disease 1 0.9999998807907104
in O 0 0.0011073678033426404
humans O 0 0.00041424366645514965
. O 0 8.721833728486672e-05

We O 0 0.00011836440535262227
generated O 0 3.838250268017873e-05
a O 0 1.0946627298835665e-05
mouse O 0 2.5329751224489883e-05
model O 0 4.664914285967825e-06
for O 0 1.0137972594748135e-06
this O 0 3.324013960082084e-06
disease O 0 8.145917672663927e-05
by O 0 1.3554516726799193e-06
using O 0 8.149432687787339e-06
gene O 0 4.166565486229956e-05
targeting O 0 0.00011334672308294103
. O 0 6.947127258172259e-05

vWf B-Disease 0 0.08080242574214935
- I-Disease 1 0.9301338195800781
deficient I-Disease 1 0.8983251452445984
mice O 0 0.006088630296289921
appeared O 0 9.525572386337444e-05
normal O 0 2.2229429305298254e-05
at O 0 2.8292080969549716e-05
birth O 0 0.0003838798147626221
; O 0 2.3465038339054445e-06
they O 0 2.3587720079376595e-06
were O 0 5.540024631045526e-06
viable O 0 1.7436501366319135e-05
and O 0 7.943035598145798e-06
fertile O 0 0.00018245949468109757
. O 0 3.63775143341627e-05

Neither O 0 0.003493753494694829
vWf O 0 0.00523217162117362
nor O 0 0.0007682889117859304
vWf O 0 0.00222103763371706
propolypeptide O 0 0.04190313443541527
( O 0 0.00013116294576320797
von B-Disease 1 0.9935845732688904
Willebrand I-Disease 1 0.9751937389373779
antigen O 0 0.001995568862184882
II O 0 0.007933632470667362
) O 0 3.785050466831308e-06
were O 0 3.6561389151756885e-06
detectable O 0 1.7099011529353447e-05
in O 0 2.6170373530476354e-06
plasma O 0 3.5682580346474424e-05
, O 0 7.545419521193253e-06
platelets O 0 7.865449879318476e-05
, O 0 2.1841040052095195e-06
or O 0 3.5309637951286277e-06
endothelial O 0 3.159090192639269e-05
cells O 0 3.3470253129053162e-06
of O 0 1.0135024695046013e-06
the O 0 7.25613244867418e-06
homozygous O 0 0.0007446705712936819
mutant O 0 0.0006859166896902025
mice O 0 0.0012010775972157717
. O 0 7.921980432001874e-05

The O 0 0.00017949202447198331
mutant O 0 0.00176521809771657
mice O 0 0.10085488110780716
exhibited O 0 0.08263938128948212
defects O 1 0.9903370141983032
in O 0 0.000111065644887276
hemostasis O 1 0.6741359829902649
with O 0 1.109226741391467e-05
a O 0 6.110619870014489e-05
highly O 0 0.00021651059796568006
prolonged O 1 0.8074547052383423
bleeding O 1 0.8826037049293518
time O 0 1.5305675333365798e-05
and O 0 1.2310038073337637e-05
spontaneous O 0 9.32468828978017e-05
bleeding O 0 0.10416963696479797
events O 0 3.0580263228330296e-06
in O 0 2.7746032174036372e-06
approximately O 0 2.293905708938837e-06
10 O 0 3.601155412980006e-06
% O 0 2.9203868052718462e-06
of O 0 6.733446298312629e-06
neonates O 0 0.035322535783052444
. O 0 8.83757893461734e-05

As O 0 6.838138506282121e-05
in O 0 2.208592923125252e-05
the O 0 9.18682781048119e-06
human O 0 1.933344356075395e-05
disease O 0 0.0209211353212595
, O 0 3.529307605276699e-06
the O 0 3.562821120794979e-06
factor O 0 7.0911896727920976e-06
VIII O 0 0.0010153716430068016
level O 0 4.810080554307206e-06
in O 0 2.5150791316264076e-06
these O 0 1.2600278296304168e-06
mice O 0 0.00023006476112641394
was O 0 2.7085647161584347e-05
reduced O 0 4.427584372024285e-06
strongly O 0 1.3839528492098907e-06
as O 0 4.0789973354549147e-07
a O 0 1.2700629667961039e-06
result O 0 5.971592713649443e-07
of O 0 1.8386781164281274e-07
the O 0 1.1545015468072961e-06
lack O 0 8.006532880244777e-06
of O 0 1.5442127505593817e-06
protection O 0 2.7666295864037238e-05
provided O 0 1.7671722162049264e-05
by O 0 1.6449206668767147e-05
vWf O 0 0.000662834441754967
. O 0 7.389872189378366e-05

Defective O 1 0.9482889771461487
thrombosis B-Disease 1 0.9988632202148438
in O 0 0.0004352028772700578
mutant O 0 0.00869736634194851
mice O 0 0.10411778092384338
was O 0 0.0006442219601012766
also O 0 5.751688149757683e-06
evident O 0 6.049789135431638e-06
in O 0 1.1299559901090106e-06
an O 0 1.3736125765717588e-06
in O 0 5.836483069288079e-06
vivo O 0 0.00016083817172329873
model O 0 1.3260303603601642e-05
of O 0 2.7376807338441722e-05
vascular B-Disease 1 0.9999533891677856
injury I-Disease 1 0.9991831183433533
. O 0 0.00031402515014633536

In O 0 9.672971646068618e-05
this O 0 1.0555480912444182e-05
model O 0 1.633661668165587e-05
, O 0 3.7689353575842688e-06
the O 0 4.8707497626310214e-06
exteriorized O 0 0.00046127752284519374
mesentery O 0 0.000479165930300951
was O 0 7.252992509165779e-05
superfused O 0 0.00021157608716748655
with O 0 1.0228824976366013e-05
ferric O 0 0.002611754462122917
chloride O 0 3.8373091229004785e-05
and O 0 2.7689516173268203e-06
the O 0 3.3039136724255513e-06
accumulation O 0 2.6439256544108503e-05
of O 0 4.158673164056381e-06
fluorescently O 0 0.07589328289031982
labeled O 0 0.0005589136853814125
platelets O 0 0.0003414349630475044
was O 0 3.3712523872964084e-05
observed O 0 1.2301317838137038e-05
by O 0 4.766089205077151e-06
intravital O 0 0.0003487438661977649
microscopy O 0 0.00011161816655658185
. O 0 6.016921906848438e-05

We O 0 0.00014359889610204846
conclude O 0 5.232806142885238e-05
that O 0 3.933221250917995e-06
these O 0 2.63111883214151e-06
mice O 0 8.54650788824074e-05
very O 0 6.39070822217036e-06
closely O 0 3.8678623241139576e-05
mimic O 0 0.1706468015909195
severe O 1 0.996828019618988
human O 0 0.2688703238964081
von B-Disease 1 1.0
Willebrand I-Disease 1 0.9999998807907104
disease I-Disease 1 0.9999995231628418
and O 0 0.0003753870551008731
will O 0 1.5829016774659976e-05
be O 0 1.7675025674179778e-06
very O 0 5.84388487823162e-07
useful O 0 5.754847620664805e-07
for O 0 3.216914308268315e-07
investigating O 0 2.025265075644711e-06
the O 0 4.271325337867893e-07
role O 0 6.458616894633451e-07
of O 0 4.219163542984461e-07
vWf O 0 1.2479182259994559e-05
in O 0 1.655232722441724e-06
normal O 0 1.783129118848592e-05
physiology O 0 4.9458711146144196e-05
and O 0 1.3244909496279433e-05
in O 0 0.0007140684756450355
disease O 0 0.13328519463539124
models O 0 5.150317883817479e-05
. O 0 1.1595107025641482e-05
. O 0 3.7622088711941615e-05

Oral O 0 0.0030342084355652332
contraceptives O 0 0.15121980011463165
and O 0 7.325958722503856e-05
the O 0 3.518403900670819e-05
risk O 0 0.0014717676676809788
of O 0 0.000514511892106384
hereditary B-Disease 1 1.0
ovarian I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.000798670225776732

Hereditary B-Disease 1 0.9999992847442627
Ovarian I-Disease 1 1.0
Cancer I-Disease 1 0.9999953508377075
Clinical O 1 0.6301780939102173
Study O 0 0.0005325888632796705
Group O 0 0.000805992225650698
. O 0 0.0001503398671047762

BACKGROUND O 0 0.0010825337376445532
Women O 0 0.00019994481408502907
with O 0 1.873483597591985e-05
mutations O 0 6.433684029616416e-05
in O 0 3.206104338460136e-06
either O 0 4.467079179448774e-06
the O 0 5.6924368436739314e-06
BRCA1 O 0 0.0008806288824416697
or O 0 3.7252855236147298e-06
the O 0 3.645981905719964e-06
BRCA2 O 0 0.00016429413517471403
gene O 0 4.604317837220151e-06
have O 0 1.036611251947761e-06
a O 0 4.261411504558055e-06
high O 0 0.0014480091631412506
lifetime O 0 0.014560490846633911
risk O 0 0.010870416648685932
of O 0 0.024994684383273125
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999986886978149
. O 0 0.0005006740684621036

Oral O 0 0.0017785337986424565
contraceptives O 1 0.7487257122993469
protect O 0 0.08887404948472977
against O 1 0.956531822681427
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999982118606567
in O 0 2.699758260860108e-05
general O 0 9.098730515688658e-06
, O 0 5.253701601759531e-06
but O 0 1.8293137600267073e-06
it O 0 6.240646825972362e-07
is O 0 3.245182540467795e-07
not O 0 3.9100982007767016e-07
known O 0 1.0545926443228382e-06
whether O 0 5.495745654116035e-07
they O 0 1.563348519084684e-06
also O 0 1.514710334049596e-06
protect O 0 2.8290974114497658e-06
against O 0 3.362413963259314e-06
hereditary B-Disease 0 0.0044244020245969296
forms I-Disease 0 2.4804830900393426e-05
of I-Disease 0 0.23141887784004211
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 0.00047456397442147136

METHODS O 0 0.00037540349876508117
We O 0 5.862239413545467e-05
enrolled O 0 8.186348713934422e-05
207 O 0 0.00019284544396214187
women O 0 7.994378393050283e-05
with O 0 0.005012450739741325
hereditary B-Disease 1 0.9999998807907104
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
and O 0 1.428685209248215e-05
161 O 0 2.0503524865489453e-05
of O 0 8.280002816718479e-07
their O 0 1.2804899597540498e-05
sisters O 0 0.0002649202069733292
as O 0 8.860378670760838e-07
controls O 0 1.0290986210748088e-05
in O 0 1.8557514067651937e-06
a O 0 8.737707503314596e-06
case O 0 1.1605692634475417e-05
- O 0 0.003605147358030081
control O 0 4.3392094084993005e-05
study O 0 1.8283200915902853e-05
. O 0 2.8074671718059108e-05

All O 0 4.775581692229025e-05
the O 0 3.415202445467003e-05
patients O 0 0.00012255614274181426
carried O 0 2.294174555572681e-05
a O 0 1.1031429494323675e-05
pathogenic O 0 2.1662539438693784e-05
mutation O 0 8.95646371645853e-06
in O 0 3.1502968340646476e-06
either O 0 1.377091757603921e-05
BRCA1 O 0 0.0004468191182240844
( O 0 1.950702881003963e-06
179 O 0 1.6305721146636643e-05
women O 0 1.9949537090724334e-05
) O 0 2.834863607859006e-06
or O 0 5.083145424578106e-06
BRCA2 O 0 0.00036859154351986945
( O 0 5.05509206050192e-06
28 O 0 8.201992022804916e-05
women O 0 4.0886425267672166e-05
) O 0 1.3609082088805735e-05
. O 0 2.8371025109663606e-05

The O 0 8.131466893246397e-05
control O 0 0.00014741615450475365
women O 0 4.437233292264864e-05
were O 0 9.59954377321992e-06
enrolled O 0 1.5242295376083348e-05
regardless O 0 2.081639649986755e-06
of O 0 5.292865239425737e-07
whether O 0 1.8275176216775435e-06
or O 0 2.4444448172289412e-06
not O 0 1.5524727814408834e-06
they O 0 3.291918346803868e-06
had O 0 2.4427101379842497e-05
either O 0 1.2269203580217436e-05
mutation O 0 7.476840255549178e-05
. O 0 2.946602035081014e-05

Lifetime O 0 0.001586517901159823
histories O 0 0.00023755960864946246
of O 0 2.353025774937123e-05
oral O 0 0.00018333843036089092
- O 0 0.034357912838459015
contraceptive O 0 0.013027165085077286
use O 0 7.2100756369763985e-06
were O 0 1.3106742699164897e-05
obtained O 0 6.387204848579131e-06
by O 0 7.810268698449363e-07
interview O 0 1.6773696188465692e-05
or O 0 8.100818149614497e-07
by O 0 4.11005657952046e-07
written O 0 7.839872182557883e-07
questionnaire O 0 7.040590389806312e-06
and O 0 1.2536416988950805e-06
were O 0 4.4040098146069795e-06
compared O 0 3.860653578158235e-06
between O 0 3.664135647341027e-06
patients O 0 9.920598677126691e-05
and O 0 3.0862668154441053e-06
control O 0 8.22131842141971e-05
women O 0 3.943566480302252e-05
, O 0 3.2588643534836592e-06
after O 0 9.22968229133403e-06
adjustment O 0 4.506345248955768e-06
for O 0 3.3904234442161396e-07
year O 0 1.201892587232578e-06
of O 0 6.635636395913025e-07
birth O 0 0.00014940723485779017
and O 0 8.655542842461728e-06
parity O 0 0.0001779491431079805
. O 0 3.483392356429249e-05

RESULTS O 0 0.0007886746316216886
The O 0 7.378099689958617e-05
adjusted O 0 0.00110530701931566
odds O 0 0.000764920434448868
ratio O 0 0.0005713067366741598
for O 0 0.12048560380935669
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999994039535522
associated O 0 3.818178811343387e-05
with O 0 1.4757257531528012e-06
any O 0 8.798480166660738e-07
past O 0 1.3498672615241958e-06
use O 0 8.286054367090401e-07
of O 0 1.1830808261947823e-06
oral O 0 4.012731369584799e-05
contraceptives O 0 0.28231024742126465
was O 0 0.0022644426207989454
0 O 0 0.00021521106828004122
. O 0 6.752800982212648e-05

5 O 0 0.0003107399679720402
( O 0 2.792037594190333e-05
95 O 0 2.966357715195045e-05
percent O 0 2.1225450836936943e-05
confidence O 0 1.748314025462605e-05
interval O 0 1.371074358758051e-05
, O 0 1.7772147202776978e-06
0 O 0 3.6147052924206946e-06
. O 0 5.789025294689054e-07
3 O 0 1.3367440487854765e-06
to O 0 1.0425796972413082e-06
0 O 0 1.1090808584413026e-05
. O 0 2.2521799110108986e-06
8 O 0 1.72267737070797e-05
) O 0 9.268553185393102e-06
. O 0 2.3466660422855057e-05

The O 0 0.00016020724433474243
risk O 0 0.000878454593475908
decreased O 0 7.809360977262259e-05
with O 0 2.8864706109743565e-06
increasing O 0 4.339881797932321e-06
duration O 0 1.2551630788948387e-05
of O 0 9.063231800610083e-07
use O 0 2.904228040279122e-06
( O 0 3.2923985600064043e-06
P O 0 0.00045444414718076587
for O 0 9.148046729023918e-07
trend O 0 6.088424015615601e-06
, O 0 2.259037728435942e-06
< O 0 1.852275636338163e-05
0 O 0 8.078536666289438e-06
. O 0 8.736656127439346e-07
001 O 0 2.145173857570626e-05
) O 0 5.595045422523981e-07
; O 0 2.256371232078891e-07
use O 0 3.389447158497205e-07
for O 0 3.3901972074090736e-07
six O 0 2.372122253291309e-06
or O 0 7.488904429919785e-07
more O 0 2.3993169406821835e-07
years O 0 2.370898755543749e-06
was O 0 1.6788868379080668e-05
associated O 0 9.857983513938962e-07
with O 0 5.449271043289627e-07
a O 0 4.313445060688537e-06
60 O 0 1.6884532669791952e-05
percent O 0 3.104978532064706e-05
reduction O 0 2.1240313799353316e-05
in O 0 2.7055237296735868e-05
risk O 0 0.0011674287961795926
. O 0 5.524884181795642e-05

Oral O 0 0.001773027703166008
- O 0 0.00706107635051012
contraceptive O 0 0.002459118142724037
use O 0 3.143342837574892e-05
protected O 0 0.002491166815161705
against O 1 0.7576522827148438
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999899864196777
both O 0 3.340516968819429e-06
for O 0 1.956452479134896e-06
carriers O 0 7.994180123205297e-06
of O 0 7.447964094353665e-07
the O 0 1.0028429642261472e-05
BRCA1 O 0 0.023937132209539413
mutation O 0 6.226744881132618e-05
( O 0 1.6596363821008708e-06
odds O 0 5.197208156459965e-05
ratio O 0 1.981160676223226e-05
, O 0 2.1599000774585875e-06
0 O 0 6.10649112786632e-06
. O 0 3.6146047932561487e-07
5 O 0 7.950978329063219e-07
; O 0 4.132353126351518e-07
95 O 0 1.7053488363671931e-06
percent O 0 3.14586577587761e-06
confidence O 0 1.0294607818650547e-05
interval O 0 6.956814104341902e-06
, O 0 1.1515303413034417e-06
0 O 0 2.061595068880706e-06
. O 0 2.5316111873507907e-07
3 O 0 8.744766546442406e-07
to O 0 6.281327387114288e-07
0 O 0 5.648720161843812e-06
. O 0 3.9731924061925383e-07
9 O 0 2.206212684541242e-06
) O 0 2.3752411948407826e-07
and O 0 2.0982548676329316e-07
for O 0 2.446305416015093e-07
carriers O 0 1.3398007467912976e-06
of O 0 3.8512879996233096e-07
the O 0 8.242584954132326e-06
BRCA2 O 0 0.0008851792081259191
mutation O 0 2.0850784494541585e-05
( O 0 1.8953221569972811e-06
odds O 0 5.8381276176078245e-05
ratio O 0 1.1381341209926177e-05
, O 0 1.3618616776511772e-06
0 O 0 2.0387758468132233e-06
. O 0 2.697297531994991e-07
4 O 0 8.447588584203913e-07
; O 0 5.007958634450915e-07
95 O 0 1.1125639503006823e-06
percent O 0 1.8033108517556684e-06
confidence O 0 5.2558966672222596e-06
interval O 0 3.706542429426918e-06
, O 0 7.721264978499676e-07
0 O 0 2.5956585432140855e-06
. O 0 2.5788531843318196e-07
2 O 0 5.212635301177215e-07
to O 0 2.6097418981407827e-07
1 O 0 1.2918868605993339e-06
. O 0 6.245493295864435e-07
1 O 0 3.761311972994008e-06
) O 0 4.018825620732969e-06
. O 0 1.3268096154206432e-05

CONCLUSIONS O 0 0.0007991984602995217
Oral O 0 0.00043209875002503395
- O 0 0.003123324830085039
contraceptive O 0 0.0038950685411691666
use O 0 1.1084093785029836e-05
may O 0 3.123543501715176e-05
reduce O 0 1.1225406524317805e-05
the O 0 6.413236405933276e-06
risk O 0 0.0008546513272449374
of O 0 0.010074799880385399
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999995231628418
in O 0 6.958266021683812e-05
women O 0 8.878240623744205e-05
with O 0 1.482166499044979e-05
pathogenic O 0 7.255758828250691e-05
mutations O 0 1.703142152109649e-05
in O 0 3.6733727029059082e-06
the O 0 1.8025932149612345e-05
BRCA1 O 0 0.01496436633169651
or O 0 0.00013762102753389627
BRCA2 O 0 0.007628747262060642
gene O 0 0.0009563736384734511

A O 0 0.00042407630826346576
Japanese O 0 0.0002005068672588095
family O 0 0.00015074970724526793
with O 0 3.772117634071037e-05
adrenoleukodystrophy B-Disease 1 0.9999703168869019
with O 0 9.554609277984127e-06
a O 0 1.6518484699190594e-05
codon O 0 5.0764290790539235e-05
291 O 0 4.1520885133650154e-05
deletion O 0 7.390964310616255e-05
: O 0 2.7080247946287272e-06
a O 0 1.3831699106958695e-05
clinical O 0 0.00039961322909221053
, O 0 1.2265729310456663e-05
biochemical O 0 0.0009982084156945348
, O 0 8.845233423926402e-06
pathological O 0 0.00011830077710328624
, O 0 6.248994850466261e-06
and O 0 1.8714943507802673e-05
genetic O 0 0.00046944478526711464
report O 0 4.922095831716433e-05
. O 0 3.696826024679467e-05

We O 0 0.00015600823098793626
report O 0 2.344733184145298e-05
a O 0 6.742505775036989e-06
Japanese O 0 1.9132494344376028e-05
family O 0 7.002212078077719e-05
with O 0 0.0022428391966968775
adrenoleukodystrophy B-Disease 1 1.0
( O 0 0.012378048151731491
ALD B-Disease 1 0.9999997615814209
) O 0 2.453537035762565e-06
with O 0 1.0311684945918387e-06
a O 0 3.6259436910768272e-06
three O 0 3.132632855340489e-06
base O 0 3.5756056604441255e-05
pair O 0 4.203638673061505e-05
deletion O 0 9.964522905647755e-05
( O 0 4.103925220988458e-06
delGAG O 0 9.966385550796986e-05
291 O 0 2.222743751190137e-05
) O 0 2.2411347799788928e-06
in O 0 3.4368797514616745e-06
the O 0 9.574074647389352e-05
ALD B-Disease 1 0.9999966621398926
gene O 0 0.00018714729230850935
. O 0 8.472551417071372e-05

A O 0 0.00017079361714422703
variety O 0 2.3049815354170278e-05
of O 0 1.323310425505042e-05
phenotypes O 0 0.000357105047442019
were O 0 2.427846447972115e-05
observed O 0 1.4595471839129459e-05
within O 0 4.576952051138505e-06
this O 0 6.29539954388747e-06
family O 0 0.00023870870063547045
. O 0 7.354840636253357e-05

While O 0 0.0001487221452407539
the O 0 2.747580765571911e-05
proband O 0 0.018235664814710617
( O 0 1.3609861525765155e-05
patient O 0 0.001711241202428937
1 O 0 1.3394186680670828e-05
) O 0 1.8873838598665316e-06
was O 0 3.018462120962795e-05
classified O 0 9.110347491514403e-06
as O 0 1.0964596413032268e-06
having O 0 7.514196568081388e-06
a O 0 2.601849473649054e-06
rare O 0 5.204581611906178e-06
intermediate O 0 1.2044757568219211e-05
type O 0 5.934412001806777e-06
of O 0 1.5562053476969595e-06
adult O 0 8.904346759663895e-05
cerebral O 0 0.409366637468338
and O 0 0.00025412492686882615
cerebello O 1 0.951300323009491
- O 1 0.9072356820106506
brain O 0 0.37158718705177307
stem O 0 1.9672908820211887e-05
forms O 0 1.6595557781329262e-06
, O 0 1.6716036270736367e-06
his O 0 2.8329199267318472e-05
younger O 0 0.0001965882402146235
brother O 0 0.003685391740873456
( O 0 1.983894890145166e-06
patient O 0 3.098296656389721e-05
2 O 0 3.743498382391408e-06
) O 0 8.033385938688298e-07
and O 0 2.662831775523955e-06
nephew O 0 0.03542737662792206
( O 0 4.703865215560654e-06
patient O 0 9.081936877919361e-05
3 O 0 9.757151019584853e-06
) O 0 1.7815997352954582e-06
had O 0 2.973310802190099e-05
a O 0 7.441381603712216e-05
childhood O 1 0.9808032512664795
ALD B-Disease 1 0.9999996423721313
type O 0 0.004594853613525629
. O 0 0.0001643928699195385

Another O 0 0.0007977286004461348
nephew O 0 0.43473395705223083
( O 0 8.38356718304567e-05
patient O 0 0.0032467686105519533
4 O 0 3.196199031663127e-05
) O 0 1.589952603353595e-06
of O 0 1.8245398223371012e-06
patient O 0 0.012237981893122196
1 O 0 2.253880120406393e-05
was O 0 0.00020276123541407287
classified O 0 1.9458297174423933e-05
as O 0 1.5169973721640417e-06
having O 0 8.39576568978373e-06
an O 0 3.6432290926313726e-06
adolescent O 0 0.00030737242195755243
form O 0 2.8498039682745002e-05
. O 0 4.856865416513756e-05

The O 0 0.00010728651977842674
tau O 0 0.00013531690638046712
level O 0 2.1434090740513057e-05
in O 0 7.758393621770665e-06
the O 0 2.472184678481426e-05
cerebrospinal O 1 0.8070328831672668
fluid O 0 0.3636605441570282
( O 0 3.5035849577980116e-05
CSF O 1 0.7730476260185242
) O 0 3.1557094644085737e-06
in O 0 4.541931957646739e-06
patient O 0 0.0012539380695670843
1 O 0 4.335244739195332e-06
was O 0 1.3152219253242947e-05
as O 0 3.71372863128272e-07
high O 0 3.14542467094725e-06
as O 0 3.6399470104697684e-07
that O 0 2.7806748903458356e-07
of O 0 1.5284914525182103e-06
patients O 0 0.003722628578543663
with O 0 0.024214696139097214
Alzheimers B-Disease 1 0.9999998807907104
disease I-Disease 1 0.9833065867424011
( O 0 1.3894919902668335e-05
AD B-Disease 0 0.0003296626964583993
) O 0 2.1556406863965094e-05
. O 0 3.2263695175061e-05

His O 0 0.0008366903639398515
brain O 0 0.00926786009222269
magnetic O 0 0.00023281089670490474
resonance O 0 0.0005814068717882037
image O 0 0.0013818981824442744
( O 0 1.3853361451765522e-05
MRI O 1 0.540969729423523
) O 0 1.2545538993435912e-05
showed O 0 0.0014132767682895064
abnormalities B-Disease 1 0.8199653029441833
in I-Disease 0 4.537870609055972e-06
the I-Disease 0 4.1572138798073865e-06
bilateral I-Disease 0 4.276712206774391e-05
cerebellar I-Disease 0 0.0038245057221502066
hemispheres I-Disease 0 0.013331599533557892
and O 0 0.002819086192175746
brain O 1 0.9225449562072754
stem O 0 0.00016383639012929052
, O 0 4.974262537871255e-06
but O 0 1.8139841131414869e-06
not O 0 6.73550005103607e-07
in O 0 9.665109246270731e-07
the O 0 8.644207809993532e-06
cerebral O 0 0.30836790800094604
white O 0 3.752255724975839e-05
matter O 0 2.3088564375939313e-06
, O 0 1.396038328493887e-06
where O 0 2.290799102411256e-06
marked O 0 6.124915671534836e-06
reductions O 0 4.873848865827313e-06
of O 0 1.0982198546116706e-06
the O 0 1.1069779247918632e-05
cerebral O 0 0.44415298104286194
blood O 0 0.0007755564874969423
flow O 0 9.78684147412423e-06
and O 0 9.359339856018778e-06
oxygen O 0 0.003561242949217558
metabolism O 0 3.103756171185523e-05
were O 0 5.988056273054099e-06
clearly O 0 5.001380941394018e-06
demonstrated O 0 4.1370790313521866e-06
by O 0 2.0185816538287327e-06
positron O 0 0.0001242373400600627
emission O 0 2.270121331093833e-05
tomography O 0 0.00016334193060174584
( O 0 8.751969289733097e-06
PET O 0 0.0003021170268766582
) O 0 1.3886284250475e-05
. O 0 2.8013428163831122e-05

In O 0 0.0006163244834169745
patients O 0 0.0657334253191948
2 O 0 2.413992115180008e-05
and O 0 5.212106316321297e-06
3 O 0 7.557071057817666e-06
, O 0 8.495675842823402e-07
the O 0 1.3135521612639423e-06
autopsy O 0 0.0022991627920418978
findings O 0 1.3608174413093366e-05
showed O 0 5.030397733207792e-05
massive O 0 0.0021649657282978296
demyelination B-Disease 1 0.9981465339660645
of I-Disease 0 3.3710732623148942e-06
the I-Disease 0 7.30489773559384e-05
cerebral I-Disease 1 0.984310507774353
white I-Disease 0 0.00014898601511958987
matter I-Disease 0 1.7504327161077526e-06
with O 0 1.0709570688050007e-06
sparing O 0 5.271564077702351e-06
of O 0 9.099225053432747e-07
the O 0 7.633670065843035e-06
U O 0 0.1786947101354599
- O 0 0.10445790737867355
fibers O 0 0.0007628705934621394
, O 0 1.4532126897393027e-06
compatible O 0 2.8701902010652702e-06
with O 0 1.1289455414953409e-06
the O 0 3.601395974328625e-06
findings O 0 9.717220564198215e-06
of O 0 1.4442100109590683e-05
childhood O 1 0.9507380723953247
ALD B-Disease 1 0.9999991655349731
. O 0 0.0004213143256492913

Oleic O 0 0.010554680600762367
and O 0 0.0003484529152046889
erucic O 0 0.00844532810151577
acids O 0 0.00013922419748269022
( O 0 1.0907019714068156e-05
Lorenzos O 0 0.00012784826685674489
Oil O 0 6.9373495534819085e-06
) O 0 9.936723017744953e-07
were O 0 1.2516455853983643e-06
administered O 0 2.528952109059901e-06
to O 0 1.976614612431149e-06
patients O 0 1.517679265816696e-05
1 O 0 1.4680699678137898e-06
and O 0 1.0180242497881409e-06
4 O 0 2.910177727244445e-06
, O 0 5.924177912675077e-07
but O 0 5.221247647568816e-07
sufficient O 0 3.471649961284129e-06
effectiveness O 0 1.2717326171696186e-05
was O 0 2.6424941097502597e-05
not O 0 4.417609034135239e-06
obtained O 0 2.394500916125253e-05
. O 0 3.116548032267019e-05

The O 0 6.495218258351088e-05
findings O 0 2.6141360649489798e-05
in O 0 3.427508318054606e-06
this O 0 1.2844619732277351e-06
family O 0 1.0033662874775473e-05
suggest O 0 2.6893224003288196e-06
that O 0 1.1812588809334557e-06
delGAG291 O 0 4.583968620863743e-05
is O 0 3.994818484898133e-07
part O 0 4.257985040112544e-07
of O 0 3.8683788261550944e-07
the O 0 2.1332671167328954e-06
cause O 0 9.361518095829524e-06
of O 0 1.923845957207959e-06
Japanese O 0 0.0005398039356805384
ALD B-Disease 1 0.9999825954437256
with O 0 8.407198038185015e-06
phenotypic O 0 0.00011644646292552352
variations O 0 0.00019786077609751374
. O 0 9.466262417845428e-05

Moreover O 0 0.0003862969751935452
, O 0 2.1230511265457608e-05
although O 0 3.1464417133975076e-06
the O 0 8.186067361748428e-07
scale O 0 6.084685992391314e-06
of O 0 4.7679120029897604e-07
the O 0 1.3314207762959995e-06
study O 0 1.412121264365851e-06
is O 0 5.578060608968372e-07
limited O 0 1.6963092548394343e-06
, O 0 7.117186555660737e-07
there O 0 3.626240356879862e-07
is O 0 2.684850812784134e-07
a O 0 1.8208876326752943e-06
possibility O 0 2.1272189769661054e-06
that O 0 1.1456077118054964e-06
PET O 0 0.0002746313693933189
can O 0 3.4170384424214717e-06
detect O 0 0.00012014678941341117
an O 0 7.984274816408288e-06
insidious B-Disease 0 0.004129564855247736
lesion I-Disease 0 0.25698691606521606
which O 0 7.258914592966903e-06
is O 0 3.961700713261962e-06
undetectable O 0 3.744023706531152e-05
by O 0 1.2331247489782982e-06
computed O 0 3.1169289286481217e-05
tomogram O 0 0.0006915480480529368
( O 0 2.544917833802174e-06
CT O 0 0.03448506444692612
) O 0 1.260534986613493e-06
or O 0 1.785096401363262e-06
MRI O 0 0.006463572382926941
analysis O 0 2.3516809051216114e-06
, O 0 9.279902997150202e-07
and O 0 5.499321673596569e-07
that O 0 3.2172272312891437e-07
the O 0 3.537141708420677e-07
higher O 0 6.191468173710746e-07
level O 0 4.13858828096636e-07
of O 0 2.2679995481666992e-07
tau O 0 5.304206297296332e-06
reflects O 0 8.148633128257643e-07
the O 0 4.159115576385375e-07
process O 0 8.672809599374887e-07
of O 0 3.019141331606079e-06
neuronal B-Disease 0 0.0164394062012434
degeneration I-Disease 1 0.7288283705711365
in O 0 0.0059248702600598335
ALD B-Disease 1 0.9999994039535522
. O 0 0.00044608928146772087

Lorenzos O 0 0.011532356031239033
Oil O 0 0.00012402709398884326
should O 0 7.179316071415087e-06
be O 0 1.143445501838869e-06
given O 0 6.660064286734269e-07
in O 0 7.285041192517383e-07
the O 0 1.0935252703347942e-06
early O 0 7.075794655975187e-06
stage O 0 4.678999539464712e-05
. O 0 6.262262104428373e-06
. O 0 2.5211447791662067e-05

Nonsense O 0 0.0021992058027535677
mutation O 0 0.0003977505839429796
in O 0 3.313352499390021e-05
exon O 0 0.00010465190280228853
4 O 0 1.2005273674731143e-05
of O 0 2.245066980322008e-06
human O 0 3.4274562494829297e-06
complement O 0 1.3487320757121779e-05
C9 O 0 0.0061675854958593845
gene O 0 9.767857591214124e-06
is O 0 6.390979478965164e-07
the O 0 9.162933451989375e-07
major O 0 3.7987269934092183e-06
cause O 0 4.035320671391673e-06
of O 0 2.858378593373345e-06
Japanese O 0 0.00030341307865455747
complement B-Disease 0 0.024572977796196938
C9 I-Disease 1 0.9999850988388062
deficiency I-Disease 1 0.9989938139915466
. O 0 0.00017286832735408098

Deficiency B-Disease 1 0.996492326259613
of I-Disease 0 3.1694795325165614e-05
the I-Disease 0 2.4115739506669343e-05
ninth I-Disease 0 0.00031684048008173704
component I-Disease 0 7.697782166360412e-06
of I-Disease 0 1.3803214642393868e-06
human I-Disease 0 3.4448767110006884e-06
complement I-Disease 0 1.2095359124941751e-05
( O 0 4.182840712019242e-06
C9 O 0 0.023461515083909035
) O 0 1.956409505510237e-06
is O 0 3.8557897141799913e-07
the O 0 9.050837093127484e-07
most O 0 2.010652451645001e-06
common O 0 0.00010531963926041499
complement B-Disease 1 0.9999790191650391
deficiency I-Disease 1 0.9999991655349731
in O 0 2.47016032517422e-05
Japan O 0 0.0008827509009279311
but O 0 6.722897524014115e-06
is O 0 1.4694819583382923e-06
rare O 0 2.178636805183487e-06
in O 0 2.0672237042163033e-06
other O 0 1.399604343532701e-06
countries O 0 9.012455848278478e-06
. O 0 4.1197501559508964e-05

We O 0 6.52499875286594e-05
studied O 0 2.892803786380682e-05
the O 0 4.647870810003951e-06
molecular O 0 1.4972624740039464e-05
basis O 0 3.1882827897788957e-06
of O 0 8.281833288492635e-06
C9 B-Disease 1 0.9999086856842041
deficiency I-Disease 1 0.9454470872879028
in O 0 5.00000714964699e-06
four O 0 1.252613674296299e-05
Japanese O 0 0.00018561966135166585
C9 B-Disease 1 0.9618973731994629
- I-Disease 1 0.9965818524360657
deficient I-Disease 1 0.9944016337394714
patients O 0 0.0102586904540658
who O 0 0.00016529585991520435
had O 0 0.11186648905277252
suffered O 1 0.9999083280563354
from O 0 0.20271629095077515
meningococcal B-Disease 1 0.9999998807907104
meningitis I-Disease 1 0.9999986886978149
. O 0 0.0008309444529004395

Direct O 0 0.0001023722579702735
sequencing O 0 9.815704834181815e-05
of O 0 1.2781366422132123e-05
amplified O 0 0.0001191021510749124
C9 O 0 0.0003562264610081911
cDNA O 0 3.420606299187057e-05
and O 0 9.129847057920415e-06
DNA O 0 4.33018576586619e-05
revealed O 0 2.7875625164597295e-05
a O 0 4.777766662300564e-06
nonsense O 0 1.3021227459830698e-05
substitution O 0 3.546937932696892e-06
( O 0 1.5619535815858399e-06
CGA O 0 2.4366563593503088e-05
- O 0 0.0003371905768290162
- O 0 0.0007578203221783042
> O 0 4.9140995542984456e-05
TGA O 0 0.0001278913114219904
) O 0 1.746407519931381e-06
at O 0 2.7273545128991827e-06
codon O 0 8.306242307298817e-06
95 O 0 2.321518877579365e-06
in O 0 1.3101217746225302e-06
exon O 0 1.3164617485017516e-05
4 O 0 3.968098553741584e-06
in O 0 1.0664409728633473e-06
the O 0 3.4617053188412683e-06
four O 0 6.184314406709746e-05
C9 B-Disease 1 0.9714022278785706
- I-Disease 1 0.954138457775116
deficient I-Disease 0 0.1616820991039276
individuals O 0 3.154881051159464e-05
. O 0 4.36556147178635e-05

An O 0 0.00010315916006220505
allele O 0 0.0002355738397454843
- O 0 0.00010454378207214177
specific O 0 1.1448484656284563e-05
polymerase O 0 6.989429675741121e-05
chain O 0 0.00011289594112895429
reaction O 0 7.969426405907143e-06
system O 0 4.653206360671902e-06
designed O 0 2.232524275314063e-05
to O 0 1.9067837229158613e-06
detect O 0 3.966936856159009e-05
exclusively O 0 1.2598620742210187e-06
only O 0 3.2566288155067014e-07
one O 0 2.6939403596770717e-07
of O 0 1.9299878317724506e-07
the O 0 7.61989895181614e-07
normal O 0 4.802375769941136e-06
and O 0 1.5604914551659022e-06
mutant O 0 2.3260565285454504e-05
alleles O 0 6.8115828071313445e-06
indicated O 0 7.93802973930724e-06
that O 0 4.501451940086554e-07
all O 0 1.701193781400434e-07
the O 0 8.314733577208244e-07
four O 0 1.2923742360726465e-05
patients O 0 0.0002279956970596686
were O 0 9.38234370551072e-06
homozygous O 0 2.2557358533958904e-05
for O 0 3.4321098496548075e-07
the O 0 7.659132279513869e-07
mutation O 0 2.4690079953870736e-06
in O 0 8.476567927573342e-07
exon O 0 1.1727388482540846e-05
4 O 0 2.891451913455967e-06
and O 0 5.513831524694979e-07
that O 0 3.244928734602581e-07
the O 0 3.6641321798924764e-07
parents O 0 2.7799001145467628e-06
of O 0 7.400216190944775e-07
patient O 0 0.00025975442258641124
2 O 0 1.2238714589329902e-05
were O 0 1.9677261661854573e-05
heterozygous O 0 0.00014941893459763378
. O 0 4.908296250505373e-05

The O 0 5.587122359429486e-05
common O 0 2.67188352154335e-05
mutation O 0 4.12142435379792e-05
at O 0 9.169374607154168e-06
codon O 0 1.663484908931423e-05
95 O 0 5.822284038004e-06
in O 0 2.71940439233731e-06
exon O 0 3.4495547879487276e-05
4 O 0 1.1827248272311408e-05
might O 0 3.6616766010411084e-06
be O 0 8.746669095671677e-07
responsible O 0 1.6732896028770483e-06
for O 0 5.095241704111686e-07
most O 0 2.788168103506905e-06
Japanese O 0 0.001988137373700738
C9 B-Disease 1 0.9999736547470093
deficiency I-Disease 1 0.9925277233123779
. O 0 1.6316096662194468e-05
. O 0 4.3251919123576954e-05

BRCA1 O 0 0.010715526528656483
required O 0 9.945556666934863e-05
for O 0 2.1382011254900135e-05
transcription O 0 0.0001194536016555503
- O 0 0.0027540053706616163
coupled O 0 0.0002329116832697764
repair O 0 0.00803455151617527
of O 0 1.2779233657056466e-05
oxidative O 0 0.2816760241985321
DNA O 0 0.0906129777431488
damage O 0 0.2716895341873169
. O 0 0.00011186856136191636

The O 0 0.0009304879931733012
breast B-Disease 1 0.9999693632125854
and I-Disease 1 0.9981655478477478
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
susceptibility O 0 0.26046279072761536
gene O 0 0.00037163900560699403
BRCA1 O 0 0.0006728935986757278
encodes O 0 4.8655158025212586e-05
a O 0 6.111196853453293e-05
zinc O 0 0.10914067924022675
finger O 0 0.0016351358499377966
protein O 0 8.12429152574623e-06
of O 0 2.410102979411022e-06
unknown O 0 3.4536853490862995e-05
function O 0 2.5199453375535086e-05
. O 0 4.290855213184841e-05

Association O 0 0.00017583004955668002
of O 0 1.2921153938805219e-05
the O 0 1.3155995475244708e-05
BRCA1 O 0 0.00046104940702207386
protein O 0 7.955885848787148e-06
with O 0 1.6245741107923095e-06
the O 0 3.1141412364377175e-06
DNA O 0 6.44233514321968e-05
repair O 0 0.03560343012213707
protein O 0 2.4612483684904873e-05
Rad51 O 0 0.00011672707478282973
and O 0 1.3484082046488766e-06
changes O 0 8.832486741994217e-07
in O 0 6.945941777303233e-07
the O 0 5.584863060903444e-07
phosphorylation O 0 2.2199353679752676e-06
and O 0 1.3606853599412716e-06
cellular O 0 1.673493352427613e-05
localization O 0 6.098843186919112e-06
of O 0 4.956577299708442e-07
the O 0 1.9213302948628552e-06
protein O 0 1.013681321637705e-05
after O 0 2.140453398169484e-05
exposure O 0 2.6603327569318935e-05
to O 0 1.7263248537346954e-06
DNA O 0 3.5570872569223866e-05
- O 0 0.0009600715711712837
damaging O 0 8.626356429886073e-05
agents O 0 4.871288638241822e-06
are O 0 4.832020294998074e-07
consistent O 0 1.1973610298809945e-06
with O 0 5.032990202380461e-07
a O 0 2.5827296212810325e-06
role O 0 2.5530055154376896e-06
for O 0 1.924644038808765e-06
BRCA1 O 0 0.0005429506418295205
in O 0 3.3432832424296066e-05
DNA O 0 0.0022439267486333847
repair O 1 0.7977277040481567
. O 0 0.00017509593453723937

Here O 0 0.00016855083231348544
, O 0 2.2170785086927935e-05
it O 0 3.0421795145230135e-06
is O 0 1.5036698641779367e-06
shown O 0 2.122807472915156e-06
that O 0 1.1104026498287567e-06
mouse O 0 3.793039286392741e-05
embryonic O 0 5.853323818882927e-05
stem O 0 0.00010147305147256702
cells O 0 0.00011262937914580107
deficient B-Disease 0 0.0047591798938810825
in I-Disease 0 6.869833214295795e-06
BRCA1 I-Disease 0 0.0015066512860357761
are O 0 2.2634606011706637e-06
defective O 0 0.00013194367056712508
in O 0 1.4952157698644442e-06
the O 0 8.540402518519841e-07
ability O 0 2.0541667709039757e-06
to O 0 4.083383657871309e-07
carry O 0 2.1729597392550204e-06
out O 0 2.757535867203842e-06
transcription O 0 8.762207471590955e-06
- O 0 0.00016564408724661916
coupled O 0 7.10112726665102e-05
repair O 0 0.00383152742870152
of O 0 2.8819295039284043e-06
oxidative O 0 0.03669881820678711
DNA O 0 0.009702220559120178
damage O 0 0.016780171543359756
, O 0 3.3555427307874197e-06
and O 0 1.7319810012850212e-06
are O 0 9.589310820956598e-07
hypersensitive O 0 6.267887511057779e-05
to O 0 2.7662276806950103e-06
ionizing O 0 0.0003876849077641964
radiation O 0 0.001665896037593484
and O 0 2.2918764443602413e-05
hydrogen O 0 0.00048309072735719383
peroxide O 0 0.03999482840299606
. O 0 8.33050871733576e-05

These O 0 9.717108332552016e-05
results O 0 9.52908958424814e-05
suggest O 0 1.9113711459795013e-05
that O 0 4.024033842142671e-06
BRCA1 O 0 0.00018453366647008806
participates O 0 1.2147111192462035e-05
, O 0 2.9210552838776493e-06
directly O 0 2.490229007889866e-06
or O 0 1.9526742107700557e-06
indirectly O 0 5.823533683724236e-06
, O 0 9.005137258100149e-07
in O 0 1.1979149121543742e-06
transcription O 0 1.393898310197983e-05
- O 0 0.001645454904064536
coupled O 0 0.00014316932356450707
repair O 0 0.028876634314656258
of O 0 4.397223619889701e-06
oxidative O 0 0.2738912105560303
DNA O 0 0.012739153578877449
damage O 0 0.024758173152804375
. O 0 2.0567875253618695e-05
. O 0 3.781474879360758e-05

Truncation O 0 0.004767793230712414
mutations O 0 0.0013019032776355743
in O 0 3.281729732407257e-05
the O 0 1.2448611414583866e-05
transactivation O 0 0.00018088573415298015
region O 0 1.2502088793553412e-05
of O 0 4.265168627171079e-06
PAX6 O 0 0.007485761772841215
result O 0 1.871765562100336e-05
in O 0 7.339501735259546e-06
dominant O 0 0.00010337679123040289
- O 0 0.0015623040962964296
negative O 0 6.834513624198735e-05
mutants O 0 0.00032647434272803366
. O 0 4.739423093269579e-05

PAX6 O 0 0.034387052059173584
is O 0 7.102874951669946e-05
a O 0 2.776419569272548e-05
transcription O 0 2.9697002901230007e-05
factor O 0 9.026150110003073e-06
with O 0 1.680596483311092e-06
two O 0 3.348778136569308e-06
DNA O 0 4.0388757042819634e-05
- O 0 9.058557770913467e-05
binding O 0 9.036778465087991e-06
domains O 0 9.155708539765328e-06
( O 0 1.8887739088313538e-06
paired O 0 1.3427719750325195e-05
box O 0 3.717571235029027e-05
and O 0 8.320124834426679e-06
homeobox O 0 3.505737186060287e-05
) O 0 5.891528189749806e-07
and O 0 5.293819071994221e-07
a O 0 2.214763071606285e-06
proline O 0 2.3328695533564314e-05
- O 0 3.8484609831357375e-05
serine O 0 1.8048205674858764e-05
- O 0 7.909299893071875e-05
threonine O 0 5.435577986645512e-05
( O 0 4.987748525309144e-06
PST O 0 9.866848995443434e-05
) O 0 3.918914899259107e-06
- O 0 6.0726815718226135e-05
rich O 0 3.5912467865273356e-05
transactivation O 0 0.0003514367563184351
domain O 0 8.373914170078933e-05
. O 0 8.792003063717857e-05

PAX6 O 0 0.033212922513484955
regulates O 0 0.0012713578762486577
eye O 0 0.004365413449704647
development O 0 3.476439815131016e-05
in O 0 1.0686944733606651e-05
animals O 0 7.238086709548952e-06
ranging O 0 6.2936705944594e-06
from O 0 2.7297639917378547e-06
jellyfish O 0 1.0557686437095981e-05
to O 0 1.978666659852024e-06
Drosophila O 0 1.1949873623962048e-05
to O 0 4.886996975983493e-06
humans O 0 2.30307432502741e-05
. O 0 2.3524109565187246e-05

Heterozygous O 0 0.005416267551481724
mutations O 0 0.0006783626740798354
in O 0 2.2649963284493424e-05
the O 0 1.2166935448476579e-05
human O 0 1.3652602319780272e-05
PAX6 O 0 0.0024351486936211586
gene O 0 3.2111696782521904e-05
result O 0 6.521776413137559e-06
in O 0 2.547795702412259e-06
various O 0 2.940199465228943e-06
phenotypes O 0 0.0001423932844772935
, O 0 6.3937559389160015e-06
including O 0 3.268873842898756e-05
aniridia B-Disease 1 0.9999995231628418
, O 0 0.01432847511023283
Peters B-Disease 1 0.9999457597732544
anomaly I-Disease 1 0.9998757839202881
, O 0 0.00021312781609594822
autosomal B-Disease 1 0.6191702485084534
dominant I-Disease 0 0.016168193891644478
keratitis I-Disease 0 0.2806662321090698
, O 0 3.034717337868642e-05
and O 0 0.00015075516421347857
familial B-Disease 1 0.9840455055236816
foveal I-Disease 1 0.9997292160987854
dysplasia I-Disease 1 0.9999792575836182
. O 0 0.0005037803202867508

It O 0 8.466381405014545e-05
is O 0 1.1240382264077198e-05
believed O 0 1.1522419299581088e-05
that O 0 9.461245440434141e-07
the O 0 1.262715272787318e-06
mutated O 0 9.502276043349411e-06
allele O 0 5.968551704427227e-06
of O 0 1.1949277904932387e-06
PAX6 O 0 0.000228032426093705
produces O 0 3.11010785480903e-06
an O 0 1.6406389704570756e-06
inactive O 0 2.500216032785829e-05
protein O 0 7.761686902085785e-06
and O 0 1.576826980453916e-05
aniridia B-Disease 1 0.9999337196350098
is O 0 1.1869200534420088e-05
caused O 0 0.00013299511920195073
due O 0 1.8164881112170406e-05
to O 0 2.211608807556331e-05
genetic O 0 0.000642930215690285
haploinsufficiency O 0 0.019468877464532852
. O 0 6.461943848989904e-05

However O 0 0.00013978008064441383
, O 0 1.3050928828306496e-05
several O 0 4.702873866335722e-06
truncation O 0 6.923160253791139e-05
mutations O 0 5.156956831342541e-05
have O 0 5.471692020364571e-06
been O 0 5.172586952539859e-06
found O 0 2.735398311415338e-06
to O 0 1.3986008298161323e-06
occur O 0 1.5332539078372065e-06
in O 0 8.908682502806187e-07
the O 0 3.766984036701615e-06
C O 0 0.003385092131793499
- O 0 0.0002118429256370291
terminal O 0 2.7623378628049977e-05
half O 0 1.9121760033158353e-06
of O 0 1.312343897552637e-06
PAX6 O 0 0.004407252185046673
in O 0 3.4745178709272295e-05
patients O 0 0.000560412066988647
with O 0 3.243207174818963e-05
Aniridia B-Disease 1 0.9998593330383301
resulting O 0 4.578315565595403e-05
in O 0 4.019508196506649e-06
mutant O 0 3.062184259761125e-05
proteins O 0 2.1625507997669047e-06
that O 0 6.970986419219116e-07
retain O 0 5.87054637435358e-06
the O 0 1.8852647372114006e-06
DNA O 0 1.4393096535059158e-05
- O 0 2.4899891286622733e-05
binding O 0 2.8882275273645064e-06
domains O 0 4.022637313028099e-06
but O 0 1.1126085155410692e-06
have O 0 1.1412155345169595e-06
lost O 0 5.3492449296754785e-06
most O 0 3.1738224492983136e-07
of O 0 7.706955784669844e-07
the O 0 5.774210421805037e-06
transactivation O 0 0.0005293904687277973
domain O 0 9.722816321300343e-05
. O 0 5.523598883883096e-05

It O 0 0.0001156179714598693
is O 0 9.400865565112326e-06
not O 0 2.9123657441232353e-06
clear O 0 1.9904312011931324e-06
whether O 0 8.028392244341376e-07
such O 0 6.398413461283781e-07
mutants O 0 6.104010390117764e-05
really O 0 1.0236778507533018e-05
behave O 0 6.697594471916091e-06
as O 0 1.0347198440285865e-06
loss O 0 2.5312316211056896e-05
- O 0 2.1109301087562926e-05
of O 0 9.693134188637487e-07
- O 0 8.205950871342793e-05
function O 0 3.12813699565595e-06
mutants O 0 1.711661388981156e-05
as O 0 1.8506068499846151e-06
predicted O 0 2.011424658121541e-05
by O 0 5.790632258140249e-06
haploinsufficiency O 0 0.000828920747153461
. O 0 4.492417792789638e-05

Contrary O 0 0.00018107297364622355
to O 0 8.627795978100039e-06
this O 0 1.668523509579245e-06
theory O 0 1.630198539714911e-06
, O 0 6.564186492141744e-07
our O 0 9.237608651346818e-07
data O 0 1.6568341152378707e-06
showed O 0 3.3251301374548348e-06
that O 0 2.981265652124421e-07
these O 0 2.766882403193449e-07
mutants O 0 4.380557129479712e-06
are O 0 4.4066806026421546e-07
dominant O 0 5.4501310842169914e-06
- O 0 3.5265129554318264e-05
negative O 0 2.6892710138781695e-06
in O 0 1.300337885368208e-06
transient O 0 2.9105529392836615e-05
transfection O 0 0.000117785923066549
assays O 0 1.8055710825137794e-05
when O 0 6.22542756900657e-06
they O 0 1.5470532161998563e-06
are O 0 5.584330438068719e-07
coexpressed O 0 1.957137465069536e-05
with O 0 1.790841110960173e-06
wild O 0 1.381901529384777e-05
- O 0 0.0003945880744140595
type O 0 0.0002857531944755465
PAX6 O 0 0.0059690698981285095
. O 0 9.511749522062019e-05

We O 0 0.00015925441402941942
found O 0 2.1898413251619786e-05
that O 0 2.3666900688112946e-06
the O 0 3.2997827474900987e-06
dominant O 0 2.7254818633082323e-05
- O 0 0.00034598750062286854
negative O 0 7.018634732958162e-06
effects O 0 8.051109944062773e-06
result O 0 1.6685872878952068e-06
from O 0 5.229769612924429e-07
the O 0 7.988402899172797e-07
enhanced O 0 8.278224413516e-06
DNA O 0 1.0344048860133626e-05
binding O 0 3.203876303814468e-06
ability O 0 1.8430441741656978e-06
of O 0 8.851974939716456e-07
these O 0 4.103279479750199e-06
mutants O 0 0.00019036086450796574
. O 0 5.2996274462202564e-05

Kinetic O 0 0.0004951784503646195
studies O 0 7.298715354409069e-05
of O 0 9.715627129480708e-06
binding O 0 2.230502650490962e-05
and O 0 9.116361979977228e-06
dissociation O 0 0.00011230829113628715
revealed O 0 1.9591465388657525e-05
that O 0 6.728200787620153e-07
various O 0 6.82204813529097e-07
truncation O 0 4.576534411171451e-05
mutants O 0 9.349851461593062e-05
have O 0 3.564778808140545e-06
3 O 0 6.140553978184471e-06
- O 0 5.4877917136764154e-05
5 O 0 3.557762056516367e-06
- O 0 1.0798468792927451e-05
fold O 0 3.3561027521500364e-06
higher O 0 9.404786283084832e-07
affinity O 0 1.3115255796947167e-06
to O 0 3.3018807243934134e-07
various O 0 4.570482303734025e-07
DNA O 0 4.973693648935296e-06
- O 0 1.3677962670044508e-05
binding O 0 1.6404512734879972e-06
sites O 0 1.4453537460212829e-06
when O 0 1.5933345594021375e-06
compared O 0 1.4552180118698743e-06
with O 0 8.808042935015692e-07
the O 0 3.0334565508383093e-06
wild O 0 2.9936792998341843e-05
- O 0 0.0006999879260547459
type O 0 0.00027438352117314935
PAX6 O 0 0.0031480975449085236
. O 0 9.186143142869696e-05

These O 0 4.512034502113238e-05
results O 0 3.1478612072532997e-05
provide O 0 3.848849701171275e-06
a O 0 2.0173038137727417e-06
new O 0 1.5932312180666486e-06
insight O 0 2.7024675546272192e-06
into O 0 4.6421644128713524e-07
the O 0 6.398145728780946e-07
role O 0 1.4884635675116442e-06
of O 0 9.89751129054639e-07
mutant O 0 0.0001103752656490542
PAX6 O 0 0.0006938917213119566
in O 0 4.174146306468174e-05
causing O 0 0.054985757917165756
aniridia B-Disease 1 0.9996839761734009
. O 0 3.0552946554962546e-05
. O 0 8.179872384062037e-05

Reversal O 0 0.009437297470867634
of O 0 0.0013400573516264558
severe O 1 0.999998927116394
hypertrophic B-Disease 1 0.9999998807907104
cardiomyopathy I-Disease 1 1.0
and O 0 0.009919471107423306
excellent O 0 0.0018553325207903981
neuropsychologic O 0 0.21456697583198547
outcome O 0 3.1802974262973294e-05
in O 0 4.864324637310347e-06
very B-Disease 0 7.20983507562778e-06
- I-Disease 0 0.0031310117337852716
long I-Disease 0 5.8266254200134426e-05
- I-Disease 0 0.0009572036797180772
chain I-Disease 0 0.0003452741075307131
acyl I-Disease 0 0.00019565565162338316
- I-Disease 0 0.0025285312440246344
coenzyme I-Disease 0 0.00046571329585276544
A I-Disease 0 0.009076776914298534
dehydrogenase I-Disease 1 0.975375771522522
deficiency I-Disease 1 0.9289039969444275
. O 0 0.00011535037629073486

Very B-Disease 0 0.00027597681037150323
- I-Disease 0 0.0011853567557409406
long I-Disease 0 0.00010605392162688076
- I-Disease 0 0.00037589072599075735
chain I-Disease 0 0.0001459350751247257
acyl I-Disease 0 6.853597005829215e-05
- I-Disease 0 9.898599819280207e-05
coenzyme I-Disease 0 5.935082663199864e-05
A I-Disease 0 9.349904576083645e-05
dehydrogenase I-Disease 0 0.002037246711552143
( I-Disease 0 3.2491381716681644e-05
VLCAD I-Disease 1 0.9731546640396118
) I-Disease 0 0.0006185754900798202
deficiency I-Disease 1 0.7160211801528931
is O 0 2.8058316274837125e-06
a O 0 0.00011531277414178476
disorder O 0 0.24141260981559753
of O 0 3.253560407756595e-06
fatty O 0 0.00014724575157742947
acid O 0 2.4354667402803898e-05
beta O 0 5.938403774052858e-06
oxidation O 0 6.8673566602228675e-06
that O 0 1.8087035869029933e-06
reportedly O 0 2.368435889366083e-05
has O 0 1.179087803393486e-06
high O 0 5.039280949858949e-06
rates O 0 2.1958308025205042e-06
of O 0 1.9348672140040435e-06
morbidity O 0 0.002271313453093171
and O 0 8.3099992480129e-05
mortality O 0 0.03501459211111069
. O 0 0.00010958337952615693

We O 0 0.00010703413136070594
describe O 0 3.6792302125832066e-05
the O 0 3.6173332773614675e-06
outcome O 0 2.9521688702516258e-06
of O 0 7.985325964909862e-07
a O 0 5.9183325902267825e-06
5 O 0 9.212586519424804e-06
- O 0 7.191532495198771e-05
year O 0 3.5829928037856007e-06
- O 0 7.316387200262398e-05
old O 0 0.000218628192669712
girl O 0 0.00863451138138771
with O 0 0.004512689542025328
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 0.9999991655349731
who O 0 4.8407644499093294e-05
was O 0 3.2930660381680354e-05
first O 0 2.9101693144184537e-06
seen O 0 6.918149665580131e-06
at O 0 7.9448318501818e-06
5 O 0 5.097232588013867e-06
months O 0 3.883577392116422e-06
of O 0 9.973369969884516e-07
age O 0 0.000201143542653881
with O 0 0.005591468419879675
severe O 1 0.9999996423721313
hypertrophic B-Disease 1 1.0
cardiomyopathy I-Disease 1 1.0
, O 1 0.972491979598999
hepatomegaly B-Disease 1 1.0
, O 0 0.45902490615844727
encephalopathy B-Disease 1 0.9917570948600769
, O 0 2.642171602929011e-05
and O 0 6.799825496273115e-05
hypotonia B-Disease 1 0.5914155840873718
. O 0 0.00013541408407036215

Biochemical O 0 0.01965458132326603
studies O 0 0.009470922872424126
indicated O 1 0.99955815076828
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
caused O 0 0.016259130090475082
by O 0 7.70150563766947e-06
a O 0 5.285183942760341e-05
stable O 0 0.00199522590264678
yet O 0 4.887385875917971e-05
inactive O 0 0.0002012358163483441
enzyme O 0 0.00011649834050331265
. O 0 6.687550921924412e-05

Molecular O 0 0.0015990197425708175
genetic O 0 0.0002639062877278775
analysis O 0 2.0133340512984432e-05
of O 0 7.41328722142498e-06
her O 0 0.001231687841936946
VLCAD O 1 0.827477216720581
gene O 0 9.016295371111482e-05
revealed O 0 9.574695286573842e-05
a O 0 2.1298568753991276e-05
T1372C O 0 0.004690398462116718
( O 0 5.216999852564186e-06
F458L O 0 8.690079266671091e-05
) O 0 3.947994173358893e-06
missense O 0 3.352218845975585e-05
mutation O 0 1.3092176232021302e-05
and O 0 6.375788416335126e-06
a O 0 4.955223630531691e-05
1668 O 0 0.47314611077308655
ACAG O 0 0.12385821342468262
1669 O 0 0.005157278850674629
splice O 0 0.002582769375294447
site O 0 0.0002897992089856416
mutation O 0 0.0004231084312777966
. O 0 0.00013317723642103374

After O 0 0.00048089964548125863
initial O 0 0.00014894679770804942
treatment O 0 7.079707575030625e-05
with O 0 6.645447683695238e-06
intravenous O 0 0.00023553523351438344
glucose O 0 0.0002444881829433143
and O 0 1.5612265997333452e-05
carnitine O 0 0.0004362938925623894
, O 0 3.130608092760667e-06
the O 0 3.911872681783279e-06
patient O 0 0.00018523333710618317
has O 0 2.5605643259041244e-06
thrived O 0 1.0354994628869463e-05
on O 0 1.571598659211304e-06
a O 0 5.382230028772028e-06
low O 0 7.993616600288078e-05
- O 0 0.0011987036559730768
fat O 0 6.097988080000505e-05
diet O 0 7.232269581436412e-06
supplemented O 0 4.351863481133478e-06
with O 0 1.3017523770031403e-06
medium O 0 1.8292968888999894e-05
- O 0 7.43847995181568e-05
chain O 0 6.375608063535765e-05
triglyceride O 0 3.868562635034323e-05
oil O 0 7.95851883594878e-06
and O 0 3.0933565540181007e-06
carnitine O 0 5.941006384091452e-05
and O 0 2.478959686413873e-06
avoidance O 0 2.7823809432447888e-05
of O 0 1.0003479474107735e-05
fasting O 0 0.00047952818567864597
. O 0 6.301641406025738e-05

Her O 0 0.3688148260116577
ventricular O 1 0.9986990690231323
hypertrophy O 1 0.9606344699859619
resolved O 0 0.0005363195668905973
significantly O 0 6.719577504554763e-05
over O 0 6.712909453199245e-06
1 O 0 7.99104782345239e-06
year O 0 4.484574674279429e-06
, O 0 1.5618671795891714e-06
and O 0 5.943882115388988e-06
cognitively O 0 0.011459372006356716
, O 0 2.0867594230367104e-06
she O 0 1.0531080079090316e-05
is O 0 4.0066427686724637e-07
in O 0 5.381764935918909e-07
the O 0 1.4051465768716298e-06
superior O 0 1.0210793334408663e-05
range O 0 3.6170918065181468e-06
for O 0 3.5947084597864887e-06
age O 0 9.864290041150525e-05
. O 0 3.0776744097238407e-05

Clinical O 0 0.01896381936967373
recognition O 0 0.0004211727937217802
of O 0 0.05006029084324837
VLCAD B-Disease 1 1.0
deficiency I-Disease 1 1.0
is O 0 2.2004800484864973e-05
important O 0 2.6880582026933553e-06
because O 0 3.889433628501138e-06
it O 0 6.337018589874788e-07
is O 0 1.4608241372116026e-07
one O 0 1.3605098558855389e-07
of O 0 1.556681894498979e-07
the O 0 1.1243062090215972e-06
few O 0 4.50216566605377e-06
directly O 0 6.026173286954872e-05
treatable O 1 0.7051349878311157
causes O 0 1.3976547961647157e-05
of O 0 2.4496292098774575e-05
cardiomyopathy B-Disease 1 0.9999995231628418
in O 0 0.00032367274980060756
children O 0 0.0010983931133523583
. O 0 1.3511008546629455e-05
. O 0 3.146144445054233e-05

Cloning O 0 0.0004881895147264004
of O 0 2.2898619135958143e-05
a O 0 1.6656264051562175e-05
novel O 0 6.459057203755947e-06
member O 0 2.2707793050358305e-06
of O 0 8.009427006072656e-07
the O 0 3.577287543521379e-06
low O 0 0.00010599295637803152
- O 0 0.00043215701589360833
density O 0 6.897749699419364e-05
lipoprotein O 0 0.024621468037366867
receptor O 0 0.0002646387438289821
family O 0 0.0001252462388947606
. O 0 6.781647971365601e-05

A O 0 0.00024481682339683175
gene O 0 9.431959188077599e-05
encoding O 0 2.0463321561692283e-05
a O 0 1.1624113540165126e-05
novel O 0 1.4462430044659413e-05
transmembrane O 0 5.952143692411482e-05
protein O 0 1.2137511475884821e-05
was O 0 1.2305988093430642e-05
identified O 0 2.249580347779556e-06
by O 0 6.020472369527852e-07
DNA O 0 3.4859724564739736e-06
sequence O 0 1.6722575537642115e-06
analysis O 0 8.892401979210263e-07
within O 0 8.562822131352732e-07
the O 0 4.240605903760297e-06
insulin B-Disease 0 0.030272318050265312
- I-Disease 1 0.992356538772583
dependent I-Disease 1 0.9740139245986938
diabetes I-Disease 1 1.0
mellitus I-Disease 1 0.9999997615814209
( O 0 0.00011607485794229433
IDDM B-Disease 1 0.5605461001396179
) O 0 1.1758654181903694e-05
locus O 0 0.00015554390847682953
IDDM4 O 0 0.004760076757520437
on O 0 5.222895197221078e-05
chromosome O 0 0.014145196415483952
11q13 O 0 0.004567516036331654
. O 0 0.00017641916929278523

Based O 0 8.005608106032014e-05
on O 0 1.0075708814838436e-05
its O 0 6.963385203562211e-06
chromosomal O 0 0.0007829813403077424
position O 0 3.883540193783119e-05
, O 0 2.1171665594010847e-06
this O 0 4.936989057569008e-07
gene O 0 1.8019441085925791e-06
is O 0 3.3264007015532115e-07
a O 0 7.078771773194603e-07
candidate O 0 1.688610154815251e-06
for O 0 1.1500027312649763e-06
conferring O 0 0.0004150058375671506
susceptibility O 0 0.008047337643802166
to O 0 0.00028213602490723133
diabetes B-Disease 1 0.9995023012161255
. O 0 0.00025548998382873833

The O 0 0.0001189864706248045
gene O 0 0.0001481229264754802
, O 0 1.4704066416015849e-05
termed O 0 5.1734925364144146e-05
low O 0 5.543111910810694e-05
- O 0 0.00019201279792468995
density O 0 3.7011512176832184e-05
lipoprotein O 0 0.000734266301151365
receptor O 0 3.117133746854961e-05
related O 0 6.1144046412664466e-06
protein O 0 1.201299255626509e-05
5 O 0 8.623303983767983e-06
( O 0 1.9703061298059765e-06
LRP5 O 0 0.0005148709751665592
) O 0 6.910005936333619e-07
, O 0 4.7038690809131367e-07
encodes O 0 2.1998553165758494e-06
a O 0 1.0866473303394741e-06
protein O 0 1.6358659422621713e-06
of O 0 8.592820108788146e-07
1615 O 0 0.00024644279619678855
amino O 0 6.142861366242869e-06
acids O 0 1.6238647049249266e-06
that O 0 2.3196434995043091e-07
contains O 0 4.777051003657107e-07
conserved O 0 1.4428005670197308e-06
modules O 0 3.091168309765635e-06
which O 0 7.2316794330618e-07
are O 0 2.769083948805928e-07
characteristic O 0 1.1723043371603126e-06
of O 0 4.2965487523360935e-07
the O 0 2.383037781328312e-06
low O 0 0.00031668710289523005
- O 0 0.00984115805476904
density O 0 7.131230813683942e-05
lipoprotein O 0 0.10013409703969955
( O 0 2.226076139777433e-05
LDL O 0 0.002845420967787504
) O 0 9.71657209447585e-06
receptor O 0 7.844484207453206e-05
family O 0 9.099395538214594e-05
. O 0 5.925062214373611e-05

These O 0 4.7861136408755556e-05
modules O 0 7.719385757809505e-05
include O 0 8.92776733962819e-06
a O 0 9.8853715826408e-06
putative O 0 5.930403494858183e-05
signal O 0 1.5632587746949866e-05
peptide O 0 5.866925221198471e-06
for O 0 6.794907676521689e-07
protein O 0 3.3870021525217453e-06
export O 0 1.7387779962518835e-06
, O 0 8.059291758399922e-07
four O 0 3.084172021772247e-06
epidermal O 0 4.5647218939848244e-05
growth O 0 7.5131501944269985e-06
factor O 0 6.402200597221963e-06
( O 0 2.4880830551410327e-06
EGF O 0 0.00010884002404054627
) O 0 9.506332503406156e-07
repeats O 0 3.5441112231637817e-06
with O 0 1.624496690055821e-06
associated O 0 6.88714408170199e-06
spacer O 0 5.508459798875265e-05
domains O 0 2.1046726033091545e-05
, O 0 4.406101652421057e-06
three O 0 1.1517651728354394e-05
LDL O 0 0.011918222531676292
- O 0 0.004598117433488369
receptor O 0 2.0494549971772358e-05
( O 0 1.8282968312632875e-06
LDLR O 0 0.00024256101460196078
) O 0 1.0048926242234302e-06
repeats O 0 2.5103631742240395e-06
, O 0 4.840266569772211e-07
a O 0 9.66557081483188e-07
single O 0 9.584397048456594e-06
transmembrane O 0 2.4833279894664884e-05
spanning O 0 1.4165226275508758e-05
domain O 0 9.34870695346035e-06
, O 0 1.7359099047098425e-06
and O 0 2.3266075004357845e-06
a O 0 1.2955331840203144e-05
cytoplasmic O 0 0.00033398836967535317
domain O 0 0.00010211506014456972
. O 0 6.142257188912481e-05

The O 0 4.010600969195366e-05
encoded O 0 5.042924385634251e-05
protein O 0 1.872249413281679e-05
has O 0 2.973136361106299e-06
a O 0 1.83861311597866e-06
unique O 0 1.780618049451732e-06
organization O 0 1.8460310684531578e-06
of O 0 1.2569003047246952e-06
EGF O 0 0.0008744167862460017
and O 0 1.513118240836775e-05
LDLR O 0 0.13989460468292236
repeats O 0 5.334787056199275e-05
; O 0 2.833150119840866e-06
therefore O 0 2.570551487224293e-06
, O 0 2.0833613234572113e-06
LRP5 O 0 0.0023470481391996145
likely O 0 3.353866532052052e-06
represents O 0 8.849813752931368e-07
a O 0 9.245329124496493e-07
new O 0 7.90255171523313e-07
category O 0 1.758001076268556e-06
of O 0 6.304792918854218e-07
the O 0 1.696753315627575e-05
LDLR O 1 0.6016821265220642
family O 0 0.00021229588310234249
. O 0 4.904025627183728e-05

Both O 0 7.470083801308647e-05
human O 0 3.560728146112524e-05
and O 0 1.9945580788771622e-05
mouse O 0 0.0003025035257451236
LRP5 O 0 0.059836164116859436
cDNAs O 0 0.00039205452776513994
have O 0 1.4762685168534517e-05
been O 0 1.4070750694372691e-05
isolated O 0 1.2584315300046e-05
and O 0 1.0989512020387338e-06
the O 0 1.2957032140548108e-06
encoded O 0 6.227506219147472e-06
mature O 0 3.8022283206373686e-06
proteins O 0 1.1993541875199298e-06
are O 0 4.890895297648967e-07
95 O 0 2.6034579150291393e-06
% O 0 1.7058578123396728e-06
identical O 0 1.0700957318476867e-05
, O 0 1.7025489569277852e-06
indicating O 0 7.779776751704048e-06
a O 0 2.2170409010868752e-06
high O 0 2.3899545340100303e-05
degree O 0 1.5343362974817865e-05
of O 0 1.5539749256276991e-06
evolutionary O 0 2.4844412109814584e-05
conservation O 0 1.648510806262493e-05
. O 0 8.105917913781013e-06
. O 0 4.1727093048393726e-05

The O 0 0.00012679348583333194
APC B-Disease 0 0.0005109826452098787
variants O 0 4.507802805164829e-05
I1307K O 0 0.00017879134975373745
and O 0 1.580388743604999e-05
E1317Q O 0 0.0003251322195865214
are O 0 4.5481169763661455e-06
associated O 0 0.00015760058886371553
with O 1 0.9663320779800415
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.028670404106378555
but O 0 3.834726521745324e-05
not O 0 7.529957201768411e-06
always O 0 5.6071676226565614e-06
with O 0 1.930567123054061e-06
a O 0 1.829157190513797e-05
family O 0 7.975853077368811e-05
history O 0 3.8559152017114684e-05
. O 0 4.316538979765028e-05

Classical O 0 0.3390663266181946
familial B-Disease 1 0.9999994039535522
adenomatous I-Disease 1 0.9999995231628418
polyposis I-Disease 1 1.0
( O 0 0.20057478547096252
FAP B-Disease 1 0.553672194480896
) O 0 2.5914345314959064e-05
is O 0 4.40677013102686e-06
a O 0 1.870077903731726e-05
high O 0 0.1545390784740448
- O 1 0.9995778203010559
penetrance O 1 0.9981765747070312
autosomal B-Disease 1 0.986005425453186
dominant I-Disease 1 0.5621961951255798
disease I-Disease 1 0.6434953808784485
that O 0 9.15166674531065e-06
predisposes O 0 0.00021755271882284433
to O 0 2.5073652523133205e-06
hundreds O 0 5.013926511310274e-06
or O 0 2.9639156764460495e-06
thousands O 0 6.446558472816832e-06
of O 0 0.0002980223798658699
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999998807907104
and I-Disease 1 0.9786974787712097
carcinoma I-Disease 1 1.0
and O 0 0.00022715421800967306
that O 0 6.470388143497985e-06
results O 0 1.5464996977243572e-05
from O 0 3.1261358799383743e-06
truncating O 0 8.117226389003918e-05
mutations O 0 1.2055203114869073e-05
in O 0 2.3761388092680136e-06
the O 0 1.3216532352089416e-05
APC B-Disease 0 0.0003934251144528389
gene O 0 0.00010815408313646913
. O 0 5.81346575927455e-05

A O 0 0.0006242516101337969
variant O 0 0.00045591112575493753
of O 0 7.60848488425836e-05
FAP B-Disease 0 0.09723848849534988
is O 0 0.0003335874353069812
attenuated B-Disease 1 0.9884944558143616
adenomatous I-Disease 1 0.9999986886978149
polyposis I-Disease 1 0.9999957084655762
coli I-Disease 1 0.9998996257781982
, O 0 6.808798934798688e-05
which O 0 6.183983714436181e-06
results O 0 1.1355429705872666e-05
from O 0 5.361752755561611e-06
germ O 0 0.0015583289787173271
- O 0 0.0004688113112933934
line O 0 5.228236841503531e-05
mutations O 0 4.127333340875339e-06
in O 0 6.07083450177015e-07
the O 0 6.57349517041439e-07
5 O 0 2.054107881122036e-06
and O 0 6.233420322132588e-07
3 O 0 1.295458559980034e-06
regions O 0 8.41079497604369e-07
of O 0 9.886680345516652e-07
the O 0 7.61289174988633e-06
APC B-Disease 0 0.00036912073846906424
gene O 0 6.697232311125845e-05
. O 0 4.1687479097163305e-05

Attenuated B-Disease 1 0.9999008178710938
adenomatous I-Disease 1 0.9999994039535522
polyposis I-Disease 1 0.9999996423721313
coli I-Disease 1 0.9999996423721313
patients O 1 0.9999817609786987
have O 0 0.02464425005018711
" O 0 0.00048356736078858376
multiple O 0 0.013203341513872147
" O 1 0.9535240530967712
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999985694885254
( O 0 2.563968882896006e-05
typically O 0 9.13092662813142e-06
fewer O 0 2.6095481189258862e-06
than O 0 1.0056136261482607e-06
100 O 0 1.9029996565222973e-06
) O 0 7.188881454567309e-07
without O 0 1.2392940789140994e-06
the O 0 1.7884995031636208e-06
florid O 0 0.000266933289822191
phenotype O 0 0.0001341257884632796
of O 0 3.8671169022563845e-06
classical O 0 8.37977058836259e-05
FAP B-Disease 0 0.0026194744277745485
. O 0 0.00014795410970691592

Another O 0 0.0003267602005507797
group O 0 7.646437734365463e-05
of O 0 1.0297916560375597e-05
patients O 0 0.0005593464593403041
with O 0 8.940829502535053e-06
multiple O 0 0.0009360936819575727
adenomas B-Disease 1 0.6077433824539185
has O 0 1.9438339222688228e-05
no O 0 9.254588803742081e-06
mutations O 0 6.272016435104888e-06
in O 0 1.2048431017319672e-06
the O 0 4.248572622600477e-06
APC B-Disease 0 5.64910369575955e-05
gene O 0 3.365596512594493e-06
, O 0 8.067405019573926e-07
and O 0 7.594130693178158e-07
their O 0 9.740517270984128e-06
phenotype O 0 0.0007664557197131217
probably O 0 6.554093033628305e-06
results O 0 1.7603816786504467e-06
from O 0 4.718570210116013e-07
variation O 0 1.583551579642517e-06
at O 0 1.1203929716430139e-05
a O 0 8.617417734058108e-06
locus O 0 7.563517283415422e-05
, O 0 3.2369591735914582e-06
or O 0 2.328896243852796e-06
loci O 0 5.546410193346674e-06
, O 0 1.1701084758897196e-06
elsewhere O 0 2.784578100545332e-06
in O 0 1.135727075052273e-06
the O 0 5.374505690269871e-06
genome O 0 5.4308369726641104e-05
. O 0 3.1287963793147355e-05

Recently O 0 0.0014425931731238961
, O 0 4.17534465668723e-05
however O 0 4.802247531188186e-06
, O 0 1.6193891951843398e-06
a O 0 2.826357558660675e-06
missense O 0 2.1515497792279348e-05
variant O 0 1.1721617738658097e-05
of O 0 2.524191131669795e-06
APC B-Disease 0 0.0005646028439514339
( O 0 3.745926733245142e-06
I1307K O 0 0.0003645500692073256
) O 0 1.9121760033158353e-06
was O 0 1.2235703252372332e-05
described O 0 4.809158326679608e-06
that O 0 8.3549934970506e-07
confers O 0 6.921574822627008e-06
an O 0 2.6615039132593665e-06
increased O 0 3.5574503272073343e-05
risk O 0 0.002589939394965768
of O 0 0.038404904305934906
colorectal B-Disease 1 1.0
tumors I-Disease 1 1.0
, O 0 0.0002314868033863604
including O 0 3.041108720935881e-05
multiple O 0 0.002914216835051775
adenomas B-Disease 1 0.6352152228355408
, O 0 1.940807305800263e-05
in O 0 2.9460878067766316e-05
Ashkenazim O 0 0.0012536018621176481
. O 0 7.746663322905079e-05

We O 0 0.00015852566866669804
have O 0 1.5023945707071107e-05
studied O 0 1.0891666534007527e-05
a O 0 4.169586190982955e-06
set O 0 2.6871687168750213e-06
of O 0 1.5488437838939717e-06
164 O 0 0.0007995367050170898
patients O 0 0.0009885553736239672
with O 0 5.618566137854941e-05
multiple O 1 0.9964820146560669
colorectal B-Disease 1 1.0
adenomas I-Disease 1 0.9999997615814209
and I-Disease 0 0.20795407891273499
/ I-Disease 1 0.8167545795440674
or I-Disease 0 0.03692649304866791
carcinoma I-Disease 1 0.9999998807907104
and O 0 4.4447802793001756e-05
analyzed O 0 0.0001215467564179562
codons O 0 5.5129057727754116e-05
1263 O 0 0.0006141281919553876
- O 0 0.00022916734451428056
1377 O 0 0.0002237467997474596
( O 0 3.7358981899160426e-06
exon O 0 3.565869701560587e-05
15G O 0 7.813568663550541e-05
) O 0 8.957932777775568e-07
of O 0 5.74060095459572e-07
the O 0 1.9951062313339207e-06
APC B-Disease 0 2.5245246433769353e-05
gene O 0 5.263360435492359e-06
for O 0 2.3105171749193687e-06
germ O 0 0.00034625816624611616
- O 0 0.00025787483900785446
line O 0 7.011165871517733e-05
variants O 0 5.292233981890604e-05
. O 0 3.914214903488755e-05

Three O 0 0.0005854908959008753
patients O 0 0.015023288317024708
with O 0 1.04618184195715e-05
the O 0 9.097219844989013e-06
I1307K O 0 0.0003551691770553589
allele O 0 2.639779086166527e-05
were O 0 1.5658191841794178e-05
detected O 0 3.2427309633931145e-05
, O 0 1.1469360288174357e-06
each O 0 1.0454092489453615e-06
of O 0 3.225354248570511e-06
Ashkenazi O 0 0.00037954829167574644
descent O 0 0.00041630331543274224
. O 0 0.00010678629041649401

Four O 0 0.001400643028318882
patients O 0 0.3256813883781433
had O 0 0.000344756874255836
a O 0 8.399283251492307e-05
germ O 0 0.019618095830082893
- O 0 0.0006749365129508078
line O 0 6.0654812841676176e-05
E1317Q O 0 9.042668534675613e-05
missense O 0 2.0223224055371247e-05
variant O 0 9.636922186473384e-06
of O 0 1.142911287388415e-06
APC O 0 8.400861406698823e-05
that O 0 1.9289955162093975e-06
was O 0 5.622939352178946e-05
not O 0 9.494372648077842e-07
present O 0 5.866812671229127e-07
in O 0 1.0135681804968044e-06
controls O 0 1.2768245142069645e-05
; O 0 4.7631127131353423e-07
one O 0 1.6138668001985934e-07
of O 0 1.310047537117498e-07
these O 0 2.393372824371909e-07
individuals O 0 4.3362348378650495e-07
had O 0 8.60964701132616e-06
an O 0 8.437805831817968e-07
unusually O 0 1.564505510032177e-05
large O 0 1.0192871968683903e-06
number O 0 6.505214287244598e-07
of O 0 1.9236513253417797e-06
metaplastic B-Disease 0 0.18794769048690796
polyps I-Disease 0 0.00014541790005750954
of I-Disease 0 2.73296268460399e-06
the I-Disease 0 3.089174424530938e-05
colorectum I-Disease 0 0.04277897998690605
. O 0 9.811212657950819e-05

There O 0 9.998579480452463e-05
is O 0 9.272824172512628e-06
increasing O 0 8.37102925288491e-06
evidence O 0 3.7375161809904967e-06
that O 0 1.2343754178800737e-06
there O 0 1.5784900142534752e-06
exist O 0 3.1842532735026907e-06
germ O 0 7.702864240854979e-05
- O 0 3.096864020335488e-05
line O 0 5.10827385369339e-06
variants O 0 1.0073355269923923e-06
of O 0 4.014923717932106e-07
the O 0 2.757115225904272e-06
APC B-Disease 0 6.782818672945723e-05
gene O 0 4.615964826371055e-06
that O 0 9.771777058631415e-07
predispose O 0 7.426633146678796e-06
to O 0 5.314284976520867e-07
the O 0 7.323535555769922e-07
development O 0 1.2648171150431153e-06
of O 0 5.173751105758129e-06
multiple O 1 0.9923956394195557
colorectal B-Disease 1 1.0
adenomas I-Disease 1 1.0
and I-Disease 1 0.9950684309005737
carcinoma I-Disease 1 1.0
, O 0 0.000725017802324146
but O 0 1.0918622137978673e-05
without O 0 3.361099516041577e-06
the O 0 1.9395247363718227e-06
florid O 0 0.00022324452584143728
phenotype O 0 3.9815891796024516e-05
of O 0 6.386952122738876e-07
classical O 0 8.669438102515414e-06
FAP B-Disease 0 0.0001233438670169562
, O 0 2.8291515263845213e-06
and O 0 3.192639724147739e-06
possibly O 0 1.14230078906985e-05
with O 0 1.659386384744721e-06
importance O 0 3.709274096763693e-05
for O 1 0.7780838012695312
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
risk O 0 0.28451159596443176
in O 0 5.6532685448473785e-06
the O 0 3.3341705147904577e-06
general O 0 6.396830031007994e-06
population O 0 4.595908194460208e-06
. O 0 5.160929049452534e-06
. O 0 2.577700615802314e-05

Genomic O 0 0.0017505665309727192
structure O 0 0.00020853620662819594
of O 0 2.0330118786660023e-05
the O 0 0.0001633480133023113
human O 0 0.05645054206252098
congenital B-Disease 1 1.0
chloride I-Disease 1 0.9999991655349731
diarrhea I-Disease 1 1.0
( O 0 0.04245247691869736
CLD B-Disease 1 0.9996215105056763
) O 0 0.00011291414557490498
gene O 0 0.00024154418497346342
. O 0 0.00012436129327397794

Congenital B-Disease 1 1.0
chloride I-Disease 1 0.9999992847442627
diarrhea I-Disease 1 1.0
( O 1 0.9101080894470215
CLD B-Disease 1 0.9999752044677734
) O 0 0.0001170755349448882
is O 0 9.160266927210614e-06
caused O 0 3.721736356965266e-05
by O 0 2.8696265417238465e-06
mutations O 0 1.2320573659962974e-05
in O 0 1.3389284276854596e-06
a O 0 3.979023858846631e-06
gene O 0 7.3956903179350775e-06
which O 0 1.8453024495102e-06
encodes O 0 1.5300538507290184e-05
an O 0 2.335761564609129e-05
intestinal O 0 0.1431833952665329
anion O 0 0.0017343690851703286
transporter O 0 0.0028515441808849573
. O 0 0.0001397021405864507

We O 0 0.0002302914363099262
report O 0 2.9085769710945897e-05
here O 0 4.106555934413336e-06
the O 0 1.5122219565455453e-06
complete O 0 7.405776159430388e-06
genomic O 0 1.3978920833324082e-05
organization O 0 2.31476292356092e-06
of O 0 6.173185056468355e-07
the O 0 2.5466879378654994e-06
human O 0 7.652183739992324e-06
CLD B-Disease 0 0.08545485883951187
gene O 0 9.370941370434593e-06
which O 0 1.6212187574637937e-06
spans O 0 1.2535050700535066e-05
approximately O 0 4.873068064625841e-06
39kb O 0 0.0001080871734302491
, O 0 1.489728788328648e-06
and O 0 1.8950274807139067e-06
comprises O 0 9.186100214719772e-06
21 O 0 3.34698379447218e-05
exons O 0 0.00012876366963610053
. O 0 7.5572170317173e-05

All O 0 0.0001398492750013247
exon O 0 0.0007616113289259374
/ O 0 0.00018200614431407303
intron O 0 0.0004276485415175557
boundaries O 0 3.0724746466148645e-05
conform O 0 2.2636702851741575e-05
to O 0 3.916165042028297e-06
the O 0 1.0864186151593458e-05
GT O 0 0.04005586355924606
/ O 0 0.0008487772429361939
AG O 1 0.9754509329795837
rule O 0 8.775084279477596e-05
. O 0 9.185205271933228e-05

An O 0 4.9095888243755326e-05
analysis O 0 1.8799408280756325e-05
of O 0 2.922899739132845e-06
the O 0 5.274696832202608e-06
putative O 0 7.989151345100254e-05
promoter O 0 4.461750359041616e-05
region O 0 5.816690190840745e-06
sequence O 0 5.581526238529477e-06
shows O 0 6.1635764723178e-06
a O 0 1.1916939001821447e-05
putative O 0 0.0003130676632281393
TATA O 0 0.2559764087200165
box O 0 0.0001276058901567012
and O 0 6.772149390599225e-06
predicts O 0 3.6694720620289445e-05
multiple O 0 1.4139758604869712e-05
transcription O 0 3.270978413638659e-05
factor O 0 1.94431977433851e-05
binding O 0 2.2719623302691616e-05
sites O 0 3.448074494372122e-05
. O 0 4.6118508180370554e-05

The O 0 8.686748333275318e-05
genomic O 0 0.0003297299554105848
structure O 0 0.00011837310739792883
was O 0 4.3353877117624506e-05
determined O 0 5.284847702569095e-06
using O 0 2.402502559561981e-06
DNA O 0 4.235505457472755e-06
from O 0 6.23330095095298e-07
several O 0 4.872426870861091e-07
sources O 0 6.3227122382159e-07
including O 0 5.150241122464649e-07
multiple O 0 2.6580187295621727e-06
large O 0 1.1832278687506914e-05
- O 0 0.004191898740828037
insert O 0 7.152097532525659e-05
libaries O 0 0.00011914439528482035
and O 0 2.1175260371819604e-06
genomic O 0 1.8662722141016275e-05
DNA O 0 2.2733513105777092e-05
from O 0 6.4955579546222e-06
Finnish O 1 0.5073495507240295
CLD B-Disease 1 0.9995790123939514
patients O 0 0.004177422728389502
and O 0 2.1419091353891417e-05
controls O 0 0.0004242069262545556
. O 0 0.00010067826951853931

Exon O 0 0.0023539967369288206
- O 0 0.0005029923631809652
specific O 0 1.5793280908837914e-05
primers O 0 7.952407759148628e-05
developed O 0 2.5178938813041896e-05
in O 0 2.5452065983699868e-06
this O 0 8.018811854526575e-07
study O 0 1.1658379435175448e-06
will O 0 6.290630949479237e-07
facilitate O 0 2.039542096099467e-06
mutation O 0 5.062044238002272e-06
screening O 0 3.6981814446335193e-06
studies O 0 1.993997329918784e-06
of O 0 1.9479239199426956e-06
patients O 0 0.0007452555582858622
with O 0 1.7253343685297295e-05
the O 0 0.0020453124307096004
disease O 1 0.8900288939476013
. O 0 0.00018214121519122273

Genomic O 0 0.0008165902108885348
sequencing O 0 0.0002217233704868704
of O 0 2.33138634939678e-05
a O 0 0.00012106590293115005
BAC O 0 0.03940877690911293
clone O 0 0.004012634977698326
H O 1 0.9998819828033447
_ O 0 3.337383895996027e-05
RG364P16 O 0 0.00014141472638584673
revealed O 0 1.378763045067899e-05
the O 0 1.2430652986950008e-06
presence O 0 1.5107602848729584e-06
of O 0 5.27126474025863e-07
another O 0 3.4722791042440804e-06
, O 0 1.3764752111455891e-06
highly O 0 1.685353709035553e-06
homologous O 0 4.714391707238974e-06
gene O 0 4.341156909504207e-06
3 O 0 1.3601041928268387e-06
of O 0 4.527921930730372e-07
the O 0 5.705795956600923e-06
CLD B-Disease 1 0.5190150141716003
gene O 0 7.350940450123744e-06
, O 0 7.002596476013423e-07
with O 0 6.307210469458369e-07
a O 0 1.7797079863157705e-06
similar O 0 2.16638818528736e-06
genomic O 0 1.667826290940866e-05
structure O 0 2.2982627342571504e-05
, O 0 3.4692407098191325e-06
recently O 0 2.5191764507326297e-05
identified O 0 9.291405149269849e-06
as O 0 4.738917596114334e-06
the O 0 0.003268966916948557
Pendred B-Disease 1 1.0
syndrome I-Disease 1 1.0
gene O 0 0.00049830402713269
( O 0 1.6445912478957325e-05
PDS B-Disease 0 0.028227172791957855
) O 0 7.924566489236895e-06
. O 0 9.554234566166997e-06
. O 0 3.575172377168201e-05

The O 0 0.00018441476277075708
APCI1307K O 0 0.020123718306422234
allele O 0 0.0005560836289077997
and O 0 0.002005899092182517
cancer B-Disease 1 0.9899026155471802
risk O 0 0.0005066531011834741
in O 0 5.824149866384687e-06
a O 0 1.3155005035514478e-05
community O 0 7.259939593495801e-06
- O 0 0.00013389629020821303
based O 0 2.3860009150666883e-06
study O 0 1.4882208461131086e-06
of O 0 2.6045306640298804e-06
Ashkenazi O 0 0.00013786846830043942
Jews O 0 4.7810273827053607e-05
. O 0 3.74395604012534e-05

Mutations O 0 0.0032440880313515663
in O 0 0.0001496059849159792
APC O 0 0.0017340148333460093
are O 0 2.6242470994475298e-05
classically O 0 0.2655896246433258
associated O 0 0.00024483457673341036
with O 0 0.03823850303888321
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999998807907104
polyposis I-Disease 1 1.0
( O 0 0.0294266976416111
FAP B-Disease 0 0.3575155735015869
) O 0 3.72137401427608e-05
, O 0 1.0479113370820414e-05
a O 0 0.00023210297513287514
highly O 0 0.3622156083583832
penetrant O 1 0.9999855756759644
autosomal B-Disease 1 1.0
dominant I-Disease 1 0.9999790191650391
disorder I-Disease 1 1.0
characterized O 0 0.07979969680309296
by O 0 2.6918320145341568e-05
multiple O 0 0.35661792755126953
intestinal O 1 0.9998987913131714
polyps B-Disease 1 0.6057648062705994
and O 0 5.4359355999622494e-05
, O 0 1.265621540369466e-05
without O 0 2.1524629119085148e-05
surgical O 0 0.20408029854297638
intervention O 0 2.147466511814855e-05
, O 0 1.8438985307511757e-06
the O 0 2.3418315322487615e-06
development O 0 2.083514118567109e-05
of O 0 0.25934547185897827
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.0013572771567851305
CRC B-Disease 1 0.8092985153198242
) O 0 4.023844303446822e-05
. O 0 4.9974110879702494e-05

APC B-Disease 0 0.00572813069447875
is O 0 6.837505497969687e-05
a O 0 0.0001626636367291212
tumour O 1 0.9999752044677734
- O 0 0.0008485629805363715
suppressor O 0 0.00014303383068181574
gene O 0 1.1948734027100727e-05
, O 0 1.691506440693047e-06
and O 0 2.2377582808985608e-06
somatic O 0 0.00013497126928996295
loss O 0 0.0020986520685255527
occurs O 0 1.3086596482025925e-05
in O 0 0.00013292033690959215
tumours B-Disease 1 0.9999946355819702
. O 0 0.0003380016714800149

The O 0 0.00028091450803913176
germline O 0 0.005961207672953606
T O 0 0.014134055934846401
- O 0 8.801314834272489e-05
to O 0 4.353627446107566e-06
- O 0 4.8214566049864516e-05
A O 0 1.3011247574468143e-05
transversion O 0 0.0002201984461862594
responsible O 0 3.5015889352507656e-06
for O 0 3.529694367898628e-07
the O 0 1.214726012221945e-06
APC O 0 2.4134054910973646e-05
I1307K O 0 1.7476606444688514e-05
allele O 0 3.869964984914986e-06
converts O 0 2.0135325939918403e-06
the O 0 1.3323151506483555e-06
wild O 0 3.354090040375013e-06
- O 0 1.5960013115545735e-05
type O 0 2.896842488553375e-06
sequence O 0 1.4708698472531978e-06
to O 0 1.97891586140031e-06
a O 0 4.512843588599935e-05
homopolymer O 1 0.8525540232658386
tract O 0 0.09819073975086212
( O 0 5.754135145252803e-06
A8 O 0 0.2024226039648056
) O 0 2.749088935161126e-06
that O 0 1.15171155812277e-06
is O 0 2.4368757749471115e-06
genetically O 0 3.748922244994901e-05
unstable O 0 0.00030819931998848915
and O 0 6.087332167226123e-06
prone O 0 0.0006801351555623114
to O 0 1.6888365280465223e-05
somatic O 0 0.0007600506651215255
mutation O 0 0.0003203144297003746
. O 0 9.618180774850771e-05

The O 0 0.00012048810458509251
I1307K O 0 0.0008968542679212987
allele O 0 0.00015897130651865155
was O 0 4.7317684220615774e-05
found O 0 1.4115992598817684e-05
in O 0 1.2660754691751208e-05
6 O 0 0.00016961342771537602
. O 0 8.267087832791731e-05

1 O 0 0.00023421665537171066
% O 0 2.1835685402038507e-05
of O 0 8.340652129845694e-06
unselected O 0 0.0004481149953790009
Ashkenazi O 0 0.00012766211875714362
Jews O 0 1.0598238986858632e-05
and O 0 2.9708719466725597e-06
higher O 0 4.104308573005255e-06
proportions O 0 1.4000026567373425e-05
of O 0 1.3642209069075761e-06
Ashkenazim O 0 6.757606752216816e-05
with O 0 8.498588613292668e-06
family O 0 5.0431699492037296e-05
or O 0 2.9080915737722535e-06
personal O 0 1.6206458894885145e-05
histories O 0 1.8047534467768855e-05
of O 0 5.906103069719393e-06
CRC B-Disease 0 0.36259278655052185
( O 0 1.3930784007243346e-05
ref O 0 0.2934667468070984
. O 0 5.519415481103351e-06
2 O 0 2.436126487737056e-05
) O 0 1.6935038729570806e-05
. O 0 4.0151699067791924e-05

To O 0 7.388069207081571e-05
evaluate O 0 6.358140672091395e-05
the O 0 5.356764177122386e-06
role O 0 4.234237167111132e-06
of O 0 2.2101464765000856e-06
I1307K O 0 0.001760487211868167
in O 0 3.981110785389319e-05
cancer B-Disease 0 0.0965740829706192
, O 0 5.434772447188152e-06
we O 0 3.8665161810058635e-06
genotyped O 0 0.0001385212963214144
5 O 0 5.655220775224734e-06
, O 0 2.987415427924134e-06
081 O 0 0.00022639117378275841
Ashkenazi O 0 3.1712032068753615e-05
volunteers O 0 8.1471553130541e-06
in O 0 2.309757064722362e-06
a O 0 6.687459517706884e-06
community O 0 1.3844512977811974e-05
survey O 0 0.00010011153062805533
. O 0 3.937648216378875e-05

Risk O 0 0.0032111178152263165
of O 0 5.253656490822323e-05
developing O 0 0.014200400561094284
colorectal B-Disease 1 0.9999996423721313
, I-Disease 0 0.002566799521446228
breast I-Disease 1 0.8649815917015076
and I-Disease 0 2.944596235465724e-05
other I-Disease 0 1.4157677469484042e-05
cancers I-Disease 0 0.2955804765224457
were O 0 2.4847373424563557e-05
compared O 0 7.656549314560834e-06
between O 0 4.3152676880708896e-06
genotyped O 0 0.008553460240364075
I1307K O 0 0.0003146100789308548
carriers O 0 1.233860803040443e-05
and O 0 2.181143827328924e-06
non O 0 3.917887170246104e-06
- O 0 9.59976387093775e-05
carriers O 0 5.302304543874925e-06
and O 0 9.340777751276619e-07
their O 0 1.0784212918224512e-06
first O 0 3.573761659936281e-06
- O 0 0.0001925209944602102
degree O 0 5.795852848677896e-05
relatives O 0 0.0002300857740920037
. O 0 4.166267899563536e-05

Sperm O 0 0.0023596875835210085
DNA O 0 0.00023345636145677418
analysis O 0 2.245920040877536e-05
in O 0 1.263245940208435e-05
a O 0 0.00012096249702153727
Friedreich B-Disease 1 0.8815827369689941
ataxia I-Disease 1 0.989809513092041
premutation O 1 0.5692295432090759
carrier O 0 0.0007387248333543539
suggests O 0 1.0649129762896337e-05
both O 0 1.7323774272881565e-06
meiotic O 0 2.7517469789017923e-05
and O 0 2.5858546450763242e-06
mitotic O 0 2.323422631889116e-05
expansion O 0 5.494752713275375e-06
in O 0 2.86456520370848e-06
the O 0 1.066404911398422e-05
FRDA B-Disease 0 0.042242661118507385
gene O 0 0.00010187541192863137
. O 0 6.242624658625573e-05

Friedreich B-Disease 1 0.9988147020339966
ataxia I-Disease 1 0.9999620914459229
is O 0 0.0006320124957710505
usually O 0 0.00013004745414946228
caused O 0 7.557692879345268e-05
by O 0 1.0260646376991645e-06
an O 0 1.147232410403376e-06
expansion O 0 2.9550533326982986e-06
of O 0 9.933785349858226e-07
a O 0 4.566703501041047e-05
GAA O 0 0.015153184533119202
trinucleotide O 0 0.0007187424344010651
repeat O 0 3.102803020738065e-05
in O 0 3.168020839439123e-06
intron O 0 0.00023866636911407113
1 O 0 2.8782269509974867e-06
of O 0 1.4847717011434725e-06
the O 0 1.0464372280694079e-05
FRDA B-Disease 0 0.026828939095139503
gene O 0 0.00010129700240213424
. O 0 5.319384945323691e-05

Occasionally O 0 0.0007273922674357891
, O 0 3.8153284549480304e-05
a O 0 1.4109410585660953e-05
fully O 0 8.611010343884118e-06
expanded O 0 4.152518613409484e-06
allele O 0 5.662429884978337e-06
has O 0 1.1206494718862814e-06
been O 0 1.6177191355382092e-06
found O 0 1.625135041649628e-06
to O 0 1.065375613507058e-06
arise O 0 2.5798051410674816e-06
from O 0 7.227542937471299e-07
a O 0 2.3483419226977276e-06
premutation O 0 4.098429417354055e-05
of O 0 5.031608338867954e-07
100 O 0 2.4170312826754525e-06
or O 0 2.554885895733605e-06
less O 0 1.1613875358307268e-05
triplet O 0 0.051217611879110336
repeats O 0 0.0002101786813000217
. O 0 5.593978858087212e-05

We O 0 0.00011802720109699294
have O 0 1.166978654509876e-05
examined O 0 2.1380257749115117e-05
the O 0 4.081560291524511e-06
sperm O 0 3.515365460771136e-05
DNA O 0 6.702796326862881e-06
of O 0 1.3466656128002796e-06
a O 0 2.23290753638139e-05
premutation O 0 0.030716676265001297
carrier O 0 0.0019748189952224493
. O 0 5.598391726380214e-05

This O 0 6.308266893029213e-05
mans O 0 0.00023612297081854194
leucocyte O 0 0.0009151384583674371
DNA O 0 6.491565000033006e-05
showed O 0 1.5707708371337503e-05
one O 0 1.9033664102607872e-06
normal O 0 4.0640666156832594e-06
allele O 0 4.941016413795296e-06
and O 0 6.141422659311502e-07
one O 0 7.683852913942246e-07
allele O 0 4.002783953183098e-06
of O 0 1.0173459941142937e-06
approximately O 0 4.244951924192719e-06
100 O 0 1.327456357103074e-05
repeats O 0 0.00011172871018061414
. O 0 6.29754358669743e-05

His O 0 0.0004242688009981066
sperm O 0 0.0003143420326523483
showed O 0 3.993392601842061e-05
an O 0 4.318305855122162e-06
expanded O 0 8.491531843901612e-06
allele O 0 9.9569842859637e-06
in O 0 1.7213501450896729e-06
a O 0 4.547154276224319e-06
tight O 0 3.668268254841678e-05
range O 0 1.816896201489726e-06
centering O 0 4.769876795762684e-06
on O 0 1.728812435430882e-06
a O 0 2.4322230274265166e-06
size O 0 3.60058538717567e-06
of O 0 1.4028955774847418e-06
approximately O 0 1.0156679309147876e-05
320 O 0 0.00011572981748031452
trinucleotide O 0 0.0027829965110868216
repeats O 0 0.00023728254018351436
. O 0 7.533960888395086e-05

His O 0 0.0011122127762064338
affected O 0 0.0010976629564538598
son O 0 0.009147618897259235
has O 0 1.8520284356782213e-05
repeat O 0 3.184509841958061e-05
sizes O 0 2.4447701434837654e-05
of O 0 7.2594129960634746e-06
1040 O 0 0.00044027750845998526
and O 0 2.7938327548326924e-05
540 O 0 0.0002297085738973692
. O 0 7.65948643675074e-05

These O 0 3.645871038315818e-05
data O 0 1.784190499165561e-05
suggest O 0 5.865476396138547e-06
that O 0 9.042865372066444e-07
expansion O 0 2.5350420855829725e-06
occurs O 0 9.94813831312058e-07
in O 0 5.987137114971119e-07
two O 0 8.981619430414867e-07
stages O 0 1.26888107843115e-05
, O 0 8.749062772039906e-07
the O 0 5.133563831805077e-07
first O 0 1.960396957656485e-06
during O 0 3.956799446314108e-06
meiosis O 0 7.3771216193563305e-06
followed O 0 2.9817599624948343e-06
by O 0 9.698349003883777e-07
a O 0 2.790450480461004e-06
second O 0 1.4243537407310214e-05
mitotic O 0 0.00012747164873871952
expansion O 0 4.8734840675024316e-05
. O 0 4.641748091671616e-05

We O 0 7.623699639225379e-05
also O 0 1.1106367310276255e-05
show O 0 6.487905920948833e-06
that O 0 8.051770805650449e-07
in O 0 6.854480147922004e-07
all O 0 3.9332522305812745e-07
informative O 0 2.698383013921557e-06
carrier O 0 3.066875069634989e-05
father O 0 1.3952283552498557e-05
to O 0 1.4029839121576515e-06
affected O 0 1.219098976434907e-05
child O 0 2.568753552623093e-05
transmissions O 0 5.569371933233924e-05
, O 0 1.7651475445745746e-06
with O 0 7.897232876530325e-07
the O 0 7.308861995625193e-07
notable O 0 1.1121820762127754e-06
exception O 0 7.762411087242072e-07
of O 0 3.875361471727956e-07
the O 0 2.420498276478611e-06
premutation O 0 0.0015712649328634143
carrier O 0 4.0747039747657254e-05
, O 0 9.491050150245428e-07
the O 0 7.906260748313798e-07
expansion O 0 5.269387656881008e-06
size O 0 2.143204619642347e-05
decreases O 0 5.4822889069328085e-05
. O 0 7.854227078496478e-06
. O 0 3.646406912594102e-05

The O 0 0.0001188306778203696
R496H O 0 0.0007056610775180161
mutation O 0 7.113727042451501e-05
of O 0 8.98016423889203e-06
arylsulfatase O 0 0.002108817920088768
A O 0 0.0001234284573001787
does O 0 1.8844140868168324e-05
not O 0 3.892583481501788e-05
cause O 0 0.002853314159438014
metachromatic B-Disease 1 0.999954104423523
leukodystrophy I-Disease 1 0.9999485015869141
. O 0 0.00038635521195828915

Deficiency B-Disease 1 0.9995946288108826
of I-Disease 0 0.00011078958050347865
arylsulfatase I-Disease 0 0.38526812195777893
A I-Disease 0 0.0005166064947843552
( O 0 4.5416225475491956e-05
ARSA O 0 0.052291058003902435
) O 0 1.1482469744805712e-05
enzyme O 0 4.936159893986769e-05
activity O 0 3.718926018336788e-05
causes O 0 0.0006302563706412911
metachromatic B-Disease 1 0.9999948740005493
leukodystrophy I-Disease 1 0.9999980926513672
( O 0 0.0007696651737205684
MLD B-Disease 1 0.999964714050293
) O 0 8.872401667758822e-05
. O 0 0.0001058730558725074

A O 0 0.00010511515574762598
number O 0 1.3758237400907092e-05
of O 0 1.0913709047599696e-05
ARSA O 0 0.0537320077419281
gene O 0 6.913027027621865e-05
mutations O 0 5.0647806347114965e-05
responsible O 0 2.699093965929933e-05
for O 0 1.8693290257942863e-05
MLD B-Disease 1 0.9999868869781494
have O 0 3.7370995414676145e-05
been O 0 4.5737418986391276e-05
identified O 0 7.546342385467142e-05
. O 0 4.829218960367143e-05

Recently O 0 0.0005925184232182801
, O 0 1.991374301724136e-05
the O 0 6.012403900967911e-06
R496H O 0 0.00011197145795449615
mutation O 0 1.076027092494769e-05
of O 0 2.377262944719405e-06
ARSA O 0 0.11573165655136108
was O 0 3.0915383831597865e-05
proposed O 0 1.825927142817818e-06
to O 0 1.524086769677524e-06
be O 0 1.9854203401337145e-06
a O 0 7.579531484225299e-06
cause O 0 2.7095516998087987e-05
of O 0 1.2039142347930465e-05
MLD B-Disease 1 0.9999920129776001
( O 0 1.8380576875642873e-05
Draghia O 0 0.009829545393586159
et O 0 0.0004354623961262405
al O 0 0.0022464939393103123
. O 0 1.9078152035945095e-06
, O 0 2.971189132949803e-06
1997 O 0 1.8948319848277606e-05
) O 0 5.45240800420288e-06
. O 0 2.0058963855262846e-05

We O 0 0.0001194479045807384
have O 0 1.25618462334387e-05
investigated O 0 1.551170316815842e-05
the O 0 3.1333322567661526e-06
R496H O 0 9.848387708188966e-05
mutation O 0 7.914733942016028e-06
and O 0 1.790379997146374e-06
found O 0 3.6461976833379595e-06
this O 0 6.881497824906546e-07
mutation O 0 3.4946433515870012e-06
at O 0 5.005942966818111e-06
a O 0 3.031859932889347e-06
relatively O 0 3.271244850111543e-06
high O 0 3.86496003557113e-06
frequency O 0 2.815650532284053e-06
in O 0 1.1260531209700275e-06
an O 0 9.803458169699297e-07
African O 0 1.249284423465724e-06
American O 0 6.730016366418567e-07
population O 0 7.147400538087822e-07
( O 0 5.793675654786057e-07
f O 0 2.8105663659516722e-05
= O 0 5.356616384233348e-05
0 O 0 2.9867858302168315e-06
. O 0 8.478702397951565e-07
09 O 0 2.4384737116633914e-05
, O 0 2.5620104224799434e-06
n O 0 6.307273724814877e-05
= O 0 7.70293700043112e-05
61 O 0 1.6748790585552342e-05
subjects O 0 1.943689312611241e-05
) O 0 1.7043883417500183e-05
. O 0 5.660028546117246e-05

The O 0 0.00019119617354590446
ARSA O 0 0.009057227522134781
enzyme O 0 8.894579514162615e-05
activity O 0 9.808220056584105e-06
in O 0 2.7721937385649653e-06
subjects O 0 3.74391242985439e-06
with O 0 1.9259919099567924e-06
and O 0 2.6508876089792466e-06
without O 0 1.8193323967352626e-06
the O 0 1.829810912568064e-06
R496H O 0 0.00017164123710244894
mutation O 0 7.632235792698339e-06
was O 0 1.3468003089656122e-05
determined O 0 2.7978130674455315e-06
and O 0 7.101504024831229e-07
found O 0 1.9934973352064844e-06
to O 0 2.428357220196631e-06
be O 0 6.900747393956408e-06
normal O 0 4.519864160101861e-05
. O 0 3.552276757545769e-05

It O 0 0.0001249140768777579
is O 0 1.923644776979927e-05
therefore O 0 1.0739008757809643e-05
concluded O 0 9.02773354027886e-06
that O 0 1.1544353810677421e-06
the O 0 1.958937446033815e-06
R496H O 0 0.00010094264143845066
mutation O 0 8.679058737470768e-06
of O 0 3.2161087801796384e-06
ARSA O 0 0.05070752277970314
does O 0 2.8108775040891487e-06
not O 0 9.081115877052071e-07
negatively O 0 1.934494548549992e-06
influence O 0 9.358271881865221e-07
the O 0 4.897883059129526e-07
activity O 0 1.046267016135971e-06
of O 0 6.884490630909568e-07
ARSA O 0 0.03271084651350975
and O 0 3.043517153855646e-06
is O 0 1.1033217788281036e-06
not O 0 9.153421842711396e-07
a O 0 8.96939673111774e-06
cause O 0 7.057006587274373e-05
of O 0 0.00010680717241484672
MLD B-Disease 1 0.9999439716339111

Down O 0 0.0009394240914843976
- O 0 0.00041159140528179705
regulation O 0 3.126243609585799e-05
of O 0 9.292299182561692e-06
transmembrane O 0 0.0003788126341532916
carbonic O 0 0.00048606633208692074
anhydrases O 0 0.007172310259193182
in O 0 0.0015227078692987561
renal B-Disease 1 0.9999996423721313
cell I-Disease 1 0.9999858140945435
carcinoma I-Disease 1 1.0
cell O 0 0.06609947234392166
lines O 0 7.475927122868598e-05
by O 0 5.327911821950693e-06
wild O 0 1.517346299806377e-05
- O 0 0.00035309355007484555
type O 0 0.0003048561920877546
von B-Disease 1 0.971245527267456
Hippel I-Disease 1 0.9357537031173706
- I-Disease 0 0.1565133035182953
Lindau I-Disease 1 0.8103523850440979
transgenes O 0 0.003315904876217246
. O 0 0.00018848826584871858

To O 0 0.0001090061996364966
discover O 0 0.00022064780932851136
genes O 0 5.835761839989573e-05
involved O 0 2.5395393095095642e-05
in O 0 2.831796336977277e-05
von B-Disease 1 0.9929912090301514
Hippel I-Disease 1 0.9979127049446106
- I-Disease 1 0.9209635853767395
Lindau I-Disease 1 0.9851897358894348
( O 0 2.3540313122794032e-05
VHL B-Disease 0 0.005450334399938583
) O 0 5.246871751296567e-06
- O 0 7.994546467671171e-05
mediated O 0 6.218211638042703e-05
carcinogenesis O 0 0.00038648396730422974
, O 0 6.725039384036791e-06
we O 0 8.588390301156323e-06
used O 0 0.0006321573746390641
renal B-Disease 1 0.9999985694885254
cell I-Disease 1 0.9999402761459351
carcinoma I-Disease 1 1.0
cell O 0 0.18539254367351532
lines O 0 0.00047460064524784684
stably O 0 0.0005435430211946368
transfected O 0 0.00020391304860822856
with O 0 5.794029675598722e-06
wild O 0 2.037437297985889e-05
- O 0 0.001369277248159051
type O 0 0.00027531140949577093
VHL O 0 0.1286298930644989
- O 0 0.0013136306079104543
expressing O 0 0.0002098262484651059
transgenes O 0 0.001060467679053545
. O 0 0.00011689548409776762

Large O 0 0.00028246192960068583
- O 0 0.000389378285035491
scale O 0 8.613680984126404e-05
RNA O 0 3.0363735277205706e-05
differential O 0 2.0242538084858097e-05
display O 0 9.295969903178047e-06
technology O 0 1.1187444215465803e-05
applied O 0 2.5168187676172238e-06
to O 0 8.155194564096746e-07
these O 0 5.350344736143597e-07
cell O 0 2.2334825189318508e-05
lines O 0 1.3820806998410262e-05
identified O 0 3.5740820294449804e-06
several O 0 8.477036885778944e-07
differentially O 0 2.144490645150654e-05
expressed O 0 1.4646941508544842e-06
genes O 0 1.7711405462250696e-06
, O 0 6.072768314879795e-07
including O 0 1.1177526175742969e-06
an O 0 2.971225967485225e-06
alpha O 0 5.8030309446621686e-05
carbonic O 0 0.00012569036334753036
anhydrase O 0 0.00016032154962886125
gene O 0 2.905640758399386e-05
, O 0 1.2606525160663296e-05
termed O 0 0.00019575943588279188
CA12 O 0 0.002688449574634433
. O 0 8.589048957219347e-05

The O 0 7.648552127648145e-05
deduced O 0 0.0002036742225755006
protein O 0 3.38689424097538e-05
sequence O 0 8.812312444206327e-06
was O 0 1.9302677173982374e-05
classified O 0 4.843715487368172e-06
as O 0 7.983308023540303e-07
a O 0 2.167260163332685e-06
one O 0 3.080033366131829e-06
- O 0 0.0020777175668627024
pass O 0 4.433570211404003e-05
transmembrane O 0 0.0029960419051349163
CA O 0 0.0005148660857230425
possessing O 0 1.0098448910866864e-05
an O 0 3.924367774743587e-06
apparently O 0 8.972458454081789e-05
intact O 0 1.1172132872161455e-05
catalytic O 0 7.149757948354818e-06
domain O 0 3.6654496398114134e-06
in O 0 2.507764520487399e-06
the O 0 9.299285920860711e-06
extracellular O 0 0.0002875468344427645
CA O 0 0.0031223262194544077
module O 0 0.0008586551412008703
. O 0 7.326832565013319e-05

Reintroduced O 0 0.001383594935759902
wild O 0 0.00019989488646388054
- O 0 0.0006327148876152933
type O 0 0.00014419412764254957
VHL B-Disease 0 0.004010175354778767
strongly O 0 1.2561618859763257e-05
inhibited O 0 1.4890632883179933e-05
the O 0 1.4178319815982832e-06
overexpression O 0 6.31180500931805e-06
of O 0 8.473319326185447e-07
the O 0 2.570264769019559e-06
CA12 O 0 0.0020998830441385508
gene O 0 6.235879936866695e-06
in O 0 2.0308159491833067e-06
the O 0 2.2844329578219913e-05
parental O 1 0.9861574172973633
renal B-Disease 1 0.9999998807907104
cell I-Disease 1 0.9999963045120239
carcinoma I-Disease 1 1.0
cell O 1 0.883687436580658
lines O 0 0.020063629373908043
. O 0 0.0002532712824176997

Similar O 0 0.00025858861044980586
results O 0 0.0001460564526496455
were O 0 2.1452495275298133e-05
obtained O 0 1.0994816875609104e-05
with O 0 5.609071649814723e-06
CA9 O 0 0.0013103735400363803
, O 0 1.5504192560911179e-06
encoding O 0 4.126640760659939e-06
another O 0 8.272005288745277e-06
transmembrane O 0 0.000416255701566115
CA O 0 0.0006925947382114828
with O 0 1.1500466143843369e-06
an O 0 5.205857178225415e-06
intact O 0 7.557317439932376e-05
catalytic O 0 7.283481681952253e-05
domain O 0 6.282896356424317e-05
. O 0 5.283228529151529e-05

Although O 0 0.00013738330744672567
both O 0 1.758504004101269e-05
domains O 0 2.6275702111888677e-05
of O 0 3.454482794040814e-06
the O 0 1.641244671191089e-05
VHL B-Disease 0 0.009912233799695969
protein O 0 8.782922122918535e-06
contribute O 0 2.5767390070541296e-06
to O 0 1.0263053127346211e-06
regulation O 0 4.0166073631553445e-06
of O 0 1.2788797221219284e-06
CA12 O 0 0.008720175363123417
expression O 0 3.561998937584576e-06
, O 0 1.3860425269740517e-06
the O 0 1.624465653549123e-06
elongin O 0 9.835193486651406e-05
binding O 0 6.0125416894152295e-06
domain O 0 1.0925256901828106e-05
alone O 0 2.805791882565245e-05
could O 0 1.1573475603654515e-05
effectively O 0 5.435733328340575e-05
regulate O 0 0.0001225365122081712
CA9 O 0 0.0014449483714997768
expression O 0 6.188821862451732e-05
. O 0 5.4187417845241725e-05

We O 0 0.0002359249338041991
mapped O 0 0.00045810057781636715
CA12 O 0 0.0029911065939813852
and O 0 4.620042454916984e-05
CA9 O 0 0.0018589745741337538
loci O 0 5.536455864785239e-05
to O 0 7.730129254923668e-06
chromosome O 0 0.00022085531963966787
bands O 0 9.997129382099956e-05
15q22 O 0 0.00029908979195170105
and O 0 2.9835133318556473e-05
17q21 O 0 0.0020918864756822586
. O 0 0.00011430404265411198

2 O 0 0.0004229122423566878
respectively O 0 0.00012828422768507153
, O 0 1.3641814803122543e-05
regions O 0 1.9763620002777316e-05
prone O 0 0.0002878891536965966
to O 0 5.735836111853132e-06
amplification O 0 0.00011514574725879356
in O 0 4.608614744938677e-06
some O 0 3.4409627005516086e-06
human O 0 2.586560367490165e-05
cancers B-Disease 0 0.07101257145404816
. O 0 6.807032332289964e-05

Additional O 0 0.00010367629147367552
experiments O 0 9.132985724136233e-05
are O 0 4.489187631406821e-06
needed O 0 7.374449069175171e-06
to O 0 1.211047674587462e-06
define O 0 5.1816864470310975e-06
the O 0 1.1885643971254467e-06
role O 0 2.3823401988920523e-06
of O 0 3.2317741442966508e-06
CA O 0 0.015973364934325218
IX O 0 0.0030053232330828905
and O 0 2.4127333745127544e-05
CA O 0 0.002094114199280739
XII O 0 0.0002568121999502182
enzymes O 0 6.171046152303461e-06
in O 0 1.166308265965199e-06
the O 0 1.1998644140476245e-06
regulation O 0 3.5931693673774134e-06
of O 0 9.544750128043233e-07
pH O 0 0.00012373756908345968
in O 0 1.204831733048195e-06
the O 0 1.239132075170346e-06
extracellular O 0 1.3193851373216603e-05
microenvironment O 0 7.475228630937636e-05
and O 0 9.627696044844924e-07
its O 0 9.375092417940323e-07
potential O 0 3.4168560887337662e-06
impact O 0 7.235208613565192e-06
on O 0 7.426147203659639e-05
cancer B-Disease 0 0.2412366420030594
cell O 0 0.0036449788603931665
growth O 0 8.272891864180565e-05
. O 0 5.8301604440202937e-05

A O 0 0.00036835618084296584
gene O 0 0.00018109939992427826
encoding O 0 6.121520709712058e-05
a O 0 2.0722429326269776e-05
transmembrane O 0 0.00015349386376328766
protein O 0 2.0960276742698625e-05
is O 0 2.2406520656659268e-06
mutated O 0 2.434196721878834e-05
in O 0 2.875097925425507e-05
patients O 0 0.06142771616578102
with O 0 0.2874552309513092
diabetes B-Disease 1 1.0
mellitus I-Disease 1 1.0
and O 1 0.9787549376487732
optic B-Disease 1 1.0
atrophy I-Disease 1 0.9999994039535522
( O 1 0.9287835955619812
Wolfram B-Disease 1 1.0
syndrome I-Disease 1 1.0
) O 0 0.00017966206360142678
. O 0 0.000145613681524992

Wolfram B-Disease 1 0.9999996423721313
syndrome I-Disease 1 1.0
( O 0 0.19174417853355408
WFS B-Disease 1 0.9998852014541626
; O 0 0.0032226634211838245
OMIM O 1 0.9868213534355164
222300 O 0 0.31153666973114014
) O 0 3.185612877132371e-05
is O 0 1.0791119166242424e-05
an O 0 0.0008779579657129943
autosomal B-Disease 1 0.9999592304229736
recessive I-Disease 1 0.9999992847442627
neurodegenerative I-Disease 1 0.9999998807907104
disorder I-Disease 1 0.9998935461044312
defined O 0 8.691770199220628e-05
by O 0 9.643312296248041e-06
young O 0 0.00011858199286507443
- O 0 0.07155551761388779
onset O 0 0.2025824785232544
non O 0 0.00026488787261769176
- O 1 0.901053786277771
immune O 0 0.15459109842777252
insulin B-Disease 0 0.06784839928150177
- I-Disease 1 0.9795331358909607
dependent I-Disease 1 0.7724493741989136
diabetes I-Disease 1 0.9999998807907104
mellitus I-Disease 1 0.9999988079071045
and O 0 0.006426869425922632
progressive O 1 0.9306947588920593
optic B-Disease 1 0.9999978542327881
atrophy I-Disease 1 0.9974104762077332
. O 0 0.0006851422367617488

Linkage O 0 0.0012598753673955798
to O 0 5.0701932195806876e-05
markers O 0 0.00013416491856332868
on O 0 4.16906586906407e-05
chromosome O 0 0.20779027044773102
4p O 1 0.9963852167129517
was O 0 0.00048389958101324737
confirmed O 0 2.2038781025912613e-05
in O 0 5.291120942274574e-06
five O 0 1.702575355011504e-05
families O 0 5.432934267446399e-05
. O 0 2.864954512915574e-05

On O 0 5.797428093501367e-05
the O 0 9.044883881870192e-06
basis O 0 5.1545343922043685e-06
of O 0 2.9736354463238968e-06
meiotic O 0 0.0005169296055100858
recombinants O 0 0.44663622975349426
and O 0 0.00408936059102416
disease O 1 0.9402806162834167
- O 0 0.2722715735435486
associated O 0 4.176364018348977e-05
haplotypes O 0 4.8148031055461615e-05
, O 0 3.723921508935746e-06
the O 0 5.496823177963961e-06
WFS B-Disease 0 0.17895810306072235
gene O 0 1.1152035767736379e-05
was O 0 1.0606984687910881e-05
localized O 0 9.586562555341516e-06
to O 0 1.643744553803117e-06
a O 0 1.0324534741812386e-05
BAC O 0 0.0002425184502499178
/ O 0 2.5853125407593325e-05
P1 O 0 0.00013873795978724957
contig O 0 4.5759712520521134e-05
of O 0 1.3184958334022667e-06
less O 0 3.5425330224825302e-06
than O 0 3.1137078622123227e-06
250 O 0 1.969648656086065e-05
kb O 0 0.012062731198966503
. O 0 5.1294373406562954e-05

Mutations O 0 0.0025157099589705467
in O 0 7.031459244899452e-05
a O 0 3.722924884641543e-05
novel O 0 2.619910992507357e-05
gene O 0 2.312341530341655e-05
( O 0 3.7436161619552877e-06
WFS1 O 0 0.0002263450005557388
) O 0 1.0683240816433681e-06
encoding O 0 2.4739999844314298e-06
a O 0 3.146375775031629e-06
putative O 0 2.7886737370863557e-05
transmembrane O 0 3.2179166737478226e-05
protein O 0 6.003671842336189e-06
were O 0 6.938540082046529e-06
found O 0 3.013595460288343e-06
in O 0 1.0270219945596182e-06
all O 0 9.627585768612335e-07
affected O 0 1.1129947779409122e-05
individuals O 0 1.1477610541987815e-06
in O 0 2.3047512058838038e-06
six O 0 0.00010248048056382686
WFS B-Disease 1 0.849927544593811
families O 0 2.0634794054785743e-05
, O 0 1.6207919770749868e-06
and O 0 9.716485465105507e-07
these O 0 7.133883173082722e-07
mutations O 0 8.509764484188054e-06
were O 0 5.38458061782876e-06
associated O 0 6.5399381128372625e-06
with O 0 8.009144949028268e-06
the O 0 0.0006783998687751591
disease O 1 0.9258543252944946
phenotype O 0 0.08046010881662369
. O 0 0.00011253663251409307

WFS1 O 0 0.26915961503982544
appears O 0 0.0002072058996418491
to O 0 1.1247405382164288e-05
function O 0 6.464917532866821e-06
in O 0 3.6476305922406027e-06
survival O 0 3.46312444889918e-05
of O 0 1.725640117911098e-06
islet O 0 0.00043617963092401624
beta O 0 4.804368654731661e-05
- O 0 0.005352783016860485
cells O 0 1.9120492652291432e-05
and O 0 5.856711595697561e-06
neurons O 0 5.3142841352382675e-05
. O 0 6.617128747166134e-06
. O 0 2.1509262296603993e-05

Stable O 0 0.0006756840739399195
interaction O 0 3.2104591809911653e-05
between O 0 5.285986844683066e-06
the O 0 1.9787571545748506e-06
products O 0 1.952763568624505e-06
of O 0 5.78079379920382e-07
the O 0 2.3968498226167867e-06
BRCA1 O 0 0.0002823736285790801
and O 0 2.3526150471298024e-05
BRCA2 O 0 0.03921710327267647
tumor B-Disease 0 0.0011372690787538886
suppressor O 0 8.437438373221084e-05
genes O 0 1.1373279448889662e-05
in O 0 7.162779184000101e-06
mitotic O 0 0.0001129175943788141
and O 0 4.089914000360295e-05
meiotic O 0 0.008292554877698421
cells O 0 0.0007945456309244037
. O 0 0.00010943154484266415

BRCA1 O 0 0.03146051988005638
and O 0 0.00015095957496669143
BRCA2 O 0 0.0024641063064336777
account O 0 1.5266372429323383e-05
for O 0 1.4969250514695887e-06
most O 0 1.363122009934159e-06
cases O 0 1.184642201224051e-06
of O 0 1.6028049003580236e-06
familial O 0 0.013936130329966545
, O 0 1.4939164429961238e-05
early O 0 9.20213497010991e-05
onset O 1 0.9745002388954163
breast B-Disease 1 0.9829791188240051
and I-Disease 0 0.01156014297157526
/ I-Disease 1 0.9511564373970032
or I-Disease 1 0.9877490401268005
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999934434890747
and O 0 1.1374168025213294e-05
encode O 0 1.175911347672809e-05
products O 0 5.315700946084689e-06
that O 0 6.786960966564948e-07
each O 0 1.0869707693927921e-06
interact O 0 5.324854100763332e-06
with O 0 9.595837582310196e-06
hRAD51 O 0 0.0008383256499655545
. O 0 7.116149208741263e-05

Results O 0 0.0004537164932116866
presented O 0 5.1716528105316684e-05
here O 0 1.1202882888028398e-05
show O 0 8.908937161322683e-06
that O 0 3.117763753834879e-06
BRCA1 O 0 0.00016705894086044282
and O 0 1.550703018438071e-05
BRCA2 O 0 0.0012061732122674584
coexist O 0 2.2510897906613536e-05
in O 0 1.8670754116101307e-06
a O 0 7.620650194439804e-06
biochemical O 0 8.313320722663775e-05
complex O 0 1.8965745766763575e-05
and O 0 5.987028089293744e-06
colocalize O 0 0.0003235681797377765
in O 0 2.8303309136390453e-06
subnuclear O 0 0.00012928851356264204
foci O 0 2.1667807232006453e-05
in O 0 2.2054848614061484e-06
somatic O 0 5.584459722740576e-05
cells O 0 1.5817457097000442e-05
and O 0 1.0469117341926903e-06
on O 0 1.4032154922460904e-06
the O 0 1.3228876696302905e-06
axial O 0 6.9000038820377085e-06
elements O 0 1.6534010001123534e-06
of O 0 2.7281816983304452e-06
developing O 0 7.263942825375125e-05
synaptonemal O 0 0.01210412010550499
complexes O 0 0.0004058179911226034
. O 0 6.004764145473018e-05

Like O 0 0.000513033417519182
BRCA1 O 0 0.004347559530287981
and O 0 0.00012181524652987719
RAD51 O 0 0.038304366171360016
, O 0 4.107322820345871e-05
BRCA2 O 0 0.0004802317707799375
relocates O 0 0.00011741160415112972
to O 0 1.1803617780969944e-05
PCNA O 0 0.0022135768085718155
+ O 0 2.47536208917154e-05
replication O 0 1.1434060070314445e-05
sites O 0 3.7418315059767338e-06
following O 0 3.855260274576722e-06
exposure O 0 1.7713598936097696e-05
of O 0 1.9730925941985333e-06
S O 0 0.0005267647211439908
phase O 0 1.796041578927543e-05
cells O 0 1.0088535418617539e-05
to O 0 3.6612084386433708e-06
hydroxyurea O 0 0.00025924426154233515
or O 0 1.926504774019122e-05
UV O 0 0.00803535059094429
irradiation O 0 0.0003888871578965336
. O 0 0.0001255837269127369

Thus O 0 0.0003265247796662152
, O 0 4.083491148776375e-05
BRCA1 O 0 0.00037049216916784644
and O 0 2.150901491404511e-05
BRCA2 O 0 0.00040330944466404617
participate O 0 6.630483312619617e-06
, O 0 2.114321659973939e-06
together O 0 2.322043656022288e-06
, O 0 1.251900926035887e-06
in O 0 1.118413706535648e-06
a O 0 8.792685548542067e-06
pathway O 0 3.086780270677991e-05
( O 0 1.561211888656544e-06
s O 0 7.634605572093278e-05
) O 0 7.106605721673986e-07
associated O 0 7.861764288463746e-07
with O 0 2.1488024515292636e-07
the O 0 6.112202299846103e-07
activation O 0 3.547915639501298e-06
of O 0 8.758496505834046e-07
double O 0 7.880856719566509e-05
- O 0 0.0012470583897083998
strand O 0 5.843174221809022e-05
break O 0 5.2953342674300075e-05
repair O 0 0.03202075511217117
and O 0 1.006345610221615e-05
/ O 0 5.072741623735055e-05
or O 0 7.57850602894905e-06
homologous O 0 4.8739857447799295e-05
recombination O 0 0.00016416887228842825
. O 0 9.016467083711177e-05

Dysfunction O 0 0.4118383824825287
of O 0 5.523767686099745e-05
this O 0 2.2167761926539242e-05
pathway O 0 0.00011482339323265478
may O 0 3.479066435829736e-05
be O 0 8.288946560242039e-07
a O 0 1.4536216212945874e-06
general O 0 1.6287192465824774e-06
phenomenon O 0 2.7597666303336155e-06
in O 0 7.388362632809731e-07
the O 0 6.193682793309563e-07
majority O 0 1.1934507710975595e-06
of O 0 4.86616272610263e-07
cases O 0 1.4278991784522077e-06
of O 0 4.328898739913711e-06
hereditary B-Disease 1 0.9967796206474304
breast I-Disease 1 0.9928404092788696
and I-Disease 0 0.043183621019124985
/ I-Disease 1 0.9956830739974976
or I-Disease 1 0.995474636554718
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
. O 0 5.5203548981808126e-05
. O 0 6.749131716787815e-05

A O 0 0.00031148619018495083
novel O 0 0.00010908940021181479
Arg362Ser O 0 0.0006086908397264779
mutation O 0 3.7497873563552275e-05
in O 0 2.456508127579582e-06
the O 0 4.157380317337811e-06
sterol O 0 0.00024818629026412964
27 O 0 0.00014624347386416048
- O 0 0.0005919986288063228
hydroxylase O 0 0.00010996606579283252
gene O 0 1.0048456715594511e-05
( O 0 1.7965871847991366e-06
CYP27 O 0 0.00023053113545756787
) O 0 7.810097599758592e-07
: O 0 5.710139134862402e-07
its O 0 7.335061695812328e-07
effects O 0 3.365358907103655e-06
on O 0 1.4068265272726421e-06
pre O 0 2.6144551156903617e-05
- O 0 1.2255954061402008e-05
mRNA O 0 4.0061213439912535e-06
splicing O 0 1.0799149094964378e-05
and O 0 3.303929361209157e-06
enzyme O 0 3.413274680497125e-05
activity O 0 2.640000639075879e-05
. O 0 2.8033497073920444e-05

A O 0 0.00035696334089152515
novel O 0 9.603406942915171e-05
C O 0 0.00011610828369157389
to O 0 2.897535978263477e-06
A O 0 1.1126137906103395e-05
mutation O 0 1.0706603461585473e-05
in O 0 2.8119393391534686e-06
the O 0 3.931549144908786e-06
sterol O 0 0.000236172039876692
27 O 0 0.00014425464905798435
- O 0 0.0023853862658143044
hydroxylase O 0 0.0001562976831337437
gene O 0 1.0725958418333903e-05
( O 0 2.477612497386872e-06
CYP27 O 0 0.00020149654301349074
) O 0 1.0569134474280872e-06
was O 0 3.7928302845102735e-06
identified O 0 2.3783288725098828e-06
by O 0 7.274509812305041e-07
sequencing O 0 7.716981599514838e-06
amplified O 0 5.994843377266079e-05
CYP27 O 0 0.0003887777857016772
gene O 0 6.6042434809787665e-06
products O 0 2.317795633643982e-06
from O 0 1.3118445849613636e-06
a O 0 2.009813761105761e-05
patient O 0 0.0009798406390473247
with O 0 0.00011443185940152034
cerebrotendinous B-Disease 1 0.999992847442627
xanthomatosis I-Disease 1 0.9999656677246094
( O 0 8.796279871603474e-05
CTX B-Disease 1 0.7852665781974792
) O 0 3.594384543248452e-05
. O 0 5.1487411838024855e-05

The O 0 0.00016077376494649798
mutation O 0 0.00029887285199947655
changed O 0 5.016519935452379e-05
the O 0 1.0458526048751082e-05
adrenodoxin O 0 0.00012303788389544934
cofactor O 0 2.5202672986779362e-05
binding O 0 1.6249821783276275e-05
residue O 0 5.110346683068201e-05
362Arg O 0 7.247053144965321e-05
to O 0 5.862948455614969e-06
362Ser O 0 0.0001596274960320443
( O 0 5.248283287073718e-06
CGT O 0 0.00011659591109491885
362Arg O 0 8.059210813371465e-05
to O 0 7.163079771999037e-06
AGT O 0 0.0013850239338353276
362Ser O 0 0.00038330472307279706
) O 0 2.169152139686048e-06
, O 0 7.375373911600036e-07
and O 0 2.387760332567268e-06
was O 0 0.00022649420134257525
responsible O 0 2.9069851734675467e-05
for O 0 2.427117397019174e-05
deficiency O 0 0.3565502166748047
in O 0 2.303973133166437e-06
the O 0 4.4203193283465225e-06
sterol O 0 0.00040541921043768525
27 O 0 7.777885184623301e-05
- O 0 9.719406079966575e-05
hydroxylase O 0 3.946952710975893e-05
activity O 0 2.4055839276115876e-06
, O 0 6.457705126194924e-07
as O 0 4.185559419056517e-07
confirmed O 0 8.888857792044291e-07
by O 0 3.009236309026164e-07
expression O 0 5.066595463176782e-07
of O 0 3.6466460073825147e-07
mutant O 0 9.29784891923191e-06
cDNA O 0 1.4286061741586309e-05
into O 0 1.1053037269448396e-05
COS O 0 0.00525053171440959
- O 0 0.00030165709904395044
1 O 0 3.9470505726058036e-05
cells O 0 7.865794759709388e-05
. O 0 4.749440631712787e-05

Quantitative O 0 0.0003778150712605566
analysis O 0 5.66080016142223e-05
showed O 0 5.421171590569429e-05
that O 0 1.5751712680867058e-06
the O 0 1.2942175544594647e-06
expression O 0 1.7471755882070283e-06
of O 0 8.619929303677054e-07
CYP27 O 0 9.578675962984562e-05
gene O 0 5.440856057248311e-06
mRNA O 0 3.6576491311279824e-06
in O 0 1.148442038356734e-06
the O 0 3.407165650060051e-06
patient O 0 8.633985999040306e-05
represented O 0 1.8239592463942245e-05
52 O 0 0.00011767365504056215
. O 0 6.444177415687591e-05

5 O 0 0.00028921739431098104
% O 0 3.2280502637149766e-05
of O 0 6.018933163431939e-06
the O 0 1.1574214113352355e-05
normal O 0 4.7496898332610726e-05
level O 0 7.732935773674399e-05
. O 0 7.366274076048285e-05

As O 0 7.383646152447909e-05
the O 0 3.0159042580635287e-05
mutation O 0 6.462277087848634e-05
occurred O 0 2.5932935386663303e-05
at O 0 6.857233074697433e-06
the O 0 3.0266974135884084e-06
penultimate O 0 3.245081825298257e-05
nucleotide O 0 7.1085769377532415e-06
of O 0 8.862871823112073e-07
exon O 0 1.9439747120486572e-05
6 O 0 7.345446647377685e-06
( O 0 8.776029858381662e-07
- O 0 7.484016350645106e-06
2 O 0 8.943711691244971e-07
position O 0 1.0702902955017635e-06
of O 0 4.5385488078864e-07
exon O 0 1.4174672287481371e-05
6 O 0 1.3065720850136131e-05
- O 0 7.558341167168692e-05
intron O 0 0.0001280086871702224
6 O 0 7.560928224847885e-06
splice O 0 8.539665577700362e-05
site O 0 1.0154122719541192e-05
) O 0 4.6980946422081615e-07
of O 0 2.6093340466104564e-07
the O 0 1.0652831861079903e-06
gene O 0 4.252922281011706e-06
, O 0 1.1962492862949148e-06
we O 0 1.4024943766344222e-06
hypothesized O 0 3.558036951289978e-06
that O 0 5.757642043136002e-07
the O 0 1.7991280856222147e-06
mutation O 0 6.266404670896009e-05
may O 0 2.699801916605793e-05
partially O 0 5.6216693337773904e-05
affect O 0 2.3769841845933115e-06
the O 0 1.032133809530933e-06
normal O 0 3.841776106128236e-06
splicing O 0 9.689597391115967e-06
efficiency O 0 4.765553057950456e-06
in O 0 1.4665420167148113e-06
exon O 0 2.162769487767946e-05
6 O 0 7.865358384151477e-06
and O 0 1.8841323026208556e-06
cause O 0 4.229919341014465e-06
alternative O 0 2.7719715944840573e-06
splicing O 0 1.5530000382568687e-05
elsewhere O 0 9.346103979623877e-06
, O 0 1.6037681689340388e-06
which O 0 1.55793827616435e-06
resulted O 0 5.385818894865224e-06
in O 0 3.715099637702224e-06
decreased O 0 4.847786112804897e-05
transcript O 0 1.5555227946606465e-05
in O 0 3.6230089790478814e-06
the O 0 1.3527524970413651e-05
patient O 0 0.0008359664934687316
. O 0 5.711614358006045e-05

Transfection O 0 0.003135278355330229
of O 0 4.7100915253395215e-05
constructed O 0 0.0009376227390021086
minigenes O 0 0.008434616960585117
, O 0 5.770758889411809e-06
with O 0 1.6447701227662037e-06
or O 0 2.1758710317953955e-06
without O 0 1.8124675307262805e-06
the O 0 1.3535978951040306e-06
mutation O 0 5.10348763782531e-06
, O 0 1.3661568800671375e-06
into O 0 5.6782096180540975e-06
COS O 0 0.02047869563102722
- O 0 6.496631249319762e-05
1 O 0 3.5926143482356565e-06
cells O 0 3.3566948332008906e-06
confirmed O 0 1.6252033674390987e-06
that O 0 2.6928307761409087e-07
the O 0 1.5460664144484326e-06
mutant O 0 5.034165224060416e-05
minigene O 0 0.0007682845462113619
was O 0 2.717366260185372e-05
responsible O 0 4.994765276933322e-06
for O 0 5.874371140635049e-07
a O 0 1.8978416846948676e-06
mRNA O 0 3.178664428560296e-06
species O 0 1.0249203796774964e-06
alternatively O 0 3.577086317818612e-06
spliced O 0 1.8153608834836632e-05
at O 0 1.0767917956400197e-05
an O 0 2.7982587198494002e-06
activated O 0 0.00015046779299154878
cryptic O 0 2.1289673895807937e-05
5 O 0 3.051259227504488e-06
splice O 0 3.9471033232985064e-05
site O 0 7.685226592002437e-06
88 O 0 1.2106355825380888e-05
bp O 0 3.322331758681685e-05
upstream O 0 4.637935035134433e-06
from O 0 5.235153821558924e-07
the O 0 8.627619649814733e-07
3 O 0 1.6793420627436717e-06
end O 0 1.9691112811415223e-06
of O 0 1.6041996104831924e-06
exon O 0 0.00017336021119263023
6 O 0 7.477481995010749e-05
. O 0 2.7698930352926254e-05

Our O 0 0.00010560051305219531
data O 0 4.105694097233936e-05
suggest O 0 1.4880539310979657e-05
that O 0 1.6063627299445216e-06
the O 0 1.7070964304366498e-06
C O 0 2.449605926813092e-05
to O 0 1.0560781902313465e-06
A O 0 7.633204404555727e-06
mutation O 0 5.807898560306057e-06
at O 0 3.5440536976238945e-06
the O 0 1.2903539072794956e-06
penultimate O 0 2.36321739066625e-05
nucleotide O 0 6.277186457737116e-06
of O 0 6.657257358710922e-07
exon O 0 1.1093187822552864e-05
6 O 0 2.4386240511375945e-06
of O 0 3.9975742538445047e-07
the O 0 2.960808160423767e-06
CYP27 O 0 0.012333055958151817
gene O 0 6.520003807963803e-06
not O 0 1.1829995401058113e-06
only O 0 1.5971074844856048e-06
causes O 0 1.4801805264141876e-05
the O 0 0.00014648729120381176
deficiency B-Disease 1 0.5571012496948242
in I-Disease 0 2.5963022380892653e-06
the I-Disease 0 5.48783509657369e-06
sterol I-Disease 0 0.00045926542952656746
27 I-Disease 0 7.307699706871063e-05
- I-Disease 0 0.00015558130689896643
hydroxylase I-Disease 0 3.627293699537404e-05
activity I-Disease 0 4.200028342893347e-06
, O 0 1.1391201724109123e-06
but O 0 1.0380110779806273e-06
also O 0 1.651004367886344e-06
partially O 0 1.8301270756637678e-05
leads O 0 1.4994210459917667e-06
to O 0 7.325931505874905e-07
alternative O 0 1.731241127345129e-06
pre O 0 9.417968612979166e-06
- O 0 6.434175702452194e-06
mRNA O 0 2.710298304009484e-06
splicing O 0 3.6330395687400596e-06
of O 0 1.1930410437344108e-06
the O 0 5.34401306140353e-06
gene O 0 3.4723052522167563e-05
. O 0 2.967430009448435e-05

To O 0 3.9126698538893834e-05
our O 0 1.1671945685520768e-05
knowledge O 0 6.366498382703867e-06
, O 0 1.924634943861747e-06
this O 0 3.751439408006263e-07
is O 0 3.8046553640924685e-07
the O 0 4.636970345472946e-07
first O 0 2.8855210985057056e-06
report O 0 1.9808453544101212e-06
regarding O 0 1.4365245988301467e-06
effects O 0 3.2310497317666886e-06
on O 0 1.705425233922142e-06
pre O 0 3.60459707735572e-05
- O 0 1.4708148228237405e-05
mRNA O 0 2.8118802219978534e-06
splicing O 0 3.588957042666152e-06
of O 0 5.268937570690468e-07
a O 0 2.2727203941030893e-06
mutation O 0 5.1547945076890755e-06
at O 0 3.687918479045038e-06
the O 0 1.3368384088607854e-06
- O 0 3.289481537649408e-05
2 O 0 1.3797806559523451e-06
position O 0 1.001991108751099e-06
of O 0 4.4795771714234434e-07
a O 0 4.660187642002711e-06
5 O 0 1.5601608538418077e-05
splice O 0 0.000731971173081547
site O 0 0.0001504263491369784
. O 0 7.236535748234019e-05

ATM O 0 0.036042485386133194
germline O 0 0.010250899940729141
mutations O 0 0.0007666462915949523
in O 0 0.0001105281917261891
classical O 0 0.015272319316864014
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999991655349731
telangiectasia I-Disease 1 1.0
patients O 1 0.9439162015914917
in O 0 1.3730540558754e-05
the O 0 1.0621207366057206e-05
Dutch O 0 0.00025828133220784366
population O 0 2.237375156255439e-05
. O 0 3.4970089473063126e-05

Germline O 0 0.03144501894712448
mutations O 0 0.0011246363865211606
in O 0 1.8093718608724885e-05
the O 0 1.04763357740012e-05
ATM O 0 0.08917093276977539
gene O 0 1.756978963385336e-05
are O 0 1.772145765244204e-06
responsible O 0 1.795825664885342e-05
for O 0 1.3827490874973591e-05
the O 1 0.9101837277412415
autosomal B-Disease 1 1.0
recessive I-Disease 1 1.0
disorder I-Disease 1 1.0
ataxia B-Disease 1 1.0
- I-Disease 1 0.9999998807907104
telangiectasia I-Disease 1 1.0
( O 0 0.01642238348722458
A B-Disease 1 0.9999927282333374
- I-Disease 1 0.999998927116394
T I-Disease 1 0.9999995231628418
) O 0 3.4055006835842505e-05
. O 0 4.999575685360469e-05

In O 0 9.440480062039569e-05
our O 0 2.4820472390274517e-05
study O 0 7.816759534762241e-06
, O 0 3.4638517263374524e-06
we O 0 1.7444034483560245e-06
have O 0 7.808815780663281e-07
determined O 0 1.295794618272339e-06
the O 0 6.018824478815077e-07
ATM O 0 0.00012903971946798265
mutation O 0 5.0208650463900995e-06
spectrum O 0 3.2615444069961086e-06
in O 0 3.6319308946985984e-06
19 O 0 2.8501519409473985e-05
classical O 0 9.411917744728271e-06
A B-Disease 1 0.9999403953552246
- I-Disease 1 0.9999988079071045
T I-Disease 1 1.0
patients O 0 0.0006381541606970131
, O 0 6.183578875607054e-07
including O 0 3.6147633863947704e-07
some O 0 3.246250344091095e-07
immigrant O 0 5.395736025093356e-06
populations O 0 2.0620748273358913e-06
, O 0 6.849729174973618e-07
as O 0 4.025244493277569e-07
well O 0 4.448304196102981e-07
as O 0 3.8299930338325794e-07
12 O 0 1.427848815183097e-06
of O 0 6.16392526353593e-07
Dutch O 0 2.124870297848247e-05
ethnic O 0 7.72354906075634e-06
origin O 0 2.5087021640501916e-05
. O 0 4.748969877255149e-05

Both O 0 4.1494640754535794e-05
the O 0 1.9013572455151007e-05
protein O 0 2.859784581232816e-05
truncation O 0 6.661385123152286e-05
test O 0 4.135826384299435e-05
( O 0 4.850853201787686e-06
PTT O 0 2.6957523004966788e-05
) O 0 6.848285352134553e-07
and O 0 6.530798941639659e-07
the O 0 7.390744372059999e-07
restriction O 0 3.3704982342896983e-06
endonuclease O 0 3.7861111195525154e-05
fingerprinting O 0 2.5356719561386853e-05
( O 0 3.611249439927633e-06
REF O 0 0.011314149014651775
) O 0 9.035899779519241e-07
method O 0 9.566848575559561e-07
were O 0 1.5081820947671076e-06
used O 0 8.517911851413373e-07
and O 0 9.626336350265774e-07
compared O 0 1.3121260735715623e-06
for O 0 2.113151253979595e-07
their O 0 1.7816031459005899e-06
detection O 0 1.5923098544590175e-05
efficiency O 0 2.0883799152215943e-05
, O 0 1.5401814152937732e-06
identifying O 0 1.0006036063714419e-05
76 O 0 8.591954610892572e-06
% O 0 9.287392686019302e-07
and O 0 6.457692620642774e-07
60 O 0 1.7319049447905854e-06
% O 0 6.754553396604024e-07
of O 0 3.959642924655782e-07
the O 0 2.7119169772049645e-06
mutations O 0 3.1501069315709174e-05
, O 0 5.430043074738933e-06
respectively O 0 6.241892697289586e-05
. O 0 3.412623846088536e-05

Most O 0 0.00020129300537519157
patients O 0 0.019354017451405525
were O 0 5.0650320190470666e-05
found O 0 1.1675709174596705e-05
to O 0 4.733908554044319e-06
be O 0 1.3700600902666338e-05
compound O 0 0.0003052409447263926
heterozygote O 0 0.0009753035265021026
. O 0 9.70043329289183e-05

Seventeen O 0 0.001610931009054184
mutations O 0 0.00035318746813572943
were O 0 2.6270939997630194e-05
distinct O 0 7.81071594246896e-06
, O 0 1.7750634242474916e-06
of O 0 6.30353042652132e-07
which O 0 1.558413714519702e-06
10 O 0 2.5857141281449003e-06
were O 0 9.934867193805985e-06
not O 0 5.5799191613914445e-06
reported O 0 4.260165951563977e-05
previously O 0 6.551916158059612e-05
. O 0 3.994824510300532e-05

Mutations O 0 0.0019710888154804707
are O 0 2.1913392629357986e-05
small O 0 1.9319068087497726e-05
deletions O 0 7.284447201527655e-05
or O 0 1.4943383575882763e-05
point O 0 2.8348362320684828e-05
mutations O 0 8.28678093967028e-05
frequently O 0 3.158373147016391e-05
affecting O 0 5.7316057791467756e-05
splice O 0 0.0019320971332490444
sites O 0 0.0002102955331793055
. O 0 0.00017637711425777525

Moreover O 0 0.0006462741293944418
, O 0 5.308844265528023e-05
a O 0 6.11429859418422e-05
16 O 0 0.0001416068698745221
. O 0 6.157503958093002e-05

7 O 0 0.0016568349674344063
- O 0 0.0010159730445593596
kb O 0 0.0012670729774981737
genomic O 0 0.00013770714576821774
deletion O 0 8.523092401446775e-05
of O 0 3.2134601042344e-06
the O 0 3.919191385648446e-06
3 O 0 5.359135684557259e-06
end O 0 1.6143069387908326e-06
of O 0 3.556964145445818e-07
the O 0 1.6445488881799974e-06
gene O 0 6.22614606982097e-06
, O 0 1.0851374554476934e-06
most O 0 3.3894568218784116e-07
likely O 0 1.724669459690631e-06
a O 0 1.5343508721343824e-06
result O 0 1.229511440214992e-06
of O 0 2.7821656090054603e-07
recombination O 0 1.8779793435896863e-06
between O 0 9.82700839813333e-07
two O 0 2.2298995645542163e-06
LINE O 0 0.0002872208133339882
elements O 0 2.9053028356429422e-06
, O 0 5.1244101086922456e-06
was O 0 7.609014573972672e-05
identified O 0 4.812044426216744e-05
. O 0 2.5971046852646396e-05

The O 0 6.442893209168687e-05
most O 0 1.7136833776021376e-05
frequently O 0 3.0271012292359956e-05
found O 0 1.8625140000949614e-05
mutation O 0 2.6596453608362935e-05
, O 0 3.1504953312833095e-06
identified O 0 5.572261670749867e-06
in O 0 1.4312066696220427e-06
three O 0 4.883587280346546e-06
unrelated O 0 1.9452025298960507e-05
Turkish O 0 7.382335752481595e-05
A B-Disease 1 0.999823272228241
- I-Disease 1 0.9999865293502808
T I-Disease 1 0.9999995231628418
individuals O 0 3.823456154350424e-06
, O 0 3.0019293717487017e-06
was O 0 0.0001317780843237415
previously O 0 1.0380335879744962e-05
described O 0 3.6995184018451255e-06
to O 0 6.54197606309026e-07
be O 0 9.953215567293228e-07
a O 0 5.450016487884568e-06
Turkish O 0 4.331429227022454e-05
A B-Disease 1 0.9984266757965088
- I-Disease 1 0.9999210834503174
T I-Disease 1 0.9999939203262329
founder O 0 0.002968434477224946
mutation O 0 0.0004730379150714725
. O 0 0.0001286410551983863

The O 0 5.938514004810713e-05
presence O 0 1.546104613225907e-05
of O 0 2.7471205612528138e-06
a O 0 8.01103851699736e-06
founder O 0 8.361819345736876e-05
mutation O 0 4.902045930066379e-06
among O 0 5.43745557024522e-07
relatively O 0 1.927235643961467e-06
small O 0 7.436054829668137e-07
ethnic O 0 8.140788168020663e-07
population O 0 1.0177718650083989e-06
groups O 0 6.29291662335163e-07
in O 0 6.133456622592348e-07
Western O 0 2.059598500636639e-06
Europe O 0 9.722105460241437e-06
could O 0 7.974535037647001e-06
indicate O 0 2.6459470063855406e-06
a O 0 2.3608336050529033e-06
high O 0 3.597820978029631e-05
carrier O 0 3.2402265787823126e-05
frequency O 0 6.553461389557924e-06
in O 0 2.2248652840062277e-06
such O 0 2.2647907371720066e-06
communities O 0 3.58532925019972e-05
. O 0 6.17863261140883e-05

In O 0 0.0006871746736578643
patients O 0 0.0023783002980053425
of O 0 3.7439945117512252e-06
Dutch O 0 2.5732648282428272e-05
ethnic O 0 2.737906243055477e-06
origin O 0 2.591016254882561e-06
, O 0 1.4750194168300368e-06
however O 0 8.72456666911603e-07
, O 0 5.76821605591249e-07
no O 0 1.2529748119050055e-06
significant O 0 1.7123531961260596e-06
founder O 0 3.734218262252398e-05
effect O 0 3.860723609250272e-06
could O 0 4.594063284457661e-06
be O 0 3.6465871744439937e-06
identified O 0 3.81486643163953e-05
. O 0 2.7247981051914394e-05

The O 0 0.00012792852066922933
observed O 0 0.00012335646897554398
genetic O 0 4.8097968829097226e-05
heterogeneity O 0 5.331349530024454e-05
including O 0 6.985160325712059e-06
the O 0 5.618863724521361e-06
relative O 0 3.203278538421728e-05
high O 0 5.6180517276516184e-05
percentage O 0 1.4068765267438721e-05
of O 0 1.1264623935858253e-06
splice O 0 0.0037493726704269648
- O 0 0.006993055809289217
site O 0 3.75571362383198e-05
mutations O 0 1.6610043530818075e-05
had O 0 1.7720965843182057e-05
no O 0 2.5817053028731607e-06
reflection O 0 5.781566414952977e-06
on O 0 5.61521574127255e-06
the O 0 2.9237726266728714e-05
phenotype O 0 0.002936905948445201
. O 0 6.820965063525364e-05

All O 0 0.00022313343652058393
patients O 0 0.008092355914413929
manifested O 0 0.00028648594161495566
classical O 0 5.311213681125082e-05
A B-Disease 1 0.9834145903587341
- I-Disease 1 0.9985236525535583
T I-Disease 1 0.9998873472213745
and O 0 6.347667294903658e-06
increased O 0 9.357939234178048e-06
cellular O 0 0.00021356536308303475
radioresistant O 0 0.001575351576320827
DNA O 0 4.979134973837063e-05
synthesis O 0 6.136699812486768e-05
. O 0 6.17875048192218e-05

Determination O 0 0.0002184902405133471
of O 0 1.6320420400006697e-05
the O 0 8.790690117166378e-06
genomic O 0 4.2436869989614934e-05
structure O 0 1.2346259609330446e-05
of O 0 1.551099558128044e-06
the O 0 8.276314474642277e-06
COL4A4 O 0 0.034024082124233246
gene O 0 1.0218187526334077e-05
and O 0 2.3096490622265264e-06
of O 0 4.094187715963926e-06
novel O 0 0.0001390780962537974
mutations O 0 0.00930938869714737
causing O 1 0.7057530879974365
autosomal B-Disease 1 0.9999645948410034
recessive I-Disease 1 0.9999983310699463
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0014482532860711217

Autosomal B-Disease 1 0.9999963045120239
recessive I-Disease 1 0.9999997615814209
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
is O 0 0.0010673251235857606
a O 0 0.0017537561943754554
progressive O 1 0.9281324744224548
hematuric B-Disease 1 0.9998714923858643
glomerulonephritis I-Disease 1 0.9999995231628418
characterized O 0 0.019172759726643562
by O 0 6.412650691345334e-05
glomerular B-Disease 1 0.9634891748428345
basement I-Disease 1 0.9998390674591064
membrane I-Disease 1 0.9043734073638916
abnormalities I-Disease 1 0.99973064661026
and O 0 6.22139050392434e-05
associated O 0 2.1689204004360363e-05
with O 0 1.1447982615209185e-05
mutations O 0 3.620302231865935e-05
in O 0 1.893845933409466e-06
either O 0 2.955504442070378e-06
the O 0 5.705921012122417e-06
COL4A3 O 0 0.04230383411049843
or O 0 2.2073090804042295e-06
the O 0 2.835180112015223e-06
COL4A4 O 0 0.0019941485952585936
gene O 0 4.7744738367327955e-06
, O 0 9.37463596528687e-07
which O 0 5.629653969663195e-07
encode O 0 2.7903547561436426e-06
the O 0 1.251317371497862e-06
alpha3 O 0 8.068576426012442e-05
and O 0 3.647359335445799e-06
alpha4 O 0 0.0009847963228821754
type O 0 0.00013261623098514974
IV O 1 0.761357307434082
collagen O 0 0.0010596708161756396
chains O 0 0.0006048171198926866
, O 0 2.0827848857152276e-05
respectively O 0 0.00011646223720163107
. O 0 5.392657840275206e-05

To O 0 6.47330452920869e-05
date O 0 3.6658831959357485e-05
, O 0 4.635220193449641e-06
mutation O 0 7.526374702138128e-06
screening O 0 4.993193215341307e-06
in O 0 1.4421787000173936e-06
the O 0 9.372740805702051e-07
two O 0 2.1316400307114236e-06
genes O 0 3.951109192712465e-06
has O 0 2.870951448130654e-06
been O 0 1.1376555448805448e-05
hampered O 0 0.00012474956747610122
by O 0 6.376307624123001e-07
the O 0 9.169918371298991e-07
lack O 0 4.0159061427402776e-06
of O 0 1.4691428305013687e-06
genomic O 0 6.825941818533465e-05
structure O 0 9.824507287703454e-05
information O 0 3.8676298572681844e-05
. O 0 5.45895891264081e-05

We O 0 0.0001811899128369987
report O 0 2.0503797713899985e-05
here O 0 2.799331696223817e-06
the O 0 1.3843158512827358e-06
complete O 0 3.7100860481587006e-06
characterization O 0 4.041047304781387e-06
of O 0 6.12067765359825e-07
the O 0 1.4917403632352944e-06
48 O 0 9.621559001971036e-06
exons O 0 6.5054764490923844e-06
of O 0 8.146581649270956e-07
the O 0 3.676077994896332e-06
COL4A4 O 0 0.03789317235350609
gene O 0 5.383240932133049e-06
, O 0 8.836944402901281e-07
a O 0 1.23454026379477e-06
comprehensive O 0 7.948362508614082e-06
gene O 0 3.7775066630274523e-06
screen O 0 8.224173143389635e-06
, O 0 1.4712361462443369e-06
and O 0 5.247155172583007e-07
the O 0 4.178444612534804e-07
subsequent O 0 1.571607640471484e-06
detection O 0 3.6895787616231246e-06
of O 0 6.051187710909289e-07
10 O 0 2.7258852242084686e-06
novel O 0 2.2338542748912005e-06
mutations O 0 4.772497959493194e-06
in O 0 4.581935172609519e-06
eight O 0 0.03649389371275902
patients O 1 0.9981405735015869
diagnosed O 1 0.9999828338623047
with O 1 0.616441011428833
autosomal B-Disease 1 0.9999985694885254
recessive I-Disease 1 0.9999997615814209
Alport I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0014678030274808407

Furthermore O 0 0.000430481944931671
, O 0 2.4177288651117124e-05
we O 0 5.3003282118879724e-06
identified O 0 5.418135515355971e-06
a O 0 1.923332320075133e-06
glycine O 0 8.28261545393616e-06
to O 0 1.4587265013688011e-06
alanine O 0 7.833289600966964e-06
substitution O 0 2.020453621298657e-06
in O 0 1.2318859035076457e-06
the O 0 1.4284290728028282e-06
collagenous O 0 0.00018069300858769566
domain O 0 5.198370672587771e-06
that O 0 1.4122815628070384e-06
is O 0 1.6367430362151936e-06
apparently O 0 2.2786020053899847e-05
silent O 0 1.0323038623027969e-05
in O 0 1.154272467829287e-06
the O 0 3.6759902286576107e-06
heterozygous O 0 4.782842370332219e-05
carriers O 0 1.9050834453082643e-05
, O 0 1.8549428659753175e-06
in O 0 6.902214408910368e-06
11 O 0 0.00011455632193246856
. O 0 3.8072776078479365e-05

5 O 0 0.00015890311624389142
% O 0 1.2687273738265503e-05
of O 0 1.5100443988558254e-06
all O 0 1.3379544725466985e-06
control O 0 1.5623481885995716e-05
individuals O 0 1.1988944379481836e-06
, O 0 9.831152283368283e-07
and O 0 6.748417149538e-07
in O 0 1.0844877351701143e-06
one O 0 1.6728348555261618e-06
control O 0 8.0188056017505e-06
individual O 0 1.20268487080466e-06
homozygous O 0 1.2318351764406543e-05
for O 0 6.004840997775318e-07
this O 0 1.595607841409219e-06
glycine O 0 3.0517156119458377e-05
substitution O 0 2.251126352348365e-05
. O 0 4.4578460801858455e-05

There O 0 0.0001086541815311648
has O 0 1.7418835341231897e-05
been O 0 1.2208628504595254e-05
no O 0 2.6503187200432876e-06
previous O 0 1.5154212178458693e-06
finding O 0 1.158848817794933e-06
of O 0 4.11415072676391e-07
a O 0 2.1441035187308444e-06
glycine O 0 7.902666766312905e-06
substitution O 0 1.4891180626364076e-06
that O 0 9.143877264250477e-07
is O 0 8.673380875734438e-07
not O 0 9.81814650913293e-07
associated O 0 1.2815779655284132e-06
with O 0 1.000005568130291e-06
any O 0 2.897408876378904e-06
obvious O 0 4.539678411674686e-05
phenotype O 0 0.00234212726354599
in O 0 3.584737714845687e-05
homozygous O 0 0.0013409638777375221
individuals O 0 2.104775012412574e-05
. O 0 6.0120990383438766e-05

Founder O 0 0.005179189145565033
BRCA1 O 0 0.00627620704472065
and O 0 0.00010105185356223956
BRCA2 O 0 0.0018730368465185165
mutations O 0 8.51354852784425e-05
in O 0 1.118243108066963e-05
French O 0 8.287033415399492e-05
Canadian O 0 0.0017134281806647778
breast B-Disease 1 0.9998778104782104
and I-Disease 1 0.9981599450111389
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
families O 0 0.0038723142351955175
. O 0 0.00014917791122570634

We O 0 0.0001620249531697482
have O 0 1.7695905626169406e-05
identified O 0 1.2211306966491975e-05
four O 0 3.818966888502473e-06
mutations O 0 8.041610271902755e-06
in O 0 8.994896916192374e-07
each O 0 6.185477445797005e-07
of O 0 1.2695978739429847e-06
the O 0 0.0003053937398362905
breast B-Disease 1 0.9999266862869263
cancer I-Disease 1 0.9435374140739441
- O 0 0.07319432497024536
susceptibility O 0 0.0005830806330777705
genes O 0 1.94760814338224e-05
, O 0 6.852787919342518e-06
BRCA1 O 0 0.00021612491400446743
and O 0 1.4933268175809644e-05
BRCA2 O 0 0.00025485112564638257
, O 0 2.612102662169491e-06
in O 0 2.2422339043259853e-06
French O 0 1.6078805856523104e-05
Canadian O 0 0.00015841778076719493
breast B-Disease 1 0.9973247051239014
cancer I-Disease 1 0.9650514125823975
and O 0 0.1340198516845703
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
families O 0 0.00032861370709724724
from O 0 7.223512511700392e-05
Quebec O 0 0.001863872050307691
. O 0 0.00015313747280742973

To O 0 0.00018545723287388682
identify O 0 0.00017923650739248842
founder O 0 0.0003368585021235049
effects O 0 8.785357204033062e-05
, O 0 9.173082617053296e-06
we O 0 4.74604121336597e-06
examined O 0 2.915002369263675e-05
independently O 0 1.4081463632464875e-05
ascertained O 0 4.332523894845508e-05
French O 0 1.359363341180142e-05
Canadian O 0 5.8697805798146874e-05
cancer B-Disease 0 0.029585542157292366
families O 0 6.505401415779488e-06
for O 0 6.180825380397437e-07
the O 0 5.965707146060595e-07
distribution O 0 1.3515341379388701e-06
of O 0 7.32093099031772e-07
these O 0 1.5453441619683872e-06
eight O 0 3.4388111089356244e-05
mutations O 0 0.00018514698604121804
. O 0 3.534596908139065e-05

Mutations O 0 0.002196171320974827
were O 0 8.70779695105739e-05
found O 0 2.39620258071227e-05
in O 0 6.247124019864714e-06
41 O 0 1.579710624355357e-05
of O 0 2.4903333724068943e-06
97 O 0 6.671009759884328e-05
families O 0 4.8335226892959327e-05
. O 0 4.008796167909168e-05

Six O 0 0.00011491211625980213
of O 0 1.588887971593067e-05
eight O 0 3.109467797912657e-05
mutations O 0 4.010149496025406e-05
were O 0 9.894860340864398e-06
observed O 0 9.412115105078556e-06
at O 0 2.0667328499257565e-05
least O 0 1.3237862731330097e-05
twice O 0 8.901859837351367e-05
. O 0 3.9157381252152845e-05

The O 0 0.000215215579373762
BRCA1 O 0 0.009202380664646626
C4446T O 0 0.006634170189499855
mutation O 0 0.00019858144514728338
was O 0 3.0297902412712574e-05
the O 0 1.4569593531632563e-06
most O 0 8.633380730316276e-07
common O 0 2.1279070097079966e-06
mutation O 0 1.174234967038501e-05
found O 0 5.232610874372767e-06
, O 0 1.3335912854017806e-06
followed O 0 2.900137360484223e-06
by O 0 1.4794500202697236e-06
the O 0 1.1636025192274246e-05
BRCA2 O 0 0.0012199035845696926
8765delAG O 0 0.0010822976473718882
mutation O 0 0.00027793951448984444
. O 0 7.571066089440137e-05

Together O 0 0.00017956476949620992
, O 0 9.89488762570545e-06
these O 0 1.767526214280224e-06
mutations O 0 8.313762918987777e-06
were O 0 2.519044755899813e-06
found O 0 1.955502966666245e-06
in O 0 1.079891944755218e-06
28 O 0 6.076648332964396e-06
of O 0 4.5285139549378073e-07
41 O 0 1.779899321263656e-05
families O 0 2.795948603306897e-06
identified O 0 5.752302513428731e-06
to O 0 1.3619525134345167e-06
have O 0 3.2054103940026835e-06
a O 0 1.6311818399117328e-05
mutation O 0 0.0002238551969639957
. O 0 5.225017594057135e-05

The O 0 8.799938223091885e-05
odds O 0 0.00012168139801360667
of O 0 2.9404407086985884e-06
detection O 0 1.4065264622331597e-05
of O 0 6.75906335345644e-07
any O 0 3.101114032233454e-07
of O 0 3.2224104984379665e-07
the O 0 1.4170007034408627e-06
four O 0 1.9929304471588694e-05
BRCA1 O 0 0.00829321052879095
mutations O 0 7.770382944727316e-05
was O 0 8.633614925201982e-05
18 O 0 0.00010019308683695272
. O 0 5.698111272067763e-05

7x O 0 0.011136786080896854
greater O 0 0.00011101271229563281
if O 0 1.0350255251978524e-05
one O 0 2.0593488443410024e-06
or O 0 1.6092729993033572e-06
more O 0 4.599376097758068e-07
cases O 0 2.753357648543897e-06
of O 0 0.0026296109426766634
ovarian B-Disease 1 1.0
cancer I-Disease 1 0.9999996423721313
were O 0 0.001168111921288073
also O 0 9.305069397669286e-06
present O 0 2.9726543289143592e-06
in O 0 3.727577677636873e-06
the O 0 2.2320387870422564e-05
family O 0 0.0002782531955745071
. O 0 5.644461634801701e-05

The O 0 5.3984924306860194e-05
odds O 0 7.94787410995923e-05
of O 0 3.6075628031539964e-06
detection O 0 1.2877752851636615e-05
of O 0 9.358057582176116e-07
any O 0 6.158156224955746e-07
of O 0 6.644007726208656e-07
the O 0 2.7845594559039455e-06
four O 0 3.907509017153643e-05
BRCA2 O 0 0.0203156229108572
mutations O 0 8.444578998023644e-05
was O 0 9.601192141417414e-05
5 O 0 4.838069071411155e-05
. O 0 3.441622538957745e-05

3x O 0 0.002992211375385523
greater O 0 0.00012124543718528003
if O 0 1.618079113541171e-05
there O 0 2.7679643608280458e-06
were O 0 3.7857832921872614e-06
at O 0 4.928084308630787e-06
least O 0 1.2125037756050006e-06
five O 0 1.49234085711214e-06
cases O 0 1.2704530263363267e-06
of O 0 1.7857973944046535e-05
breast B-Disease 1 0.9999655485153198
cancer I-Disease 1 0.9238141179084778
in O 0 1.286949100176571e-05
the O 0 3.213151285308413e-05
family O 0 0.0003289453452453017
. O 0 7.301576260942966e-05

Interestingly O 0 0.0007849186658859253
, O 0 1.7882890460896306e-05
the O 0 2.57868350672652e-06
presence O 0 3.001737695740303e-06
of O 0 1.3529501075026928e-06
a O 0 0.006361436564475298
breast B-Disease 1 0.9999535083770752
cancer I-Disease 1 0.9417482018470764
case O 0 2.516419772291556e-05
< O 0 7.5018651841674e-05
36 O 0 9.705940101412125e-06
years O 0 2.109471779476735e-06
of O 0 8.440155738753674e-07
age O 0 2.6577386961434968e-05
was O 0 1.2053179489157628e-05
strongly O 0 1.822711965360213e-06
predictive O 0 2.3343732209468726e-06
of O 0 2.632215512221592e-07
the O 0 5.752636411671119e-07
presence O 0 4.6303503609124164e-07
of O 0 2.1688903473204846e-07
any O 0 3.657191598449572e-07
of O 0 4.871558303420898e-07
the O 0 3.4700015021371655e-06
eight O 0 4.209583858028054e-05
mutations O 0 0.00012740965757984668
screened O 0 0.0003150428819935769
. O 0 7.598638330819085e-05

Carriers O 0 0.0002646392385940999
of O 0 1.131381304730894e-05
the O 0 8.099357728497125e-06
same O 0 5.913982022320852e-06
mutation O 0 1.0315804502170067e-05
, O 0 9.841770634011482e-07
from O 0 6.570386972271081e-07
different O 0 7.814805940142833e-07
families O 0 4.483757948037237e-06
, O 0 1.2419170616340125e-06
shared O 0 1.825133267630008e-06
similar O 0 3.6691851619252702e-06
haplotypes O 0 2.4307748390128836e-05
, O 0 1.936994294737815e-06
indicating O 0 6.033719728293363e-06
that O 0 2.8730772783092107e-07
the O 0 6.162462113934453e-07
mutant O 0 9.11143342818832e-06
alleles O 0 4.75118122267304e-06
were O 0 6.727669187966967e-06
likely O 0 2.932280949607957e-06
to O 0 8.88378224317421e-07
be O 0 1.246832539436582e-06
identical O 0 2.6939401323033962e-06
by O 0 6.306873387984524e-07
descent O 0 5.5664613682893105e-06
for O 0 6.760339488209866e-07
a O 0 9.335540198662784e-06
mutation O 0 1.3158342881069984e-05
in O 0 1.8407712332191295e-06
the O 0 7.012011792539852e-06
founder O 0 0.0002318265032954514
population O 0 1.7715810827212408e-05
. O 0 3.579613985493779e-05

The O 0 3.531066613504663e-05
identification O 0 3.9090671634767205e-05
of O 0 7.84725671110209e-06
common O 0 2.3189335479401052e-05
BRCA1 O 0 0.006458469666540623
and O 0 4.219543552608229e-05
BRCA2 O 0 0.012872444465756416
mutations O 0 2.8270394977880642e-05
will O 0 2.0615084395103622e-06
facilitate O 0 5.114864961797139e-06
carrier O 0 4.407913365866989e-05
detection O 0 1.702611189102754e-05
in O 0 3.019901669176761e-06
French O 0 2.5145149265881628e-05
Canadian O 0 0.0009431734797544777
breast B-Disease 1 0.9995356798171997
cancer I-Disease 1 0.996446430683136
and O 1 0.6214799284934998
breast B-Disease 1 0.9999998807907104
/ I-Disease 1 0.9999997615814209
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999997615814209
families O 0 0.0055003357119858265
. O 0 0.00019394409900996834

Are O 0 0.0002075264201266691
Dp71 O 0 0.0017728522652760148
and O 0 5.7861827372107655e-05
Dp140 O 0 0.0017957978416234255
brain O 0 0.0022827412467449903
dystrophin O 0 0.000389058084692806
isoforms O 0 3.427708725212142e-05
related O 0 1.6670232071192004e-05
to O 0 8.690588401805144e-06
cognitive B-Disease 0 0.002235142746940255
impairment I-Disease 1 0.6764546036720276
in O 0 0.005399622954428196
Duchenne B-Disease 1 0.9999979734420776
muscular I-Disease 1 0.9999949932098389
dystrophy I-Disease 1 0.9999958276748657
? O 0 0.04101753607392311

Molecular O 0 0.0006165339727886021
study O 0 4.7750170779181644e-05
and O 0 1.7429785657441244e-05
neuropsychological O 0 0.00028683821437880397
analysis O 0 7.3511791924829595e-06
were O 0 9.106151992455125e-06
performed O 0 2.2063426513341255e-05
concurrently O 0 6.207049864315195e-06
on O 0 1.5135858120629564e-05
49 O 0 0.00919949822127819
patients O 0 0.0008580522844567895
with O 0 0.0011998094851151109
Duchenne B-Disease 1 0.9999982118606567
muscular I-Disease 1 0.9999973773956299
dystrophy I-Disease 1 0.9999994039535522
( O 0 0.009721670299768448
DMD B-Disease 1 0.9999998807907104
) O 0 6.965151897020405e-06
in O 0 1.9361759768798947e-06
order O 0 1.2147237384851906e-06
to O 0 6.8761710281251e-07
find O 0 1.9291976514068665e-06
a O 0 1.4661532077298034e-06
molecular O 0 2.0454503101063892e-05
explanation O 0 2.712129116844153e-06
for O 0 7.441936418217665e-07
the O 0 6.7337991822569165e-06
cognitive B-Disease 0 0.001973464386537671
impairment I-Disease 0 0.014143030159175396
observed O 0 2.2492849893751554e-05
in O 0 1.754584263835568e-05
most O 0 0.0003314870991744101
DMD B-Disease 1 1.0
patients O 1 0.9612857103347778
. O 0 0.0001948105200426653

Complete O 0 0.00023388504632748663
analysis O 0 2.675868927326519e-05
of O 0 3.513758883855189e-06
the O 0 7.667729732929729e-06
dystrophin O 0 0.0002499240217730403
gene O 0 1.762802457960788e-05
was O 0 2.3036764105199836e-05
performed O 0 8.737741154618561e-06
to O 0 9.633996569391456e-07
define O 0 2.0716761355288327e-06
the O 0 7.639406476300792e-07
localization O 0 3.3052624530682806e-06
of O 0 8.449562187706761e-07
deletions O 0 9.42744009080343e-06
and O 0 3.7793950014020083e-06
duplications O 0 1.7287042282987386e-05
in O 0 4.3915533751714975e-06
relation O 0 6.602713710890384e-06
to O 0 2.829753157129744e-06
the O 0 6.758632935088826e-06
different O 0 2.6631681976141408e-05
DMD B-Disease 1 0.9999926090240479
promoters O 0 0.00264876801520586
. O 0 0.0001054593303706497

Qualitative O 0 0.00032009463757276535
analysis O 0 3.466461566858925e-05
of O 0 5.305652393872151e-06
the O 0 5.593761216005078e-06
Dp71 O 0 0.0002452361804898828
transcript O 0 1.7096892406698316e-05
and O 0 1.8650501942829578e-06
testing O 0 3.2085667953651864e-06
for O 0 3.8611585750913946e-07
the O 0 3.7315680856409017e-07
specific O 0 3.6653972301792237e-07
first O 0 1.1804019095507101e-06
exon O 0 5.316608167049708e-06
of O 0 7.728315267740982e-07
Dp140 O 0 0.0001561054086778313
were O 0 6.907133865752257e-06
also O 0 2.256206471429323e-06
carried O 0 1.771772076608613e-05
out O 0 2.290823067596648e-05
. O 0 2.924201726273168e-05

Neuropsychological O 0 0.011032133363187313
analysis O 0 0.00021728695719502866
assessed O 0 0.0001797509758034721
verbal O 0 0.0001779905433068052
and O 0 3.526600630721077e-05
visuospatial O 0 0.01677190512418747
intelligence O 0 0.00011877878569066525
, O 0 5.035432877775747e-06
verbal O 0 3.252523674746044e-05
memory O 0 0.00040322449058294296
, O 0 4.568940312310588e-06
and O 0 5.407455319073051e-06
reading O 0 8.650508971186355e-05
skills O 0 0.00028531055431813
. O 0 5.088987745693885e-05

Comparison O 0 8.640871237730607e-05
of O 0 1.3836527614330407e-05
molecular O 0 5.366438199416734e-05
and O 0 9.318123375123832e-06
psychometric O 0 0.00044808979146182537
findings O 0 2.2010906832292676e-05
demonstrated O 0 1.4224126061890274e-05
that O 0 1.130515329350601e-06
deletions O 0 7.0691844484827016e-06
and O 0 2.89919444185216e-06
duplications O 0 2.4583910999353975e-05
that O 0 2.8243314318388e-06
were O 0 7.078528142301366e-06
localized O 0 2.2891545086167753e-05
in O 0 2.8237925562279997e-06
the O 0 2.5535800887155347e-06
distal O 0 5.5346077715512365e-05
part O 0 1.4799708196733263e-06
of O 0 3.9677547647443134e-07
the O 0 2.724146497712354e-06
gene O 0 7.216286576294806e-06
seemed O 0 6.575899078598013e-06
to O 0 7.499217531403701e-07
be O 0 1.2093788654965465e-06
preferentially O 0 9.124563803197816e-06
associated O 0 5.509292805072619e-06
with O 0 1.1397469279472716e-05
cognitive B-Disease 0 0.011682081036269665
impairment I-Disease 0 0.10197064280509949
. O 0 0.00011733683641068637

Two O 0 0.00012848647020291537
altered O 0 0.0002051120827673003
Dp71 O 0 0.00022028603416401893
transcripts O 0 2.4239972844952717e-05
and O 0 2.738452167250216e-06
two O 0 1.6839078398334095e-06
deleted O 0 1.5035182514111511e-05
Dp140 O 0 2.1722533347201534e-05
DNA O 0 4.324466772231972e-06
sequences O 0 1.718994553812081e-06
were O 0 3.116866082564229e-06
found O 0 4.1527123357809614e-06
in O 0 4.185362286079908e-06
four O 0 0.00011762585927499458
patients O 0 0.042027547955513
with O 0 0.00958533026278019
severe O 1 0.9999986886978149
cerebral B-Disease 1 0.9999995231628418
dysfunction I-Disease 1 0.9998699426651001
. O 0 0.0009437500848434865

These O 0 5.731009878218174e-05
findings O 0 4.0496055589756e-05
suggest O 0 9.795769074116834e-06
that O 0 9.452308518120844e-07
some O 0 4.0746195395513496e-07
sequences O 0 1.9045719454879873e-06
located O 0 2.87039279101009e-06
in O 0 8.109358873298333e-07
the O 0 1.5806411965968437e-06
distal O 0 2.373263123445213e-05
part O 0 1.1750153134926222e-06
of O 0 4.046289632242406e-07
the O 0 2.199400114477612e-06
gene O 0 3.6258227282814914e-06
and O 0 1.1785144806708558e-06
, O 0 5.837674166286888e-07
in O 0 3.8743823438380787e-07
particular O 0 5.01036197420035e-07
, O 0 5.82347809086059e-07
some O 0 6.049456260370789e-07
DMD B-Disease 1 0.9826589822769165
isoforms O 0 3.078013151025516e-06
expressed O 0 1.7883237433125032e-06
in O 0 2.9518705559894443e-06
the O 0 7.635266956640407e-05
brain O 1 0.974677562713623
may O 0 0.00016758001584094018
be O 0 7.741962235741084e-07
related O 0 5.52757285277039e-07
to O 0 9.181451900985849e-07
the O 0 9.478120773565024e-06
cognitive B-Disease 0 0.020735450088977814
impairment I-Disease 0 0.47463470697402954
associated O 0 0.0001969610311789438
with O 0 0.006183225195854902
DMD B-Disease 1 0.9999998807907104
. O 0 0.00013845566718373448
. O 0 0.00010895070590777323

I1307K O 0 0.009266786277294159
APC O 0 0.002072371542453766
and O 0 7.54426364437677e-05
hMLH1 O 0 0.001026923069730401
mutations O 0 8.900773536879569e-05
in O 0 5.1825513764924835e-06
a O 0 8.420012818532996e-06
non O 0 9.497102837485727e-06
- O 0 7.140859088394791e-05
Jewish O 0 9.616624083719216e-06
family O 0 1.1942309356527403e-05
with O 0 1.5735553461126983e-05
hereditary B-Disease 1 0.9922096729278564
non I-Disease 1 0.9607126712799072
- I-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999998807907104
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0028039170429110527

We O 0 0.00011325337982270867
describe O 0 6.323902198346332e-05
a O 0 1.6628222510917112e-05
French O 0 4.521183291217312e-05
Canadian O 0 0.00020895538909826428
hereditary B-Disease 1 0.9787629246711731
non I-Disease 1 0.9582645893096924
- I-Disease 1 1.0
polyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
( O 0 0.03283356502652168
HNPCC B-Disease 1 0.9999169111251831
) O 0 2.8270449547562748e-05
kindred O 0 0.0002787008124869317
which O 0 2.7574201340030413e-06
carries O 0 1.1881589671247639e-05
a O 0 1.0834232853085268e-05
novel O 0 1.2488218089856673e-05
truncating O 0 0.00010848565580090508
mutation O 0 5.201636304263957e-05
in O 0 2.202432369813323e-05
hMLH1 O 0 0.0017751313280314207
. O 0 7.333389658015221e-05

Interestingly O 0 0.0014392819721251726
, O 0 4.414286740939133e-05
the O 0 1.4318428839033004e-05
I1307K O 0 0.0003803115978371352
APC O 0 0.00012972817057743669
polymorphism O 0 5.927255187998526e-05
, O 0 4.938505753671052e-06
associated O 0 3.511805743983132e-06
with O 0 1.3845271951140603e-06
an O 0 3.0768683245696593e-06
increased O 0 4.563677794067189e-05
risk O 0 0.004032550845295191
of O 0 0.019092656672000885
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.0009948270162567496
is O 0 4.055092631460866e-06
also O 0 3.653211024357006e-06
present O 0 1.969265440493473e-06
in O 0 3.5645543903228827e-06
this O 0 5.7788270169112366e-06
family O 0 0.00017482998373452574
. O 0 4.5721721107838675e-05

The O 0 0.00014130742056295276
I1307K O 0 0.0007531528826802969
polymorphism O 0 0.00020726004731841385
has O 0 2.184643381042406e-05
previously O 0 2.3457641873392276e-05
only O 0 1.622353920538444e-06
been O 0 7.2845114118536e-06
identified O 0 5.347454134607688e-06
in O 0 1.3683996940017096e-06
individuals O 0 1.077945171346073e-06
of O 0 1.1783447462221375e-06
self O 0 0.0023993339855223894
- O 0 0.0429377555847168
reported O 0 9.180337656289339e-05
Ashkenazi O 0 0.00010531400766922161
Jewish O 0 5.8123627241002396e-05
origins O 0 0.00016553797468077391
. O 0 0.00010123433457920328

In O 0 0.00011101017298642546
addition O 0 2.6037858333438635e-05
, O 0 5.4448837545351125e-06
in O 0 1.9612871255958453e-06
this O 0 8.956804435911181e-07
family O 0 1.3673946341441479e-05
, O 0 9.683626558398828e-07
there O 0 6.25082066108007e-07
appears O 0 1.5091086424945388e-06
to O 0 5.986383939671214e-07
be O 0 1.4340703273774125e-06
no O 0 1.1002431392626022e-06
relationship O 0 1.1042480991818593e-06
between O 0 4.6145598275870725e-07
the O 0 1.9206891010981053e-06
I1307K O 0 4.816433283849619e-05
polymorphism O 0 6.602939720323775e-06
and O 0 8.928789156925632e-07
the O 0 7.502500807277102e-07
presence O 0 1.5125839354368509e-06
or O 0 1.7366021438647294e-06
absence O 0 9.095710993278772e-06
of O 0 8.689262358529959e-06
cancer B-Disease 0 0.37818393111228943
. O 0 1.5498706488870084e-05
. O 0 5.107687320560217e-05

Identification O 0 0.00017684408521745354
of O 0 1.5480285583180375e-05
a O 0 1.6502521248185076e-05
novel O 0 1.0927435141638853e-05
mutation O 0 7.834290045138914e-06
of O 0 1.3385096053752932e-06
the O 0 5.42150564797339e-06
CPO O 0 7.972985622473061e-05
gene O 0 6.266103355301311e-06
in O 0 1.6401992297687684e-06
a O 0 8.84566361492034e-06
Japanese O 0 5.318320108926855e-05
hereditary B-Disease 1 0.5595105886459351
coproporphyria I-Disease 0 0.3995150327682495
family O 0 0.00036165156052447855
. O 0 6.414778908947483e-05

Hereditary B-Disease 1 0.9999566078186035
coproporphyria I-Disease 1 0.9997997879981995
( O 0 0.030514266341924667
HCP B-Disease 1 0.9980213642120361
) O 0 4.730424188892357e-05
is O 0 7.58509258957929e-06
an O 0 0.00010690957424230874
autosomal B-Disease 1 0.9981281161308289
dominant I-Disease 1 0.9973489046096802
disease I-Disease 1 0.9977021813392639
characterized O 0 0.0013462604256346822
by O 0 2.2749802155885845e-05
a O 0 0.26361507177352905
deficiency B-Disease 1 0.985592782497406
of I-Disease 0 7.973295396368485e-06
coproporphyrinogen I-Disease 1 0.5470091104507446
oxidase I-Disease 0 0.0007644434808753431
( O 0 1.0429464964545332e-05
CPO O 0 0.0003613362496253103
) O 0 2.474488383086282e-06
caused O 0 5.30004990650923e-06
by O 0 9.414541182195535e-07
a O 0 5.264806532068178e-06
mutation O 0 1.5147526028158609e-05
in O 0 2.743826826190343e-06
the O 0 1.1642573554127011e-05
CPO O 0 0.00046778708929196
gene O 0 7.165675197029486e-05
. O 0 4.9834859964903444e-05

Only O 0 9.755499195307493e-05
11 O 0 6.325868889689445e-05
mutations O 0 1.8484499378246255e-05
of O 0 1.32393654439511e-06
the O 0 2.396072886767797e-06
gene O 0 7.1298209149972536e-06
have O 0 2.5010006083903136e-06
been O 0 6.77654315950349e-06
reported O 0 3.425960676395334e-05
in O 0 0.00010276701505063102
HCP B-Disease 1 0.9994420409202576
patients O 0 0.03928476199507713
. O 0 0.00010181112156715244

We O 0 0.00021270595607347786
report O 0 3.305557038402185e-05
another O 0 1.1018487384717446e-05
mutation O 0 1.6579324437770993e-05
in O 0 3.699860826600343e-06
a O 0 1.1569910384423565e-05
Japanese O 0 8.524596341885626e-05
family O 0 0.00019820233865175396
. O 0 4.6471737732645124e-05

Polymerase O 0 0.003139456966891885
chain O 0 0.0014306593220680952
reaction O 0 0.00010032061982201412
- O 0 0.00011428463767515495
single O 0 1.7644037143327296e-05
strand O 0 2.798167770379223e-05
conformational O 0 1.6450210750917904e-05
polymorphism O 0 1.5926652849884704e-05
and O 0 1.501998667663429e-06
direct O 0 2.0392890291986987e-06
sequence O 0 2.5792787710088305e-06
analyses O 0 5.030628017266281e-06
demonstrated O 0 7.127944627427496e-06
a O 0 5.0270168685528915e-06
C O 0 6.93792462698184e-05
to O 0 1.861906412159442e-06
T O 0 6.173060683067888e-05
substitution O 0 9.995688969866023e-07
in O 0 7.776866368658375e-07
exon O 0 6.65125571686076e-06
1 O 0 8.593909797127708e-07
of O 0 4.915557383355917e-07
the O 0 2.0250063244020566e-06
CPO O 0 2.9183125661802478e-05
gene O 0 4.941063707519788e-06
at O 0 4.079459358763415e-06
nucleotide O 0 7.95949836174259e-06
position O 0 5.864390914211981e-06
85 O 0 3.939359430660261e-06
, O 0 6.51922505312541e-07
which O 0 6.158015253276972e-07
lies O 0 2.312655396963237e-06
in O 0 8.566497058382083e-07
the O 0 1.6252993191301357e-06
putative O 0 3.2217521948041394e-05
presequence O 0 4.290642391424626e-05
for O 0 1.8188189869761118e-06
targeting O 0 1.5561070540570654e-05
to O 0 1.1568972695386037e-05
mitochondria O 0 0.0004158206284046173
. O 0 8.646789501653984e-05

This O 0 4.1707680793479085e-05
mutation O 0 5.5096421419875696e-05
changes O 0 6.045238933438668e-06
the O 0 2.4677437977516092e-06
codon O 0 1.0858965652005281e-05
for O 0 7.469396337000944e-07
glutamine O 0 6.953145657462301e-06
to O 0 1.1632968153207912e-06
a O 0 2.989647100548609e-06
termination O 0 1.5865351087995805e-05
codon O 0 1.5602829080307856e-05
at O 0 9.931020940712187e-06
amino O 0 1.9191738829249516e-05
acid O 0 2.1295683836797252e-05
position O 0 2.8857832148787566e-05
29 O 0 8.8578111899551e-05
. O 0 3.7209767469903454e-05

MaeI O 0 0.0046621812507510185
restriction O 0 0.00014379718049895018
analysis O 0 2.3568210963276215e-05
showed O 0 2.3464734113076702e-05
two O 0 1.5043983694340568e-06
other O 0 9.98852328848443e-07
carriers O 0 7.097792604326969e-06
in O 0 2.0780710201506736e-06
the O 0 8.670868737681303e-06
family O 0 0.00025065711815841496
. O 0 4.74830849270802e-05

The O 0 0.00034346533357165754
C O 0 0.12413755059242249
- O 1 0.6547539234161377
T O 0 0.14621898531913757
mutation O 0 1.2741606042254716e-05
is O 0 1.507985075477336e-06
located O 0 2.9122072646714514e-06
within O 0 1.2680974350587348e-06
a O 0 5.150755441718502e-06
recently O 0 1.4858885151625145e-05
proposed O 0 4.117999196751043e-06
putative O 0 1.635588523640763e-05
alternative O 0 3.931477749574697e-06
translation O 0 4.588608135236427e-06
initiation O 0 7.387872301478637e-06
codon O 0 2.099802986776922e-05
( O 0 3.947512595914304e-06
TIC O 0 0.00018999022722709924
- O 0 9.175287414109334e-05
1 O 0 2.512259925424587e-06
) O 0 6.055701646801026e-07
, O 0 3.2677007766324095e-07
supporting O 0 1.0307458069291897e-06
that O 0 1.09563916339539e-06
TIC O 0 0.0003450856893323362
- O 0 0.000160127819981426
1 O 0 1.720273644423287e-06
is O 0 3.51372790419191e-07
the O 0 5.571553174377186e-07
real O 0 5.030723968957318e-06
TIC O 0 8.958813123172149e-05
rather O 0 2.4738890260778135e-06
than O 0 1.930285407070187e-06
TIC O 0 0.0006352657219395041
- O 0 0.0001479549682699144
2 O 0 9.415104614163283e-06
. O 0 5.167409653950017e-06
. O 0 2.681046498764772e-05

Human B-Disease 0 0.000740750867407769
complement I-Disease 0 0.0025890071410685778
factor I-Disease 1 0.8464198112487793
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999911785125732
associated O 0 0.13765139877796173
with O 1 0.9978154897689819
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
. O 0 0.0035739338491111994

This O 0 2.9251388696138747e-05
study O 0 1.0758833923318889e-05
reports O 0 7.098381502146367e-06
on O 0 1.9791100385191385e-06
six O 0 7.574885330541292e-06
cases O 0 3.9757574086252134e-06
of O 0 4.088334389962256e-05
deficiency B-Disease 1 0.9940277338027954
in I-Disease 0 3.7606052956107305e-06
the I-Disease 0 2.14366014006373e-06
human I-Disease 0 1.6002039728846285e-06
complement I-Disease 0 6.685571861453354e-06
regulatory I-Disease 0 2.423687510599848e-05
protein I-Disease 0 3.833008304354735e-05
Factor I-Disease 0 5.560732097364962e-05
H I-Disease 1 0.9999619722366333
( O 0 8.677486221131403e-06
FH O 0 0.0023407882545143366
) O 0 8.173273613465426e-07
in O 0 5.386688712860632e-07
the O 0 8.79191247804556e-07
context O 0 2.494969066901831e-06
of O 0 4.693635219155112e-06
an O 1 0.8774787187576294
acute B-Disease 1 1.0
renal I-Disease 1 1.0
disease I-Disease 1 1.0
. O 0 0.0054745785892009735

Five O 0 7.477725011995062e-05
of O 0 6.223284799489193e-06
the O 0 7.037911473162239e-06
cases O 0 4.3036366150772665e-06
were O 0 7.903096047812141e-06
observed O 0 4.925843313685618e-06
in O 0 3.665156100396416e-06
children O 0 8.325657108798623e-05
presenting O 0 0.00030631694244220853
with O 1 0.99445641040802
idiopathic O 1 1.0
hemolytic B-Disease 1 1.0
uremic I-Disease 1 1.0
syndrome I-Disease 1 1.0
( O 0 0.47212499380111694
HUS B-Disease 1 0.9999995231628418
) O 0 0.0002944951702374965
. O 0 0.00014961996930651367

Two O 0 1.9299877749290317e-05
of O 0 4.9209320422960445e-06
the O 0 8.229068953369278e-06
children O 0 5.561559009947814e-05
exhibited O 0 0.0008353879093192518
a O 0 0.024114567786455154
homozygous O 1 0.9999376535415649
deficiency O 1 0.9969344139099121
characterized O 0 3.230452421121299e-05
by O 0 9.491602099842567e-07
the O 0 1.815083010114904e-06
absence O 0 4.3717386688513216e-06
of O 0 3.8100762367321295e-07
the O 0 9.089615105040139e-07
150 O 0 1.8472885585651966e-06
- O 0 2.2139092834549956e-05
kD O 0 8.814531611278653e-06
form O 0 6.244010251066356e-07
of O 0 7.633908012394386e-07
Factor O 0 1.02799122032593e-05
H O 1 0.9968820810317993
and O 0 1.6944013623287901e-06
the O 0 1.4273520037022536e-06
presence O 0 1.2449895621102769e-06
, O 0 7.786752007632458e-07
upon O 0 1.2168641205789754e-06
immunoblotting O 0 3.5749540984397754e-05
, O 0 3.085179116624204e-07
of O 0 2.33250517567285e-07
the O 0 8.825650184007827e-07
42 O 0 1.1040079698432237e-05
- O 0 4.242776412866078e-05
kD O 0 5.159274223842658e-05
Factor O 0 1.2528848856163677e-05
H O 1 0.9738976359367371
- O 0 4.660950435209088e-05
like O 0 2.4904807105485816e-06
protein O 0 3.873436071444303e-06
1 O 0 3.23288691106427e-06
( O 0 1.7935656160261715e-06
FHL O 0 0.00011009848094545305
- O 0 2.844362643372733e-05
1 O 0 1.549208718643058e-06
) O 0 3.1462207061849767e-07
and O 0 3.1582214887748705e-07
other O 0 7.635858878529689e-07
FH O 0 0.020491452887654305
- O 0 0.00021505191398318857
related O 0 8.849452569847926e-06
protein O 0 1.4868836842651945e-05
( O 0 4.042119144287426e-06
FHR O 0 0.0005019446834921837
) O 0 4.583901500154752e-06
bands O 0 5.324017911334522e-05
. O 0 3.0336095733218826e-05

Southern O 0 0.0005613901885226369
blot O 0 0.0012121264589950442
and O 0 2.6342513592680916e-05
PCR O 0 5.925480218138546e-05
analysis O 0 3.7475024328159634e-06
of O 0 1.335076376562938e-06
DNA O 0 6.254682830331149e-06
of O 0 9.664150866228738e-07
one O 0 9.682716154202353e-06
patient O 0 0.004134755581617355
with O 0 0.0005449581076391041
homozygous O 1 0.9997798800468445
deficiency O 1 0.9829117059707642
ruled O 0 2.1291052689775825e-05
out O 0 2.4159412532753777e-06
the O 0 5.699333769371151e-07
presence O 0 5.375194405132788e-07
of O 0 1.933620836780392e-07
a O 0 1.8548296338849468e-06
large O 0 2.0327574929979164e-06
deletion O 0 1.2509985026554205e-05
of O 0 7.974914524311316e-07
the O 0 6.779542673029937e-06
FH O 0 0.2515665590763092
gene O 0 7.4665363172243815e-06
as O 0 1.1081693855885533e-06
the O 0 7.953040949360002e-06
underlying O 0 0.004992671776562929
defect O 0 0.03561948612332344
for O 0 2.1766949430457316e-05
the O 0 0.04207771271467209
deficiency O 1 0.9965068697929382
. O 0 0.00010069210111396387

The O 0 4.2949573980877176e-05
other O 0 6.483780452981591e-06
four O 0 7.425931471516378e-06
children O 0 1.741229061735794e-05
presented O 0 9.196706741931848e-06
with O 0 4.153882400714792e-05
heterozygous O 1 0.9782797694206238
deficiency O 1 0.9510840773582458
and O 0 8.522677489963826e-06
exhibited O 0 5.328838597051799e-05
a O 0 1.3804366972181015e-05
normal O 0 2.5013227059389465e-05
immunoblotting O 0 0.00013123711687512696
pattern O 0 2.856242417692556e-06
of O 0 4.0818540014697646e-07
proteins O 0 1.4495806226477725e-06
of O 0 1.3198318811191712e-06
the O 0 3.238175486330874e-05
FH O 1 0.934285044670105
family O 0 0.00042122419108636677
. O 0 8.413472096435726e-05

Factor B-Disease 1 0.9985581040382385
H I-Disease 1 1.0
deficiency I-Disease 1 0.9999616146087646
is O 0 1.1147931218147278e-05
the O 0 7.935532266856171e-06
only O 0 4.551985693979077e-05
complement B-Disease 1 0.9999089241027832
deficiency I-Disease 1 0.9999997615814209
associated O 0 0.0003428653290029615
with O 0 0.00047076851478777826
HUS B-Disease 1 0.9999939203262329
. O 0 0.00035131096956320107

These O 0 4.141055978834629e-05
observations O 0 4.5430522732203826e-05
suggest O 0 1.61404132086318e-05
a O 0 5.4645579439238645e-06
role O 0 5.504056844074512e-06
for O 0 4.088748482899973e-06
FH O 0 0.08228159695863724
and O 0 8.67460676090559e-06
/ O 0 4.167277074884623e-05
or O 0 8.403543688473292e-06
FH O 0 0.007804603781551123
receptors O 0 1.2236638212925754e-05
in O 0 2.06149456971616e-06
the O 0 8.426053682342172e-06
pathogenesis O 0 0.0003262332174926996
of O 0 3.927016950910911e-05
idiopathic O 1 0.9999747276306152
HUS B-Disease 1 0.9999986886978149
. O 0 0.00013964965182822198
. O 0 0.00014785988605581224

Further O 0 0.0001335062988800928
evidence O 0 2.322199725313112e-05
for O 0 4.186408204986947e-06
a O 0 8.374070603167638e-06
major O 0 1.2116774087189697e-05
ancient O 0 1.5568493836326525e-05
mutation O 0 0.001868086983449757
underlying O 0 0.1780199259519577
myotonic B-Disease 1 0.9999995231628418
dystrophy I-Disease 1 0.999998927116394
from O 0 0.00010059152555186301
linkage O 0 0.017271695658564568
disequilibrium O 0 0.012369383126497269
studies O 0 1.1621387784543913e-05
in O 0 3.064224074478261e-06
the O 0 4.862237801717129e-06
Japanese O 0 3.8340607716236264e-05
population O 0 1.879948285932187e-05
. O 0 3.1277821108233184e-05

The O 0 0.07971198111772537
myotonic B-Disease 1 0.9999997615814209
dystrophy I-Disease 1 1.0
( O 1 0.968021035194397
DM B-Disease 1 1.0
) O 0 0.00018840738630387932
mutation O 0 0.00014907424338161945
is O 0 6.852526894363109e-06
an O 0 1.744620021781884e-05
unstable O 0 0.31951552629470825
( O 0 1.819258432078641e-05
CTG O 0 0.0042059412226080894
) O 0 3.059073605982121e-06
n O 0 2.705023143789731e-05
repeat O 0 1.0008957360696513e-05
, O 0 1.1003794497810304e-06
present O 0 7.577310725537245e-07
at O 0 3.575067239580676e-06
a O 0 1.2984902468815562e-06
copy O 0 1.3571745967055904e-06
number O 0 2.3251494951637142e-07
of O 0 2.5985812612816517e-07
5 O 0 4.01868783228565e-06
- O 0 4.662826540879905e-05
37 O 0 6.34373373031849e-06
repeats O 0 3.2749467209214345e-06
on O 0 9.898737971525406e-07
normal O 0 3.3198450637428323e-06
chromosomes O 0 3.1160545859165723e-06
but O 0 5.684314601239748e-07
amplified O 0 4.553802682494279e-06
to O 0 6.63979562887107e-07
50 O 0 2.1119838038430316e-06
- O 0 1.0955379366350826e-05
3000 O 0 7.030243978078943e-06
copies O 0 3.056746209040284e-06
on O 0 1.7953427231987007e-05
DM B-Disease 1 0.9999680519104004
chromosomes O 0 0.00024973778636194766
. O 0 5.711603444069624e-05

Previous O 0 0.0004498659400269389
findings O 0 0.00013302467414177954
in O 0 2.801484333758708e-05
Caucasian O 0 0.00014831133012194186
populations O 0 1.5267347407643683e-05
of O 0 3.75215859094169e-06
a O 0 0.009832222014665604
DM B-Disease 1 0.9999998807907104
founder O 0 0.023817704990506172
chromosome O 0 0.0011416130000725389
raise O 0 8.002501999726519e-06
a O 0 2.7328376290824963e-06
question O 0 1.2092531278540264e-06
about O 0 5.259308863969636e-07
the O 0 6.328774588837405e-07
molecular O 0 5.832209808431799e-06
events O 0 1.5706350495747756e-06
involved O 0 2.6979739686794346e-06
in O 0 1.3563580978370737e-06
the O 0 4.658672423829557e-06
expansion O 0 6.024799949955195e-05
mutation O 0 0.0001804340718081221
. O 0 5.393665924202651e-05

To O 0 9.841768769547343e-05
investigate O 0 8.97736317710951e-05
whether O 0 1.3042479622527026e-05
a O 0 1.0138534889847506e-05
founder O 0 8.977080142358318e-05
chromosome O 0 0.00012943234469275922
for O 0 2.332270241822698e-06
the O 0 5.875553688383661e-05
DM B-Disease 1 0.9999995231628418
mutation O 0 5.798910206067376e-05
exists O 0 1.9607280137279304e-06
in O 0 1.031465671985643e-06
the O 0 8.489083143103926e-07
Japanese O 0 5.152558514964767e-06
population O 0 1.1631791494437493e-06
, O 0 8.767522103880765e-07
we O 0 1.5395102082038647e-06
genotyped O 0 4.872247882303782e-05
families O 0 2.5668914531706832e-06
using O 0 2.0363586372695863e-06
polymorphic O 0 2.9687207643291913e-05
markers O 0 4.9518417654326186e-05
near O 0 9.718506771605462e-05
the O 0 7.607854513480561e-06
( O 0 7.962747986312024e-06
CTG O 0 0.001070977421477437
) O 0 2.64566710939107e-06
n O 0 1.6792102542240173e-05
repeat O 0 1.4481641301244963e-05
region O 0 6.422613751055906e-06
and O 0 1.1858487596327905e-05
constructed O 0 0.0006728797452524304
haplotypes O 0 0.00047350619570352137
. O 0 9.853290976025164e-05

Six O 0 0.00014535165973939002
different O 0 1.8809954781318083e-05
haplotypes O 0 7.119163637980819e-05
were O 0 2.4055925678112544e-05
found O 0 1.9804412659141235e-05
and O 0 6.763222336303443e-05
DM B-Disease 1 0.9999982118606567
alleles O 0 0.00011746993550332263
were O 0 9.288675209973007e-05
always O 0 5.4754338634666055e-05
haplotype O 0 0.0004655051452573389
A O 0 0.0002505510638002306
. O 0 0.00010373247641837224

To O 0 7.868736429372802e-05
find O 0 2.9822500437148847e-05
an O 0 3.485470415398595e-06
origin O 0 2.0122733985772356e-06
of O 0 1.0280970172971138e-06
the O 0 8.020992936508264e-06
( O 0 7.975500921020284e-06
CTG O 0 0.000461985997390002
) O 0 1.805656324904703e-06
n O 0 1.5969466403475963e-05
repeat O 0 1.0098660823132377e-05
mutation O 0 4.9225463953916915e-06
and O 0 5.983449682389619e-07
to O 0 6.322313765849685e-07
investigate O 0 1.861727128016355e-06
the O 0 4.2512129994065617e-07
mechanism O 0 1.0374221801612293e-06
of O 0 1.979122288275903e-07
the O 0 7.37368566205987e-07
expansion O 0 3.2873440432013012e-06
mutation O 0 3.4428273920639185e-06
in O 0 7.009150522208074e-07
the O 0 9.577547643857542e-07
Japanese O 0 2.9182319849496707e-06
population O 0 9.013995168061228e-07
we O 0 5.673932150784822e-07
have O 0 5.739840389651363e-07
studied O 0 1.6873881349965814e-06
90 O 0 2.908674105128739e-06
Japanese O 0 1.309487379330676e-05
DM B-Disease 1 0.9974486231803894
families O 0 6.234862667042762e-06
comprising O 0 4.223115411150502e-06
190 O 0 8.984602573036682e-06
affected O 0 6.1986565924598835e-06
and O 0 2.719451003940776e-06
130 O 0 1.912640072987415e-05
unaffected O 0 0.00010084931273013353
members O 0 1.7060601749108173e-05
. O 0 3.721416578628123e-05

The O 0 0.00016387435607612133
results O 0 0.00013736067921854556
suggest O 0 1.6019483155105263e-05
that O 0 1.8268887060912675e-06
a O 0 2.6565007829049136e-06
few O 0 1.465198579353455e-06
common O 0 2.388623670412926e-06
ancestral O 0 5.6864133512135595e-05
mutations O 0 1.20854319902719e-05
in O 0 1.813423750718357e-06
both O 0 1.6103382449728088e-06
Caucasian O 0 2.1654814190696925e-05
and O 0 2.454234618198825e-06
Japanese O 0 6.846621545264497e-06
populations O 0 2.1091900634928606e-06
have O 0 1.0489195574336918e-06
originated O 0 1.1893400824192213e-06
by O 0 2.538893681958143e-07
expansion O 0 1.3373255569604225e-06
of O 0 5.451547622215003e-07
an O 0 2.5546762572048465e-06
ancestral O 0 8.17640102468431e-05
n O 0 0.00012342353875283152
= O 0 6.925313209649175e-05
5 O 0 7.235732937260764e-06
repeat O 0 1.2464682185964193e-05
to O 0 3.533301651259535e-06
n O 0 0.00010689938062569126
= O 0 0.0001021965072141029
19 O 0 2.084895459120162e-05
- O 0 5.406049604061991e-05
37 O 0 3.049190308956895e-05
copies O 0 1.6337800843757577e-05
. O 0 3.1811228836886585e-05

These O 0 4.177810114924796e-05
data O 0 1.6153098840732127e-05
support O 0 5.535767741093878e-06
multistep O 0 1.9609669834608212e-05
models O 0 5.574185706791468e-06
of O 0 2.465854777256027e-06
triplet O 0 0.01905849389731884
repeat O 0 5.143211456015706e-05
expansion O 0 6.69466999170254e-06
that O 0 1.7173427977468236e-06
have O 0 1.6236107285294565e-06
been O 0 1.4305693412097753e-06
proposed O 0 1.5299775668609072e-06
for O 0 1.375063447994762e-06
both O 0 2.4339205992873758e-05
DM B-Disease 1 0.9999977350234985
and O 0 8.692516712471843e-05
Friedreichs B-Disease 1 0.7475159764289856
ataxia I-Disease 1 0.9560841917991638
. O 0 4.2309540731366724e-05
. O 0 8.031682955333963e-05

The O 0 0.00010252915672026575
molecular O 0 0.00014772912254557014
basis O 0 1.916324436024297e-05
of O 0 0.00032067744177766144
C6 B-Disease 1 1.0
deficiency I-Disease 1 0.9999992847442627
in O 0 1.1708334568538703e-05
the O 0 2.4788676000753185e-06
western O 0 5.834924650116591e-06
Cape O 0 9.153404243988916e-05
, O 0 5.765246896771714e-06
South O 0 2.2772072043153457e-05
Africa O 0 2.740836498560384e-05
. O 0 3.3998316212091595e-05

Deficiency B-Disease 1 0.998695433139801
of I-Disease 0 2.554350794525817e-05
the I-Disease 0 1.6283622244372964e-05
sixth I-Disease 0 0.00012432088260538876
component I-Disease 0 7.375925633823499e-06
of I-Disease 0 1.0023992444985197e-06
human I-Disease 0 2.668701881702873e-06
complement I-Disease 0 1.5139583410928026e-05
( O 0 3.3101835015258985e-06
C6 O 0 0.0006628059782087803
) O 0 1.2315475714785862e-06
has O 0 1.3131437981428462e-06
been O 0 3.313730530862813e-06
reported O 0 4.442963927431265e-06
in O 0 3.6837002426182153e-07
a O 0 8.703483445060556e-07
number O 0 2.791235829135985e-07
of O 0 2.521736348626291e-07
families O 0 1.6994018778859754e-06
from O 0 3.676298376831255e-07
the O 0 6.671074288533418e-07
western O 0 2.8366837341309292e-06
Cape O 0 4.664169318857603e-05
, O 0 3.770516968870652e-06
South O 0 1.0224045581708197e-05
Africa O 0 1.4214741895557381e-05
. O 0 2.7175012291991152e-05

Meningococcal B-Disease 1 0.9999409914016724
disease I-Disease 1 0.9999542236328125
is O 0 0.00014587354962714016
endemic O 0 0.00011583115701796487
in O 0 7.958808055263944e-06
the O 0 4.626784630090697e-06
Cape O 0 9.626989776734263e-05
and O 0 3.4895747376140207e-06
almost O 0 1.7011856243698276e-06
all O 0 6.02786087711138e-07
pedigrees O 0 3.800736885750666e-05
of O 0 7.872449714341201e-06
total O 1 0.8640570640563965
C6 B-Disease 1 1.0
deficiency I-Disease 1 0.9999998807907104
( O 0 2.9549933969974518e-05
C6Q0 O 0 0.2734658718109131
) O 0 1.8637540506460937e-06
have O 0 3.1387123726744903e-06
been O 0 1.1146315955556929e-05
ascertained O 0 3.9396501961164176e-05
because O 0 2.5887463834806113e-06
of O 0 8.662619620736223e-06
recurrent O 1 0.9918525815010071
disease O 1 0.973601758480072
. O 0 0.00014707412628922611

We O 0 0.00012877128028776497
have O 0 1.5745610653539188e-05
sequenced O 0 2.6123390853172168e-05
the O 0 2.261781673951191e-06
expressed O 0 2.060808583337348e-06
exons O 0 4.0041350075625814e-06
of O 0 7.850878205317713e-07
the O 0 2.030260020546848e-06
C6 O 0 0.00013164345000404865
gene O 0 2.7560161015571794e-06
from O 0 8.095373686956009e-07
selected O 0 1.649245064072602e-06
cases O 0 6.432670716094435e-07
and O 0 1.43013699016592e-06
have O 0 4.354096745373681e-06
found O 0 6.1468640524253715e-06
three O 0 7.64930882724002e-06
molecular O 0 0.05808159336447716
defects O 1 0.954978883266449
leading O 0 6.0344653320498765e-05
to O 0 2.6927409635391086e-05
total O 0 0.17381174862384796
deficiency O 1 0.9803987145423889
879delG O 0 0.0019403517944738269
, O 0 4.114858711545821e-06
which O 0 2.2372462353814626e-06
is O 0 5.645471219395404e-07
the O 0 1.0421541674077162e-06
common O 0 5.125167717778822e-06
defect O 0 0.0005474725039675832
in O 0 2.755834884737851e-06
the O 0 2.8874369490949903e-06
Cape O 0 5.1306506065884605e-05
and O 0 3.981616373494035e-06
hitherto O 0 4.684996383730322e-05
unreported O 0 1.7750360711943358e-05
, O 0 1.9278993477200856e-06
and O 0 2.5086401365115307e-06
1195delC O 0 5.698447785107419e-05
and O 0 3.4792567475960823e-06
1936delG O 0 0.00022327496844809502
, O 0 1.8893576907430543e-06
which O 0 1.2078850204488845e-06
have O 0 2.0662500901380554e-06
been O 0 4.494885160966078e-06
previously O 0 8.035738574108109e-06
reported O 0 5.125211828271858e-06
in O 0 1.846571649366524e-06
African O 0 1.1147420991619583e-05
- O 0 0.0062960353679955006
Americans O 0 2.874357596738264e-05
. O 0 2.6430130674270913e-05

We O 0 0.0001140505846706219
also O 0 1.2238096132932696e-05
show O 0 7.965558324940503e-06
that O 0 9.371051987727697e-07
the O 0 1.552626940792834e-06
879delG O 0 0.00011721428018063307
and O 0 2.6371521016699262e-05
1195delC O 1 0.5405072569847107
defects O 1 0.8439695239067078
are O 0 2.9598086257465184e-06
associated O 0 7.077009286149405e-06
with O 0 9.933843102771789e-06
characteristic O 0 0.0004364225605968386
C6 O 1 0.7100710272789001
/ O 0 0.0003890774096362293
C7 O 0 0.019604811444878578
region O 0 4.356474892119877e-05
DNA O 0 0.00013181303802412003
marker O 0 0.00018137329607270658
haplotypes O 0 9.561055048834532e-05
, O 0 4.373639967525378e-06
although O 0 1.574962539052649e-06
small O 0 3.3072142286982853e-06
variations O 0 1.304591387452092e-05
were O 0 3.98868796764873e-05
observed O 0 0.00011366797116352245
. O 0 5.3922616643831134e-05

The O 0 0.00021053668751847
1936delG O 0 0.03264746814966202
defect O 0 0.03335248678922653
was O 0 7.56940571591258e-05
observed O 0 6.297038908087416e-06
only O 0 9.686129942565458e-07
once O 0 2.909370323322946e-06
in O 0 5.821790409754612e-07
the O 0 7.363601071119774e-07
Cape O 0 2.255940307804849e-05
, O 0 1.3464191397360992e-06
but O 0 7.541416948697588e-07
its O 0 1.5135969988477882e-06
associated O 0 9.866394066193607e-06
haplotype O 0 0.00010559175279922783
could O 0 1.4687234397570137e-05
be O 0 7.464115697075613e-06
deduced O 0 9.149826655630022e-05
. O 0 4.4050681026419625e-05

The O 0 5.538070763577707e-05
data O 0 2.0043149561388418e-05
from O 0 4.852491201745579e-06
the O 0 3.222224449928035e-06
haplotypes O 0 3.847899643005803e-05
indicate O 0 8.512467502441723e-06
that O 0 6.852865794826357e-07
these O 0 4.990852175978944e-07
three O 0 4.285064278519712e-06
molecular O 0 0.04037095233798027
defects O 1 0.8183944225311279
account O 0 5.758208317274693e-06
for O 0 1.2534840152511606e-06
the O 0 2.257035521324724e-05
defects O 1 0.822543203830719
in O 0 2.7766839139076183e-06
all O 0 5.68212499274523e-07
the O 0 1.380131948280905e-06
38 O 0 2.2700045519741252e-05
unrelated O 0 1.2180774319858756e-05
C6Q0 O 0 0.011160294525325298
individuals O 0 1.3802347211822052e-06
we O 0 9.74275508269784e-07
have O 0 8.875923072082514e-07
studied O 0 2.8518386443465715e-06
from O 0 1.5302912288461812e-06
the O 0 5.900856194784865e-06
Cape O 0 0.0002923060383182019
. O 0 4.756420457852073e-05

We O 0 0.00017225017654709518
have O 0 1.4896924767526798e-05
also O 0 3.6609676499210764e-06
observed O 0 4.2091828618140426e-06
the O 0 3.5816501622321084e-06
879delG O 0 0.0005718740867450833
defect O 0 0.00018310974701307714
in O 0 3.0828662147541763e-06
two O 0 1.0346960152674e-05
Dutch O 1 0.5222744941711426
C6 B-Disease 1 0.9999996423721313
- I-Disease 1 0.9997605681419373
deficient I-Disease 1 0.9999585151672363
kindreds O 0 0.00024309767468366772
, O 0 5.029702606407227e-06
but O 0 2.454775312799029e-06
the O 0 3.946040578739485e-06
879delG O 0 0.0021869565825909376
defect O 0 0.00034649562439881265
in O 0 2.411873310848023e-06
the O 0 2.7251080609858036e-06
Cape O 0 0.00048486224841326475
probably O 0 2.954221417894587e-05
did O 0 4.343670298112556e-06
not O 0 7.669357273698552e-07
come O 0 6.838176318524347e-07
from O 0 5.969582730358525e-07
The O 0 1.0336723335058196e-06
Netherlands O 0 1.733756289468147e-05
. O 0 4.509780410444364e-06
. O 0 2.1932793970336206e-05

Complement B-Disease 1 0.9965689182281494
C7 I-Disease 1 0.9999998807907104
deficiency I-Disease 1 0.9999998807907104
: O 0 6.582753849215806e-05
seven O 0 2.745603160292376e-05
further O 0 1.85490571311675e-05
molecular O 0 0.010380571708083153
defects O 1 0.9370025396347046
and O 0 1.4027154065843206e-05
their O 0 2.9054692276986316e-05
associated O 0 8.255239663412794e-05
marker O 0 0.0005481860716827214
haplotypes O 0 0.0007218248210847378
. O 0 9.014653187477961e-05

Seven O 0 0.00017198413843289018
further O 0 5.5231721489690244e-05
molecular O 0 8.733576396480203e-05
bases O 0 0.00010068105621030554
of O 0 0.003859808901324868
C7 B-Disease 1 1.0
deficiency I-Disease 1 1.0
are O 0 7.013713184278458e-05
described O 0 0.0005374812753871083
. O 0 8.686664659762755e-05

All O 0 2.9086435461067595e-05
these O 0 7.673420441278722e-06
new O 0 1.273753514396958e-05
molecular O 0 0.0007144163246266544
defects O 0 0.37708795070648193
involve O 0 1.409516880812589e-05
single O 0 2.9735885618720204e-05
- O 0 0.00010424473293824121
nucleotide O 0 8.700124453753233e-06
events O 0 1.215345946548041e-06
, O 0 8.032696428017516e-07
deletions O 0 2.99855037155794e-06
and O 0 1.0673220458556898e-06
substitutions O 0 4.554810402623843e-06
, O 0 7.060197617647646e-07
some O 0 2.0447271253942745e-07
of O 0 3.0898547720425995e-07
which O 0 1.3618680441140896e-06
alter O 0 8.886654541129246e-06
splice O 0 4.3335439841030166e-05
sites O 0 3.1093693451111903e-06
, O 0 2.2841607005830156e-06
and O 0 5.00567057315493e-06
others O 0 2.3123968276195228e-05
codons O 0 8.759466436458752e-05
. O 0 4.321357482695021e-05

They O 0 0.00013235234655439854
are O 0 7.0930964284343645e-06
distributed O 0 5.607060757029103e-06
along O 0 2.2954745872993954e-06
the O 0 3.0517887807945954e-06
C7 O 0 0.0016005595680326223
gene O 0 6.658236998191569e-06
, O 0 1.3199678505770862e-06
but O 0 6.709944955218816e-07
predominantly O 0 1.3110228564983117e-06
towards O 0 1.9741391952265985e-06
the O 0 3.2859493330761325e-06
3 O 0 2.5718149117892608e-05
end O 0 3.518310040817596e-05
. O 0 3.141766501357779e-05

All O 0 4.691389040090144e-05
were O 0 4.128009095438756e-05
found O 0 1.73208045453066e-05
in O 0 1.3281832252687309e-05
compound O 0 0.0003781923733185977
heterozygous O 0 0.0003295907226856798
individuals O 0 2.5566025215084665e-05
. O 0 5.549543129745871e-05

The O 0 0.0004781452298630029
C6 O 0 0.3188801109790802
/ O 0 0.0012068426003679633
C7 O 0 0.014489928260445595
marker O 0 0.0004934431635774672
haplotypes O 0 0.0003061032621189952
associated O 0 3.820749407168478e-05
with O 0 1.2181216334283818e-05
most O 0 4.914652890875004e-05
C7 B-Disease 1 0.999941349029541
defects I-Disease 1 0.9997803568840027
are O 0 2.7697900804923847e-05
tabulated O 0 0.02315080352127552
. O 0 1.1237712897127494e-05
. O 0 4.8134810640476644e-05

A O 0 0.00029554375214502215
genome O 0 0.00015213788719847798
- O 0 8.469755266560242e-05
wide O 0 1.6688110918039456e-05
search O 0 1.344721022178419e-05
for O 0 6.909393505338812e-06
chromosomal O 0 0.016978980973362923
loci O 0 0.00020395407045725733
linked O 0 0.0004833076673094183
to O 0 4.086604167241603e-05
mental O 1 0.9323639273643494
health O 0 0.001052310923114419
wellness O 0 0.006413944996893406
in O 0 1.530614281364251e-05
relatives O 0 0.00015717916539870203
at O 0 0.0004009786352980882
high O 0 0.03704104200005531
risk O 0 0.03990960493683815
for O 0 0.0015675094909965992
bipolar B-Disease 1 1.0
affective I-Disease 1 0.9999839067459106
disorder I-Disease 1 0.9865038394927979
among O 0 3.842112619167892e-06
the O 0 5.235635853750864e-06
Old O 0 0.00017866762937046587
Order O 0 2.1319012375897728e-05
Amish O 0 0.0012152778217568994
. O 0 6.376331293722615e-05

Bipolar B-Disease 1 0.9999998807907104
affective I-Disease 1 0.9999991655349731
disorder I-Disease 1 0.9999997615814209
( O 0 0.3705541789531708
BPAD B-Disease 1 0.9999998807907104
; O 1 0.6522570848464966
manic B-Disease 1 0.9999998807907104
- I-Disease 1 0.9999998807907104
depressive I-Disease 1 1.0
illness I-Disease 1 0.9999839067459106
) O 0 2.4096980268950574e-05
is O 0 2.9063946840324206e-06
characterized O 0 9.016170224640518e-06
by O 0 7.070999004099576e-07
episodes O 0 3.197008936695056e-06
of O 0 2.6258146590407705e-06
mania B-Disease 0 0.029875749722123146
and O 0 1.7074862626031972e-05
/ O 0 0.00017994886729866266
or O 0 2.1062951418571174e-05
hypomania B-Disease 0 0.04591931775212288
interspersed O 0 5.360974682844244e-05
with O 0 6.854767434560927e-06
periods O 0 5.0204824219690636e-05
of O 0 4.4544885895447806e-05
depression B-Disease 1 0.9958844780921936
. O 0 0.00021897826809436083

Compelling O 0 0.0003348424506839365
evidence O 0 5.6838925956981257e-05
supports O 0 2.4000337361940183e-05
a O 0 1.3351921552384738e-05
significant O 0 7.163592272263486e-06
genetic O 0 1.723725836200174e-05
component O 0 6.692493116133846e-06
in O 0 2.41932821154478e-06
the O 0 5.06468995808973e-06
susceptibility O 0 0.0002812097955029458
to O 0 2.3417611373588443e-05
develop O 0 0.002860053675249219
BPAD B-Disease 1 0.999984622001648
. O 0 0.00018692277080845088

To O 0 7.675535016460344e-05
date O 0 5.5428263294743374e-05
, O 0 6.326684342639055e-06
however O 0 2.2452595658251084e-06
, O 0 1.5416876522067469e-06
linkage O 0 9.375580702908337e-06
studies O 0 1.6776629081505234e-06
have O 0 1.5526696870438172e-06
attempted O 0 1.0728915185609367e-05
only O 0 8.87656597114983e-07
to O 0 1.6183887510123895e-06
identify O 0 1.668190634518396e-05
chromosomal O 0 0.0011759905610233545
loci O 0 2.3686752683715895e-05
that O 0 2.6224361135973595e-06
cause O 0 1.8921611626865342e-05
or O 0 2.8278079753363272e-06
increase O 0 2.7494795631355373e-06
the O 0 6.041297183401184e-06
risk O 0 6.781595584470779e-05
of O 0 5.8516197896096855e-06
developing O 0 0.0008575422689318657
BPAD B-Disease 1 0.9999686479568481
. O 0 0.0002120049757650122

To O 0 4.440560223883949e-05
determine O 0 3.450972872087732e-05
whether O 0 7.71830582380062e-06
there O 0 2.930788014054997e-06
could O 0 4.531604190560756e-06
be O 0 2.1641353669110686e-06
protective O 0 7.097770139807835e-05
alleles O 0 1.1770468518079724e-05
that O 0 1.6126542732308735e-06
prevent O 0 1.3485352610587142e-05
or O 0 3.4295292152819457e-06
reduce O 0 8.537400390196126e-06
the O 0 2.5372864911332726e-06
risk O 0 1.489157057221746e-05
of O 0 1.117348688239872e-06
developing O 0 0.0001633188803680241
BPAD B-Disease 1 0.9999792575836182
, O 0 3.5848590869136387e-06
similar O 0 1.1486885114209144e-06
to O 0 1.4552402944900678e-06
what O 0 9.307601089858508e-07
is O 0 5.653024004459439e-07
observed O 0 1.9216822693124413e-06
in O 0 2.2348131096805446e-06
other O 0 1.818717282731086e-05
genetic B-Disease 1 0.999988317489624
disorders I-Disease 1 0.9999997615814209
, O 0 9.283476538257673e-05
we O 0 2.6967089070240036e-05
used O 0 0.003200949402526021
mental O 1 0.9986140727996826
health O 0 0.08892053365707397
wellness O 0 0.4186526834964752
( O 0 4.78886568089365e-06
absence O 0 9.653139386500698e-06
of O 0 4.514557076618075e-06
any O 0 0.0019694226793944836
psychiatric B-Disease 1 0.9999926090240479
disorder I-Disease 1 0.9995162487030029
) O 0 3.4763711482810322e-06
as O 0 1.0860185284400359e-06
the O 0 2.880654619730194e-06
phenotype O 0 4.670088674174622e-05
in O 0 1.6002802567527397e-06
our O 0 2.6330417313147336e-06
genome O 0 4.843531314691063e-06
- O 0 1.280320248042699e-05
wide O 0 3.5077857774012955e-06
linkage O 0 1.7682879843050614e-05
scan O 0 4.5801105443388224e-05
of O 0 5.980494961477234e-07
several O 0 8.96410256245872e-07
large O 0 2.6328759759053355e-06
multigeneration O 0 0.00023968411551322788
Old O 0 1.2504831829573959e-05
Order O 0 2.6488885396247497e-06
Amish O 0 6.381673301802948e-05
pedigrees O 0 0.00010496821778360754
exhibiting O 0 2.223773844889365e-05
an O 0 3.504141204757616e-06
extremely O 0 0.00011282899504294619
high O 0 0.0011459083762019873
incidence O 0 0.0064245471730828285
of O 0 8.259255264420062e-05
BPAD B-Disease 1 0.9999977350234985
. O 0 0.0002726044040173292

We O 0 0.0001232038630405441
have O 0 1.3225661859905813e-05
found O 0 9.946660611603875e-06
strong O 0 3.920971266779816e-06
evidence O 0 1.7851339180197101e-06
for O 0 9.446090416531661e-07
a O 0 9.659713214205112e-06
locus O 0 9.892380330711603e-05
on O 0 2.6523204724071547e-05
chromosome O 0 0.07841953635215759
4p O 1 0.9024864435195923
at O 0 6.051280797692016e-05
D4S2949 O 0 0.00013779803703073412
( O 0 2.876023700082442e-06
maximum O 0 1.2547693586384412e-05
GENEHUNTER O 0 0.0012643418740481138
- O 0 9.227442205883563e-05
PLUS O 0 2.6600459023029543e-05
nonparametric O 0 4.9714297347236425e-05
linkage O 0 5.413958933786489e-05
score O 0 3.8154521462274715e-05
= O 0 7.57121088099666e-05
4 O 0 4.924575023323996e-06
. O 0 1.162173475677264e-06
05 O 0 0.00011725205695256591
, O 0 4.648682079277933e-06
P O 0 0.0021544061601161957
= O 0 2.6916421120404266e-05
5 O 0 1.7350179177810787e-06
. O 0 4.208321797705139e-07
22 O 0 2.5150743567792233e-06
x O 0 7.009203272900777e-06
10 O 0 1.688581164671632e-06
( O 0 7.525194405388902e-07
- O 0 1.612219784874469e-05
4 O 0 4.0895401980378665e-06
) O 0 8.418281822741847e-07
; O 0 1.626240532459633e-06
SIBPAL O 0 9.230213618138805e-05
Pempirical O 0 3.212829687981866e-05
value O 0 1.1321995998514467e-06
< O 0 8.49781008582795e-06
3 O 0 2.2378203539119568e-06
x O 0 2.0973133359802887e-05
10 O 0 3.3456531127740163e-06
( O 0 1.4447804232986527e-06
- O 0 6.077988291508518e-05
5 O 0 2.7993689855065895e-06
) O 0 4.6465851255561574e-07
) O 0 2.86429525431231e-07
and O 0 4.5346203592089296e-07
suggestive O 0 8.088620234047994e-06
evidence O 0 7.020282168923586e-07
for O 0 5.360620889405254e-07
a O 0 6.655316610704176e-06
locus O 0 6.896973354741931e-05
on O 0 4.1353574488312006e-05
chromosome O 0 0.3627341389656067
4q O 1 0.9761263132095337
at O 0 9.621410572435707e-05
D4S397 O 0 0.00015176723536569625
( O 0 2.3391619379253825e-06
maximum O 0 1.0717012628447264e-05
GENEHUNTER O 0 0.0010195838985964656
- O 0 7.236425153678283e-05
PLUS O 0 1.4347611795528792e-05
nonparametric O 0 3.865240796585567e-05
linkage O 0 3.930677121388726e-05
score O 0 3.797617318923585e-05
= O 0 0.00012219580821692944
3 O 0 3.1912272788758855e-06
. O 0 9.207248012899072e-07
29 O 0 1.2852160580223426e-05
, O 0 1.9700880784512265e-06
P O 0 0.0006167248939163983
= O 0 1.599453935341444e-05
2 O 0 1.1736332226064405e-06
. O 0 3.762015694519505e-07
57 O 0 2.428857442282606e-06
x O 0 1.2187467291369103e-05
10 O 0 1.7706540802464588e-06
( O 0 1.0038467053163913e-06
- O 0 2.5665032808319665e-05
3 O 0 4.1802368286880665e-06
) O 0 7.831503694433195e-07
; O 0 1.2434861673682462e-06
SIBPAL O 0 8.292891288874671e-05
Pempirical O 0 4.056427496834658e-05
value O 0 9.58375153459201e-07
< O 0 6.364834916894324e-06
1 O 0 1.5010435845397296e-06
x O 0 2.558072992542293e-05
10 O 0 3.074885398746119e-06
( O 0 1.0914706081166514e-06
- O 0 5.8648893173085526e-05
3 O 0 5.129020792082883e-06
) O 0 6.118944497757184e-07
) O 0 3.7803428654115123e-07
that O 0 3.1974371950127534e-07
are O 0 5.69092151181394e-07
linked O 0 5.520207196241245e-05
to O 0 2.3935328499646857e-05
mental O 1 0.9462628364562988
health O 0 0.00690228259190917
wellness O 0 0.2654598355293274
. O 0 0.00010203874990111217

These O 0 6.914016557857394e-05
findings O 0 3.81952959287446e-05
are O 0 4.1622206481406465e-06
consistent O 0 4.452464963833336e-06
with O 0 9.089571904041804e-07
the O 0 1.5958255517034559e-06
hypothesis O 0 2.591453721834114e-06
that O 0 4.5774791601616016e-07
certain O 0 5.187725378164032e-07
alleles O 0 6.094849140936276e-06
could O 0 5.477299509948352e-06
prevent O 0 1.3210471479396801e-05
or O 0 2.2289045773504768e-06
modify O 0 6.076671525079291e-06
the O 0 2.537310820116545e-06
clinical O 0 3.436893530306406e-05
manifestations O 0 1.3143568139639683e-05
of O 0 3.455738124102936e-06
BPAD B-Disease 1 0.9999984502792358
and O 0 3.3895117667270824e-05
perhaps O 0 2.7921014407183975e-05
other O 0 6.605018370464677e-06
related O 0 0.001030574319884181
affective B-Disease 1 0.9997965693473816
disorders I-Disease 1 0.9997747540473938
. O 0 0.000278437917586416

Segregation O 0 0.02208658866584301
distortion O 0 0.06777298450469971
in O 0 0.02614470012485981
myotonic B-Disease 1 0.9999978542327881
dystrophy I-Disease 1 0.9999990463256836
. O 0 0.005923730321228504

Myotonic B-Disease 1 0.9999998807907104
dystrophy I-Disease 1 1.0
( O 1 0.9985278844833374
DM B-Disease 1 1.0
) O 0 0.00026659350260160863
is O 0 1.6346295524272136e-05
an O 0 4.359504237072542e-05
autosomal B-Disease 1 0.8352363705635071
dominant I-Disease 1 0.8906891345977783
disease I-Disease 1 0.7910750508308411
which O 0 8.390243237954564e-06
, O 0 2.3646011868549976e-06
in O 0 1.0740531024566735e-06
the O 0 2.1544465198530816e-06
typical O 0 1.768224137776997e-05
pedigree O 0 0.0004674137744586915
, O 0 1.131809881371737e-06
shows O 0 1.1281061915724422e-06
a O 0 1.6994213183352258e-06
three O 0 2.613814558571903e-06
generation O 0 2.7092364689451642e-05
anticipation O 0 6.828194455010816e-05
cascade O 0 0.00034224806586280465
. O 0 4.915735189570114e-05

This O 0 7.312412344617769e-05
results O 0 0.00015659602649975568
in O 0 0.00018982833717018366
infertility B-Disease 1 0.9998912811279297
and O 1 0.9889214038848877
congenital B-Disease 1 1.0
myotonic I-Disease 1 1.0
dystrophy I-Disease 1 1.0
( O 0 0.004433756694197655
CDM B-Disease 0 0.3586839437484741
) O 0 2.228810899396194e-06
with O 0 9.522211144030734e-07
the O 0 1.9523520222719526e-06
disappearance O 0 8.016233914531767e-05
of O 0 1.552305548102595e-05
DM B-Disease 1 0.9999979734420776
in O 0 2.291801865794696e-05
that O 0 2.4549026420572773e-05
pedigree O 0 0.021091792732477188
. O 0 0.0001243739970959723

The O 0 3.152433055220172e-05
concept O 0 2.3719554519630037e-05
of O 0 4.792895651917206e-06
segregation O 0 6.918086000951007e-05
distortion O 0 9.727528231451288e-05
, O 0 3.206272594979964e-06
where O 0 1.8295004338142462e-06
there O 0 5.974156351840065e-07
is O 0 3.6588036778084643e-07
preferential O 0 3.918111360690091e-06
transmission O 0 1.3010539987590164e-05
of O 0 6.1751637758789e-07
the O 0 1.5185590882538236e-06
larger O 0 3.656571152532706e-06
allele O 0 1.5787514712428674e-05
at O 0 2.1053450836916454e-05
the O 0 1.6739995771786198e-05
DM B-Disease 1 0.9999707937240601
locus O 0 0.00013581964594777673
, O 0 4.840695964958286e-06
has O 0 2.68565736405435e-06
been O 0 2.217975861640298e-06
put O 0 1.365370167150104e-06
forward O 0 1.7301582602158305e-06
to O 0 1.2116761354263872e-06
explain O 0 8.912353223422542e-06
partially O 0 4.84127267554868e-05
the O 0 2.0304751160438173e-06
maintenance O 0 0.00011577396799111739
of O 0 7.048968200251693e-06
DM B-Disease 1 0.9999980926513672
in O 0 1.0815856512635946e-05
the O 0 1.6091584257083014e-05
population O 0 2.700311415537726e-05
. O 0 6.421076250262558e-05

In O 0 0.00017452020256314427
a O 0 5.901390250073746e-05
survey O 0 7.031666609691456e-05
of O 0 1.2332822734606452e-05
DM B-Disease 1 0.9998244643211365
in O 0 1.2911988960695453e-05
Northern O 0 1.1907214684470091e-05
Ireland O 0 1.9882925698766485e-05
, O 0 7.78032608650392e-06
59 O 0 6.237727211555466e-05
pedigrees O 0 0.00013251144264359027
were O 0 5.7741777709452435e-05
ascertained O 0 0.0004492572043091059
. O 0 6.428287451853976e-05

Sibships O 0 0.007164225913584232
where O 0 4.6771889174124226e-05
the O 0 4.17487808590522e-06
status O 0 1.8756775261863368e-06
of O 0 4.119969787552691e-07
all O 0 3.545328013387916e-07
the O 0 8.118660161926528e-07
members O 0 2.1856603780179285e-06
had O 0 2.8444168492569588e-05
been O 0 5.552332368097268e-06
identified O 0 4.4067492126487195e-06
were O 0 2.6556167540547904e-06
examined O 0 6.414484687411459e-06
to O 0 8.068058718890825e-07
determine O 0 2.666442696863669e-06
the O 0 7.610893248966022e-07
transmission O 0 1.2476313713705167e-05
of O 0 9.306376114182058e-07
the O 0 1.5525556591455825e-05
DM B-Disease 1 0.9999661445617676
expansion O 0 1.1487462870718446e-05
from O 0 4.537057066045236e-06
affected O 0 1.2759906894643791e-05
parents O 0 1.0829222446773201e-05
to O 0 3.276180677858065e-06
their O 0 3.2716929126763716e-05
offspring O 0 0.00032298415317200124
. O 0 3.841531361103989e-05

Where O 0 0.000221657392103225
the O 0 5.658921872964129e-05
transmitting O 0 0.015370362438261509
parent O 0 0.0005016091745346785
was O 0 7.164814451243728e-05
male O 0 4.1392868297407404e-05
, O 0 1.043014071910875e-05
58 O 0 0.00010307518095942214
. O 0 4.7177243686746806e-05

3 O 0 0.00020428377320058644
% O 0 1.1673448170768097e-05
of O 0 1.8002987189902342e-06
the O 0 3.8231905818975065e-06
offspring O 0 3.9223155908985063e-05
were O 0 1.3886972737964243e-05
affected O 0 6.792635304009309e-06
, O 0 9.73347709987138e-07
and O 0 7.227142759802518e-07
in O 0 5.964677143310837e-07
the O 0 8.118489631669945e-07
case O 0 6.429647214645229e-07
of O 0 3.4159330652983044e-07
a O 0 7.706501492066309e-06
female O 0 0.00010865584044950083
transmitting O 0 0.11680925637483597
parent O 0 0.00018580540199764073
, O 0 7.792757060087752e-06
68 O 0 9.369548934046179e-05
. O 0 4.870129487244412e-05

7 O 0 0.001404344686307013
% O 0 0.00018340014503337443
were O 0 9.714940097182989e-05
affected O 0 0.0003080639289692044
. O 0 0.00013141844829078764

Studies O 0 0.0002579296997282654
on O 0 7.521785300923511e-05
meiotic O 0 0.0005083578289486468
drive O 0 0.0002893053460866213
in O 0 8.452175825368613e-05
DM B-Disease 1 0.9999927282333374
have O 0 1.564295234857127e-05
shown O 0 3.15161901198735e-06
increased O 0 2.899578703363659e-06
transmission O 0 1.1958423783653416e-05
of O 0 3.90998252441932e-07
the O 0 9.160426088783424e-07
larger O 0 3.0019293717487017e-06
allele O 0 1.0356317943660542e-05
at O 0 6.3315010265796445e-06
the O 0 9.217613296641503e-06
DM B-Disease 1 0.9998611211776733
locus O 0 8.414145850110799e-05
in O 0 1.0549423677730374e-05
non O 0 0.00012082048488082364
- O 1 0.9887143969535828
DM O 1 0.9999977350234985
heterozygotes O 0 0.0006143325590528548
for O 0 2.2707839889335446e-05
CTGn O 0 0.009594121016561985
. O 0 0.00010566266428213567

This O 0 4.271446232451126e-05
study O 0 1.9511197024257854e-05
provides O 0 7.146424195525469e-06
further O 0 3.0047681320866104e-06
evidence O 0 1.9507606339175254e-06
that O 0 1.1545422466952004e-06
the O 0 5.561139460041886e-06
DM B-Disease 1 0.999085545539856
expansion O 0 1.2117398000555113e-05
tends O 0 7.272752554854378e-06
to O 0 1.839849687712558e-06
be O 0 4.170345619058935e-06
transmitted O 0 4.479904237086885e-05
preferentially O 0 9.252588642993942e-05
. O 0 5.581680670729838e-05

Diagnosis O 1 0.9995265007019043
of O 0 0.006124969571828842
hemochromatosis B-Disease 1 0.9999995231628418
. O 0 0.002459464594721794

If O 0 0.006083729676902294
untreated O 1 0.9986206293106079
, O 0 0.03564555570483208
hemochromatosis B-Disease 1 1.0
can O 0 0.002884983317926526
cause O 0 0.031758781522512436
serious O 0 0.3826485872268677
illness O 1 0.9622494578361511
and O 0 1.9596473066485487e-05
early B-Disease 0 8.800542127573863e-05
death I-Disease 0 0.012419999577105045
, O 0 6.342240340018179e-06
but O 0 3.3012083804351278e-06
the O 0 2.3905717171146534e-05
disease O 0 0.08043278008699417
is O 0 4.733628429676173e-06
still O 0 1.6136102203745395e-05
substantially O 0 7.284551247721538e-05
under O 0 0.00028234938508830965
- O 1 0.9978938698768616
diagnosed O 1 0.9978085160255432
. O 0 7.291320798685774e-05

The O 0 8.034073835005984e-05
cornerstone O 0 0.00011666520003927872
of O 0 4.362917024991475e-06
screening O 0 1.9615134078776464e-05
and O 0 5.7513589126756415e-06
case O 0 3.837337771983584e-06
detection O 0 1.120096021622885e-05
is O 0 6.499341793642088e-07
the O 0 5.573657517743413e-07
measurement O 0 6.865949217171874e-06
of O 0 1.6453191165055614e-06
serum O 0 0.00027865011361427605
transferrin O 0 8.820723451208323e-05
saturation O 0 2.0703228074125946e-05
and O 0 3.3468145375081804e-06
the O 0 6.645435405516764e-06
serum O 0 0.000519092078320682
ferritin O 0 0.0009130507241934538
level O 0 0.0001136278806370683
. O 0 7.559148798463866e-05

Once O 0 0.0007682511932216585
the O 0 5.9903686633333564e-05
diagnosis O 1 0.9258070588111877
is O 0 1.4736605407961179e-05
suspected O 0 0.0003149435215163976
, O 0 6.2334952417586464e-06
physicians O 0 2.5389388611074537e-05
must O 0 2.975323241116712e-06
use O 0 4.623873337550322e-06
serum O 0 0.000642157974652946
ferritin O 0 0.001199479796923697
levels O 0 2.8553260563057847e-05
and O 0 1.4681492757517844e-05
hepatic O 0 0.0144381457939744
iron O 0 0.1242094412446022
stores O 0 0.00011097735114162788
on O 0 9.342542762169614e-05
liver O 1 0.8708432912826538
biopsy O 1 0.9042838215827942
specimens O 0 1.6888478057808243e-05
to O 0 4.27680924985907e-06
assess O 0 0.002122919773682952
patients O 0 7.421488407999277e-05
for O 0 5.615787017632101e-07
the O 0 1.6793836721262778e-06
presence O 0 4.243470357323531e-06
of O 0 6.959694019315066e-06
iron B-Disease 1 0.9806535840034485
overload I-Disease 1 0.8222947120666504
. O 0 0.00010039766493719071

Liver O 1 0.9999281167984009
biopsy O 1 0.9996304512023926
is O 0 7.626949809491634e-05
also O 0 8.300175977637991e-06
used O 0 2.3051115931593813e-06
to O 0 7.188867812146782e-07
establish O 0 3.898933755408507e-06
the O 0 1.0841082485057996e-06
presence O 0 1.7655180499787093e-06
or O 0 1.3585654414782766e-06
absence O 0 4.918018476018915e-06
of O 0 4.804652235179674e-06
cirrhosis B-Disease 1 0.9816958904266357
, O 0 1.0953696801152546e-05
which O 0 7.129004643502412e-06
can O 0 1.1709351383615285e-05
affect O 0 0.00010213375935563818
prognosis O 1 0.8513274788856506
and O 0 7.993982580956072e-05
management O 0 0.001339826500043273
. O 0 5.040943142375909e-05

A O 0 0.0005213626427575946
DNA O 0 0.00030041663558222353
- O 0 0.00028046491206623614
based O 0 5.81692847845261e-06
test O 0 5.516416422324255e-06
for O 0 9.964755918190349e-07
the O 0 2.9364393867581384e-06
HFE O 0 0.0015732034808024764
gene O 0 5.3403650781547185e-06
is O 0 1.0623227808537195e-06
commercially O 0 2.263214582853834e-06
available O 0 4.4615768501898856e-07
, O 0 3.1949406320563867e-07
but O 0 1.753964085082771e-07
its O 0 2.446296036850981e-07
place O 0 1.0098335678776493e-06
in O 0 9.579064226272749e-07
the O 0 6.615704023715807e-06
diagnosis O 1 0.5473324060440063
of O 0 5.930081897531636e-05
hemochromatosis B-Disease 1 1.0
is O 0 6.0642090829787776e-05
still O 0 6.894329999340698e-05
being O 0 4.062400694238022e-05
evaluated O 0 0.0001470023562433198
. O 0 4.817867011297494e-05

Currently O 0 0.00015569735842291266
, O 0 1.1500332220748533e-05
the O 0 3.2163757168746088e-06
most O 0 8.510093607583258e-07
useful O 0 1.049052571033826e-06
role O 0 1.1122489240733557e-06
for O 0 4.009283713912737e-07
this O 0 6.012347171235888e-07
test O 0 8.396085831918754e-06
is O 0 5.384254677665012e-07
in O 0 3.9278472740988946e-07
the O 0 8.344975412910571e-07
detection O 0 1.047495607053861e-05
of O 0 5.3183880481810775e-06
hemochromatosis B-Disease 1 0.9999992847442627
in O 0 1.5449813872692175e-05
the O 0 8.142688784573693e-06
family O 0 1.7343880244879983e-05
members O 0 9.403046874467691e-07
of O 0 1.5886354276517523e-06
patients O 0 0.000331733375787735
with O 0 2.742131755439914e-06
a O 0 0.00014707625086884946
proven O 0 0.0011083637364208698
case O 0 2.5608378564356826e-06
of O 0 2.4278963337565074e-06
the O 0 0.0002484946162439883
disease O 1 0.6519511342048645
. O 0 7.903765799710527e-05

It O 0 0.0001398276654072106
is O 0 3.11728217639029e-05
crucial O 0 8.66854315972887e-05
to O 0 0.0001955338811967522
diagnose O 1 0.9999967813491821
hemochromatosis B-Disease 1 1.0
before O 1 0.9795420169830322
hepatic B-Disease 1 0.9999773502349854
cirrhosis I-Disease 1 0.999994158744812
develops O 0 0.28663814067840576
because O 0 0.00034621034865267575
phlebotomy O 1 0.9351477026939392
therapy O 1 0.6226060390472412
can O 0 0.0008380820509046316
avert O 1 0.9998143315315247
serious O 1 0.9999804496765137
chronic O 1 1.0
disease O 1 0.9995294809341431
and O 0 0.0002701665216591209
can O 0 1.6341509763151407e-05
even O 0 8.004983101272956e-06
lead O 0 1.0278843546984717e-05
to O 0 3.6074802665098105e-06
normal O 0 4.0385755710303783e-05
life O 0 3.373040453880094e-05
expectancy O 0 0.000102440026239492
. O 0 8.616678314865567e-06
. O 0 3.1584877433488145e-05

Prevalence O 0 0.0021091520320624113
of O 0 3.881873999489471e-05
the O 0 3.138760439469479e-05
I1307K O 0 0.0012152412673458457
APC B-Disease 0 0.00023150004562921822
gene O 0 1.6932197468122467e-05
variant O 0 1.69477061717771e-05
in O 0 1.8621602748680743e-06
Israeli O 0 6.60234218230471e-06
Jews O 0 2.220822580056847e-06
of O 0 5.58899785119138e-07
differing O 0 2.9537686714320444e-06
ethnic O 0 1.6394158137700288e-06
origin O 0 4.01121360482648e-06
and O 0 2.2300901036942378e-05
risk O 0 0.11663447320461273
for O 0 0.4132980704307556
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 0.0012076193233951926

BACKGROUND O 0 0.002034815028309822
& O 0 0.0014932060148566961
AIMS O 0 0.00010500455391593277
Israeli O 0 2.814042272802908e-05
Jews O 0 7.814069249434397e-06
of O 0 1.2922737369081005e-06
European O 0 6.547089924424654e-06
birth O 0 0.0027607528027147055
, O 0 6.9952266130712815e-06
i O 0 1.8275810361956246e-05
. O 0 3.14895544306637e-07
e O 0 2.7373371267458424e-06
. O 0 2.5527469915687107e-07
, O 0 4.952334506924672e-07
Ashkenazim O 0 6.010059678374091e-06
, O 0 1.0676468491510605e-06
have O 0 1.345035570921027e-06
the O 0 1.4407351955014747e-05
highest O 1 0.9989363551139832
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
incidence O 0 0.17783008515834808
of O 0 4.637572601495776e-06
any O 0 5.905410489503993e-06
Israeli O 0 0.00019061221973970532
ethnic O 0 3.3488035114714876e-05
group O 0 0.00021896279940847307
. O 0 6.015057806507684e-05

The O 0 0.0002288328396389261
I1307K O 0 0.0011524974834173918
APC B-Disease 0 0.0003176205209456384
gene O 0 5.6874927395256236e-05
variant O 0 4.447705941856839e-05
was O 0 7.53050553612411e-05
found O 0 1.869724837888498e-05
in O 0 1.9017035810975358e-05
6 O 0 0.00024117321299854666
. O 0 6.035685510141775e-05

1 O 0 9.326485451310873e-05
% O 0 1.0478393960511312e-05
of O 0 1.8001887838181574e-06
American O 0 2.274572125315899e-06
Jews O 0 2.9887746677559335e-06
, O 0 1.167918981082039e-06
28 O 0 4.7345047278213315e-06
% O 0 4.985272425983567e-07
of O 0 5.506180400516314e-07
their O 0 0.007338236086070538
familial O 1 0.9999970197677612
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
cases O 0 0.00038311953539960086
, O 0 2.4211301933974028e-05
but O 0 5.2574109759007115e-06
not O 0 1.2893428902316373e-06
in O 0 3.3695530419208808e-06
non O 0 1.610970139154233e-05
- O 0 0.001813542447052896
Jews O 0 6.68200445943512e-05
. O 0 6.056383790564723e-05

We O 0 0.00019579152285587043
assessed O 0 0.00010791426757350564
the O 0 1.0275922250002623e-05
I1307K O 0 0.00041918648639693856
prevalence O 0 9.584031067788601e-05
in O 0 3.164285772072617e-06
Israeli O 0 1.0680617378966417e-05
Jews O 0 1.8920388811238809e-06
of O 0 4.7247482370949e-07
differing O 0 2.084730795104406e-06
ethnic O 0 1.6184520745810005e-06
origin O 0 6.0051838772778865e-06
and O 0 4.3781186832347885e-05
risk O 0 0.06637661904096603
for O 0 0.09300372749567032
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 0.0009815257508307695

METHODS O 0 0.00033692485885694623
DNA O 0 9.543192572891712e-05
samples O 0 1.8740214727586135e-05
from O 0 3.679760766317486e-06
500 O 0 4.456152510101674e-06
unrelated O 0 4.198570877633756e-06
Jews O 0 1.3119222330715274e-06
of O 0 5.046062483415881e-07
European O 0 4.032739525428042e-06
or O 0 2.6344432626501657e-06
non O 0 4.2827928155020345e-06
- O 0 2.381829108344391e-05
European O 0 1.1074583881054423e-06
origin O 0 1.018002990349487e-06
, O 0 8.078167752501031e-07
with O 0 1.101158431993099e-06
or O 0 1.696487061053631e-06
without O 0 1.7722658185448381e-06
a O 0 1.5663928252251935e-06
personal O 0 1.3706048775929958e-05
and O 0 9.41712369240122e-06
/ O 0 4.7633922804379836e-05
or O 0 1.978379714273615e-06
family O 0 4.2408973968122154e-06
history O 0 1.1848998155983281e-06
of O 0 1.6152955595316598e-06
neoplasia B-Disease 0 0.11749385297298431
, O 0 4.436527888174169e-06
were O 0 8.220510608225595e-06
examined O 0 1.9677974705700763e-05
for O 0 9.97222855403379e-07
the O 0 3.392982989680604e-06
I1307K O 0 9.268165013054386e-05
variant O 0 7.3096680353046395e-06
by O 0 9.265524454349361e-07
the O 0 1.1985697483396507e-06
allele O 0 1.2856523426307831e-05
- O 0 4.5965709432493895e-05
specific O 0 3.0720482300239382e-06
oligonucleotide O 0 8.900959801394492e-05
( O 0 6.612625838897657e-06
ASO O 0 0.03464873135089874
) O 0 9.667934136814438e-06
method O 0 3.6480414564721286e-05
. O 0 5.409938603406772e-05

RESULTS O 0 0.0011106536258012056
In O 0 3.887635102728382e-05
persons O 0 2.6733720005722716e-05
at O 0 9.539317397866398e-05
average O 0 0.003739622887223959
risk O 0 0.028828848153352737
for O 0 0.05592380836606026
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
, O 0 0.00046177158947102726
I1307K O 0 0.09355983883142471
was O 0 0.0002869974123314023
found O 0 1.1305884981993586e-05
in O 0 7.763663234072737e-06
5 O 0 5.764835077570751e-05
. O 0 4.7998899390222505e-05

0 O 0 0.0005505247390829027
% O 0 2.5695913791423663e-05
of O 0 5.053048880654387e-06
120 O 0 1.1632874702627305e-05
European O 0 9.153352038993035e-06
and O 0 1.1054671631427482e-05
1 O 0 3.9183676562970504e-05
. O 0 4.233037179801613e-05

6 O 0 0.00038742777542211115
% O 0 1.845385122578591e-05
of O 0 4.626034751709085e-06
188 O 0 1.8778589947032742e-05
non O 0 8.776474714977667e-06
- O 0 1.775745658960659e-05
European O 0 3.097530907325563e-06
Jews O 0 6.880224646010902e-06
( O 0 3.411340230741189e-06
P O 0 0.0029682975728064775
= O 0 4.7090630687307566e-05
0 O 0 7.638767783646472e-06
. O 0 2.8342717541818274e-06
08 O 0 5.906918158871122e-05
) O 0 1.1860534868901595e-05
. O 0 2.4912194930948317e-05

It O 0 0.0001227114407811314
occurred O 0 0.00015914603136479855
in O 0 4.440585689735599e-05
15 O 0 0.00011759714834624901
. O 0 6.029483847669326e-05

4 O 0 0.0002621218445710838
% O 0 2.2109470592113212e-05
of O 0 4.574189915729221e-06
52 O 0 2.886840229621157e-05
Ashkenazi O 0 7.099853974068537e-05
Israelis O 0 5.768987102783285e-05
with O 0 7.091234874678776e-05
familial O 1 0.998473584651947
cancer B-Disease 1 0.9934840798377991
( O 0 3.085705975536257e-05
P O 1 0.6884133219718933
= O 0 0.0005752797005698085
0 O 0 1.4959681720938534e-05
. O 0 1.2708140957329306e-06
02 O 0 8.746820822125301e-05
) O 0 5.022977802582318e-07
and O 0 9.73490614342154e-07
was O 0 2.5596809791750275e-05
not O 0 9.314287581219105e-07
detected O 0 5.05247044202406e-06
in O 0 9.925178119374323e-07
51 O 0 8.697237717569806e-06
non O 0 1.6891448240130558e-06
- O 0 6.351579486363335e-06
European O 0 1.068705159923411e-06
Jews O 0 3.479269935269258e-06
at O 0 3.880863368976861e-05
increased O 0 0.001050857244990766
cancer B-Disease 1 0.8204593062400818
risk O 0 0.0006547789671458304
. O 0 4.4592408812604845e-05

Colorectal B-Disease 1 0.9998013377189636
neoplasia I-Disease 1 0.9987240433692932
occurred O 0 0.030376305803656578
personally O 0 0.009027392603456974
or O 0 1.4091338925936725e-05
in O 0 3.2548389299336122e-06
the O 0 2.785669721561135e-06
families O 0 3.914895387424622e-06
of O 0 6.4169296365435e-07
13 O 0 6.185251550050452e-06
of O 0 9.348575531475944e-07
20 O 0 1.2100746062060352e-05
Ashkenazi O 0 5.9536934713833034e-05
I1307K O 0 9.959905582945794e-05
carriers O 0 1.1745171832444612e-05
, O 0 1.4853071661491413e-06
8 O 0 1.9086412521573948e-06
of O 0 6.258437679207418e-07
whom O 0 1.465154764446197e-05
also O 0 4.474130037124269e-06
had O 0 2.0126410163356923e-05
a O 0 4.728020485345041e-06
personal O 0 2.159830546588637e-05
or O 0 7.737674422969576e-06
family O 0 1.5629128029104322e-05
history O 0 6.646462225035066e-06
of O 0 1.507174783910159e-05
noncolonic O 1 0.8171305060386658
neoplasia B-Disease 1 0.9037042260169983
. O 0 0.00021208424004726112

CONCLUSIONS O 0 0.0007937911432236433
The O 0 8.85384069988504e-05
I1307K O 0 0.0020143266301602125
APC O 0 0.0007644803263247013
variant O 0 0.00022096149041317403
may O 0 2.9005774194956757e-05
represent O 0 2.7550097456696676e-06
a O 0 1.1096383786934894e-05
susceptibility O 0 0.00020302219490986317
gene O 0 2.0692885300377384e-05
for O 0 1.9445458747213706e-05
colorectal B-Disease 1 0.9999977350234985
, I-Disease 0 5.566365871345624e-05
or I-Disease 0 4.954194082529284e-06
other I-Disease 0 1.0256937912345165e-06
, I-Disease 0 1.5995943613233976e-05
cancers I-Disease 0 0.0007441792986355722
in O 0 5.31874320586212e-06
Ashkenazi O 0 8.931270713219419e-05
Jews O 0 5.452927780424943e-06
, O 0 1.6719416180421831e-06
and O 0 4.700197223428404e-06
partially O 0 0.00032544697751291096
explains O 0 3.7178854199737543e-06
the O 0 1.0200398037341074e-06
higher O 0 1.5807927411515266e-05
incidence O 0 0.0026682140305638313
of O 0 0.00808822363615036
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
in O 0 8.468319720122963e-05
European O 0 0.00025630436721257865
Israelis O 0 0.0034601364750415087
. O 0 0.00012037406850140542

Systematic O 0 0.0004318131832405925
analysis O 0 6.630534335272387e-05
of O 0 2.815610059769824e-05
coproporphyrinogen O 0 0.01896757259964943
oxidase O 0 0.0015000004786998034
gene O 0 0.0007839648751541972
defects O 1 0.8681132793426514
in O 0 7.103281677700579e-05
hereditary B-Disease 1 0.9910776615142822
coproporphyria I-Disease 1 0.7732487320899963
and O 0 0.00012486953346524388
mutation O 0 0.0006856611580587924
update O 0 0.0004887405084446073
. O 0 9.593513095751405e-05

Hereditary B-Disease 1 0.9998736381530762
coproporphyria I-Disease 1 0.9986183643341064
( O 0 0.006855370942503214
HC B-Disease 1 0.9996358156204224
) O 0 0.00010824044875334948
is O 0 1.968878677871544e-05
an O 0 0.003338845446705818
acute O 1 0.9999991655349731
hepatic B-Disease 1 0.9999967813491821
porphyria I-Disease 1 0.9999974966049194
with O 0 0.17167875170707703
autosomal O 1 0.9993252754211426
dominant O 0 0.20071697235107422
inheritance O 0 0.05368232727050781
caused O 0 0.008847551420331001
by O 0 1.2466262887755875e-05
deficient B-Disease 0 0.018350722268223763
activity I-Disease 0 3.171850949001964e-06
of I-Disease 0 2.041454990830971e-06
coproporphyrinogen I-Disease 1 0.5221751928329468
III I-Disease 0 0.17160673439502716
oxidase I-Disease 0 0.00024955521803349257
( O 0 1.8365122741670348e-05
CPO O 0 0.0002261213376186788
) O 0 2.312870856258087e-05
. O 0 3.0399314709939063e-05

Clinical O 0 0.0194211658090353
manifestations O 0 0.0006837789551354945
of O 0 3.5044333344558254e-05
the O 0 0.020436560735106468
disease O 1 0.9864523410797119
are O 0 1.9598268409026787e-05
characterized O 0 0.0018838250543922186
by O 0 5.65357695450075e-05
acute O 1 0.9975557327270508
attacks O 0 0.13003991544246674
of O 0 0.008613153360784054
neurological B-Disease 1 0.9999998807907104
dysfunction I-Disease 1 0.9997268319129944
often O 0 0.0003212046576663852
precipitated O 0 0.0058380477130413055
by O 0 5.548844001168618e-06
drugs O 0 1.504842202848522e-05
, O 0 4.545263891486684e-06
fasting O 0 3.68235087080393e-05
, O 0 5.837975095346337e-06
cyclical O 0 0.0008330921991728246
hormonal O 0 0.005198272410780191
changes O 0 9.00192571862135e-06
, O 0 3.3480944694019854e-05
or O 0 0.0034429868683218956
infectious B-Disease 1 0.9931894540786743
diseases I-Disease 1 0.6055196523666382
. O 0 0.00014746790111530572

Skin O 1 0.9999783039093018
photosensitivity O 1 0.9996943473815918
may O 0 0.11595723778009415
also O 0 6.317573570413515e-05
be O 0 1.5026539585960563e-05
present O 0 3.0596940632676706e-05
. O 0 6.545427459059283e-05

The O 0 6.06942230660934e-05
seven O 0 3.811967690126039e-05
exons O 0 5.5584310757694766e-05
, O 0 4.220691607770277e-06
the O 0 3.2685379665053915e-06
exon O 0 4.2917228711303324e-05
/ O 0 1.5034436728456058e-05
intron O 0 5.770010830019601e-05
boundaries O 0 6.5058729887823574e-06
and O 0 9.64788000601402e-07
part O 0 6.685601761091675e-07
of O 0 4.2742507844195643e-07
3 O 0 1.8095212226398871e-06
noncoding O 0 6.649555871263146e-06
sequence O 0 9.200998078995326e-07
of O 0 4.0148779589799233e-07
the O 0 1.4496192761725979e-06
CPO O 0 5.454691199702211e-05
gene O 0 3.6717333387059625e-06
were O 0 3.859637672576355e-06
systematically O 0 1.7316113371634856e-05
analyzed O 0 3.572180730770924e-06
by O 0 4.1840269204840297e-07
an O 0 1.035090008372208e-06
exon O 0 1.3659870091942139e-05
- O 0 1.8099724911735393e-05
by O 0 1.6187963183256215e-06
- O 0 5.6882632634369656e-05
exon O 0 6.582923379028216e-05
denaturing O 0 0.00042301061330363154
gradient O 0 0.0003016314876731485
gel O 0 0.008746768347918987
electrophoresis O 0 0.0006542762275785208
( O 0 7.718681445112452e-06
DGGE O 0 0.0010554605396464467
) O 0 1.1875322343257722e-06
strategy O 0 1.7345164451398887e-06
followed O 0 8.747661581764987e-07
by O 0 4.1797835592660704e-07
direct O 0 7.857027526370075e-07
sequencing O 0 6.254873824218521e-06
in O 0 3.2962598197627813e-06
seven O 0 2.0662460883613676e-05
unrelated O 0 7.181950059020892e-05
heterozygous O 0 0.001779078971594572
HC B-Disease 1 0.9943253397941589
patients O 0 0.019801564514636993
from O 0 7.196356818894856e-06
France O 0 7.828738307580352e-05
, O 0 1.142325891123619e-05
Holland O 0 0.00037163440720178187
, O 0 2.4906232738430845e-06
and O 0 3.1012225463200593e-06
Czech O 0 4.654021540773101e-05
Republic O 0 3.626190664363094e-05
. O 0 5.3413950809044763e-05

Seven O 0 0.0002147719933418557
novel O 0 8.385709952563047e-05
mutations O 0 3.5938850487582386e-05
and O 0 3.4135207442886895e-06
two O 0 1.9914848508051364e-06
new O 0 8.535169399692677e-06
polymorphisms O 0 0.0001141334796557203
were O 0 5.013114423491061e-05
detected O 0 0.00027902916190214455
. O 0 4.80019225506112e-05

Among O 0 9.266734559787437e-05
these O 0 1.3445735930872615e-05
mutations O 0 2.9130296752555296e-05
two O 0 2.3810907805454917e-06
are O 0 2.1921482584730256e-06
missense O 0 4.809627353097312e-05
( O 0 3.409259079489857e-06
G197W O 0 0.0001495696051279083
, O 0 3.206624342055875e-06
W427R O 0 0.00010592959733912721
) O 0 9.784870371731813e-07
, O 0 4.3597873400358367e-07
two O 0 5.245448733148805e-07
are O 0 1.1298773188173072e-06
nonsense O 0 1.2310753845667932e-05
( O 0 7.956575700518442e-07
Q306X O 0 2.9037018975941464e-05
, O 0 1.329731958321645e-06
Q385X O 0 4.5877470256527886e-05
) O 0 6.826682579230692e-07
, O 0 4.2121800447603164e-07
two O 0 3.6950751791664516e-07
are O 0 4.6768963102294947e-07
small O 0 1.3256724287202815e-06
deletions O 0 2.010458047152497e-05
( O 0 2.8761087378370576e-06
662de14bp O 0 0.00010086547263199463
; O 0 3.1853103337198263e-06
1168del3bp O 0 9.173939906759188e-05
removing O 0 7.63959815230919e-06
a O 0 3.0984349450591253e-06
glycine O 0 2.604277506179642e-05
at O 0 1.938513378263451e-05
position O 0 1.1991221981588751e-05
390 O 0 1.4695795471197926e-05
) O 0 1.095755123969866e-06
, O 0 5.953873483122152e-07
and O 0 6.650163300037093e-07
one O 0 7.046501764307322e-07
is O 0 5.99512475218944e-07
a O 0 2.0259199118299875e-06
splicing O 0 2.63916499534389e-05
mutation O 0 1.4162348634272348e-05
( O 0 2.599540493974928e-06
IVS1 O 0 0.00010706700413720682
- O 0 6.45335967419669e-05
15c O 0 0.00013797578867524862
- O 0 0.000284880050458014
- O 0 0.002148845000192523
> O 0 0.0001200464612338692
g O 0 0.0004558794025797397
) O 0 1.265548235096503e-06
which O 0 6.895490400893323e-07
creates O 0 1.8424009340378689e-06
a O 0 1.4015263332112227e-06
new O 0 3.1920947094477015e-06
acceptor O 0 5.7231947721447796e-05
splice O 0 0.0004712185764219612
site O 0 0.00012856257671955973
. O 0 9.755034261615947e-05

The O 0 8.584071474615484e-05
pathological O 0 0.00018477768753655255
significance O 0 1.7320027836831287e-05
of O 0 3.5088999084109673e-06
the O 0 5.797445737698581e-06
point O 0 1.4166293112793937e-05
mutations O 0 2.0020739611936733e-05
G197W O 0 5.299405165715143e-05
, O 0 2.1047294467280153e-06
W427R O 0 3.126738374703564e-05
, O 0 8.153336352734186e-07
and O 0 5.48221407825622e-07
the O 0 7.172494065343926e-07
in O 0 2.160069016099442e-06
- O 0 0.00037518885801546276
frame O 0 0.0005271768313832581
deletion O 0 0.00010282405855832621
390delGly O 0 0.00029539247043430805
were O 0 7.5844127422897145e-06
assessed O 0 2.702240635699127e-06
by O 0 3.141405784390372e-07
their O 0 6.178992748573364e-07
respective O 0 1.8102048215951072e-06
expression O 0 1.3341256135390722e-06
in O 0 1.0112607924384065e-06
a O 0 4.380674454296241e-06
prokaryotic O 0 8.960488230513874e-06
system O 0 4.205423465464264e-06
using O 0 4.576729224936571e-06
site O 0 2.9569553589681163e-05
- O 0 0.00010756207484519109
directed O 0 4.390403046272695e-05
mutagenesis O 0 0.000335534947225824
. O 0 6.06490284553729e-05

These O 0 6.184384983498603e-05
mutations O 0 0.00012195041927043349
resulted O 0 2.100423807860352e-05
in O 0 4.088900368515169e-06
the O 0 3.2811799428600352e-06
absence O 0 1.962085661944002e-05
or O 0 1.7067269482140546e-06
a O 0 3.1143670184974326e-06
dramatic O 0 1.4165861102810595e-05
decrease O 0 1.3524531823350117e-05
of O 0 2.6657919534045504e-06
CPO O 0 0.00038341034087352455
activity O 0 3.6028854083269835e-05
. O 0 3.498730075079948e-05

The O 0 5.248033266980201e-05
two O 0 2.511016464268323e-05
polymorphisms O 0 0.00017791282152757049
were O 0 1.5642161088180728e-05
localized O 0 2.739571573329158e-05
in O 0 3.247289214414195e-06
noncoding O 0 2.234209023299627e-05
part O 0 1.446520400349982e-06
of O 0 4.219316735998291e-07
the O 0 2.1901255422562826e-06
gene O 0 4.424553480930626e-06
1 O 0 1.6732544736441923e-06
) O 0 4.261588628651225e-07
a O 0 2.8560734790517017e-06
C O 0 0.000292384676868096
/ O 0 2.09669324249262e-05
G O 0 0.00027107782079838216
polymorphism O 0 1.3024170584685635e-05
in O 0 3.251376710977638e-06
the O 0 3.171603111695731e-06
promotor O 0 0.00021065895271021873
region O 0 7.337499937420944e-06
, O 0 2.4467958610330243e-06
142 O 0 1.1130011444038246e-05
bp O 0 4.438155883690342e-05
upstream O 0 2.6391303435957525e-06
from O 0 4.982852601642662e-07
the O 0 5.395145876718743e-07
transcriptional O 0 6.276797648752108e-06
initiation O 0 2.8549297894642223e-06
site O 0 6.302715974015882e-06
( O 0 9.297699534727144e-07
- O 0 5.076506204204634e-05
142C O 0 0.00013819464948028326
/ O 0 3.124711656710133e-05
G O 0 0.0038194290827959776
) O 0 7.691551218158565e-07
, O 0 6.807374006712053e-07
and O 0 8.864274150255369e-07
2 O 0 1.6508500948475557e-06
) O 0 3.8985291439530556e-07
a O 0 1.545818804515875e-06
6 O 0 6.8965432546974625e-06
bp O 0 3.744791683857329e-05
deletion O 0 1.0191599358222447e-05
polymorphism O 0 6.116556505730841e-06
in O 0 1.2285152024560375e-06
the O 0 1.3108791563354316e-06
3 O 0 2.815408834067057e-06
noncoding O 0 6.299464985204395e-06
part O 0 7.442865808116039e-07
of O 0 4.990714046471112e-07
the O 0 2.4262712940981146e-06
CPO O 0 5.287381281959824e-05
gene O 0 5.274188879411668e-06
, O 0 1.6287719972751802e-06
574 O 0 1.488637371949153e-05
bp O 0 2.156496157112997e-05
downstream O 0 2.463078999426216e-06
of O 0 3.699179558225296e-07
the O 0 6.478505838458659e-07
last O 0 1.8444595752953319e-06
base O 0 2.5519491373415804e-06
of O 0 3.143665310290089e-07
the O 0 1.7353719385937438e-06
normal O 0 1.2506763596320525e-05
termination O 0 4.641748091671616e-05
codon O 0 3.580447082640603e-05
( O 0 9.710847734822892e-06
+ O 0 4.938683923683129e-05
574 O 0 0.00010139567166334018
delATTCTT O 0 0.0002318693877896294
) O 0 2.6867850465350784e-05
. O 0 4.825205178349279e-05

Five O 0 0.00037042226176708937
intragenic O 0 0.004742795135825872
dimorphisms O 0 0.003145599504932761
are O 0 7.625520993315149e-06
now O 0 7.363794793491252e-06
well O 0 3.209855321983923e-06
characterized O 0 1.0281961294822395e-05
and O 0 1.4555137113347882e-06
the O 0 1.1658135008474346e-06
high O 0 1.1794334568548948e-05
degree O 0 6.559525900229346e-06
of O 0 1.0173877171837375e-06
allelic O 0 8.044253627303988e-05
heterogeneity O 0 0.00012527107901405543
in O 0 5.640899689751677e-05
HC B-Disease 1 0.9845595955848694
is O 0 8.95835182745941e-06
demonstrated O 0 1.7432228560210206e-05
with O 0 1.0482424386282219e-06
seven O 0 1.296786194870947e-06
new O 0 9.85459905677999e-07
different O 0 5.387104806686693e-07
mutations O 0 3.706171128214919e-06
making O 0 6.174433337946539e-07
a O 0 8.454390467704798e-07
total O 0 8.298208626911219e-07
of O 0 5.023950393479026e-07
nineteen O 0 8.036679355427623e-05
CPO O 0 0.002447874750941992
gene B-Disease 0 0.0001520333025837317
defects I-Disease 0 0.41804811358451843
reported O 0 0.00010177384683629498
so O 0 7.312554771488067e-06
far O 0 1.063441413862165e-05
. O 0 8.68796996655874e-06
. O 0 4.89195590489544e-05

Coincidence O 0 0.00035941938403993845
of O 0 1.4462830222328193e-05
two O 0 9.49304649111582e-06
novel O 0 1.6207912267418578e-05
arylsulfatase O 0 0.00021206200472079217
A O 0 2.086866879835725e-05
alleles O 0 2.977067015308421e-05
and O 0 7.766640919726342e-06
mutation O 0 5.5069729569368064e-05
459 O 0 0.00013200045214034617
+ O 0 6.085075074224733e-05
1G O 0 0.0003907761420123279
> O 0 3.8115169445518404e-05
A O 0 8.583902854297776e-06
within O 0 2.4947262318164576e-06
a O 0 1.390430497849593e-05
family O 0 0.00012345977302175015
with O 0 0.00033533413079567254
metachromatic B-Disease 1 0.999998927116394
leukodystrophy I-Disease 1 0.9999696016311646
: O 0 3.7083243569213664e-06
molecular O 0 1.2432476069079712e-05
basis O 0 2.9613163405883824e-06
of O 0 4.768066446558805e-06
phenotypic O 0 0.00014535868831444532
heterogeneity O 0 0.0012756834039464593
. O 0 0.00015357353549916297

In O 0 9.103985939873382e-05
a O 0 4.3608848500298336e-05
family O 0 3.572670539142564e-05
with O 0 2.7759610929933842e-06
three O 0 8.034175152715761e-06
siblings O 0 0.0011588676134124398
, O 0 1.2959368405063287e-06
one O 0 9.986655413740664e-07
developed O 0 6.151016350486316e-06
classical O 0 1.0688004294934217e-05
late O 0 0.0008047029259614646
infantile O 1 0.9956658482551575
metachromatic B-Disease 1 0.9999995231628418
leukodystrophy I-Disease 1 0.9999996423721313
( O 0 0.0007393794949166477
MLD B-Disease 1 0.9999886751174927
) O 0 1.0333439604437444e-05
, O 0 7.72030125517631e-06
fatal O 0 0.005448812153190374
at O 0 0.0005829436122439802
age O 0 8.267245721071959e-05
5 O 0 6.7882638177252375e-06
years O 0 5.1349084060348105e-06
, O 0 2.893222927013994e-06
with O 0 2.180675983254332e-05
deficient O 1 0.680460512638092
arylsulfatase O 0 0.0034711111802607775
A O 0 9.018195123644546e-05
( O 0 7.139374247344676e-06
ARSA O 0 0.0030665684025734663
) O 0 1.2688800552496105e-06
activity O 0 1.42213434628502e-06
and O 0 1.3940784810984042e-06
increased O 0 8.871176760294475e-06
galactosylsulfatide O 0 0.027851250022649765
( O 0 2.432481778669171e-05
GS O 1 0.999937891960144
) O 0 1.726751543174032e-05
excretion O 0 0.00011131630162708461
. O 0 6.11207724432461e-05

The O 0 3.275745257269591e-05
two O 0 6.645993380516302e-06
other O 0 2.872027607736527e-06
siblings O 0 0.0006870930665172637
, O 0 7.191924851213116e-06
apparently O 0 0.00011398600327083841
healthy O 0 1.207817331305705e-05
at O 0 1.0457987627887633e-05
12 O 0 7.745928996882867e-06
( O 0 6.315354426078557e-07
1 O 0 1.002337057798286e-06
/ O 0 2.3018317278911127e-06
2 O 0 1.0731869224400725e-06
) O 0 2.113743988729766e-07
and O 0 4.174724210770364e-07
15 O 0 2.463908458594233e-06
years O 0 2.147754685211112e-06
, O 0 7.60928912768577e-07
respectively O 0 2.3880566004663706e-06
, O 0 3.09768523720777e-07
and O 0 2.8310819288890343e-07
their O 0 2.0980478439014405e-06
father O 0 8.399651414947584e-05
, O 0 2.2904996512806974e-06
apparently O 0 3.128551543341018e-05
healthy O 0 2.7320220397086814e-06
as O 0 3.238115482417925e-07
well O 0 8.841867042974627e-07
, O 0 1.6848459836182883e-06
presented O 0 5.661685008817585e-06
ARSA O 0 0.004301625303924084
and O 0 8.899690328689758e-06
GS O 1 0.9984310269355774
values O 0 2.2869091935717734e-06
within O 0 9.148621984422789e-07
the O 0 8.513202374160755e-07
range O 0 4.449264906725148e-06
of O 0 3.173741060891189e-05
MLD B-Disease 1 0.9999996423721313
patients O 0 0.3673921823501587
. O 0 0.00011632993118837476

Mutation O 0 0.0012427641777321696
screening O 0 0.0003412462247069925
and O 0 3.069785816478543e-05
sequence O 0 2.1843870854354464e-05
analysis O 0 9.781168955669273e-06
disclosed O 0 2.6992200218955986e-05
the O 0 1.147075977314671e-06
involvement O 0 3.049711494895746e-06
of O 0 5.653261609950277e-07
three O 0 2.7629296255327063e-06
different O 0 4.426178293215344e-06
ARSA O 1 0.531206488609314
mutations O 0 2.0520681573543698e-05
being O 0 2.611494892335031e-06
the O 0 9.911888128044666e-07
molecular O 0 9.34834224608494e-06
basis O 0 1.9029199620490544e-06
of O 0 4.810786776943132e-06
intrafamilial O 0 0.0010767503408715129
phenotypic O 0 0.00032417921465821564
heterogeneity O 0 0.0013215206563472748
. O 0 0.000156700742081739

The O 0 0.00019683470600284636
late O 0 0.0005969884223304689
infantile O 1 0.9275420904159546
patient O 1 0.6715937256813049
inherited O 0 0.4984036386013031
from O 0 1.3923066035204101e-05
his O 0 0.0005703955539502203
mother O 0 0.0011824037646874785
the O 0 1.7304653283645166e-06
frequent O 0 1.0434756404720247e-05
0 O 0 3.292067412985489e-05
- O 0 0.0001439051266061142
type O 0 2.5841049136943184e-05
mutation O 0 2.1561299945460632e-05
459 O 0 4.9704151024343446e-05
+ O 0 3.0254273951868527e-05
1G O 0 0.0001473453303333372
> O 0 2.643731568241492e-05
A O 0 6.645764642598806e-06
, O 0 1.451226580684306e-06
and O 0 8.518261438439367e-07
from O 0 8.353981684194878e-07
his O 0 1.141107532021124e-05
father O 0 5.3249979828251526e-05
a O 0 2.619581664475845e-06
novel O 0 1.6182528952413122e-06
, O 0 6.881681997583655e-07
single O 0 5.450890057545621e-06
basepair O 0 4.506883124122396e-05
microdeletion O 0 1.708960553514771e-05
of O 0 5.19344780514075e-07
guanine O 0 1.0383396329416428e-05
at O 0 3.849055246973876e-06
nucleotide O 0 9.26007214729907e-06
7 O 0 5.160525233804947e-06
in O 0 1.4477583363259328e-06
exon O 0 3.148833638988435e-05
1 O 0 5.405140200309688e-06
( O 0 2.792239229165716e-06
7delG O 0 8.779184281593189e-05
) O 0 6.823813237133436e-06
. O 0 2.2171672753756866e-05

The O 0 0.00012931638048030436
two O 0 9.167416283162311e-05
clinically O 0 0.32719311118125916
unaffected O 0 0.0007505696266889572
siblings O 0 0.00020800602214876562
carried O 0 2.7487623810884543e-05
the O 0 5.692648301192094e-06
maternal O 0 0.0007096659974195063
mutation O 0 5.260409670881927e-05
459 O 0 7.724475290160626e-05
+ O 0 4.733389141620137e-05
1G O 0 0.00025138037744909525
> O 0 3.8291869714157656e-05
A O 0 8.445666935585905e-06
and O 0 2.1488713173312135e-06
, O 0 9.812342796067242e-07
on O 0 1.0009157449530903e-06
their O 0 2.097379592669313e-06
paternal O 0 4.1895116737578064e-05
allele O 0 8.722256097826175e-06
, O 0 1.0675764769985108e-06
a O 0 1.7597607211428112e-06
novel O 0 2.9294355954334605e-06
cytosine O 0 5.372563464334235e-06
to O 0 1.085019562196976e-06
thymidine O 0 1.793895171431359e-05
transition O 0 6.605900580325397e-06
at O 0 7.95508185547078e-06
nucleotide O 0 2.32223974307999e-05
2435 O 0 7.082908268785104e-05
in O 0 3.0524438443535473e-06
exon O 0 2.091975875373464e-05
8 O 0 7.54602342567523e-06
, O 0 1.1367098977643764e-06
resulting O 0 2.0168670289422153e-06
in O 0 6.62503282455873e-07
substitution O 0 1.1415082781240926e-06
of O 0 1.4551236517945654e-06
alanine O 0 0.00014133936201687902
464 O 0 6.146774103399366e-05
by O 0 8.022890142456163e-06
valine O 0 0.005456533282995224
( O 0 1.576870636199601e-05
A464V O 0 0.0003561164776328951
) O 0 1.122965659305919e-05
. O 0 2.8970998755539767e-05

The O 0 0.00014044919225852937
fathers O 0 0.0006236961344256997
genotype O 0 0.0006666145636700094
thus O 0 3.768461101572029e-05
was O 0 0.0001101898742490448
7delG O 0 0.0015752811450511217
/ O 0 0.0003285538696218282
A464V O 0 0.000991162029094994
. O 0 9.183682414004579e-05

Mutation O 0 0.003172357100993395
A464V O 0 0.00434140907600522
was O 0 0.0002878332161344588
not O 0 5.4905726756260265e-06
found O 0 6.685877906420501e-06
in O 0 6.474277597590117e-06
18 O 0 0.0007538734353147447
unrelated O 0 0.008943376131355762
MLD B-Disease 1 0.999998927116394
patients O 0 0.023942040279507637
and O 0 1.5023917512735352e-05
50 O 0 4.2577568819979206e-05
controls O 0 0.0002242433256469667
. O 0 5.6839951867004856e-05

A464V O 0 0.009670896455645561
, O 0 9.821190178627148e-05
although O 0 2.3045377020025626e-05
clearly O 0 2.410546221653931e-05
modifying O 0 7.511278090532869e-05
ARSA O 0 0.002578853629529476
and O 0 6.023013702360913e-05
GS O 1 0.9999899864196777
levels O 0 4.478870323509909e-05
, O 0 6.0101624512753915e-06
apparently O 0 5.435189086711034e-05
bears O 0 3.387960168765858e-05
little O 0 1.9126152892567916e-06
significance O 0 2.3442626115866005e-06
for O 0 1.7971834722629865e-06
clinical O 0 6.626651884289458e-05
manifestation O 0 4.770784653373994e-05
of O 0 2.4605255021015182e-05
MLD B-Disease 1 0.999991774559021
, O 0 2.028104972850997e-05
mimicking O 0 0.00017591725918464363
the O 0 1.2685773072007578e-05
frequent O 0 0.0004423299978952855
ARSA O 1 0.832173228263855
pseudodeficiency O 0 0.00594961317256093
allele O 0 0.0009430561913177371
. O 0 0.0001717986015137285

Our O 0 0.0002159183204639703
results O 0 0.0001121287205023691
demonstrate O 0 3.079533053096384e-05
that O 0 2.69057181867538e-06
in O 0 3.927022135030711e-06
certain O 0 5.374413376557641e-06
genetic O 0 0.00016102967492770404
conditions O 0 0.029206616804003716
MLD B-Disease 1 0.9999743700027466
- O 0 0.044942937791347504
like O 0 5.219036393100396e-05
ARSA O 0 0.4318523406982422
and O 0 3.134240614599548e-05
GS O 1 0.999955415725708
values O 0 4.142234956816537e-06
need O 0 3.956874934374355e-06
not O 0 1.1054366950702388e-06
be O 0 6.737221838193364e-07
paralleled O 0 4.9225509428652e-06
by O 0 3.903930519300047e-06
clinical O 0 0.18115323781967163
disease O 0 0.2615549862384796
, O 0 4.241059286869131e-06
a O 0 1.2146925655542873e-05
finding O 0 1.974323640752118e-05
with O 0 2.78270472335862e-05
serious O 0 0.0027260142378509045
diagnostic O 0 0.10623963922262192
and O 0 0.0007765903137624264
prognostic O 1 0.8566688299179077
implications O 0 0.0009938490111380816
. O 0 0.00018435233505442739

Moreover O 0 0.0007626800797879696
, O 0 6.0151840443722904e-05
further O 0 3.146816379739903e-05
ARSA O 0 0.0044691734947264194
alleles O 0 7.940814975881949e-05
functionally O 0 9.089231753023341e-05
similar O 0 6.160596512927441e-06
to O 0 5.6499161473766435e-06
A464V O 0 0.0008257601293735206
might O 0 1.5932486348901875e-05
exist O 0 1.3234972584541538e-06
which O 0 6.736264595019748e-07
, O 0 4.964122695128026e-07
together O 0 9.33124169932853e-07
with O 0 1.5072877204147517e-06
0 O 0 3.651881343103014e-05
- O 0 0.0011189833749085665
type O 0 7.041463686618954e-05
mutations O 0 4.0108952816808596e-05
, O 0 7.809732778696343e-06
may O 0 5.5142194469226524e-05
cause O 0 3.7765592423966154e-05
pathological O 0 0.0005896640941500664
ARSA O 0 0.41961541771888733
and O 0 0.00013728732301387936
GS O 1 0.9999985694885254
levels O 0 4.480134884943254e-05
, O 0 3.4922447866847506e-06
but O 0 3.628223339546821e-06
not O 0 2.7514258817973314e-06
clinical O 0 2.777950430754572e-05
outbreak O 0 4.136769348406233e-05
of O 0 2.2446515686169732e-06
the O 0 0.002806713106110692
disease O 1 0.8161671161651611
. O 0 1.5572741176583804e-05
. O 0 6.0510610637720674e-05

Human O 0 0.03859223052859306
MLH1 O 1 0.9999264478683472
deficiency O 1 0.9999394416809082
predisposes O 0 0.04887847602367401
to O 0 0.0004330736119300127
hematological B-Disease 1 0.9991015195846558
malignancy I-Disease 1 0.9997350573539734
and O 0 0.012179821729660034
neurofibromatosis B-Disease 1 0.999981164932251
type I-Disease 0 0.0033683008514344692
1 I-Disease 0 0.0002532718062866479
. O 0 0.00017546645540278405

Heterozygous O 0 0.004324905574321747
germ O 0 0.019839942455291748
- O 0 0.002017711289227009
line O 0 0.00013460780610330403
mutations O 0 1.6734869859647006e-05
in O 0 2.4935227429523366e-06
the O 0 4.690735295298509e-06
DNA O 0 0.00014940097753424197
mismatch O 0 0.12812986969947815
repair O 0 0.3873063027858734
genes O 0 5.756254540756345e-05
lead O 0 0.00011540120613062754
to O 0 0.00017630818183533847
hereditary B-Disease 1 0.9999984502792358
nonpolyposis I-Disease 1 0.9999998807907104
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
. O 0 0.0016517539042979479

The O 0 0.0007864999934099615
disease O 1 0.915613055229187
susceptibility O 0 0.0007281315629370511
of O 0 9.441088877792936e-06
individuals O 0 2.3076097932062112e-05
who O 0 0.00013761472655460238
constitutionally O 0 0.00022728160547558218
lack O 0 1.1848404028569348e-05
both O 0 2.461273425069521e-06
wild O 0 1.8231523426948115e-05
- O 0 0.00284003047272563
type O 0 9.732419130159542e-05
alleles O 0 4.0729675674811006e-05
is O 0 7.9964902397478e-06
unknown O 0 5.9212212363490835e-05
. O 0 5.0543345423648134e-05

We O 0 0.00011695178545778617
have O 0 1.8569235180621035e-05
identified O 0 1.580268144607544e-05
three O 0 5.664730906573823e-06
offspring O 0 5.89347182540223e-05
in O 0 7.751412340439856e-06
a O 0 0.0061557539738714695
hereditary B-Disease 1 0.9999990463256836
nonpolyposis I-Disease 1 1.0
colorectal I-Disease 1 1.0
cancer I-Disease 1 1.0
family O 0 0.4659086763858795
who O 0 0.006817071698606014
developed O 0 0.010526279918849468
hematological B-Disease 1 0.9926249384880066
malignancy I-Disease 1 0.9791421890258789
at O 0 0.0001135804268415086
a O 0 1.0039356311608572e-05
very O 0 2.3305294689635048e-06
early O 0 6.303545433183899e-06
age O 0 1.6077226973720826e-05
, O 0 7.818995868547063e-07
and O 0 6.619229111493041e-07
at O 0 4.264566086931154e-06
least O 0 3.8013038761164353e-07
two O 0 1.8693044978590478e-07
of O 0 2.970773778088187e-07
them O 0 6.643203391831776e-07
displayed O 0 9.964707714971155e-06
signs O 0 2.573554593254812e-05
of O 0 5.029112344345776e-06
neurofibromatosis B-Disease 1 0.9999570846557617
type I-Disease 0 0.0008795462199486792
1 I-Disease 0 7.268467015819624e-05
( O 0 1.8072127204504795e-05
NF1 B-Disease 0 0.003250901121646166
) O 0 2.4600351025583223e-05
. O 0 4.205298682791181e-05

DNA O 0 0.00046153657604008913
sequence O 0 6.0092384956078604e-05
analysis O 0 9.87849216471659e-06
and O 0 3.3412466109439265e-06
allele O 0 9.94700167211704e-06
- O 0 1.616421104699839e-05
specific O 0 8.479155439999886e-07
amplification O 0 1.2492982932599261e-05
in O 0 1.0383862445451086e-06
two O 0 4.172477929387242e-06
siblings O 0 0.004222080111503601
revealed O 0 6.425995525205508e-05
a O 0 2.0729801690322347e-05
homozygous O 0 0.001273913076147437
MLH1 O 0 0.019552059471607208
mutation O 0 5.608165520243347e-05
( O 0 5.462869921757374e-06
C676T O 0 0.00020568315812852234
- O 0 0.001455735182389617
- O 0 0.0034975153394043446
> O 0 0.0004914150340482593
Arg226Stop O 0 0.0011602030135691166
) O 0 2.2123640519566834e-05
. O 0 5.410201265476644e-05

Thus O 0 0.00038913669413886964
, O 0 3.8641384890070185e-05
a O 0 4.4824599171988666e-05
homozygous O 0 0.0006336185615509748
germ O 0 0.0019039750332012773
- O 0 0.0008445827988907695
line O 0 0.0002248078671982512
MLH1 O 0 0.017179172486066818
mutation O 0 7.416134030791e-05
and O 0 3.257235584896989e-05
consequent O 1 0.9475896954536438
mismatch O 1 0.9999979734420776
repair O 1 1.0
deficiency O 1 0.9999991655349731
results O 0 0.0027219972107559443
in O 0 3.1774903618497774e-05
a O 0 0.0008655792917124927
mutator O 1 0.8375080823898315
phenotype O 0 0.06614093482494354
characterized O 0 0.00017188348283525556
by O 0 4.734210597234778e-05
leukemia B-Disease 1 0.9999691247940063
and O 0 0.004709275905042887
/ O 1 0.9438878893852234
or O 1 0.899874746799469
lymphoma B-Disease 1 1.0
associated O 0 0.010698126628994942
with O 0 0.0023698366712778807
neurofibromatosis B-Disease 1 0.9999960660934448
type I-Disease 0 0.0018475842662155628
1 I-Disease 0 4.096979682799429e-05
. O 0 1.4956528502807487e-05
. O 0 4.165394420851953e-05

Missense O 0 0.0036139918956905603
mutations O 0 0.0008396014454774559
in O 0 1.9775367036345415e-05
the O 0 3.4988017887371825e-06
most O 0 1.5572059055557474e-06
ancient O 0 1.876942633316503e-06
residues O 0 3.979399025411112e-06
of O 0 7.094741363289359e-07
the O 0 6.863984708616044e-06
PAX6 O 0 0.00463838828727603
paired O 0 4.586373324855231e-05
domain O 0 1.2275324479560368e-05
underlie O 0 3.0718390917172655e-05
a O 0 6.814364041929366e-06
spectrum O 0 3.0039343982934952e-05
of O 0 4.4417884055292234e-05
human O 0 0.1112561970949173
congenital B-Disease 1 1.0
eye I-Disease 1 0.9999974966049194
malformations I-Disease 1 0.9999890327453613
. O 0 0.0014395143371075392

Mutations O 0 0.0005818325444124639
of O 0 1.6030317055992782e-05
the O 0 1.439742209186079e-05
human O 0 1.948241697391495e-05
PAX6 O 0 0.016560545191168785
gene O 0 0.00034542533103376627
underlie O 1 0.7544236183166504
aniridia B-Disease 1 0.9999998807907104
( O 0 0.018205292522907257
congenital B-Disease 1 0.9999980926513672
absence I-Disease 0 0.00022417769650928676
of I-Disease 0 3.34453670802759e-06
the I-Disease 0 2.694708928174805e-05
iris I-Disease 0 0.2066873013973236
) O 0 2.2605374851991655e-06
, O 0 1.1030660971300676e-06
a O 0 7.048047336866148e-06
rare O 0 3.5638371628010646e-05
dominant O 0 0.027192696928977966
malformation B-Disease 1 0.9933611154556274
of I-Disease 0 6.696348918922013e-06
the I-Disease 0 0.00012601677735801786
eye I-Disease 1 0.8226850032806396
. O 0 0.00012884361785836518

The O 0 0.0001333669642917812
spectrum O 0 0.00014616122643928975
of O 0 3.166177339153364e-05
PAX6 O 0 0.05797611176967621
mutations O 0 0.0005444396520033479
in O 0 0.0004913967568427324
aniridia B-Disease 1 0.9999997615814209
patients O 1 0.6133811473846436
is O 0 3.953593477490358e-06
highly O 0 4.656948931369698e-06
biased O 0 1.9818504370050505e-05
, O 0 1.417979433426808e-06
with O 0 1.3596568351204041e-06
92 O 0 1.3546230547945015e-05
% O 0 4.7308080297625565e-07
of O 0 2.419068891867937e-07
all O 0 1.0092279580931063e-06
reported O 0 2.680279612832237e-05
mutations O 0 9.989370482799131e-06
leading O 0 5.80464256927371e-06
to O 0 4.226362761983182e-06
premature O 0 9.406333265360445e-05
truncation O 0 6.599364496651106e-06
of O 0 6.084153483243426e-07
the O 0 3.4859692732425174e-06
protein O 0 1.542963036627043e-05
( O 0 1.1299678135401336e-06
nonsense O 0 5.650756520481082e-06
, O 0 8.668907298670092e-07
splicing O 0 5.3306362133298535e-06
, O 0 8.291381732306036e-07
insertions O 0 4.364931101008551e-06
and O 0 1.1357411722201505e-06
deletions O 0 7.648448445252143e-06
) O 0 6.441872528739623e-07
and O 0 6.387110147443309e-07
just O 0 2.5737820124049904e-06
2 O 0 9.996108474297216e-07
% O 0 5.299900749378139e-07
leading O 0 6.791668170080811e-07
to O 0 1.921075920563453e-07
substitution O 0 3.579641543183243e-07
of O 0 2.788569872791413e-07
one O 0 2.5388501398992958e-06
amino O 0 1.0050067430711351e-05
acid O 0 4.2378810576337855e-06
by O 0 5.608010837931943e-07
another O 0 4.116939180676127e-06
( O 0 2.8574820589710725e-06
missense O 0 5.4129988711792976e-05
) O 0 1.2106609574402682e-05
. O 0 3.0946317565394565e-05

The O 0 8.177345443982631e-05
extraordinary O 0 5.592874367721379e-05
conservation O 0 1.5271309166564606e-05
of O 0 1.8627927147463197e-06
the O 0 3.753941200557165e-06
PAX6 O 0 0.0004218977119307965
protein O 0 9.894397408061195e-06
at O 0 3.6338572044769535e-06
the O 0 1.7613439240449225e-06
amino O 0 8.530571903975215e-06
acid O 0 4.844048362429021e-06
level O 0 1.8077308823194471e-06
amongst O 0 2.333264774279087e-06
vertebrates O 0 6.281719834078103e-06
predicts O 0 2.273808786412701e-05
that O 0 2.3285631414182717e-06
pathological O 0 6.00081511947792e-05
missense O 0 0.00011063638521591201
mutations O 0 4.7933950554579496e-05
should O 0 6.44639840174932e-06
in O 0 3.3411413369321963e-06
fact O 0 2.6706370590545703e-06
be O 0 1.1194359785804409e-06
common O 0 8.247848199971486e-07
even O 0 2.3525581127614714e-06
though O 0 1.248897319783282e-06
they O 0 1.047622845362639e-06
are O 0 4.5332151898946904e-07
hardly O 0 4.074991466040956e-06
ever O 0 6.874505288578803e-06
seen O 0 2.5372879463247955e-05
in O 0 5.078399772173725e-05
aniridia B-Disease 1 0.9999967813491821
patients O 0 0.022316470742225647
. O 0 0.00010381440370110795

This O 0 9.837574907578528e-05
indicates O 0 0.00010299245332134888
that O 0 4.142499619774753e-06
there O 0 3.6107983305555535e-06
is O 0 1.036599428516638e-06
a O 0 3.2856296456884593e-06
heavy O 0 0.004420852288603783
ascertainment O 0 0.0009516294812783599
bias O 0 7.031384029687615e-06
in O 0 8.748846198614046e-07
the O 0 5.835547653987305e-07
selection O 0 1.0824697938005556e-06
of O 0 1.9715917005669326e-06
patients O 0 0.00012816257367376238
for O 0 3.0610697194788372e-06
PAX6 O 0 0.007164043374359608
mutation O 0 1.4543768884323072e-05
analysis O 0 1.9745909867197042e-06
and O 0 1.1679478575388202e-06
that O 0 1.0077948218167876e-06
the O 0 3.493377107588458e-06
missing O 0 0.00014677377475891262
PAX6 O 0 0.00440590875223279
missense O 0 0.0004722845624201
mutations O 0 0.00017261762695852667
frequently O 0 6.872235098853707e-05
may O 0 0.00014819810166954994
underlie O 0 0.00020151844364590943
phenotypes O 0 0.0001534128241473809
distinct O 0 1.7032834875863045e-05
from O 0 2.788551319099497e-05
textbook O 0 0.0019071062561124563
aniridia B-Disease 1 0.9999115467071533
. O 0 0.0001941054069902748

Here O 0 0.00013473918079398572
we O 0 1.7297003068961203e-05
present O 0 7.375891073024832e-06
four O 0 6.0703987401211634e-06
novel O 0 1.427132883691229e-05
PAX6 O 0 0.00021822209237143397
missense O 0 6.8438530433923e-05
mutations O 0 2.429060077702161e-05
, O 0 1.34978222376958e-06
two O 0 1.1383090168237686e-06
in O 0 5.068739028502023e-06
association O 0 2.2803737010690384e-05
with O 0 1.1060819815611467e-05
atypical O 0 0.013112116605043411
phenotypes O 0 0.027098126709461212
ectopia B-Disease 0 0.12030844390392303
pupillae I-Disease 0 0.026268288493156433
( O 0 3.7064082789584063e-06
displaced B-Disease 0 3.5304368793731555e-05
pupils I-Disease 0 8.906734001357108e-05
) O 0 8.70612529979553e-06
and O 0 0.00021018146071583033
congenital B-Disease 1 0.999997615814209
nystagmus I-Disease 1 0.6043850183486938
( O 0 4.4084558794565964e-06
searching B-Disease 0 3.4316268283873796e-05
gaze I-Disease 0 0.0002339086786378175
) O 0 9.158198963632458e-07
, O 0 4.232184380725812e-07
and O 0 4.579679853122798e-07
two O 0 8.249846246144443e-07
in O 0 2.5969832222472178e-06
association O 0 4.91859555040719e-06
with O 0 1.5142163647396956e-06
more O 0 2.9795824048051145e-06
recognizable O 0 0.0003607593826018274
aniridia B-Disease 1 0.9992695450782776
phenotypes O 0 0.002117134863510728
. O 0 7.599058153573424e-05

Strikingly O 0 0.002397392177954316
, O 0 3.0412767955567688e-05
all O 0 2.858749439837993e-06
four O 0 5.856404641235713e-06
mutations O 0 1.1255001481913496e-05
are O 0 6.876078941786545e-07
located O 0 2.540012701501837e-06
within O 0 9.82018832473841e-07
the O 0 2.1149992335267598e-06
PAX6 O 0 0.000182861287612468
paired O 0 1.520166279078694e-05
domain O 0 2.8974613996979315e-06
and O 0 1.8145118474421906e-06
affect O 0 3.11390658680466e-06
amino O 0 3.6962142075935844e-06
acids O 0 1.2919226719532162e-06
which O 0 3.2011473649617983e-07
are O 0 2.0605087058811478e-07
highly O 0 7.065612521728326e-07
conserved O 0 9.022311928674753e-07
in O 0 5.14335965817736e-07
all O 0 5.986007067804167e-07
known O 0 6.364227829180891e-06
paired O 0 4.894601079286076e-05
domain O 0 2.9151247872505337e-05
proteins O 0 3.558878233889118e-05
. O 0 4.836823791265488e-05

Our O 0 0.00013738882262259722
results O 0 4.125998020754196e-05
support O 0 5.522801529878052e-06
the O 0 2.3211780444398755e-06
hypothesis O 0 3.100279400314321e-06
that O 0 4.5956488747833646e-07
the O 0 5.253077688394114e-07
under O 0 1.7865202153188875e-06
- O 0 9.336065886600409e-06
representation O 0 1.4123838809609879e-06
of O 0 1.2164487088739406e-06
missense O 0 0.00015151160187087953
mutations O 0 5.0215934606967494e-05
is O 0 1.9686681298480835e-06
caused O 0 1.277953833778156e-05
by O 0 1.8596863355924143e-06
ascertainment O 0 0.00015168808749876916
bias O 0 1.299197811022168e-05
and O 0 5.862546004209435e-06
suggest O 0 5.174886155145941e-06
that O 0 6.531334406645328e-07
a O 0 2.5315364382549888e-06
substantial O 0 9.955931091099046e-06
burden O 0 0.00019849929958581924
of O 0 7.988411198311951e-06
PAX6 B-Disease 1 0.8937034606933594
- I-Disease 1 0.9373676180839539
related I-Disease 0 0.0016665211878716946
disease I-Disease 0 0.18943654000759125
remains O 0 1.147985221905401e-05
to O 0 2.5704434847284574e-06
be O 0 4.552013706415892e-06
uncovered O 0 0.00014738690515514463
. O 0 5.1012398216698784e-06
. O 0 1.7080985344364308e-05

The O 0 0.00010195248614763841
chromosomal O 0 0.002075206721201539
order O 0 1.3205659342929721e-05
of O 0 2.9630057269969257e-06
genes O 0 1.551698733237572e-05
controlling O 0 4.119467121199705e-05
the O 0 4.278510459698737e-06
major O 0 1.2411566785885952e-05
histocompatibility O 0 0.00030296877957880497
complex O 0 2.9899330911575817e-05
, O 0 4.131153218622785e-06
properdin O 0 0.0008765857201069593
factor O 0 1.0722911611082964e-05
B O 0 0.00011876600183313712
, O 0 2.261165036543389e-06
and O 0 2.599855542939622e-05
deficiency B-Disease 0 0.0030643956270068884
of I-Disease 0 3.001549089276523e-07
the I-Disease 0 1.0980271554217325e-06
second I-Disease 0 6.674117685179226e-06
component I-Disease 0 4.941176484862808e-06
of I-Disease 0 2.5972210551117314e-06
complement I-Disease 0 8.545880700694397e-05
. O 0 5.01102622365579e-05

The O 0 5.9183592384215444e-05
relationship O 0 2.4035356545937248e-05
of O 0 2.8419394766387995e-06
the O 0 2.8600284167623613e-06
genes O 0 8.358727427548729e-06
coding O 0 1.7588259652256966e-05
for O 0 2.9853165415261174e-06
HLA O 0 0.00020498031517490745
to O 0 2.1859959815628827e-06
those O 0 2.2714179976901505e-06
coding O 0 1.3941190445621032e-05
for O 0 2.802371227517142e-06
properdin O 0 0.0013155224733054638
Factor O 0 8.835630978865083e-06
B O 0 3.364745498402044e-05
allotypes O 0 6.208695413079113e-05
and O 0 2.6233242351736408e-06
for O 0 1.9679513570736162e-05
deficiency B-Disease 0 0.07469846308231354
of I-Disease 0 4.037400742618047e-07
the I-Disease 0 1.0632360272211372e-06
second I-Disease 0 3.4008094189630356e-06
component I-Disease 0 2.1693756480090087e-06
of I-Disease 0 5.442103656605468e-07
complement I-Disease 0 1.0474876944499556e-05
( O 0 2.5006095256685512e-06
C2 O 0 0.010732569731771946
) O 0 1.2391971040415228e-06
was O 0 5.288553438731469e-06
studied O 0 2.3185252757684793e-06
in O 0 1.7406611050319043e-06
families O 0 3.7540630728472024e-06
of O 0 2.103421138599515e-06
patients O 0 0.006752238608896732
with O 0 0.002286548726260662
connective O 1 0.9999932050704956
tissue O 1 0.9999973773956299
disorders O 1 0.9999969005584717
. O 0 0.0005507995374500751

Patients O 1 0.8733271956443787
were O 0 0.00011345896928105503
selected O 0 1.893961052701343e-05
because O 0 7.096648459992139e-06
they O 0 3.1370816486742115e-06
were O 0 4.168790837866254e-06
heterozygous O 0 3.204256063327193e-05
or O 0 7.2045563683786895e-06
homozygous O 0 0.001899993745610118
for O 0 0.008278903551399708
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999991655349731
. O 0 0.0001689546916168183

12 O 0 0.00047536668716929853
families O 0 6.556928565260023e-05
with O 0 6.549825229740236e-06
15 O 0 1.760208760970272e-05
matings O 0 6.151224806671962e-05
informative O 0 4.3753603677032515e-05
for O 0 0.008834375999867916
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999997615814209
were O 0 0.00032687827479094267
found O 0 0.00015265854017343372
. O 0 7.569809531560168e-05

Of O 0 9.413826774107292e-05
57 O 0 0.00017034877964761108
informative O 0 6.180647324072197e-05
meioses O 0 0.00036644242936745286
, O 0 2.7020346351491753e-06
two O 0 1.17054605652811e-06
crossovers O 0 1.256224095413927e-05
were O 0 9.658074304752517e-06
noted O 0 2.757120455498807e-06
between O 0 3.7094457638886524e-06
the O 0 0.027858417481184006
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999985694885254
gene O 0 1.2821138625440653e-05
and O 0 2.410261686236481e-06
the O 0 6.40827283859835e-06
HLA O 0 0.001402069698087871
- O 0 0.005550619680434465
B O 0 0.00013946095714345574
gene O 0 3.676999995150254e-06
, O 0 7.06855132648343e-07
with O 0 4.3727416709771205e-07
a O 0 1.295835431847081e-06
recombinant O 0 4.127175998291932e-06
fraction O 0 3.1929930628393777e-06
of O 0 2.801345317493542e-06
0 O 0 9.139197209151462e-05
. O 0 3.067869693040848e-05

035 O 0 0.3550190031528473
. O 0 0.005196930840611458

A O 0 0.00030217316816560924
lod O 0 0.0025773688685148954
score O 0 2.535053135943599e-05
of O 0 2.9099003313604044e-06
13 O 0 2.0787727407878265e-05
was O 0 1.7141966964118183e-05
calculated O 0 4.704363163909875e-06
for O 0 1.7612397869015695e-06
linkage O 0 0.00033927022013813257
between O 0 0.006426239386200905
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999992847442627
and O 0 6.432420195778832e-05
HLA O 0 0.09874162822961807
- O 0 0.021933073177933693
B O 0 0.0001427187235094607
at O 0 2.2718904801877216e-06
a O 0 8.506823405696196e-07
maximum O 0 2.2675203581457026e-06
likelihood O 0 1.5363627881015418e-06
value O 0 2.587440803836216e-07
of O 0 2.3189379305676994e-07
the O 0 5.335043624654645e-07
recombinant O 0 4.749740128318081e-06
fraction O 0 3.384838691999903e-06
of O 0 3.0375267670024186e-06
0 O 0 0.00012109430099371821
. O 0 5.676514774677344e-05

04 O 0 0.2885860502719879
. O 0 0.003278666641563177

18 O 0 0.0012093500699847937
families O 0 0.00010655874939402565
with O 0 8.78832634043647e-06
21 O 0 1.2486480045481585e-05
informative O 0 7.986590389919002e-06
matings O 0 2.4879689590306953e-05
for O 0 2.3501095256506233e-06
both O 0 2.4629334802739322e-06
properdin O 0 0.0004548575961962342
Factor O 0 1.1308979992463719e-05
B O 0 3.4311589843127877e-05
allotype O 0 4.860608896706253e-05
and O 0 3.1032966489874525e-06
HLA O 0 0.0002924178261309862
- O 0 0.000599446939304471
B O 0 0.00015578644524794072
were O 0 1.1316024938423652e-05
found O 0 3.1661744287703186e-05
. O 0 4.65182529296726e-05

Of O 0 9.835249511525035e-05
72 O 0 0.00018484058091416955
informative O 0 6.615300662815571e-05
meioses O 0 0.0002721997443586588
, O 0 5.666146535077132e-06
three O 0 3.006806082339608e-06
recombinants O 0 0.00035739527083933353
were O 0 6.3959146245906595e-06
found O 0 2.1382124941737857e-06
, O 0 7.312864340747183e-07
giving O 0 9.004725143313408e-07
a O 0 1.1134607120766304e-06
recombinant O 0 4.574355443764944e-06
fraction O 0 4.951605205860687e-06
of O 0 2.7149344532517716e-06
0 O 0 0.0001323306350968778
. O 0 4.375923526822589e-05

042 O 0 0.04500727728009224
. O 0 0.002214703941717744

A O 0 0.000319791171932593
lod O 0 0.0022757090628147125
score O 0 3.230162474210374e-05
of O 0 2.911782303272048e-06
16 O 0 7.653928150830325e-06
between O 0 3.7125637391000055e-06
HLA O 0 0.0003895617264788598
- O 0 0.0001874801964731887
B O 0 3.117083542747423e-05
and O 0 1.354470896330895e-06
Factor O 0 4.6727063818252645e-06
B O 0 2.310306990693789e-05
allotypes O 0 3.881470547639765e-05
was O 0 5.416699423221871e-06
calculated O 0 1.70391342635412e-06
at O 0 1.4064510196476476e-06
a O 0 7.622217594871472e-07
maximum O 0 1.8314310636924347e-06
likelihood O 0 1.8045581100523123e-06
value O 0 2.898874242873717e-07
of O 0 2.1518599169212393e-07
the O 0 8.244757054853835e-07
recombinant O 0 5.123828941577813e-06
fraction O 0 5.052417691331357e-06
of O 0 3.514569925755495e-06
0 O 0 0.00013348185166250914
. O 0 4.648308458854444e-05

04 O 0 0.21801359951496124
. O 0 0.0036293193697929382

A O 0 0.00016939152556005865
crossover O 0 0.00010656545055098832
was O 0 7.577414362458512e-05
shown O 0 3.993639893451473e-06
to O 0 1.0299047517037252e-06
have O 0 1.2151640476076864e-06
occurred O 0 2.8174338240205543e-06
between O 0 7.807788620084466e-07
genes O 0 1.617938096387661e-06
for O 0 4.941539373248816e-07
Factor O 0 3.5558828130888287e-06
B O 0 1.666452590143308e-05
and O 0 3.823828137683449e-06
HLA O 0 0.0006810145569033921
- O 0 0.014637607149779797
D O 0 0.023064905777573586
, O 0 1.0847401199498563e-06
in O 0 1.1548208931344561e-06
which O 0 2.449978410368203e-06
HLA O 0 0.00022913739667274058
- O 0 0.0019762187730520964
D O 0 0.00528482161462307
segregared O 0 7.425644434988499e-05
with O 0 3.7138493098609615e-06
HLA O 0 0.0005615655682049692
- O 0 0.00011687540973071009
A O 0 2.8761072826455347e-05
and O 0 2.856401988537982e-05
B O 0 0.0013127282727509737
. O 0 4.2408748413436115e-05

These O 0 3.115276922471821e-05
studies O 0 2.309273804712575e-05
suggest O 0 7.520441158703761e-06
that O 0 8.081943292381766e-07
the O 0 1.135369757321314e-06
genes O 0 2.4910675620049005e-06
for O 0 1.1521784699652926e-06
Factor O 0 1.4347803698910866e-05
B O 0 0.006053053308278322
and O 0 0.009905759245157242
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999943971633911
are O 0 1.4074170167077682e-06
located O 0 4.058121703565121e-06
outside O 0 3.609978875829256e-06
those O 0 7.838391979930748e-07
for O 0 1.5475741292902967e-06
HLA O 0 0.002443170640617609
, O 0 1.3150337281331304e-06
that O 0 2.90592168994408e-07
the O 0 3.1065991379364277e-07
order O 0 5.919383170294168e-07
of O 0 5.008943162465584e-07
genese O 0 0.0009629466221667826
is O 0 1.9815406631096266e-06
HLA O 0 6.946769281057641e-05
- O 0 4.012620775029063e-05
A O 0 1.0566459422989283e-05
, O 0 3.4268025501660304e-06
- O 0 0.00018388658645562828
B O 0 6.135160947451368e-05
, O 0 1.7874542663776083e-06
- O 0 0.00036267374525777996
D O 0 0.0014852660242468119
, O 0 2.4465437036269577e-06
Factor O 0 6.97251562087331e-06
B O 0 0.00010095746256411076
allotype O 0 0.006711904425173998
, O 0 0.003714438294991851
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999970197677612
, O 0 2.4889279757189797e-06
that O 0 5.232608373262337e-07
the O 0 1.173792270492413e-06
genes O 0 4.38992856288678e-06
coding O 0 6.474965630332008e-05
for O 0 0.0019280388951301575
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999992847442627
and O 0 2.8054679205524735e-05
Factor O 0 2.178462455049157e-05
B O 0 8.058780076680705e-05
allotypes O 0 5.6282726291101426e-05
are O 0 4.866357699029322e-07
approximately O 0 1.206906290462939e-06
3 O 0 2.4222115371230757e-06
- O 0 2.7276633772999048e-05
- O 0 3.078305599046871e-05
5 O 0 2.0226361812092364e-06
centimorgans O 0 1.0109617505804636e-05
from O 0 5.752964966632135e-07
the O 0 1.40370002554846e-06
HLA O 0 8.739875920582563e-05
- O 0 3.106660733465105e-05
A O 0 1.0627053598000202e-05
and O 0 5.896243692404823e-06
HLA O 0 0.0009126811055466533
- O 0 0.0017485347343608737
B O 0 5.556194810196757e-05
loci O 0 4.879648258793168e-06
, O 0 6.899917934788391e-07
and O 0 4.695362463280617e-07
that O 0 3.282358704836952e-07
the O 0 9.511473990642116e-07
apparent O 0 2.3889539079391398e-05
lack O 0 3.207073859812226e-06
of O 0 9.597900998414843e-07
recombinants O 0 0.00015924788021948189
between O 0 1.0552495268711937e-06
the O 0 4.728823114419356e-06
Factor O 0 1.2745384992740583e-05
B O 0 0.00013932803994975984
gene O 0 2.2935575543669984e-05
and O 0 0.008287929929792881
C2 B-Disease 1 1.0
deficiency I-Disease 1 0.9999982118606567
gene O 0 1.840899494709447e-05
suggests O 0 2.8512129119917518e-06
that O 0 4.3852409703504236e-07
these O 0 3.101439460806432e-07
two O 0 9.762351282915915e-07
genes O 0 4.2212950575049035e-06
lie O 0 2.2205656932783313e-05
in O 0 1.3780972949462011e-06
close O 0 3.7456873087649e-06
proximity O 0 4.42098507846822e-06
to O 0 1.9306646663608262e-06
one O 0 5.431369118014118e-06
another O 0 2.2162095774547197e-05
. O 0 3.530093454173766e-05

Distribution O 0 0.00010038723121397197
of O 0 2.3499020244344138e-05
emerin O 0 0.0007387547520920634
and O 0 1.8271679437020794e-05
lamins O 0 0.0008624379988759756
in O 0 6.557474989676848e-06
the O 0 7.205559541034745e-06
heart O 0 0.00323944422416389
and O 0 7.875911251176149e-06
implications O 0 2.2457828890765086e-05
for O 0 1.0749029570433777e-05
Emery B-Disease 0 0.0186693724244833
- I-Disease 1 0.8061825037002563
Dreifuss I-Disease 1 0.993779718875885
muscular I-Disease 1 0.9994795918464661
dystrophy I-Disease 1 0.9998149275779724
. O 0 0.0004612951015587896

Emerin O 0 0.028383569791913033
is O 0 5.338227856555022e-05
a O 0 2.0410310753504746e-05
nuclear O 0 6.66128980810754e-05
membrane O 0 2.6773850549943745e-05
protein O 0 7.846582775528077e-06
which O 0 1.43845898037398e-06
is O 0 9.871549764284282e-07
missing O 0 1.1386930964363273e-05
or O 0 2.22690300688555e-06
defective O 0 0.00012859972775913775
in O 0 1.2796245755453128e-05
Emery B-Disease 0 0.07155375927686691
- I-Disease 1 0.9224759340286255
Dreifuss I-Disease 1 0.999169111251831
muscular I-Disease 1 0.999970555305481
dystrophy I-Disease 1 0.9999927282333374
( O 0 0.0004451587738003582
EDMD B-Disease 1 0.9999924898147583
) O 0 5.630328814731911e-05
. O 0 5.8620324125513434e-05

It O 0 5.770819916506298e-05
is O 0 4.225214070174843e-06
one O 0 1.4621583659391035e-06
member O 0 1.2373408253552043e-06
of O 0 4.1628376834523806e-07
a O 0 5.0297649067942984e-06
family O 0 1.639342553971801e-05
of O 0 2.5547296900185756e-06
lamina O 0 0.04204787313938141
- O 0 0.020096639171242714
associated O 0 1.123969559557736e-05
proteins O 0 2.4602265966677805e-06
which O 0 1.113719804379798e-06
includes O 0 1.7135864709416637e-06
LAP1 O 0 0.001732282224111259
, O 0 2.8129986731073586e-06
LAP2 O 0 0.00017160311108455062
and O 0 7.902213837951422e-06
lamin O 0 0.0052453288808465
B O 0 0.009281732141971588
receptor O 0 7.042881043162197e-05
( O 0 1.6289726772811264e-05
LBR O 0 0.0015840003034099936
) O 0 1.7522115740575828e-05
. O 0 3.124601425952278e-05

A O 0 0.0002054667565971613
panel O 0 4.663093568524346e-05
of O 0 1.0882405149459373e-05
16 O 0 9.261618833988905e-05
monoclonal O 0 0.00023411819711327553
antibodies O 0 0.00012129537935834378
( O 0 5.490216608450282e-06
mAbs O 0 4.445992817636579e-05
) O 0 1.4144733313514735e-06
has O 0 7.536556836384989e-07
been O 0 1.050995251716813e-06
mapped O 0 3.266306748628267e-06
to O 0 5.867428285455389e-07
six O 0 1.3103666560709826e-06
specific O 0 8.150257144734496e-07
sites O 0 2.0990005396015476e-06
throughout O 0 1.2129896731494227e-06
the O 0 2.273934569529956e-06
emerin O 0 5.827814675285481e-05
molecule O 0 3.383521971045411e-06
using O 0 1.3259203797133523e-06
phage O 0 6.595671038667206e-06
- O 0 1.0979248145304155e-05
displayed O 0 5.4622028073936235e-06
peptide O 0 3.4802058053173823e-06
libraries O 0 1.5233791827995447e-06
and O 0 1.4775648651266238e-06
has O 0 1.2281075214559678e-06
been O 0 1.3572691841545748e-06
used O 0 1.241688551090192e-06
to O 0 1.971892515939544e-06
localize O 0 6.853885133750737e-05
emerin O 0 0.00015041114238556474
in O 0 3.627513933679438e-06
human O 0 4.535158041107934e-06
and O 0 2.237597254861612e-05
rabbit O 0 0.011211274191737175
heart O 0 0.028728868812322617
. O 0 8.359362982446328e-05

Several O 0 0.00028036037110723555
mAbs O 0 0.001150860101915896
against O 0 4.8974212404573336e-05
different O 0 1.0777062016131822e-05
emerin O 0 0.0007824797066859901
epitopes O 0 0.0004557868523988873
did O 0 2.8497115636128e-05
not O 0 2.9177922442613635e-06
recognize O 0 1.2199294360470958e-05
intercalated O 0 0.0003317011578474194
discs O 0 7.979573274496943e-05
in O 0 7.587740583403502e-06
the O 0 1.4076616935199127e-05
heart O 0 0.06643947213888168
, O 0 5.569811946770642e-06
though O 0 2.1082933017169125e-06
they O 0 1.8628032876222278e-06
recognized O 0 2.7083269742433913e-06
cardiomyocyte O 0 4.636833182303235e-05
nuclei O 0 1.6296782632707618e-05
strongly O 0 5.494653123605531e-06
, O 0 9.873640465229983e-07
both O 0 5.764569550592569e-07
at O 0 6.251516424526926e-06
the O 0 1.613531253497058e-06
rim O 0 1.6765316104283556e-05
and O 0 2.5659589937276905e-06
in O 0 3.244475465180585e-06
intranuclear O 0 0.00045822636457160115
spots O 0 3.577399183996022e-05
or O 0 1.2914686521980911e-05
channels O 0 6.632431177422404e-05
. O 0 6.456905248342082e-05

A O 0 0.001067268312908709
polyclonal O 0 0.0032234936952590942
rabbit O 0 0.001341772498562932
antiserum O 0 0.0010086846305057406
against O 0 4.900565909338184e-05
emerin O 0 0.004360007122159004
did O 0 2.4944692995632067e-05
recognize O 0 8.99500992090907e-06
both O 0 1.740003767736198e-06
nuclear O 0 2.5356237529194914e-05
membrane O 0 1.2156509001215454e-05
and O 0 3.392989583517192e-06
intercalated O 0 0.0008480091928504407
discs O 0 5.359252463676967e-05
but O 0 1.9752144453377696e-06
, O 0 7.422792123179534e-07
after O 0 1.6836477243487025e-06
affinity O 0 4.4689199967251625e-06
purification O 0 8.032152436499018e-06
against O 0 1.0847008979908423e-06
a O 0 2.2413530587073183e-06
pure O 0 8.127413821057416e-06
- O 0 0.0002233584236819297
emerin O 0 0.00014315746375359595
band O 0 5.606055310636293e-06
on O 0 1.183104586743866e-06
a O 0 1.502043119216978e-06
western O 0 3.3343007999064866e-06
blot O 0 0.0003642914234660566
, O 0 2.980406634378596e-06
it O 0 2.0496015622484265e-06
stained O 0 0.0006054501864127815
only O 0 2.0403281268954743e-06
the O 0 3.5122143344779033e-06
nuclear O 0 0.0002087797474814579
membrane O 0 0.00016568071441724896
. O 0 4.2275340092601255e-05

These O 0 6.871751975268126e-05
results O 0 5.981868889648467e-05
would O 0 9.731381396704819e-06
not O 0 2.027481741606607e-06
be O 0 1.3554969200413325e-06
expected O 0 1.578130309098924e-06
if O 0 9.364780453324784e-07
immunostaining O 0 5.358342605177313e-05
at O 0 1.0358165127399843e-05
intercalated O 0 0.002699990989640355
discs O 0 4.349624941824004e-05
were O 0 6.353760454658186e-06
due O 0 2.274070993735222e-06
to O 0 6.409284196706722e-07
a O 0 2.5539186481182696e-06
product O 0 7.544452955698944e-07
of O 0 2.622246029204689e-07
the O 0 1.8586545138532529e-06
emerin O 0 0.0005276086158119142
gene O 0 3.23056315210124e-06
and O 0 1.9111860183329554e-06
, O 0 1.5214161521726055e-06
therefore O 0 1.1157546850881772e-06
, O 0 4.0202112927545386e-07
cast O 0 1.0895788591369637e-06
some O 0 3.1400517741531075e-07
doubt O 0 1.7945047829925898e-06
upon O 0 6.965470333852863e-07
the O 0 1.1919698863493977e-06
hypothesis O 0 8.896143299352843e-06
that O 0 2.362212399020791e-05
cardiac B-Disease 1 0.9977497458457947
defects I-Disease 1 0.9990382194519043
in O 0 0.005229511298239231
EDMD B-Disease 1 0.9999998807907104
are O 0 2.4801613108138554e-05
caused O 0 6.073087206459604e-05
by O 0 1.7195978898598696e-06
absence O 0 5.703445822291542e-06
of O 0 2.5313167952845106e-06
emerin O 0 0.0023109985049813986
from O 0 1.3490292076312471e-05
intercalated O 0 0.0478827990591526
discs O 0 0.0031739722471684217
. O 0 0.00010632996418280527

Although O 0 0.00026511121541261673
emerin O 0 0.0013663636054843664
was O 0 5.722889181924984e-05
abundant O 0 1.0871555787161924e-05
in O 0 2.792127361317398e-06
the O 0 2.5408292003703536e-06
membranes O 0 1.6784784747869708e-05
of O 0 2.346821702303714e-06
cardiomyocyte O 0 0.0031390723306685686
nuclei O 0 5.8532459661364555e-05
, O 0 2.2514991542266216e-06
it O 0 9.840719030762557e-07
was O 0 1.1110265404568054e-05
absent O 0 2.453881052133511e-06
from O 0 6.971983452785935e-07
many O 0 6.051314471733349e-07
non O 0 4.347607500676531e-06
- O 0 0.00019711640197783709
myocyte O 0 0.0030216779559850693
cells O 0 1.3245668014860712e-05
in O 0 3.4656559364520945e-06
the O 0 2.1409472537925467e-05
heart O 0 0.030277105048298836
. O 0 6.925762863829732e-05

This O 0 3.517478035064414e-05
distribution O 0 1.5377670933958143e-05
of O 0 3.4283714285265887e-06
emerin O 0 0.0012827384052798152
was O 0 2.268245407321956e-05
similar O 0 1.4931722489563981e-06
to O 0 7.177482643783151e-07
that O 0 3.3847115332719113e-07
of O 0 4.2212363382532203e-07
lamin O 0 0.00015727480058558285
A O 0 1.3325055078894366e-05
, O 0 1.1766928764700424e-06
a O 0 2.066900378849823e-06
candidate O 0 4.7268663365684915e-06
gene O 0 3.651932729553664e-06
for O 0 6.717025939906307e-07
an O 0 5.037728897150373e-06
autosomal O 0 0.001187398680485785
form O 0 1.5462283045053482e-05
of O 0 7.259621634148061e-05
EDMD B-Disease 1 0.9999980926513672
. O 0 0.00024516673875041306

In O 0 0.00022050771804060787
contrast O 0 0.00022449959942605346
, O 0 3.517256845952943e-05
lamin O 0 0.09277345985174179
B1 O 1 0.8277145624160767
was O 0 7.992456812644377e-05
absent O 0 1.2311586942814756e-05
from O 0 2.4141195353877265e-06
cardiomyocyte O 0 0.00020083463459741324
nuclei O 0 3.0140696253511123e-05
, O 0 2.794887677737279e-06
showing O 0 2.8783462767023593e-05
that O 0 5.551622507482534e-06
lamin O 0 0.12792740762233734
B1 O 0 0.4670712649822235
is O 0 1.124316895584343e-06
not O 0 5.695058007404441e-07
essential O 0 4.144892500335118e-07
for O 0 3.019677876636706e-07
localization O 0 2.693082251425949e-06
of O 0 9.731184036354534e-07
emerin O 0 0.0001883272925624624
to O 0 2.3913771656225435e-06
the O 0 6.198886694619432e-06
nuclear O 0 0.0024429960176348686
lamina O 0 0.003044858807697892
. O 0 7.740550063317642e-05

Lamin O 1 0.9265100359916687
B1 O 1 0.9947403073310852
is O 0 4.3691474274965e-05
also O 0 1.6325822798535228e-05
almost O 0 1.161354248324642e-05
completely O 0 3.1236388167599216e-05
absent O 0 1.711814729787875e-05
from O 0 9.970068276743405e-06
skeletal O 0 0.0429861843585968
muscle O 0 0.06880216300487518
nuclei O 0 0.004750506021082401
. O 0 0.00020797863544430584

In O 0 0.0006989919929765165
EDMD B-Disease 1 0.9998173117637634
, O 0 1.15141147034592e-05
the O 0 2.2193130462255795e-06
additional O 0 3.0494788916257676e-06
absence O 0 5.933427019044757e-06
of O 0 3.3197816264873836e-06
lamin O 0 0.060929469764232635
B1 O 0 0.2696376442909241
from O 0 7.44899125493248e-06
heart O 0 0.001554197515361011
and O 0 2.843429865606595e-05
skeletal O 0 0.19714459776878357
muscle O 0 0.03747539967298508
nuclei O 0 0.0017086260486394167
which O 0 1.415521910530515e-05
already O 0 0.00019173471082467586
lack O 0 5.002494071959518e-05
emerin O 0 0.08083027601242065
may O 0 1.4236719835025724e-05
offer O 0 9.419471211913333e-07
an O 0 5.21090612437547e-07
alternative O 0 9.017227853291843e-07
explanation O 0 8.081133842097188e-07
of O 0 4.4837483414994495e-07
why O 0 3.4998497540073004e-06
these O 0 7.400407184832147e-07
tissues O 0 3.1847681384533644e-05
are O 0 1.7458979755247128e-06
particularly O 0 9.854160452960059e-06
affected O 0 4.540955706033856e-05
. O 0 8.048437848628964e-06
. O 0 5.2750270697288215e-05

Genetic O 0 0.0005999628338031471
mapping O 0 0.00014895944332238287
of O 0 1.1706403711286839e-05
the O 0 3.311194814159535e-05
copper B-Disease 0 0.00455519650131464
toxicosis I-Disease 0 0.010535560548305511
locus O 0 0.00011753942089853808
in O 0 1.1632519090198912e-05
Bedlington O 0 0.0020518768578767776
terriers O 0 0.00038472257438115776
to O 0 6.922532520547975e-06
dog O 0 0.00029506091959774494
chromosome O 0 0.00032528353040106595
10 O 0 7.684910997340921e-06
, O 0 1.40603924592142e-06
in O 0 9.893434480545693e-07
a O 0 4.471864940569503e-06
region O 0 1.2870828868472017e-05
syntenic O 0 0.0005157476989552379
to O 0 2.0339091406640364e-06
human O 0 5.132323622092372e-06
chromosome O 0 0.00021944977925159037
region O 0 4.2065737943630666e-05
2p13 O 0 0.0015391007764264941
- O 0 0.00407424895092845
p16 O 0 0.0005499486578628421
. O 0 8.59058927744627e-05

Abnormal O 1 0.9962782263755798
hepatic B-Disease 1 0.9997925162315369
copper I-Disease 1 0.9723888635635376
accumulation I-Disease 0 0.15214742720127106
is O 0 1.4528422980220057e-05
recognized O 0 1.164532750408398e-05
as O 0 8.669545422890224e-06
an O 0 0.0034215489868074656
inherited B-Disease 1 1.0
disorder I-Disease 1 0.9999969005584717
in O 0 2.972128459077794e-05
man O 0 0.0023361649364233017
, O 0 4.418493972480064e-06
mouse O 0 3.59960577043239e-05
, O 0 4.9655272960080765e-06
rat O 0 0.0003052816609852016
and O 0 1.5597204765072092e-05
dog O 0 0.0010195951908826828
. O 0 6.121357000665739e-05

The O 0 0.000122467361507006
major O 0 8.10929705039598e-05
cause O 0 7.528688729507849e-05
of O 0 1.8169179384130985e-05
hepatic B-Disease 1 0.923148512840271
copper I-Disease 1 0.7551379799842834
accumulation I-Disease 0 0.0019344121683388948
in O 0 1.1843071661132853e-05
man O 0 0.00025474760332144797
is O 0 1.619205363567744e-06
a O 0 1.2989959031983744e-05
dysfunctional O 0 0.010173691436648369
ATP7B O 0 0.10233045369386673
gene O 0 4.5237709855427966e-05
, O 0 1.6595649867667817e-05
causing O 0 0.147909015417099
Wilson B-Disease 1 0.6581583023071289
disease I-Disease 1 0.690322995185852
( O 0 7.861588528612629e-05
WD B-Disease 1 0.9805759787559509
) O 0 3.172452124999836e-05
. O 0 6.76782219670713e-05

Mutations O 0 0.0012347938027232885
in O 0 4.661105776904151e-05
the O 0 1.8707592971622944e-05
ATP7B O 0 0.010017717257142067
genes O 0 1.3476495041686576e-05
have O 0 3.775388904614374e-06
also O 0 2.242648633909994e-06
been O 0 4.494979748415062e-06
demonstrated O 0 7.53995982449851e-06
in O 0 2.40557233155414e-06
mouse O 0 5.80339583393652e-05
and O 0 2.0018867871840484e-05
rat O 0 0.015103637240827084
. O 0 8.964317385107279e-05

The O 0 0.00015911052469164133
ATP7B O 0 0.008558528497815132
gene O 0 4.8620273446431383e-05
has O 0 9.516268619336188e-06
been O 0 6.780453986721113e-06
excluded O 0 5.8860296121565625e-06
in O 0 7.814716695975221e-07
the O 0 1.1858392099384218e-06
much O 0 3.887831553583965e-06
rarer O 0 0.00010963877139147371
human O 0 2.237793341919314e-05
copper B-Disease 1 0.8753801584243774
overload I-Disease 1 0.9996509552001953
disease O 0 0.2862277328968048
non B-Disease 0 4.6287656005006284e-05
- I-Disease 0 0.01835932582616806
Indian I-Disease 0 9.884374594548717e-05
childhood I-Disease 1 0.9037940502166748
cirrhosis I-Disease 1 0.9993638396263123
, O 0 8.268302190117538e-05
indicating O 0 0.0011831230949610472
genetic O 0 0.0005652718828059733
heterogeneity O 0 0.0009160304325632751
. O 0 0.00015926595369819552

By O 0 0.00010326811752747744
investigating O 0 0.00011128976620966569
the O 0 2.9090097086736932e-05
common O 0 0.00018685789837036282
autosomal O 1 0.9544959664344788
recessive O 1 0.99124675989151
copper B-Disease 1 0.9885199666023254
toxicosis I-Disease 1 0.9983412027359009
( O 0 3.651487349998206e-05
CT B-Disease 0 0.433851420879364
) O 0 3.421088194954791e-06
in O 0 3.4696706734393956e-06
Bedlington O 0 0.005769631825387478
terriers O 0 0.006638184655457735
, O 0 4.717710908153094e-06
we O 0 2.5946931145881535e-06
have O 0 9.531260047879186e-07
identified O 0 1.458617930438777e-06
a O 0 6.523603701680258e-07
new O 0 1.818777263906668e-06
locus O 0 6.824158481322229e-05
involved O 0 1.5095322851266246e-05
in O 0 0.00017468834994360805
progressive O 1 0.9999047517776489
liver B-Disease 1 1.0
disease I-Disease 1 0.9999995231628418
. O 0 0.0005175843834877014

We O 0 0.00025510514387860894
examined O 0 0.0002101271675201133
whether O 0 1.8930455553345382e-05
the O 0 2.314810626558028e-05
WD B-Disease 1 0.9374884366989136
gene O 0 8.245232311310247e-05
ATP7B O 0 0.015378952957689762
was O 0 7.089449354680255e-05
also O 0 5.19883678862243e-06
causative O 0 9.031161425809842e-06
for O 0 1.8612229268910596e-06
CT B-Disease 0 0.14479078352451324
by O 0 2.7817939098895295e-06
investigating O 0 9.447150659980252e-06
the O 0 6.074539214750985e-06
chromosomal O 0 0.04947260394692421
co O 0 0.0021275747567415237
- O 0 8.650631934870034e-05
localization O 0 1.2703543688985519e-05
of O 0 2.387929043834447e-06
ATP7B O 0 0.003287379862740636
and O 0 3.839783403236652e-06
C04107 O 0 4.60921655758284e-05
, O 0 8.041840260375466e-07
using O 0 1.4304793012342998e-06
fluorescence O 0 1.0741784535639454e-05
in O 0 3.551185500327847e-06
situ O 0 2.83531189779751e-05
hybridization O 0 9.917778697854374e-06
( O 0 3.5167688565707067e-06
FISH O 0 9.511614734947216e-06
) O 0 6.904005658725509e-06
. O 0 2.6082067051902413e-05

C04107 O 0 0.014392167329788208
is O 0 4.576499486574903e-05
an O 0 1.4913841368979774e-05
anonymous O 0 4.605390495271422e-05
microsatellite O 0 0.00023894461628515273
marker O 0 8.058703679125756e-05
closely O 0 2.8220294552738778e-05
linked O 0 0.00014065705181565136
to O 0 3.06518777506426e-05
CT B-Disease 1 0.94135981798172
. O 0 0.00015958503354340792

However O 0 0.00022163540415931493
, O 0 7.322173769352958e-05
BAC O 0 0.0008564573945477605
clones O 0 0.00016017943562474102
containing O 0 3.202606239938177e-05
ATP7B O 0 0.0017267416696995497
and O 0 1.1288591849734075e-05
C04107 O 0 0.00010130347072845325
mapped O 0 2.5685063519631512e-05
to O 0 1.8560825765234767e-06
the O 0 2.2357617126544937e-06
canine O 0 0.00025737055693753064
chromosome O 0 0.00034410800435580313
regions O 0 1.9889070244971663e-05
CFA22q11 O 0 0.006697601638734341
and O 0 1.245621115231188e-05
CFA10q26 O 0 0.002401478122919798
, O 0 2.0001909888378577e-06
respectively O 0 7.854886462155264e-06
, O 0 1.0183310905631515e-06
demonstrating O 0 9.415705790161155e-06
that O 0 4.562836238619639e-06
WD B-Disease 0 0.4850292205810547
cannot O 0 9.69711436482612e-06
be O 0 2.7334529022482457e-06
homologous O 0 2.088282235490624e-05
to O 0 1.6796828276710585e-05
CT B-Disease 1 0.7689394950866699
. O 0 8.528726175427437e-05

The O 0 0.00016306337784044445
copper O 0 0.000291642703814432
transport O 0 6.144688813947141e-05
genes O 0 2.4590781322331168e-05
CTR1 O 0 0.0003178958431817591
and O 0 7.325537808355875e-06
CTR2 O 0 0.016896581277251244
were O 0 1.446874830435263e-05
also O 0 2.8458259748731507e-06
excluded O 0 5.77655100642005e-06
as O 0 6.331950430649158e-07
candidate O 0 1.48615299622179e-06
genes O 0 1.3470508974933182e-06
for O 0 8.191299230020377e-07
CT B-Disease 0 0.12252254784107208
since O 0 7.021854798949789e-06
they O 0 9.671923635323765e-07
both O 0 3.742916021565179e-07
mapped O 0 1.0575673513812944e-05
to O 0 2.7641076485451777e-06
canine O 0 0.00046233402099460363
chromosome O 0 0.0008877782383933663
region O 0 0.00017153850058093667
CFA11q22 O 0 0.014289762824773788
. O 0 8.606078336015344e-05

2 O 0 0.0013815205311402678
- O 0 0.003011790569871664
22 O 0 0.00043811966315843165
. O 0 0.00013926535029895604

5 O 0 0.003684560302644968
. O 0 0.0014909030869603157

A O 0 0.0002596078848000616
transcribed O 0 0.0002485519216861576
sequence O 0 2.4394646970904432e-05
identified O 0 8.757312571106013e-06
from O 0 1.786891630217724e-06
the O 0 2.7522025902726455e-06
C04107 O 0 0.00013020938786212355
- O 0 6.41734222881496e-05
containing O 0 1.1677802831400186e-05
BAC O 0 0.00017842724628280848
was O 0 2.095957643177826e-05
found O 0 1.290932459596661e-06
to O 0 4.5159981709730346e-07
be O 0 4.077542996583361e-07
homologous O 0 1.2258257129360572e-06
to O 0 5.928529844823061e-07
a O 0 2.3199895622383337e-06
gene O 0 3.9698775253782514e-06
expressed O 0 9.85225028671266e-07
from O 0 1.3098293720759102e-06
human O 0 2.075579686788842e-06
chromosome O 0 0.0001156681464635767
2p13 O 0 0.0002461995172780007
- O 0 0.0009025106555782259
p16 O 0 5.053385393694043e-05
, O 0 1.2341799902060302e-06
a O 0 1.3367033488975721e-06
region O 0 3.3996095680777216e-06
devoid O 0 4.148220341448905e-06
of O 0 5.666518063662807e-07
any O 0 1.959952214747318e-06
positional O 0 9.523065818939358e-05
candidate O 0 8.478725794702768e-05
genes O 0 8.016898937057704e-05
. O 0 5.815345866722055e-05

Molecular O 0 0.00042635921272449195
analysis O 0 3.810113776125945e-05
of O 0 4.3429167817521375e-06
the O 0 5.405645424616523e-06
APC B-Disease 0 4.837571032112464e-05
gene O 0 6.302902420429746e-06
in O 0 1.9042560097659589e-06
205 O 0 1.214017356687691e-05
families O 0 4.626916961569805e-06
: O 0 9.386766919305956e-07
extended O 0 4.666187123802956e-06
genotype O 0 0.00015148012607824057
- O 0 0.00018067716155201197
phenotype O 0 8.193644316634163e-05
correlations O 0 1.4294647371571045e-05
in O 0 1.0808988918142859e-05
FAP B-Disease 0 0.00012075737322447821
and O 0 3.5420669064478716e-06
evidence O 0 1.8034088498097844e-06
for O 0 5.108032610223745e-07
the O 0 9.800652378544328e-07
role O 0 2.0999334537918912e-06
of O 0 1.4572802911061444e-06
APC B-Disease 0 0.00019417038129176944
amino O 0 1.586005419085268e-05
acid O 0 3.183866283507086e-05
changes O 0 2.168105675082188e-05
in O 0 0.19096970558166504
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
predisposition O 1 0.9927834272384644
. O 0 0.0005151606164872646

BACKGROUND O 0 0.0017048611771315336
/ O 0 0.0003654354368336499
AIMS O 0 7.40814721211791e-05
The O 0 6.574168310180539e-06
development O 0 1.2488146239775233e-05
of O 0 0.0015744129195809364
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
and O 0 2.227785807917826e-05
a O 0 9.336172297480516e-06
variable O 0 9.623376172385179e-06
range O 0 1.8568615587355453e-06
of O 0 1.9390604393265676e-06
extracolonic O 0 0.07108396291732788
manifestations O 0 0.00025499792536720634
in O 0 0.027624424546957016
familial B-Disease 1 1.0
adenomatous I-Disease 1 0.9999997615814209
polyposis I-Disease 1 1.0
( O 0 0.004028071649372578
FAP B-Disease 0 0.06144227460026741
) O 0 4.885482667305041e-06
is O 0 8.561294748687942e-07
the O 0 9.714873385746614e-07
result O 0 2.7584878807829227e-06
of O 0 6.766364322174923e-07
the O 0 7.225761692097876e-06
dominant O 0 0.00011657012510113418
inheritance O 0 0.00033124638139270246
of O 0 0.003449255833402276
adenomatous B-Disease 1 0.9999998807907104
polyposis I-Disease 1 0.9999990463256836
coli I-Disease 1 0.9999490976333618
( O 0 7.877415191615e-05
APC B-Disease 0 0.000601309584453702
) O 0 1.754152799549047e-05
gene O 0 0.00010018459579441696
mutations O 0 0.0002081861748592928
. O 0 0.00010790602391352877

In O 0 5.4397056374000385e-05
this O 0 4.685629392042756e-06
study O 0 3.5958123589807656e-06
, O 0 9.365950290884939e-07
direct O 0 1.4034121704753488e-06
mutation O 0 2.8878419016109547e-06
analysis O 0 7.413679554701957e-07
of O 0 3.3234897500733496e-07
the O 0 1.99378996512678e-06
APC B-Disease 0 6.152797141112387e-05
gene O 0 3.6248613923817175e-06
was O 0 9.492973731539678e-06
performed O 0 6.323849447653629e-06
to O 0 1.3298663361638319e-06
determine O 0 1.5900430298643187e-05
genotype O 0 0.0011220360174775124
- O 0 0.00038379579200409353
phenotype O 0 7.049660780467093e-05
correlations O 0 9.907192179525737e-06
for O 0 1.7045147160388296e-06
nine O 0 1.9204808268113993e-05
extracolonic O 0 0.0006323634879663587
manifestations O 0 7.62198715165141e-06
and O 0 1.4173238014336675e-06
to O 0 1.1805527719843667e-06
investigate O 0 3.7412034998851595e-06
the O 0 1.986297320399899e-06
incidence O 0 6.563284114236012e-05
of O 0 1.8679338609217666e-06
APC B-Disease 0 0.000409318832680583
mutations O 0 5.214196426095441e-05
in O 0 2.2392237951862626e-05
non O 0 0.007126083131879568
- O 1 0.9999680519104004
FAP O 1 0.999983549118042
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 0.0007683222647756338

METHODS O 0 0.0004403941857162863
The O 0 5.213360782363452e-05
APC B-Disease 0 0.0002663899795152247
gene O 0 4.852962592849508e-05
was O 0 2.1617202946799807e-05
analysed O 0 2.3212433006847277e-05
in O 0 3.3538342449901393e-06
190 O 0 1.4121352251095232e-05
unrelated O 0 2.151283115381375e-05
FAP B-Disease 0 8.401975355809554e-05
and O 0 8.42192366690142e-06
15 O 0 5.797367339255288e-05
non O 0 0.0006622838554903865
- O 1 0.9999070167541504
FAP O 1 0.999941349029541
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 0 0.45913058519363403
using O 0 7.438033208018169e-05
denaturing O 0 0.05201336741447449
gradient O 0 0.001305558136664331
gel O 0 0.015072343870997429
electrophoresis O 0 0.00020471701282076538
, O 0 2.0261845747882035e-06
the O 0 1.344643123957212e-06
protein O 0 4.698113116319291e-06
truncation O 0 1.210213031299645e-05
test O 0 9.92018249235116e-06
, O 0 1.7452205156587297e-06
and O 0 1.6738656540837837e-06
direct O 0 6.4044538703456055e-06
sequencing O 0 7.95847736299038e-05
. O 0 3.464184919721447e-05

RESULTS O 0 0.0016793501563370228
Chain O 0 0.0005739313783124089
terminating O 0 0.00016044160292949528
signals O 0 3.066725912503898e-05
were O 0 6.846660653536674e-06
only O 0 1.6701743561498006e-06
identified O 0 7.95348114479566e-06
in O 0 5.235820481175324e-06
patients O 0 9.860021236818284e-05
belonging O 0 1.0049166121461894e-05
to O 0 1.274776082027529e-06
the O 0 5.040021278546192e-06
FAP B-Disease 0 0.00018864954472519457
group O 0 2.4828308596624993e-05
( O 0 4.094992618774995e-06
105 O 0 4.533254468697123e-05
patients O 0 0.0001952129096025601
) O 0 1.326722303929273e-05
. O 0 2.847894029400777e-05

Amino O 0 0.000827771844342351
acid O 0 0.00019058315956499428
changes O 0 1.27459070426994e-05
were O 0 8.472983608953655e-06
identified O 0 6.950142960704397e-06
in O 0 2.4117814518831437e-06
four O 0 2.628196671139449e-05
patients O 0 0.0004142813559155911
, O 0 1.1833121789095458e-06
three O 0 7.183316483860835e-07
of O 0 6.147200792838703e-07
whom O 0 9.871391739579849e-06
belonged O 0 1.705028989817947e-05
to O 0 6.006879971209855e-07
the O 0 2.102181724694674e-06
non O 0 1.9393122784094885e-05
- O 0 0.007973848842084408
FAP O 0 0.0003016743576154113
group O 0 0.0001087541168089956
of O 0 0.007373694330453873
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9982832670211792
. O 0 0.00041307855281047523

Genotype O 0 0.4081413149833679
- O 0 0.2711666226387024
phenotype O 0 0.004738945979624987
correlations O 0 0.0002163092140108347
identified O 0 8.970576163847e-05
significant O 0 6.7365672293817624e-06
differences O 0 5.039973075326998e-06
in O 0 2.5237552563339705e-06
the O 0 1.5064053968671942e-06
nature O 0 1.2906948541058227e-06
of O 0 6.621975217058207e-07
certain O 0 3.3689748306642286e-06
extracolonic O 0 0.004345896188169718
manifestations O 0 5.427875657915138e-05
in O 0 5.186870475881733e-05
FAP B-Disease 0 0.04563647508621216
patients O 0 0.00037033570697531104
belonging O 0 2.6482612156542018e-05
to O 0 4.416000592755154e-06
three O 0 1.7902173567563295e-05
mutation O 0 0.00015578139573335648
subgroups O 0 0.00025222808471880853
. O 0 9.148318349616602e-05

CONCLUSIONS O 0 0.0008914659265428782
Extended O 0 0.00030742253875359893
genotype O 0 0.0030743905808776617
- O 0 0.004051235970109701
phenotype O 0 0.00031982039217837155
correlations O 0 3.109542012680322e-05
made O 0 4.952899871568661e-06
in O 0 2.3390859951177845e-06
this O 0 9.034072832037054e-07
study O 0 1.7483438341514557e-06
may O 0 1.109414006350562e-05
have O 0 7.378117174994259e-07
the O 0 4.929697183797543e-07
potential O 0 1.312111066908983e-06
to O 0 5.511560061677301e-07
determine O 0 1.2935253153045778e-06
the O 0 3.34421287107034e-07
most O 0 2.669776222319342e-07
appropriate O 0 6.909933176757477e-07
surveillance O 0 3.774085826080409e-06
and O 0 3.3110643471445655e-06
prophylactic O 0 0.0015829590847715735
treatment O 0 0.000817304418887943
regimens O 0 0.00033703941153362393
for O 0 5.598174993792782e-06
those O 0 2.8899614335387014e-05
patients O 0 0.000394609262002632
with O 0 1.0222729542874731e-05
mutations O 0 0.00029419740894809365
associated O 0 1.6054413208621554e-05
with O 0 2.0705558199551888e-05
life O 0 0.0003339603717904538
threatening O 0 0.0662277489900589
conditions O 0 0.021679196506738663
. O 0 0.00012323394184932113

This O 0 2.911457522714045e-05
study O 0 1.5546107533737086e-05
also O 0 7.203813765954692e-06
provided O 0 5.084139502287144e-06
evidence O 0 2.2715914838045137e-06
for O 0 9.532205353934842e-07
the O 0 1.8993409867107403e-06
pathological O 0 4.1176925151376054e-05
nature O 0 1.919740498124156e-06
of O 0 1.455574647479807e-06
amino O 0 2.2446030925493687e-05
acid O 0 9.635884453018662e-06
changes O 0 1.0546449402681901e-06
in O 0 2.3312361463467823e-06
APC O 0 6.677654891973361e-05
associated O 0 2.2548729248228483e-06
with O 0 1.2324204590186127e-06
both O 0 2.962361577374395e-06
FAP B-Disease 0 0.00010318886779714376
and O 0 2.722455610637553e-05
non O 0 0.0016238666139543056
- O 1 0.9999483823776245
FAP O 1 0.9999904632568359
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
patients O 1 0.9993407130241394
. O 0 0.00011498489766381681
. O 0 0.00016097132174763829

Inherited B-Disease 1 0.9999940395355225
colorectal I-Disease 1 1.0
polyposis I-Disease 1 0.9999955892562866
and O 1 0.9251431822776794
cancer B-Disease 1 0.9999743700027466
risk O 0 0.005082201678305864
of O 0 5.29003636984271e-06
the O 0 4.021423956146464e-05
APC O 0 0.0015509583754464984
I1307K O 0 0.0010195820359513164
polymorphism O 0 0.0005794645403511822
. O 0 0.00016327667981386185

Germ O 0 0.011198393069207668
- O 0 0.0012821631971746683
line O 0 6.996111187618226e-05
and O 0 5.192623120819917e-06
somatic O 0 3.0062388759688474e-05
truncating O 0 6.284147821133956e-05
mutations O 0 1.1323819308017846e-05
of O 0 9.651247410147334e-07
the O 0 3.609228315326618e-06
APC B-Disease 0 8.098894613794982e-05
gene O 0 3.9485289562435355e-06
are O 0 5.776561806669633e-07
thought O 0 2.954106548713753e-06
to O 0 3.2656714665790787e-06
initiate O 0 0.00312716793268919
colorectal B-Disease 1 0.9999998807907104
tumor I-Disease 1 0.9985467791557312
formation O 0 0.02622610703110695
in O 0 0.2748313248157501
familial B-Disease 1 1.0
adenomatous I-Disease 1 1.0
polyposis I-Disease 1 1.0
syndrome I-Disease 1 1.0
and O 0 0.10860851407051086
sporadic O 1 0.9991694688796997
colorectal O 1 1.0
carcinogenesis O 1 0.997548520565033
, O 0 0.0005435732891783118
respectively O 0 0.001097877393476665
. O 0 0.00014522959827445447

Recently O 0 0.0010072480654343963
, O 0 5.145673640072346e-05
an O 0 3.9766295230947435e-05
isoleucine O 0 0.029187826439738274
- O 0 0.001977881183847785
- O 0 0.0007514596218243241
> O 0 8.325561066158116e-05
lysine O 0 3.784621003433131e-05
polymorphism O 0 3.5339195164851844e-05
at O 0 1.5644995073671453e-05
codon O 0 4.640947008738294e-05
1307 O 0 0.000149629675433971
( O 0 2.761583346000407e-06
I1307K O 0 2.0413737729541026e-05
) O 0 4.3274232552903413e-07
of O 0 2.726714853906742e-07
the O 0 1.718542080197949e-06
APC B-Disease 0 3.248320717830211e-05
gene O 0 3.280247710790718e-06
has O 0 8.190729090529203e-07
been O 0 1.4645348755948362e-06
identified O 0 1.5252879848048906e-06
in O 0 7.03067371432553e-07
6 O 0 1.1706839359248988e-05
% O 0 1.562711872793443e-06
- O 0 3.525013380567543e-05
7 O 0 5.813467851112364e-06
% O 0 4.422531674208585e-07
of O 0 4.058734077716508e-07
the O 0 2.5426691081520403e-06
Ashkenazi O 0 4.502389128901996e-05
Jewish O 0 1.790558781067375e-05
population O 0 1.5306070054066367e-05
. O 0 3.522697807056829e-05

To O 0 0.00016541047079954296
assess O 0 0.0003157058672513813
the O 0 1.8019261915469542e-05
risk O 0 3.059390655835159e-05
of O 0 1.0847195426322287e-06
this O 0 1.1225982916585053e-06
common O 0 4.771114163304446e-06
APC B-Disease 0 6.636663601966575e-05
allelic O 0 6.335890793707222e-05
variant O 0 9.279503865400329e-05
in O 0 0.0011800611391663551
colorectal O 1 0.9999997615814209
carcinogenesis O 1 0.8943809270858765
, O 0 0.00012346412404440343
we O 0 9.021984624268953e-06
have O 0 2.068213689199183e-06
analyzed O 0 5.256533313513501e-06
a O 0 1.5910902675386751e-06
large O 0 3.8006332943041343e-06
cohort O 0 3.726263821590692e-05
of O 0 1.487234840169549e-06
unselected O 0 0.0002446112921461463
Ashkenazi O 0 4.271120633347891e-05
Jewish O 0 1.218941997649381e-05
subjects O 0 1.3413487067737151e-05
with O 0 6.037666025804356e-05
adenomatous B-Disease 1 0.9172735810279846
polyps I-Disease 0 0.0775253027677536
and O 0 7.95694359112531e-05
. O 0 0.00012692752352450043
or O 1 0.8641332387924194
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
, I-Disease 0 1.5093106412678026e-05
for O 0 2.2041792817617534e-06
the O 0 1.3741033399128355e-05
APC O 0 0.00046808371553197503
I1307K O 0 0.0005918809911236167
polymorphism O 0 0.00043795144301839173
. O 0 6.304514681687579e-05

The O 0 0.00019454231369309127
APC O 0 0.001065604155883193
I1307K O 0 0.0005669512902386487
allele O 0 0.00010661088890628889
was O 0 6.37220946373418e-05
identified O 0 1.1851183444377966e-05
in O 0 2.295980266353581e-06
48 O 0 1.638433059270028e-05
( O 0 8.340807085005508e-07
10 O 0 1.0658980045263888e-06
. O 0 3.8272216329460207e-07
1 O 0 1.1709926184266806e-06
% O 0 1.1098139793830342e-06
) O 0 7.606510621371854e-07
of O 0 1.7311948568021762e-06
476 O 0 0.0008504174184054136
patients O 0 0.0010645760921761394
. O 0 6.263823888730258e-05

Compared O 0 0.0003140987828373909
with O 0 1.0172577276534867e-05
the O 0 3.8693597161909565e-06
frequency O 0 8.639848601887934e-06
in O 0 2.342298103030771e-06
two O 0 1.929990958160488e-06
separate O 0 5.430183136923006e-06
population O 0 1.9867709397658473e-06
control O 0 6.969417881919071e-06
groups O 0 7.869565479268203e-07
, O 0 7.507804298256815e-07
the O 0 2.4890775875974214e-06
APC O 0 7.288060442078859e-05
I1307K O 0 7.132060272851959e-05
allele O 0 1.437280934624141e-05
is O 0 8.565264124626992e-07
associated O 0 1.4228724012355087e-06
with O 0 5.567495122704713e-07
an O 0 1.7206970142069622e-06
estimated O 0 9.50002868194133e-06
relative O 0 4.682039434555918e-05
risk O 0 1.7376825780957006e-05
of O 0 2.543644086472341e-06
1 O 0 4.4259581045480445e-05
. O 0 4.6768498577876016e-05

5 O 0 0.0014498761156573892
- O 0 0.002062264597043395
1 O 0 0.0002668386441655457
. O 0 0.00014335100422613323

7 O 0 0.0043013128452003
for O 0 0.0004974912735633552
colorectal B-Disease 1 0.9999995231628418
neoplasia I-Disease 1 0.9967142343521118
( O 0 3.0267692636698484e-05
both O 0 2.0726974980789237e-05
P O 1 0.7254059910774231
= O 0 0.0003936408902518451
. O 0 4.098461431567557e-06
01 O 0 0.001400183653458953
) O 0 1.685758434177842e-05
. O 0 4.253090082784183e-05

Furthermore O 0 0.0005247993976809084
, O 0 2.5733777874847874e-05
compared O 0 1.5031269867904484e-05
with O 0 7.697738510614727e-06
noncarriers O 0 0.0011870232410728931
, O 0 1.3745463547820691e-05
APC O 0 0.00011640250158961862
I1307K O 0 0.00011633647955022752
carriers O 0 1.6897822206374258e-05
had O 0 1.5949834050843492e-05
increased O 0 3.252142505516531e-06
numbers O 0 2.8749734610755695e-06
of O 0 1.86211059371999e-06
adenomas B-Disease 0 0.03990679979324341
and O 0 0.04814028739929199
colorectal B-Disease 1 1.0
cancers I-Disease 1 0.9997811913490295
per O 0 0.0012769760796800256
patient O 1 0.8309640884399414
( O 0 2.096733260259498e-05
P O 1 0.7479569911956787
= O 0 0.0009595666779205203
. O 0 1.6225612853304483e-06
03 O 0 0.00034068027161993086
) O 0 9.166508334601531e-07
, O 0 3.3030744361894904e-07
as O 0 2.796887486056221e-07
well O 0 2.966959584682627e-07
as O 0 5.219694685365539e-07
a O 0 3.850189841614338e-06
younger O 0 4.2213221604470164e-05
age O 0 4.651558992918581e-05
at O 0 0.0002131570945493877
diagnosis O 1 0.6252623796463013
. O 0 0.00013708484766539186

We O 0 0.00017533030768390745
conclude O 0 6.393880175892264e-05
that O 0 3.319293909953558e-06
the O 0 3.1794315873412415e-06
APC O 0 5.02411785419099e-05
I1307K O 0 4.614186764229089e-05
variant O 0 1.4399577594303992e-05
leads O 0 6.580102308362257e-06
to O 0 5.723977665184066e-06
increased O 0 0.00033000452094711363
adenoma B-Disease 1 0.999927282333374
formation O 0 2.5502542484900914e-05
and O 0 2.3185561985883396e-06
directly O 0 1.917552026498015e-06
contributes O 0 1.2802439641745877e-06
to O 0 4.375524156330357e-07
3 O 0 2.093918055834365e-06
% O 0 1.2844386674260022e-06
- O 0 1.6153560864040628e-05
4 O 0 2.2421741050493438e-06
% O 0 6.864312354082358e-07
of O 0 8.105972710836795e-07
all O 0 5.339662493497599e-06
Ashkenazi O 0 0.005205652676522732
Jewish O 1 0.6671211123466492
colorectal B-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
. O 0 0.0008875071653164923

The O 0 6.991656118771061e-05
estimated O 0 7.261255086632445e-05
relative O 0 8.313122089020908e-05
risk O 0 8.19389388198033e-05
for O 0 4.131933565076906e-06
carriers O 0 0.0003401584690436721
may O 0 5.553948358283378e-05
justify O 0 1.2853262887801975e-05
specific O 0 9.715697615320096e-07
clinical O 0 1.1320310477458406e-05
screening O 0 6.999885044933762e-06
for O 0 8.54338395583909e-07
the O 0 9.882024869511952e-07
360 O 0 5.3653384384233505e-06
, O 0 9.90141984402726e-07
000 O 0 1.402582711307332e-06
Americans O 0 7.005267548265692e-07
expected O 0 8.671065074850048e-07
to O 0 7.385502271972655e-07
harbor O 0 2.1405143343145028e-05
this O 0 3.0046595611565863e-07
allele O 0 3.6718349747388856e-06
, O 0 7.012647529336391e-07
and O 0 8.744975161789625e-07
genetic O 0 6.474727797467494e-06
testing O 0 5.228440841165138e-06
in O 0 8.527462682650366e-07
the O 0 5.370700364437653e-07
setting O 0 2.045373776127235e-06
of O 0 6.11658151683514e-07
long O 0 4.456689930520952e-05
- O 0 0.0030052659567445517
term O 0 2.179931652790401e-05
- O 0 0.0004793429106939584
outcome O 0 4.322331278672209e-06
studies O 0 3.439020701989648e-06
may O 0 1.8418950276100077e-05
impact O 0 1.34261317725759e-05
significantly O 0 0.0001740089210215956
on O 1 0.819266140460968
colorectal B-Disease 1 1.0
cancer I-Disease 1 1.0
prevention O 0 0.07687590271234512
in O 0 3.2050415029516444e-05
this O 0 9.05764136405196e-06
population O 0 3.212211231584661e-05
. O 0 5.1778170018224046e-05

Localization O 0 0.0003131371922791004
of O 0 1.782000435923692e-05
human O 0 1.6101732398965396e-05
BRCA1 O 0 0.00025887376978062093
and O 0 3.7816373605892295e-06
its O 0 7.562196969956858e-06
loss O 0 0.0001634583022678271
in O 0 2.7920768843614496e-06
high O 0 0.00031137693440541625
- O 0 0.006183694116771221
grade O 0 0.00010130520968232304
, O 0 5.600092208624119e-06
non B-Disease 0 6.96358983987011e-05
- I-Disease 1 0.9794051647186279
inherited I-Disease 1 0.9995423555374146
breast I-Disease 1 0.9999146461486816
carcinomas I-Disease 1 0.9999923706054688
. O 0 0.0007766022463329136

Although O 0 8.352494478458539e-05
the O 0 1.099420933314832e-05
link O 0 2.2311282009468414e-05
between O 0 7.646092853974551e-06
the O 0 3.1398856663145125e-05
BRCA1 O 1 0.6545435786247253
tumour B-Disease 1 0.9999890327453613
- O 0 0.00862104818224907
suppressor O 0 0.0002600984007585794
gene O 0 2.8425867640180513e-05
and O 0 2.7281525035505183e-05
hereditary B-Disease 1 0.9988428354263306
breast I-Disease 1 0.9999946355819702
and I-Disease 1 0.9999492168426514
ovarian I-Disease 1 1.0
cancer I-Disease 1 0.9999998807907104
is O 0 1.3981427400722168e-05
established O 0 1.0761554221971892e-05
, O 0 1.587352812748577e-06
the O 0 8.910424185160082e-07
role O 0 2.339313596166903e-06
, O 0 1.1474218126750202e-06
if O 0 3.5170805290363205e-07
any O 0 2.435806436551502e-07
, O 0 4.06706845978988e-07
of O 0 6.847887448202528e-07
BRCA1 O 0 0.00014312073471955955
in O 0 8.420044650847558e-06
non B-Disease 0 8.987564797280356e-05
- I-Disease 1 0.8787699341773987
familial I-Disease 1 0.9766309857368469
cancers I-Disease 1 0.9914985299110413
is O 0 2.1217983885435387e-05
unclear O 0 9.841637802310288e-05
. O 0 4.3896117858821526e-05

BRCA1 O 1 0.6429468989372253
mutations O 0 0.0020102951675653458
are O 0 1.9785287804552354e-05
rare O 0 3.4237000363646075e-05
in O 0 3.5508739529177547e-05
sporadic B-Disease 0 0.063758485019207
cancers I-Disease 1 0.994766116142273
, O 0 6.461592420237139e-05
but O 0 1.2573279491334688e-05
loss O 0 8.468537271255627e-05
of O 0 2.3647205580346053e-06
BRCA1 O 0 0.002985264640301466
resulting O 0 7.99683402874507e-06
from O 0 1.8501232261769474e-06
reduced O 0 9.151047379418742e-06
expression O 0 2.501599510651431e-06
or O 0 2.164612169508473e-06
incorrect O 0 1.9221814000047743e-05
subcellular O 0 7.843750790925696e-05
localization O 0 3.483528780634515e-05
is O 0 2.376379143242957e-06
postulated O 0 6.777629096177407e-06
to O 0 1.16598687327496e-06
be O 0 8.108462452582899e-07
important O 0 5.494068773259642e-07
in O 0 2.151875605704845e-06
non B-Disease 0 3.795521115534939e-05
- I-Disease 1 0.6199005246162415
familial I-Disease 1 0.9805712103843689
breast I-Disease 1 0.999975323677063
and I-Disease 1 0.9995146989822388
ovarian I-Disease 1 1.0
cancers I-Disease 1 0.9999998807907104
. O 0 0.0013500319328159094

Epigenetic O 0 0.004487971309572458
loss O 0 0.12510576844215393
, O 0 3.99789641960524e-05
however O 0 5.963084277027519e-06
, O 0 2.7434473395260284e-06
has O 0 1.430457587048295e-06
not O 0 5.098663677927107e-07
received O 0 1.1977197118540062e-06
general O 0 6.068275411053037e-07
acceptance O 0 3.8096434309409233e-06
due O 0 3.224154852432548e-06
to O 0 8.113629519357346e-07
controversy O 0 2.028084963967558e-06
regarding O 0 1.0204894351772964e-06
the O 0 6.009619255564758e-07
subcellular O 0 1.9659441022668034e-05
localization O 0 5.843400231242413e-06
of O 0 9.557920748193283e-07
BRCA1 O 0 0.0001852230925578624
proteins O 0 4.301138233131496e-06
, O 0 1.272344547942339e-06
reports O 0 1.178465026896447e-06
of O 0 4.3995544274366694e-07
which O 0 1.1267255786151509e-06
have O 0 1.1527511105668964e-06
ranged O 0 5.416420208348427e-06
from O 0 9.202849469147623e-07
exclusively O 0 1.869806965260068e-06
nuclear O 0 2.7607022275333293e-05
, O 0 8.443070100838668e-07
to O 0 9.103261504606053e-07
conditionally O 0 1.5944799088174477e-05
nuclear O 0 1.0000941983889788e-05
, O 0 5.907652962378052e-07
to O 0 6.618730594709632e-07
the O 0 3.7728946153947618e-06
ER O 0 0.010307624004781246
/ O 0 2.6174784579779953e-05
golgi O 0 0.0006441968725994229
, O 0 2.017045972024789e-06
to O 0 1.7588847640581662e-06
cytoplasmic O 0 3.473835386103019e-05
invaginations O 0 8.71224983711727e-05
into O 0 5.7811585065792315e-06
the O 0 7.650213774468284e-06
nucleus O 0 0.0001300112489843741
. O 0 3.9092534279916435e-05

In O 0 5.803589738206938e-05
an O 0 1.1937276212847792e-05
attempt O 0 2.183574906666763e-05
to O 0 3.925846158381319e-06
resolve O 0 1.2919996152049862e-05
this O 0 1.00443855899357e-06
issue O 0 1.935448608492152e-06
, O 0 1.4383876987267286e-06
we O 0 1.2021183692922932e-06
have O 0 2.009528998314636e-06
comprehensively O 0 4.899785199086182e-05
characterized O 0 9.952761502063368e-06
19 O 0 9.977240551961586e-06
anti O 0 2.5460574761382304e-05
- O 0 0.02236669883131981
BRCA1 O 0 0.013338782824575901
antibodies O 0 0.00034266142756678164
. O 0 7.363632903434336e-05

These O 0 0.00011107889440609142
reagents O 0 0.00023888675787020475
detect O 0 0.00014570188068319112
a O 0 1.852000059443526e-05
220 O 0 3.8914444303372875e-05
- O 0 0.00015358917880803347
kD O 0 0.00010114864562638104
protein O 0 1.544348015158903e-05
localized O 0 2.076416785712354e-05
in O 0 2.121390707543469e-06
discrete O 0 6.997855507506756e-06
nuclear O 0 7.32542757759802e-05
foci O 0 3.4016804420389235e-05
in O 0 2.5841291062533855e-06
all O 0 2.1920814106124453e-06
epithelial O 0 0.00012177610915387049
cell O 0 0.0001101554007618688
lines O 0 1.7079779354389757e-05
, O 0 9.011777706291468e-07
including O 0 8.100447530523525e-07
those O 0 1.5514457345489063e-06
derived O 0 6.400564416253474e-06
from O 0 2.0659839719883166e-05
breast B-Disease 1 0.9078407883644104
malignancies I-Disease 0 0.2560349106788635
. O 0 0.00018927112978417426

Immunohistochemical O 0 0.009371251799166203
staining O 0 0.0015955893322825432
of O 0 5.248928937362507e-05
human O 0 8.588549098931253e-05
breast O 1 0.8787360787391663
specimens O 0 0.00014063667913433164
also O 0 5.108821642352268e-05
revealed O 0 0.0009932133834809065
BRCA1 O 0 0.001598972361534834
nuclear O 0 0.00021234402083791792
foci O 0 0.0003055609413422644
in O 0 0.000230540128541179
benign O 1 0.9766537547111511
breast O 1 0.9966813921928406
, O 0 0.0002457511145621538
invasive B-Disease 0 0.29512524604797363
lobular I-Disease 1 0.9999170303344727
cancers I-Disease 1 0.9777359962463379
and O 0 0.00011343300138833001
low B-Disease 0 0.11408807337284088
- I-Disease 1 0.9713232517242432
grade I-Disease 1 0.6732717156410217
ductal I-Disease 1 0.997115969657898
carcinomas I-Disease 1 0.9999958276748657
. O 0 0.0006639444036409259

Conversely O 0 0.0013184287818148732
, O 0 5.079688344267197e-05
BRCA1 O 0 0.0003917392168659717
expression O 0 1.6830388631206006e-05
was O 0 4.851171615882777e-05
reduced O 0 9.17206853046082e-06
or O 0 3.3224389426322887e-06
undetectable O 0 3.24772008752916e-05
in O 0 6.600154733860109e-07
the O 0 7.454793831129791e-07
majority O 0 1.2391853942972375e-06
of O 0 7.361130087701895e-07
high O 0 0.000436887756222859
- O 0 0.1619940847158432
grade O 0 0.0026268300134688616
, O 0 2.5112871298915707e-05
ductal B-Disease 1 0.6100417375564575
carcinomas I-Disease 1 0.9999023675918579
, O 0 1.609827631909866e-05
suggesting O 0 1.824006176320836e-05
that O 0 1.199976509269618e-06
absence O 0 4.307722520024981e-06
of O 0 2.2112237729743356e-06
BRCA1 O 0 0.16817311942577362
may O 0 6.754547212040052e-05
contribute O 0 2.111810545102344e-06
to O 0 6.236226681721746e-07
the O 0 1.2785345688826055e-06
pathogenesis O 0 1.5970823369571008e-05
of O 0 4.765439030052221e-07
a O 0 2.699891638258123e-06
significant O 0 2.5060192001546966e-06
percentage O 0 1.4516152077703737e-05
of O 0 4.278021151549183e-06
sporadic B-Disease 0 0.4071880280971527
breast I-Disease 1 0.9999630451202393
cancers I-Disease 1 0.998223602771759
. O 0 7.270144124049693e-05
. O 0 0.00011566770990611985

